<SEC-DOCUMENT>0001040130-23-000033.txt : 20230523
<SEC-HEADER>0001040130-23-000033.hdr.sgml : 20230523
<ACCEPTANCE-DATETIME>20230523084026
ACCESSION NUMBER:		0001040130-23-000033
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		71
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230523
DATE AS OF CHANGE:		20230523

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PETMED EXPRESS INC
		CENTRAL INDEX KEY:			0001040130
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				650680967
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28827
		FILM NUMBER:		23946630

	BUSINESS ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
		BUSINESS PHONE:		(561) 426-4444

	MAIL ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>pets-20230331.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:5cf93b28-3379-44eb-90e7-0c74c316f7e6,g:9a7e90f8-ce57-4497-9c85-b6b094af0e8b,d:9ecb58a0f25a461393eca5efcfd32a38--><html xmlns:pets="http://www.1800petmeds.com/20230331" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pets-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF80L2ZyYWc6MzAxNTBlNjUwYmZmNGFlYTg5NTk5MDlmNTA0OTNhNmMvdGFibGU6NWY4YjQ0N2JjZjNmNGUzMmIyOTgwNmZlOGM5MGM2MjAvdGFibGVyYW5nZTo1ZjhiNDQ3YmNmM2Y0ZTMyYjI5ODA2ZmU4YzkwYzYyMF8zLTEtMS0xLTIzNzU_c0f9976e-c1a4-4f65-8a2d-4922be50e93a">0001040130</ix:nonNumeric><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF80L2ZyYWc6MzAxNTBlNjUwYmZmNGFlYTg5NTk5MDlmNTA0OTNhNmMvdGFibGU6NWY4YjQ0N2JjZjNmNGUzMmIyOTgwNmZlOGM5MGM2MjAvdGFibGVyYW5nZTo1ZjhiNDQ3YmNmM2Y0ZTMyYjI5ODA2ZmU4YzkwYzYyMF80LTEtMS0xLTIzNzU_0c3cb554-0dc1-46e8-93e3-16a4ac108cd0">false</ix:nonNumeric><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF80L2ZyYWc6MzAxNTBlNjUwYmZmNGFlYTg5NTk5MDlmNTA0OTNhNmMvdGFibGU6NWY4YjQ0N2JjZjNmNGUzMmIyOTgwNmZlOGM5MGM2MjAvdGFibGVyYW5nZTo1ZjhiNDQ3YmNmM2Y0ZTMyYjI5ODA2ZmU4YzkwYzYyMF81LTEtMS0xLTIzNzU_499ef45a-c899-4396-8c7b-9376ebf436ee">2023</ix:nonNumeric><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF80L2ZyYWc6MzAxNTBlNjUwYmZmNGFlYTg5NTk5MDlmNTA0OTNhNmMvdGFibGU6NWY4YjQ0N2JjZjNmNGUzMmIyOTgwNmZlOGM5MGM2MjAvdGFibGVyYW5nZTo1ZjhiNDQ3YmNmM2Y0ZTMyYjI5ODA2ZmU4YzkwYzYyMF82LTEtMS0xLTIzNzU_204e2740-e03d-4447-a289-c723bdff7bb6">FY</ix:nonNumeric><ix:nonNumeric contextRef="ic064ca7b2fd745a38c86d90733a87d1c_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNTQ4Mw_bad1a77d-7eb3-4209-80fa-1d8f0ecbb508">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="if0c556c9dc3149ad958abdf08932a7ed_D20220401-20230331" name="pets:RestrictionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzkzNDU4NDg4NDU1MDU_5ab669ee-e73c-4623-8194-b9f525c9a887">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pets-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7959696f96db466e9b00f9fc4eeb82c1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i7e972f5105664cb4aee0fea2a9f74009_I20230523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-05-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i714efa7810e34b859f1f6107bd4f64a9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3416e47de26f43d58c4f271301261758_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2b4c181220f4db39c9e0becba7ebc10_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79b8b340525c4eb8a08f09d3a55ef8a2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a927b1cae4d427ca9524b822d0e3777_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6297e382c64245aba14e3a8758776fd1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77867fa115ad4229b78a690feec18c68_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i783e64f7e14c4d83b9dd294bf39fd8e0_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58e3d762d5314a6990e530bcd4c4d18d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9f02128e65f491da7c5d94342b58dc4_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd67589c03824ef980cf575bb38a75f9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c9234aa9292474bad6f7065593e5f0b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdec80ecca1749bf87b375959dbfc52b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b4c2f87185043989137055d2cf642fa_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18b907b4447547178f92755a7a787369_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i019127a3a95243a6ae3e4c850c18876f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f72edc903074ac9927be8cc9b515cf9_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i720e3acebcb8463bb9efd73321969a20_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id57c020e5fba46ae82ba2f4abefb2b4e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec836f5f293f4210978b95ba487a929f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i334440618f40456d855578e189633732_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacce33dd5fc6414cb3f16213192efa4d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdbd311dff074129bf3e72c5fa9aa7b6_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93b7f39ad4204f01a6bd5a6bc7e705f0_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdc896f1488b4f28b0e4be3ebf752847_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbfe4071fa8748809761483ffc9187bb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa78064ed1984d9f9c65b1990c55e3c4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71efad11f57045af997e37ccc67cbd53_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icef79238d6ce4776ae259ffdd5d344cc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03c0530e258a4275a1cb7f76f5abe23b_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i7c2721102f674c4aa792ac925c98947d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a150376f36844e98abbac7a0ca44c05_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i355171bb92204bbb82826b85e8bf5b37_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25eddc1271dc4574990d86ce132c99cc_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:InternetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf2f8f507c6540bfbb2862fd908a210f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:InternetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09000bea25814401814d1dc5f414ac60_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:ContactCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7e6d5eacd904a1ab0d4099df9b503b8_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:ContactCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ac40e1ea4424774953a5e7ade0e7c7f_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cf2f2c5e86445fda1c2ded520e7311d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bdcdb0588154445be242f59b58aab0c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:InternetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0f32aa6e61a47c49a1913e3aa0f4787_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:ContactCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6721acf8ca444c08943e0f7c291b888b_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb7030b6bef24f45acc0d76a3d1c20ec_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec916a6095784855b5980a214c776678_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0813952b1f39495398373f357ec689b3_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb4d6d234160419aa86c9553574519da_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic064ca7b2fd745a38c86d90733a87d1c_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pets:FurnitureFixturesEquipmentAndComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04245b0d956b455691aa8ab5e83c2f75_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pets:FurnitureFixturesEquipmentAndComputerSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32b7a8cc1d0c404abe3d6754f1eff32b_D20160101-20160131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">pets:DelrayBeachPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6809ba90db9c49ca8ac16d709434847a_I20160131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">pets:DelrayBeachPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="tenant"><xbrli:measure>pets:tenant</xbrli:measure></xbrli:unit><xbrli:context id="ieadfd9293a5a48bba384353d2ebc519c_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">pets:DelrayBeachPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fe3d97a1db0465f973b838299721edd_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">pets:DelrayBeachPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7915a8c7c6604a17bc9a1722e6e42a01_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">pets:DelrayBeachPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i880955555f9e48a3af629feacb66f2ca_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pets:SixSuppliersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if77a6bc751f7420aa5579831f599629c_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pets:SixSuppliersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3de47f4a3e584d9180f1d51a89d74e32_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f4bce0e12164f66a7a0fbf509e0433d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1866466e5d2446d92c17b6f5b54ae88_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f77d055886f40e0890b240ffc4c5900_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f90b592a09143caa1086b6421f0c29f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b5b4824cd0443c996bd2417b7318871_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e83a64a31d84e95a0d0bb5607943684_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0086d69f42d465fbe2be778fd3669ae_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8009934e1ce1437faf934a21e11f53fa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3cce94c3217479d9c47e9c7a9569964_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d41bb6533e64a78b0c413d60ab6d296_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id29065364981439b8297fe9c2b387741_I19980430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>1998-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71c12e540590434c98c58ec2c09fb08c_D19980401-19980430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>1998-04-01</xbrli:startDate><xbrli:endDate>1998-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11c1a95cfc3b42c8b1207c680949ce01_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd52e04a4fe84d1c97fb1a7b1eb50021_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0d6d76e24604cb9a18256bc00a989e9_I20220509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-05-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae9efd376d404db3a83df403c4b1f447_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i997f8d9c4d5c47d4a9bbe74962ed4629_I20221107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-11-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i113e079495ae443ea4acdecad992dd93_I20230206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fa97c770ada498d940f7db2777193c8_I20150731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3711637129e84cf495f85a1e1f12d159_D20150701-20150731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-07-01</xbrli:startDate><xbrli:endDate>2015-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibec5936930e84c289028e660f01b73b1_I20160731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2f86689eec24b90a4591646dcc402a8_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida16bfdaf8b04ccd9cabdceb30574a33_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35389028e9874b27a83eed9c5fc398cb_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia83cc28d498c4c9fafb92ce48449955b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c496648613e49b6bd05ae478b147763_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53ec65434cab4c1eb2a83616f99420e5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0c556c9dc3149ad958abdf08932a7ed_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b2659243cd348e8b9a71f890d8f3847_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9e138b657114015a8d3f172c1e19f7e_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac19f43c73124a22b4617cf091f81d03_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7745f099643450b9ec65034832f389e_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f3fed9704204153a8fa0b54b227b2e1_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6933ff7bd564ae78075d75944fc25ee_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0074779789d04c76ba59318f55ccc983_D20230203-20230203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-03</xbrli:startDate><xbrli:endDate>2023-02-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7487aada4c7e48a9a152a316a2197596_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9d97a210a094cbb962f8e5009bfda1a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:DirectorPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief448de592ce4068b2e177f1aeea6dd8_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia93b8106781d4da387b3b15296d47a35_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:DirectorPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77c3d270a0834d03b39b41eb3e174586_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad7317540db946209e8de1718fbdb1da_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:DirectorPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie95c7dd15e734cdb96435d11a9f08ac5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorEquityCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:NonvestedRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96546148fd614f969f6f32c7d9c77fc6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorEquityCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:NonvestedRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i890f993d4c6947ce85fae3592689d54b_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorEquityCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:NonvestedRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iada85d4fb9a84a7ab431b36c77c5b07d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorEquityCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:NonvestedRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c2de17c1b084f35b8463988b326e824_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">pets:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1f7c6a0ee004443b3a68de9782c1f9c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6267e0b588824a56aa5efdad685990fc_D20210731-20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d21b0cfcbc8452ea6025a3a67ef8073_I20210611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="payment"><xbrli:measure>pets:payment</xbrli:measure></xbrli:unit><xbrli:context id="i4891cfdf6fc44c6aa3c0da9831b5308f_D20211231-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2432cc60a7f84868839476ea9782eeae_D20210810-20210810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-10</xbrli:startDate><xbrli:endDate>2021-08-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2edb519042c6474b9a2fd6eca193f849_D20210731-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-30</xbrli:startDate><xbrli:endDate>2021-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i315520404bf24ebea1c2cb0c8e23b089_D20210830-20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-30</xbrli:startDate><xbrli:endDate>2021-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63b1d72605c8405d8b027717916a080b_D20210830-20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-30</xbrli:startDate><xbrli:endDate>2021-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7afc070e4bdf46fc9f7d226e6741e1c6_D20210830-20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-30</xbrli:startDate><xbrli:endDate>2021-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1384889b25bd4d7185122232ce1451e8_I20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cbb8d45015a45ea84ddf37d27c11a68_D20210830-20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-30</xbrli:startDate><xbrli:endDate>2021-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6808984e22ee45d58ea010775c3f55d4_I20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1dce613dc084e329c47918a37fe1c39_D20210830-20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-30</xbrli:startDate><xbrli:endDate>2021-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5e6ea897b514a6f9570f9ac37ce2bb2_I20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i449b1d02eb98411ca0c78fbbde6ac2f1_D20210830-20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-30</xbrli:startDate><xbrli:endDate>2021-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i844106ae017246048418122f69f34ad0_I20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i068c52c343b44cc193b5a62f93d38549_D20210830-20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-30</xbrli:startDate><xbrli:endDate>2021-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic863aef22f2d409193398f92e79e7c7f_I20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id26b0819bb5b4b09bda518b2201d5648_D20220803-20220803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-03</xbrli:startDate><xbrli:endDate>2022-08-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0add0f1e60f4b04ae873731c0197067_D20220802-20220802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-02</xbrli:startDate><xbrli:endDate>2022-08-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff7afa81075f467a8ee51d67a09ed71b_D20220803-20220803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-03</xbrli:startDate><xbrli:endDate>2022-08-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd16eafa395744a48017a3ee602c42e8_D20220803-20220803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-03</xbrli:startDate><xbrli:endDate>2022-08-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25dd78455488483794c262cbc7525f11_I20220802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc34f00e393f4f85af3ba71ed34d459b_D20230113-20230113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-13</xbrli:startDate><xbrli:endDate>2023-01-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0a27942ed9c40ff9ddc967a8de7b5f6_D20221231-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide541b5ccbaf4aae8f5059586a8aac5b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d8f4dc33edd40a281b970a2cbdbe0c5_D20220419-20220419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pets:PartnershipAgreementWithVetsterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-19</xbrli:startDate><xbrli:endDate>2022-04-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib12c1e8fbbbd41d29aae9c4166df1e67_I20220419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pets:PartnershipAgreementWithVetsterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fd3857af0904bd9905af80251e8beaf_D20230113-20230113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pets:PetCareRxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-13</xbrli:startDate><xbrli:endDate>2023-01-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81d9acb2bf774cea93998dcf45c5f344_D20230401-20230523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pets:PetCareRxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-05-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52baab8375b34634bc096512ff056e08_D20230401-20230523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-05-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3432de5afd244aea63998346817ce66_D20230401-20230523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-05-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21b9d44505884d13926569569baba59c_D20230401-20230523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-05-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cc0c13fe26b4d4896753ec70f10be17_I20230522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4469b631590844adbaaf420a00aa612e_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pets:ProphetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb424c34659d462d8120e942e5596384_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pets:ProphetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97c463b50b984fe9b48aa37d4d2bd8a2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pets:ProphetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzM2_0a58d2f3-5e5d-4cc9-903c-9ac18b6b7c03">10-K</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzI4_3162c1e2-9f2f-4210-bbc8-8aef91acd113">x</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8xMDk5NTExNjMyNjQz_74b99867-4384-47ca-9f9a-d42a7c08b7a1"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8xMDk5NTExNjMyNjQz_e9f7da1d-3418-4640-ae19-242c71b72fe5">March 31</ix:nonNumeric>, 2023</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzI0_c1a340b9-3f6f-49a0-b4e4-5fc4e878cb1f">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from __________ to __________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzMw_01f75d42-8313-43df-a48d-53f87bc73d2e">000-28827</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_____________________________________________________________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV82NTk3MDY5NzcxNDYx_969ef4ea-f8f0-4876-afd5-83110f73318a">PETMED EXPRESS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8wLTAtMS0xLTIzNzU_cd85869f-fa80-4e19-9a17-e804170c56a7">Florida</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8wLTItMS0xLTIzNzU_d572a750-d18b-43e6-bc7a-b8f9b0030bed">65-0680967</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(State or other jurisdiction of <br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(IRS Employer<br/>Identification No.)</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8zLTAtMS0xLTIzNzUvdGV4dHJlZ2lvbjo2YTU2MTY4MTQ2MTk0ODA0YWIxOTBiYTBhNTkwZDM4Yl80_465bd8b1-5363-4488-9834-6357bc97bc54">420 South Congress Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8zLTAtMS0xLTIzNzUvdGV4dHJlZ2lvbjo2YTU2MTY4MTQ2MTk0ODA0YWIxOTBiYTBhNTkwZDM4Yl84_fcf03a24-4a19-46ea-8672-42afd4f4abc3">Delray Beach</ix:nonNumeric>, <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8zLTAtMS0xLTIzNzUvdGV4dHJlZ2lvbjo2YTU2MTY4MTQ2MTk0ODA0YWIxOTBiYTBhNTkwZDM4Yl8xMg_a84e7cd1-5bc7-46db-ac55-4ab77e8cce69">Florida</ix:nonNumeric> <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8zLTAtMS0xLTIzNzUvdGV4dHJlZ2lvbjo2YTU2MTY4MTQ2MTk0ODA0YWIxOTBiYTBhNTkwZDM4Yl8xNQ_6c0f283a-c62d-4858-b1b7-cba4382b41d3">33445</ix:nonNumeric></span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Address of principal executive offices) (Zip Code)</span></td></tr><tr style="height:8pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Registrant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">s telephone number, including area code: (<ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF82LTAtMS0xLTIzNzUvdGV4dHJlZ2lvbjpjYTk2OWZlOWQ4M2E0NDdlYTJhNDY1MzJjMTgyY2I4ZV81Nw_c9384ae9-170f-41ea-860e-874fdd8d0bac">561</ix:nonNumeric>) <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF82LTAtMS0xLTIzNzUvdGV4dHJlZ2lvbjpjYTk2OWZlOWQ4M2E0NDdlYTJhNDY1MzJjMTgyY2I4ZV82MQ_4688c264-4bae-46a6-85d5-ff5eaf4069d5">526-4444</ix:nonNumeric></span></div></td></tr><tr style="height:8pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr style="height:8pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8xMi0wLTEtMS0yMzc1L3RleHRyZWdpb246NmZhM2QzZmFjNmRmNDJkNzhjMDUyZTA1NGYxYmE3ZjBfNA_7e841f8c-bd47-4174-b5a6-f911961ccd28">Common Stock, PETS <br/>$.001 Par value per share</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8xMi0xLTEtMS0yMzc1_d198a5e8-c9ab-4125-9966-8e2ce59074a2">PETS</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8xMi0yLTEtMS0yMzc1L3RleHRyZWdpb246ZWYxNmJlMzYzMzQyNDdmZjg2YjFjY2Q2MDk0Y2FhOGVfOA_41593fc2-573b-4d20-b336-4bb14aa7e84e">NASDAQ</ix:nonNumeric> Stock Market LLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(NASDAQ Global Select Market)</span></div></td></tr><tr style="height:8pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Securities registered under Section 12(g) of the Act:</span></td></tr><tr style="height:8pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">NONE</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_____________________________________________________________________</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzMx_5b9c17bd-118e-4c67-be26-4b4a3162e1ae">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzI2_faea22a2-1ee9-47db-ac84-56012e293eb2">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzMy_3b992ed8-c8ab-4d53-8671-e944ccac94cb">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzMz_ea59d16e-868c-474d-a4b6-39974e8acce1">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.267%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:114%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NDdkN2FhNDJhMTk0NGQ4Yzk4NDcxM2QwMGRmYTIzZDcvdGFibGVyYW5nZTo0N2Q3YWE0MmExOTQ0ZDhjOTg0NzEzZDAwZGZhMjNkN18wLTQtMS0xLTIzNzU_b322a986-8856-444a-8129-edef1898f007">Accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:114%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Smaller reporting company </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NDdkN2FhNDJhMTk0NGQ4Yzk4NDcxM2QwMGRmYTIzZDcvdGFibGVyYW5nZTo0N2Q3YWE0MmExOTQ0ZDhjOTg0NzEzZDAwZGZhMjNkN18xLTUtMS0xLTIzNzU_04984b96-e407-4697-8aae-d03dda51f9be">o</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NDdkN2FhNDJhMTk0NGQ4Yzk4NDcxM2QwMGRmYTIzZDcvdGFibGVyYW5nZTo0N2Q3YWE0MmExOTQ0ZDhjOTg0NzEzZDAwZGZhMjNkN18yLTUtMS0xLTIzNzU_176a82bb-432f-4009-8cbd-4a1922906e3a">o</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzM0_8cbd792e-1872-4a5b-9f6f-c2893b7708fc">x</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzI3_aec5231c-7834-4e2c-a169-4182aec9025b">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the registrant&#8217;s Common Stock held by non-affiliates of the registrant as of September 30, 2022, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, was $<ix:nonFraction unitRef="usd" contextRef="i7959696f96db466e9b00f9fc4eeb82c1_I20220930" decimals="-5" name="dei:EntityPublicFloat" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8xMDk5NTExNjMxNzk2_5327fdf5-8a41-42cc-b04f-b7457f459b2d">396.4</ix:nonFraction> million based on the closing sales price of the registrant&#8217;s Common Stock on that date, as reported on the NASDAQ Global Select Market.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s Common Stock outstanding as of May&#160;23, 2023, was <ix:nonFraction unitRef="shares" contextRef="i7e972f5105664cb4aee0fea2a9f74009_I20230523" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8xMDk5NTExNjMxMTQy_ddd46181-49b3-4b12-90d9-f71533996921">21,170,977</ix:nonFraction>.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV82NTk3MDY5NzcxNDU5_bbd6fa68-77cc-481b-bb1d-f31e121fd7bc" escape="true">Information to be set forth in our Proxy Statement relating to our 2023 Annual Meeting of Shareholders to be held on August&#160;3, 2023, is incorporated by reference in Items 10, 11, 12, 13, and 14 of Part III of this report.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">PETMED EXPRESS, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2023 Annual Report on Form 10-K </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.687%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_10">PART I</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_10">1</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_13">Item 1.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_13">Business</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_13">1</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_16">Item 1A.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_16">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_16">8</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_19">Item 1B.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_19">20</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_22">Item 2</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_22">Properties</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_22">20</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_25">Item 3.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_25">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_25">20</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_28">Item 4.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_28">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_28">20</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_31">PART II</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_31">21</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_34">Item 5.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_34">Market for Registrant's Common Equity, Related S</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_34">hare</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_34">holder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_34">21</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_37">Item 6.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_37">[Reserved]</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_37">23</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_40">Item 7.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_40">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_40">24</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_67">Item 7A.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_67">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_67">35</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_70">Item 8.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_70">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_70">37</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_142">Item 9.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_142">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_142">62</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_145">Item 9A.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_145">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_145">62</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_148">Item 9B.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_148">Other Information</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_148">63</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_151">Item 9C.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_151">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_151">63</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_154">PART III</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_154">64</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_157">Item 10.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_157">Directors, Executive Officers, and Corporate Governance</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_157">64</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_160">Item 11.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_160">Executive Compensation</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_160">64</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_163">Item 12.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_163">Security Ownership of Certain Beneficial Owners and Management and Related S</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_163">hare</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_163">holder Matters</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_163">64</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_166">Item 13.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_166">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_166">64</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_169">Item 14.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_169">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_169">64</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_172">PART IV</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_172">65</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_175">Item 15.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_175">Exhibit and Financial Statement Schedules</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_175">65</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_178">Item 16.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_178">Form 10-K Summary</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_178">67</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_181">SIGNATURES</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_181">68</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information in this Annual Report on Form 10-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (&#8220;Securities Act&#8221;) and Section 21E of the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;). You can identify these forward-looking statements by the words "believes," "intends," "expects," "may," "will," "should," "plan," "projects," "contemplates," "intends," "budgets," "predicts," "estimates," "anticipates," or similar expressions. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties, and assumptions. Actual future results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in Part I, Item 1A of this Annual Report on Form 10-K under the heading &#8220;Risk Factors.&#8221; A reader, whether investing in our common stock or not, should not place undue reliance on these forward-looking statements, which apply only as of the date of the filing of this Annual Report on Form 10-K. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE REGARDING COMPANY REFERENCES</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">When used in this Annual Report on Form 10-K, unless otherwise stated or the context otherwise indicates, "PetMed Express,"  &#8220;PetMeds,&#8221; "PetMed," "the Company," "we," "our," and "us" refers collectively to PetMed Express, Inc. and its direct and indirect wholly owned subsidiaries, taken as a whole.</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_13"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. BUSINESS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PetMed Express, Inc. and subsidiaries, d/b/a PetMeds&#174;, is a leading nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses. PetMeds markets and sells directly to consumers through its websites, toll-free numbers, and mobile applications. The Company offers consumers an attractive alternative for obtaining pet medications, foods, and supplies in terms of convenience, price, speed of delivery, and valued customer service.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Founded in 1996, the Company's executive headquarters offices are currently located at 420 South Congress Avenue, Delray Beach, Florida 33445, and our telephone number is (561) 526-4444. The Company has a March 31 fiscal year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for pet medicines, foods, and health products and services is a large and growing market.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the American Pet Products Association, pet spending in the United States increased 11% to $136.8 billion in 2022. Veterinary care and Rx medications represented $35.9 billion, or 26% of the total spending on pets in the United States. The pet medication market, which includes prescription medication, nonprescription medication and insurance, is estimated to be approximately $13 billion, with veterinarians having the majority of the prescription market share. The dog and cat population is approximately 111.6 million, with approximately 66% of all households having a pet.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Products and Services</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer a broad selection of products and services for dogs, cats, and horses. Our current product line contains approximately 15,000 SKUs of the most popular pet medications, health products, foods, and supplies. These products include a majority of the well-known brands of pet medications, and with our April 2023 acquisition of PetCareRx, will now include a broader product catalog assortment beyond medication. Generally, our prices for pet medications and foods are competitive with the prices for medications and foods charged by veterinarians, online retailers and other retailers. We also offer additional pet supplies on our website for sale, some of which are drop shipped to our customers by third parties. These pet supplies include: beds, crates, stairs, and other popular pet supplies. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We research new products, and regularly select new products or the latest generation of existing products to become part of our product selection. In addition, we also refine our current products to respond to changing consumer-purchasing habits. Our website is designed to give us the flexibility to change featured products or promotions. Our product line </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provides customers with a wide variety of selections across the most popular health categories for dogs, cats, and horses. Our current products include:</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Prescription Medications (OTC) and supplies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prescription Medications (Rx)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. </span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pet Foods:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium Pet Foods, including Veterinary Prescription Diets</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Products and Services:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pet Services, including Telemedicine and Pet Insurance. Pet Telemedicine: Services provided through our VetLive (powered by Vetster) service which allows for consultation with, diagnosis from, or even in some states a prescription written by, a board-certified veterinarian.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments and Strategic Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of PetCareRx</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2023, we completed our acquisition of PetCareRx, Inc. (&#8220;PetCareRx&#8221;), a leading online supplier of pet medications, foods, and supplies, for aggregate consideration of approximately $36.0 million in an all-cash transaction.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition was completed pursuant to an Agreement and Plan of Merger, dated January&#160;17, 2023, pursuant to which a wholly owned subsidiary of PETS was merged with and into PetCareRx.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the acquisition of PetCareRx, we gained an approximately 10,000-item catalog and PetCare Rx brings approximately 286,000 customers, enabling PETS to more rapidly expand beyond our Company&#8217;s historical core offering of pet prescriptions and into more extensive offerings of premium food, supplements, treats, and other pet supplies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PetCareRx will continue to operate under the PetCareRx brand as a separate and additional distribution channel for our company.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pet Insurance Partnership with Pumpkin Insurance Services</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, we announced a strategic partnership with Pumpkin Insurance Services, Inc. (&#8220;Pumpkin&#8221;), a leading provider of best-in-class pet insurance plans (&#8220;Pumpkin&#8221;), under which we are partnering with Pumpkin to offer our customers access to  high-quality health and wellness pet insurance products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This partnership will give our customers direct access to co-branded insurance products developed in conjunction with Pumpkin and their underwriters that will be offered by our new subsidiary, PetMeds Insurance Services, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently expect that such products will become available for purchase during the fiscal year ending March 31, 2024.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pet Telemedicine Partnership with Vetster Inc.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In April 2022, we announced a multi-year exclusive partnership with Vetster Inc., a veterinary telehealth company based in Canada that provides online access to veterinary services through its platform to pet owners in the United States, Canada, and the United Kingdom.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the partnership, we became the exclusive e-commerce provider of pet products sold on the Vetster platform in the United States, and Vetster became the exclusive provider of telehealth and telemedicine services to the Company.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a result of this partnership, our customers now have access through our website to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">VetLive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, an online veterinary appointment service that is integrated with the Vetster platform.  The partnership has an initial term of three years, subject to year-to-year mutual renewals thereafter.  As a part of our partnership with Vetster, the Company also made an approximately $5.0 million investment in Vetster as a part of larger Series B financing round that Vetster completed in April 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Growth Strategy</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key components of our growth strategy are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9679;     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leverage our brand</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  We believe that our primary brands, namely &#8220;1-800-PetMeds&#8221;, &#8220;PetMeds,&#8221; and "PetCare Rx" are widely known among pet owners and are synonymous with pet health and well-being.  We intend to further invest in promoting and popularizing these brands through our marketing, promotion, and other efforts.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9679;     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Continue to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> e</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">xpand our product and service offerings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Although our sales have historically been concentrated in pet medications, we have begun taking steps to broaden our product offerings, including the acquisition of a catalog portfolio of premium pet foods that we acquired with our acquisition of PetCareRx.  We intend to continue to grow the catalog of products that we offer to our customers, including additional premium food and pet wellness products that our customers want, and we are investigating an expansion of our own private label products.  Such offerings may include ancillary and/or complementary products or services, such as the telehealth services that we offer through Vetster and the pet health insurance products that we intend to offer in conjunction with Pumpkin.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9679;       </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Continue to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">grow our customer base and grow sales from existing customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  We intend to further invest in growing our customer base through our traditional marketing efforts, as well as through strategic transactions and partnerships and the exploration of other channels.  Furthermore, we intend to grow our share of our existing customers&#8217; spend by continuing to expand our product offerings.  We intend to continue to build and enhance the content library on our websites and apps regarding pet health and wellness in order to attract customers and give customers a reason to return.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#9679;      </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Continue to pursue strategic partnerships and transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  We intend to continue to pursue strategic partnerships and transactions that will grow sales from existing customers and expand our customer base, as well as grow our product catalog and offerings.  Such partnerships or transactions may take the form of acquisitions (similar to our recent PetCareRx acquisition), or they may take the form of partnerships (such as our Pumpkin and Vetster partnerships) that involve making complementary valuable services available to our customers.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Sales Channels</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer our products through two main sales channels: (1) the Internet, through our website and mobile apps, and (2) our Customer Support Center through our toll-free number. We have designed our website and mobile application to provide a convenient, cost-effective, and informative shopping experience that encourages consumers to purchase products important for a pet&#8217;s health and quality of life. We believe that these channels allow us to increase the visibility of our brand name and provide our customers with increased shopping flexibility and excellent service.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internet</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to combine our product selection and pet health information with the shopping ease of the Internet to deliver a convenient and personalized shopping experience. Our website offers health and nutritional product selections for dogs, cats, and horses, and relevant editorial and easily obtainable or retrievable resource information. Customers can search our website for products and access resources on a variety of information on dogs, cats, and horses. Customers can shop at our website by category, product line, individual product, or symptom. We attracted approximately 28&#160;million visits to our website (including our mobile app) during fiscal 2023, approximately 8% of those visits resulted in an order, and our website generated approximately 86.4% of our total sales for the same time period. Through our website, pet owners have access to health information covering pets&#8217; behavior and illnesses, and natural and pharmaceutical remedies specifically for a pet&#8217;s problem. The pet education content on our main website is periodically updated with the latest research for pet owners. As part of our multichannel strategy, we also offer mobile versions of our website (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.petmeds.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and an application for mobile phones, tablets, and other devices. Our website and mobile application features include: AutoShip subscription (&#8220;AutoShip&#8221;); &#8220;ask-the-vet&#8221;; VetLive; live web chat; easy refill medication reminders; local veterinarian finder; and express checkout to provide our customers with fast, easy, and helpful service from their mobile devices.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021 we launched the new AutoShip program on our website. AutoShip is a new convenient way for our loyal customer base to have future pet medication orders delivered directly to them without the need to place an order each time. Approximately 44% of our sales were generated via our AutoShip program in our fourth quarter ended March&#160;31, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Support Center</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customer care representatives receive and process inbound and outbound customer calls, facilitate our live web chat, and process customer e-mails. Our telephone system is equipped with certain features including pop-up screens and call blending capabilities that give us the ability to efficiently utilize our customer care representatives&#8217; time, providing excellent customer care, service, and support. Our customer care representatives receive base pay and are rewarded with commissions for sales, and bonuses and other awards for achieving certain quality goals.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Customers</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Approximately 2.2&#160;million customers have purchased from us within the last two fiscal years, excluding customers acquired in April 2023 as a part of our PetCareRx acquisition. We attracted approximately 274,000 and 325,000 new customers in fiscal 2023 and 2022, respectively. Our customers are located throughout the United States, with approximately 50% of customers residing in California, Florida, Texas, New York, Pennsylvania, North Carolina, Georgia, and Virginia. Our primary focus has been on retail customers and the average purchase remained approximately $93 for both fiscal 2023 and fiscal 2022, respectively.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of the date of the filing of this Annual Report on Form 10-K, PetCareRx had approximately 286,000 customers who have purchased from them within the last two fiscal years.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketing</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goal of our marketing strategy is to build brand recognition, increase customer traffic, add new customers, build strong customer loyalty, maximize reorders, and develop incremental revenue opportunities. We have an integrated marketing campaign that includes digital marketing, television advertising, and direct mail/print and e-mail.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Digital Marketing</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We advertise and market our products primarily online. We make our brand available to Internet consumers by purchasing targeted keywords and achieving prominent placement on the top search engines and search engine networks. We utilize Internet display and streaming video advertisements, social media, and comparison shopping, and we are also members of an affiliate program with merchant clients and affiliate websites.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Television Advertising</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our television advertising is designed to build brand equity, create brand awareness, and generate initial purchases of products via the telephone and the Internet. Our television commercials, using engaging imagery and dialogue, typically focus on our expertise as a 26 year-old pet pharmacy, the convenience and ease of purchasing medication offered by veterinarians, and our empathetic service level.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Direct Mail/Print and E-mail</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use direct mail/print and e-mail to engage our current customers with reminders, offers and useful content to help them manage improved pet health outcomes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Order Processing</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our websites allow customers to easily browse and purchase all of our products online. Our websites are designed to be fast, secure, and easy to use with order and shipping confirmations, and with online order tracking capabilities. We provide our customers with toll-free telephone access to our customer care representatives. Our Customer Support Center  generally operates from 7:00 AM to 11:00 PM, Monday through Thursday, 7:00 AM to 9:00 PM on Friday, 9:00 AM to 6:00 PM on Saturday, and 9:00 AM to 5:00 PM on Sunday, Eastern Time. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of customers purchasing products from PetMeds consists of a few simple steps. A customer first places an order online or by calling our toll-free telephone number. The following information is needed to process prescription orders: pet information, prescription information, and the veterinarian&#8217;s name and phone number. This information is entered into our order processing system. Then our pharmacists and pharmacy technicians verify all prescriptions. The order processing system checks for the verification for prescription medication orders and a valid payment method for all orders. Verified orders are then sent to our fulfillment centers, where items are picked, and then shipped via the United States Postal Service, United Parcel Service, and Federal Express.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Care and Support</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that a high level of customer care and support is critical in retaining and expanding our customer base. Customer care representatives participate in ongoing training programs under the supervision of our training managers. These training sessions include a variety of topics such as product knowledge, computer usage, customer service tips, and the relationship between our Company and veterinarians. Our customer care representatives respond to customers&#8217; e-mails, calls, and live web chats that are related to products, order status, prices, and shipping. We believe our customer care representatives are a valuable source of feedback regarding customer satisfaction.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warehousing and Shipping</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We inventory our products and fill most customer orders from our corporate headquarters in Delray Beach, Florida. With our acquisition of PetCareRx, we will continue to fulfill PetCareRx orders from their facility in Lynbrook, New York. We have an in-house fulfillment and distribution operation, which is used to manage the entire supply chain, beginning with the placement of the order, continuing through order processing, and then fulfilling and shipping of the product to the customer. We offer a variety of shipping options, including next day delivery. We ship to anywhere in the United States served by the United States Postal Service or United Parcel Service. Priority orders are expedited in our fulfillment process. Our goal is to ship the products the same day that the order is received. For prescription medications, our goal is to ship the product immediately after the prescription has been authorized by the customer&#8217;s veterinarian. We currently offer free shipping to all customers whose order value is $49 or more.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchasing and Supply of Products</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We purchase our products from a variety of sources, including certain manufacturers, domestic distributors, and wholesalers. There were six suppliers from whom we purchased approximately 68.5% of all products in fiscal 2023. We believe that having strong relationships with product manufacturers and distributors will ensure the availability of an adequate volume of products ordered by our customers. Part of our growth strategy included developing direct relationships with all of the leading pharmaceutical manufacturers of the more popular prescription and non-prescription medications. We now have direct relationships with all these major manufacturers. With our acquisition of PetCareRx, we will acquire relationships with approximately thirteen new significant suppliers of pet foods and health and wellness products.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Technology</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize integrated technologies in our call centers, e-commerce, order entry, and inventory control/fulfillment operations. Our systems are custom configured to optimize our computer telephone integration and mail-order processing. The systems are designed to maintain a large database of specialized information and process a large volume of orders efficiently and effectively. Our systems provide our team and our customers with product availability information and updated customer and order status information to enhance our customer experience. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our information systems provide our customers and customer care representatives with information about past and pending orders. Customers are able to review and modify the terms of their automatic product shipments online, or via contacting our Customer Support Center.  We have separated and integrated our front and back-end systems to best handle the uptime and information processing requirements needed for our customer facing and order processing needs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented network access, systems, policies, and procedures to allow for a remote and hybrid work environment, utilizing a combination of on-premise, cloud, and SaaS products.  We are able to leverage industry standard processes to monitor, manage, and respond to customer, user, and system related issues.  We continue to expand our SaaS and cloud based tool sets to reduce reliance on legacy systems and increase accessibility and resiliency. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pet medications and food market is highly competitive and highly fragmented. Our competitors consist of veterinarians, and online and traditional retailers. We believe that the following are the principal competitive factors in our market:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product selection and availability, including the availability of prescription and non-prescription medications;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Brand recognition;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reliability and speed of delivery;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Personalized service and convenience;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Price; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Website and mobile application usability and content.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete with veterinarians, and online and traditional retailers for the sale of prescription and non-prescription pet medications, foods, and other health products. Many pet owners may prefer the convenience of purchasing their pet medications or other health products at the time of a veterinarian visit. In order to effectively compete with veterinarians, we must continue to educate pet owners about the service, convenience, and savings offered by our Company.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the following are the main competitive strengths that differentiate PetMeds from our competitors:</span></div><div style="margin-top:1pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="margin-top:1pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pure play channel leader, in an estimated $13.0 billion industry;</span></div><div style="margin-top:1pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Expanded catalog of non prescription products from the PetCareRx acquisition</span></div><div style="margin-top:1pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;1-800-PetMeds&#8221; brand name with 26 years of experience; consumers know us as the trusted pet medication experts;</span></div><div style="margin-top:1pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Licensed/registered/permitted pharmacy to conduct business in 50 states (and the U.S. Virgin Islands), and a Pharmacy Verified website (a website verification program by the National Association of Boards of Pharmacy&#174;, which identifies online pharmacies and pharmacy-related websites as safe and legitimate); and</span></div><div style="margin-top:1pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Exceptional customer care and support.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct our business under the trade name &#8220;PetMeds&#8221; and use a family of trade names all containing the term &#8220;PetMeds&#8221; or &#8220;PetMed&#8221; in some form. We believe the &#8220;1-800-PetMeds&#8221; trade name, which is also our toll-free telephone number, and the &#8220;PetMeds&#8221; family of trademarks, have added significant value and are important factors in the marketing of our products. We have also obtained the right to use and control the Internet addresses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.1800petmeds.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.1888petmeds.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.petmedexpress.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.petmed.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.petmeds.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We also obtained the right to use and control the Internet addresses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">www.petmeds.pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">www.petmed.pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">www.1800petmeds.pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">through a National Association of Boards of Pharmacy&#174; initiative to ensure high standards for online pharmacies. We do not expect to lose the ability to use the Internet addresses; however, there can be no assurance in this regard and the loss of these addresses may have a material adverse effect on our financial position and results of operations. We are the exclusive owners of United States Trademark Registrations for &#8220;America&#8217;s Largest Pet Pharmacy&#174;,&#8221; &#8220;America&#8217;s Most Trusted Pet Pharmacy&#174;,&#8221; &#8220;Trusted Pet Medication Experts&#174;,&#8221; &#8220;PetMed Express, Inc.&#174;,&#8221;1-800-PetMeds and Design&#174;,&#8221; 1-800-PetMeds&#174;,&#8221; and &#8220;PetMeds&#174;,&#8221; among numerous others. We have also applied for trademark protection for &#8220;Your Trusted Pet Health Expert</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.&#8221;</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a part of our acquisition of PetCareRx, we have also acquired the PetCareRx&#174; trademark and www.petcarerx.com</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">domain name.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a broad range of federal, state, and local laws and regulations that relate to our business. Dispensing prescription medications is governed at the state level by Boards of Pharmacy, or similar regulatory agencies, of each state where prescription medications are dispensed. We are subject to regulation by the State of Florida and are licensed as a community pharmacy by the Florida Board of Pharmacy. Our current license is valid until February&#160;28, 2025, and well in advance of that date a renewal application will be submitted to the Board of Pharmacy.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our pharmacy practice is also licensed and/or regulated by 49 other state pharmacy boards, the District of Columbia Board of Pharmacy, the U.S. Virgin Islands Board of Pharmacy, and the United States Drug Enforcement Administration ("DEA"), and with respect to our products, by other regulatory authorities including, but not necessarily limited to, the United States Food and Drug Administration (&#8220;FDA&#8221;) and the United States Environmental Protection Agency ("EPA"). </span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ur registration with the DEA, and state registrations/permits as required, permit us to dispense Schedule IV and Schedule V controlled substances. As a licensed pharmacy in the State of Florida, we are subject to the Florida Pharmacy Act and regulations promulgated thereunder. To the extent that we are unable to maintain our license as a community pharmacy with the Florida Board of Pharmacy, or if we do not maintain the licenses/registrations/permits granted by other state pharmacy boards (including the home state pharmacy license in New York for PetCareRx), or if we become subject to actions by the DEA, FDA EPA, or other enforcement regulators, our distribution of prescription medications to pet owners could cease, which could have a material adverse effect on our financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the foregoing, the FDA regulates animal feed, including pet food, under the Federal Food, Drug, and Cosmetic Act (the &#8220;FFDCA&#8221;) and its implementing regulations. Although pet foods are not required to obtain premarket approval from the FDA, the FFDCA requires that all animal foods are safe for consumption, produced under sanitary conditions, contain no harmful substances, and are truthfully labeled. Most states also require that pet foods distributed in the state be registered or licensed with the appropriate state regulatory agency. In addition, most facilities that manufacture, process, pack, or hold foods, including pet foods, must register with the FDA and renew their registration every two years, and are subject to periodic FDA inspection. This includes most foreign, as well as domestic facilities. Registration must occur before the facility begins its pet food manufacturing, processing, packing, or holding operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The labeling of pet foods is regulated by both the FDA and some state regulatory authorities. FDA regulations require proper identification of the product, a net quantity statement, a statement of the name and place of business of the manufacturer or distributor, and proper  listing of all the ingredients in order of predominance by weight. Most states also enforce their own labeling regulations. The degree of oversight of the implementation of these regulations varies by state, but typically includes a state review and approval of each product label as a condition of sale in that state.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The FDA also regulates the inclusion of specific claims in pet food labeling. For example, pet food products that are labeled or marketed with claims that may suggest that they are intended to treat or prevent disease in pets would potentially meet the statutory definitions of both a food and a drug.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our planned distribution of pet insurance products under our strategic partnership with Pumpkin will also subject us to state laws and regulations relating to the sale of insurance products, including registering as an insurance distributor in states in which we offer and sell the Pumpkin co-branded pet insurance products and otherwise complying with state and federal laws relating to the sale and distribution of insurance products.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We rely on legal and operational compliance programs, as well as outside counsel, to guide our business in complying with applicable laws and regulations in the areas in which we do business. In addition, regulatory regime changes may add cost and complexity to our compliance efforts. It is difficult to predict with certainty the potential impact of future regulatory compliance efforts and future costs associated with such matters. Our failure to comply with such laws and regulations may result in adverse actions that could disrupt our operations and adversely affect our financial results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Resources</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">People are the most valuable asset we have. The collective sum of the individual differences, life experiences, knowledge, inventiveness, innovation, self-expression, unique capabilities and talent that our employees invest in their work represents a significant part of not only our culture, but our reputation and the Company&#8217;s achievement as well. We strive to create an inclusive culture that embraces and encourages diversity.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our employees&#8217; differences in age, color, disability, ethnicity, family or marital status, gender identity or expression, language, national origin, physical and mental ability, political affiliation, race, religion, sexual orientation, socio-economic status, veteran status, and other characteristics that make our employees unique. We strive to ensure that all employees have opportunities to develop the skills they need to grow and excel in their fields. Human capital management is a priority for our executives and Board of Directors, and we are committed to identifying and developing the talent necessary for our long-term success. We have a talent and succession planning process and have established programs to support the development of our talent pipeline for critical roles in our organization. We conduct an annual review with human resources and the departmental leadership teams, focusing on high performing and high potential talent, diverse talent and succession for our critical roles.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also recognize that it is important to develop our future leaders. We provide a variety of resources to help our employees build and develop their skills, including an internal leadership development class, online development resources, mentorship, as well as individual development opportunities and projects for key talent as well as opportunities for career advancement. Additionally, we have leadership development resources for our future leaders as they continue to develop their skills.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also foster a strong corporate culture that promotes high standards of ethics and compliance for our business, including policies that set forth principles to guide employee, officer, director, and vendor conduct, such as our Code of Business Conduct and Ethics. We also maintain a whistleblower policy and anonymous hotline for the confidential reporting of any suspected policy violations or unethical business conduct on the part of our employees, officers, directors, or vendors. All staff members are also required to complete anti-harassment training.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of May&#160;23, 2023 we had 302 full time employees, including: 137 in customer care; 15 in marketing; 48 in fulfillment and purchasing; 62 in our pharmacy; 17 in information technology and 15 in accounting/human resources. None of our employees are represented by a labor union or governed by any collective bargaining agreements. We consider relations with our employees to be good. The majority of our employees work at our Delray Beach, Florida headquarters and distribution center, and approximately 78 employees work at the office and distribution center in New York that we acquired as a part of the PetCareRx acquisition. Many of our personnel are currently working remotely or in a hybrid work model.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We believe that this helps provide a differentiator in this competitive labor market.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic, we implemented significant changes that we determined were in the best interest of our employees as well as the communities in which we operate. These measures include allowing most employees to work from home and implementing additional safety measures for employees continuing critical on-site </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">work. We believe in supporting our employees&#8217; health and well-being. Our goal is to help employees make informed decisions about their health by providing the tools and resources necessary to achieve a healthier lifestyle. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We offer our employees a wide array and highly competitive benefits such as life and health (medical, dental, and vision) insurance, medical and dependent care flexible spending accounts, paid time off (including gender neutral parental leave) and retirement benefits, as well as emotional well-being services through our health insurance program.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer competitive compensation packages to attract and retain the best people, and we help care for our people so they can focus on our mission. Our employees' total compensation package includes competitive salary, bonuses or sales commissions, and/or equity. We generally offer annual equity grants to the majority of full-time exempt employees. Having compensation</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tied to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> annual equity grants helps ensure that our employees will be committed to the Company&#8217;s long-term growth and success. We conduct annual pay equity analysis and continue to be committed to pay equity.comp isn't really tied to equity grants, it just includes them.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our website address is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.petmeds.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The information on our website is not, and shall not be deemed to be, a part of or incorporated into this Annual Report on Form 10-K or any other filings we make with the Securities and Exchange Commission ("SEC"). We file annual, quarterly, and current reports, proxy statements, and other information with the SEC. Our SEC filings, including our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and any amendments to those reports filed or furnished pursuant to the Exchange Act are available free of charge over the Internet on our website or at the SEC's web site at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our SEC filings will be available through our website as soon as reasonably practicable after we have electronically filed or furnished them to the SEC.</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_16"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and financial results are subject to various risks and uncertainties, including those described below, that could materially and adversely affect our business, financial condition, operating results and the trading price of our common stock. Because of the following factors, as well as other factors affecting the Company&#8217;s results of operations and financial condition, past financial performance should not be considered to be a reliable indicator of future performance, and investors should not use historical trends to anticipate results or trends in future periods. This discussion of risk factors contains forward-looking statements. This section should be read in conjunction with Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and the consolidated financial statements and accompanying notes in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8221; of this Annual Report on Form 10-K.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Regulatory Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">We may inadvertently fail to comply with various state or federal regulations covering our pet health business, including the dispensing of prescription pet medications which may subject us to reprimands, sanctions, probations, fines, suspensions, or the loss of one or more of our pharmacy licenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our pet health business, which includes the sale and delivery of prescription pet medications is generally governed by state laws and state regulations, and with respect to controlled substances, also by federal law. Governmental authorities that regulate our business have broad latitude to make, interpret, and enforce the laws and regulations that govern us. Since our pharmacy is located in the State of Florida, the Company is governed by the laws and regulations of the State of Florida. Each prescription pet medication sale we make is likely also to be covered by the laws of the state where the customer is located. The laws and regulations relating to the sale and delivery of prescription pet medications vary from state to state, but generally require that prescription pet medications be dispensed with the authorization from a prescribing veterinarian. Our current home-state license with the Florida Board of Pharmacy is valid until February&#160;28, 2025, and PetCareRx&#8217;s home-state license in the State of New York is valid until April&#160;30, 2025, and there is no guarantee that we will be able to renew such licenses when required. To the extent that we are unable to maintain our license as a community pharmacy with the Florida Board of Pharmacy (and to the extent we are unable to maintain PetCareRx&#8217;s license in New York), or if we do not maintain the licenses granted by other state boards, or if we become subject to actions by the FDA, or other enforcement regulators, our dispensing of prescription medications to pet owners could cease, which could have a material adverse effect on our operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The expansion of our business into the offer and sale of pet insurance products will also subject us to additional laws and regulations regarding those activities, including registering as an insurance distributor in states in which we offer and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">sell the Pumpkin co-branded pet insurance products and otherwise complying with state and federal laws relating to the sale and distribution of insurance products.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to routine litigation and administrative complaints incidental to its business. Management does not believe that the resolution of any or all of such routine litigation and administrative complaints is likely to have a material adverse effect on the Company&#8217;s financial condition or results of operations. While we make every effort to fully comply with all applicable state rules, laws, and regulations, from time to time we have been the subject of administrative complaints regarding the authorization of prescriptions prior to shipment. We cannot assure you that we will not be the subject of administrative complaints in the future. We cannot guarantee you that we will not be subject to reprimands, sanctions, probations, or fines, or that one or more of our pharmacy licenses will not be suspended or revoked. If we were unable to maintain our license as a community pharmacy in the State of Florida, or if we are not granted licensure in a state that begins to require licensure, or if one or more of the licenses granted by other state boards should be suspended or revoked, our ability to continue to sell prescription medications and to continue our business as it is presently conducted could be in jeopardy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Business Risks</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our failure to properly manage our inventory may result in excessive inventory carrying costs, or inadequate supply of products, which could materially adversely affect our financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our current product line contains approximately 15,000 SKUs including the SKUs acquired in our acquisition of PetCareRx. A significant portion of PetMeds sales is attributable to products representing approximately 100 SKUs, including the most popular flea and tick, and heartworm preventative brands. We need to properly manage our inventory to provide an adequate supply of these products and avoid excessive inventory of the products representing the balance of the SKUs. We generally place orders for products with our suppliers based upon our internal estimates of the amounts of inventory we will need to fill future orders. These estimates may be significantly different from the actual orders we receive.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that subsequent orders fall short of original estimates, we may be left with excess inventory. Significant excess inventory could result in price discounts, increased inventory carrying costs, and obsolescence. Similarly, if we fail to have an adequate supply of some SKUs, we may lose sales opportunities. We cannot guarantee that we will maintain appropriate inventory levels. Any failure on our part to maintain appropriate inventory levels may have a material adverse effect on our financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Resistance from veterinarians to authorize prescriptions, or attempts or efforts by veterinarians to discourage pet owners from purchasing from us could cause our sales to decrease and could materially adversely affect our financial condition and results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since we began our operations, some veterinarians have resisted providing our customers with a copy of their pet&#8217;s prescription or authorizing the prescription to our pharmacy staff, thereby effectively preventing us from filling such prescriptions under state law. We have also been informed by customers and consumers that veterinarians have tried to discourage pet owners from purchasing from internet mail-order pharmacies.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The laws and regulations relating to the sale and delivery of prescription pet medications vary from state to state. Although veterinarians in some states are required by law to provide a pet owner with a prescription if medically appropriate, if the number of veterinarians who refuse to authorize prescriptions should increase, or if veterinarians are successful in discouraging pet owners from purchasing from internet mail-order pharmacies, our sales could decrease, and our financial condition and results of operations may be materially adversely affected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Significant portions of our sales are made to residents of eight states. If we should lose our pharmacy license in one or more of these states, our financial condition and results of operations would be materially adversely affected.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we ship pet medications to customers in all 50 states, approximately 50% of our sales for the fiscal year ended March&#160;31, 2023, were made to customers located in the states of California, Florida, Texas, New York, Pennsylvania, North Carolina, Georgia, and Virginia. If for any reason our license to operate a pharmacy in one or more of those states should be suspended or revoked, or if it is not renewed, our ability to sell prescription medications to residents of those states would cease and our financial condition and results of operations in future periods would be materially adversely affected.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">We have direct buying relationships with all the major pet medication manufacturers and each contractual relationship depends on our compliance with each respective manufacturer&#8217;s minimum advertised pricing policies (MAPP).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains direct purchasing relationships with all the major pet medication manufacturers. These relationships entitle the Company to buy directly from the manufacturer under the terms and conditions of a purchasing agreement which dictates purchase pricing of inventory and criteria to obtain additional discounts and rebates. The terms of these agreements also require the Company to comply with the manufacturers&#8217; MAPP. Each advertisement and/or promotion of a product below the MAPP price, should they occur, would be a violation of the policy. This policy applies to all advertisements of products in all media including, without limitation, flyers, posters, coupons, mailers, inserts, newspapers, magazines, on-line catalogs, mail order catalogs, public signage and all Internet or similar electronic media, television, radio and public signage, including websites, email newsletters, forums, and auction sites.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the discretion of the manufacturers, non-compliance with the MAPP can result in one or more of the following actions: (1) forfeiture of future rebates or discounts from the manufacturer, (2) suspension of future purchases from the manufacturer, (3) or termination of current or future business relationship. The Company has and will continue to make every attempt to abide by the manufacturers MAPP. However, no assurances can be made that the Company will not violate MAPP inadvertently. A reduction or discontinuance of these rebates or discounts would increase our costs and could reduce our profitability. If any of these major pet medication manufacturers were to terminate our purchasing relationship it could materially adversely affect our business. If the manufacturers are not able to enforce their MAPP industry-wide, then our profit margins and results of operations may also be impacted negatively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The loss of any of our key suppliers would negatively impact our business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have direct purchasing relationships with all of the major pet medication manufacturers, from the majority of which we purchase significant quantities of pet medication products.. We do maintain annual purchasing contracts with these major manufacturers. While we believe that our supplier relationships are good, a supplier could discontinue selling to us at any time. The loss of any of our key suppliers of pet medications offered by us would have a negative impact on our business, financial condition, and results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shipping is a critical part of our business and any changes in, or disruptions to, our shipping arrangements could adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently rely on third-party national, regional, and local logistics providers to deliver the products we offer on our website. If we are not able to negotiate acceptable pricing and other terms with these providers, or if these providers experience performance problems or other difficulties in processing our orders or delivering our products to customers, it could negatively impact our results of operations and our customers&#8217; experience. In addition, our ability to receive inbound inventory efficiently and ship merchandise to customers may be negatively affected by factors beyond our and these providers&#8217; control, including inclement weather, fire, flood, power loss, earthquakes, acts of war or terrorism or other events, such as labor shortages and disputes, financial difficulties, volatility in the prices of fuel, gasoline and commodities such as paper and packing supplies, system failures and other disruptions to the operations of the shipping companies on which we rely. We are also subject to risks of damage or loss during delivery by our shipping vendors. If the products ordered by our customers are not delivered in a timely fashion or are damaged or lost during the delivery process, our customers could become dissatisfied and cease buying products through our website and mobile applications, which would adversely affect our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The quality of our customer service and support is important to our customers, and if we fail to provide adequate levels of customer service and support, we could lose customers, which would harm our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We believe that a high level of customer care and support is critical in retaining and expanding our customer base. Although our customer care representatives participate in ongoing training programs on a variety of topics, such as product knowledge, computer usage, customer service tips, and the relationship between our Company and veterinarians, any perceived or actual decline in our customer-service response times or in the quality of our customer care representatives, even if episodic or temporary, could hurt our business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If customers perceive that our customer care and support does not compare favorably to our competitors, then we may lose customers to such competitors.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The content of our website could expose us to various kinds of liability, which, if prosecuted successfully, could negatively impact our business.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we post product and pet health information and other content on our website, we face potential liability for negligence, copyright infringement, patent infringement, trademark infringement, defamation, and/or other claims based on the nature and content of the materials we post. Various claims have been brought, and sometimes successfully prosecuted, against Internet content distributors. We could be exposed to liability with respect to the unauthorized duplication of content or unauthorized use of other parties&#8217; proprietary technology. Although we maintain general liability insurance, our insurance may not cover potential claims of this type or may not be adequate to indemnify us for all liability that may be imposed. Any imposition of liability that is not covered by insurance, or is in excess of insurance coverage, could materially adversely affect our financial condition and results of operations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We may not be able to protect our intellectual property rights, and/or we may be found to infringe on the proprietary rights of others.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on a combination of trademarks, trade secrets, copyright laws, and contractual restrictions to protect our intellectual property rights. These afford only limited protection. Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy our non-prescription private label or generic equivalents, when and if developed, as well as aspects of our sales formats, or to obtain and use information that we regard as proprietary, including the technology used to operate our website and our content, and our trademarks. Litigation or proceedings before the United States Patent and Trademark Office or other bodies may be necessary in the future to enforce our intellectual property rights, to protect our trade secrets and domain names, or to determine the validity and scope of the proprietary rights of others. Any litigation or adverse proceeding could result in substantial costs and diversion of resources and could seriously harm our business and operating results. Third parties may also claim infringement by us with respect to past, current, or future technologies. We expect that participants in our market will be increasingly involved in infringement claims as the number of services and competitors in our industry segment grows. Any claim, whether meritorious or not, could be time-consuming, result in costly litigation, cause service upgrade delays, or require us to enter into royalty or licensing agreements. These royalty or licensing agreements might not be available on terms acceptable to us or at all. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If we are unable to protect our Internet addresses or to prevent others from using Internet addresses that are confusingly similar, our business may be adversely impacted.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Internet addresses, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.1800petmeds.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.1888petmeds.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.petmedexpress.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.petmed.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.petmeds.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.petmeds.pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.petmed.pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.1800petmeds.pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">petcarerx.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, are critical to our brand recognition and our overall success. If we are unable to protect these Internet addresses, our competitors could capitalize on our brand recognition. There may be similar Internet addresses used by competitors. Governmental agencies and their designees generally regulate the acquisition and maintenance of Internet addresses. The regulation of Internet addresses in the United States and in foreign countries has changed and may undergo further change in the near future. Furthermore, the relationship between regulations governing Internet addresses and laws protecting trademarks and similar proprietary rights is unclear. Therefore, we may not be able to protect our own Internet addresses or prevent third parties from acquiring Internet addresses that are confusingly similar to, infringe upon, or otherwise decrease the value of our Internet addresses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Since most of our operations are housed in a single location, we are more susceptible to a business interruption in the event of damage to, or disruptions in, our facility, particularly with respect to extreme weather events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our headquarters and principal distribution center are currently located in one location in South Florida, and most of our shipments of products to our customers are made from this primary distribution center. Because we consolidate our operations in one location, we are more susceptible to power and equipment failures, and business interruptions in the event of fires, floods, and other natural disasters than if we had additional locations. Furthermore, because we are located in South Florida, which is a hurricane-sensitive area and is susceptible to sea-level rise, we are particularly susceptible to the risk of damage to, or total destruction of, our headquarters and distribution center and surrounding transportation infrastructure caused by a hurricane or rising sea levels. Additionally, recent intense weather conditions may cause property insurance premiums to significantly increase in the future. We recognize that the frequency and intensity of extreme weather events, sea-level rise, and other climatic changes may continue to increase and, as a result, our exposure to these events may increase. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We cannot assure you that we are adequately insured to cover the amount of any losses relating to any of these potential events, including business interruptions resulting from damage to or destruction of our headquarters and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">distribution center, or power and equipment failures relating to our call center or websites, or interruptions or disruptions to major transportation infrastructure, or other events that do not occur on our premises. The occurrence of one or more of these events could adversely impact our ability to generate revenues in future periods.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A failure or misuse of our information systems and customer-facing technology systems, including our online payment methods, could adversely affect our results of operations, expose us to third-party claims, or increase our exposure to fraud and other risks.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is dependent upon the efficient operation of our information systems. In particular, we rely on our information systems to effectively manage our business model strategy, with tools to track and manage sales, inventory, marketing, customer service efforts, the preparation of our consolidated financial and operating data, credit card information, and customer information. The failure of our information systems to perform as designed or the failure to maintain and enhance or protect the integrity of these systems could disrupt our business operations, adversely impact sales and the results of operations, expose us to customer or third-party claims, or result in adverse publicity.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our information technology, we are able to provide an improved overall shopping and interconnected retail experience that empowers our customers to shop and interact with us from computers, tablets, smartphones and other mobile devices. We use our website and our mobile application both as sales channels for our products and also as methods of providing product and other relevant information to our customers to drive online sales. Our online programs, communities and knowledge center allow us to inform, assist and interact with our customers. We also continually seek to enhance all of our online properties to provide an attractive user-friendly interface for our customers. Disruptions, failures or other performance issues with these customer-facing technology systems could impair the benefits that they provide to our online business and negatively affect our relationship with our customers.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, we currently accept payments using a variety of different payment methods which may subject us to additional regulations and compliance requirements, and may also increase our exposure to fraud, criminal activity, and other risks. In the future, as technology develops and we begin to offer new payment options to consumers, including by integrating emerging mobile and other payment methods, we may be subject to additional regulations, compliance requirements, or fraud. If we fail to comply with the rules or requirements of any provider of a payment method we accept, if the volume of fraud in our transactions limits or terminates our rights to use payment methods we currently accept, or if a data breach occurs relating to our payment systems, we may, among other things, be subject to fines or higher transaction fees and may lose, or face restrictions placed upon, our ability to accept credit card payments from consumers or facilitate other types of online payments. If any of these events were to occur, our business, financial condition, and results of operations could be materially and adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our failure or the failure of third-party service providers to protect our website, networks, and systems against cybersecurity incidents, or otherwise to protect our confidential information, could damage our reputation and brand and substantially harm our business, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our services being web based, we collect, process, transmit and store large amounts of data about our customers, employees, suppliers and others, including credit card information and personally identifiable information, as well as other confidential and proprietary information. We also employ third-party service providers for a variety of reasons, including storing, processing and transmitting proprietary, personal and confidential information on our behalf. While we rely on tokenization solutions licensed from third parties in an effort to securely transmit confidential and sensitive information, including credit card numbers, advances in computer capabilities, new technological discoveries or other developments may result in the whole or partial failure of these solutions to protect confidential and sensitive information from being breached or compromised. Similarly, our security measures, and those of our third-party service providers, may not detect or prevent all attempts to hack our systems or those of our third-party service providers. Distributed Denial-of-Service ("DDoS") attacks, viruses, malicious software, break-ins, phishing attacks, ransomware, social engineering, security breaches or other cybersecurity incidents and similar disruptions that may jeopardize the security of information stored in or transmitted by our website, networks and systems or that we or our third-party service providers otherwise maintain, including payment card systems, may subject us to fines or higher transaction fees or limit or terminate our access to certain payment methods. We and our service providers may not anticipate or prevent all types of attacks until after they have already been launched, and techniques used to obtain unauthorized access to or sabotage systems change frequently and may not be known until launched against us or our third-party service providers. In addition, cybersecurity incidents can also occur as a result of non-technical issues, including intentional or inadvertent breaches by our employees or by persons with whom we have commercial relationships.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breaches of our security measures or those of our third-party service providers or any cybersecurity incident could result in unauthorized access to our website, networks and systems; unauthorized access to and misappropriation of consumer and/or employee information, including personally identifiable information, or other confidential or proprietary information of ourselves or third parties; viruses, worms, spyware or other malware being served from our website, networks or systems; deletion or modification of content or the display of unauthorized content on our website; interruption, disruption or malfunction of operations; costs relating to cybersecurity incident remediation, deployment of additional personnel and protection technologies, response to governmental investigations and media inquiries and coverage; engagement of third party experts and consultants; litigation, regulatory action and other potential liabilities. If any of these cybersecurity incidents occur, or there is a public perception that we, or our third-party service providers, have suffered such a breach, our reputation and brand could also be damaged and we could be required to expend significant capital and other resources to alleviate problems caused by such cybersecurity incidents. As a consequence, our business could be materially and adversely affected and we could also be exposed to litigation and regulatory action and possible liability. In addition, any party who is able to illicitly obtain a customer&#8217;s password could access the customer&#8217;s transaction data or personal information. Any compromise or breach of our security measures, or those of our third-party service providers, could violate applicable privacy, data security and other laws, and cause significant legal and financial exposure, adverse publicity and a loss of confidence in our security measures, which could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs of mitigating cybersecurity risks are significant and are likely to increase in the future. These costs include, but are not limited to, retaining the services of cybersecurity providers; compliance costs arising out of existing and future cybersecurity, data protection and privacy laws and regulations; and costs related to maintaining redundant networks, data backups and other damage-mitigation measures.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not carry cyber insurance, which may expose us to certain potential losses for damages or result in penalization with fines in an amount exceeding our resources.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Our migration of data and systems to a new information technology platform may disrupt our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As an established web-based seller of pet products, we rely on a combination of legacy public-facing websites, internal applications and services, and back-end business intelligence systems.  We are in the process of migrating and upgrading many of our platforms and applications to more modular, web-based and SaaS systems.  If we are not able to realize the anticipated benefits of our migration to this new infrastructure, our business could be harmed.  There may be unforeseen issues as a result of these migrations that may cause disruptions to the availability of our products due to service outages, downtime or other similar issues that could harm our business. We also may be subject to additional risk of cybersecurity breaches or other improper access to our data or confidential information following our migration to these new computing platforms. In addition, our new platforms may operate differently than anticipated when introduced or when new versions or enhancements are released. As we increase our reliance on our systems, our exposure to damage from service interruptions may increase. Further, our transition could involve significant time and expense and could negatively impact our ability to deliver our products and services, which could harm our financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our marketing, e-commerce, and other business activities are subject to a variety of federal and state laws and regulations relating to privacy, data protection, marketing and advertising and consumer protection, many of which may evolve or expand beyond their current scope, and our failure to comply with this complex set of evolving laws and regulations could adversely affect our business, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collect, maintain, use, and share personal information provided to us through our various marketing activities, including email and social media marketing and postal mailings, as well as other consumer, employee, and business-to-business interactions, in order to provide a better experience for our customers, employees, and vendors. Our current and future marketing and advertising practices depend on our ability to collect, maintain, use, and share this personal information with certain service providers and other third-party vendors, and we are subject to various federal and state laws and regulations that govern such marketing and advertising practices. In addition, we also collect, store, and transmit employees&#8217; health information for certain reasons, such as administering employee benefits; accommodating disabilities and injuries; complying with public health requirements; and maintaining employee safety in the workplace.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laws and regulations relating to privacy, data protection, cybersecurity, marketing and advertising, and consumer protection are evolving and subject to potentially differing interpretations. While we strive to comply with all such regulations and believe that we are good stewards of our customers&#8217; data, this area is rapidly evolving, and it is possible that these requirements may be interpreted and applied in a manner that is inconsistent from one jurisdiction to another or may conflict with other rules or our practices. If so, we may be subject to proceedings or actions against us by </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">governmental entities or others, and we may suffer damage to our reputation as a result of such proceedings or actions. We may also be contractually required to indemnify and hold harmless third parties from the costs or consequences of non-compliance with any laws, regulations or other legal obligations relating to privacy, data protection, cybersecurity or consumer protection or any inadvertent or unauthorized use or disclosure of data that we store or handle as part of operating our business.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state governmental authorities continue to evaluate the privacy implications inherent in the use of third-party &#8220;cookies&#8221; and other methods of online tracking for behavioral advertising and other purposes. The U.S. government and state governments have enacted, have considered or are considering enacting, legislation or regulations that could significantly restrict the ability of companies and individuals to engage in these activities, such as by regulating the level of consumer notice and consent required before a company can employ cookies or other electronic tracking tools or the use of data gathered with such tools. Additionally, some providers of consumer devices and web browsers have implemented, or announced plans to implement, means to make it easier for Internet users to prevent the placement of cookies or to block other tracking technologies, which could result in the use of third-party cookies and other methods of online tracking becoming significantly less effective. The regulation of the use of these cookies and other current online tracking and advertising practices or a loss in our ability to make effective use of services that employ such technologies could increase our costs of operations and limit our ability to acquire new customers on cost-effective terms and consequently, materially and adversely affect our business, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, various federal and state legislative and regulatory bodies, or self-regulatory organizations, may expand current laws or regulations, enact new laws or regulations or issue revised rules or guidance regarding privacy, data protection, cybersecurity, consumer protection, and advertising. For example, in June 2018, the State of California enacted the California Consumer Privacy Act of 2018 (the &#8220;CCPA&#8221;), which became effective on January 1, 2020. The CCPA requires companies that process information of California residents to make new disclosures to consumers about their data collection, use and sharing practices, and allows consumers to opt out of selling their data to third parties and provides a new cause of action for data breaches. Further, on November 3, 2020, the California Privacy Rights Act (the &#8220;CPRA&#8221;) was voted into law by California residents. The CPRA significantly amends the CCPA, and imposes additional data protection obligations on companies doing business in California, including additional consumer rights processes and opt outs for certain uses of sensitive data. It also creates a new California data protection agency specifically tasked to enforce the law, which could result in increased regulatory scrutiny of businesses conducting activities in California in the areas of data protection and security. The substantive requirements for businesses subject to the CPRA went into effect on January 1, 2023, and will be enforced effective from July 1, 2023. Other states in which we operate have also enacted laws similar to CPRA and similar laws have been proposed in other states and at the federal level, and if passed, such laws may have potentially conflicting requirements that would make compliance challenging. Additionally, the Federal Trade Commission (the &#8220;FTC&#8221;) and many state attorneys general are interpreting federal and state consumer protection laws to impose standards for the online collection, use, dissemination and security of data. Consumer protection laws require us to publish statements that describe how we handle personal data and choices individuals may have about the way we handle their personal data. If such information that we publish is considered untrue, we may be subject to government claims of unfair or deceptive trade practices, which could lead to significant liabilities and consequences. Further, according to the FTC, violating consumers&#8217; privacy rights or failing to take appropriate steps to keep consumers&#8217; personal data secure may constitute unfair acts or practices in or affecting commerce in violation of Section 5(a) of the Federal Trade Commission Act. Each of these privacy, security, and data protection laws and regulations, and any other such changes or new laws or regulations, could impose significant limitations, require changes to our business, impose fines and other penalties or restrict our use or storage of personal information, which may increase our compliance expenses and make our business more costly or less efficient to conduct. Any such changes could compromise our ability to develop an adequate marketing strategy and pursue our growth strategy effectively, which, in turn, could adversely affect our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">We face the risk of litigation resulting from unauthorized text messages sent in violation of the Telephone Consumer Protection Act.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We send short message service, or SMS, text messages to customers and job candidates. The actual or perceived improper sending of text messages may subject us to potential risks, including liabilities or claims relating to consumer protection laws. For example, the Telephone Consumer Protection Act of 1991, a federal statute that protects consumers from unwanted telephone calls, faxes, and text messages, restricts telemarketing and the use of automated SMS text messages without proper consent. Numerous class-action suits under federal and state laws have been filed in recent years against companies who conduct SMS texting programs, with many resulting in multi-million-dollar settlements to the plaintiffs. Federal or state regulatory authorities or private litigants may claim that the notices and disclosures we provide, form of consents we obtain, or our SMS texting practices are not adequate or violate applicable law, resulting in civil claims against </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">us. While we strive to comply with all applicable laws and regulations, the scope and interpretation of the laws that are or may be applicable to the delivery of text messages are continuously evolving and developing. If we do not comply with these laws or regulations or if we become liable under these laws or regulations, we could face direct liability, could be required to change some portions of our business model, or could face negative publicity, and our business, financial condition, and results of operations could be adversely affected as a result. Even an unsuccessful challenge of our SMS texting practices by our customers, regulatory authorities, or other third parties could result in negative publicity and could require a costly response from and defense by us. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our operating results are difficult to predict and may fluctuate, and a portion of our sales are seasonal.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors that may cause our operating results to fluctuate include:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to obtain new customers at a reasonable cost, retain existing customers, or encourage reorders;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to increase the number of visitors to our website, or our ability to convert visitors to our website into customers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The mix of medications and other pet products sold by us;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to manage inventory levels or obtain an adequate supply of products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to adequately maintain, upgrade, and develop our website, the systems that we use to process customers&#8217; orders and payments, or our computer network;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased competition within our market niche;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Price competition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">New products introduced to the market, including generics;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increases in the cost of advertising;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The amount and timing of operating costs and capital expenditures relating to expansion of our product line or operations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential disruption to the distribution network;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruption of our toll-free telephone service, technical difficulties, or systems and Internet outages or slowdowns;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of further outbreaks of COVID-19, and any future similar outbreak, on our business operations and generally on the economy, including the measures taken by governmental authorities to address it; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unfavorable general economic trends.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the seasonality of our business, we believe that quarter-to-quarter comparisons of our operating results are not a good indication of our future performance. The majority of our product sales are affected by the seasons, due to the seasonality of mainly flea, tick, and heartworm medications. For the quarters ended June 30, 2022, September 30, 2022, December 30, 2022, and March&#160;31, 2023, Company sales were 27%, 26%, 23%, and 24%, respectively. In addition to the seasonality of our sales, our annual and quarterly operating results have fluctuated in the past and may fluctuate significantly in the future due to a variety of factors, including weather, many of which are out of our control. Any change in one or more of these factors could materially adversely affect our financial condition and results of operations in future periods.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Uncertainties in economic conditions and their impact on consumer spending patterns could adversely impact our business, financial condition, and results of operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results of operations are sensitive to changes in certain macro-economic conditions that impact consumer spending on pet products and services. Some of the factors that may affect consumer spending on pet products and services include consumer confidence, levels of unemployment, inflation, interest rates, tax rates and general uncertainty regarding the overall future economic environment. We may experience declines in sales or changes in the types of products sold during economic downturns. Any material decline in the amount of consumer spending or other adverse economic changes could reduce our sales, and a decrease in the sales of higher-margin products could reduce profitability and, in each case, harm our business, financial condition, and results of operations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have grown, and continue to seek to grow our business through acquisitions of, or investments in, new or complementary businesses, facilities, technologies, offerings, or products, or through strategic alliances, and the failure to manage these acquisitions, investments, or other strategic alliances, or to integrate them with our existing business, could have a material adverse effect on us.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the past 12 months, we acquired one company (PetCareRx) and entered into two strategic partnerships to enable us to offer telehealth services and pet insurance to our customers. We expect that we may in the future consider additional opportunities to acquire or make investments in new or complementary businesses, facilities, technologies, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">offerings, or products, or enter into other strategic alliances, which may enhance our capabilities, complement our current products and services or expand the breadth of our markets. Acquisitions, investments and other strategic alliances, including our recent acquisition of PetCareRx, involve numerous risks, including:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">problems integrating the acquired business, facilities, technologies or products, including issues maintaining uniform standards, procedures, controls and policies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated costs associated with acquisitions, investments or strategic alliances;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">losses we may incur as a result of declines in the value of an investment or as a result of incorporating an investee&#8217;s financial performance into our financial results;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of management&#8217;s attention from our existing business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks associated with entering new markets in which we may have limited or no experience;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risks associated with businesses we acquire or invest in, which may differ from or be more significant than the risks our other businesses face;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential unknown liabilities associated with a business we acquire or in which we invest; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased legal and accounting compliance costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our ability to successfully grow through strategic transactions depends upon our ability to identify, negotiate, complete and integrate suitable target businesses, facilities, technologies, products and services. These efforts could be expensive and time-consuming and may disrupt our ongoing business and prevent management from focusing on our operations. Also, our acquisitions may not result in the benefits or growth originally anticipated from such acquisitions. As a result of future strategic transactions, we might need to issue additional equity securities, spend our cash, or incur debt (which may only be available on unfavorable terms, if at all) or contingent liabilities, any of which could reduce our profitability and harm our business. If we are unable to identify suitable acquisitions, investments or strategic relationships, or if we are unable to integrate any acquired businesses, facilities, technologies, offerings and products effectively, our business, financial condition, and results of operations could be materially and adversely affected. Also, while we employ several different methodologies to assess potential business opportunities, the new businesses or investments may not meet or exceed our expectations or desired objectives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The market for pet telemedicine is immature and uncertain. If the telemedicine market does not develop, develops more slowly than we expect, or encounters negative publicity, or if our approach does not achieve a high level of customer acceptance, the growth and results of our partnership with Vetster may be adversely affected which could result in an impairment of  our investment..</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pet telehealth market is, in general, immature and uncertain. It is uncertain whether the telemedicine market and our approach to pet telehealth with Vetster will achieve and sustain high levels of demand, consumer acceptance and market adoption. The COVID-19 pandemic increased acceptance and utilization of telemedicine services, but it is uncertain whether such increase in demand will continue.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demand for pet telemedicine and telehealth services is affected by a number of factors, many of which are beyond our control. Some of these potential factors include:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market adoption and ongoing usage of pet telehealth and telemedicine services and solutions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">awareness and adoption of technology in healthcare generally;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability of products and services that compete with ours;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ability to maintain and expand a network of qualified providers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ease of adoption and use;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">features and platform experience;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">performance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">brand;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">security and privacy; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pricing.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success will depend to a substantial extent on the willingness of our customers to use, and to increase the frequency and extent of their utilization of, our solution being offered in conjunction with Vetster, as well as on our ability to demonstrate the value of pet telehealth and telemedicine to veterinarians and pet owners. Negative publicity concerning the pet telehealth and telemedicine market could limit market acceptance of our solutions and services.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Financial Risks</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are subject to payment-related risks that could increase our operating costs, expose us to fraud or theft, subject us to potential liability and potentially disrupt our business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accept payments using a variety of methods, including credit and debit cards, PayPal, and checks, and we may offer new payment options over time. Acceptance of these payment options subjects us to rules, regulations, contractual obligations and compliance requirements, including payment network rules and operating guidelines, data security standards and certification requirements, and rules governing electronic funds transfers. These requirements may change over time or be reinterpreted, making compliance more difficult or costly. For certain payment methods, including credit and debit cards, we pay interchange and other fees, which may increase over time and raise our operating costs. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on third parties to provide payment processing services, including the processing of credit cards, debit cards, and other forms of electronic payment. If these companies become unable to provide these services to us, or if their systems are compromised, it could potentially disrupt our business. The payment methods that we offer also subject us to potential fraud and theft by criminals, who are becoming increasingly more sophisticated, seeking to obtain unauthorized access to or exploit weaknesses that may exist in the payment systems. If we fail to comply with applicable rules or requirements for the payment methods we accept, or if payment-related data is compromised due to a breach or misuse of data, we may be liable for costs incurred by payment card issuing banks and other third parties or subject to fines and higher transaction fees, or our ability to accept or facilitate certain types of payments may be impaired. As a result, our business and operating results could be adversely affected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business could be adversely affected if we fail to implement and maintain effective disclosure controls and procedures and internal control over financial reporting.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the audit of our financial statements for the fiscal year ending March 31, 2023, we concluded that as of March 31, 2023, our disclosure controls and procedures and our internal control over financial reporting were not effective due to a material weakness relating to [inappropriate] segregation of duties over the preparation, approval and posting of manual journal entries. If we are unable to implement and maintain effective disclosure controls and procedures and remediate the material weaknesses in a timely manner, or if we identify other material weaknesses in the future, our ability to produce accurate and timely financial statements and public reports could be impaired, which could adversely affect our business and financial condition. In addition, investors may lose confidence in our reported information and the market price of our common stock may decline.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Risks Relating to Taxes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxing authorities may successfully assert that we should have collected, or in the future should collect, sales and use, value added, or similar taxes, and any such assessments could adversely affect our business, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past several years, states have adopted laws that attempt to impose tax collection obligations on out-of-state companies. Additionally, the Supreme Court of the United States ("Supreme Court") ruled in South Dakota v. Wayfair, Inc. et al, or Wayfair, that online sellers can be required to collect sales and use tax despite not having a physical presence in the buyer&#8217;s state. In response to Wayfair, or otherwise, states or local governments may adopt, or begin to enforce, laws requiring us to register, calculate, collect, and remit taxes on sales in their jurisdictions. While we currently collect and remit applicable sales taxes to the extent required in all states in which we sell, a successful assertion by one or more states seeking to tax us on sales that occurred in prior tax years, or to collect more taxes in a jurisdiction in which we currently do collect some taxes, could result in substantial tax liabilities, including taxes on past sales, as well as penalties and interest. The imposition by state governments or local governments of sales tax collection obligations on out-of-state sellers could also create additional administrative burdens for us, put us at a competitive disadvantage if they do not impose similar obligations on our competitors, and decrease our future sales, which could have a material adverse effect on our business and results of operations. New legislation or regulations, the application of laws and regulations from jurisdictions, or the application of existing laws and regulations to the Internet and commercial online services could similarly result in significant additional taxes on our business. For instance, the Supreme Court&#8217;s decision and the enactment and enforcement of laws resulting therefrom could also impact where we are required to file state income taxes. As a result, our effective income tax rate as well as the cost and growth of our business could be materially and adversely affected, which could in turn have a material adverse effect on our financial condition and results of operations. In addition, because the Company&#8217;s </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products and services are available over the Internet, states may claim that the Company is required to do business as a foreign corporation in one or more of those jurisdictions. Failure to qualify as a foreign corporation in a jurisdiction where the Company is required to do so could subject it to taxes and penalties, and such jurisdictions may charge the Company with violations of local laws. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Industry Risks</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face significant competition from veterinarians and online and traditional retailers, as well as challenges from strategic alliances amongst our competitors, and may not be able to compete profitably with them.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete directly and indirectly with veterinarians for the sale of pet medications and other health products. Veterinarians hold a competitive advantage over us because many pet owners may find it more convenient or preferable to purchase these products directly from their veterinarians at the time of an office visit. We also compete directly and indirectly with both online and traditional retailers. Both online and traditional retailers may hold a competitive advantage over us because of longer operating histories, established brand names, greater resources, and/or an established customer base. Online retailers may have a competitive advantage over us because of established affiliate relationships to drive traffic to their website. Traditional retailers may hold a competitive advantage over us because pet owners may prefer to purchase these products from a store instead of online. In addition, we face growing competition from online and multichannel retailers, some of whom may have a lower cost structure than ours, as customers now routinely use computers, tablets, smartphones, and other mobile devices and mobile applications to shop online and compare prices and products in real time. In order to effectively compete in the future, we may be required to offer promotions and other incentives, which may result in lower operating margins and adversely affect the results of operations. We also face a significant challenge from our competitors forming alliances with each other, such as those between online and traditional retailers. These relationships may enable both their online and retail stores to negotiate better pricing and better terms from suppliers by aggregating the demand for products and negotiating volume discounts, which could be a competitive disadvantage to us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Product recalls and concerns regarding the safety and quality of the pet products we sell could affect our business.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to laws and regulations by various federal and state regulatory authorities regarding the safety and quality of the pet products that we sell. We purchase products from various suppliers, one or more of which might not adhere to product safety requirements or our quality control standards, and we may not be able to identify the deficiency before merchandise ships to our customers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our suppliers are required to comply with applicable product safety laws, and we are dependent upon them to ensure such compliance.  Any issues of product safety or allegations that the products we sell are in violation of governmental regulations, including, but not limited to, issues involving products manufactured in foreign countries or issues of mislabeling or adulteration, could cause those products to be recalled. If our suppliers fail to manufacture or import merchandise that adheres to our quality control standards, product safety requirements, or applicable governmental regulations, our reputation and brand could be damaged, potentially leading to decreased sales or increases in customer litigation against us.  If consumers lose confidence in the safety and quality of the food or other products that we sell or in the suppliers that provide such products, then our sales could be adversely affected.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse publicity about these types of concerns, even if not valid, may discourage consumers from buying the products we offer, and such publicity cause disruptions with suppliers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The real or perceived sale of contaminated food products by us could result in product liability claims against our suppliers or us, expose us or our suppliers to governmental enforcement action or private litigation, or lead to costly recalls and a loss of consumer confidence, any of which could have an adverse effect on our business, financial condition, and results of operations. We may also in the future voluntarily recall or withdraw products that we consider do not meet our standards in order to protect our brand and reputation. While we carry product liability insurance, our insurance may not be adequate to cover all liabilities that we may incur in connection with product liability claims. In addition, we may be unable to continue to maintain our existing insurance coverage or obtain comparable insurance at a reasonable cost, if at all, or secure additional coverage, which may result in future product liability claims being uninsured. Any of these factors could negatively impact our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pandemics or other health crises, such as the possible resurgence of the COVID-19 pandemic, may adversely affect our results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outbreak and global spread of the COVID-19 pandemic, including the spread of recent variants, and related containment efforts created, and may continue to contribute to, significant economic disruption in the United States and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">around the world. A resurgence of the COVID-19 pandemic, variations of the COVID-19 virus, or other pandemics could adversely affect our business operations. It is impossible to predict the effect and ultimate impact of the possible resurgence of the COVID-19 pandemic, a variation of the COVID-19 virus, or other pandemic. In response to the COVID-19 pandemic, we implemented working from home where possible and enhanced disinfection and social distancing within our workplace. Future COVID-19 surges or variants, as well as other pandemics, may result in us again encouraging employees to work from home, which could adversely impact costs, operations, and morale, as well as result in consumer privacy, IT security, and fraud concerns.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Governmental lockdowns and other restrictions at the onset of the COVID-19 pandemic negatively impacted, and in the event of a future resurgence or a different pandemic or health crisis may again negatively impact, the operations of and ability to ship from our fulfillment center. Our future results of operations and overall financial performance could be uncertain should a new virus strain of COVID-19, a new pandemic, or other health crisis occur.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Securities Risks</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our stock price fluctuates from time to time and may fall below expectations of securities analysts and investors, and could subject us to litigation, which may result in you suffering a loss on your investment.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our common stock may fluctuate significantly in response to a number of factors, many of which are out of our control. These factors include: changes in accounting treatments or principles; announcements by our competitors of new products and services offerings; significant contracts, acquisitions, or strategic relationships; additions or departures of key personnel; any future sales of our common stock or other securities; stock market price and volume fluctuations of publicly traded companies; and general political, economic, and market conditions. In some future quarter our operating results may fall below the expectations of securities analysts and investors, which could result in a decrease in the trading price of our common stock. In addition, if the Company fails to meet expectations related to future growth, profitability, dividends, or other market expectations, the price of the Company&#8217;s common stock may decline significantly, which could have a material adverse impact on investor confidence and employee retention. In the past, securities class action litigation has often been brought against a company following periods of volatility in the market price of its securities. We may be the target of similar litigation in the future. Securities litigation could result in substantial costs and divert management's attention and resources, which could seriously harm our business and operating results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We may issue additional shares of preferred stock that could defer a change of control or dilute the interests of our common shareholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our charter documents could defer a takeover effort which could inhibit your ability to receive an acquisition premium for your shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our charter permits our Board of Directors to issue up to 5.0&#160;million shares of preferred stock without shareholder approval. Currently there are 2,500 shares of our Convertible Preferred Stock issued and outstanding. This leaves slightly less than 5.0&#160;million shares of preferred stock available for issuance at the discretion of our Board of Directors. These shares, if issued, could contain dividend, liquidation, conversion, voting, or other rights which could adversely affect the rights of our common shareholders and which could also be utilized, under some circumstances, as a method of discouraging, delaying, or preventing a change in control. Provisions of our articles of incorporation, bylaws and Florida law could make it more difficult for a third party to acquire us, even if many of our shareholders believe it is in their best interest.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our ability to pay regular dividends to our shareholders and the amounts of any such dividends are subject to the discretion of the Board and may be limited by our financial condition, or limitations under Florida law.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have paid regular dividends to our shareholders since 2009, any such determination to pay dividends and the amounts thereof will be at the discretion of the Board and will be dependent on then-existing conditions, including our financial condition, income, legal requirements, including limitations under Florida law, and other factors the Board deems relevant. The Board has previously decided, and may in the future decide, in its sole discretion, to change the amount or frequency of dividends or discontinue the payment of dividends entirely. For example, the Board may determine to reserve and/or utilize cash resources that would otherwise be available for distributions in order to fund additional strategic transactions or investments in our business. For these reasons, shareholders should not rely on dividends to receive a return on investment. Accordingly, realization of any gain on shares of our common stock may depend solely on the appreciation of the price of our common stock, which may not occur.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B. UNRESOLVED STAFF COMMENTS</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_22"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. PROPERTIES</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own our facilities, including our principal executive offices and distribution center, which are located at 420 South Congress Avenue, Delray Beach, Florida 33445 (the &#8220;Delray Beach Property&#8221;). The Delray Beach Property consists of approximately 634,000 square feet of land or 14.6 acres with two building complexes totaling approximately 185,000 square feet, with additional land for future use. The first building complex consists of approximately 125,000 square feet and the second building complex consists of approximately 60,000 square feet each consisting of both office and warehouse space. The Company occupies approximately 97,000 square feet of the first building for its principal offices and distribution center. As of March&#160;31, 2023, 48% of the Property was leased to two tenants with a remaining weighted average lease term of 2 years. We believe that our facilities are sufficient for our current needs and are in good condition in all material respects.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with our acquisition of PetCareRx, in April 2023 we assumed the leases of two buildings occupied by PetCareRx located in Lynbrook, New York.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These facilities, which aggregate approximately 35,000 square feet, are used by PetCareRx as a shipping and fulfillment center and as an executive office.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The leases expire in April 2027 and include the option to renew for an additional five years. PetCareRx also has a lease in Brooklyn that it does not occupy and is subleased. This lease expires in May 2024.</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_25"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. LEGAL PROCEEDINGS</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are involved from time to time in various claims and lawsuits in the ordinary course of business, including claims related to products, product warranties, contracts, employment, intellectual property, consumer protection, pharmacy and other regulatory matters. We have settled complaints that had been filed with various states&#8217; pharmacy boards in the past. There can be no assurances made that other states will not attempt to take similar actions against us in the future. We also initiate litigation to protect our trade or service marks. There can be no assurance that we will be successful in protecting our trade or service marks. In the opinion of management, none of the claims and suits, either individually or in the aggregate, are reasonably likely to have a material adverse effect on our operations or consolidated financial statements. Legal costs related to the above matters are expensed as incurred.</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_28"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_34"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. MARKET FOR REGISTRANT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market Information</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the NASDAQ Global Select Market (&#8220;NASDAQ&#8221;) under the symbol &#8220;PETS.&#8221; </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were 134 holders of record of our common stock on May&#160;23, 2023, and approximately 48,300 of our holders are &#8220;street name&#8221; or beneficial holders, whose shares are held by banks, brokers, or other financial institutions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Policy</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have paid cash dividends every quarter since August 2009. For the fiscal years ended March 31, 2023 and 2022, we declared and paid cash dividends totaling $25.3 million ($0.30 per share per quarter) and $24.8 million ($0.30 per share per quarter), respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Board of Directors declared a quarterly dividend of $0.30 per share on May&#160;22, 2023. The dividend will be payable on June&#160;12, 2023 to common shareholders of record on June&#160;6, 2023.  The declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter. When considering whether to declare a dividend, our Board of Directors will take into account:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;    General economic and business conditions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;    Our financial condition and operating results;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;    Our available cash and current and anticipated cash needs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;    Our capital requirements;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;    Strategic uses of cash for growth initiatives;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;    Contractual, legal, tax and regulatory restrictions on the payment of dividends by us; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;    Such other factors as our Board of Directors may deem relevant.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has $110.0 million  of shares authorized under previously approved share repurchase programs. The share repurchase program does not have an expiration date and is intended to be implemented through purchases made from time to time in either the open market or through private transactions at the Company's discretion, subject to market conditions and other factors, in accordance with SEC requirements. There can be no assurances as to the timing and number of shares that will be repurchased under the share repurchase program, and the Company may modify or discontinue the share repurchase program at any time subject to compliance with applicable regulatory requirements. Shares purchased pursuant to the share repurchase program will either be cancelled or held in the Company's treasury. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the quarter and fiscal year ended March&#160;31, 2023, the Company did not repurchase any shares of its common stock. As of March&#160;31, 2023, the Company had approximately $28.7 million remaining under the Company&#8217;s share repurchase program. Since the inception of the share repurchase program up to March&#160;31, 2023, approximately 6.2 million shares have been repurchased under the program for approximately $81.3 million, averaging approximately $13.15 per share.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Graph</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Set forth below is a line graph comparing the five-year cumulative performance of our common stock with the NASDAQ Composite, the Russell 2000, and our SIC Code 5912 (pharmacy peer group) from March 31, 2018, to March 31, 2023. The graph assumes that $100 was invested on March 31, 2018, in each of our Common Stock, the NASDAQ Composite, the Russell 2000, and the SIC Code 5912 (pharmacy peer group). Because we have historically paid dividends on a quarterly basis, the graph assumes that dividends were reinvested. The performance graph and related information below shall not be deemed &#8220;filed&#8221; with the SEC, nor shall such information be incorporated by reference into any future </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">filing under the Securities Act or Exchange Act, except to the extent that we specifically incorporate it by reference into such filing.</span></div><div style="margin-top:12pt;text-align:justify"><img src="pets-20230331_g1.jpg" alt="3791" style="height:421px;margin-bottom:5pt;vertical-align:text-bottom;width:633px"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance graph data:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PetMed Express, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.52</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.15</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.03</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.77</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.61</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NASDAQ Composite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.43</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.01</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.54</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.33</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.03</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SIC Code 5912</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.33</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.87</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.44</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.55</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.60</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Russell 2000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.67</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.39</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.19</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.35</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.85</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Authorized for Issuance under Equity Compensation Plans</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth securities authorized for issuance under equity compensation plans, including individual compensation arrangements, by us under our 2015 Outside Director Equity Compensation Restricted Stock Plan, 2016 </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee Equity Compensation Restricted Stock Plan and 2022 Employee Equity Compensation Restricted Stock Plan as of March&#160;31, 2023:</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EQUITY COMPENSATION PLAN INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.388%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of securities<br/>to be issued upon<br/>exercise of outstanding<br/>options, warrants and rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average<br/>exercise price of<br/>outstanding options,<br/>warrants and rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of securities<br/>remaining available<br/>for future issuance<br/>under equity<br/>compensation plans</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 Outside Director Equity Compensation Restricted Stock Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 Employee Equity Compensation Restricted Stock Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Employee Equity Compensation Restricted Stock Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:63pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The number of shares of common stock available for issuance under the 2015 Outside Director Equity Compensation Restricted Stock Plan automatically increase on the first trading day of January each calendar year during the term of the 2015 Outside Director Equity Compensation Restricted Stock Plan, by an amount equal to ten percent (10%) of the total number of shares of common stock authorized under the 2015 Outside Director Equity Compensation Restricted Stock Plan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February&#160;3, 2023, we issued 6,000 shares of our common stock to a consultant pursuant to a consulting agreement in exchange for consulting services. The securities were issued in reliance upon the exemption from the registration requirements of the Securities Act, as set forth in Section 4(a)(2) under the Securities Act as a transaction by an issuer not involving any public offering.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_37"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. [RESERVED]</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7. MANAGEMENT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_43"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PetMed Express, Inc. and subsidiaries, d/b/a PetMeds&#174; (the "Company") is a leading nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses. PetMeds markets and sells directly to consumers through its websites, toll-free numbers, and mobile applications. The Company offers consumers an attractive alternative for obtaining pet medications, foods, and supplies in terms of convenience, price, speed of delivery, and valued customer service.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Founded in 1996, the Company's executive headquarters offices are currently located at 420 South Congress Avenue, Delray Beach, Florida 33445, and our telephone number is (561) 526-4444. The Company has a March 31 fiscal year.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presently, our product line includes approximately 15,000 of the most popular pet medications, health products, and supplies for dogs, cats, and horses.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market our products through national advertising campaigns which aim to increase the recognition of the &#8220;PetMeds&#8221; brand name, increase traffic on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.petmeds.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, acquire new customers, and maximize repeat purchases. Approximately 86.4% of all sales were generated via the Internet in fiscal 2023 and 84.2% in fiscal 2022.  Our sales consist of products sold mainly to retail consumers. The twelve-month average purchase remained approximately $93 per order for the fiscal years ended March&#160;31, 2023, and March&#160;31, 2022.</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_46"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discussion and analysis of our financial condition and the results of our operations contained herein are based upon our consolidated financial statements and the data used to prepare them. Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. On an ongoing basis we re-evaluate our judgments and estimates including those related to product returns, bad debts, inventories, and income taxes. We base our estimates and judgments on our historical experience, knowledge of current conditions, and our beliefs of what could occur in the future considering available information. Actual results may differ from these estimates under different assumptions or conditions. Our estimates are guided by observing the following critical accounting policies.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognition</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for revenue under ASC Topic 606 ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers")</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and generate revenue by selling pet medication products and pet supplies mainly to retail customers. Certain pet supplies offered on our website are drop shipped to customers. We consider ourself the principal in the arrangement because we control the specified good before it is transferred to the customer. Revenue contracts contain one performance obligation, which is delivery of the product; customer care and support is deemed not to be a material right to the contract. The transaction price is adjusted at the date of sale for any applicable sales discounts and an estimate of product returns, which are estimated based on historical patterns, however this is not considered a key judgment. There are no amounts excluded from the variable consideration. Revenue is recognized when control transfers to the customer at the point in time in which the shipment of the product occurs. This key judgment is determined as the shipping point, which represents the point in time where we have a present right to payment, title has transferred to the customer, and the customer has assumed the risks and rewards of ownership.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outbound shipping and handling fees are an accounting policy election and are included in sales as we consider ourself the principal in the arrangement given responsibility for supplier selection and discretion over pricing. Shipping costs associated with outbound freight after control over a product has transferred to a customer are an accounting policy election and are accounted for as fulfillment costs and are included in cost of sales. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate sales in the following two categories: (1) reorder sales vs new order sales, and (2) internet sales vs call center sales. The following table illustrates sales by various classifications: </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.055%"></td><td style="width:0.1%"></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales (In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Variance</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reorder sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New order sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,687)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,559)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internet sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Call center sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,858&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,559)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.055%"></td><td style="width:0.1%"></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales (In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Variance</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reorder sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New order sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,798)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internet sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Call center sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,215&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,798)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please note that we changed the definition of a new customer on April 1, 2022, to include anyone who has not ordered over the past thirty-six months. The reorder and new order sales amounts for the years ended March&#160;31, 2022, and March&#160;31, 2021 reflect this new customer definition change. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the previous definition of a new customer, reorder and new order sales were $250.4 million and $23.0 million, respectively, for the year ended March&#160;31, 2022. Under the previous definition of a new customer, reorder and new order sales were $272.6 million and $36.6 million, respectively, for year ended ended March&#160;31, 2021. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Virtually all of our sales are paid by credit cards and we usually receive the cash settlement in two to three banking days. Credit card sales minimize accounts receivable balances relative to sales. We had no material contract asset or contract liability balances as of March&#160;31, 2023, or March&#160;31, 2022.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain an allowance for doubtful accounts for losses that we estimate will arise from customers&#8217; inability to make required payments, arising from either credit card chargebacks or insufficient funds checks. We determine our estimates of the uncollectability of accounts receivable by analyzing historical bad debts and current economic trends. The allowance for doubtful accounts was approximately $35&#160;thousand and $39&#160;thousand at March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation of inventory</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of prescription and non-prescription pet medications and pet supplies that are available for sale and are priced at the lower of cost or net realizable value using a weighted average cost method. We write down our inventory </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for estimated obsolescence. The inventory reserve was approximately $48&#160;thousand and $81&#160;thousand at March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our advertising expense consists primarily of Internet marketing, direct mail/print, and television advertising. Internet costs are expensed in the month incurred and direct mail/print advertising costs are expensed when the related brochures and postcards are produced, distributed, or superseded. Television advertising costs are expensed as the advertisements are televised.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting for income taxes</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes under the provisions of ASC Topic 740 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), which generally requires recognition of deferred tax assets and liabilities for the expected future tax benefits or consequences of events that have been included in our consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting carrying values and the tax bases of assets and liabilities and are measured by applying enacted tax rates and laws for the taxable years in which those differences are expected to reverse.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">COVID-19 and Other Macroeconomic Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The COVID-19 pandemic had a significant impact around the world and has created significant volatility, uncertainty, and economic disruption. It prompted governments and businesses to take unprecedented measures in response. While economies of various countries have rebounded from the global Covid-19 economic shutdown that began in the late first quarter and early second quarter 2020, the impact of the Covid-19 pandemic continued, to varying degrees, in 2022 and continues, to varying degrees, in 2023 due to mounting inflationary cost pressures and potential recession indicators that have now negatively impacted the global economy. We continue to monitor the effects of the pandemic and macroeconomic environment and take appropriate steps to mitigate the impact on our business, employees and financial condition; however, the nature and extent of this impact in future periods remains difficult to predict due to numerous uncertainties outside our control.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_49"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following should be read in conjunction with our consolidated financial statements and the related notes thereto included elsewhere herein. The following table sets forth, as a percentage of sales, certain operating data appearing in our consolidated statements of income:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year Ended March 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_52"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted EBITDA </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To provide investors and the market with additional information regarding our financial results, we have disclosed (see below) adjusted EBITDA, a non-GAAP financial measure that we calculate as net income excluding share-based compensation expense; depreciation; income tax provision; interest income (expense); and other non-operational expenses. We have provided reconciliations below of adjusted EBITDA to net income, the most directly comparable GAAP financial measures.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have included adjusted EBITDA, herein, because it is a key measure used by our management and Board of Directors to evaluate our operating performance, generate future operating plans, and make strategic decisions regarding the allocation of capital. In particular, the exclusion of certain expenses in calculating adjusted EBITDA facilitates operating performance comparability across reporting periods by removing the effect of non-cash expenses and other expenses. Accordingly, we believe that adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and Board of Directors.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe it is useful to exclude non-cash charges, such as share-based compensation expense, depreciation from our adjusted EBITDA because the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations. We believe it is useful to exclude income tax provision and interest income (expense</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s neither are components of our core business operations. We also believe that it is useful to exclude other expenses, including the investment banking fee related to the Vetster partnership, acquisition costs related to PetCareRx, employee severance and an estimated state sales tax accrual as these items are not indicative of our ongoing operations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA has limitations as a financial measure, and these non-GAAP measures should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:</span></div><div style="margin-top:12pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Although depreciation  is a non-cash charge, the assets being depreciated  may have to be replaced in the future and adjusted EBITDA does not reflect capital expenditure requirements for such replacements or for new capital expenditures;</span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA does not reflect share-based compensation. Share-based compensation has been, and will continue to be for the foreseeable future, a material recurring expense in our business and an important part of our compensation strategy;</span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA does not reflect interest income (expense), net; or changes in, or cash requirements for, our working capital;</span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA does not reflect transaction related costs and other items which are either not representative of our underlying operations or are incremental costs that result from an actual or planned transaction and include litigation matters, integration consulting fees, internal salaries and wages (to the extent the individuals are assigned full-time to integration and transformation activities) and certain costs related to integrating and converging IT systems; </span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA does not reflect certain non-operating expenses including the employee severance which reduces cash available to us; </span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA does not reflect certain expenses including the estimated state sales tax accrual which reduces cash available to us.</span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other companies, including companies in our industry, may calculate adjusted EBITDA differently, which reduces the measures usefulness as comparative measures.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of these and other limitations, Adjusted EBITDA should only be considered as supplemental to, and alongside with other GAAP based financial performance measures, including various cash flow metrics, net income, net margin, and our other GAAP results.</span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of net income, the most directly comparable GAAP measure to Adjusted EBITDA  for each of the periods indicated:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:41.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.136%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.405%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.646%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation of Non-GAAP Measures<br/>PetMed Express, Inc.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">($ in thousands, except percentages)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$<br/>Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%<br/>Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Reconciliation of GAAP Net Income to Adjusted EBITDA:</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(5,102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,066</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(11,168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">-184</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Add (subtract):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based Compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,630</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,509</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">121</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(927)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,368</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2,295)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">-168</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">994</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">687</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">307</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">45</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(857)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">832</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acquisition/Partnership Transactions and Other Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,010</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,010</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State Sales Tax Accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">n/m</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,648</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,538</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(5,890)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">-62</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.539%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">($ in thousands, except percentages)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$<br/>Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%<br/>Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Reconciliation of GAAP Net Income to Adjusted EBITDA:</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">233</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">21,100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(20,867)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">-99</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Add (subtract):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based Compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,617</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,549</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,068</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">45</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,351</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,971</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4,620)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">-77</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,546</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,738</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">808</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2,070)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1,735)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acquisition/Partnership Transactions and Other Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,904</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,904</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Employee Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">364</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">364</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State Sales Tax Accrual</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">n/m</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">19,770</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34,023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(14,253)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">-42</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_55"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal 2023 Compared to Fiscal 2022</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Sales</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales decreased by approximately $16.6 million, or 6.1%, to $256.9 million for the fiscal year ended March&#160;31, 2023, from approximately $273.4 million for the fiscal year ended March&#160;31, 2022. The decrease in sales for the fiscal year ended March&#160;31, 2023, was primarily due to the increased cost to acquire new customers and competitive pressures. Sales for fiscal year 2023 were impacted by a much more competitive environment, and a crowded advertising market which had substantially higher advertising costs compared to the same period in the prior year. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired approximately 274,000 new customers for the fiscal year ended March&#160;31, 2023, compared to approximately 325,000 new customers for the same period the prior year. Financial data in the tables below reflects the new 36-month definition of new customers. Prior year new and reorder customers and sales have been recalculated utilizing the new 36-month definition of a new customer (described below). The following chart illustrates sales by various sales classifications:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.055%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales (In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reorder sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New order sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,687)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-16.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,559)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internet sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Call center sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-19.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,858&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,559)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-6.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please note that we changed the definition of a new customer on April 1, 2022, to include anyone who has not ordered over the past thirty-six months. The reorder and new order sales amounts for the years ended March&#160;31, 2022  reflect this new customer definition change. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the previous definition of a new customer, reorder and new order sales were $250.4 million and $23.0 million, respectively, and acquired new customers were approximately 263,000, for the year ended March&#160;31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021 we launched the new AutoShip &amp; Save subscription program (&#8220;AutoShip&#8221;) on our website. AutoShip is a new convenient way for our loyal customer base to have future pet medication orders delivered directly to them without the need to place an order each time. During the quarter ended June 30, 2022 we made a change to the methodology on how we calculate the percentage of our revenue that was generated by our AutoShip program. We now report AutoShip sales, as a percent of sales, net of discounts and credits for the entire quarter. Previously, we reported AutoShip sales as a percent of total sales on the last month in the quarter. This change to the calculation resulted in a decrease to the AutoShip percentage that was previously reported by only a few percentage points. We believe that this change reflects a more accurate representation of our subscription business for stakeholders to gauge our performance.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are encouraged by the adoption of our AutoShip program and have seen an increasingly positive trend over the last several quarters since we launched this program. For example, our quarterly AutoShip percentage was 44.4%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of net sales for the most recent quarter ended March&#160;31, 2023, up from 30.9% of net sales for the same period last year and up from 42.3% of net sales sequentially in the prior quarter. We have set a goal of generating approximately 50.0% of our PetMeds net sales via the AutoShip program for fiscal 2024.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Going forward sales may be adversely affected due to increased competition and consumers giving more consideration to price. The changes in consumer behavior post pandemic makes future sales somewhat challenging to predict. No guarantees can be made that sales will continue to grow in the future. The majority of our product sales are affected by the seasons, due to the seasonality of mainly heartworm, and flea and tick medications. For the quarters ended June 30, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 30, December 31, and March 31 of fiscal year 2023, our sales were approximately 27%, 26%, 23%, and 24%, respectively. For the quarters ended  June 30, September 30, December 31, and March 31 of fiscal year 2022, our sales were approximately 29%, 25%, 22%, and 24%, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Cost of sales</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales decreased by approximately $9.5 million, or 4.9% to $185.8 million for the fiscal year ended March&#160;31, 2023, from $195.3 million for the fiscal year ended March&#160;31, 2022. The cost of sales decrease can be directly related to the decrease in sales during fiscal year 2023. As a percentage of sales, cost of sales was 72.4% in fiscal year 2023, as compared to 71.4% in fiscal 2022. The cost of sales percentage increase was primarily due to increased per order freight expense.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Gross profit</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit decreased by approximately $7.1 million, or 9.0%, to $71.0 million for the fiscal year ended March&#160;31, 2023, from $78.1 million for the fiscal year ended March&#160;31, 2022. The decrease in gross profit can be directly related to the decrease in sales and an increase in per order freight expense during fiscal 2023. Gross profit as a percentage of sales for fiscal 2023 was 27.6% compared to 28.6% for fiscal 2022. The gross profit and gross profit percentage decreased </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fiscal year ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compared to the previous fiscal year.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">General and administrative expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased by approximately $18.6 million, or 60.5%, to $49.5 million for the fiscal year ended March&#160;31, 2023, from $30.8 million for the fiscal year ended March&#160;31, 2022. The increase in general and administrative expenses for the fiscal year ended March&#160;31, 2023 was due to a $5.8 million increase in payroll expenses, of which $2.1 million is from increased stock compensation and $0.4 million from accrued severance, as well as a $1.9 million increase of professional fees, a $1.0 million increase of software and systems expense, and a $0.2 million increase of other overhead expenses. In addition, general and administrative expenses increased for the fiscal year ended March&#160;31, 2023 due to a $7.8 million sales tax accrual and $1.9 million of acquisition related expenses. General and administrative expenses as a percentage of sales was 19.3% for the fiscal year ended March&#160;31, 2023, compared to 11.3% for the fiscal year ended March&#160;31, 2022. We currently expect general and administrative expense as a percentage of sales to approximate 17.0%, and expect stock compensation expense to approximate $6.4 million, in fiscal 2024.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Advertising expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising expenses increased by approximately $0.6 million to $19.4 million for the fiscal year ended March&#160;31, 2023, from $18.8 million for the fiscal year ended March&#160;31, 2022. This increase for the fiscal year ended March&#160;31, 2023, can be attributed to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lower advertising COOP dollars and increased agency fees. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The advertising costs of acquiring a new customer, defined as total advertising costs divided by new customers acquired, was $71 for the fiscal year ended March&#160;31, 2023, compared to $58 for the fiscal year ended March&#160;31, 2022, per the new definition of new customers. The increase to customer acquisition costs for the fiscal year ended March&#160;31, 2023, was due to an increase in overall advertising prices and less efficient variable marketing spend. The advertising cost of acquiring a new customer can be impacted by the advertising environment, the effectiveness of our advertising creative, spending, and price competition. Historically, the advertising environment fluctuates due to supply and demand. A more favorable advertising environment may positively impact future sales, whereas a less favorable advertising environment may negatively impact future sales. As a percentage of sales, advertising expense was 7.6% and 6.9% for the fiscal years ended March&#160;31, 2023, and 2022, respectively. We anticipate advertising as a percentage of sales to be approximately 8.0% for fiscal year 2024. However, the advertising percentage may fluctuate quarter to quarter due to seasonality and advertising availability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Depreciation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the fiscal year ended March&#160;31, 2023, increased to approximately $3.5 million from $2.7 million for the fiscal year ended March&#160;31, 2022. This increase to depreciation expense for the fiscal year ended March&#160;31, 2023 can be attributed to  new property and equipment additions in fiscal 2023.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other income</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income increased by approximately $1.7 million, to $3.0 million for the fiscal year ended March&#160;31, 2023, from $1.4 million for the fiscal year ended March&#160;31, 2022. The increase was primarily related to additional interest income as a result of higher interest rates. Interest income may decrease in the future as we utilize our cash balances on any quarterly dividend payment, on future investments or partnerships, on our operating activities, if the current interest rate environment changes,  or on our share repurchase program, which has approximately $28.7 million remaining as of March&#160;31, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Provision for income taxes</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal years ended March&#160;31, 2023 and 2022, we recorded an income tax provision of approximately $1.4 million and $6.0 million, respectively. The decrease to the income tax provision for fiscal 2023 is related to a decrease in operating income compared to fiscal 2022. The effective tax rate for the fiscal year ended March&#160;31, 2023 was approximately 85.3%, compared to approximately 22.1% for the fiscal year ended March&#160;31, 2022. The increase to the effective rate for the fiscal year ended March&#160;31, 2023, can be attributed to one-time non-deductible acquisition costs and non-deductible restricted stock compensation. The state tax rate increased due to continued expansion of operations and associated state income tax filing requirements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Net income</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income decreased by approximately $20.9 million, or 98.9%, to approximately $0.2 million for the fiscal year ended March&#160;31, 2023, from approximately $21.1 million for the fiscal year ended March&#160;31, 2022. The decrease to net income was primarily related to a decrease in sales and resulting gross profit, an increase in general and administrative expenses including the sales tax accrual for $7.8 million and $1.9 million related to acquisition related expenses, and an increase in advertising expenses, during the fiscal year.</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_58"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal 2022 Compared to Fiscal 2021</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Sales</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales decreased by approximately $35.80 million, or 11.6%, to $273.4 million for the fiscal year ended March&#160;31, 2022, from approximately $309.2 million for the fiscal year ended March&#160;31, 2021. The decrease in sales for the fiscal year ended March&#160;31, 2022 was primarily due to decreased reorder sales and new order sales.  Sales for fiscal year 2022 were</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">impacted by a much more competitive environment, and a crowded advertising market which had substantially higher advertising costs compared to the same period in the prior year. Veterinary visits increased during fiscal year 2022, compared to being down during the prior year. We believe the increase in veterinary visits was primarily due to pet owners needing to visit their veterinarian for their pets&#8217;annual exam in order to renew their prescriptions, as many veterinarians were closed in the prior year due to the pandemic. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We acquired approximately 325,000 new customers for the fiscal year ended March&#160;31, 2022, compared to approximately 546,000 new customers for the same period the prior year. Financial data in the tables below reflects the new 36-month definition of new customers. Prior year new and reorder customers and sales have been recalculated utilizing the new 36-month definition of a new customer (described below). The following chart illustrates sales by various sales classifications:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.055%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales (In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reorder sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New order sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,798)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internet sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Call center sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,215&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,798)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please note that we changed the definition of a new customer on April 1, 2022, to include anyone who has not ordered over the past thirty-six months. The reorder and new order sales amounts for the years ended March&#160;31, 2022 and 2021 reflect this new customer definition change. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the previous definition of a new customer, reorder and new order sales were $250.4 million and $23.0 million, respectively, and acquired new customers were approximately 263,000, for the year ended March&#160;31, 2022. Under the previous definition of a new customer, reorder and new order sales were $272.6 million and $36.6 million, respectively, and acquired new customers were approximately 443,000, for the year ended March&#160;31, 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our product sales are affected by the seasons, due to the seasonality of mainly heartworm, and flea and tick medications. For the quarters ended June 30, September 30, December 31, and March 31 of fiscal 2022, our sales were approximately 29%, 25%, 22%, and 24%, respectively. For the quarters ended  June 30, September 30, December 31, and March 31 of fiscal 2021, our sales were approximately 31%, 25%, 21%, and 23%, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Cost of sales</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales decreased by approximately $23.9 million, or 10.9% to $195.3 million for the fiscal year ended March&#160;31, 2022, from $219.3 million for the fiscal year ended March&#160;31, 2021. The cost of sales increase can be directly related to the increase in sales during fiscal 2022. As a percentage of sales, cost of sales was 71.4% in fiscal 2022, as compared to 70.9% in fiscal 2021. The cost of sales percentage increase was adversely impacted due to the major manufacturers, with whom we have a purchasing relationship, shifting their rebate funding from discounting product costs to more cooperative marketing rebates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Gross profit</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit decreased by approximately $11.9 million, or 13.2%, to $78.1 million for the fiscal year ended March&#160;31, 2022, from $89.9 million for the fiscal year ended March&#160;31, 2021. The decrease in gross profit can be directly related to the decrease in sales during fiscal 2022. Gross profit as a percentage of sales for fiscal 2022 was 28.6% compared to 29.1% for fiscal 2021. The decrease in the gross profit percentage was adversely impacted due to the major manufacturers, with whom we have a purchasing relationship, shifting their rebate funding from discounting product costs to more cooperative marketing rebates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">General and administrative expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased by approximately $2.5 million, or 9.0%, to $30.8 million for the fiscal year ended March&#160;31, 2022 from $28.3 million for the fiscal year ended March&#160;31, 2021. The increase in general and administrative expenses for the fiscal year ended March&#160;31, 2022 was primarily due to the following: a $1.4 million increase in payroll expenses, the majority of which related to increased stock compensation expense; a $989,000 increase in professional fees related to brand and marketing consultation, legal, and investment banking; and a $514,000 increase in other expenses which include property expenses, travel related expense, insurance expense, and other expenses. Partially offsetting the increase was a decrease of $397,000 primarily related to decreased bank service fees due to the decrease in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sales. General and administrative expenses as a percentage of sales was 11.3% for the fiscal year ended March&#160;31, 2022, compared to 9.1% for the fiscal year ended March&#160;31, 2021. </span></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Advertising expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising expenses decreased by approximately $2.8 million to $18.8 million for the fiscal year ended March&#160;31, 2022, from $21.6 million for the fiscal year ended March&#160;31, 2021. The decrease in advertising expenses for fiscal 2022 was due to receiving increased cooperative marketing funds from product manufacturers to offset our advertising expenses, within the terms of our contractual relationships. Overall advertising spending was flat compared to fiscal 2021, yet total net advertising expenses decreased due to increased cooperative advertising rebates. The advertising costs of acquiring a new customer, defined as total advertising costs divided by new customers acquired, was $58 for the fiscal year ended March&#160;31, 2022, compared to $40 for the fiscal year ended March&#160;31, 2021.  The increase to customer acquisition costs for the fiscal year ended March&#160;31, 2022, was due to an increase in overall advertising prices and a less efficient variable marketing spend. Advertising cost of acquiring a new customer can be impacted by the advertising environment, the effectiveness of our advertising creative, advertising spending, and price competition. Historically, the advertising environment fluctuates due to supply and demand. A more favorable advertising environment may positively impact future sales, whereas a less favorable advertising environment may negatively impact future sales. As a percentage of sales, advertising expense was 6.9% and 7.0% for the fiscal years ended March&#160;31, 2022, and 2021, respectively. However, the advertising percentage may fluctuate quarter to quarter due to seasonality and advertising availability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Depreciation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the fiscal year ended March&#160;31, 2022 increased slightly to approximately $2.7 million from $2.4 million for the fiscal year ended March&#160;31, 2021. This increase to depreciation expense for the fiscal year ended March&#160;31, 2022 can be attributed to new property and equipment additions in fiscal 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other income</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income decreased by approximately $0.3 million to $1.4 million for the fiscal year ended March&#160;31, 2022, from $1.6 million for the fiscal year ended March&#160;31, 2021. The decrease was related to a reduction in advertising income in fiscal 2022. Interest income was flat compared to the prior year. Interest income may decrease in the future as we utilize our cash balances on its share repurchase plan, with approximately $28.7 million remaining as of March&#160;31, 2022, on any quarterly dividend payment, on future investment/partnerships, or on its operating activities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Provision for income taxes</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal years ended March&#160;31, 2022 and 2021, we recorded an income tax provision of approximately $6.0 million and $8.6 million, respectively. The decrease to the income tax provision for fiscal 2022 is related to a decrease in operating income compared to fiscal 2021. The effective tax rate for the fiscal years ended March&#160;31, 2022 and 2021 were 22.1% and 22.0%, respectively. The slight increase to the effective rate for the fiscal year ended March&#160;31, 2022, can be attributed to receiving more one-time tax benefits in fiscal 2021 than in fiscal 2022 The one-time tax benefits received in fiscal 2021 included a one-time state income tax refund of $285,000 in the June 2020 quarter and a $135,000 income tax benefit related to restricted stock compensation in the September 2020 and March 2021 quarters. This compared to a $196,000 one-time state income tax refund and a $131,000 benefit due to a state rate reduction in the March 2022 quarter. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Net income</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income decreased by approximately $9.5 million, or 31%, to approximately $21.1 million for the fiscal year ended March&#160;31, 2022 from approximately $30.6 million for the fiscal year ended March&#160;31, 2021. The decrease to net income was primarily related to a decrease in sales and resulting gross profit, and an increase in general and administrative expenses,  partially offset by a decrease in advertising expenses, during the fiscal year.</span></div><div><span><br/></span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_61"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our working capital at March&#160;31, 2023 and 2022 was approximately $95.0 million and approximately $117.8 million, respectively. The $22.8 million decrease in working capital was primarily attributable to a decrease in income generated by </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operations and  the use of  cash to fund both the $5 million investment in the Vetster partnership and infrastructure and $5.3 million of property and equipment additions. Net cash provided by operating activities was $27.8 million and $18.5 million for the fiscal years ended March&#160;31, 2023 and 2022, respectively. This change is due to a net increase in accounts payable and accrued expenses, and a decrease in inventory due to changes in our inventory practices in the fiscal year ended March&#160;31, 2023, partially offset by lower net income. Net cash used in investing activities was $10.3 million and $1.8 million for the fiscal years ended March&#160;31, 2023 and 2022, respectively. This change in investing activities is related to the investment in the Vetster partnership and and higher levels of property and equipment additions including web development improvements acquired in fiscal 2023. Net cash used in financing activities was $24.5 million and $24.4 million for the fiscal years ended March&#160;31, 2023 and 2022, respectively, due to the payment of an aggregate  $1.20 per share dividend in each fiscal year. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we had approximately $28.7 million remaining under our share repurchase program. On May&#160;22, 2023, our Board of Directors declared a  $0.30 per share dividend, with a June&#160;6, 2023 record date and a June&#160;12, 2023 payment date. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:line-through">up</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter. When considering whether to declare a dividend, our Board of Directors will take into account:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;    General economic and business conditions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;    Our financial condition and operating results;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;    Our available cash and current and anticipated cash needs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;    Our capital requirements;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;    Strategic uses of cash for growth initiatives;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;    Contractual, legal, tax and regulatory restrictions on the payment of dividends by us; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;    Such other factors as our Board of Directors may deem relevant.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 3, 2023, we closed on our acquisition of PetCareRx  for aggregate cash consideration of approximately $36.0 million.  At March&#160;31, 2023 we had no other material outstanding purchase or lease commitments. We are not currently bound by any long- or short-term agreements for the purchase or lease of property and equipment. Any material amounts expended for property and equipment would be the result of an increase in the capacity needed to adequately provide for any future increase in our business. To date we have paid for any needed additions to our capital equipment infrastructure from working capital funds and anticipate this being the case in the future. Our primary source of working capital is cash from operations. We presently have no need for alternative sources of working capital and have no commitments.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition to the foregoing, the Company cannot predict the long-term impact on its development timelines, revenue levels and its liquidity due to the worldwide spread of COVID-19 and other macroeconomic factors, including inflationary cost pressures and potential recession indicators. Based upon the Company&#8217;s current assessment, it does not expect the impact of the COVID-19 pandemic effects and other macroeconomic factors to materially impact the Company&#8217;s operations. However, the Company is continuing to assess the impact that the continuing spread of COVID-19 and other macroeconomic factors may have on its operations.</span></div><div><span><br/></span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_64"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than disclosures included in Note 1 of the Consolidated Financial Statements, which are incorporated by reference as if fully set forth herein, we do not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, will have a material effect on our consolidated financial position, results of operations, or cash flows.</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_67"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk generally represents the risk that losses may occur in the value of financial instruments as a result of movements in interest rates, foreign currency exchange rates, and commodity prices. Our financial instruments include cash and cash equivalents, accounts receivable, and accounts payable. The book values of cash equivalents, accounts receivable, and accounts payable are considered to be representative of fair value because of the short maturity of these instruments. Interest rates affect our return on excess cash and cash equivalents. At March&#160;31, 2023, we had $104.1 million in cash and cash equivalents, and the majority of our cash and cash equivalents generate interest income based on prevailing interest rates. A significant change in interest rates would impact the amount of interest income generated from our excess cash and cash equivalents. It would also impact the market value of our cash and cash equivalents. Our cash and cash equivalents are subject to market risk, primarily interest rate and credit risk. Our cash and cash equivalents are managed by a limited number of outside professional managers within investment guidelines set by our Board of Directors. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such guidelines include security type, credit quality, and maturity, and are intended to limit market risk by maintaining cash in federally-insured bank deposit accounts and restricting cash equivalents to highly-liquid investments with a maturities of three months or less. We do not hold any derivative financial instruments that could expose us to significant market risk. At March&#160;31, 2023, we had no debt obligations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">36</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PETMED EXPRESS, INC. AND SUBSIDIARIES</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:90.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Page</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_73">Report of Independent Registered Public Accounting Firm (PCAOB ID:</a><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83MC9mcmFnOjUwZjIwOTBjOWFhNTQ4YTNiZjE4MzhlNDFjMWVlNjBiL3RhYmxlOjZkOTk1ZmIyOTg1MTRkYzg5NmQ1YWQ5YWNkYjRhYmJiL3RhYmxlcmFuZ2U6NmQ5OTVmYjI5ODUxNGRjODk2ZDVhZDlhY2RiNGFiYmJfMS0wLTEtMS0yMzc1L3RleHRyZWdpb246NWRhOGJhNjZhYTQzNDU0ZmJmN2UxYzFjMmE2NWFiZTRfNzA_a6b72f2f-a863-4e3a-a12d-76e96a56f8ae">49</ix:nonNumeric><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_73">)</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_73">38</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_76">Consolidated Balance Sheets as of </a>March&#160;31, 2023<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_76"> and </a>2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_76">39</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_79">Consolidated Statements of Income for each of the three years in the period ended </a>March&#160;31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_79">40</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_82">Consolidated Statements of Changes in Shareholders&#8217; Equity for each of the three years in the period ended </a>March&#160;31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_82">41</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_85">Consolidated Statements of Cash Flows for each of the three years in the period ended </a>March&#160;31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_85">42</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_88">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_88">43</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_136">Report of Management on Internal Control Over Financial Reporting</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_136">58</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_139">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9ecb58a0f25a461393eca5efcfd32a38_139">60</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">37</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of PetMed Express, Inc. and subsidiaries</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of PetMed Express, Inc. and its subsidiaries (the Company) as of March&#160;31, 2023 and 2022, the related consolidated statements of income, changes in shareholders&#8217; equity and cash flows for each of the three years in the period ended March&#160;31, 2023, and the related notes to the consolidated financial statements (collectively, the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of March&#160;31, 2023 and 2022, and the results of their operations and their cash flows for each of the three years in the period ended March&#160;31, 2023, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s and subsidiaries' internal control over financial reporting as of March&#160;31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013. Our report dated May&#160;23, 2023 expressed an opinion that the Company had not maintained effective internal control over financial reporting as of March&#160;31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013 .</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Matter</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (i) relate to accounts or disclosures that are material to the financial statements and (ii) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83My9mcmFnOmZmMjI0MmQ3NjY4YjQyYTk5MGE1OWY1Y2E0MDRkMDIwL3RleHRyZWdpb246ZmYyMjQyZDc2NjhiNDJhOTkwYTU5ZjVjYTQwNGQwMjBfMzMzNw_92baf9fd-f7d7-4067-b0e5-411681afaed8">RSM US LLP</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2007.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83My9mcmFnOmZmMjI0MmQ3NjY4YjQyYTk5MGE1OWY1Y2E0MDRkMDIwL3RleHRyZWdpb246ZmYyMjQyZDc2NjhiNDJhOTkwYTU5ZjVjYTQwNGQwMjBfMzMzOA_8ac18bf6-cc45-4d18-94c2-a88984eb2ea9">Fort Lauderdale, Florida</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;23, 2023</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">38</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PETMED EXPRESS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except for per share amounts)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNC0xLTEtMS0yMzc1_aa3447da-eff8-4594-a992-579c41b7cf20">104,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNC0zLTEtMS0yMzc1_738a1f9a-dc1e-48ea-bed6-f35a586882a6">111,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, less allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNS0wLTEtMS0yMzc1L3RleHRyZWdpb246NjgyZTdiNzY4OTQ4NGRhNDg1OTAyMDNiY2Q0OWFhYTZfNjU_a5b21e48-85ec-4508-860f-031986e4d6f9">35</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNS0wLTEtMS0yMzc1L3RleHRyZWdpb246NjgyZTdiNzY4OTQ4NGRhNDg1OTAyMDNiY2Q0OWFhYTZfNzI_4e998e50-83b1-4688-9e9f-790eeb4c26dc">39</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNS0xLTEtMS0yMzc1_58ec4f3b-f343-43fd-bd6b-00b65fddb93d">1,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNS0zLTEtMS0yMzc1_d35df2b1-1c20-45b7-9350-a8d761c8ce07">1,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories - finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNi0xLTEtMS0yMzc1_dcce7415-6ced-4a51-a7c8-473c1937c7fa">19,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNi0zLTEtMS0yMzc1_0de4243c-830e-4ba8-9ba0-7f66904f05ad">32,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNy0xLTEtMS0yMzc1_72253d81-e5bf-46f9-b785-491ae234c800">4,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNy0zLTEtMS0yMzc1_0c0b7312-a18d-4edf-8837-3773f5279749">4,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfOC0xLTEtMS0yMzc1_69286241-6f8a-4f45-a060-5047f6e0002c">1,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:PrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfOC0zLTEtMS0yMzc1_9749b105-82a0-49d2-a03a-1e156e2a9c8c">681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTAtMS0xLTEtMjM3NQ_8eec5112-d2f5-4b4d-86af-0ace3fe7a299">131,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTAtMy0xLTEtMjM3NQ_c69e9d20-0732-4700-b639-55ff48674c39">150,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTMtMS0xLTEtMjM3NQ_e40a3614-0f89-4759-b281-9277482ebe8a">26,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTMtMy0xLTEtMjM3NQ_dd46a9e9-1538-4108-8077-8585ef4e763b">24,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTQtMS0xLTEtMjM3NQ_1950da11-2c20-40f7-9d4e-9da37bda41e4">5,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTQtMy0xLTEtMjM3NQ_34f11394-d8ea-4e90-a7e0-1c7668d70b52">860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTUtMS0xLTEtNDY4NjE_343ba841-18c7-4a58-9fdf-98b063c39c06">628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTUtMy0xLTEtNDY4Njk_f5a33a8f-8714-4c1c-8620-1155940dc2e3">&#8211;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total noncurrent assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTYtMS0xLTEtMjM3NQ_32f4e0ee-46ef-4821-a880-1e47fc49a53b">32,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTYtMy0xLTEtMjM3NQ_f89e70fb-e8c8-47dc-b2e1-ee2ccf76e057">25,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTgtMS0xLTEtMjM3NQ_caf7d48c-65a6-4917-bbfb-152b7472642e">164,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTgtMy0xLTEtMjM3NQ_bb2d1e3d-533e-427f-957e-083adc18319a">176,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LIABILITIES AND SHAREHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjMtMS0xLTEtMjM3NQ_ebdf9af9-5d41-4f5f-bc89-5fb5f631d701">25,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjMtMy0xLTEtMjM3NQ_8f8fa9d7-8979-48d9-8914-28246621d3e6">27,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="pets:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjQtMS0xLTEtMjM3NQ_ee94923c-1d1f-44a8-9d72-bdf69457e364">11,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="pets:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjQtMy0xLTEtMjM3NQ_04cb039d-d6d0-4b08-bb82-822d0a6149cb">5,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjYtMS0xLTEtMjM3NQ_f2891451-c319-4e4d-be8a-d6f05ed53792">36,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjYtMy0xLTEtMjM3NQ_ee6ce710-f2b8-4876-8cfd-718ce7f8e2ee">33,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjgtMS0xLTEtMjM3NQ_51e7563b-5fe3-41ab-ab57-4613134a2111">&#8211;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjgtMy0xLTEtMjM3NQ_59b2af25-f28c-44ed-a0c0-c31011b3c778">936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzAtMS0xLTEtNDY5ODI_29cbb90c-0d61-4c71-a7ce-742dbd35708b">3,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzAtMy0xLTEtNDY5OTA_bfc30073-b6ee-4a06-b660-a84afdd5bf9e">&#8211;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzAtMS0xLTEtMjM3NQ_73204927-8aa6-46ae-9512-4460ef795d9f">40,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzAtMy0xLTEtMjM3NQ_0dcd470d-4159-43b7-89b7-c00bec272e6c">34,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzItMS0xLTEtMjM3NQ_553aeb59-0edf-4c90-b611-960f02e752e2"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzItMy0xLTEtMjM3NQ_f84141f1-2551-4e4a-88b3-0db5c8febd9e"></ix:nonFraction></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders' equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzIx_3c851fa3-c5e5-411d-bc4f-405743745f15"><ix:nonFraction unitRef="usdPerShare" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzIx_46c2ea72-8a94-4deb-b463-2a11134b54ee">.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzM1_1c98ec42-6c16-4db6-b27d-66039a1edab5"><ix:nonFraction unitRef="shares" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzM1_a84040dd-4c03-45c4-8c74-bed924bab26b">5,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzU3_15d279e4-b2cb-46d7-8060-bf5b234e88d5"><ix:nonFraction unitRef="shares" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzU3_33d54900-0b69-4c06-8b9f-ae1a592b0a82"><ix:nonFraction unitRef="shares" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzU3_508fd268-8ff8-4640-9c9c-6c1470b5b0c3"><ix:nonFraction unitRef="shares" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzU3_9c3566a4-13ce-45fa-944a-93f06015a84e">3</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> convertible shares issued and outstanding with a liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzEzNQ_d5d3f869-705a-4dc7-937c-36f6e853bc82"><ix:nonFraction unitRef="usdPerShare" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzEzNQ_f01a4ea6-5066-4855-987e-acc26089b7c0">4</ix:nonFraction></ix:nonFraction> per share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMS0xLTEtMjM3NQ_604f386a-e494-42ce-bf5f-fbc788289606">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMy0xLTEtMjM3NQ_06af4464-553f-4ff5-8fe0-a111d8cc9fba">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzE4_a5837df7-42b5-4967-b7e4-e099a8d0efe0"><ix:nonFraction unitRef="usdPerShare" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzE4_fd47d065-d204-49ca-873c-409c25a40d8f">.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzMy_d4f0d3a9-d89c-47ed-9395-ebff57589250"><ix:nonFraction unitRef="shares" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzMy_e1c18375-8011-4a47-b2e0-b37a25585345">40,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzU0_37e4ad86-c459-481d-b7da-eac52bc4a625"><ix:nonFraction unitRef="shares" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzU0_445ef6d9-94a0-41bd-ad78-071c7bb32dc2">21,084</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzYx_1d83efe2-abc7-4d94-ae54-0a7818ace439"><ix:nonFraction unitRef="shares" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzYx_7519cef8-5e50-4f55-bddf-c5836ec4edec">20,979</ix:nonFraction></ix:nonFraction> shares issued and outstanding, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMS0xLTEtMjM3NQ_4c06692b-474a-4fc8-a333-4a74d180405b">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMy0xLTEtMjM3NQ_4bcc9b35-d3b8-48b9-9b81-ff4e076262c7">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzctMS0xLTEtMjM3NQ_4da5f399-9233-47e3-9364-383744627cf7">18,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzctMy0xLTEtMjM3NQ_72a55746-346d-4b8a-bf84-d42170067069">11,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzgtMS0xLTEtMjM3NQ_ba1f7e2b-ee2a-47d0-968c-fbf89321746c">105,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzgtMy0xLTEtMjM3NQ_644f7bfd-56e9-459e-ac72-9cae8e5d85b3">130,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders' equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNDAtMS0xLTEtMjM3NQ_f1fa5dc1-4ce0-43c5-b936-a0434d048790">123,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNDAtMy0xLTEtMjM3NQ_635e1548-5123-461a-a86e-9f1c5149b438">142,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNDItMS0xLTEtMjM3NQ_2f2a1de5-3482-4d1f-8a8c-16b480b05748">164,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNDItMy0xLTEtMjM3NQ_92028c26-1e95-4ba3-9633-9243158df3d9">176,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">39</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PETMED EXPRESS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except for per share amounts)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMy0xLTEtMS0yMzc1_79bf46b7-49a0-4e13-861a-167f9aa577df">256,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMy0zLTEtMS0yMzc1_d1185e71-6ac9-4ee5-b056-bd981176e964">273,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMy01LTEtMS0yMzc1_d9788913-b60e-486d-a735-c12d18aad1d2">309,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfNC0xLTEtMS0yMzc1_7be41f1b-bed9-47a2-b358-158999b7b72d">185,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfNC0zLTEtMS0yMzc1_18e21fa0-0f05-4959-9abb-8a06c26a3e34">195,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfNC01LTEtMS0yMzc1_35c32b6e-7c72-4244-a995-d09a6a674ab6">219,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfNi0xLTEtMS0yMzc1_20c7fffb-9433-40c7-abab-d3142c2ae5b0">71,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfNi0zLTEtMS0yMzc1_bd5ac786-68b7-4b73-afe4-9100ac204917">78,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfNi01LTEtMS0yMzc1_2193baf7-0fca-4794-95d9-25bef2f17d5f">89,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfOS0xLTEtMS0yMzc1_2f034576-680d-41f2-9670-f12d0cb56b25">49,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfOS0zLTEtMS0yMzc1_aa8228f0-b1f9-46a5-a95f-8135a52ab401">30,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfOS01LTEtMS0yMzc1_a49b0c49-aba4-433c-b0a4-031123d5e7ab">28,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTAtMS0xLTEtMjM3NQ_626ed563-bea9-4aec-a880-bb300e759eb1">19,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTAtMy0xLTEtMjM3NQ_21c9d5a6-a658-4002-a539-45173d978714">18,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTAtNS0xLTEtMjM3NQ_cc6dca2f-ace4-455f-8652-75c86d9d30b4">21,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTEtMS0xLTEtMjM3NQ_1f57b94c-2669-41b1-a198-b811506a6bf8">3,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTEtMy0xLTEtMjM3NQ_33fc5639-c9bf-4f12-af0e-4c8b0ba80837">2,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTEtNS0xLTEtMjM3NQ_a9d9729f-ed39-4c0c-a1ce-735769c67fa2">2,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTItMS0xLTEtMjM3NQ_84c38e6f-2f01-4c76-9059-1a3e46e0c1d4">72,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTItMy0xLTEtMjM3NQ_30852859-897c-4ec6-9c5a-5f5fc9c65cc8">52,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTItNS0xLTEtMjM3NQ_dab2cf7e-458e-482c-a0fa-abcae076e805">52,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTQtMS0xLTEtMjM3NQ_25429755-855f-4cc3-a323-0f7c9d0a7080">1,430</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTQtMy0xLTEtMjM3NQ_88ac6a93-9a24-4290-9676-21c10aebc8d4">25,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTQtNS0xLTEtMjM3NQ_13d7a910-7759-4195-93a4-c73bf2bbc01c">37,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTctMS0xLTEtMjM3NQ_1e44c04a-1dbc-4cc4-a3a1-3647fd26db83">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTctMy0xLTEtMjM3NQ_3ad864c6-8b69-4812-90f5-987cdadf81aa">335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTctNS0xLTEtMjM3NQ_167bbee1-8732-4906-9b9f-2296e8bc7040">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTgtMS0xLTEtMjM3NQ_dbe2b274-c682-453a-a594-d58a9b19a1f7">944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTgtMy0xLTEtMjM3NQ_20e45602-3272-4304-8d9c-a6f27bfd5802">1,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTgtNS0xLTEtMjM3NQ_ebfb5d53-a398-4888-bf79-166320340dfe">1,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTktMS0xLTEtMjM3NQ_03417507-b2de-4b5a-81ed-aa11f27cfa6d">3,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTktMy0xLTEtMjM3NQ_a52f62d8-cdbd-45f9-ad12-db6d75d70cf6">1,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTktNS0xLTEtMjM3NQ_35fbe69a-964c-46da-9484-c09647c03a96">1,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjEtMS0xLTEtMjM3NQ_bd927f07-d118-427d-8499-8f23f58cb76c">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjEtMy0xLTEtMjM3NQ_d8dcb703-796f-4491-85eb-c8fffec9690f">27,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjEtNS0xLTEtMjM3NQ_3457ffb8-7b9b-4e67-b692-810d827a5ab8">39,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjMtMS0xLTEtMjM3NQ_a689c7bb-1078-47bd-9705-19a4966f9a60">1,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjMtMy0xLTEtMjM3NQ_c535e803-2e13-460f-b54a-8ca130149858">5,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjMtNS0xLTEtMjM3NQ_8de28684-21d9-459f-b33d-ebfbc6397c42">8,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjUtMS0xLTEtMjM3NQ_b0b879c1-d383-410f-82f6-788ecb51a526">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjUtMy0xLTEtMjM3NQ_cd21e5e9-a3b1-404a-b44e-502b37e2ba78">21,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjUtNS0xLTEtMjM3NQ_b37b92ad-6302-4c1c-9722-1599e99b008d">30,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjgtMS0xLTEtMjM3NQ_d2bfa01c-5a29-4917-ac8a-c8b57d6cb921">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjgtMy0xLTEtMjM3NQ_cd71d48f-7fea-42f3-ac1c-4dcc52bdc801">1.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjgtNS0xLTEtMjM3NQ_c1dde608-280e-42e5-a7f7-3ef179fa31ea">1.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjktMS0xLTEtMjM3NQ_310a9d87-3c9d-4890-ad9c-31a332bc8486">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjktMy0xLTEtMjM3NQ_4ff76ea3-5102-4d22-af2e-527b972b54cc">1.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjktNS0xLTEtMjM3NQ_341ca90e-d139-4023-844a-f76312e36e42">1.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzItMS0xLTEtMjM3NQ_caaab262-9e9c-415f-b508-c1817251a4a3">20,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzItMy0xLTEtMjM3NQ_d5af1298-eb0c-46f5-a6de-2b144b7cee44">20,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzItNS0xLTEtMjM3NQ_43703929-3717-458e-8737-57ed602d93fe">20,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzMtMS0xLTEtMjM3NQ_341bc466-6949-4767-80a3-cccf357ea1a8">20,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzMtMy0xLTEtMjM3NQ_51f9369a-7607-45fa-9b11-d0fa60d21797">20,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzMtNS0xLTEtMjM3NQ_0d1d058d-0425-47c6-8807-565c73abde28">20,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzUtMS0xLTEtMjM3NQ_c59059b5-129b-4d95-b0bb-6cbed7c9d83e">1.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzUtMy0xLTEtMjM3NQ_67dd887f-eb29-4d2f-bb60-07fc22c9bd32">1.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzUtNS0xLTEtMjM3NQ_7daa72a1-8985-4800-88c8-6ed8022212c7">1.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">40</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PETMED EXPRESS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years ended March&#160;31, 2021, March&#160;31, 2022, and March&#160;31, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.056%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Convertible<br/>Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2b4c181220f4db39c9e0becba7ebc10_I20200331" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMy0xLTEtMS0yMzc1_6aa455fc-0628-428c-bb6e-bb3a23b1cc87">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2b4c181220f4db39c9e0becba7ebc10_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMy0zLTEtMS0yMzc1_fd1b8126-a048-4a8f-93c5-c46a63f98bd6">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79b8b340525c4eb8a08f09d3a55ef8a2_I20200331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMy01LTEtMS0yMzc1_9b90263b-b296-43b5-bd64-f98f3d45a841">20,166</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b8b340525c4eb8a08f09d3a55ef8a2_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMy03LTEtMS0yMzc1_135f3042-69b9-4f3d-b875-2fe6bfd1f0d4">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a927b1cae4d427ca9524b822d0e3777_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMy05LTEtMS0yMzc1_d6d617c7-85e9-4c3d-88e3-eba90baf5388">3,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6297e382c64245aba14e3a8758776fd1_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMy0xMS0xLTEtMjM3NQ_581cc90a-e9e4-497e-8338-6c12fdbd2c24">126,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77867fa115ad4229b78a690feec18c68_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMy0xMy0xLTEtMjM3NQ_0656e63d-b5b7-4be8-80ce-ad1d0c8adabe">130,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock, net</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i783e64f7e14c4d83b9dd294bf39fd8e0_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfNS01LTEtMS0yMzc1_da397f65-2893-4a22-a31b-57218ba2c3ff">103</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58e3d762d5314a6990e530bcd4c4d18d_D20200401-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfNy05LTEtMS0yMzc1_65a941d7-827f-4543-b418-95479e511c76">3,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfNy0xMy0xLTEtMjM3NQ_5c2188d5-7c51-4f7b-b3d0-f523aaf9054c">3,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9f02128e65f491da7c5d94342b58dc4_D20200401-20210331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTEtMTEtMS0xLTIzNzU_108b2168-b3be-4210-b96c-a766acc4a76e">22,639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTEtMTMtMS0xLTIzNzU_e5a1dd15-a61f-4f21-9abf-f683f98399ad">22,639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f02128e65f491da7c5d94342b58dc4_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTMtMTEtMS0xLTIzNzU_1d9ef895-2ac6-481a-a389-3abf51d618d8">30,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTMtMTMtMS0xLTIzNzU_563a9182-1523-40b2-ba61-23a7b035bdf6">30,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd67589c03824ef980cf575bb38a75f9_I20210331" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTUtMS0xLTEtMjM3NQ_1e950cdd-7d36-4973-b2c7-00eeefd28af3">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd67589c03824ef980cf575bb38a75f9_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTUtMy0xLTEtMjM3NQ_62614b78-67ce-4e7e-98fa-0e9fbabe6fbe">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c9234aa9292474bad6f7065593e5f0b_I20210331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTUtNS0xLTEtMjM3NQ_9768811e-7379-4b23-bb3c-2f9c7cd50f36">20,269</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c9234aa9292474bad6f7065593e5f0b_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTUtNy0xLTEtMjM3NQ_18e91b2f-84fe-44cf-ac93-ccc3090b6eb9">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdec80ecca1749bf87b375959dbfc52b_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTUtOS0xLTEtMjM3NQ_83852823-6d70-4f22-bafa-c89b4f767bde">7,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b4c2f87185043989137055d2cf642fa_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTUtMTEtMS0xLTIzNzU_e76be814-3145-43c7-baca-cb2f9f5281b2">134,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18b907b4447547178f92755a7a787369_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTUtMTMtMS0xLTIzNzU_696d78dc-71fe-4763-9fde-cb510ce9bc5e">141,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock, net</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i019127a3a95243a6ae3e4c850c18876f_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTctNS0xLTEtMjM3NQ_14c65d40-a1d2-4ef6-a185-99305e4b7a34">710</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i019127a3a95243a6ae3e4c850c18876f_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTctNy0xLTEtMjM3NQ_2c4505aa-e0a5-415d-a585-ebc4e947c627">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTctMTMtMS0xLTIzNzU_af4f4cf6-2ed0-46db-b77b-a3080067cd44">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f72edc903074ac9927be8cc9b515cf9_D20210401-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTktOS0xLTEtMjM3NQ_2a61c069-19f2-4a33-ab80-852940686f3a">4,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTktMTMtMS0xLTIzNzU_43587b7c-35fd-4749-8a47-e9fe4999d10c">4,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i720e3acebcb8463bb9efd73321969a20_D20210401-20220331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjEtMTEtMS0xLTIzNzU_c68a4a71-5e59-41d0-8d94-22c06e16de4d">24,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjEtMTMtMS0xLTIzNzU_bb0399fd-8a4f-4897-8df5-8555d6281611">24,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720e3acebcb8463bb9efd73321969a20_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjMtMTEtMS0xLTIzNzU_ecc03ea8-73d4-4cf5-a75d-7adaa98d72aa">21,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjMtMTMtMS0xLTIzNzU_d2955d76-1810-4df8-96b3-ba69e204b243">21,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id57c020e5fba46ae82ba2f4abefb2b4e_I20220331" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjUtMS0xLTEtMjM3NQ_da1dd40e-0f47-47e1-b7c4-269842154cd8">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57c020e5fba46ae82ba2f4abefb2b4e_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjUtMy0xLTEtMjM3NQ_d9c13f25-cc37-49cd-a549-0f65c940afce">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec836f5f293f4210978b95ba487a929f_I20220331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjUtNS0xLTEtMjM3NQ_18af31c3-cbcb-47d4-9bef-17c7ae5e107c">20,979</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec836f5f293f4210978b95ba487a929f_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjUtNy0xLTEtMjM3NQ_1b4ce978-c294-4c98-93c7-418b494c449e">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i334440618f40456d855578e189633732_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjUtOS0xLTEtMjM3NQ_9a68b809-9700-4441-97a7-2be1700fdd31">11,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacce33dd5fc6414cb3f16213192efa4d_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjUtMTEtMS0xLTIzNzU_c0b303e0-5d3b-461f-9a67-9b1b8968aa51">130,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjUtMTMtMS0xLTIzNzU_5b0a47c2-88cf-428e-ba09-f1e1d9be664b">142,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock, net</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibdbd311dff074129bf3e72c5fa9aa7b6_D20220401-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjctNS0xLTEtMjM3NQ_49e898ad-668f-4baa-b791-1481dee1e9f9">105</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93b7f39ad4204f01a6bd5a6bc7e705f0_D20220401-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjktOS0xLTEtMjM3NQ_8dc047ce-d1c3-409f-b8b2-90505993ffd4">6,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjktMTMtMS0xLTIzNzU_52a5cf8b-a5e4-48cb-a71c-d082567b2955">6,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdc896f1488b4f28b0e4be3ebf752847_D20220401-20230331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzEtMTEtMS0xLTIzNzU_7555c55c-9446-4786-a577-47a0bdd3e2a6">25,241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzEtMTMtMS0xLTIzNzU_a92b3fcd-51ca-4bd6-918d-c6a771c2b0b1">25,241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdc896f1488b4f28b0e4be3ebf752847_D20220401-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzMtMTEtMS0xLTIzNzU_180dafef-2f9b-4b36-a1e2-4a38d50bee47">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzMtMTMtMS0xLTIzNzU_70ec8acd-c6b4-4791-96c4-76019876945a">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbfe4071fa8748809761483ffc9187bb_I20230331" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzUtMS0xLTEtMjM3NQ_4d03b4b4-1931-4375-999d-d7982bdc2680">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbfe4071fa8748809761483ffc9187bb_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzUtMy0xLTEtMjM3NQ_4d7a99c1-1ee3-4216-958c-fbd09d3a968b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa78064ed1984d9f9c65b1990c55e3c4_I20230331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzUtNS0xLTEtMjM3NQ_a1a66b88-c01f-4073-bcac-cf6cb40b6e9f">21,084</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa78064ed1984d9f9c65b1990c55e3c4_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzUtNy0xLTEtMjM3NQ_98fdafde-ae0b-487f-86da-097f45aa6951">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71efad11f57045af997e37ccc67cbd53_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzUtOS0xLTEtMjM3NQ_d0604cce-15c8-44c2-b3e9-b46e38157a67">18,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icef79238d6ce4776ae259ffdd5d344cc_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzUtMTEtMS0xLTIzNzU_18615d1e-bbe1-4cc3-8f99-3bb1978fe689">105,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzUtMTMtMS0xLTIzNzU_fc02745e-d9d8-4bca-aea4-8a18cf01d92e">123,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">41</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PETMED EXPRESS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMy0xLTEtMS0yMzc1_de0f4ee4-0b81-40a7-9e4c-abd1095f0b5a">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMy0zLTEtMS0yMzc1_8c7a18a7-f087-4b0e-94ec-5ff716bb5b4a">21,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMy01LTEtMS0yMzc1_497ad03f-bb41-416d-845e-662f7c045355">30,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNS0xLTEtMS0yMzc1_31abed63-09ef-4d35-8fb5-6878f8dab3fd">3,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNS0zLTEtMS0yMzc1_34aa7ee9-c6b6-43f8-9f49-343323986575">2,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNS01LTEtMS0yMzc1_fd139dba-535c-4633-9552-c2461dd3db81">2,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNi0xLTEtMS0yMzc1_f65532d0-c02e-4e13-8efc-d9b202b18e5c">6,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNi0zLTEtMS0yMzc1_d4bc9f76-4243-4fc7-8a61-00c9e0d5d3d0">4,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNi01LTEtMS0yMzc1_ccf4d3e1-2e27-461c-955a-0a60f434f012">3,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNy0xLTEtMS0yMzc1_7285c290-8555-40c0-88de-062f53063d66">1,564</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNy0zLTEtMS0yMzc1_61d0bb84-af71-468c-862e-cc6838041112">345</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNy01LTEtMS0yMzc1_0649364c-505c-4ef8-8269-e5a518cf22e1">311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfOC0xLTEtMS0yMzc1_c12a03fd-f905-41e3-8df9-07388edf42ec">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfOC0zLTEtMS0yMzc1_259fe610-1300-4156-9c57-daf50cf309ed">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfOC01LTEtMS0yMzc1_b00e4467-5c4e-4b88-a57c-0527b5584ae7">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Increase) decrease in operating assets and increase (decrease) in liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTAtMS0xLTEtMjM3NQ_e851f67e-e5f9-4b34-b6d7-55bc80333b5f">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTAtMy0xLTEtMjM3NQ_68e94e96-5d0d-4b71-9757-be9b7be35fb9">509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTAtNS0xLTEtMjM3NQ_ec43c124-b6f3-4886-871b-9982c74f016d">1,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories - finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTEtMS0xLTEtMjM3NQ_37d0c18e-a58d-4ad3-aa8f-5ad3c8583f7b">13,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTEtMy0xLTEtMjM3NQ_b57140bc-8429-4c62-99f2-7d72d8678713">1,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTEtNS0xLTEtMjM3NQ_eb028268-f774-4315-81c0-e95bdc2ebd6f">16,536</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTItMS0xLTEtMjM3NQ_6316115e-0459-46c1-a2bd-78e315fac611">1,202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTItMy0xLTEtMjM3NQ_a2b40924-306d-4431-82ab-99121e850831">278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTItNS0xLTEtMjM3NQ_1f481654-3664-4055-ab42-a00bfe2a2a4c">959</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTMtMS0xLTEtMjM3NQ_45c28604-8f33-4c89-bdf8-8234f1774173">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTMtMy0xLTEtMjM3NQ_d069691e-06c7-4a1a-93cf-dbc5dec171ba">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTMtNS0xLTEtMjM3NQ_2eb731b5-56a5-465f-bce8-394b0c687db5">974</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTQtMS0xLTEtMjM3NQ_d657fd33-9536-4745-84f8-cfefa6d608bd">2,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTQtMy0xLTEtMjM3NQ_f478fdb4-30ea-494d-b84d-8cc7b0d7fcbd">12,048</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTQtNS0xLTEtMjM3NQ_3a27c9ef-ea0c-46b6-a008-afff095441de">19,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTUtMS0xLTEtMjM3NQ_b24f3cd0-d894-4fcd-8b48-bc2ef995302a">8,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTUtMy0xLTEtMjM3NQ_d6f13907-96d3-4f32-a79f-e83c94e41199">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTUtNS0xLTEtMjM3NQ_bebef5df-6829-4286-8a11-5711a41a85ab">1,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTYtMS0xLTEtMjM3NQ_ff77e6d3-a15c-48c9-9c64-51e9d96a344b">&#8211;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTYtMy0xLTEtMjM3NQ_166b7779-f19e-4672-abe2-364edc0ffc66">&#8211;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTYtNS0xLTEtMjM3NQ_d22a1d6d-e556-4ba3-85d0-fb969f0fd250">471</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTctMS0xLTEtMjM3NQ_8379d842-3621-4975-8ea4-671bd7b8e742">27,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTctMy0xLTEtMjM3NQ_705fc710-b734-4efe-af53-d30c97afcf95">18,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTctNS0xLTEtMjM3NQ_b8e0626a-65ba-4d67-812b-6789dbb205c4">40,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of minority interest investment in Vetster</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjAtMS0xLTEtMjUxNTU_8caa7831-042b-4647-b589-99b4629ac528">5,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjAtMy0xLTEtMjUxNTk_f02951d1-54a4-4627-ac88-45740efce801">&#8211;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjAtNS0xLTEtMjUxNjg_eb3f7682-1deb-473d-be28-98f763bfd4a8">&#8211;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjAtMS0xLTEtMjM3NQ_0eb0ec59-d284-4db5-8b7a-cf3fe2585806">5,260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjAtMy0xLTEtMjM3NQ_c61e5d3d-428a-477a-9587-6ced0357630a">1,752</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjAtNS0xLTEtMjM3NQ_9de354c8-018c-415a-87f5-d0097d6ff0f1">2,432</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjEtMS0xLTEtMjM3NQ_8f86ebcb-8900-4bfb-9da3-09310badb2c6">10,260</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjEtMy0xLTEtMjM3NQ_bb63ddf5-fd33-4bbc-ab3b-371f0a868128">1,752</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjEtNS0xLTEtMjM3NQ_69632b09-7cc8-4e85-8fa3-af080c879eda">2,432</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjQtMS0xLTEtMjM3NQ_4e75c44a-1e43-448a-9bf9-20664840b06c">24,537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjQtMy0xLTEtMjM3NQ_61009a0f-46a8-4b24-bbec-09310717798d">24,384</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjQtNS0xLTEtMjM3NQ_9d453e24-353a-47b1-a70f-13b34f1b21bf">22,687</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjYtMS0xLTEtMjM3NQ_3c65f63e-2483-4516-9d39-6cf479688549">24,537</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjYtMy0xLTEtMjM3NQ_4d63b3f0-79d5-4b15-a4e9-f7a8cfa1a318">24,384</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjYtNS0xLTEtMjM3NQ_c9e9f692-e181-4283-aed0-26352fa5efe1">22,687</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjgtMS0xLTEtMjM3NQ_45cd6530-4d8f-4085-b4de-c3cdffdb8a8c">6,994</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjgtMy0xLTEtMjM3NQ_d2a990c6-691b-402c-bb2f-b70efca46719">7,638</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjgtNS0xLTEtMjM3NQ_b225042b-d80b-4604-a815-585859917524">14,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzAtMS0xLTEtMjM3NQ_d27452ce-2faa-46fa-b7e6-365b3ce35ca5">111,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18b907b4447547178f92755a7a787369_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzAtMy0xLTEtMjM3NQ_9b26a215-8c5f-4a79-95ba-9e5ffa443ec1">118,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77867fa115ad4229b78a690feec18c68_I20200331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzAtNS0xLTEtMjM3NQ_bce7b0ef-9f01-47bd-9fd9-41a83637a9bd">103,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, at end of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzItMS0xLTEtMjM3NQ_10bd4ee3-6480-44fb-87a9-3d98383630a0">104,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzItMy0xLTEtMjM3NQ_30cf4159-1369-4505-b268-9afc5fa7428a">111,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18b907b4447547178f92755a7a787369_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzItNS0xLTEtMjM3NQ_5887bbc1-6e9c-4059-9955-14b17dd1e9ae">118,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzYtMS0xLTEtMjM3NQ_8d6a2169-d338-440e-b004-aed8401b23f7">4,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzYtMy0xLTEtMjM3NQ_c457f53e-1c27-4de9-9d70-afef404502a2">6,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzYtNS0xLTEtMjM3NQ_f62ea809-e4d0-4daf-a5dc-5b8877190cab">10,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable in accrued expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:LiabilitiesAssumed1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNDAtMS0xLTEtMjM3NQ_97ee71e6-8e53-4758-ba01-085a857f9d2b">1,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:LiabilitiesAssumed1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNDAtMy0xLTEtMjM3NQ_bbfeac13-d50f-45d2-a90a-7a858561f333">558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:LiabilitiesAssumed1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNDAtNS0xLTEtMjM3NQ_bbc577f9-7480-448e-86b8-331fca80e42e">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">42</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_88"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:120%"> </span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_91"></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MjQ_b31856bd-130e-4602-85eb-61bbdf5400d6" continuedAt="i704881cbaa334272b3247bc22b987bc8" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i704881cbaa334272b3247bc22b987bc8" continuedAt="i2eb0f6006fc74603b6c920a0b8465a72"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PetMed Express, Inc. and subsidiaries, d/b/a PetMeds&#174; (collectively, the "Company"), is a leading nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses. The Company markets and sells directly to consumers through its websites, toll-free numbers, and mobile applications. The Company offers consumers an attractive alternative for obtaining pet medications, foods, and supplies in terms of convenience, price, speed of delivery, and valued customer service.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Founded in 1996, the Company's executive headquarters offices are currently located in Delray Beach, Florida. The Company has a March 31 fiscal year and references herein to fiscal 2023, 2022, or 2021 refer to the Company's fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively.</span></div><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MjE_95c811a3-b44e-426b-9968-438514c7fff2" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and include PetMed Express, Inc. and its  wholly owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MTk_a5c1b3b1-5f67-46fe-9397-2fd5b665fa0b" continuedAt="i60f9a5f1fe584416885dd2ea3ca744d4" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates revenue by selling pet medication products and pet supplies. Certain pet supplies offered on the Company&#8217;s website are drop shipped to customers. The Company considers itself the principal in the arrangement because the Company controls the specified good before it is transferred to the customer. Revenue contracts contain one performance obligation, which is delivery of the product. Customer care and support is deemed not to be a material right to the contract. The transaction price is adjusted at the date of sale for any applicable sales discounts and an estimate of product returns, which are estimated based on historical patterns; however, this is not considered a key judgment.  Revenue is recognized when control transfers to the customer at the point in time in which shipment of the product occurs. This key judgment is determined as the shipping point represents the point in time in which the Company has a present right to payment, title has transferred to the customer, and the customer has assumed the risks and rewards of ownership. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outbound shipping and handling fees are an accounting policy election and are included in sales as the Company considers itself the principal in the arrangement given responsibility for supplier selection and discretion over pricing. Shipping costs associated with outbound freight after control over a product has transferred to a customer are an accounting policy election and are accounted for as fulfillment costs and are included in cost of sales.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)&#160;&#160;&#160;&#160;Summary of Significant Accounting Policies (Continued)</span></div></div><ix:continuation id="i2eb0f6006fc74603b6c920a0b8465a72" continuedAt="i8e6af7f1b34642f7b97da522d2915331"><ix:continuation id="i60f9a5f1fe584416885dd2ea3ca744d4"><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disaggregates sales in the following two categories: (1) reorder sales vs new order sales, and (2) internet sales vs call center sales. <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MjI_a654d18f-3b46-4105-ab62-0ed6c4892afb" continuedAt="iff30ae63997f4985b8dd6bb9eaab2d1d" escape="true">The following table illustrates sales by various classifications:</ix:nonNumeric></span></div><ix:continuation id="iff30ae63997f4985b8dd6bb9eaab2d1d"><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"></td><td style="width:29.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales (In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reorder sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c0530e258a4275a1cb7f76f5abe23b_D20220401-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMy0xLTEtMS0yMzc1_7e6920eb-ca95-4f17-9446-f625aa16c469">232,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03c0530e258a4275a1cb7f76f5abe23b_D20220401-20230331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMy0zLTEtMS0yMzc1_94ef7964-ec10-445f-ad8e-92a4a8cbebbe">90.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c2721102f674c4aa792ac925c98947d_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMy01LTEtMS0yMzc1_1afdcc1f-ddf3-4d7f-985c-a529d37755fc">244,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c2721102f674c4aa792ac925c98947d_D20210401-20220331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMy03LTEtMS0yMzc1_a4b1b0c6-b2f9-4f23-99a5-f52b51e86f50">89.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03c0530e258a4275a1cb7f76f5abe23b_D20220401-20230331" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMy05LTEtMS0yMzc1_ff7967a8-69f2-43ba-8066-3a92a25a93d0">11,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i03c0530e258a4275a1cb7f76f5abe23b_D20220401-20230331" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMy0xMS0xLTEtMjM3NQ_c6a2a2cf-8ad8-4634-9b88-06cc0d5facb4">4.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New order sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a150376f36844e98abbac7a0ca44c05_D20220401-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNC0xLTEtMS0yMzc1_6c226187-bf23-4b42-bb5c-fd787198a693">24,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a150376f36844e98abbac7a0ca44c05_D20220401-20230331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNC0zLTEtMS0yMzc1_6b60b596-8954-4338-b468-c1407e17f445">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i355171bb92204bbb82826b85e8bf5b37_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNC01LTEtMS0yMzc1_2060f07b-d50b-4d94-97b9-bb96e7325842">28,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i355171bb92204bbb82826b85e8bf5b37_D20210401-20220331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNC03LTEtMS0yMzc1_52d9ab56-39ff-4285-b125-f49a1b272043">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a150376f36844e98abbac7a0ca44c05_D20220401-20230331" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNC05LTEtMS0yMzc1_b9707769-812d-44a5-a187-1c1adb383465">4,687</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i0a150376f36844e98abbac7a0ca44c05_D20220401-20230331" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNC0xMS0xLTEtMjM3NQ_3309979e-4b5b-44f5-acf6-6a497d5b56b1">16.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNi0xLTEtMS0yMzc1_7bbdd364-d318-4ea1-aaba-10ec0a16e212">256,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNi0zLTEtMS0yMzc1_7114bc31-5a50-4c0e-a7b1-d7121a5414b2">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNi01LTEtMS0yMzc1_49081fe9-edc8-4bf1-9e30-bb4e01f2a267">273,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNi03LTEtMS0yMzc1_69e571c3-5bbc-4778-85ef-39ac2d527ea6">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNi05LTEtMS0yMzc1_2b0540ac-fe3d-47fa-b8e5-ba6f6c60509e">16,559</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNi0xMS0xLTEtMjM3NQ_0cda8670-bb76-474d-ae79-787ea9e8a231">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internet sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25eddc1271dc4574990d86ce132c99cc_D20220401-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOC0xLTEtMS0yMzc1_75bb4dc4-c1bd-4a7d-88aa-28205cb018b5">221,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i25eddc1271dc4574990d86ce132c99cc_D20220401-20230331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOC0zLTEtMS0yMzc1_212efa5d-e4bf-4bbe-a3a3-97e3ae52fa37">86.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf2f8f507c6540bfbb2862fd908a210f_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOC01LTEtMS0yMzc1_f0d5748a-00b4-4d20-9ae6-20db42d9b410">230,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf2f8f507c6540bfbb2862fd908a210f_D20210401-20220331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOC03LTEtMS0yMzc1_1a9a2b1d-ec1d-4bf7-aee9-c7ee2991ca49">84.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25eddc1271dc4574990d86ce132c99cc_D20220401-20230331" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOC05LTEtMS0yMzc1_79edb6ef-1dc4-45b5-b11a-30c7e4fe84b8">8,369</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i25eddc1271dc4574990d86ce132c99cc_D20220401-20230331" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOC0xMS0xLTEtMjM3NQ_dfded334-66d7-4cc2-805b-403f5bea7db1">3.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Call center sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09000bea25814401814d1dc5f414ac60_D20220401-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOS0xLTEtMS0yMzc1_a50700fc-74d4-47e9-96af-fc02ef2a5d05">34,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09000bea25814401814d1dc5f414ac60_D20220401-20230331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOS0zLTEtMS0yMzc1_841ae2b9-60c6-41fc-8c8a-ecc131f542f3">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7e6d5eacd904a1ab0d4099df9b503b8_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOS01LTEtMS0yMzc1_da6c7cf9-f800-47df-9560-2d4683c6f89f">43,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib7e6d5eacd904a1ab0d4099df9b503b8_D20210401-20220331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOS03LTEtMS0yMzc1_73528f54-71a3-4ee0-8b3b-b326bb8eb498">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09000bea25814401814d1dc5f414ac60_D20220401-20230331" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOS05LTEtMS0yMzc1_11809235-ff56-43ee-b6be-3a484ef5190a">8,190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i09000bea25814401814d1dc5f414ac60_D20220401-20230331" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOS0xMS0xLTEtMjM3NQ_602a7383-ace0-477b-b9b3-b9ae8488efe9">19.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMTEtMS0xLTEtMjM3NQ_aa00a4e0-dd3d-40cf-a365-ab51aa110fab">256,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMTEtMy0xLTEtMjM3NQ_a5684f79-a508-462a-91fb-1f79acfc396a">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMTEtNS0xLTEtMjM3NQ_f0ada208-8167-4fed-96d8-30874d9b8ebc">273,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMTEtNy0xLTEtMjM3NQ_fafae6de-1233-42b9-a6ba-39954b5d07ee">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMTEtOS0xLTEtMjM3NQ_8b556b91-cfce-4161-a162-1d4e07a54fc9">16,559</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMTEtMTEtMS0xLTIzNzU_c64873f1-44fb-426a-9e9c-c5957870627e">6.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"></td><td style="width:29.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales (In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reorder sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c2721102f674c4aa792ac925c98947d_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMy0xLTEtMS0yMzc1_e3ab1fe0-7271-49db-aa71-75f384c32a5f">244,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c2721102f674c4aa792ac925c98947d_D20210401-20220331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMy0zLTEtMS0yMzc1_96b0ed4f-c020-4347-ae6e-57037b2132e3">89.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ac40e1ea4424774953a5e7ade0e7c7f_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMy01LTEtMS0yMzc1_dbceaeb5-5306-4f87-b2e6-6f076a0df57e">263,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ac40e1ea4424774953a5e7ade0e7c7f_D20200401-20210331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMy03LTEtMS0yMzc1_ac58c6c9-0814-418d-b717-307659385269">85.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c2721102f674c4aa792ac925c98947d_D20210401-20220331" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMy05LTEtMS0yMzc1_c7cca39b-639b-4c4a-a708-a3b77953bb4c">18,647</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i7c2721102f674c4aa792ac925c98947d_D20210401-20220331" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMy0xMS0xLTEtMjM3NQ_c93fcb48-b461-444f-9ecc-f09427ef68d4">7.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New order sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i355171bb92204bbb82826b85e8bf5b37_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNC0xLTEtMS0yMzc1_5107c913-8c73-4c21-825a-f406006dc215">28,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i355171bb92204bbb82826b85e8bf5b37_D20210401-20220331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNC0zLTEtMS0yMzc1_cef99d13-ccc5-4bc5-a8e6-f78f575a3261">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf2f2c5e86445fda1c2ded520e7311d_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNC01LTEtMS0yMzc1_3004befc-7f7b-42cd-991b-15b4683472c8">46,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8cf2f2c5e86445fda1c2ded520e7311d_D20200401-20210331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNC03LTEtMS0yMzc1_552b3716-ed20-4a38-81cc-3006a9e777f1">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i355171bb92204bbb82826b85e8bf5b37_D20210401-20220331" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNC05LTEtMS0yMzc1_01134d67-8b2b-40f4-bd18-daca7d13a912">17,151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i355171bb92204bbb82826b85e8bf5b37_D20210401-20220331" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNC0xMS0xLTEtMjM3NQ_33982f84-c299-473a-9157-b7dd65504abc">37.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNi0xLTEtMS0yMzc1_7d9700b0-9f32-4c23-8b7e-86d609aae637">273,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNi0zLTEtMS0yMzc1_4170cda1-13ab-44fe-9fda-42c9e0549eef">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNi01LTEtMS0yMzc1_a20e330c-9322-40c6-b8fe-726f18fef16b">309,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNi03LTEtMS0yMzc1_8d8f8973-c611-482f-a5ad-ef723b47cc61">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNi05LTEtMS0yMzc1_ccf461f5-5ce6-414a-bd63-e524f7dd5921">35,798</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNi0xMS0xLTEtMjM3NQ_4594a500-4709-4ca1-a069-c26747161356">11.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internet sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf2f8f507c6540bfbb2862fd908a210f_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOC0xLTEtMS0yMzc1_a15ed05e-ed04-430d-83aa-21c19dd19f61">230,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf2f8f507c6540bfbb2862fd908a210f_D20210401-20220331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOC0zLTEtMS0yMzc1_9ec0b23e-cff3-4b69-8399-6d4bd9861034">84.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bdcdb0588154445be242f59b58aab0c_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOC01LTEtMS0yMzc1_0c0a55dc-04e0-4d2f-9e1a-9fa65d2c8180">259,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bdcdb0588154445be242f59b58aab0c_D20200401-20210331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOC03LTEtMS0yMzc1_21516098-fc83-47a1-b8d4-fd96fefbe3c1">83.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf2f8f507c6540bfbb2862fd908a210f_D20210401-20220331" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOC05LTEtMS0yMzc1_633b4436-da69-490b-9383-0d2ed705839e">29,141</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iaf2f8f507c6540bfbb2862fd908a210f_D20210401-20220331" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOC0xMS0xLTEtMjM3NQ_1e9cf6f2-af71-463b-8006-c191f0b39bf7">11.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Call center sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7e6d5eacd904a1ab0d4099df9b503b8_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOS0xLTEtMS0yMzc1_6b49899a-49a9-46f3-9456-bf01949d936e">43,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib7e6d5eacd904a1ab0d4099df9b503b8_D20210401-20220331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOS0zLTEtMS0yMzc1_ad6018ee-da5d-444b-8f49-aa7296c3eb13">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f32aa6e61a47c49a1913e3aa0f4787_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOS01LTEtMS0yMzc1_7075c00a-44af-440e-8735-8d3cb5c99391">49,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic0f32aa6e61a47c49a1913e3aa0f4787_D20200401-20210331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOS03LTEtMS0yMzc1_2f470590-913a-4297-9849-cbc598119719">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7e6d5eacd904a1ab0d4099df9b503b8_D20210401-20220331" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOS05LTEtMS0yMzc1_47ea013f-3035-480d-a5f8-a12374dba9b8">6,657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib7e6d5eacd904a1ab0d4099df9b503b8_D20210401-20220331" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOS0xMS0xLTEtMjM3NQ_c33050df-05c2-4d99-853d-c43d18fe210e">13.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMTEtMS0xLTEtMjM3NQ_f2ef81d9-0a3c-443c-899e-f9194e3f77aa">273,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMTEtMy0xLTEtMjM3NQ_613a3957-9021-45f4-a791-501bd570e314">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMTEtNS0xLTEtMjM3NQ_171cee22-c9da-4fb8-82ea-51997fcabbf0">309,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="3" name="pets:RevenueFromContractWithCustomerPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMTEtNy0xLTEtMjM3NQ_23bb0016-4f6a-4ca2-9a1d-cd4ae06def0b">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="pets:RevenueFromContractWithCustomerVariance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMTEtOS0xLTEtMjM3NQ_d981eba1-6329-4692-85c6-94a1b21b4f47">35,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="3" sign="-" name="pets:RevenueFromContractWithCustomerVariancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMTEtMTEtMS0xLTIzNzU_f83cda13-155b-413f-abf7-c9f2bba8c94b">11.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company changed the definition of a new customer on April 1, 2022, to include anyone who has not ordered over the past thirty-six months. The reorder and new order sales amounts for the years ended March&#160;31, 2022 and March&#160;31, 2021, respectively, reflect this new customer definition change. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the previous definition of a new customer, reorder and new order sales were $<ix:nonFraction unitRef="usd" contextRef="i6721acf8ca444c08943e0f7c291b888b_D20210401-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY0MTA2OQ_12edf5ef-8c55-4878-af3d-5c343b7950b3">250.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idb7030b6bef24f45acc0d76a3d1c20ec_D20210401-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY0MTA3OQ_27fd307a-c67e-40f7-93f1-9bdc39181a59">23.0</ix:nonFraction> million, respectively, for the year ended March&#160;31, 2022. Under the previous definition of a new customer, reorder and new order sales were $<ix:nonFraction unitRef="usd" contextRef="iec916a6095784855b5980a214c776678_D20200401-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY0MTA5NA_27e8162d-d0af-4f1c-90f2-94e3117abada">272.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0813952b1f39495398373f357ec689b3_D20200401-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY0MTEwMw_3d46cd50-039e-478b-a330-d96c14941b6b">36.6</ix:nonFraction> million, respectively, for the  year ended March&#160;31, 2021. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Virtually all of the Company&#8217;s sales are paid by credit cards and the Company usually receives the cash settlement in two to three banking days. Credit card sales minimize accounts receivable balances relative to sales. The Company had no material contract asset or liability balances as of March&#160;31, 2023 and 2022.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains an allowance for doubtful accounts for losses that the Company estimates will arise from customers&#8217; inability to make required payments, arising from either credit card chargebacks or insufficient funds checks. The Company determines its estimates of the uncollectability of accounts receivable by analyzing historical bad debts and current economic trends in compliance with the provisions of Accounting Standards Codification ("ASC") Topic 326 ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses").</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The allowance for doubtful accounts was approximately $<ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMzcyNg_b1c5cdc4-5421-4eed-a39a-91d83e34cb99">35</ix:nonFraction> thousand  and $<ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2MzI2OQ_fac7d24b-efda-4187-8188-b0515d33adf2">39</ix:nonFraction> thousand at March&#160;31, 2023 and March&#160;31, 2022, respectively.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)&#160;&#160;&#160;&#160;Summary of Significant Accounting Policies (Continued)</span></div></div><ix:continuation id="i8e6af7f1b34642f7b97da522d2915331" continuedAt="i1bafe2289cb24a3ba9cc3fe230c3fd6e"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MzE_c68feb92-a23d-4330-9833-93a8127b090c" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents at March&#160;31, 2023 and 2022 consisted of the Company&#8217;s cash accounts and money market accounts with a maturity of three months or less. The carrying amount of cash equivalents approximates fair value. The Company maintains its cash in bank deposit accounts which, at times,  may exceed federally insured limits. The Company has not experienced any losses in such accounts.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MjY_29f997b9-a24c-4c53-a5f3-8e6bff7fc332" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MzM_dd1b3c99-27b7-475f-9b80-b1a57b259015" continuedAt="i234ce4512e494625904472b8de8a195b" escape="true">Inventories</ix:nonNumeric></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i234ce4512e494625904472b8de8a195b">Inventories consist of prescription and non-prescription pet medications and pet supplies that are available for sale and are priced at the lower of cost or net realizable value using a weighted average cost method. The Company writes down its inventory for estimated obsolescence.</ix:continuation> The inventory reserve was approximately $<ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:InventoryValuationReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNTEyNQ_64e468b2-31ac-460b-9368-2c72b2984ed7">48</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:InventoryValuationReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNTEzMg_23706bee-217d-409b-8303-249be6f80b51">81</ix:nonFraction> thousand at March&#160;31, 2023 and 2022, respectively.</span></div><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3Mjc_1a7399f2-8dd3-400b-8b5c-685b0c66dab4" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets. Our building is being depreciated over a period of <ix:nonNumeric contextRef="ieb4d6d234160419aa86c9553574519da_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNTM3Mw_e93d9c9d-456a-4ec4-9401-253911112b6c">thirty years</ix:nonNumeric>. The furniture, fixtures, equipment, and computer software are being depreciated over periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNTQ4Mw_bad1a77d-7eb3-4209-80fa-1d8f0ecbb508">three</span> to <ix:nonNumeric contextRef="i04245b0d956b455691aa8ab5e83c2f75_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNTQ4OQ_805d72e4-4a4e-4509-90c4-18c863c5f163">ten years</ix:nonNumeric>.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MjM_1b8abe6f-19d7-4129-98e1-f876492c4257" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-lived Assets</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets is measured by a comparison of the carrying amount of the asset to the undiscounted cash flows expected to be generated from the asset.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MjA_60cd28f8-bc62-4471-9d7c-17077c162db0" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intangible assets consist of a toll-free telephone number and internet domain names. In accordance with the ASC Topic 350 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) the intangible assets are not being amortized and are subject to an annual review for impairment.</span></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="pets:OtherAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNjU5NzA2OTc5NjkzMQ_30d4b3ef-88d2-4648-b25e-9eeee25cabef" continuedAt="iba45947a8fb145488c097c0e49d4fd01" escape="true">Other Assets</ix:nonNumeric></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iba45947a8fb145488c097c0e49d4fd01">Other assets consist of the initial minority interest investment in Vetster.</ix:continuation> Details can be found in Note 12 below.</span></div><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MTY_d8eea629-8f2b-4c1d-bd3f-5d3b948695a7" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the Company's cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to the short-term nature of these instruments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3Mjg_63559c86-d792-48ff-9be7-bf6aec0b728a" continuedAt="i7f825155523940999cf606b210adaadb" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's advertising expense consists primarily of Internet marketing, direct mail/print, and television advertising. Internet costs are expensed in the month incurred and direct mail/print advertising costs are expensed </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)&#160;&#160;&#160;&#160;Summary of Significant Accounting Policies (Continued)</span></div></div><ix:continuation id="i1bafe2289cb24a3ba9cc3fe230c3fd6e" continuedAt="i99d8db28f8dc447e9615071ee76431fc"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7f825155523940999cf606b210adaadb">when the related catalogs, brochures, and postcards are produced, distributed, or superseded. Television advertising costs are expensed as the advertisements are televised.</ix:continuation></span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately <ix:nonFraction unitRef="number" contextRef="i32b7a8cc1d0c404abe3d6754f1eff32b_D20160101-20160131" decimals="2" name="pets:PercentageOfPropertyLeasedToTenants" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzEwNg_986e0344-c1b5-47f6-95a0-a4dc9f2a8d91">48</ix:nonFraction>% of our Delray Beach property, or approximately <ix:nonFraction unitRef="sqft" contextRef="i6809ba90db9c49ca8ac16d709434847a_I20160131" decimals="-3" name="us-gaap:AreaOfRealEstateProperty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzE0NA_e19b4b37-6fdc-4bee-af17-6d5ce500c16b">88,000</ix:nonFraction> square feet was leased to <ix:nonFraction unitRef="tenant" contextRef="i32b7a8cc1d0c404abe3d6754f1eff32b_D20160101-20160131" decimals="INF" name="pets:NumberOfTenants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNDA1MjI_3ea848b2-6a43-4450-a84f-5bdaa0116c0e">two</ix:nonFraction> tenants. At</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the leases with these <ix:nonFraction unitRef="tenant" contextRef="ieadfd9293a5a48bba384353d2ebc519c_D20220401-20230331" decimals="INF" name="pets:NumberOfTenants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNDA1MjY_a5dc2a83-af87-4443-a530-99985959a454">two</ix:nonFraction> tenants had a remaining weighted average lease term of <ix:nonNumeric contextRef="ieadfd9293a5a48bba384353d2ebc519c_D20220401-20230331" name="pets:LessorOperatingLeaseRemainingWeightedAverageLeaseTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzI3Ng_1ac70759-4e9c-46de-ae77-4d0ccd4ef9c5">2.0</ix:nonNumeric> years. The Company recorded approximately $<ix:nonFraction unitRef="usd" contextRef="ieadfd9293a5a48bba384353d2ebc519c_D20220401-20230331" decimals="-3" name="us-gaap:RentalIncomeNonoperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzMxNg_543435d9-bb6e-4ea3-a44d-531e1d25a08d">710</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="i5fe3d97a1db0465f973b838299721edd_D20210401-20220331" decimals="-3" name="us-gaap:RentalIncomeNonoperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzMyNA_1a07da5a-0fb3-4bc6-8a08-8c52b22b4aeb">689</ix:nonFraction> thousand in rental revenue in fiscal 2023 and 2022, respectively, which was included in other income. The Company expects to receive the following future lease payments, under the current lease agreements, over the next five years: $<ix:nonFraction unitRef="usd" contextRef="i7915a8c7c6604a17bc9a1722e6e42a01_I20230331" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzU0OQ_7efc7150-529d-4891-b35e-f1887d9a3379">731</ix:nonFraction> thousand in fiscal 2024; $<ix:nonFraction unitRef="usd" contextRef="i7915a8c7c6604a17bc9a1722e6e42a01_I20230331" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzU2OA_716f821a-d6ec-4c5e-86db-fece113f33ba">566</ix:nonFraction> thousand in fiscal 2025, $<ix:nonFraction unitRef="usd" contextRef="i7915a8c7c6604a17bc9a1722e6e42a01_I20230331" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzU4Nw_5219e687-8422-4f3c-bf0f-9ddc3a8ee934">110</ix:nonFraction> thousand in fiscal 2026, and $<ix:nonFraction unitRef="usd" contextRef="i7915a8c7c6604a17bc9a1722e6e42a01_I20230331" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzYxMA_3396c76e-639e-4d0c-9528-293ca70a1255"><ix:nonFraction unitRef="usd" contextRef="i7915a8c7c6604a17bc9a1722e6e42a01_I20230331" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedFiveYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzYxMA_e19d8b79-6ce1-493a-9310-cf3854bc6f64">0</ix:nonFraction></ix:nonFraction> thousand in fiscal 2027 and 2028.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MTc_77692c16-444b-4199-a1f9-0c974098a912" continuedAt="i1b3c57a93bee4b19a4a94766a6648332" escape="true">Comprehensive Income</ix:nonNumeric></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><ix:continuation id="i1b3c57a93bee4b19a4a94766a6648332" continuedAt="i83fe3a3b51bf44de8d04c4843b741868"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies ASC Topic 220 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reporting Comprehensive Income</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i83fe3a3b51bf44de8d04c4843b741868">&#8221;) which requires that all items that are recognized under accounting standards as components of comprehensive income be reported in a financial statement that is displayed with the same prominence as other financial statements. The items of other comprehensive income that are typically required to be displayed are foreign currency items, minimum pension liability adjustments, and unrealized gains and losses on certain investments in debt and equity securities. For the fiscal years ended March&#160;31, 2023, 2022 and 2021, the Company had no components of comprehensive income and therefore does not report comprehensive income or Consolidated Statements of Comprehensive Income.</ix:continuation> </span></div><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MzQ_7f6b5115-a729-41f2-9e18-d3fa73b89bb0" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the provisions of ASC Topic 740 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) which generally requires the recognition of deferred tax assets and liabilities for the expected future tax benefits or consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting carrying values and the tax bases of assets and liabilities and are measured by applying enacted tax rates and laws for the taxable years in which those differences are expected to reverse. As required by &#8220;Accounting for Uncertainty in Income Taxes&#8221; guidance, which clarifies ASC Topic 740, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the Consolidated Financial Statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies &#8220;Accounting for Uncertainty in Income Taxes&#8221; guidance to all tax positions for which the statute of limitations remains open. The Company had <ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTY0OTI2NzQ0NTc2MDQ_3c543b00-ffa2-430a-9c3f-9dde8c739249"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTY0OTI2NzQ0NTc2MDQ_8fd1e0a0-961b-40f9-87ef-e75933882505">no</ix:nonFraction></ix:nonFraction> liabilities for uncertain tax positions for both fiscal 2023 and fiscal 2022. The Company files tax returns in the U.S. federal jurisdiction and Florida,  Arizona, California, Connecticut, Idaho, Maryland, Michigan, Oklahoma, South Carolina, Virginia, Wisconsin, New Jersey, Georgia, Indiana, New York and the District of Columbia. With few exceptions, the Company is no longer subject to U.S. federal, state or local income tax examinations by tax authorities for years ending March&#160;31, 2019, or earlier. Any interest and penalties related to income taxes will be recorded to other income (expenses).</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MzI_49cd202e-31b9-4829-9e20-918d63ab492a" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Concentrations</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases its products from a variety of sources, including certain manufacturers, domestic distributors, and wholesalers. We have multiple suppliers for each of our product lines to obtain the lowest cost. There were six suppliers from which we purchased approximately <ix:nonFraction unitRef="number" contextRef="i880955555f9e48a3af629feacb66f2ca_D20220401-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfOTQyOQ_96949aa6-0844-4f81-9d81-930e9f959e9e">69</ix:nonFraction>%  and <ix:nonFraction unitRef="number" contextRef="if77a6bc751f7420aa5579831f599629c_D20210401-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY0ODU4OQ_50390ce7-fb08-4690-bdb2-b3aa19a84b83">77</ix:nonFraction>% of all products in fiscal 2023 and 2022, respectively.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MTg_43aa84e6-ae8a-4165-ad6c-3e00d36ef112" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting for Share Based Compensation</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records compensation expense associated with restricted stock in accordance with ASC Topic 718 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Based Payment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The compensation expense related to all of the Company&#8217;s stock-based compensation arrangements is recorded as a component of general and administrative expenses.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)&#160;&#160;&#160;&#160;Summary of Significant Accounting Policies (Continued)</span></div></div><ix:continuation id="i99d8db28f8dc447e9615071ee76431fc"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3Mjk_b506a18b-bed0-4622-906c-ee02c48a7fa8" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, will have a material effect on the Company&#8217;s consolidated financial position, results of operations, or cash flows.</span></div></ix:nonNumeric></ix:continuation><div id="i9ecb58a0f25a461393eca5efcfd32a38_94"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RleHRyZWdpb246MmJiYTYxYTRkOTY0NDM1NTg5MDdjOWMzMmMwMDFkYWFfMTIx_c9a46f5f-3561-49e1-b72b-8e284b784e96" continuedAt="icbbb919b9f4d43a5b3fd1770c1bf4ee6" escape="true">Property and Equipment, Net</ix:nonNumeric></span></div><ix:continuation id="icbbb919b9f4d43a5b3fd1770c1bf4ee6"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RleHRyZWdpb246MmJiYTYxYTRkOTY0NDM1NTg5MDdjOWMzMmMwMDFkYWFfMTIy_1843ee11-e36c-4545-8a76-0b19794ecc46" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Major classifications of property and equipment consist of the following (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"></td><td style="width:69.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de47f4a3e584d9180f1d51a89d74e32_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfMy0xLTEtMS0yMzc1_5d536928-81a7-445c-a040-6f008a8ec7af">14,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f4bce0e12164f66a7a0fbf509e0433d_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfMy0zLTEtMS0yMzc1_4306be32-708f-49bb-9956-187a264d2e65">14,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1866466e5d2446d92c17b6f5b54ae88_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNC0xLTEtMS0yMzc1_f2afb0ce-bce2-4d5c-a619-2adf9974fcb6">3,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f77d055886f40e0890b240ffc4c5900_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNC0zLTEtMS0yMzc1_4feee6fa-8229-4bb8-bbdd-2fc9b26830a4">3,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building Improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f90b592a09143caa1086b6421f0c29f_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNS0xLTEtMS0yMzc1_f4474a7c-8a0c-4500-adf6-ddfdaedd6bc0">3,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b5b4824cd0443c996bd2417b7318871_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNS0zLTEtMS0yMzc1_b48fca57-dca6-4d50-8b86-ee4f0682fd09">2,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e83a64a31d84e95a0d0bb5607943684_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNi0xLTEtMS0yMzc1_56c07ee3-6212-4ea7-89be-27e04b1a4281">9,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0086d69f42d465fbe2be778fd3669ae_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNi0zLTEtMS0yMzc1_66b0f609-eb6d-427c-a036-eda5de43c210">5,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8009934e1ce1437faf934a21e11f53fa_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNy0xLTEtMS0yMzc1_4cb735d7-86d6-4bf5-a8fe-27f5cc671b82">9,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3cce94c3217479d9c47e9c7a9569964_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNy0zLTEtMS0yMzc1_00bfead6-d3d4-4ed9-9776-179ffe02a54f">9,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfOC0xLTEtMS0yMzc1_07fef377-d2d8-499c-9d09-816558ffcd35">41,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfOC0zLTEtMS0yMzc1_0ef803bc-5f2c-47ab-9b1e-c16af3856882">36,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfOS0xLTEtMS0yMzc1_7bcbb73a-2973-455b-aae7-d648bbe73f9f">15,231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfOS0zLTEtMS0yMzc1_31fee37f-1f49-456e-b590-6c0499907653">11,685</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfMTEtMS0xLTEtMjM3NQ_ead0f069-9f1f-45b3-8396-c6874fbe8663">26,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfMTEtMy0xLTEtMjM3NQ_34cd8635-6075-4934-b6a8-fc029ad07360">24,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i9ecb58a0f25a461393eca5efcfd32a38_100"></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90ZXh0cmVnaW9uOjY2YmU5OWQ3MjZjYTRhNmI4ZmMyMTY3ODlhMzQ4YjZhXzE3MA_6ae61ecd-b6e3-4f13-ac53-2f5d6128d25e" continuedAt="i20438bfeeef7445a86a6fbf044c184ba" escape="true">Accrued Expenses and Other Current Liabilities</ix:nonNumeric></span></div><ix:continuation id="i20438bfeeef7445a86a6fbf044c184ba"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90ZXh0cmVnaW9uOjY2YmU5OWQ3MjZjYTRhNmI4ZmMyMTY3ODlhMzQ4YjZhXzE2OQ_2fb52252-ac0f-43fe-84b8-a41c0f4398c1" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Major classifications of accrued expenses and other current liabilities consist of the following (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"></td><td style="width:69.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzMtMS0xLTEtMjM3NQ_3f61e7a6-aaf9-42cf-9219-a7499bba715b">5,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzMtMy0xLTEtMjM3NQ_df9c45f0-f3b4-4965-874c-d211a8e52b4c">1,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued credit card fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="pets:AccruedCreditCardFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzQtMS0xLTEtMjM3NQ_b356bfb0-7af0-4d7a-bc20-350d41bcc1eb">401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="pets:AccruedCreditCardFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzQtMy0xLTEtMjM3NQ_370a2c10-5f49-4f69-838c-305542110dfb">428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salaries and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzUtMS0xLTEtMjM3NQ_0acfceb6-9593-49f9-b0b8-ce4e91206d2a">1,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzUtMy0xLTEtMjM3NQ_d76b79c6-9f37-4157-acba-5c6d9be45024">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued merchandise credits / reward program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="pets:AccruedMerchandiseCreditsAndRewardsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzYtMS0xLTEtMjM3NQ_e21dce7b-6cea-4c31-a7b3-5e969f796e3f">1,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="pets:AccruedMerchandiseCreditsAndRewardsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzYtMy0xLTEtMjM3NQ_8dab2300-f9ef-495d-985b-38ab0cf3c6d6">1,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzctMS0xLTEtMjM3NQ_eb77c33d-805d-4be5-bbbd-33326375d123">559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzctMy0xLTEtMjM3NQ_ebf38236-c15e-4e98-86be-c7f7856d1535">459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales return allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="pets:AccruedSalesReturnsAndAllowancesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzgtMS0xLTEtMjM3NQ_114b1617-ea85-4760-93dc-428bfc79fa67">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="pets:AccruedSalesReturnsAndAllowancesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzgtMy0xLTEtMjM3NQ_0dcaf801-10ff-4649-aba1-346353acdbd7">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued dividends payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzktMS0xLTEtMjM3NQ_bc731e61-2226-4bb8-b7da-a0f3e9a58e85">1,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:DividendsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzktMy0xLTEtMjM3NQ_7cd2cca4-e496-41fc-9caa-990ea06e8b3f">558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued real estate taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzEwLTEtMS0xLTIzNzU_2f531f82-d1f6-4bd3-9dc6-0f831a883029">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzEwLTMtMS0xLTIzNzU_a504e461-1628-4d52-aaf0-e767316e6775">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzExLTEtMS0xLTIzNzU_465a623f-3fdb-46fc-bc29-c03db5e40678">406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzExLTMtMS0xLTIzNzU_8683da2f-8937-4f13-89d0-7bbdbeba084b">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="pets:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzEzLTEtMS0xLTIzNzU_e1bda705-c9c9-4124-88b4-454ed99db1ae">11,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="pets:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzEzLTMtMS0xLTIzNzU_b07ab58a-74e7-4a22-8ca8-0dfb4823c35c">5,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i9ecb58a0f25a461393eca5efcfd32a38_103"></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzEzODE_8de99699-55b0-476e-8b28-6329714acbe9" continuedAt="i311f34f4dadc47f68b767f4df9a6fa98" escape="true">Income Taxes</ix:nonNumeric></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i311f34f4dadc47f68b767f4df9a6fa98" continuedAt="i6399feb7d4a94dbd8dc9f489b7a22380">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzEzODI_47a932fe-d521-416c-b0c4-48bb1bcbc210" continuedAt="i3f30ea944a414a0db54d4d4285162f4a" escape="true">The tax </ix:nonNumeric></ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div><div style="margin-top:10pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes (Continued)</span></div></div><ix:continuation id="i6399feb7d4a94dbd8dc9f489b7a22380" continuedAt="i9c0825080f5a4960958fd535ed109105"><ix:continuation id="i3f30ea944a414a0db54d4d4285162f4a"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are as follows (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"></td><td style="width:69.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzMtMS0xLTEtMjM3NQ_498eb0ef-9c82-4ae9-af36-a3eff1b87661">1,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzMtMy0xLTEtMjM3NQ_fe3fdef4-c407-4c67-9cef-427443b3aee0">364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzQtMS0xLTEtMjM3NQ_15dbdb69-e9f0-4dea-8ead-b889658db06a">1,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzQtMy0xLTEtMjM3NQ_4eba37b5-0335-404f-bf9d-6b971e3dadad">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt and inventory reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzUtMS0xLTEtMjM3NQ_37de034b-5849-4b8f-b8af-8d3206be8c05">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzUtMy0xLTEtMjM3NQ_2e81708a-9c59-469f-ac1f-b5a725b583da">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzctMS0xLTEtMjM3NQ_55b053e3-dae4-43dd-abaa-81eec842be6d">3,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzctMy0xLTEtMjM3NQ_fe43c2eb-f568-4cd9-a6b9-4a507f814e90">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzEwLTEtMS0xLTIzNzU_b6e6bc92-5ea7-430e-b6ae-7c66395bffc0">2,527</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzEwLTMtMS0xLTIzNzU_00e3f132-be7e-438b-9c5f-7b2a3c79b615">1,989</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net deferred tax assets (liabilities)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzEyLTEtMS0xLTIzNzU_eb7d1f49-9db9-4400-a679-85584b22b66c">628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:DeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzEyLTMtMS0xLTIzNzU_467928ab-ecb9-4bbe-a3ca-c3cd1bf60181">936</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, the Company had <ix:nonFraction unitRef="usd" contextRef="i0d41bb6533e64a78b0c413d60ab6d296_I20230331" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzQxOA_0818778b-3559-41ed-82cd-b549716343d8">no</ix:nonFraction> federal or state net operating loss carryforwards.</span></div><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzEzODM_220766c2-7bb0-47af-a781-0b19c77d41dc" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the income tax provision consist of the following (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"></td><td style="width:54.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzQtMS0xLTEtMjM3NQ_b0511a30-c410-423d-850b-185af39689a9">1,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzQtMy0xLTEtMjM3NQ_cd58d72f-c130-4917-be37-9d37ffd131d4">5,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzQtNS0xLTEtMjM3NQ_25486641-faaa-4a47-9dbc-ddc9ba8bf6d9">7,446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzUtMS0xLTEtMjM3NQ_a109e299-7daa-43da-b7f2-e909169a19b5">1,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzUtMy0xLTEtMjM3NQ_caa8f9e5-d1c0-4f8f-8f9c-2a424e4d406d">515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzUtNS0xLTEtMjM3NQ_7ec555ee-7cd9-4112-ae36-4b5bdf107c7a">856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzYtMS0xLTEtMjM3NQ_a8feeadc-0cde-4936-a0c3-4541de7722bb">2,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzYtMy0xLTEtMjM3NQ_9a3de9a5-6338-4235-b412-9aa83d6eac5e">6,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzYtNS0xLTEtMjM3NQ_a36172d9-15af-40de-9b1e-c1baa95a0b4a">8,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzktMS0xLTEtMjM3NQ_5d0e9d62-53c1-479f-b591-0f740ebe0539">982</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzktMy0xLTEtMjM3NQ_d4425e2f-6e5e-4bd9-b011-e379dcbfe81f">317</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzktNS0xLTEtMjM3NQ_430a555c-738f-434f-8227-1e02d71f8be6">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzEwLTEtMS0xLTIzNzU_f22614ac-e77c-477c-b20e-6c274ead767a">582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzEwLTMtMS0xLTIzNzU_efbabc2d-8d63-4b15-9f27-abb53fb640cb">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzEwLTUtMS0xLTIzNzU_85e0fdd0-b020-419f-bbfd-92fc38882fc5">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzExLTEtMS0xLTIzNzU_0c4140f0-ff7a-4e2b-bea5-93fb0b405101">1,564</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzExLTMtMS0xLTIzNzU_fc15e8a9-0d3e-47ec-bfe3-cbd471df6b5b">345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzExLTUtMS0xLTIzNzU_1ab5adef-034e-45fb-a864-cb0332b183fd">311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzEzLTEtMS0xLTIzNzU_51caf488-730e-44f9-8b96-f8d3d9e4d146">1,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzEzLTMtMS0xLTIzNzU_53e36139-8156-4b2a-9920-18ae0cec4c65">5,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzEzLTUtMS0xLTIzNzU_96caec58-b9eb-4723-957d-6e0533539cc7">8,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div><div style="margin-top:10pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes (Continued)</span></div></div><ix:continuation id="i9c0825080f5a4960958fd535ed109105" continuedAt="i164e38139af741288cfb7fa282b7142f"><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzEzODA_b4ae7117-732a-4ee9-beaa-a488fcbcafc3" continuedAt="i0154515e508f4dfaabe67e10c2193100" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income tax provision computed at the U.S. federal statutory tax rates to income tax expense is as follows (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"></td><td style="width:54.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes at U.S. statutory rates</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzMtMS0xLTEtMjM3NQ_f6b45725-42d9-4591-9cd3-3f66258741c2">333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzMtMy0xLTEtMjM3NQ_421e2187-08e4-437d-ba10-e4d1be54d288">5,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzMtNS0xLTEtMjM3NQ_6cb9fc5a-0904-4225-b589-9b1aae5d2db1">8,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzQtMS0xLTEtMjM3NQ_88a9a873-d504-4a46-b55b-24e76940e47e">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzQtMy0xLTEtMjM3NQ_3c356d4e-3e3d-4bd2-b986-40767dc09424">379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzQtNS0xLTEtMjM3NQ_89b29f26-8ae6-45c7-85f9-bd39a52d857d">708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzUtMS0xLTEtNDg3OTM_4bf1582d-1109-4726-add9-fae3cb973124">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzUtMy0xLTEtNDg4MDQ_52ebd06c-23ed-4eee-860e-c35bb944d865">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzUtNS0xLTEtNDk1OTg_25a58ddc-6e5a-4dd8-9924-809dac1aa7ec">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock shortfall (windfall) adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzUtMS0xLTEtMjM3NQ_0e124d92-86c0-4796-a5b9-b4fd7727ecfa">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzUtMy0xLTEtMjM3NQ_7d7e1baa-dc42-4284-9573-b67766a0177b">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzUtNS0xLTEtMjM3NQ_4c316c34-012a-4ae1-a2f8-ae095d806dad">135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzYtMS0xLTEtMjM3NQ_3d90acfe-cc57-4685-876f-23d3bf206ca2">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzYtMy0xLTEtMjM3NQ_75b5f864-893d-4301-8f81-8fd1183822fe">185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzYtNS0xLTEtMjM3NQ_d45ac858-c51e-4ce6-a753-a88e08e3eced">393</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzgtMS0xLTEtMjM3NQ_0ff40c77-a33c-4498-b9c4-895a3d1fb783">1,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzgtMy0xLTEtMjM3NQ_f054f819-9025-4741-9701-6d3f31d16af4">5,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzgtNS0xLTEtMjM3NQ_a782bd38-1b2c-425a-ad5f-0f7f3dba3534">8,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2023, the Company recognized a stock compensation shortfall charge of approximately $<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzc2OTY1ODEzOTgwMzY_9af58416-b2c2-41b7-8280-0bd9b1129692">208</ix:nonFraction> thousand and recognized a one-time charge of approximately $<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzc2OTY1ODEzOTgwOTY_b5803a94-9331-47d8-8201-cddc3c5a588f">382</ix:nonFraction> thousand related to a return to provision true up of the fiscal 2022 income tax provision. In fiscal 2022, the Company recognized a stock compensation shortfall charge of approximately $<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzc2OTY1ODEzOTcxMDc_6e9598b6-4f9b-4fce-b750-05ec0ea2fc4d">33</ix:nonFraction> thousand, and recognized a one-time benefit of approximately $<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzc2OTY1ODEzOTcxNjM_296b723d-f4fb-49e3-979c-f26c74a9ccb6">29</ix:nonFraction> thousand, related to a return to provision true up of the fiscal 2021 income tax provision. In fiscal 2021 the Company recognized a stock compensation windfall benefit of approximately $<ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzc2OTY1ODEzOTczNDE_beb66582-8103-47c6-892a-999c995cdc2b">135</ix:nonFraction> thousand, and recognized a one-time benefit of approximately $<ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzc2OTY1ODEzOTczOTc_1822d3fd-6074-4b36-b138-97603fe25aed">194</ix:nonFraction> thousand, related to a return to provision true up of the fiscal 2020 income tax provision.</span></div><ix:continuation id="i0154515e508f4dfaabe67e10c2193100"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The differences between the effective income tax rate and the statutory U.S. federal income tax rate are as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.727%"><tr><td style="width:1.0%"></td><td style="width:54.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal rate on income before taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzMtMS0xLTEtNDg5NDI_28207e45-5070-4b0e-9660-698606bdc965">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzMtMy0xLTEtNDkwMzE_fb302b2c-cf6c-4a03-b7c6-c0b65886af15">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzMtNS0xLTEtNDkyNjA_bc83fad2-e1ad-461b-9345-10aa5597abbf">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzQtMS0xLTEtNDg5NTY_96f6fe9f-90e2-4d09-afe0-c6b89958b77e">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzQtMy0xLTEtNDkwNDA_be8d63ed-19dc-42ec-8d92-ef4767f05ccd">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzQtNS0xLTEtNDkyNjk_1324bcff-0493-4f33-af7c-5631d517729e">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="3" name="pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzUtMS0xLTEtNDg5NjU_20485845-5819-402b-960a-8ea3ef5062f7">25.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="3" name="pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzUtMy0xLTEtNDkwNDk_c9d3dcce-8374-4eda-9b48-7fb6d66e9811">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="3" name="pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzUtNS0xLTEtNDkyNzg_55329626-7ec5-45f3-ac89-320baaf8a87d">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock shortfall (windfall) adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzYtMS0xLTEtNDg5NzM_63a468ae-5c2b-407d-aa28-ca02717f1f41">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzYtMy0xLTEtNDkwNTg_8a2e212f-fa49-4711-be58-2d70b4fbb7bd">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzYtNS0xLTEtNDkyODY_e3e14b2a-1a81-4327-a75b-17bf4d0fb696">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzctMS0xLTEtNDg5ODE_f0bd5234-9e59-47a5-9729-add8557fed24">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzctMy0xLTEtNDkwNjc_265649db-b3e7-4544-b432-101647c785f5">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzctNS0xLTEtNDkyOTQ_a5b08f1e-9739-4a81-b00e-eb522f7c6ca1">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Effective Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzktMS0xLTEtNDg5ODk_ca91a4f9-7edf-422e-b4eb-47e580a77795">85.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzktMy0xLTEtNDkwNzU_485c9134-a323-4ca3-88f9-ef4109fd6f27">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzktNS0xLTEtNDkzMDI_4283de09-256d-48ff-97ec-0da836e21a4c">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i164e38139af741288cfb7fa282b7142f">The primary drivers for the increase in effective tax rate for the fiscal 2023 include the recognition of  permanent differences related to one-time acquisition costs and a non-deductible portion of restricted stock compensation. The state tax rate for fiscal 2023 includes continued expansion of operations as well as a one-time true up for new state filings for fiscal 2022.</ix:continuation> </span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_106"></div><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzI1MDY_1f9f06f4-4e95-4336-99fc-6fbc8afb290a" continuedAt="iba2937a06844410596498935b7c3a075" escape="true"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(5)&#160;&#160;&#160;&#160;Shareholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Equity</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred Stock</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 1998, the Company issued <ix:nonFraction unitRef="shares" contextRef="id29065364981439b8297fe9c2b387741_I19980430" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0Xzcy_f17bd57f-bde5-4078-9eef-468d10c0442a">250,000</ix:nonFraction> shares of its $<ix:nonFraction unitRef="usdPerShare" contextRef="id29065364981439b8297fe9c2b387741_I19980430" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzkzNDU4NDg4NDAyNjk_45af075c-e45c-4bcf-b230-35fc1bfc0790">.001</ix:nonFraction> par value preferred stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="id29065364981439b8297fe9c2b387741_I19980430" decimals="INF" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzEzNQ_e0ca2a86-cdab-4abc-9855-c93d0db09ba6">4.00</ix:nonFraction> per share, less issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i71c12e540590434c98c58ec2c09fb08c_D19980401-19980430" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzE3Mg_55233ad3-61b8-4602-907e-febccc400796">112</ix:nonFraction> thousand. Each share of the preferred stock is convertible into approximately </span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div><div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6)&#160;&#160;&#160;&#160;Shareholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Equity (Continued)</span></div></div><ix:continuation id="iba2937a06844410596498935b7c3a075"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="id29065364981439b8297fe9c2b387741_I19980430" decimals="2" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzI0NA_3dda27f4-a659-4047-b117-9aecaecc601b">4.05</ix:nonFraction> shares of common stock at the election of the shareholder. The shares have a liquidation value of $<ix:nonFraction unitRef="usdPerShare" contextRef="id29065364981439b8297fe9c2b387741_I19980430" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzM0NQ_7514ea5e-25b6-4fc1-a20c-b8ad43cec03a">4.00</ix:nonFraction> per share and may pay dividends at the sole discretion of the Company. The Company does not anticipate paying dividends to the preferred shareholders in the foreseeable future. Each share of preferred stock is entitled to one vote on all matters submitted to a vote of shareholders of the Company. At March&#160;31, 2023 and 2022, <ix:nonFraction unitRef="shares" contextRef="i11c1a95cfc3b42c8b1207c680949ce01_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzY2MA_875ad199-e19d-42f2-bd3f-7f7f37bb8cd1"><ix:nonFraction unitRef="shares" contextRef="ifd52e04a4fe84d1c97fb1a7b1eb50021_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzY2MA_e9ad8e5e-76f5-4889-8908-69de7413db81">2,500</ix:nonFraction></ix:nonFraction> shares of the convertible preferred stock remained unconverted and outstanding.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Company has $<ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzEwOTk1MTE2MzIzNjY_9ebdaf26-90b4-422c-ac5b-9a32388aab40">110.0</ix:nonFraction> million  of shares authorized under previously approved share repurchase programs. The share repurchase program does not have an expiration date and is intended to be implemented through purchases made from time to time in either the open market or through private transactions at the Company's discretion, subject to market conditions and other factors, in accordance with Securities and Exchange Commission requirements. There can be no assurances as to the timing and number of shares that will be repurchased under the share repurchase program, and the Company may modify or discontinue the share repurchase program at any time subject to compliance with applicable regulatory requirements. Shares purchased pursuant to the share repurchase program will either be cancelled or held in the Company's treasury.  During fiscal 2023 and 2022 the Company had <ix:nonFraction unitRef="shares" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzE5MTU_17f3ed3e-a8be-4443-b2a6-fed611d8c6fd"><ix:nonFraction unitRef="shares" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzE5MTU_f29d92f8-8f07-4316-a118-82d03fba28c7">no</ix:nonFraction></ix:nonFraction> share repurchases. At March&#160;31, 2023 the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzE5NzM_ab31aedf-2684-43a2-abf1-d3271d3476ae">28.7</ix:nonFraction> million remaining under the Company&#8217;s share repurchase program.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company&#8217;s financial performance. <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:DividendsDeclaredTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzI1MDc_2bd8612e-68ec-4d56-9da5-519ea5c2bb3b" continuedAt="iaf8da77477fc4434b9368336cbde5205" escape="true">During fiscal 2023, our Board of Directors declared the following dividends:</ix:nonNumeric></span></div><div style="margin-top:12pt;padding-left:36pt"><ix:continuation id="iaf8da77477fc4434b9368336cbde5205"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.272%"><tr><td style="width:1.0%"></td><td style="width:20.254%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.045%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.045%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Declaration Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Per Share<br/>Dividend</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount<br/>(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment Date</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ib0d6d76e24604cb9a18256bc00a989e9_I20220509" decimals="2" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzItMi0xLTEtMjM3NQ_2c834c52-c635-467e-932e-fafc54522c86">0.30</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 20, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib0d6d76e24604cb9a18256bc00a989e9_I20220509" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzItNi0xLTEtMjM3NQ_0b2f5b8e-5789-4dab-b1af-ae5c6113f8e9">6,297</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 27, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 25, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="iae9efd376d404db3a83df403c4b1f447_I20220725" decimals="2" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzMtMi0xLTEtMjM3NQ_b369b55b-69fb-47a4-a3f6-295eb7d70bdf">0.30</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 12, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iae9efd376d404db3a83df403c4b1f447_I20220725" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzMtNi0xLTEtMjM3NQ_f5f6e30d-28bd-41cf-b918-6a0d0d0d50ad">6,323</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 19, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 7, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i997f8d9c4d5c47d4a9bbe74962ed4629_I20221107" decimals="2" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzQtMi0xLTEtMjM3NQ_a79bbef6-f433-483c-a1fa-bec8251c3453">0.30</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 18, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i997f8d9c4d5c47d4a9bbe74962ed4629_I20221107" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzQtNi0xLTEtMjM3NQ_ca3ef7e1-c798-410c-9cac-711d016bf6cb">6,323</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 6, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i113e079495ae443ea4acdecad992dd93_I20230206" decimals="2" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzUtMi0xLTEtMjM3NQ_2704b643-91a6-44f9-b485-c729dcfdf36b">0.30</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 20, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i113e079495ae443ea4acdecad992dd93_I20230206" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzUtNi0xLTEtMjM3NQ_089410a1-d4d7-475a-aca3-d74c8cb7cd2d">6,325</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2023</span></td></tr></table></ix:continuation></div></ix:continuation><div id="i9ecb58a0f25a461393eca5efcfd32a38_109"></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzIzMTM_c075cd7d-5b58-416c-958d-cc1e0afc012a" continuedAt="ib3aad99f3a174e5fb93c59444000fed2" escape="true">Restricted Stock</ix:nonNumeric></span></div><ix:continuation id="ib3aad99f3a174e5fb93c59444000fed2" continuedAt="i48c77d01a08e43b5a6031282caab6fe4"><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2015, the Company&#8217;s 2015 Outside Director Equity Compensation Restricted Stock Plan (&#8220;2015 Director Plan&#8221;) became effective upon the approval of the plan by the Company&#8217;s Shareholders. The 2015 Director Plan authorized <ix:nonFraction unitRef="shares" contextRef="i3fa97c770ada498d940f7db2777193c8_I20150731" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzI1Mw_52177db4-edce-46c1-9dfa-08282d9d39e8">400,000</ix:nonFraction> shares of the Company's common stock available for issuance under the plan and provides for an automatic increase every year in the amount of shares available for issuance under the plan of <ix:nonFraction unitRef="number" contextRef="i3711637129e84cf495f85a1e1f12d159_D20150701-20150731" decimals="2" name="pets:PercentageOfAutomaticIncreaseInSharesAvailableForIssuance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzQ0Ng_5be3636c-28f0-479e-bfd8-3570a9bf56a2">10</ix:nonFraction>% of the shares authorized under the plan. In July 2016, the Company&#8217;s 2016 Employee Equity Compensation Restricted Stock Plan (&#8220;2016 Employee Plan&#8221;) became effective upon the approval of the plan by the Company&#8217;s Shareholders. The 2016 Employee Plan authorized <ix:nonFraction unitRef="shares" contextRef="ibec5936930e84c289028e660f01b73b1_I20160731" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzcwOQ_b6a919db-975e-4ff3-a2c9-2ec1368615fc">1,000,000</ix:nonFraction> shares of the Company's Common stock available for issuance under the plan. In July 2022, the Company&#8217;s 2022 Employee Equity Compensation Restricted Stock Plan (&#8220;2022 Employee Plan&#8221;) became effective upon the approval of the plan by the Company&#8217;s shareholders. The 2022 Employee Plan authorized <ix:nonFraction unitRef="shares" contextRef="ia2f86689eec24b90a4591646dcc402a8_I20220731" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwOTk1MTE2MzAzOTQ_657af689-5bcc-4125-873d-9c244bd46ef1">1,000,000</ix:nonFraction> shares of the Company's common stock available for issuance.The value of the restricted stock is determined based on the market value of the stock at the issuance date. The restriction period or forfeiture period is determined by the Company&#8217;s Compensation Committee and is to be no less than <ix:nonNumeric contextRef="ida16bfdaf8b04ccd9cabdceb30574a33_D20220701-20220731" name="pets:RestrictionPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwMDQ_90d4820a-8de6-4574-93c0-7a2d9be5fd83">1</ix:nonNumeric> year and no more than <ix:nonNumeric contextRef="i35389028e9874b27a83eed9c5fc398cb_D20220701-20220731" name="pets:RestrictionPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwMjQ_3371af5e-c2a7-468d-990e-297d06a2999d">ten years</ix:nonNumeric> unless otherwise specified by the Compensation Committee.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records compensation expense associated with restricted stock in accordance with ASC Topic 718 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Based Payment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) (ASU 2016-09). At March&#160;31, 2023, the Company had <ix:nonFraction unitRef="shares" contextRef="ia83cc28d498c4c9fafb92ce48449955b_I20230331" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzExMDQ_a9c6983c-84ca-4f31-812e-8def1b9a3f98">960,007</ix:nonFraction> restricted common shares issued under the 2016 Employee Plan and <ix:nonFraction unitRef="shares" contextRef="i8c496648613e49b6bd05ae478b147763_I20230331" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzExNzI_9aad001d-bc07-4975-a5a0-89baecc36cfb">240,755</ix:nonFraction> restricted common shares issued under the 2015 Director Plan. <ix:nonFraction unitRef="shares" contextRef="i53ec65434cab4c1eb2a83616f99420e5_I20230331" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwOTk1MTE2MzEzNTU_fcb5ebad-12c1-4229-9155-7fe1a62f59b4">No</ix:nonFraction> shares had been issued under the 2022 Employee Plan as of March&#160;31, 2023. All shares in the 2016 Employee Plan and 2015 Director Plan were issued subject to a restriction or forfeiture period that lapses ratably on the first, second, and third anniversaries of the date of grant, and the fair value of which is being </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div><div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6)&#160;&#160;&#160;&#160;Restricted Stock (Continued)</span></div></div><ix:continuation id="i48c77d01a08e43b5a6031282caab6fe4" continuedAt="ibe5c10719841439499b7e5e311c16d6b"><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amortized over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzkzNDU4NDg4NDU1MDU_5ab669ee-e73c-4623-8194-b9f525c9a887">one</span> to <ix:nonNumeric contextRef="i1b2659243cd348e8b9a71f890d8f3847_D20220401-20230331" name="pets:RestrictionPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzkzNDU4NDg4NDU1Mzk_bf534249-8394-4272-a7dd-dd5676175d3c">three-year</ix:nonNumeric> restriction period, with the exception of performance restricted shares which were issued to the Chief Executive Officer and Chief Financial Officer.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company issued <ix:nonFraction unitRef="shares" contextRef="ib9e138b657114015a8d3f172c1e19f7e_D20210801-20210831" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwOTk1MTE2MzQ0NDU_fbe183ab-7798-43e2-bcff-1a67099a309a">90,000</ix:nonFraction> restricted shares and <ix:nonFraction unitRef="shares" contextRef="iac19f43c73124a22b4617cf091f81d03_D20210801-20210831" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwOTk1MTE2MzQ0NTU_27e45f23-c839-4328-8c84-1e79d9eabf3d">510,000</ix:nonFraction> performance restricted shares to the Company&#8217;s CEO, in accordance with the CEO&#8217;s employment agreement, under the 2016 Employee Plan.  The performance restricted shares are based on achieving absolute stock hurdles within the <ix:nonNumeric contextRef="iac19f43c73124a22b4617cf091f81d03_D20210801-20210831" name="pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzkzNDU4NDg4NDU1Mzg_bfa2a13d-1fec-4a25-8783-02f5929cd313">three-year</ix:nonNumeric> period from the grant date. If the shares meet the absolute stock price hurdle, they will only vest on the third anniversary of the date of grant. As of March&#160;31, 2023, none of the performance stock hurdles were met.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company issued <ix:nonFraction unitRef="shares" contextRef="if7745f099643450b9ec65034832f389e_D20220801-20220831" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwOTk1MTE2MzQ0ODQ_8101f77c-f97e-48bd-89a6-34b8987ec54a">13,000</ix:nonFraction> restricted shares and <ix:nonFraction unitRef="shares" contextRef="i7f3fed9704204153a8fa0b54b227b2e1_D20220801-20220831" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwOTk1MTE2MzQ0OTI_c7ee0ea6-dde9-43dd-8521-2d3dc932f7e6">3,000</ix:nonFraction> performance restricted shares to the Company's new CFO, in accordance with the CFO's employment agreement, under the 2016 Employee Plan. The performance restricted shares are based on the attainment of performance criteria equally weighted between adjusted EBITDA and revenue. The shares for each grant will be released from restriction equally over a <ix:nonNumeric contextRef="if6933ff7bd564ae78075d75944fc25ee_D20220801-20220831" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzkzNDU4NDg4NDU1NDA_19d08ef2-88a4-4008-a46f-6c13ccb09981">three year</ix:nonNumeric> period on the anniversary of the grant date, and in the case of the performance restricted shares, subject to the attainment of performance criteria.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the fiscal years ended March&#160;31, 2023, 2022, and 2021, the Company recognized compensation expense related to the 2016 Employee Plan and the 2015 Director Plan of $<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-5" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzE2MzM_dd0208f0-4c2d-4041-b870-689d472580a4">6.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-5" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzE2Mzc_f3eb7b13-f6f3-4425-aa53-cc900077a6ae">4.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-5" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzE2NDU_d7431a4e-4875-4c97-ae81-131952a5c165">3.3</ix:nonFraction> million, respectively. All stock-based compensation expense is recognized as a payroll-related expense and it is included within the general and administrative expenses line item within the Company&#8217;s Consolidated Statements of Income, and the offset is included in the additional paid-in capital line item of the Company&#8217;s Consolidated Balance Sheets.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February&#160;3, 2023, we issued <ix:nonFraction unitRef="shares" contextRef="i0074779789d04c76ba59318f55ccc983_D20230203-20230203" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwOTk1MTE2MzEzOTU_66d2b6bc-1807-4822-9ae6-1e587ee92567">6,000</ix:nonFraction> shares of our common stock to a consultant pursuant to a consulting agreement in exchange for consulting services. The securities were issued in reliance upon the exemption from the registration requirements of the Securities Act, as set forth in Section 4(a)(2) under the Securities Act as a transaction by an issuer not involving any public offering and the standard Securities Act restrictive legend and stop transfer instructions were noted on the stock certificate.</span></div><ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzIzMTQ_c8917680-492f-45e4-8335-729085a1df7d" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s non-vested restricted stock at March&#160;31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is as follows (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"></td><td style="width:54.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee<br/>Plan<br/>Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Director<br/>Plan<br/>Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Both Plans<br/>Number of<br/>Shares</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested restricted stock outstanding at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7487aada4c7e48a9a152a316a2197596_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzItMS0xLTEtMjM3NQ_03357ee6-93fa-430b-8025-8b5f0c92dc6b">702</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9d97a210a094cbb962f8e5009bfda1a_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzItMy0xLTEtMjM3NQ_e26f42db-58f3-4952-b492-b31887b55411">69</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzItNS0xLTEtMjM3NQ_d17b520c-fa2c-442e-8199-7a1f6b75a243">771</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock granted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ief448de592ce4068b2e177f1aeea6dd8_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzQtMS0xLTEtMjM3NQ_5bbf84e0-43eb-4d33-a40a-91cfdc809892">88</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia93b8106781d4da387b3b15296d47a35_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzQtMy0xLTEtMjM3NQ_2745e31c-e454-49cc-a82f-d89291130b59">39</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzQtNS0xLTEtMjM3NQ_c440fe02-a8ac-4b73-9e5b-d794c0af261b">127</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ief448de592ce4068b2e177f1aeea6dd8_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzYtMS0xLTEtMjM3NQ_7b6f9a23-2591-4ef6-a04a-f9353cbc858e">88</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia93b8106781d4da387b3b15296d47a35_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzYtMy0xLTEtMjM3NQ_0059c36e-bb5d-4d32-a660-59c5055010a0">30</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzYtNS0xLTEtMjM3NQ_88dcb886-a3a5-448c-a010-e8f9048f615a">118</ix:nonFraction>)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock forfeited or expired</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ief448de592ce4068b2e177f1aeea6dd8_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzgtMS0xLTEtMjM3NQ_22e1df68-c24f-4f44-94fe-4cab512f09aa">18</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia93b8106781d4da387b3b15296d47a35_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzgtMy0xLTEtMjM3NQ_22caf30a-9c2d-46a4-943f-471bb53e3442">9</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzgtNS0xLTEtMjM3NQ_fa3eeb37-7a4c-4909-b770-6852696b7ea6">27</ix:nonFraction>)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested restricted stock outstanding at March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77c3d270a0834d03b39b41eb3e174586_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzEwLTEtMS0xLTIzNzU_9b299c0b-63fa-46b5-b1e4-90a6d66695cf">684</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iad7317540db946209e8de1718fbdb1da_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzEwLTMtMS0xLTIzNzU_311e1329-d5a5-41fc-8df3-fc20213e4549">69</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzEwLTUtMS0xLTIzNzU_889c66ee-1723-44c8-93d0-dc8c4b726136">753</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and 2022, there were <ix:nonFraction unitRef="shares" contextRef="ie95c7dd15e734cdb96435d11a9f08ac5_I20230331" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzE3ODE_2c97510b-b0cc-41db-80a5-0bda7f58351b">752,829</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i96546148fd614f969f6f32c7d9c77fc6_I20220331" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzE3ODg_0027880f-7607-4ef3-91e0-7c68ce545825">770,652</ix:nonFraction>, non-vested restricted shares subject to restriction and forfeiture outstanding, respectively. During the fiscal years ended March&#160;31, 2023 and 2022, the Company issued, net of forfeitures, <ix:nonFraction unitRef="shares" contextRef="i890f993d4c6947ce85fae3592689d54b_D20220401-20230331" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzE5NTY_9a152243-faef-4877-917c-979b74d2e4c5">99,390</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="iada85d4fb9a84a7ab431b36c77c5b07d_D20210401-20220331" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzE5NjM_34c23e49-5650-4205-85b1-0c38e54642fb">709,599</ix:nonFraction> restricted shares, respectively. The weighted-average grant date fair value of restricted shares was $<ix:nonFraction unitRef="usdPerShare" contextRef="i890f993d4c6947ce85fae3592689d54b_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzc2OTY1ODE0MDQ4Nzg_00c51082-238a-4ff5-8d62-70afd34f9734">21.57</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="iada85d4fb9a84a7ab431b36c77c5b07d_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzc2OTY1ODE0MDQ4Njk_8c89718e-a621-45ef-bcd8-40d2b9bbbe94">30.47</ix:nonFraction> for fiscal years 2023 and 2022, respectively.  The total fair value of restricted shares vested was $<ix:nonFraction unitRef="usd" contextRef="i890f993d4c6947ce85fae3592689d54b_D20220401-20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzc2OTY1ODE0MDQ5MTE_aab71b9d-14b7-48ea-96be-3362ba30f66e">2.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iada85d4fb9a84a7ab431b36c77c5b07d_D20210401-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzc2OTY1ODE0MDQ4OTM_f8178e37-17d8-490b-b2fb-fb26514a5047">3.0</ix:nonFraction> million for fiscal years 2023 and 2022, respectively.  At March&#160;31, 2023 and 2022, there were $<ix:nonFraction unitRef="usd" contextRef="ie95c7dd15e734cdb96435d11a9f08ac5_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzIwMjQ_acdb95fd-5142-4509-b3d2-4fd5270f79b9">9.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i96546148fd614f969f6f32c7d9c77fc6_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzIwMzE_87780225-9aac-4128-82c7-2221ce9856eb">13.4</ix:nonFraction> million of unrecognized compensation costs related to the restricted stock subject to restriction and forfeiture awards, respectively, which </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div><div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6)&#160;&#160;&#160;&#160;Restricted Stock (Continued)</span></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibe5c10719841439499b7e5e311c16d6b">is expected to be recognized over the remaining weighted average restriction and forfeiture period of <ix:nonNumeric contextRef="i890f993d4c6947ce85fae3592689d54b_D20220401-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzIyNjk_4c4e94d7-ef34-4bb4-94cb-94a9b95010e0">1.6</ix:nonNumeric> and <ix:nonNumeric contextRef="iada85d4fb9a84a7ab431b36c77c5b07d_D20210401-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzIyNzY_f692fbb5-8f81-4637-b0e8-9eed7a474875">2.3</ix:nonNumeric> years for fiscal 2023 and 2022, respectively.</ix:continuation></span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_112"></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(7)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTIvZnJhZzpjYWFhMjk5ZWFlYWM0YmExOTAxN2QzMmZmOGJjYmEzNS90ZXh0cmVnaW9uOmNhYWEyOTllYWVhYzRiYTE5MDE3ZDMyZmY4YmNiYTM1XzEzMjk_ecdee0db-4c43-4a84-9a50-4893c8a33e6a" continuedAt="i05c657f94cec4cd7902de221bff86bd4" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i05c657f94cec4cd7902de221bff86bd4"><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company carries cash and cash equivalents and investments at fair value in the Consolidated Balance Sheets. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. ASC Topic 820 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Fair Value Measurements&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) establishes a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs which are supported by little or no market activity.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. At March&#160;31, 2023 and 2022 the Company had invested the majority of its $<ix:nonFraction unitRef="usd" contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTIvZnJhZzpjYWFhMjk5ZWFlYWM0YmExOTAxN2QzMmZmOGJjYmEzNS90ZXh0cmVnaW9uOmNhYWEyOTllYWVhYzRiYTE5MDE3ZDMyZmY4YmNiYTM1XzEwOTk1MTE2MzAyMzU_52656de7-86da-446a-99f8-9e480f4dd0af">104.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTIvZnJhZzpjYWFhMjk5ZWFlYWM0YmExOTAxN2QzMmZmOGJjYmEzNS90ZXh0cmVnaW9uOmNhYWEyOTllYWVhYzRiYTE5MDE3ZDMyZmY4YmNiYTM1XzEwOTk1MTE2MzAyNDQ_a10578fc-4d7d-4d82-a3b4-3db53f550f58">111.1</ix:nonFraction> million cash and cash equivalents balance in money market funds which are classified within Level 1.</span></div></ix:continuation><div id="i9ecb58a0f25a461393eca5efcfd32a38_115"></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(8)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90ZXh0cmVnaW9uOjkyNzg1N2U1OTIzMzQ1NTdhNmQyOWY5NWU3MzBkMGMxXzExMTU_17bf944d-799b-4a21-94db-fd2b7b77d454" continuedAt="i13e663c27ac648c8ad864d5ac4cacea9" escape="true">Net Income Per Share</ix:nonNumeric></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><ix:continuation id="i13e663c27ac648c8ad864d5ac4cacea9" continuedAt="i4b68a74220514f808c61d61d40b9e41d"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the provisions of ASC Topic 260 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) basic net income per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted net income per common share includes the dilutive effect of potential restricted stock and the effects of the potential conversion of preferred shares, calculated using the </span></ix:continuation></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div><div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(8)&#160;&#160;&#160;&#160;Net Income Per Share (Continued)</span></div></div><ix:continuation id="i4b68a74220514f808c61d61d40b9e41d"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">treasury stock method. Unvested restricted stock, and convertible preferred shares issued by the Company represent the only dilutive effect reflected in diluted weighted average shares outstanding.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90ZXh0cmVnaW9uOjkyNzg1N2U1OTIzMzQ1NTdhNmQyOWY5NWU3MzBkMGMxXzExMTQ_90d0c50f-410a-4e65-ac01-e49de628d9be" continuedAt="ib87db8bca1f64142941a63586f66813e" escape="true">The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented (in thousands, except for per share amounts):</ix:nonNumeric></span></div><div style="margin-top:12pt;padding-left:36pt"><ix:continuation id="ib87db8bca1f64142941a63586f66813e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"></td><td style="width:54.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (numerator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzQtMS0xLTEtMjM3NQ_ffdf4b63-f1b7-4e99-b201-b453572a15ae">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzQtMy0xLTEtMjM3NQ_c1ed6152-80fa-4d10-85de-f3ed6295e8b9">21,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzQtNS0xLTEtMjM3NQ_8d197b32-fda8-4d7d-9144-a73c4baa894e">30,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares (denominator)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding used in basic computation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzgtMS0xLTEtMjM3NQ_a3ad0c4f-5d72-4661-9bf9-505ef76a761c">20,275</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzgtMy0xLTEtMjM3NQ_0f5f1d0e-10f7-4945-80ee-65a9a7cadc7f">20,176</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzgtNS0xLTEtMjM3NQ_fcf45a4e-401d-4dc1-94a0-59b5d583c185">20,060</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares issuable upon the vesting of restricted stock</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzktMS0xLTEtMjM3NQ_df00b9fa-c9ae-4b64-ad4a-5877ec28c181">54</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzktMy0xLTEtMjM3NQ_80eda5cf-8987-4326-aa24-d1170b74e690">172</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzktNS0xLTEtMjM3NQ_fb4f4b1b-af76-4ee8-a69d-5acbee9b3c8a">49</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares issuable upon conversion of preferred shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzEwLTEtMS0xLTIzNzU_0ca874e5-f4a6-4779-92a7-4f47df712c85">10</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzEwLTMtMS0xLTIzNzU_2bb5eb30-dca4-4454-b061-c401b598603f">10</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzEwLTUtMS0xLTIzNzU_d1c7777d-97a5-4b7a-8a37-3efd43e2b512">10</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in diluted computation</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzExLTEtMS0xLTIzNzU_e2f8c6e3-caff-4bf6-91d4-14b69752ed76">20,339</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzExLTMtMS0xLTIzNzU_49d68d64-282b-42c6-95b1-cf4f61d916a8">20,358</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzExLTUtMS0xLTIzNzU_7e57a4d2-196a-4cbc-be7a-b2ff29c2870a">20,119</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzE1LTEtMS0xLTIzNzU_4d7371e5-aa2b-4492-a47a-a3bb5f963ae9">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzE1LTMtMS0xLTIzNzU_f61d7210-2a5c-434f-9710-7e3cfd3e3b5f">1.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzE1LTUtMS0xLTIzNzU_a03392b1-208e-40c1-a2e8-0545ac91671b">1.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzE2LTEtMS0xLTIzNzU_c0d26afb-b9bf-4819-b2e9-2ab3e5b21ffe">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzE2LTMtMS0xLTIzNzU_a51117a3-a7ee-4e73-9ec6-a58469f3b983">1.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzE2LTUtMS0xLTIzNzU_04e97e54-8bf2-4c73-b8b2-8f61c1721d5b">1.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, 2022, and 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="shares" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90ZXh0cmVnaW9uOjkyNzg1N2U1OTIzMzQ1NTdhNmQyOWY5NWU3MzBkMGMxXzg3OA_e9e2c629-3dff-4aeb-a98c-65e210e96006">745,854</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90ZXh0cmVnaW9uOjkyNzg1N2U1OTIzMzQ1NTdhNmQyOWY5NWU3MzBkMGMxXzg4Mg_34d9cf63-4836-4c66-8b38-8d48e5fb5906">220,727</ix:nonFraction>, and <ix:nonFraction unitRef="shares" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90ZXh0cmVnaW9uOjkyNzg1N2U1OTIzMzQ1NTdhNmQyOWY5NWU3MzBkMGMxXzg5MA_94b16787-b1e6-4215-8981-e488f2e475cc">20,952</ix:nonFraction> shares of common restricted stock, respectively, were excluded from the computations of diluted net income per common share, as their inclusion would have had an anti-dilutive effect on diluted net income per common share.</span></div></ix:continuation><div id="i9ecb58a0f25a461393eca5efcfd32a38_118"></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzk0MTA_1641dd52-bb19-42e0-a3a3-cfc4300dffa4" continuedAt="i843dd99905b8408fa6933d7dd3d21f68" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i843dd99905b8408fa6933d7dd3d21f68" continuedAt="i47f3a4b9855946f6895b4a0b3e586615"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal Matters and Routine Proceedings</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has settled complaints that had been filed with various states&#8217; pharmacy boards in the past. There can be no assurances made that other states will not attempt to take similar actions against the Company in the future. The Company also intends to vigorously defend its trade or service marks. There can be no assurance that the Company will be successful in protecting its trade or service marks. Legal costs related to the above matters are expensed as incurred. From time to time, the Company may be involved in and subject to disputes and legal proceedings, as well as demands, claims and threatened litigation that arise in the ordinary course of its business. These proceedings may include allegations involving business practices, infringement of intellectual property, employment or other matters. The ultimate outcome of any legal proceeding is often uncertain, there can be no assurance that the Company will be successful in any legal proceeding, and unfavorable outcomes could have a negative impact on our results of operations and financial condition. In accordance with ASC Topic 450-20 ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"), the Company records a liability in its financial statements for these matters when a loss is known or considered probable and the amount can be reasonably estimated. The Company reviews the status of each significant matter each accounting period as additional information is known and adjusts the loss provision when appropriate. If a matter is both probable to result in a liability and the amounts of loss can be reasonably estimated, the Company estimates and discloses the possible loss or range of loss to the extent necessary to make the financial statements not misleading. If the loss is not probable and cannot be reasonably estimated, a liability is </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div><div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9)&#160;&#160;&#160;&#160;Commitments and Contingencies (Continued)</span></div></div><ix:continuation id="i47f3a4b9855946f6895b4a0b3e586615" continuedAt="iba7eead4241f4c8b8ac216fd5ba2bdf7"><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not recorded in the Company&#8217;s financial statements. Gain contingencies are not recorded until they are realized. Legal costs related to any legal matters are expensed as incurred.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales Tax</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2018, the United States Supreme Court rendered a decision in South Dakota v. Wayfair, Inc., holding that a state may require a remote seller with no physical presence in the state to collect and remit sales tax on goods and services provided to purchasers in the state, overturning certain existing court precedent. The Company has evaluated its state tax filings with respect to the Wayfair decision and currently collects and remits applicable sales taxes in all jurisdictions in which it has a physical presence or it believes Nexus exists. During the year ended March&#160;31, 2023, the Company received an assessment for sales tax; based upon this, the Company evaluated the various jurisdictions for additional exposure and recorded an increase of $<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-5" name="us-gaap:ExciseAndSalesTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTA1OTU_92316257-a165-4725-8d7b-6dd0be62b4ee">7.8</ix:nonFraction>&#160;million for potential sales tax exposure. The Company included $<ix:nonFraction unitRef="usd" contextRef="i6c2de17c1b084f35b8463988b326e824_I20230331" decimals="-5" name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTA2MTA_3f30a977-9d90-4794-b5d6-41cbe6349b4f">4.0</ix:nonFraction>&#160;million in the "Accrued expenses and other current liabilities" line item and $<ix:nonFraction unitRef="usd" contextRef="ia1f7c6a0ee004443b3a68de9782c1f9c_I20230331" decimals="-5" name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTA2MjQ_48d200fd-a201-4fed-89eb-54c38aff392c">3.8</ix:nonFraction>&#160;million in the "Other long-term liabilities" line item in the Consolidated Balance Sheets as of March&#160;31, 2023 with the offsetting expense  recognized in the "General and administrative" line item within the Consolidated Statements of Income for the year ended March&#160;31, 2023.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employment Agreements</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Board of Directors notified Menderes Akdag (&#8220;Mr. Akdag&#8221;), former CEO &amp; President and Director, that the Company would not extend Mr. Akdag&#8217;s employment agreement with the Company, and the employment agreement would therefore end on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 30, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in accordance with the scheduled end date of the agreement. Effective </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 31, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Board of Directors appointed Bruce S. Rosenbloom (&#8220;Mr. Rosenbloom&#8221;), the Company&#8217;s former Chief Financial Officer, as Interim Chief Executive Officer and President of the Company, until a permanent successor chief executive officer was appointed. Mr. Rosenbloom received an additional cash stipend of $<ix:nonFraction unitRef="usd" contextRef="i6267e0b588824a56aa5efdad685990fc_D20210731-20210830" decimals="-3" name="pets:PaymentsForStipend" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzI2ODY_0acf2435-1dc2-4bb6-827d-c1c356af2c45">10</ix:nonFraction> thousand for the additional responsibilities while serving as Interim Chief Executive Officer and President, which ended on August&#160;30, 2021.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 11, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company and Mr. Akdag, entered into a CEO Separation Agreement and General Release setting forth certain matters relating to the expiration of Mr. Akdag&#8217;s employment with the Company (the &#8220;Separation Agreement&#8221;). The Separation Agreement provided that Mr. Akdag&#8217;s employment with the Company, and service as an officer and director of the Company, would terminate as of July 30, 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Separation Agreement also documented Mr. Akdag&#8217;s agreement that, during his remaining period of employment through July 30, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he would continue to provide his fulltime attention to the business affairs of the Company and cooperate with the Company&#8217;s Board of Directors on the transition to a new chief executive officer. The Separation Agreement provided that Mr. Akdag would be paid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonFraction unitRef="payment" contextRef="i9d21b0cfcbc8452ea6025a3a67ef8073_I20210611" decimals="INF" name="pets:NumberOfSeverancePayments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4MjMyNTk_a45be89b-b7ca-47f9-8601-2b4bc5b2a19a">two</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lump-sum severance payments of $<ix:nonFraction unitRef="usd" contextRef="i4891cfdf6fc44c6aa3c0da9831b5308f_D20211231-20211231" decimals="-3" name="pets:LumpSumSeverancePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzM2NDY_08816367-4f05-427d-9ce8-864717d087d4"><ix:nonFraction unitRef="usd" contextRef="i2432cc60a7f84868839476ea9782eeae_D20210810-20210810" decimals="-3" name="pets:LumpSumSeverancePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzM2NDY_4b76b8d0-574d-4bea-ae39-5410a6376167">325</ix:nonFraction></ix:nonFraction> thousand each, with the first such payment to be paid, and was paid, on</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August&#160;10, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the second to be paid, and was paid, on December 31, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subject to his compliance with the terms and conditions of his then existing employment agreement, and the Separation Agreement. In exchange for the Company&#8217;s agreement to make the severance payments, Mr. Akdag granted the Company a full release of any and all claims that he may</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have against the Company and its affiliates and related parties.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a part of the Separation Agreement, the Company confirmed that the <ix:nonFraction unitRef="shares" contextRef="i2edb519042c6474b9a2fd6eca193f849_D20210731-20210731" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzQyMDc_a7e024f3-4366-4515-9e86-059ea1546b7f">37,800</ix:nonFraction> restricted shares held by Mr. Akdag would be, and were, released from restriction and forfeiture on July 31, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and that the Company would, and did, cover the tax withholding obligations in connection with such release of shares from restriction and forfeiture. Under the Separation Agreement, Mr. Akdag agreed that he would continue to comply with his existing confidentiality, non-solicitation, and non-compete obligations, and he further agreed that until July 31, 2022,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he would comply with certain &#8220;standstill&#8221; covenants relating to the Company.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 25, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Board of Directors appointed Mathew N. Hulett ("Mr. Hulett&#8221;) as Chief Executive Officer and President of the Company and as a member of the Board of Directors. These appointments and the employment agreement were effective as of August 30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The employment agreement is for an initial term of three (<ix:nonNumeric contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830" name="pets:EmploymentTermInitialPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTM5NTc_1a57d3ea-61f1-4106-8a81-966b837c861d">3</ix:nonNumeric>) years commencing on August 30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and will automatically renew for successive one (<ix:nonNumeric contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830" name="pets:EmploymentTermSuccessiveRenewalPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTM5NjU_22833fa2-4a48-44c9-9692-d671dbad1218">1</ix:nonNumeric>) year terms, or for longer periods as mutually agreed upon by the parties, unless the employment agreement is expressly cancelled by either Mr. Hulett or the Company sixty (<ix:nonNumeric contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830" name="pets:EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTM5NzI_36bd3e44-88cb-417a-88d6-8f3c3210410e">60</ix:nonNumeric>) days prior to the end of the then current term, or is otherwise terminated as provided in the agreement. The employment agreement provides that Mr. Hulett will </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div><div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9)&#160;&#160;&#160;&#160;Commitments and Contingencies (Continued)</span></div></div><ix:continuation id="iba7eead4241f4c8b8ac216fd5ba2bdf7" continuedAt="i3f63848b640745788fcf389132e3a9d9"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receive an annual base salary of $<ix:nonFraction unitRef="usd" contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830" decimals="-3" name="us-gaap:OfficersCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzU2NzI_8148d1c2-aed8-4f83-b385-17cacb4774c3">500</ix:nonFraction> thousand, subject to periodic review for increases with the approval of the Board of Directors, and will be eligible to participate in the standard employee benefit plans generally available to executives and employees of the Company, including health insurance, life and disability insurance, restricted stock under the Company&#8217;s equity compensation plan(s), 401(k) plan, and paid time off and paid holidays. The employment agreement also provides that the Company will reimburse Mr. Hulett for his documented business expenses incurred in connection with his employment pursuant to the Company's standard reimbursement expense policy and practices. The employment agreement contains certain rights of Mr. Hulett and the Company to terminate Mr. Hulett&#8217;s employment, including termination by the Company for &#8220;Cause&#8221; as defined in the employment agreement, and termination by Mr. Hulett for &#8220;Good Reason&#8221; as defined in the employment agreement within twelve (<ix:nonNumeric contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830" name="pets:TerminationPeriodPeriodWithinChangeInControl" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTM5ODA_bb5dba05-4c25-4bbd-a295-937b3d90eb17">12</ix:nonNumeric>) months of a Change in Control as defined in the employment agreement. Mr. Hulett is also entitled to severance pay equal to twelve (<ix:nonNumeric contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830" name="pets:SeverancePaymentBaseSalaryPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTM5ODg_11e176ab-a145-4095-846b-96fea0084968">12</ix:nonNumeric>) months of Mr. Hulett&#8217;s current base salary and eighteen (<ix:nonNumeric contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830" name="pets:SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTM5OTY_658b97f0-3858-4120-9de2-588c165a9348">18</ix:nonNumeric>) months of health insurance benefits in the event of his termination by the Company without Cause, or termination by Mr. Hulett for Good Reason within twelve (<ix:nonNumeric contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830" name="pets:SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTQwMDQ_e5c758fb-bddd-4f89-8a80-515a581f1185">12</ix:nonNumeric>) months of a Change in Control. The foregoing severance benefits are conditioned upon Mr. Hulett&#8217;s execution of a release of claims and compliance with certain restrictive covenants. The employment agreement contains customary non-disclosure and non-solicitation provisions as well as a one (<ix:nonNumeric contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830" name="pets:NonCompeteAgreementPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTQwMTI_27150318-5bdb-4793-9b3d-dbd948e97bd4">1</ix:nonNumeric>) year non-compete following the termination of the agreement.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;30, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Hulett also received an award of <ix:nonFraction unitRef="shares" contextRef="i315520404bf24ebea1c2cb0c8e23b089_D20210830-20210830" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2ODQ1ODI_2de9c24a-1f22-4a2b-9f89-eefbc01150ce">90,000</ix:nonFraction> shares of restricted stock under the Company&#8217;s 2016 Employee Plan, which stock restrictions will lapse pro rata on each of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 30, 2022,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 30, 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 30, 2024,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which are subject to forfeiture in the event of termination of employment (except as provided in the restricted stock agreement). Mr. Hulett also received an award of <ix:nonFraction unitRef="shares" contextRef="i63b1d72605c8405d8b027717916a080b_D20210830-20210830" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2ODQ1ODY_c8848183-5f17-4fd5-b194-f9e5be026c9d">510,000</ix:nonFraction> shares of performance restricted stock under the 2016 Employee Plan, which stock restrictions will lapse on the third anniversary of the date of grant based on (i) achieving absolute stock price hurdles within the <ix:nonNumeric contextRef="i63b1d72605c8405d8b027717916a080b_D20210830-20210830" name="pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4MjM0NDk_dcff6b12-ee3d-45bd-98ad-21c81206b996">three-year</ix:nonNumeric> period from the date of grant, and (ii) continued employment through the performance period of <ix:nonNumeric contextRef="i63b1d72605c8405d8b027717916a080b_D20210830-20210830" name="pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4MjM0NTA_5b25e125-4892-441c-bf81-c751691244b4">three years</ix:nonNumeric> from the date of grant, in accordance with the following schedule: <ix:nonFraction unitRef="shares" contextRef="i7afc070e4bdf46fc9f7d226e6741e1c6_D20210830-20210830" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgxNDA_da9d7858-fdcf-49b2-8d6e-d3a7140bf4cd">85,000</ix:nonFraction> shares at the stock hurdle price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1384889b25bd4d7185122232ce1451e8_I20210830" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgxNzk_20f8ba12-aee3-4666-9901-2762c4e284b2">40</ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="i5cbb8d45015a45ea84ddf37d27c11a68_D20210830-20210830" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgxOTM_2f717ac6-010e-4bd1-8b26-20229a6d8f8d">107,000</ix:nonFraction> shares at the stock hurdle price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6808984e22ee45d58ea010775c3f55d4_I20210830" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgyMzI_06f4e227-1d05-4984-aec6-3d3b7c95b980">45</ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="ic1dce613dc084e329c47918a37fe1c39_D20210830-20210830" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgyNDY_b7b34f76-7721-404f-adaf-7fcadb3e9977">106,000</ix:nonFraction> shares at the stock hurdle price of $<ix:nonFraction unitRef="usdPerShare" contextRef="if5e6ea897b514a6f9570f9ac37ce2bb2_I20210830" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgyODU_2140fabb-9807-435d-95b8-60241864382e">50</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i449b1d02eb98411ca0c78fbbde6ac2f1_D20210830-20210830" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgyODk_3af27fb1-2d3a-41a5-bb83-f9deb41d334c">106,000</ix:nonFraction> shares at the stock hurdle price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i844106ae017246048418122f69f34ad0_I20210830" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgzMjg_0123a16c-1975-43c5-bd29-c6b839d8338a">55</ix:nonFraction>, and <ix:nonFraction unitRef="shares" contextRef="i068c52c343b44cc193b5a62f93d38549_D20210830-20210830" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgzMzY_a4a20452-eb1b-4336-ae2b-b314d912a1df">106,000</ix:nonFraction> shares at the stock hurdle price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic863aef22f2d409193398f92e79e7c7f_I20210830" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgzNzU_2c4da929-8089-4cd0-97d0-15f90d9cba73">60</ix:nonFraction>.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should none of the absolute stock price hurdles be met during the <ix:nonNumeric contextRef="i63b1d72605c8405d8b027717916a080b_D20210830-20210830" name="pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4MjM0MjU_df0c69aa-e209-42fb-b565-81f081e9ecc3">three-year</ix:nonNumeric> period from the date of grant, no shares would vest (as defined in the performance restricted stock agreement). Once the absolute stock price hurdle is achieved, it will be considered to have met the absolute stock price hurdle, regardless of the stock price on the third anniversary of the date of grant. The absolute stock price hurdle would be considered to have been met if the average closing stock price of the Company is at or above the absolute stock price hurdle for a period of ninety (<ix:nonNumeric contextRef="i63b1d72605c8405d8b027717916a080b_D20210830-20210830" name="pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTQwMTk_16115086-71a0-4666-b2a7-d920fd184e09">90</ix:nonNumeric>) consecutive trading days. If the shares would be considered to have met the absolute stock price hurdle, they will only vest on the third anniversary of date of grant, subject to Mr. Hulett&#8217;s continued employment through the performance period of <ix:nonNumeric contextRef="i63b1d72605c8405d8b027717916a080b_D20210830-20210830" name="pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4MjM0MDA_147bdbd4-ca81-4c82-b4f4-160e7034d590">three years</ix:nonNumeric> from the date of grant (except as provided in the performance restricted stock agreement). As of March&#160;31, 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">none of the performance restricted stock vested, as no performance stock price hurdles were met.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;14, 2022, the Board of Directors appointed Christine Chambers ("Ms. Chambers") to serve as the Company&#8217;s Chief Financial Officer and to assume the duties of principal financial officer and principal accounting officer effective August&#160;3, 2022 (&#8220;Effective Date&#8221;). The Company entered into an offer letter with Ms. Chambers to set the terms and conditions of Ms. Chambers&#8217; employment as Chief Financial Officer of the Company. Ms. Chambers will receive an annual base salary of $<ix:nonFraction unitRef="usd" contextRef="id26b0819bb5b4b09bda518b2201d5648_D20220803-20220803" decimals="-3" name="us-gaap:OfficersCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2NzEwOTU_909c8110-5948-489a-8583-670f4c34d4a0">375</ix:nonFraction> thousand and received a one-time sign-on bonus in the amount of $<ix:nonFraction unitRef="usd" contextRef="if0add0f1e60f4b04ae873731c0197067_D20220802-20220802" decimals="-3" name="pets:SalaryAndWageOfficerSignOnBonus" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2NzExMDc_cbf3d466-e851-485b-9078-cee8ec31fb34">50</ix:nonFraction> thousand, subject to pro rata repayment if Ms. Chambers terminates employment with the Company within the first twelve months of employment. Ms. Chambers received an initial equity award  under the 2016 Employee Plan consisting of (i) an award of <ix:nonFraction unitRef="shares" contextRef="iff7afa81075f467a8ee51d67a09ed71b_D20220803-20220803" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2ODQ2MDI_2c8a80d1-c51e-4e60-9601-5c7799e0e492">13,000</ix:nonFraction> restricted shares, and (ii) <ix:nonFraction unitRef="shares" contextRef="icd16eafa395744a48017a3ee602c42e8_D20220803-20220803" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2ODQ2MTY_6175a259-ad99-4e87-9341-1625c6bd57e3">3,000</ix:nonFraction> performance restricted shares, which performance restricted shares will be based on the attainment of performance criteria equally weighted between adjusted EBITDA and revenue as of the fiscal year ended March&#160;31, 2023. The shares for each grant will be released from restriction equally over a three (<ix:nonNumeric contextRef="icd16eafa395744a48017a3ee602c42e8_D20220803-20220803" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTQwMjc_050787e9-fdf2-4286-8a42-fb2fd7678aad">3</ix:nonNumeric>) year period on the anniversary of the grant date, subject to the attainment of performance criteria in the case of the performance restricted shares. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with Mr. Rosenbloom&#8217;s transition services and subsequent separation from employment with the Company, on August&#160;2, 2022 the Company and Mr. Rosenbloom entered into a CFO Transition and Separation Agreement (the "Separation Agreement&#8221;) pursuant to which Mr. Rosenbloom remained in his current position as CFO of the Company through and including August&#160;2, 2022, and following the termination of his </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div><div style="margin-top:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9)&#160;&#160;&#160;&#160;Commitments and Contingencies (Continued)</span></div></div><ix:continuation id="i3f63848b640745788fcf389132e3a9d9" continuedAt="i9eb48cf406c740bda85773fa5cde231a"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">status as CFO, Mr. Rosenbloom continued to serve as an employee of the Company to provide transition services to the Company through his date of termination. His employment ended on December&#160;31, 2022 ("Separation Date&#8221;). While Mr. Rosenbloom served as an employee of the Company, he continued to receive his current base salary and benefits as was in effect. The Separation Agreement provided that Mr. Rosenbloom would be paid <ix:nonFraction unitRef="payment" contextRef="i25dd78455488483794c262cbc7525f11_I20220802" decimals="INF" name="pets:NumberOfSeverancePayments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4MjM0NTE_9186bb5d-c369-4dfe-b0e0-09a6d6f9e26a">two</ix:nonFraction> lump-sum severance payments of $<ix:nonFraction unitRef="usd" contextRef="if0add0f1e60f4b04ae873731c0197067_D20220802-20220802" decimals="-3" name="pets:ContingentLumpSumSeverancePayment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2NzEyODM_59cd74e3-0cc5-4c15-8a86-f21abc1d8484"><ix:nonFraction unitRef="usd" contextRef="idc34f00e393f4f85af3ba71ed34d459b_D20230113-20230113" decimals="-3" name="pets:LumpSumSeverancePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2NzEyODM_c074de10-7bdd-4aa0-9af5-ca7ecea42e81">182</ix:nonFraction></ix:nonFraction> thousand each, with the first such payment to be paid on the Company&#8217;s next payroll date following the Separation Date, and was paid January 13, 2023, and the second to be paid on the Company&#8217;s next payroll date six-months following the Separation Date, subject to his compliance with the terms and conditions of his then existing employment agreement, and the Separation Agreement. In exchange for the Company&#8217;s agreement to make the severance payments, Mr. Rosenbloom granted the Company a full release of any and all claims that he may have against the Company and its affiliates and related parties.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a part of the Separation Agreement, the Company confirmed that the <ix:nonFraction unitRef="shares" contextRef="id0a27942ed9c40ff9ddc967a8de7b5f6_D20221231-20221231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2NzEyOTc_69a3456d-a162-43cf-8efc-5d0ca3ff766c">13,275</ix:nonFraction> restricted shares held by Mr. Rosenbloom under the 2016 Employee Plan were released from restriction and forfeiture on December&#160;31, 2022, Under the Separation Agreement, Mr. Rosenbloom&#8217;s existing non-compete obligation was reduced to a period of twelve (<ix:nonNumeric contextRef="if0add0f1e60f4b04ae873731c0197067_D20220802-20220802" name="pets:NonCompeteAgreementPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTQwMzQ_3a2f1c42-594e-4649-9e19-c87e1c3c7f9e">12</ix:nonNumeric>) months.</span></div></ix:continuation><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9eb48cf406c740bda85773fa5cde231a">In connection with the separation of the Company's former Chief Financial Officer, the Company has accrued the remaining $<ix:nonFraction unitRef="usd" contextRef="ide541b5ccbaf4aae8f5059586a8aac5b_I20230331" decimals="-3" name="pets:AccruedSeveranceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2ODQ2NDE_e0e35b5b-53d1-4e19-96e8-709b8d0475ab">182</ix:nonFraction> thousand payment with respect to the severance, pursuant to the Separation Agreement, included in "Accrued expenses and other current liabilities" on the Consolidated Balance Sheet as of March&#160;31, 2023.</ix:continuation> </span></div><div><span><br/></span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_121"></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(10)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4Xzg5Mg_2724b4d2-cb83-4f53-bd36-31674a7eb8f6" continuedAt="i59129d18e7914f878f2f72316517c038" escape="true">Employee Benefit Plan</ix:nonNumeric></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><ix:continuation id="i59129d18e7914f878f2f72316517c038"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a 401(k) Savings Plan for eligible employees. The plan is a defined contribution plan that is administered by the Company. All regular, full-time employees are eligible for voluntary participation upon completing <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4XzI2Nw_9cfb675d-f5e0-43c8-8e42-6ac99df4a5ad">one year</ix:nonNumeric> of service and having attained the age of <ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="pets:DefinedContributionPlanWithIndividualAge" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4XzMxMg_a707b76e-b627-4813-82d3-aaa3b98a6fea">21</ix:nonNumeric>. The plan provides for growth in savings through contributions and income from investments. It is subject to the provisions of the Employee Retirement Income Security Act of 1974</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as amended. Plan participants are allowed to contribute a specified percentage of their base salary. The Company matches <ix:nonFraction unitRef="number" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4XzE2NDkyNjc0NDE3Nzc3_49a388d7-d5d7-4bea-bb43-160c6bcdaea0">100</ix:nonFraction>% of the first <ix:nonFraction unitRef="number" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4XzE2NDkyNjc0NDE3Nzgz_e44c8b6e-07b3-47b8-bcc1-73b3f7539ddb">4</ix:nonFraction>% of the employees contribution. The matching contribution is funded subsequent to the calendar year. During the fiscal years ended March&#160;31, 2023, 2022, and 2021, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" decimals="-3" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4Xzc2NQ_29094337-e168-424f-b4d3-68c99e15fefa">289</ix:nonFraction> thousand, $<ix:nonFraction unitRef="usd" contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331" decimals="-3" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4Xzc2OQ_b5c31cef-f819-4604-9e94-fb5bb223ff7e">238</ix:nonFraction> thousand, and $<ix:nonFraction unitRef="usd" contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331" decimals="-3" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4Xzc3Nw_af1c14ab-db7f-45d7-8b83-952e91a52b84">245</ix:nonFraction> thousand, respectively, of 401(k) matching contribution and administration expense to general and administrative expenses.</span></ix:continuation></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_584"></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(11)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF81ODQvZnJhZzo2YmJkYTcxNWI5ZjM0MmVkODNlZjVjOGIzYWJjY2JlZS90ZXh0cmVnaW9uOjZiYmRhNzE1YjlmMzQyZWQ4M2VmNWM4YjNhYmNjYmVlXzY1OTcwNjk3NzE4Njc_fdeb5463-67ee-44ad-8f88-fb99e3c4df4e" continuedAt="i9acafcfc72974bdf9bd2ad4d05b7a845" escape="true">Minority Interest Investment in Vetster</ix:nonNumeric></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><ix:continuation id="i9acafcfc72974bdf9bd2ad4d05b7a845" continuedAt="i358a5dc08c244242ac9836a6921a2ee1"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;19, 2022, the Company engaged in a <ix:nonNumeric contextRef="i5d8f4dc33edd40a281b970a2cbdbe0c5_D20220419-20220419" name="pets:TermOfAgreement" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF81ODQvZnJhZzo2YmJkYTcxNWI5ZjM0MmVkODNlZjVjOGIzYWJjY2JlZS90ZXh0cmVnaW9uOjZiYmRhNzE1YjlmMzQyZWQ4M2VmNWM4YjNhYmNjYmVlXzY1OTcwNjk3NzE4Njg_4aa44e0f-cdf2-408e-a67b-7543f772afe8">three-year</ix:nonNumeric> partnership agreement with Vetster Inc. (&#8220;Vetster&#8221;), a veterinary telehealth Canadian company. The Company also purchased a <ix:nonFraction unitRef="number" contextRef="ib12c1e8fbbbd41d29aae9c4166df1e67_I20220419" decimals="2" name="pets:NoncontrollingInterestOwnershipPercentagePurchased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF81ODQvZnJhZzo2YmJkYTcxNWI5ZjM0MmVkODNlZjVjOGIzYWJjY2JlZS90ZXh0cmVnaW9uOjZiYmRhNzE1YjlmMzQyZWQ4M2VmNWM4YjNhYmNjYmVlXzEwOTk1MTE2MzEyNTE_a952e312-a48a-4ff5-bbf9-d65a1eaf5d5d">5</ix:nonFraction>% minority interest in Vetster in the amount of $<ix:nonFraction unitRef="usd" contextRef="ib12c1e8fbbbd41d29aae9c4166df1e67_I20220419" decimals="-5" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF81ODQvZnJhZzo2YmJkYTcxNWI5ZjM0MmVkODNlZjVjOGIzYWJjY2JlZS90ZXh0cmVnaW9uOjZiYmRhNzE1YjlmMzQyZWQ4M2VmNWM4YjNhYmNjYmVlXzEwOTk1MTE2MzIyNzA_cb2221b5-7a56-4e21-ba99-cb0b36d6e014">5.0</ix:nonFraction> million and received warrants for additional equity in Vetster, which are tied to future performance milestones. Under the terms of the agreement, the Company became the exclusive e-commerce provider for Vetster, and Vetster became the exclusive provider of telehealth and telemedicine services to the Company. The minority interest investment is being valued on the cost basis.  At March 31, 2023, we evaluated the investment in accordance with ASC Topic 321 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Equity Interests</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i358a5dc08c244242ac9836a6921a2ee1">) and determined it was not impaired.</ix:continuation> </span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_127"></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(12)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3XzEyNjE_dd16cf51-6f8c-416d-82e9-612314ed1e1f" continuedAt="i0180a86428504883907f40237a04cfde" escape="true">Subsequent Events</ix:nonNumeric></span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0180a86428504883907f40237a04cfde" continuedAt="i78bd7eac5cee46d8a1ea224e7654ac37">On January&#160;13, 2023, the Company entered into an Agreement and Plan of Merger to acquire PetCareRx, Inc. ("PetCareRx"), a leading supplier of pet medications, food, and supplies, for an aggregate consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="i7fd3857af0904bd9905af80251e8beaf_D20230113-20230113" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3XzEwOTk1MTE2MzEyOTE_37292373-683f-4313-b277-ee03fceba1a1">36.0</ix:nonFraction> million in cash, subject to adjustment. The closing of the transaction was subject to customary closing conditions and certain state pharmacy license and permit filings related to the change of control of PetCareRx. The transaction was approved by the Board of Directors of both the Company and PetCareRx, and </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">of</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7"> Contents</a></span></div></div><ix:continuation id="i78bd7eac5cee46d8a1ea224e7654ac37"><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the stockholders of PetCareRx, and closed on April&#160;3, 2023. Upon completion of the acquisition, PetCareRx became a wholly-owned subsidiary of the Company.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to March&#160;31, 2023, the Board of Directors approved and issued <ix:nonFraction unitRef="shares" contextRef="i81d9acb2bf774cea93998dcf45c5f344_D20230401-20230523" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3Xzg3OTYwOTMwMzA5NTI_337ca3a1-2ce4-4cea-9aa0-5089911fac5c">42,142</ix:nonFraction> restricted shares to employees of PetCareRx under the 2022 Employee Plan as part of a  retention initiative, which shares were issued subject to a restriction or forfeiture period that lapses on the first anniversary of the date of grant.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to March&#160;31, 2023, the Board of Directors approved and issued <ix:nonFraction unitRef="shares" contextRef="i52baab8375b34634bc096512ff056e08_D20230401-20230523" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3XzY0_b039ed59-08d8-4c06-8bd5-81415ec98d64">11,910</ix:nonFraction> restricted shares, net of forfeitures, to employees under the 2016 Employee Plan and <ix:nonFraction unitRef="shares" contextRef="id3432de5afd244aea63998346817ce66_D20230401-20230523" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3Xzc2OTY1ODE0MDEwMTA_67d038fc-f0e0-4adf-8275-fc7487cfee1d">31,000</ix:nonFraction> restricted shares to employees under the 2022 Employee Plan, which shares were issued subject to a restriction or forfeiture period that lapses ratably on the first, second, and third anniversaries of the date of grant. The Board also approved the issuance of a pro-rata portion of a non-employee director annual restricted stock grant in the amount of <ix:nonFraction unitRef="shares" contextRef="i21b9d44505884d13926569569baba59c_D20230401-20230523" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3XzEwOTk1MTE2MzIxNjY_a7d6d6f9-0229-4ccd-a9ce-fded65913de2">1,623</ix:nonFraction> restricted shares to Sandra Campos, a newly appointed director on the Board of Directors, under the 2015 Director Plan, which shares were issued subject to a restriction or forfeiture period that lapses ratably on the first, second, and third anniversaries of the date of grant.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;22, 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company&#8217;s Board of Directors declared a quarterly dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i0cc0c13fe26b4d4896753ec70f10be17_I20230522" decimals="2" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3XzExMjA_6f4e8c76-583b-423e-97f5-512827dc9b11">0.30</ix:nonFraction> per share on its common stock. The $<ix:nonFraction unitRef="usd" contextRef="i0cc0c13fe26b4d4896753ec70f10be17_I20230522" decimals="-5" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3XzExNTg_d97cfff4-541e-45d6-a0e1-d37a0d9605b1">6.3</ix:nonFraction> million dividend will be payable on June&#160;12, 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to shareholders of record at the close of business on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;6, 2023.</span></div></ix:continuation><div id="i9ecb58a0f25a461393eca5efcfd32a38_130"></div><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(13)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMzAvZnJhZzoyOTM4M2YxODUzMjc0ODFhYjc3NzNhNjA2MjYyZDg1YS90ZXh0cmVnaW9uOjI5MzgzZjE4NTMyNzQ4MWFiNzc3M2E2MDYyNjJkODVhXzQ1Mg_1211f036-7815-42cd-9a98-0bf6fd03f6ad" continuedAt="i412e0b15a33b4942bbe9ff9feb972b20" escape="true">Related Party Transaction</ix:nonNumeric></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><ix:continuation id="i412e0b15a33b4942bbe9ff9feb972b20"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Board of Directors Chairman, Gian Fulgoni, serves on the board of directors of Prophet, a brand and marketing consulting company, which PetMed Express, Inc. engaged with in March 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for $<ix:nonFraction unitRef="usd" contextRef="i4469b631590844adbaaf420a00aa612e_D20210301-20210331" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMzAvZnJhZzoyOTM4M2YxODUzMjc0ODFhYjc3NzNhNjA2MjYyZDg1YS90ZXh0cmVnaW9uOjI5MzgzZjE4NTMyNzQ4MWFiNzc3M2E2MDYyNjJkODVhXzIzMA_d87e7676-6e37-4947-a7e7-814b2c92d8b9">292</ix:nonFraction> thousand. The Company expensed $<ix:nonFraction unitRef="usd" contextRef="ibb424c34659d462d8120e942e5596384_D20210401-20220331" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMzAvZnJhZzoyOTM4M2YxODUzMjc0ODFhYjc3NzNhNjA2MjYyZDg1YS90ZXh0cmVnaW9uOjI5MzgzZjE4NTMyNzQ4MWFiNzc3M2E2MDYyNjJkODVhXzI1NQ_95b13104-2d62-4f09-84ee-90e9dc260333">32</ix:nonFraction> thousand in fiscal 2021, with the remaining $<ix:nonFraction unitRef="usd" contextRef="i97c463b50b984fe9b48aa37d4d2bd8a2_I20230331" decimals="-3" name="us-gaap:DueToRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMzAvZnJhZzoyOTM4M2YxODUzMjc0ODFhYjc3NzNhNjA2MjYyZDg1YS90ZXh0cmVnaW9uOjI5MzgzZjE4NTMyNzQ4MWFiNzc3M2E2MDYyNjJkODVhXzI5MQ_8f14d6db-ea2a-4c21-b4ce-1f28228f8446">260</ix:nonFraction> thousand expensed in fiscal 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This transaction was approved by the Company&#8217;s Board of Directors with terms that are comparable to those with an unrelated third party.</span></ix:continuation></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">57</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_136"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF MANAGEMENT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management of the Company is responsible for the preparation and integrity of the Consolidated Financial Statements appearing in our Annual Report on Form 10-K. The financial statements were prepared in conformity with generally accepted accounting principles appropriate in the circumstances and, accordingly, include certain amounts based on our best judgments and estimates. Financial information in the Annual Report on Form 10-K is consistent with that in the financial statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) under the Securities Exchange Act of 1934 (&#8220;Exchange Act&#8221;). The Company&#8217;s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the Consolidated Financial Statements. Our internal control over financial reporting is supported by a team of consultants and appropriate reviews by management, written policies and guidelines, careful selection and training of qualified personnel, and a written Corporate Code of Business Conduct and Ethics adopted by our Company&#8217;s Board of Directors, applicable to all Company Directors and all officers and employees of our Company and subsidiaries.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements and even when determined to be effective, can only provide reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee (&#8220;Committee&#8221;) of our Company&#8217;s Board of Directors, comprised solely of Directors who are independent in accordance with the requirements of The NASDAQ Stock Market LLC listing standards, the Exchange Act and the Company&#8217;s Corporate Governance Guidelines, meets with the independent auditors and management periodically to discuss internal control over financial reporting, and auditing and financial reporting matters. The Committee reviews with the independent auditors the scope and results of the audit effort. The Committee also meets periodically with the independent auditors without management present to ensure that the independent auditors have free access to the Committee.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management assessed the effectiveness of the Company&#8217;s internal control over financial reporting as of March&#160;31, 2023. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Integrated Framework - 2013. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our assessment, management believes that the Company did not maintain effective internal control over financial reporting as of March&#160;31, 2023 due to the following material weakness in internal control: the Company had inadequate segregation of duties over the preparation, approval and posting of manual journal entries. Notwithstanding the foregoing, management believes, that the material weakness did not result in a misstatement of our financial statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are developing a remediation plan that includes increasing resources and modifying processes to ensure there is adequate segregation of duties over the preparation, approval and posting of journal entries.  We are committed to maintaining a strong internal control environment and implementing measures designed to help ensure that control deficiencies contributing to the material weakness are remediated as soon as possible.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s auditors, RSM US LLP, a independent registered public accounting firm, are appointed by the Audit Committee of the Company&#8217;s Board of Directors, subject to ratification by our Company&#8217;s shareholders. RSM US LLP have audited and reported on the Consolidated Financial Statements of PetMed Express, Inc. and subsidiaries, and issued a report on the Company&#8217;s internal control over financial reporting. The reports of the independent auditors are contained in our Annual Report on Form 10-K.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/ Mathew N. Hulett</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mathew N. Hulett</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President, Chief Executive Officer, Director</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;23, 2023</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/ Christine Chambers</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Christine Chambers</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer and Treasurer</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;23, 2023</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">59</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_139"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Shareholders and the Board of Directors of PetMed Express, Inc. and subsidiaries</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Internal Control Over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited PetMed Express, Inc. and subsidiaries&#8217; (the Company) internal control over financial reporting as of March&#160;31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013. In our opinion, because of the effect of the material weakness described below, the Company has not maintained effective internal control over financial reporting as of March&#160;31, 2023, based on criteria established in Internal Control &#8212; Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements of the Company and our report dated May&#160;23, 2023 expressed an unqualified opinion.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis.  The following material weakness has been identified and included in management's assessment.  The Company has inappropriate segregation of duties over the preparation, approval and posting of manual journal entries.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This material weakness was considered in determining the nature, timing and extent of audit tests applied in our audit of the 2023 financial statements, and this report does not affect our report dated May 23, 2023 on those financial statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company's assets that could have a material effect on the financial statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ RSM US LLP</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fort Lauderdale, Florida</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;23, 2023</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">61</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_142"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_145"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A. CONTROLS AND PROCEDURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of Disclosure Controls and Procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a&#8209;15(e) and 15d-15(e) promulgated under the Exchange Act) as of March&#160;31, 2023, the end of the period covered by this report (the "Evaluation Date"). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded as of the Evaluation Date, that our disclosure controls and procedures were not effective as of March 31, 2023, due to the material weakness in internal control over financial reporting described below.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">s Report on Internal Control over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of March&#160;31, 2023 based on the framework in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Integrated Framework </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Integrated Framework, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">management concluded that our internal control over financial reporting was not effective, as of March&#160;31, 2023, as a result of the material weakness described below.  A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of management's evaluation, we identified a material weakness due to a lack of segregation of duties over the preparation, approval and posting of certain journal entries. Notwithstanding the foregoing, management believes, that the material weakness did not result in a material misstatement of our financial statements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are developing a remediation plan that includes increasing resources and modifying processes to eliminate the lack of segregation of duties over the preparation, approval and posting of journal entries.  We are committed to maintaining a strong internal control environment and implementing measures designed to help ensure that control deficiencies contributing to the material weakness are remediated as soon as possible. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as described above, there were no changes in our internal control over financial reporting during the fourth quarter ended March&#160;31, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inherent Limitations on Effectiveness of Controls</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including our Chief Executive Officer and our Chief Financial Officer, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by the collusion of two or more people or by management override of controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_148"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B. OTHER INFORMATION</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_151"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">63</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_154"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_157"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be set forth in our Proxy Statement, to be filed with the SEC within 120 days after the end of the fiscal year ended March&#160;31, 2023, relating to our 2023 Annual Meeting of Shareholders to be held on August&#160;3, 2023, and is incorporated herein by reference.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a Corporate Code of Business Conduct and Ethics applicable to all officers, directors, and employees. The Company&#8217;s Corporate Code of Business Conduct and Ethics is available on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.petmeds.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under &#8220;About Us - Corporate Governance&#8221;. You may also obtain a copy of our Corporate Code of Business Conduct and Ethics free of charge by contacting Investor Relations at 1-800-738-6337.</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_160"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11. EXECUTIVE COMPENSATION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be set forth in our Proxy Statement, to be filed with the SEC within 120 days after the end of the fiscal year ended March&#160;31, 2023, relating to our 2023 Annual Meeting of Shareholders to be held on August&#160;3, 2023, and is incorporated herein by reference.</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_163"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item (other than information required by Item 201(d) of Regulation S-K with respect to equity compensation plans, which is set forth under Item 5 in this Annual Report on Form 10-K) will be set forth in our Proxy Statement, to be filed with the SEC within 120 days after the end of the fiscal year ended March&#160;31, 2023, relating to our 2023 Annual Meeting of Shareholders to be held on August&#160;3, 2023, and is incorporated herein by reference.</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_166"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be set forth in our Proxy Statement, to be filed with the SEC within 120 days after the end of the fiscal year ended March&#160;31, 2023, relating to our 2023 Annual Meeting of Shareholders to be held on August&#160;3, 2023, and is incorporated herein by reference.</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_169"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be set forth in our Proxy Statement, to be filed with the SEC within 120 days after the end of the fiscal year ended March&#160;31, 2023, relating to our 2023 Annual Meeting of Shareholders to be held on August&#160;3, 2023, and is incorporated herein by reference.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">64</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_172"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_175"></div><div style="-sec-extract:summary;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.34pt">The following documents are filed as part of this Annual Report on Form</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10-K.</span></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Consolidated Financial Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> See the Index to Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K.</span></div><div style="margin-top:12pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The following exhibits are filed as part of this Annual Report on Form 10-K or hereby incorporated by reference to exhibits previously filed with the SEC.</span></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Articles of Incorporation and By-Laws</span></div><div style="margin-top:12pt;padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.181%"><tr><td style="width:1.0%"></td><td style="width:6.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.493%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000104291000000023/0001042910-00-000023.txt">Amended and Restated Articles of Incorporation (incorporated by reference to Exhibit 3.1 to </a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000104291000000023/0001042910-00-000023.txt">our</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000104291000000023/0001042910-00-000023.txt"> Registration Statement on Form 10-SB, File No. 000-28827, filed January 10, 2000).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104915004580/t82385_ex3-2.htm">Articles of Amendment to the Amended and Restated Articles of Incorporation</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104915004580/t82385_ex3-2.htm"> (incorporated by reference to Exhibit 3.2 </a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104915004580/t82385_ex3-2.htm">to</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104915004580/t82385_ex3-2.htm"> </a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104915004580/t82385_ex3-2.htm">our</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104915004580/t82385_ex3-2.htm"> Form 10-K for the year ended March 31, 2015, filed May 22, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774920006219/ex_179066.htm">Second Amended and Restated By-Laws of PetMed Express, Inc. (incorporated by reference to Exhibit 3.1 </a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774920006219/ex_179066.htm">to our</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774920006219/ex_179066.htm"> Form 8-K, filed March 26, 2020).</a></span></div></td></tr></table></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Instruments Defining the Rights of Security Holders</span></div><div style="margin-top:12pt;padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.181%"><tr><td style="width:1.0%"></td><td style="width:6.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.493%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000104291000000023/0001042910-00-000023.txt">Specimen common stock certificate (incorporated by reference to Exhibit 4.2 to </a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000104291000000023/0001042910-00-000023.txt">our</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000104291000000023/0001042910-00-000023.txt"> Registration Statement on Form 10-SB, File No. 000-28827, filed January 10, 2000).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="pets-20230331xexx42.htm">Description of Securities.*</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.34pt">Material Contracts</span></div><div style="margin-top:12pt;padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.181%"><tr><td style="width:1.0%"></td><td style="width:6.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.493%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.1 +</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104915004941/t82509_def14a.htm">2015 Outside Director Equity Compensation Restricted Stock Plan (incorporated by reference to Exhibit B </a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104915004941/t82509_def14a.htm">to</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104915004941/t82509_def14a.htm"> our definitive Proxy Statement for our 2015 Annual Meeting of S</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104915004941/t82509_def14a.htm">hare</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104915004941/t82509_def14a.htm">kholders filed June 8, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.1.1+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104917005258/t1700341_ex10-10z1.htm">Form of Restricted Stock Agreement used for grants of restricted stock under the 2015 Outside Director Equity Compensation Restricted Stock Plan (incorporated by reference to Exhibit 10.10.1 </a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104917005258/t1700341_ex10-10z1.htm">to our</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104917005258/t1700341_ex10-10z1.htm"> Form 10-K for the year ended March 31, 2017 filed May 23, 2017).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.2 +</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104916015952/t1600385_def14a.htm">2016 Employee Equity Compensation Restricted Stock Plan, including form of Restricted Stock Agreement used for grants of restricted stock (incorporated by reference to Exhibit A </a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104916015952/t1600385_def14a.htm">to</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104916015952/t1600385_def14a.htm"> our definitive Proxy Statement for our 2016 Annual Meeting of S</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104916015952/t1600385_def14a.htm">hare</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000157104916015952/t1600385_def14a.htm">holders filed June 13, 2016).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.3 +</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774919014942/ex_151991.htm">Form of Indemnification Agreement entered into with the Directors and Executive Officers of the Company (incorporated by reference to Exhibit 10.1 </a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774919014942/ex_151991.htm">to our</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774919014942/ex_151991.htm"> Form 10-Q for the quarter ended June 30, 2019, filed July 30, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.4 +</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774921021120/ex_279895.htm">Executive Employment Agreement with Mathew N. Hulett (incorporated by reference to Exhibit 10.1 </a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774921021120/ex_279895.htm">to our</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774921021120/ex_279895.htm"> Form 8-K filed August 30, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.5 +</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774921021120/ex_279895.htm">Restricted Stock Agreement with Mathew N. Hulett (incorporated by reference to Exhibit 10.</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774921021120/ex_279895.htm">2</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774921021120/ex_279895.htm"> </a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774921021120/ex_279895.htm">to our</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774921021120/ex_279895.htm"> Form 8-K filed August 30, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.6 +</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774921021120/ex_279895.htm">Restricted Performance Stock Agreement with Mathew N. Hulett (incorporated by reference to Exhibit 10.</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774921021120/ex_279895.htm">3</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774921021120/ex_279895.htm"> </a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774921021120/ex_279895.htm">to our</a><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1040130/000143774921021120/ex_279895.htm"> Form 8-K filed August 30, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.7+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922015277/pets20220616_def14a.htm">2022 Employee Equity Compensation Restricted Stock Plan (incorporated by reference to Exhibit A </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922015277/pets20220616_def14a.htm">to</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922015277/pets20220616_def14a.htm"> our definitive Proxy Statement for our 2022 Annual Meeting of S</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922015277/pets20220616_def14a.htm">hare</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922015277/pets20220616_def14a.htm">holders filed June 17, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.7.1+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="pets-20230331xexx1071.htm">Form of Restricted Stock Agreement used for grants of restricted stock under the 2022 Employee Equity Compensation Restricted Stock Plan.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="pets-20230331xexx1071.htm">*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.8+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922018367/pets20220802_8k.htm">CFO Transition and Separation Agreement with Bruce Rosenbloom (incorporated by reference to Exhibit 10.1 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922018367/pets20220802_8k.htm">to our</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922018367/pets20220802_8k.htm"> Form 8-K filed August 2, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.9+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922018636/ex_405957.htm">Executive Employment Agreement with Christine Chambers (incorporated by reference to Exhibit 10.1 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922018636/ex_405957.htm">to our</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922018636/ex_405957.htm"> Form 8-K filed August 3, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.10+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922018636/ex_405958.htm">Restricted Stock Agreement with Christine Chambers (incorporated by reference to Exhibit 10.2 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922018636/ex_405958.htm">to our</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922018636/ex_405958.htm"> Form 8-K filed August 3, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.11+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922018636/ex_405959.htm">Restricted Performance Stock Agreement with Christine Chambers (incorporated by reference to Exhibit 10.3 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922018636/ex_405959.htm">to our</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1040130/000143774922018636/ex_405959.htm"> Form 8-K filed August 3, 2022).</a></span></div></td></tr></table></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(21)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.34pt">Subsidiaries of Registrant</span></div><div style="margin-top:12pt;padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.181%"><tr><td style="width:1.0%"></td><td style="width:6.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.493%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="pets-20230331xexx211.htm">Subsidiaries of Registrant*</a></span></div></td></tr></table></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(23)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.34pt">Consents of Experts and Counsel</span></div><div style="margin-top:12pt;padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.181%"><tr><td style="width:1.0%"></td><td style="width:6.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.493%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="pets-20230331xexx231.htm">Consent of RSM US LLP*</a></span></div></td></tr></table></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(31)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.34pt">Certifications</span></div><div style="margin-top:12pt;padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.181%"><tr><td style="width:1.0%"></td><td style="width:6.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.493%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="pets-20230331xexx311.htm">Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a)*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="pets-20230331xexx312.htm">Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a)*</a></span></div></td></tr></table></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(32)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.34pt">Certifications</span></div><div style="margin-top:12pt;padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.181%"><tr><td style="width:1.0%"></td><td style="width:6.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.493%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="pets-20230331xexx321.htm">Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 1350**</a></span></div></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.173%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document (the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition LInkbase Document</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Filed herewith</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**Furnished herewith</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+ Indicates a management contract or compensatory plan or arrangement</span></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_178"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16. FORM 10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">K SUMMARY</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">67</span></div></div></div><div id="i9ecb58a0f25a461393eca5efcfd32a38_181"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9ecb58a0f25a461393eca5efcfd32a38_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: May&#160;23, 2023</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PETMED EXPRESS, INC.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(the &#8220;registrant&#8221;)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By: </span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mathew N. Hulett</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mathew N. Hulett</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and President</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(principal executive officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on May&#160;23, 2023.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.356%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SIGNATURE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TITLE</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mathew N. Hulett</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer, President and Director<br/>(principal executive officer)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mathew N. Hulett</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Gian M. Fulgoni</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board and Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gian M. Fulgoni</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christine Chambers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer and Treasurer<br/>(principal financial and accounting officer)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Chambers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Leslie C.G. Campbell</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leslie C.G. Campbell</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jodi Watson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jodi Watson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Peter S. Cobb</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter S. Cobb</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Diana Garvis Purcel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diana Garvis Purcel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(*)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandra Y. Campos</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(*) Appointed to the PetMed Express, Inc. Board of Directors on May 17, 2023.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">68</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>pets-20230331xexx42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i0c55615ed6904277be3419bdd0fe4501_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 4.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DESCRIPTION OF THE COMPANY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8217;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S SECURITIES REGISTERED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following is a brief description of the common stock, $0.001 par value per share (the &#8220;Common Stock&#8221;), of PetMed Express, Inc., a Florida corporation (the &#8220;Company&#8221;), which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Common Stock</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following descriptions of our Common Stock and of certain provisions of Florida law do not purport to be complete and are subject to and qualified in their entirety by reference to our amended and restated articles of incorporation, our amended and restated&#160;bylaws&#160;and the Florida Business Corporation Act, as amended (the &#8220;Florida Act&#8221;). The Company has authorized 40,000,000 shares of Common Stock of which as of May&#160;23, 2023, 21,170,977 shares of Common Stock are issued and outstanding. All of our outstanding shares of Common Stock are fully paid and&#160;non-assessable. Our Common Stock is listed on the NASDAQ Global Select Market under the symbol &#8220;PETS.&#8221;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Stock</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Holders of the Common Stock have no pre-emptive, redemption, subscription or conversion rights. Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of the Company's shareholders. Subject to the dividend rights of the holders of any outstanding preferred stock, each share of Common Stock is entitled to participate equally with respect to dividends as may be declared by the board of directors out of funds legally available therefor. In the case of voluntary or involuntary liquidation, distribution or sale of assets, dissolution, or winding up of the Company, holders of our Common Stock are entitled to receive a pro rata share of the amount distributed after provisions for payment of all debts, other liabilities and any liquidation preferences of outstanding preferred stock. The Florida Act also may affect the terms of these securities.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Limitations on Rights of Holders of Common Stock&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Preferred Stock</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The rights of holders of Common Stock may be materially limited or qualified by the rights of holders of preferred stock that we may issue in the future. Set forth below is a description of the Company&#8217;s authority to issue preferred stock and the possible terms of that stock.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our amended and restated articles of incorporation authorizes our board of directors, without further shareholder action, to provide for the issuance of up to 5,000,000 shares of preferred stock, with a par value of $0.001 per share, in one or more series, and to fix the designations, preferences, conversion rights, cumulative, relative, participating, optional or other rights, including voting rights, qualifications, limitations or restrictions, redemption and liquidation preferences of each of these series. Of the preferred stock, 250,000 shares have been designated Convertible Preferred Stock of which as of May&#160;23, 2023, 2,500 shares of Convertible Preferred Stock are issued and outstanding. We may amend from time to time our amended and restated articles of incorporation to increase the number of authorized shares of preferred stock. Any such amendment would require the approval of the holders of a majority of our shares of Common Stock entitled to vote.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholder Action by Written Consent and Special Meeting</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our amended and restated bylaws provide for action by our shareholders without a meeting with the written consent of shareholders holding the number of shares necessary to approve such action if it were taken at a meeting at which all shares entitled to vote thereon were present. Our amended and restated bylaws also provide that shareholder action can be taken at an annual meeting of the shareholders or at a special meeting which may be called, for any purpose or purposes, by the board of directors or the person or persons authorized to do so by the board of directors and must be called by the Secretary if the holders of not less than ten percent of all votes entitled to be cast on any issue proposed to be considered at such special meeting sign, date and deliver to the Secretary one or more written demands for a special meeting, describing the purpose or purposes for which it is to be held.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><img alt="image_1.jpg" src="image_1.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:1440px"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Authorized but Unissued Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our authorized but unissued shares of Common Stock and preferred stock are available for future issuance without shareholder approval, subject to the requirements of applicable law or regulation, including any listing requirement of the principal stock exchange on which our Common Stock is then listed. These additional shares may be utilized for a variety of corporate purposes, including future public offerings to raise additional capital, corporate acquisitions and employee benefit plans. The existence of authorized but unissued shares of Common Stock and preferred stock could render more difficult or discourage an attempt to obtain control of a majority of our Common Stock by means of a proxy contest, tender offer, merger or otherwise.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Board Authority to Amend Bylaws</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under our amended and restated bylaws, our board of directors has the authority to adopt, amend or repeal the bylaws without the approval of our shareholders unless the Florida Act reserves the power to amend a particular bylaw provision exclusively to the shareholders.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Certain Anti-Takeover provisions of Florida Law and our Bylaws</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Florida Business Corporation Act</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are subject to certain anti-takeover provisions that apply to public corporations under Florida law. Pursuant to Section 607.0901 of the Florida Act, a publicly held Florida corporation may not engage in a broad range of business combinations or other extraordinary corporate transactions with an &#8220;interested shareholder&#8221; without the approval of the holders of two-thirds of the voting shares of such corporation (excluding shares held by the interested shareholder), unless&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9679;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the transaction is approved by a majority of disinterested directors before the shareholder becomes an </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">interested shareholder&#59;</font></div></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9679;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the interested shareholder has owned at least 80% of the corporation&#8217;s outstanding voting shares for at least </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">five years preceding the announcement date of any such business combination&#59;</font></div></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9679;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the interested shareholder is the beneficial owner of at least 90% of the outstanding voting shares of the </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">corporation, exclusive of shares acquired directly from the corporation in a transaction not approved by a </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">majority of the disinterested directors&#59; or</font></div></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9679;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the consideration paid to the holders of the corporation&#8217;s voting stock is at least equal to certain fair price </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">criteria.</font></div></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An &#8220;interested shareholder&#8221; is defined as a person who together with affiliates and associates beneficially owns more than 10% of a corporation&#8217;s outstanding voting shares. We have not made an election in our amended and restated articles of incorporation to opt out of Section 607.0901.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, we are subject to Section 607.0902 of the Florida Act which prohibits the voting of shares in a publicly held Florida corporation that are acquired in a &#8220;control share acquisition&#8221; unless (i) our board of directors approved such acquisition prior to its consummation or (ii) after such acquisition, in lieu of prior approval by our board of directors, the holders of a majority of the corporation&#8217;s voting shares, exclusive of shares owned by officers of the corporation, employee directors or the acquiring party, approve the granting of voting rights as to the shares acquired in the control share acquisition. A &#8220;control share acquisition&#8221; is defined as an acquisition that immediately thereafter entitles the acquiring party to 20% or more of the total voting power in an election of directors.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">These statutory provisions may prevent takeover attempts that might result in a premium over the market price for shares of our common stock.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><img alt="image_1.jpg" src="image_1.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:1440px"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Advance Notice of Shareholder Proposals or Nominations</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our amended and restated bylaws provide that shareholders at an annual meeting may only consider proposals or nominations (i) specified in the notice of meeting given by or at the direction of the Board, (ii) properly brought before the meeting by or at the direction of the Board or (iii) otherwise properly brought before the meeting by a shareholder of the Company who was a shareholder of record on (a) the date of the giving of timely notice to our Corporate Secretary and (b) the record date for the meeting, who is entitled to vote at the meeting and who has given our Corporate Secretary timely written notice, in proper form. In addition to certain other applicable requirements, for business to be properly brought before an annual meeting by a shareholder, such shareholder generally must have given notice thereof in proper written form to our Corporate Secretary not less than 90 days nor more than 120 days prior to the anniversary date of the immediately preceding annual meeting of shareholders. Our amended and restated bylaws may have the effect of precluding the conduct of certain business at a meeting if the proper procedures are not followed or may discourage or defer a potential acquiror from conducting a solicitation of proxies to elect its own slate of directors or otherwise attempting to obtain control of us.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Proxy Access</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our By-Laws permit a shareholder (or a group of up to 20 shareholders) owning three percent (3%) or more of our common stock continuously for at least three years to nominate and include in our proxy statement candidates for up to the greater of 2 of 20% of our Board. To be timely, a notice of a nomination under our proxy access bylaw provisions must be delivered to or mailed and received at the principal executive offices of the Company not less than one-hundred twenty (120) days nor more than one-hundred fifty (150) days prior to the anniversary of the date that the Company first distributed its proxy statement to shareholders for the immediately preceding annual meeting of shareholders. The notice must contain certain information specified in our amended and restated bylaws.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Transfer Agent and Registrar</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The transfer agent and registrar for the Company's common stock is Continental Stock Transfer &#38; Trust Company.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7 1
<SEQUENCE>3
<FILENAME>pets-20230331xexx1071.htm
<DESCRIPTION>EX-10.7 1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="idc86fd3b8f18447c96bb673098c95c92_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:396pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Exhibit 10.7.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTRICTED STOCK AGREEMENT PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PETMED EXPRESS, INC. 2022 EMPLOYEE EQUITY COMPENSATION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RESTRICTED STOCK PLAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">      THIS RESTRICTED STOCK AGREEMENT (&#8220;Agreement&#8221;) is made this ___ day of ____, 202_ by and between _______________ (the &#34;Participant&#34;) and PetMed Express, Inc., a Florida corporation, on behalf of itself, its subsidiaries and affiliates (collectively, the &#34;Company&#34;) pursuant to the Company's 2022 Employee Equity Compensation Restricted Stock Plan (the &#34;2022 Plan&#34;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     WHEREAS, the Company desires to award the Participant shares of common stock of the Company, subject to certain restrictions as hereinafter provided, in accordance with the provisions of the 2022 Plan, the terms of which are incorporated by reference herein, and a copy of the 2022 Plan is being provided to the Participant herewith.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     NOW THEREFORE, in consideration of the foregoing and the mutual undertakings herein contained, the parties hereto agree as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1. Grant of Stock.  In accordance with the terms of the 2022 Plan and subject to the further terms, conditions and restrictions contained in this Agreement, the Company hereby grants to the Participant _______ shares (the &#34;Shares&#34;) of the Company's common stock, par value $.001 per share (the &#34;Common Stock&#34;). As long as the Shares are subject to the Restrictions set forth in Section 4 of this Agreement, such shares shall be deemed to be, and are referred to in this Agreement as, the &#34;Restricted Stock.&#34; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2. Certificates or book entries for Shares. Certificates or book entries in electronic form with the Company&#8217;s stock transfer agent evidencing Restricted Stock shall be deposited with the Company or maintained by the Company&#8217;s stock transfer agent to be held in escrow until such Shares are released to the Participant or forfeited in accordance with this Agreement. The Participant shall, simultaneously with the delivery of this Agreement, deliver to the Company a stock power, in blank, executed by the Participant. If any Restricted Stock is forfeited, the Company shall direct the Company&#8217;s stock transfer agent to make the appropriate entries in its records showing the cancellation of the Restricted Stock and to return the Shares represented thereby to the Company's treasury.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.  Adjustments in Restricted Stock.  In the event of any change in the outstanding Common Stock by reason of a stock dividend or distribution, recapitalization, merger, consolidation, split-up, combination, exchange of shares or the like, the Committee shall make equitable adjustments in the Restricted Stock corresponding to adjustments made by the Committee in the number and class of shares of Common Stock which may be issued under the 2022 Plan. Any new, additional or different securities to which the Participant shall be entitled in respect of Restricted Stock by reason of such adjustment shall be deemed to be Restricted Stock and shall be subject to the same terms, conditions, and restrictions as the Restricted Stock so adjusted. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.  Restrictions.  During applicable periods of restriction determined in accordance with Section 6 of this Agreement, Restricted Stock and all rights with respect to such Shares, may not be sold, assigned, transferred, exchanged, pledged, hypothecated or otherwise encumbered or disposed of and shall be subject to the risk of forfeiture contained in Section 5 of this Agreement (such limitations on transferability and risk of forfeiture being herein referred to as &#34;Restrictions&#34;), but the Participant shall have all other rights of a stockholder, including, but not limited to, the right to vote and receive dividends on Restricted Stock, subject to any dividend to be held in escrow pursuant to the terms of the 2022 Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5. Forfeiture of Restricted Stock. In the event that the Participant terminates employment with the Company for any reason other than his or her death or permanent disability, such event shall constitute an &#34;Event of Forfeiture&#34; and all Shares which at that time are Restricted Stock shall thereupon be forfeited by the Participant to the Company without payment of any consideration by the Company, and neither the Participant nor any successor, heir, assign or personal representative of the Participant shall have any right, title or interest in or to such Restricted Stock.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6. Lapse of Restrictions.  (a) Except as provided in subsection (b) below, the Restrictions on the Restricted Stock granted under this Agreement shall lapse ratably on each of the anniversaries of the date of this Agreement in accordance with the following schedule&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:50.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.384%"><tr><td style="width:1.0%"></td><td style="width:41.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.043%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anniversary Dates</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) In the event that a Participant's employment with the Company terminates as a result of his or her death or permanent disability, the Restrictions shall lapse on the Restricted Stock (if not already lapsed pursuant to subsection (a) above) on the date of such event. </font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upon lapse of the Restrictions in accordance with this Section, the Company shall, as soon as practicable thereafter, deliver to the Participant, or to the Participant's personal representative, the unrestricted Shares in certificate or electronic form with respect to which such Restrictions have lapsed. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7. Withholding Requirements.  The Company shall have the right to withhold from sums due to the Participant, or to require the Participant to remit to the Company, an amount sufficient to satisfy any Federal, state or local withholding tax requirements prior to making such payments or delivering, in certificate or electronic form, such Shares.</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, upon the Participant&#8217;s request and subject to approval by the Committee, and compliance with any applicable legal conditions or restrictions, the Committee may determine in its sole discretion that Participant may satisfy Participant&#8217;s personal income tax obligation (at a percentage rate greater than the tax withholding obligation of the Company) by electing to have the Company withhold from the Shares to be released to Participant upon release of the restrictions on the Restricted Stock or pay the tax obligation of Participant from the sales proceeds pursuant to a broker-assisted exercise &#8220;same day sale&#8221;, or &#8220;sell to cover&#8221; transaction, for that number of Shares having a fair market value equal to the amount Participant elects to be withheld. For this purpose, the fair market value of the Shares to be withheld shall be determined on the date that the amount of tax to be withheld is to be determined (the &#34;Tax Date&#34;). All elections by Participant to have Shares withheld to satisfy Participant&#8217;s personal income tax withholding obligations shall be made in writing in a form acceptable to the Committee and shall be subject to the following restrictions&#58; (a)  the election must be made on or prior to the applicable Tax Date&#59; (b)  once made, the election shall be irrevocable as to the particular Shares of the Restricted Stock as to which the election is made&#59; and (c)  all elections shall be subject to the consent or disapproval of the Committee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8. Effect of Employment.  Nothing contained in this Agreement shall confer upon the Participant the right to continue in the employment of the Company or affect any right which the Company may have to terminate the employment of the Participant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9. Amendment.  This Agreement may not be amended except with the consent of the Committee and by a written instrument duly executed by the Participant and the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10. Binding Effect.  This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their heirs, personal representatives, successors and assigns.  Participant acknowledges receipt of a copy of the 2022 Plan, which is annexed hereto, represents that he or she is familiar with the terms and provisions thereof and accepts the award of Shares hereunder subject to all of the terms and conditions thereof and of this Agreement.  Participant hereby agrees to accept as binding, conclusive and final all decisions and interpretations of the Committee upon any questions arising under the 2022 Plan or this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#91;Signature Page Follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Company and the Participant have each executed and delivered this Agreement as of the date first above written.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMPANY&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">__________________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________&#91;name and title&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PARTICIPANT&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">___________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________&#91;name&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>pets-20230331xexx211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib7a75b6c124b4c3295cad754b6542d3f_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exhibit 21.1</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SUBSIDIARIES OF THE REGISTRANT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PETMED EXPRESS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(as of March&#160;31, 2023)</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Subsidiaries Wholly-Owned by PetMed Express, Inc. (&#8220;Company&#8221;)</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:74.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Entity Name</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">State of Incorporation or Organization</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Southeastern Veterinary Exports, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Florida</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Global Veterinary Supply, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Florida</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">420 South Congress Avenue, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Florida</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Harry Merger Sub, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">New York</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PetMeds Insurance Services, LLC</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Florida</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Indirectly Owned Subsidiaries  </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:74.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Entity Name</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">State of Incorporation or Organization</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Congress Park South Owners Association, Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Florida</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1) Each of the named subsidiaries is not necessarily a &#8220;significant subsidiary&#8221; as defined in Rule 1-02(w) of Regulation S-X. On April 3, 2023, in connection with our acquisition PetCareRx, Inc. (&#8220;PetCareRx&#8221;), PetCareRx, a New York corporation, became a wholly-owned subsidiary of the Company, and Harry Merger Sub, Inc. ceased to exist.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(2) A not-for-profit corporation&#59; 420 South Congress Avenue, LLC holds a majority of the voting power.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>pets-20230331xexx231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic64dc720df414184b5fbcb16fba50db5_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:396pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 23.1</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We consent to the incorporation by reference in these Registration Statements (No. 333-269661, </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">No. 333-218917,  No. 333-145180)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> on Form S-8 and related Reoffer Prospectus of PetMed Express, Inc. of our reports dated May&#160;23, 2023, relating to the consolidated financial statements and the effectiveness of internal control over financial reporting (which report expresses an adverse opinion on the effectiveness of the Company&#8217;s internal control over financial reporting because of a material weakness) of PetMed Express, Inc., appearing in the Annual Report on Form 10-K of PetMed Express, Inc. for the year ended March&#160;31, 2023.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We also consent to the reference to our firm under the heading &#8220;Experts&#8221; in such Reoffer Prospectus.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; RSM US LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">West Palm Beach, Florida</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;23, 2023</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>pets-20230331xexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia89fda0125cd410ea90b2789a51adc28_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mathew N. Hulett, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Annual Report on Form 10-K of PetMed Express, Inc. for the fiscal year ended March&#160;31, 2023&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:0.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:0.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s Board of Directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:0.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May&#160;23, 2023</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Mathew N. Hulett </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mathew N. Hulett</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and President</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>pets-20230331xexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i5a6b16b2c21e4969ae39690df4afdfa7_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christine Chambers, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Annual Report on Form 10-K of PetMed Express, Inc. for the fiscal year ended March&#160;31, 2023&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:0.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:0.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s Board of Directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:0.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May&#160;23, 2023</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#47;s&#47; Christine Chambers</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Chambers</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer and Treasurer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>pets-20230331xexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ibba0f4d75f084541a004d761eebfa246_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mathew N. Hulett, and I, Christine Chambers, each certify to the best of our knowledge, based upon a review of the Annual Report on Form 10-K for the year ended March&#160;31, 2023 (the &#8220;Report&#8221;) of PetMed Express, Inc. (the &#8220;Registrant&#8221;), that&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the information contained in the Report, fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</font></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May&#160;23, 2023</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#47;s&#47; Mathew N. Hulett </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mathew N. Hulett</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and President</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#47;s&#47; Christine Chambers</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Chambers</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer and Treasurer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>pets-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:5cf93b28-3379-44eb-90e7-0c74c316f7e6,g:9a7e90f8-ce57-4497-9c85-b6b094af0e8b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pets="http://www.1800petmeds.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.1800petmeds.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.1800petmeds.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.1800petmeds.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.1800petmeds.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000003 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.1800petmeds.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000004 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncome" roleURI="http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome">
        <link:definition>0000005 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesinShareholdersEquity" roleURI="http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity">
        <link:definition>0000006 - Statement - Consolidated Statements of Changes in Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNet" roleURI="http://www.1800petmeds.com/role/PropertyandEquipmentNet">
        <link:definition>0000009 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilities" roleURI="http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilities">
        <link:definition>0000010 - Disclosure - Accrued Expenses and Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.1800petmeds.com/role/IncomeTaxes">
        <link:definition>0000011 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.1800petmeds.com/role/ShareholdersEquity">
        <link:definition>0000012 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestrictedStock" roleURI="http://www.1800petmeds.com/role/RestrictedStock">
        <link:definition>0000013 - Disclosure - Restricted Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.1800petmeds.com/role/FairValueMeasurements">
        <link:definition>0000014 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShare" roleURI="http://www.1800petmeds.com/role/NetIncomePerShare">
        <link:definition>0000015 - Disclosure - Net Income Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.1800petmeds.com/role/CommitmentsandContingencies">
        <link:definition>0000016 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlan" roleURI="http://www.1800petmeds.com/role/EmployeeBenefitPlan">
        <link:definition>0000017 - Disclosure - Employee Benefit Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MinorityInterestInvestmentinVetster" roleURI="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetster">
        <link:definition>0000018 - Disclosure - Minority Interest Investment in Vetster</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.1800petmeds.com/role/SubsequentEvents">
        <link:definition>0000019 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransaction" roleURI="http://www.1800petmeds.com/role/RelatedPartyTransaction">
        <link:definition>0000020 - Disclosure - Related Party Transaction</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000021 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000022 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetTables" roleURI="http://www.1800petmeds.com/role/PropertyandEquipmentNetTables">
        <link:definition>0000023 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilitiesTables" roleURI="http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables">
        <link:definition>0000024 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.1800petmeds.com/role/IncomeTaxesTables">
        <link:definition>0000025 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.1800petmeds.com/role/ShareholdersEquityTables">
        <link:definition>0000026 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestrictedStockTables" roleURI="http://www.1800petmeds.com/role/RestrictedStockTables">
        <link:definition>0000027 - Disclosure - Restricted Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareTables" roleURI="http://www.1800petmeds.com/role/NetIncomePerShareTables">
        <link:definition>0000028 - Disclosure - Net Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000029 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails" roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails">
        <link:definition>0000030 - Disclosure - Summary of Significant Accounting Policies - Disaggregation of Revenue by Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetDetails" roleURI="http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails">
        <link:definition>0000031 - Disclosure - Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilitiesDetails" roleURI="http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails">
        <link:definition>0000032 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredIncomeTaxesDetails" roleURI="http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails">
        <link:definition>0000033 - Disclosure - Income Taxes - Deferred Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.1800petmeds.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000034 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomeTaxProvisionDetails" roleURI="http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails">
        <link:definition>0000035 - Disclosure - Income Taxes - Components of Income Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofIncomeTaxProvisionDetails" roleURI="http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails">
        <link:definition>0000036 - Disclosure - Income Taxes - Reconciliation of Income Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails" roleURI="http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails">
        <link:definition>0000037 - Disclosure - Income Taxes - Reconciliation of Total Effective Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNarrativeDetails" roleURI="http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails">
        <link:definition>0000038 - Disclosure - Shareholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityDeclaredDividendsDetails" roleURI="http://www.1800petmeds.com/role/ShareholdersEquityDeclaredDividendsDetails">
        <link:definition>0000039 - Disclosure - Shareholder's Equity - Declared Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestrictedStockNarrativeDetails" roleURI="http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails">
        <link:definition>0000040 - Disclosure - Restricted Stock - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestrictedStockNonvestedRestrictedStockDetails" roleURI="http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails">
        <link:definition>0000041 - Disclosure - Restricted Stock - Non-vested Restricted Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.1800petmeds.com/role/FairValueMeasurementsDetails">
        <link:definition>0000042 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareBasicandDilutedNetIncomePerShareDetails" roleURI="http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails">
        <link:definition>0000043 - Disclosure - Net Income Per Share - Basic and Diluted Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareNarrativeDetails" roleURI="http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails">
        <link:definition>0000044 - Disclosure - Net Income Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails">
        <link:definition>0000045 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanDetails" roleURI="http://www.1800petmeds.com/role/EmployeeBenefitPlanDetails">
        <link:definition>0000046 - Disclosure - Employee Benefit Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MinorityInterestInvestmentinVetsterDetails" roleURI="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails">
        <link:definition>0000047 - Disclosure - Minority Interest Investment in Vetster (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.1800petmeds.com/role/SubsequentEventsDetails">
        <link:definition>0000048 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionDetails" roleURI="http://www.1800petmeds.com/role/RelatedPartyTransactionDetails">
        <link:definition>0000049 - Disclosure - Related Party Transaction (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="pets_AccruedExpensesAndOtherCurrentLiabilities" abstract="false" name="AccruedExpensesAndOtherCurrentLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pets_AccruedSalesReturnsAndAllowancesCurrent" abstract="false" name="AccruedSalesReturnsAndAllowancesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pets_ReorderMember" abstract="true" name="ReorderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_ContactCenterMember" abstract="true" name="ContactCenterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_OtherAssetsPolicyTextBlock" abstract="false" name="OtherAssetsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pets_PercentageOfPropertyLeasedToTenants" abstract="false" name="PercentageOfPropertyLeasedToTenants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pets_PerformanceRestrictedStockPriceHurdle5Member" abstract="true" name="PerformanceRestrictedStockPriceHurdle5Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_FurnitureFixturesEquipmentAndComputerSoftwareMember" abstract="true" name="FurnitureFixturesEquipmentAndComputerSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember" abstract="true" name="A2022EmployeeEquityCompensationRestrictedStockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_SalaryAndWageOfficerSignOnBonus" abstract="false" name="SalaryAndWageOfficerSignOnBonus" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pets_DelrayBeachPropertyMember" abstract="true" name="DelrayBeachPropertyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_PerformanceRestrictedStockPriceHurdle1Member" abstract="true" name="PerformanceRestrictedStockPriceHurdle1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod" abstract="false" name="SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_PerformanceRestrictedStockMember" abstract="true" name="PerformanceRestrictedStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_EmploymentTermSuccessiveRenewalPeriod" abstract="false" name="EmploymentTermSuccessiveRenewalPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_AccruedCreditCardFeesCurrent" abstract="false" name="AccruedCreditCardFeesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pets_NonvestedRestrictedStockMember" abstract="true" name="NonvestedRestrictedStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_NumberOfTenants" abstract="false" name="NumberOfTenants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pets_PartnershipAgreementWithVetsterMember" abstract="true" name="PartnershipAgreementWithVetsterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_RestrictionPeriod" abstract="false" name="RestrictionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember" abstract="true" name="TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_PerformanceRestrictedStockPriceHurdle3Member" abstract="true" name="PerformanceRestrictedStockPriceHurdle3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_AccruedSeveranceCosts" abstract="false" name="AccruedSeveranceCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pets_PetCareRxMember" abstract="true" name="PetCareRxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_PerformanceRestrictedStockPriceHurdle2Member" abstract="true" name="PerformanceRestrictedStockPriceHurdle2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_NonCompeteAgreementPeriod" abstract="false" name="NonCompeteAgreementPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_SeverancePaymentBaseSalaryPeriod" abstract="false" name="SeverancePaymentBaseSalaryPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_SixSuppliersMember" abstract="true" name="SixSuppliersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_RevenueFromContractWithCustomerVariance" abstract="false" name="RevenueFromContractWithCustomerVariance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pets_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pets_TermOfAgreement" abstract="false" name="TermOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" abstract="true" name="OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_ContingentLumpSumSeverancePayment" abstract="false" name="ContingentLumpSumSeverancePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod" abstract="false" name="SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_PaymentsForStipend" abstract="false" name="PaymentsForStipend" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pets_EmployeeAndDirectorEquityCompensationPlanMember" abstract="true" name="EmployeeAndDirectorEquityCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm" abstract="false" name="LessorOperatingLeaseRemainingWeightedAverageLeaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_TerminationPeriodPeriodWithinChangeInControl" abstract="false" name="TerminationPeriodPeriodWithinChangeInControl" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_NoncontrollingInterestOwnershipPercentagePurchased" abstract="false" name="NoncontrollingInterestOwnershipPercentagePurchased" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pets_InternetMember" abstract="true" name="InternetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pets_RevenueFromContractWithCustomerVariancePercentage" abstract="false" name="RevenueFromContractWithCustomerVariancePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pets_EmploymentTermInitialPeriod" abstract="false" name="EmploymentTermInitialPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance" abstract="false" name="PercentageOfAutomaticIncreaseInSharesAvailableForIssuance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pets_RevenueFromContractWithCustomerPercentage" abstract="false" name="RevenueFromContractWithCustomerPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pets_EmployeePlanMember" abstract="true" name="EmployeePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_NewOrderMember" abstract="true" name="NewOrderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_DefinedContributionPlanWithIndividualAge" abstract="false" name="DefinedContributionPlanWithIndividualAge" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" abstract="true" name="TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_AccruedMerchandiseCreditsAndRewardsCurrent" abstract="false" name="AccruedMerchandiseCreditsAndRewardsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm" abstract="false" name="EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pets_PerformanceRestrictedStockPriceHurdle4Member" abstract="true" name="PerformanceRestrictedStockPriceHurdle4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_NumberOfSeverancePayments" abstract="false" name="NumberOfSeverancePayments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pets_DirectorPlanMember" abstract="true" name="DirectorPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_ProphetMember" abstract="true" name="ProphetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pets_AccruedExpensesAndOtherCurrentLiabilitiesMember" abstract="true" name="AccruedExpensesAndOtherCurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pets_EarningsPerShareBasicAndDilutedEPSAbstract" abstract="true" name="EarningsPerShareBasicAndDilutedEPSAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pets_LumpSumSeverancePayments" abstract="false" name="LumpSumSeverancePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember" abstract="true" name="The2016EmployeeEquityCompensationRestrictedStockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>pets-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:5cf93b28-3379-44eb-90e7-0c74c316f7e6,g:9a7e90f8-ce57-4497-9c85-b6b094af0e8b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="pets-20230331.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.1800petmeds.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ecbcac0b-d92d-47ce-b85d-9867830e1333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_61035e67-0c4a-401a-a4b0-22320ef178d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ecbcac0b-d92d-47ce-b85d-9867830e1333" xlink:to="loc_us-gaap_CommitmentsAndContingencies_61035e67-0c4a-401a-a4b0-22320ef178d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c5a7c803-030f-4c91-bc4c-4a5ea30a0968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ecbcac0b-d92d-47ce-b85d-9867830e1333" xlink:to="loc_us-gaap_Liabilities_c5a7c803-030f-4c91-bc4c-4a5ea30a0968" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_88547d3f-4c50-4061-9601-6fb2aaa93f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ecbcac0b-d92d-47ce-b85d-9867830e1333" xlink:to="loc_us-gaap_StockholdersEquity_88547d3f-4c50-4061-9601-6fb2aaa93f72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e628b0fd-3bde-4470-a78b-36ba1cce8594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fe57e13c-d750-4d88-b845-61f94f89c335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e628b0fd-3bde-4470-a78b-36ba1cce8594" xlink:to="loc_us-gaap_CommonStockValue_fe57e13c-d750-4d88-b845-61f94f89c335" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_8348f24d-690a-4b87-886c-0fc6a9122739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e628b0fd-3bde-4470-a78b-36ba1cce8594" xlink:to="loc_us-gaap_PreferredStockValue_8348f24d-690a-4b87-886c-0fc6a9122739" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bd4daefd-7924-441d-ad45-07866fc0c20a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e628b0fd-3bde-4470-a78b-36ba1cce8594" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bd4daefd-7924-441d-ad45-07866fc0c20a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_e2a81f50-e3f4-4195-a5ab-f318fec6a15a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e628b0fd-3bde-4470-a78b-36ba1cce8594" xlink:to="loc_us-gaap_AdditionalPaidInCapital_e2a81f50-e3f4-4195-a5ab-f318fec6a15a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_5f1473e5-4b2f-4bd6-bf61-0dd3063b071a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_7215bf2c-5e4b-4fda-a64c-1d9cdda193ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_5f1473e5-4b2f-4bd6-bf61-0dd3063b071a" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_7215bf2c-5e4b-4fda-a64c-1d9cdda193ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_209f2427-2b66-4e8b-b24d-af3035a7ce4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_5f1473e5-4b2f-4bd6-bf61-0dd3063b071a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_209f2427-2b66-4e8b-b24d-af3035a7ce4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_547f9642-b43b-42a8-9052-262c86d201ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_5f1473e5-4b2f-4bd6-bf61-0dd3063b071a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_547f9642-b43b-42a8-9052-262c86d201ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_24e4bbd7-8a62-4b94-b776-6ef8abebb240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e8c9ddda-ab0b-4a9c-a9c5-2f74cd498e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_24e4bbd7-8a62-4b94-b776-6ef8abebb240" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e8c9ddda-ab0b-4a9c-a9c5-2f74cd498e3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e4162408-31c4-4124-ba07-ae1d34bc8061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_24e4bbd7-8a62-4b94-b776-6ef8abebb240" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e4162408-31c4-4124-ba07-ae1d34bc8061" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_0bb77621-1ce3-4e72-a3eb-1011056d7572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_24e4bbd7-8a62-4b94-b776-6ef8abebb240" xlink:to="loc_us-gaap_PrepaidTaxes_0bb77621-1ce3-4e72-a3eb-1011056d7572" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1bf0e378-3c44-40d2-812e-6b89691cacd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_24e4bbd7-8a62-4b94-b776-6ef8abebb240" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1bf0e378-3c44-40d2-812e-6b89691cacd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_3b593c12-55e6-4230-9f3c-7c13dd736af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_24e4bbd7-8a62-4b94-b776-6ef8abebb240" xlink:to="loc_us-gaap_InventoryFinishedGoods_3b593c12-55e6-4230-9f3c-7c13dd736af0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_596ca411-5cfa-4658-be5f-24053d39d6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6ce62db5-9c94-41e2-8896-76e8d03a9b83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_596ca411-5cfa-4658-be5f-24053d39d6a3" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6ce62db5-9c94-41e2-8896-76e8d03a9b83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3ddbd690-78db-443a-8dac-d851db0c3c91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_596ca411-5cfa-4658-be5f-24053d39d6a3" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3ddbd690-78db-443a-8dac-d851db0c3c91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c2bad882-8421-48d8-a2e9-43a8d07336af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_596ca411-5cfa-4658-be5f-24053d39d6a3" xlink:to="loc_us-gaap_LiabilitiesCurrent_c2bad882-8421-48d8-a2e9-43a8d07336af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_31085d1a-3e69-4e33-aa8c-eabb5d6715e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_9c58154b-40cd-4399-988b-5b7f66c3c824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_31085d1a-3e69-4e33-aa8c-eabb5d6715e9" xlink:to="loc_us-gaap_AssetsNoncurrent_9c58154b-40cd-4399-988b-5b7f66c3c824" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d4dfba0c-088a-44db-a022-1eb1ae1488cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_31085d1a-3e69-4e33-aa8c-eabb5d6715e9" xlink:to="loc_us-gaap_AssetsCurrent_d4dfba0c-088a-44db-a022-1eb1ae1488cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_69a49470-871b-4f92-86ea-51ee9a250fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_ef45ffd5-03f9-49c5-80f5-0669617a58df" xlink:href="pets-20230331.xsd#pets_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_69a49470-871b-4f92-86ea-51ee9a250fea" xlink:to="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_ef45ffd5-03f9-49c5-80f5-0669617a58df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ec0320ff-3712-4da8-b0db-0200d7d3eac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_69a49470-871b-4f92-86ea-51ee9a250fea" xlink:to="loc_us-gaap_AccountsPayableCurrent_ec0320ff-3712-4da8-b0db-0200d7d3eac9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="pets-20230331.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_774f6d1b-efc6-4253-abcf-28599f1827c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_61c86cd0-fc26-4d6d-b900-e22c3a021b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_774f6d1b-efc6-4253-abcf-28599f1827c4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_61c86cd0-fc26-4d6d-b900-e22c3a021b7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_624d4c2c-37e1-4a49-8484-ab3039099d52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_774f6d1b-efc6-4253-abcf-28599f1827c4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_624d4c2c-37e1-4a49-8484-ab3039099d52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_715a05fd-d024-48f9-a592-f683d3d68c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_83d1cec3-1e91-4845-b626-dee7dc6153c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_715a05fd-d024-48f9-a592-f683d3d68c4c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_83d1cec3-1e91-4845-b626-dee7dc6153c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0fbc0ed8-e215-49dc-9be7-f26933285777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_715a05fd-d024-48f9-a592-f683d3d68c4c" xlink:to="loc_us-gaap_OperatingIncomeLoss_0fbc0ed8-e215-49dc-9be7-f26933285777" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6863a98c-6050-4f2a-8d1b-6c2670ad0c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_786ed9dc-91dd-43e4-9a75-7530f14406ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_6863a98c-6050-4f2a-8d1b-6c2670ad0c28" xlink:to="loc_us-gaap_AdvertisingExpense_786ed9dc-91dd-43e4-9a75-7530f14406ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_50df63ed-a6c5-4f79-8ecc-393f83b2e878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_6863a98c-6050-4f2a-8d1b-6c2670ad0c28" xlink:to="loc_us-gaap_Depreciation_50df63ed-a6c5-4f79-8ecc-393f83b2e878" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_cba0fc49-f684-44a3-9ef8-7ac66fbe811f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_6863a98c-6050-4f2a-8d1b-6c2670ad0c28" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_cba0fc49-f684-44a3-9ef8-7ac66fbe811f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_89908e1b-12f6-48c8-aea9-d25109c73e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_740f88c0-389f-46be-993f-ee1d3957ce13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_89908e1b-12f6-48c8-aea9-d25109c73e19" xlink:to="loc_us-gaap_OperatingExpenses_740f88c0-389f-46be-993f-ee1d3957ce13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_359e6df3-211b-49f9-afc8-573c47462023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_89908e1b-12f6-48c8-aea9-d25109c73e19" xlink:to="loc_us-gaap_GrossProfit_359e6df3-211b-49f9-afc8-573c47462023" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c736757f-f8e7-4807-9216-c88462fb25ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_31da6b91-833b-4ac5-abb9-bc59440c2a36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c736757f-f8e7-4807-9216-c88462fb25ce" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_31da6b91-833b-4ac5-abb9-bc59440c2a36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8036bc61-4434-465d-ae04-7f515bd9193b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c736757f-f8e7-4807-9216-c88462fb25ce" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8036bc61-4434-465d-ae04-7f515bd9193b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_745cc7f6-606b-4615-b5cb-30433d88748a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_685d5382-de27-4533-84d5-7b8bbb6d1bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_745cc7f6-606b-4615-b5cb-30433d88748a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_685d5382-de27-4533-84d5-7b8bbb6d1bcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_dc9f5fca-0b48-452e-9ed0-e1903e055cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_745cc7f6-606b-4615-b5cb-30433d88748a" xlink:to="loc_us-gaap_InvestmentIncomeInterest_dc9f5fca-0b48-452e-9ed0-e1903e055cb4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="pets-20230331.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_94c28c37-b1a8-4a26-8d9b-78f6783afd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_6c1bd236-4293-42d6-951b-af2762f889e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_94c28c37-b1a8-4a26-8d9b-78f6783afd7f" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_6c1bd236-4293-42d6-951b-af2762f889e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eb909f4e-6f7e-450b-9ba8-ff8fee21957e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_095d02b7-8a2f-441a-a0b8-9887e689b301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eb909f4e-6f7e-450b-9ba8-ff8fee21957e" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_095d02b7-8a2f-441a-a0b8-9887e689b301" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_acdc1dae-d563-4b62-9063-7f934b1d76d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eb909f4e-6f7e-450b-9ba8-ff8fee21957e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_acdc1dae-d563-4b62-9063-7f934b1d76d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_156bd282-d767-4964-b225-d10416b13e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_ac58239d-2bd1-4daf-bb86-b411a517b0b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_156bd282-d767-4964-b225-d10416b13e95" xlink:to="loc_us-gaap_Depreciation_ac58239d-2bd1-4daf-bb86-b411a517b0b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_0452d408-3b7d-4195-8c6b-3ddc50e981d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_156bd282-d767-4964-b225-d10416b13e95" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_0452d408-3b7d-4195-8c6b-3ddc50e981d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c086ecbb-fff8-439b-a1d2-3630c7048bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_156bd282-d767-4964-b225-d10416b13e95" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c086ecbb-fff8-439b-a1d2-3630c7048bb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f4db1b6d-b69a-4fd0-8a82-84e11bd5a60d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_156bd282-d767-4964-b225-d10416b13e95" xlink:to="loc_us-gaap_NetIncomeLoss_f4db1b6d-b69a-4fd0-8a82-84e11bd5a60d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories_e2cd1408-830b-499b-bc7f-f34c8cb838f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_156bd282-d767-4964-b225-d10416b13e95" xlink:to="loc_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories_e2cd1408-830b-499b-bc7f-f34c8cb838f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_62a0c36a-b8b8-4911-bd01-f173641f097f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_156bd282-d767-4964-b225-d10416b13e95" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_62a0c36a-b8b8-4911-bd01-f173641f097f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_11de1eef-53a5-4ab4-8a8e-f4a41261542a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_156bd282-d767-4964-b225-d10416b13e95" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_11de1eef-53a5-4ab4-8a8e-f4a41261542a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4e7110ca-ae27-4d64-8e1b-a4aace236ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_156bd282-d767-4964-b225-d10416b13e95" xlink:to="loc_us-gaap_ShareBasedCompensation_4e7110ca-ae27-4d64-8e1b-a4aace236ad0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_70590220-b5cc-422c-8029-6786dfec643f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_156bd282-d767-4964-b225-d10416b13e95" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_70590220-b5cc-422c-8029-6786dfec643f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d0defcee-369c-4762-9bd4-dd7232cb2d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_156bd282-d767-4964-b225-d10416b13e95" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d0defcee-369c-4762-9bd4-dd7232cb2d47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2d05958e-b20e-4b26-97ce-c4a596451bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_156bd282-d767-4964-b225-d10416b13e95" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2d05958e-b20e-4b26-97ce-c4a596451bc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f432a7ae-3afb-4676-8302-b246853dd72f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_156bd282-d767-4964-b225-d10416b13e95" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f432a7ae-3afb-4676-8302-b246853dd72f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f73334e6-828f-45d5-bff2-ceb12afd191d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd464ee9-7915-447e-b0c4-d0d6a4420bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f73334e6-828f-45d5-bff2-ceb12afd191d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd464ee9-7915-447e-b0c4-d0d6a4420bb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_273d7bc7-6d56-4b78-8528-542e05c0f8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f73334e6-828f-45d5-bff2-ceb12afd191d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_273d7bc7-6d56-4b78-8528-542e05c0f8fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_90b02430-8772-4290-83d7-4995228f0764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f73334e6-828f-45d5-bff2-ceb12afd191d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_90b02430-8772-4290-83d7-4995228f0764" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#PropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_39c9a3d7-e0dd-401a-a1db-b946b0c29249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2ef7ec59-099e-47cf-9d13-bb1a708d0e26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_39c9a3d7-e0dd-401a-a1db-b946b0c29249" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2ef7ec59-099e-47cf-9d13-bb1a708d0e26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0e7c2f05-c531-462e-beab-259200357c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_39c9a3d7-e0dd-401a-a1db-b946b0c29249" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_0e7c2f05-c531-462e-beab-259200357c67" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_116376f1-4976-447a-b4f9-3f2a37f4416b" xlink:href="pets-20230331.xsd#pets_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a11b9bc1-1e7a-4ac5-81b6-85aac73c9e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_116376f1-4976-447a-b4f9-3f2a37f4416b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a11b9bc1-1e7a-4ac5-81b6-85aac73c9e57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_a7f24bf1-3b05-444a-9d33-d42e06c30277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_116376f1-4976-447a-b4f9-3f2a37f4416b" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_a7f24bf1-3b05-444a-9d33-d42e06c30277" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_84900d81-8ca4-497b-a278-35ede5c51600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_116376f1-4976-447a-b4f9-3f2a37f4416b" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_84900d81-8ca4-497b-a278-35ede5c51600" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedSalesReturnsAndAllowancesCurrent_6b8917ca-58ba-46bc-88fe-ff3527b36549" xlink:href="pets-20230331.xsd#pets_AccruedSalesReturnsAndAllowancesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_116376f1-4976-447a-b4f9-3f2a37f4416b" xlink:to="loc_pets_AccruedSalesReturnsAndAllowancesCurrent_6b8917ca-58ba-46bc-88fe-ff3527b36549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedCreditCardFeesCurrent_cffcb18c-b284-41c6-a4a1-19655555d275" xlink:href="pets-20230331.xsd#pets_AccruedCreditCardFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_116376f1-4976-447a-b4f9-3f2a37f4416b" xlink:to="loc_pets_AccruedCreditCardFeesCurrent_cffcb18c-b284-41c6-a4a1-19655555d275" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedMerchandiseCreditsAndRewardsCurrent_6147503d-78e8-4d86-aebe-a4da9efd943b" xlink:href="pets-20230331.xsd#pets_AccruedMerchandiseCreditsAndRewardsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_116376f1-4976-447a-b4f9-3f2a37f4416b" xlink:to="loc_pets_AccruedMerchandiseCreditsAndRewardsCurrent_6147503d-78e8-4d86-aebe-a4da9efd943b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_96e85ab0-c9e7-4ec6-b9d1-98e23d7e824f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_116376f1-4976-447a-b4f9-3f2a37f4416b" xlink:to="loc_us-gaap_DividendsPayableCurrent_96e85ab0-c9e7-4ec6-b9d1-98e23d7e824f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_0731f677-974d-4cd2-872d-23ada45797b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_116376f1-4976-447a-b4f9-3f2a37f4416b" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_0731f677-974d-4cd2-872d-23ada45797b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_e9566d0b-b01d-4c28-ad58-22624410e4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_116376f1-4976-447a-b4f9-3f2a37f4416b" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_e9566d0b-b01d-4c28-ad58-22624410e4d9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#IncomeTaxesDeferredIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_bd253b79-9310-42e0-9359-9598b4c88821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_520d979c-f0de-4196-8642-622b1e2dc3be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_bd253b79-9310-42e0-9359-9598b4c88821" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_520d979c-f0de-4196-8642-622b1e2dc3be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_ee139f4b-46c8-46d5-a69b-99375325d2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_bd253b79-9310-42e0-9359-9598b4c88821" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_ee139f4b-46c8-46d5-a69b-99375325d2bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_be3b8cfb-620f-4c1f-b79b-8a62e7fa17ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_bd253b79-9310-42e0-9359-9598b4c88821" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_be3b8cfb-620f-4c1f-b79b-8a62e7fa17ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_c5ab5f32-74d6-4b16-8854-e43307633d09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_987b24fb-866b-4dcf-8fc0-6436b4884233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_c5ab5f32-74d6-4b16-8854-e43307633d09" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_987b24fb-866b-4dcf-8fc0-6436b4884233" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_93e34c93-89b5-43e5-a7ec-9a428df4aed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_c5ab5f32-74d6-4b16-8854-e43307633d09" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_93e34c93-89b5-43e5-a7ec-9a428df4aed0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_418ce9ae-6013-4830-a95f-52f96d50143b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0418fe29-4da2-48d7-b90a-8811304973c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_418ce9ae-6013-4830-a95f-52f96d50143b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0418fe29-4da2-48d7-b90a-8811304973c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_53dbe382-2909-4df6-8273-2f5a2895773b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_418ce9ae-6013-4830-a95f-52f96d50143b" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_53dbe382-2909-4df6-8273-2f5a2895773b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#IncomeTaxesComponentsofIncomeTaxProvisionDetails"/>
  <link:calculationLink xlink:role="http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bb52914b-287f-46f7-8acf-8a672f8e2ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_76961ed8-c010-4da2-ada9-6fb5e0a24667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bb52914b-287f-46f7-8acf-8a672f8e2ddc" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_76961ed8-c010-4da2-ada9-6fb5e0a24667" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_2483a718-fc6f-45a1-8a2e-36113c4da661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bb52914b-287f-46f7-8acf-8a672f8e2ddc" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_2483a718-fc6f-45a1-8a2e-36113c4da661" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_812ff4c3-b7f3-43bf-9086-10a367c62dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_064f8347-d954-4c69-a0a8-fde814fbffcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_812ff4c3-b7f3-43bf-9086-10a367c62dd0" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_064f8347-d954-4c69-a0a8-fde814fbffcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_35eda271-23bf-4be7-bf69-7808a116e2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_812ff4c3-b7f3-43bf-9086-10a367c62dd0" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_35eda271-23bf-4be7-bf69-7808a116e2a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3e57f4fc-6e38-4551-8bc4-b815588bdef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_cb9e330b-0b87-4573-9b22-3d955b823cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3e57f4fc-6e38-4551-8bc4-b815588bdef3" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_cb9e330b-0b87-4573-9b22-3d955b823cdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_603dbb84-ae5a-447a-8f43-560f57058e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3e57f4fc-6e38-4551-8bc4-b815588bdef3" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_603dbb84-ae5a-447a-8f43-560f57058e2f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#IncomeTaxesReconciliationofIncomeTaxProvisionDetails"/>
  <link:calculationLink xlink:role="http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_556458a8-3da2-454b-acf5-d7a9825272f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_04c46339-529f-412b-80a9-697f6643ba1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_556458a8-3da2-454b-acf5-d7a9825272f3" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_04c46339-529f-412b-80a9-697f6643ba1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_e3da5d4e-ef8a-423a-be76-bef05d80a1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_556458a8-3da2-454b-acf5-d7a9825272f3" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_e3da5d4e-ef8a-423a-be76-bef05d80a1f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_ab823de0-f8b9-49a2-b9fb-f6dfe4a3b5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_556458a8-3da2-454b-acf5-d7a9825272f3" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_ab823de0-f8b9-49a2-b9fb-f6dfe4a3b5f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount_6f4b824b-21c2-48f6-93f3-fda3e245f15e" xlink:href="pets-20230331.xsd#pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_556458a8-3da2-454b-acf5-d7a9825272f3" xlink:to="loc_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount_6f4b824b-21c2-48f6-93f3-fda3e245f15e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_a534c0d6-d784-4aa8-8f4b-8e6db3225186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_556458a8-3da2-454b-acf5-d7a9825272f3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_a534c0d6-d784-4aa8-8f4b-8e6db3225186" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails"/>
  <link:calculationLink xlink:role="http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c63c70f6-2a8c-4c0f-961b-f3931b5d4682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a572bfc4-ce55-4a7b-9189-c79d1b019f20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c63c70f6-2a8c-4c0f-961b-f3931b5d4682" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a572bfc4-ce55-4a7b-9189-c79d1b019f20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_05d0f32a-1856-4cf5-968d-a4f422de6735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c63c70f6-2a8c-4c0f-961b-f3931b5d4682" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_05d0f32a-1856-4cf5-968d-a4f422de6735" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_a8ef580f-b64c-41be-8aa9-b4fb1cfcbc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c63c70f6-2a8c-4c0f-961b-f3931b5d4682" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_a8ef580f-b64c-41be-8aa9-b4fb1cfcbc2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_789ee115-a6c8-4bcf-8ba5-b7e95cc978ce" xlink:href="pets-20230331.xsd#pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c63c70f6-2a8c-4c0f-961b-f3931b5d4682" xlink:to="loc_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_789ee115-a6c8-4bcf-8ba5-b7e95cc978ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_5811be18-b32b-4538-8179-3573bff18997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c63c70f6-2a8c-4c0f-961b-f3931b5d4682" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_5811be18-b32b-4538-8179-3573bff18997" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#NetIncomePerShareBasicandDilutedNetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6ff342f-5cf4-4c62-aa2c-f02a7900e8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_40f1b740-1ebc-48f3-951b-7667b523eb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6ff342f-5cf4-4c62-aa2c-f02a7900e8ae" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_40f1b740-1ebc-48f3-951b-7667b523eb2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_b8eb885e-aeec-4abd-8bcc-910cc672b857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6ff342f-5cf4-4c62-aa2c-f02a7900e8ae" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_b8eb885e-aeec-4abd-8bcc-910cc672b857" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_196f4360-331e-498f-bd09-9088c282003a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6ff342f-5cf4-4c62-aa2c-f02a7900e8ae" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_196f4360-331e-498f-bd09-9088c282003a" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>pets-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:5cf93b28-3379-44eb-90e7-0c74c316f7e6,g:9a7e90f8-ce57-4497-9c85-b6b094af0e8b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" xlink:type="simple" xlink:href="pets-20230331.xsd#ConsolidatedStatementsofChangesinShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" xlink:type="extended" id="i05c334e4911146338bd981ce7e0f8b15_ConsolidatedStatementsofChangesinShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b4805a2a-58cd-4e2c-add4-878b918ed6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b4805a2a-58cd-4e2c-add4-878b918ed6c4" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_503d63d5-e8a4-458e-b845-8acc525d2b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_SharesOutstanding_503d63d5-e8a4-458e-b845-8acc525d2b3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bb8cf51b-1b77-435f-a136-937ab1fcd906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_StockholdersEquity_bb8cf51b-1b77-435f-a136-937ab1fcd906" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6d32bc1e-7a38-428e-bfe4-052114b1ae06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6d32bc1e-7a38-428e-bfe4-052114b1ae06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_cf969546-92a4-45c9-99a6-e3ccff8f480e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_cf969546-92a4-45c9-99a6-e3ccff8f480e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_19d6c640-d68e-4b09-a04a-4c74b067492c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_19d6c640-d68e-4b09-a04a-4c74b067492c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_1e1b7309-ccc3-4c04-b715-f527f4f67d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_DividendsCommonStock_1e1b7309-ccc3-4c04-b715-f527f4f67d08" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_73d0a701-0a4d-4448-85d7-1ddf87fd64d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_NetIncomeLoss_73d0a701-0a4d-4448-85d7-1ddf87fd64d3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_b5b299d3-21e5-4ea3-ad4e-c10de4186f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_76e7a43b-0404-4293-a028-34235d478b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dc6cb0b3-bf08-484d-96ff-ff66bdfe6145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b4805a2a-58cd-4e2c-add4-878b918ed6c4" xlink:to="loc_us-gaap_StatementTable_dc6cb0b3-bf08-484d-96ff-ff66bdfe6145" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a399aacc-0204-4ab5-a106-b21b10e0d138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_dc6cb0b3-bf08-484d-96ff-ff66bdfe6145" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a399aacc-0204-4ab5-a106-b21b10e0d138" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a399aacc-0204-4ab5-a106-b21b10e0d138_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a399aacc-0204-4ab5-a106-b21b10e0d138" xlink:to="loc_us-gaap_EquityComponentDomain_a399aacc-0204-4ab5-a106-b21b10e0d138_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ad9af337-05da-46e9-ba69-ef32cc53d13a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a399aacc-0204-4ab5-a106-b21b10e0d138" xlink:to="loc_us-gaap_EquityComponentDomain_ad9af337-05da-46e9-ba69-ef32cc53d13a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_d33f865a-8dce-45f0-b67d-30bb35114c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ad9af337-05da-46e9-ba69-ef32cc53d13a" xlink:to="loc_us-gaap_PreferredStockMember_d33f865a-8dce-45f0-b67d-30bb35114c28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bfe99d71-9d69-4eca-b842-5112d2ced972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ad9af337-05da-46e9-ba69-ef32cc53d13a" xlink:to="loc_us-gaap_CommonStockMember_bfe99d71-9d69-4eca-b842-5112d2ced972" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_708b21e3-6359-46f5-b95b-6b58cb47b1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ad9af337-05da-46e9-ba69-ef32cc53d13a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_708b21e3-6359-46f5-b95b-6b58cb47b1e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c99d258f-1fbe-4ef2-ba50-4cf654b33b28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ad9af337-05da-46e9-ba69-ef32cc53d13a" xlink:to="loc_us-gaap_RetainedEarningsMember_c99d258f-1fbe-4ef2-ba50-4cf654b33b28" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i8eae881053074bf89f46bfa2df689636_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_115428e9-345b-4472-8df2-b794da3cfe41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_115428e9-345b-4472-8df2-b794da3cfe41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ffac9ca7-71f7-438c-b3c2-0b45a0b79520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ffac9ca7-71f7-438c-b3c2-0b45a0b79520" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_6d5ed59d-e6f1-4801-b240-be3e4fffc391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_InventoryValuationReserves_6d5ed59d-e6f1-4801-b240-be3e4fffc391" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b96fe816-d08d-4d5d-a3e3-c37041d5d03d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b96fe816-d08d-4d5d-a3e3-c37041d5d03d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PercentageOfPropertyLeasedToTenants_5514d261-65b1-441b-8baf-554490c9dbf4" xlink:href="pets-20230331.xsd#pets_PercentageOfPropertyLeasedToTenants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_pets_PercentageOfPropertyLeasedToTenants_5514d261-65b1-441b-8baf-554490c9dbf4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_eb503f70-9a8b-4b05-8eb0-42c60b36b51f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_eb503f70-9a8b-4b05-8eb0-42c60b36b51f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NumberOfTenants_539443be-424e-4aae-8910-54273f88d3b0" xlink:href="pets-20230331.xsd#pets_NumberOfTenants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_pets_NumberOfTenants_539443be-424e-4aae-8910-54273f88d3b0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm_d71b6eac-13f2-472a-a0c5-19af48fb3501" xlink:href="pets-20230331.xsd#pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm_d71b6eac-13f2-472a-a0c5-19af48fb3501" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RentalIncomeNonoperating_5d125a6e-cd06-4b94-826f-1d83ca7636f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RentalIncomeNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_RentalIncomeNonoperating_5d125a6e-cd06-4b94-826f-1d83ca7636f3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_7215e30a-8a50-4059-a5fa-21a5ff312f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_7215e30a-8a50-4059-a5fa-21a5ff312f5d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_111a71d4-93ba-4b77-ad8d-6f27a1b67d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_111a71d4-93ba-4b77-ad8d-6f27a1b67d92" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_3c44dcbc-acf8-4684-8cd5-f98ca41f80ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_3c44dcbc-acf8-4684-8cd5-f98ca41f80ee" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_9a2a7606-14b2-4a4a-95f8-cecbf8180f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_9a2a7606-14b2-4a4a-95f8-cecbf8180f71" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_322312b5-e2ef-4cf1-921c-f3c3f7ba48f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_322312b5-e2ef-4cf1-921c-f3c3f7ba48f7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ce3faf1a-75dd-4714-8534-28d99d5bd130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ce3faf1a-75dd-4714-8534-28d99d5bd130" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_4219a3cb-c949-4c4e-93ec-8f8eb3918873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_4219a3cb-c949-4c4e-93ec-8f8eb3918873" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5c26e42f-7cac-419a-a5e5-66b9e44880ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5c26e42f-7cac-419a-a5e5-66b9e44880ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5c26e42f-7cac-419a-a5e5-66b9e44880ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5c26e42f-7cac-419a-a5e5-66b9e44880ce" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5c26e42f-7cac-419a-a5e5-66b9e44880ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b866bc0-a03c-401b-bc5a-d579b716327b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5c26e42f-7cac-419a-a5e5-66b9e44880ce" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b866bc0-a03c-401b-bc5a-d579b716327b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_8992892d-1437-40bc-aa4a-60c4d48be29e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b866bc0-a03c-401b-bc5a-d579b716327b" xlink:to="loc_us-gaap_BuildingMember_8992892d-1437-40bc-aa4a-60c4d48be29e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_FurnitureFixturesEquipmentAndComputerSoftwareMember_546f541f-608b-4496-ad00-e9f37f25832b" xlink:href="pets-20230331.xsd#pets_FurnitureFixturesEquipmentAndComputerSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b866bc0-a03c-401b-bc5a-d579b716327b" xlink:to="loc_pets_FurnitureFixturesEquipmentAndComputerSoftwareMember_546f541f-608b-4496-ad00-e9f37f25832b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c2a3df29-6407-437c-b514-efe57e05b8ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_srt_RangeAxis_c2a3df29-6407-437c-b514-efe57e05b8ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c2a3df29-6407-437c-b514-efe57e05b8ec_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c2a3df29-6407-437c-b514-efe57e05b8ec" xlink:to="loc_srt_RangeMember_c2a3df29-6407-437c-b514-efe57e05b8ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f0a6f5d9-4d7f-436b-835d-65e00e4d9753" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c2a3df29-6407-437c-b514-efe57e05b8ec" xlink:to="loc_srt_RangeMember_f0a6f5d9-4d7f-436b-835d-65e00e4d9753" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bc6ce522-ac55-434d-8e9a-411a8b23aaf7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f0a6f5d9-4d7f-436b-835d-65e00e4d9753" xlink:to="loc_srt_MinimumMember_bc6ce522-ac55-434d-8e9a-411a8b23aaf7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ea2b1226-fbc8-4122-be54-ebbd7bf13973" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f0a6f5d9-4d7f-436b-835d-65e00e4d9753" xlink:to="loc_srt_MaximumMember_ea2b1226-fbc8-4122-be54-ebbd7bf13973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_deb37a1c-a7b7-421e-9409-0bbb63af8a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_deb37a1c-a7b7-421e-9409-0bbb63af8a66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_deb37a1c-a7b7-421e-9409-0bbb63af8a66_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_deb37a1c-a7b7-421e-9409-0bbb63af8a66" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_deb37a1c-a7b7-421e-9409-0bbb63af8a66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ce1b1043-8ad4-4aff-90b1-ab9a01bc1151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_deb37a1c-a7b7-421e-9409-0bbb63af8a66" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ce1b1043-8ad4-4aff-90b1-ab9a01bc1151" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_b1f870d0-b952-4ccb-92b2-89fb1603e42e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ce1b1043-8ad4-4aff-90b1-ab9a01bc1151" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_b1f870d0-b952-4ccb-92b2-89fb1603e42e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7922e6de-0371-4a49-acae-ebf023420f35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7922e6de-0371-4a49-acae-ebf023420f35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7922e6de-0371-4a49-acae-ebf023420f35_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7922e6de-0371-4a49-acae-ebf023420f35" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7922e6de-0371-4a49-acae-ebf023420f35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e69e3bd2-f7db-47f5-b179-09c10ea79ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7922e6de-0371-4a49-acae-ebf023420f35" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e69e3bd2-f7db-47f5-b179-09c10ea79ea0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsTotalMember_520715f9-dd25-4954-9801-35d5ff3ef8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e69e3bd2-f7db-47f5-b179-09c10ea79ea0" xlink:to="loc_us-gaap_CostOfGoodsTotalMember_520715f9-dd25-4954-9801-35d5ff3ef8bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e4bb4a2e-a68d-48d3-a9ec-b1fbb01cac12" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_srt_CounterpartyNameAxis_e4bb4a2e-a68d-48d3-a9ec-b1fbb01cac12" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e4bb4a2e-a68d-48d3-a9ec-b1fbb01cac12_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_e4bb4a2e-a68d-48d3-a9ec-b1fbb01cac12" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e4bb4a2e-a68d-48d3-a9ec-b1fbb01cac12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bf8a2b72-70d3-4b1f-8aaf-7a2115a2c30a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_e4bb4a2e-a68d-48d3-a9ec-b1fbb01cac12" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bf8a2b72-70d3-4b1f-8aaf-7a2115a2c30a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SixSuppliersMember_3c83ce17-ae32-4c87-870b-3c5a607edce0" xlink:href="pets-20230331.xsd#pets_SixSuppliersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bf8a2b72-70d3-4b1f-8aaf-7a2115a2c30a" xlink:to="loc_pets_SixSuppliersMember_3c83ce17-ae32-4c87-870b-3c5a607edce0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_6966cc68-35a3-44e0-ae1a-0a4ed7611f61" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_srt_MajorCustomersAxis_6966cc68-35a3-44e0-ae1a-0a4ed7611f61" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_6966cc68-35a3-44e0-ae1a-0a4ed7611f61_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_6966cc68-35a3-44e0-ae1a-0a4ed7611f61" xlink:to="loc_srt_NameOfMajorCustomerDomain_6966cc68-35a3-44e0-ae1a-0a4ed7611f61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_f40870ce-cf2d-4512-aa5c-3d8245ae9b19" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_6966cc68-35a3-44e0-ae1a-0a4ed7611f61" xlink:to="loc_srt_NameOfMajorCustomerDomain_f40870ce-cf2d-4512-aa5c-3d8245ae9b19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ReorderMember_9504eaec-dcba-405b-bcb7-ab9c2ba112bc" xlink:href="pets-20230331.xsd#pets_ReorderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f40870ce-cf2d-4512-aa5c-3d8245ae9b19" xlink:to="loc_pets_ReorderMember_9504eaec-dcba-405b-bcb7-ab9c2ba112bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NewOrderMember_7f03ed88-7148-407c-9b3d-290d886b17e2" xlink:href="pets-20230331.xsd#pets_NewOrderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f40870ce-cf2d-4512-aa5c-3d8245ae9b19" xlink:to="loc_pets_NewOrderMember_7f03ed88-7148-407c-9b3d-290d886b17e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_50d485dd-fc49-4ea5-b9d1-80487fb15548" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_srt_RestatementAxis_50d485dd-fc49-4ea5-b9d1-80487fb15548" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_50d485dd-fc49-4ea5-b9d1-80487fb15548_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_50d485dd-fc49-4ea5-b9d1-80487fb15548" xlink:to="loc_srt_RestatementDomain_50d485dd-fc49-4ea5-b9d1-80487fb15548_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_4a12357e-64a4-4efa-bf09-57c787bd6b07" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_50d485dd-fc49-4ea5-b9d1-80487fb15548" xlink:to="loc_srt_RestatementDomain_4a12357e-64a4-4efa-bf09-57c787bd6b07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_f330c3ed-b18b-4f1a-97ab-be72daaa7787" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_4a12357e-64a4-4efa-bf09-57c787bd6b07" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_f330c3ed-b18b-4f1a-97ab-be72daaa7787" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_73d80bef-d651-4242-853a-6408603d0df8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_73d80bef-d651-4242-853a-6408603d0df8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_73d80bef-d651-4242-853a-6408603d0df8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_73d80bef-d651-4242-853a-6408603d0df8" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_73d80bef-d651-4242-853a-6408603d0df8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_a582c03c-a2a5-442c-b208-f8699859a999" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_73d80bef-d651-4242-853a-6408603d0df8" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_a582c03c-a2a5-442c-b208-f8699859a999" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_DelrayBeachPropertyMember_7fc48f4b-7498-49b2-a9e8-367ece7f7232" xlink:href="pets-20230331.xsd#pets_DelrayBeachPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_a582c03c-a2a5-442c-b208-f8699859a999" xlink:to="loc_pets_DelrayBeachPropertyMember_7fc48f4b-7498-49b2-a9e8-367ece7f7232" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails" xlink:type="extended" id="i9664036df4914755aa173bbe97dac13f_SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_daa31b16-4699-4498-9a39-917a1d47eb84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_b8344d9d-b093-4dcd-be27-a370fa4a20eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_daa31b16-4699-4498-9a39-917a1d47eb84" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_b8344d9d-b093-4dcd-be27-a370fa4a20eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerPercentage_b8c4baa6-184f-4bd8-bfff-3646baa3f203" xlink:href="pets-20230331.xsd#pets_RevenueFromContractWithCustomerPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_daa31b16-4699-4498-9a39-917a1d47eb84" xlink:to="loc_pets_RevenueFromContractWithCustomerPercentage_b8c4baa6-184f-4bd8-bfff-3646baa3f203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerVariance_dbee15ed-5967-4dab-ba36-06effcda27f3" xlink:href="pets-20230331.xsd#pets_RevenueFromContractWithCustomerVariance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_daa31b16-4699-4498-9a39-917a1d47eb84" xlink:to="loc_pets_RevenueFromContractWithCustomerVariance_dbee15ed-5967-4dab-ba36-06effcda27f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerVariancePercentage_e25572ba-73a6-4bdc-9d65-328e1066eec8" xlink:href="pets-20230331.xsd#pets_RevenueFromContractWithCustomerVariancePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_daa31b16-4699-4498-9a39-917a1d47eb84" xlink:to="loc_pets_RevenueFromContractWithCustomerVariancePercentage_e25572ba-73a6-4bdc-9d65-328e1066eec8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_dac8cba0-569b-47bc-9da0-ad4ff7cdd289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_daa31b16-4699-4498-9a39-917a1d47eb84" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_dac8cba0-569b-47bc-9da0-ad4ff7cdd289" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_2e8b30a4-c9f7-4a54-b81b-2bfb8469b2b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_dac8cba0-569b-47bc-9da0-ad4ff7cdd289" xlink:to="loc_srt_MajorCustomersAxis_2e8b30a4-c9f7-4a54-b81b-2bfb8469b2b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_2e8b30a4-c9f7-4a54-b81b-2bfb8469b2b3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_2e8b30a4-c9f7-4a54-b81b-2bfb8469b2b3" xlink:to="loc_srt_NameOfMajorCustomerDomain_2e8b30a4-c9f7-4a54-b81b-2bfb8469b2b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_0085ee2a-86c3-4716-94b7-5e5d1c3127ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_2e8b30a4-c9f7-4a54-b81b-2bfb8469b2b3" xlink:to="loc_srt_NameOfMajorCustomerDomain_0085ee2a-86c3-4716-94b7-5e5d1c3127ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ReorderMember_aa9a84c4-c313-4301-a62a-4f0da68a78f9" xlink:href="pets-20230331.xsd#pets_ReorderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_0085ee2a-86c3-4716-94b7-5e5d1c3127ab" xlink:to="loc_pets_ReorderMember_aa9a84c4-c313-4301-a62a-4f0da68a78f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NewOrderMember_fe4d1c76-0949-4671-aabd-c280faaff193" xlink:href="pets-20230331.xsd#pets_NewOrderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_0085ee2a-86c3-4716-94b7-5e5d1c3127ab" xlink:to="loc_pets_NewOrderMember_fe4d1c76-0949-4671-aabd-c280faaff193" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_47c259eb-dc0d-4cae-bb9c-38a12aa4f3c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_dac8cba0-569b-47bc-9da0-ad4ff7cdd289" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_47c259eb-dc0d-4cae-bb9c-38a12aa4f3c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_47c259eb-dc0d-4cae-bb9c-38a12aa4f3c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_47c259eb-dc0d-4cae-bb9c-38a12aa4f3c7" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_47c259eb-dc0d-4cae-bb9c-38a12aa4f3c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_6417f888-c15b-4f83-8271-9ad5ea348da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_47c259eb-dc0d-4cae-bb9c-38a12aa4f3c7" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_6417f888-c15b-4f83-8271-9ad5ea348da2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_InternetMember_3be5bd56-f791-4b86-b39a-fe3b53ff4a77" xlink:href="pets-20230331.xsd#pets_InternetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_6417f888-c15b-4f83-8271-9ad5ea348da2" xlink:to="loc_pets_InternetMember_3be5bd56-f791-4b86-b39a-fe3b53ff4a77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ContactCenterMember_122ea558-14b4-4864-ae27-6937edd42a94" xlink:href="pets-20230331.xsd#pets_ContactCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_6417f888-c15b-4f83-8271-9ad5ea348da2" xlink:to="loc_pets_ContactCenterMember_122ea558-14b4-4864-ae27-6937edd42a94" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#PropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails" xlink:type="extended" id="ib428012dc3004d809dc7256ab65997ae_PropertyandEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea0caab4-1f71-4718-8c84-ea9ce18d60db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_fa5b563f-94c3-4c33-a3f0-6e244e7222c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea0caab4-1f71-4718-8c84-ea9ce18d60db" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_fa5b563f-94c3-4c33-a3f0-6e244e7222c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_fb8d798d-1f26-48d2-ae48-ca54a6648412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea0caab4-1f71-4718-8c84-ea9ce18d60db" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_fb8d798d-1f26-48d2-ae48-ca54a6648412" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e0262dfa-ad6d-48b8-a551-83eee46af8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea0caab4-1f71-4718-8c84-ea9ce18d60db" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e0262dfa-ad6d-48b8-a551-83eee46af8f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ad6bf3-f254-408a-a772-3685639bca4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea0caab4-1f71-4718-8c84-ea9ce18d60db" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ad6bf3-f254-408a-a772-3685639bca4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aa32dfb7-5683-4e74-8ee1-71fc0f99d262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ad6bf3-f254-408a-a772-3685639bca4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aa32dfb7-5683-4e74-8ee1-71fc0f99d262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_aa32dfb7-5683-4e74-8ee1-71fc0f99d262_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aa32dfb7-5683-4e74-8ee1-71fc0f99d262" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_aa32dfb7-5683-4e74-8ee1-71fc0f99d262_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6174a54a-df2b-4907-b574-4ed33b756303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aa32dfb7-5683-4e74-8ee1-71fc0f99d262" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6174a54a-df2b-4907-b574-4ed33b756303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_f27999f7-3702-4c2a-a4bf-0f1223e40d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6174a54a-df2b-4907-b574-4ed33b756303" xlink:to="loc_us-gaap_BuildingMember_f27999f7-3702-4c2a-a4bf-0f1223e40d43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_fd9b24ad-d93a-48b0-bb32-2dc93e4806dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6174a54a-df2b-4907-b574-4ed33b756303" xlink:to="loc_us-gaap_LandMember_fd9b24ad-d93a-48b0-bb32-2dc93e4806dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_57d03599-627d-41bd-adc9-1f36d9272c81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6174a54a-df2b-4907-b574-4ed33b756303" xlink:to="loc_us-gaap_BuildingImprovementsMember_57d03599-627d-41bd-adc9-1f36d9272c81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_579cee36-a009-459c-9569-b69f0612f5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6174a54a-df2b-4907-b574-4ed33b756303" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_579cee36-a009-459c-9569-b69f0612f5e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_6571977b-2513-4cc4-ab0d-85b233406d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6174a54a-df2b-4907-b574-4ed33b756303" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_6571977b-2513-4cc4-ab0d-85b233406d47" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="ic7e935e06fb446f0833c269acff9645d_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_43fec5b9-bab3-49f1-922a-680dfa9b5d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_2c28fb06-2e1d-4bf4-b174-9ffaa447afe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_43fec5b9-bab3-49f1-922a-680dfa9b5d5f" xlink:to="loc_us-gaap_OperatingLossCarryforwards_2c28fb06-2e1d-4bf4-b174-9ffaa447afe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_2d58d81d-647f-443c-8bfd-58931510c93e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_43fec5b9-bab3-49f1-922a-680dfa9b5d5f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_2d58d81d-647f-443c-8bfd-58931510c93e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_b8e8305d-9b74-4a75-8971-b8bdc87b6c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_43fec5b9-bab3-49f1-922a-680dfa9b5d5f" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_b8e8305d-9b74-4a75-8971-b8bdc87b6c35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_9e185f8f-c4ac-466e-ab55-b3e0edec29b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_43fec5b9-bab3-49f1-922a-680dfa9b5d5f" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_9e185f8f-c4ac-466e-ab55-b3e0edec29b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_93ec74f6-502e-4c6e-a060-42d17150cb49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_9e185f8f-c4ac-466e-ab55-b3e0edec29b4" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_93ec74f6-502e-4c6e-a060-42d17150cb49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_93ec74f6-502e-4c6e-a060-42d17150cb49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_93ec74f6-502e-4c6e-a060-42d17150cb49" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_93ec74f6-502e-4c6e-a060-42d17150cb49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f577b7d0-0b94-48c1-9150-cd6486c98d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_93ec74f6-502e-4c6e-a060-42d17150cb49" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f577b7d0-0b94-48c1-9150-cd6486c98d54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_2a05f868-80e3-4de3-ae54-177c92945b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f577b7d0-0b94-48c1-9150-cd6486c98d54" xlink:to="loc_us-gaap_DomesticCountryMember_2a05f868-80e3-4de3-ae54-177c92945b66" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended" id="if8779eee7dc84d0b94e646b60fe138a4_ShareholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_b00b83ca-517c-43a7-98c8-f15dd05fec89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_PreferredStockSharesIssued_b00b83ca-517c-43a7-98c8-f15dd05fec89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f1edb3f7-7d86-42f4-826d-77a53013a21b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f1edb3f7-7d86-42f4-826d-77a53013a21b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_9c9f55a8-6351-4c95-b7f5-16ea834b9314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_9c9f55a8-6351-4c95-b7f5-16ea834b9314" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_3a9c40d4-ba1f-49fd-92e5-683a4add68c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_3a9c40d4-ba1f-49fd-92e5-683a4add68c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_614dc1ea-c884-4799-9263-9fd61017a86e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_614dc1ea-c884-4799-9263-9fd61017a86e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_71d53b51-1b1d-40d0-b942-4ddc5e8b7321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_71d53b51-1b1d-40d0-b942-4ddc5e8b7321" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_dc5115bf-1b41-4df0-aaa2-23c3b80db352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_dc5115bf-1b41-4df0-aaa2-23c3b80db352" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_859350a0-7a13-423b-98b6-703f8e90641a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_859350a0-7a13-423b-98b6-703f8e90641a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_20368fa9-8864-499c-bc63-16a71750c722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_20368fa9-8864-499c-bc63-16a71750c722" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_76e115aa-d666-402d-bcaa-9b97e3d9702e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_76e115aa-d666-402d-bcaa-9b97e3d9702e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_dd3ff33d-a8d0-4d59-9bd1-5a37264a69fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_dd3ff33d-a8d0-4d59-9bd1-5a37264a69fa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_6d25de8d-aaf4-4ba3-baf9-78a420800ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_6d25de8d-aaf4-4ba3-baf9-78a420800ebc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a3374a35-be1d-4aa5-947f-005d17ed21ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6d25de8d-aaf4-4ba3-baf9-78a420800ebc" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a3374a35-be1d-4aa5-947f-005d17ed21ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a3374a35-be1d-4aa5-947f-005d17ed21ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a3374a35-be1d-4aa5-947f-005d17ed21ca" xlink:to="loc_us-gaap_ClassOfStockDomain_a3374a35-be1d-4aa5-947f-005d17ed21ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6bd0a3e5-3ff7-404f-a3e1-7891cb17c32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a3374a35-be1d-4aa5-947f-005d17ed21ca" xlink:to="loc_us-gaap_ClassOfStockDomain_6bd0a3e5-3ff7-404f-a3e1-7891cb17c32b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_4083c415-651f-416a-93cd-a083e0e99d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6bd0a3e5-3ff7-404f-a3e1-7891cb17c32b" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_4083c415-651f-416a-93cd-a083e0e99d54" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#RestrictedStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails" xlink:type="extended" id="ieed0165fcf684b77a6e63f65f48c4b26_RestrictedStockNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ca34d03f-c261-4847-9b9a-60aa6d191a24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ca34d03f-c261-4847-9b9a-60aa6d191a24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance_a9732971-1347-48c8-b170-563c62cdc73f" xlink:href="pets-20230331.xsd#pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance_a9732971-1347-48c8-b170-563c62cdc73f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RestrictionPeriod_3536fe33-33bc-4073-8cfe-d71783d6babe" xlink:href="pets-20230331.xsd#pets_RestrictionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_pets_RestrictionPeriod_3536fe33-33bc-4073-8cfe-d71783d6babe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_eeebc3f5-3fb0-469a-8a00-08e354bab38f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_eeebc3f5-3fb0-469a-8a00-08e354bab38f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5f4bed38-3a0a-41b8-b223-0cb7fc66f45e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5f4bed38-3a0a-41b8-b223-0cb7fc66f45e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f6cce813-1f4d-414f-8665-874c145fe27f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_ShareBasedCompensation_f6cce813-1f4d-414f-8665-874c145fe27f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_236074ed-f650-4991-93c9-02935749576d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_236074ed-f650-4991-93c9-02935749576d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_2bd14725-070b-4164-a0e8-437887ba58d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_2bd14725-070b-4164-a0e8-437887ba58d4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4d11bf79-cb34-4fc4-82a7-72edd8cdfb68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4d11bf79-cb34-4fc4-82a7-72edd8cdfb68" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4f9212c6-8768-4c29-ae45-ed76cac7ee74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4f9212c6-8768-4c29-ae45-ed76cac7ee74" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fb1b6c56-a681-4363-b85e-41451c7b03b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fb1b6c56-a681-4363-b85e-41451c7b03b3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_af41673d-07d9-41c9-b780-8158207b6885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_af41673d-07d9-41c9-b780-8158207b6885" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2160ec-83a4-4163-a96a-b96320d4c2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2160ec-83a4-4163-a96a-b96320d4c2fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_39c0b8df-2a2b-4aad-91f6-ae960f12d26d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2160ec-83a4-4163-a96a-b96320d4c2fc" xlink:to="loc_us-gaap_PlanNameAxis_39c0b8df-2a2b-4aad-91f6-ae960f12d26d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_39c0b8df-2a2b-4aad-91f6-ae960f12d26d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_39c0b8df-2a2b-4aad-91f6-ae960f12d26d" xlink:to="loc_us-gaap_PlanNameDomain_39c0b8df-2a2b-4aad-91f6-ae960f12d26d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_39c0b8df-2a2b-4aad-91f6-ae960f12d26d" xlink:to="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember_b1536a61-8832-44c6-854c-80b529e0fb7b" xlink:href="pets-20230331.xsd#pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:to="loc_pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember_b1536a61-8832-44c6-854c-80b529e0fb7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_501ae683-9ff0-4a63-a69c-48b800fad610" xlink:href="pets-20230331.xsd#pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:to="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_501ae683-9ff0-4a63-a69c-48b800fad610" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember_b3be48a2-35e9-48bd-b33d-97d83a669892" xlink:href="pets-20230331.xsd#pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:to="loc_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember_b3be48a2-35e9-48bd-b33d-97d83a669892" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmployeeAndDirectorEquityCompensationPlanMember_873dc539-d4c3-46bc-8f15-28d59ab281eb" xlink:href="pets-20230331.xsd#pets_EmployeeAndDirectorEquityCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:to="loc_pets_EmployeeAndDirectorEquityCompensationPlanMember_873dc539-d4c3-46bc-8f15-28d59ab281eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember_498d1636-e9a4-42ea-833e-c55c842095f5" xlink:href="pets-20230331.xsd#pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:to="loc_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember_498d1636-e9a4-42ea-833e-c55c842095f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_835f1e65-37f0-4caa-a85b-94015dd55d3f" xlink:href="pets-20230331.xsd#pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:to="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_835f1e65-37f0-4caa-a85b-94015dd55d3f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b130b3ab-05f2-4aa4-9277-a95a29cf08d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2160ec-83a4-4163-a96a-b96320d4c2fc" xlink:to="loc_us-gaap_AwardTypeAxis_b130b3ab-05f2-4aa4-9277-a95a29cf08d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b130b3ab-05f2-4aa4-9277-a95a29cf08d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b130b3ab-05f2-4aa4-9277-a95a29cf08d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b130b3ab-05f2-4aa4-9277-a95a29cf08d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b0479ba-b842-40e5-a17c-2ff5f8eb2b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b130b3ab-05f2-4aa4-9277-a95a29cf08d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b0479ba-b842-40e5-a17c-2ff5f8eb2b86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_da9decee-f9a0-4d84-9484-1e6db8fccd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b0479ba-b842-40e5-a17c-2ff5f8eb2b86" xlink:to="loc_us-gaap_RestrictedStockMember_da9decee-f9a0-4d84-9484-1e6db8fccd7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NonvestedRestrictedStockMember_8c911aaf-1d37-4c7d-9a19-0ec5bcd5b9e9" xlink:href="pets-20230331.xsd#pets_NonvestedRestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b0479ba-b842-40e5-a17c-2ff5f8eb2b86" xlink:to="loc_pets_NonvestedRestrictedStockMember_8c911aaf-1d37-4c7d-9a19-0ec5bcd5b9e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ac32fee7-397a-41dd-aecb-1adfe3081446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b0479ba-b842-40e5-a17c-2ff5f8eb2b86" xlink:to="loc_us-gaap_CommonStockMember_ac32fee7-397a-41dd-aecb-1adfe3081446" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd085357-c919-4a6e-a6af-056a80570d45" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2160ec-83a4-4163-a96a-b96320d4c2fc" xlink:to="loc_srt_RangeAxis_dd085357-c919-4a6e-a6af-056a80570d45" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd085357-c919-4a6e-a6af-056a80570d45_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dd085357-c919-4a6e-a6af-056a80570d45" xlink:to="loc_srt_RangeMember_dd085357-c919-4a6e-a6af-056a80570d45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_31b975e4-07f6-4823-a6af-9bf8ba281630" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dd085357-c919-4a6e-a6af-056a80570d45" xlink:to="loc_srt_RangeMember_31b975e4-07f6-4823-a6af-9bf8ba281630" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_60a3a59d-36a5-43e1-94a2-f04a565e8366" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_31b975e4-07f6-4823-a6af-9bf8ba281630" xlink:to="loc_srt_MinimumMember_60a3a59d-36a5-43e1-94a2-f04a565e8366" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f772b24e-0f70-491f-b571-694d85503d81" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_31b975e4-07f6-4823-a6af-9bf8ba281630" xlink:to="loc_srt_MaximumMember_f772b24e-0f70-491f-b571-694d85503d81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_97c513ac-e1f9-4e6a-9031-6394120ae4f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2160ec-83a4-4163-a96a-b96320d4c2fc" xlink:to="loc_srt_TitleOfIndividualAxis_97c513ac-e1f9-4e6a-9031-6394120ae4f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_97c513ac-e1f9-4e6a-9031-6394120ae4f0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_97c513ac-e1f9-4e6a-9031-6394120ae4f0" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_97c513ac-e1f9-4e6a-9031-6394120ae4f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c5a9c54e-6948-4d28-be2e-5c3672c0ce63" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_97c513ac-e1f9-4e6a-9031-6394120ae4f0" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c5a9c54e-6948-4d28-be2e-5c3672c0ce63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_354e4e7f-73f7-4afa-8573-feacb245fce6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c5a9c54e-6948-4d28-be2e-5c3672c0ce63" xlink:to="loc_srt_ChiefExecutiveOfficerMember_354e4e7f-73f7-4afa-8573-feacb245fce6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefFinancialOfficerMember_2e598aeb-96b7-4faf-b9c7-e4e5cbd99ab9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c5a9c54e-6948-4d28-be2e-5c3672c0ce63" xlink:to="loc_srt_ChiefFinancialOfficerMember_2e598aeb-96b7-4faf-b9c7-e4e5cbd99ab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_500db0e5-b4ae-450c-8e71-e87019246e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2160ec-83a4-4163-a96a-b96320d4c2fc" xlink:to="loc_us-gaap_GranteeStatusAxis_500db0e5-b4ae-450c-8e71-e87019246e0b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_500db0e5-b4ae-450c-8e71-e87019246e0b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_500db0e5-b4ae-450c-8e71-e87019246e0b" xlink:to="loc_us-gaap_GranteeStatusDomain_500db0e5-b4ae-450c-8e71-e87019246e0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_9f4be4f4-5810-40a8-adf0-70de286baa79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_500db0e5-b4ae-450c-8e71-e87019246e0b" xlink:to="loc_us-gaap_GranteeStatusDomain_9f4be4f4-5810-40a8-adf0-70de286baa79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_125e3a19-fffe-49a2-b6ee-ee477c37fa01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_9f4be4f4-5810-40a8-adf0-70de286baa79" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_125e3a19-fffe-49a2-b6ee-ee477c37fa01" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#RestrictedStockNonvestedRestrictedStockDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails" xlink:type="extended" id="i63e733c125b74c59b50793ffe0285cda_RestrictedStockNonvestedRestrictedStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54df97d2-b7ba-4b2d-989e-e8d59faaa005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc71a1b3-ad82-40e9-8734-e7c8775b5cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54df97d2-b7ba-4b2d-989e-e8d59faaa005" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc71a1b3-ad82-40e9-8734-e7c8775b5cf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a93ac882-e1b4-4007-9158-5d042a9d7678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc71a1b3-ad82-40e9-8734-e7c8775b5cf4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a93ac882-e1b4-4007-9158-5d042a9d7678" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1d38accd-c2f4-4c5d-bc6e-b00bcd398b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc71a1b3-ad82-40e9-8734-e7c8775b5cf4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1d38accd-c2f4-4c5d-bc6e-b00bcd398b56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_32302b91-fa77-45b6-b9d7-6a9508ec98ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc71a1b3-ad82-40e9-8734-e7c8775b5cf4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_32302b91-fa77-45b6-b9d7-6a9508ec98ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7e630cd7-cbf5-4100-a5e4-75bb5c956e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc71a1b3-ad82-40e9-8734-e7c8775b5cf4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7e630cd7-cbf5-4100-a5e4-75bb5c956e4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3381752f-35a5-48d2-b4ac-e8a70e71d301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9614c66b-8ac5-4d47-a20f-cc836ac29504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54df97d2-b7ba-4b2d-989e-e8d59faaa005" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9614c66b-8ac5-4d47-a20f-cc836ac29504" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_46ea6caf-6fcc-4119-907e-7a09de6bbc23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9614c66b-8ac5-4d47-a20f-cc836ac29504" xlink:to="loc_us-gaap_PlanNameAxis_46ea6caf-6fcc-4119-907e-7a09de6bbc23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_46ea6caf-6fcc-4119-907e-7a09de6bbc23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_46ea6caf-6fcc-4119-907e-7a09de6bbc23" xlink:to="loc_us-gaap_PlanNameDomain_46ea6caf-6fcc-4119-907e-7a09de6bbc23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5386e570-f68a-4e92-8c5b-fee3f242b430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_46ea6caf-6fcc-4119-907e-7a09de6bbc23" xlink:to="loc_us-gaap_PlanNameDomain_5386e570-f68a-4e92-8c5b-fee3f242b430" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmployeePlanMember_3b46b495-4ffd-4e53-b1e0-eb3a2a59711b" xlink:href="pets-20230331.xsd#pets_EmployeePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_5386e570-f68a-4e92-8c5b-fee3f242b430" xlink:to="loc_pets_EmployeePlanMember_3b46b495-4ffd-4e53-b1e0-eb3a2a59711b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_DirectorPlanMember_329ebe78-7c8c-474b-9ca8-df102bd96bbb" xlink:href="pets-20230331.xsd#pets_DirectorPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_5386e570-f68a-4e92-8c5b-fee3f242b430" xlink:to="loc_pets_DirectorPlanMember_329ebe78-7c8c-474b-9ca8-df102bd96bbb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#NetIncomePerShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails" xlink:type="extended" id="i851ab156435d42f48021eb39ca3e8a40_NetIncomePerShareNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_aa24bc59-400c-46f0-9bb7-26d1f4dd3128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f53ba042-8c5a-4d32-a03a-5412cfcfd74a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_aa24bc59-400c-46f0-9bb7-26d1f4dd3128" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f53ba042-8c5a-4d32-a03a-5412cfcfd74a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b5d5c253-2fd7-43fd-975f-9af3fd9630ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_aa24bc59-400c-46f0-9bb7-26d1f4dd3128" xlink:to="loc_us-gaap_StatementTable_b5d5c253-2fd7-43fd-975f-9af3fd9630ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c5c9c880-6e32-4f4a-b913-0da96ca5ba3f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b5d5c253-2fd7-43fd-975f-9af3fd9630ba" xlink:to="loc_dei_LegalEntityAxis_c5c9c880-6e32-4f4a-b913-0da96ca5ba3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c5c9c880-6e32-4f4a-b913-0da96ca5ba3f_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_c5c9c880-6e32-4f4a-b913-0da96ca5ba3f" xlink:to="loc_dei_EntityDomain_c5c9c880-6e32-4f4a-b913-0da96ca5ba3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_11d65b59-c9b8-404e-b58e-23b3ad11ec89" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_c5c9c880-6e32-4f4a-b913-0da96ca5ba3f" xlink:to="loc_dei_EntityDomain_11d65b59-c9b8-404e-b58e-23b3ad11ec89" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="icbdf7c7eb2dd4ff9b453ca0c675b63f8_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExciseAndSalesTaxes_a215d802-bdb5-4d0b-a9a4-d8daf22bf28c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExciseAndSalesTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_ExciseAndSalesTaxes_a215d802-bdb5-4d0b-a9a4-d8daf22bf28c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_f5639508-2858-4635-ade2-39c7ca6229b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_f5639508-2858-4635-ade2-39c7ca6229b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PercentageOfPropertyLeasedToTenants_c46e4cd7-9d2f-48aa-b81c-674537233482" xlink:href="pets-20230331.xsd#pets_PercentageOfPropertyLeasedToTenants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_PercentageOfPropertyLeasedToTenants_c46e4cd7-9d2f-48aa-b81c-674537233482" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_82635e37-1c3b-4362-a799-064c5d17451f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_82635e37-1c3b-4362-a799-064c5d17451f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NumberOfTenants_5cb78bf1-fa67-4b4e-a3da-9a304d6af84d" xlink:href="pets-20230331.xsd#pets_NumberOfTenants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_NumberOfTenants_5cb78bf1-fa67-4b4e-a3da-9a304d6af84d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm_96c1d47e-1b94-4491-ac64-ea482367a602" xlink:href="pets-20230331.xsd#pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm_96c1d47e-1b94-4491-ac64-ea482367a602" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_f8a75e57-a8a0-42e8-8cad-0774f98ff71c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_f8a75e57-a8a0-42e8-8cad-0774f98ff71c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PaymentsForStipend_abb04984-3813-4704-895d-0c5424b35a8a" xlink:href="pets-20230331.xsd#pets_PaymentsForStipend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_PaymentsForStipend_abb04984-3813-4704-895d-0c5424b35a8a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NumberOfSeverancePayments_a773ac71-ced6-456c-ba07-9aa0de1a3a6a" xlink:href="pets-20230331.xsd#pets_NumberOfSeverancePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_NumberOfSeverancePayments_a773ac71-ced6-456c-ba07-9aa0de1a3a6a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_LumpSumSeverancePayments_5f5a5e60-9149-4966-8591-8b3aecdd5615" xlink:href="pets-20230331.xsd#pets_LumpSumSeverancePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_LumpSumSeverancePayments_5f5a5e60-9149-4966-8591-8b3aecdd5615" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_00830b44-3888-4017-9846-10df9aea4993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_00830b44-3888-4017-9846-10df9aea4993" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmploymentTermInitialPeriod_96b0b086-c03e-49f0-830a-a3287f39a519" xlink:href="pets-20230331.xsd#pets_EmploymentTermInitialPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_EmploymentTermInitialPeriod_96b0b086-c03e-49f0-830a-a3287f39a519" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmploymentTermSuccessiveRenewalPeriod_171f055b-f52f-4a5c-8826-7b6f18c67525" xlink:href="pets-20230331.xsd#pets_EmploymentTermSuccessiveRenewalPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_EmploymentTermSuccessiveRenewalPeriod_171f055b-f52f-4a5c-8826-7b6f18c67525" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm_9e9381ca-4c7b-47ad-829f-efad599cc4c7" xlink:href="pets-20230331.xsd#pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm_9e9381ca-4c7b-47ad-829f-efad599cc4c7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficersCompensation_f0794e01-c538-4768-a931-ed6f3560adc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficersCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_OfficersCompensation_f0794e01-c538-4768-a931-ed6f3560adc6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TerminationPeriodPeriodWithinChangeInControl_42603387-4d45-4f8c-a56c-1faeb138b499" xlink:href="pets-20230331.xsd#pets_TerminationPeriodPeriodWithinChangeInControl"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_TerminationPeriodPeriodWithinChangeInControl_42603387-4d45-4f8c-a56c-1faeb138b499" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SeverancePaymentBaseSalaryPeriod_e522d3b1-904e-4343-a573-6a91b05f8e90" xlink:href="pets-20230331.xsd#pets_SeverancePaymentBaseSalaryPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_SeverancePaymentBaseSalaryPeriod_e522d3b1-904e-4343-a573-6a91b05f8e90" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod_afe71926-75fc-4171-9813-27fa2f446968" xlink:href="pets-20230331.xsd#pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod_afe71926-75fc-4171-9813-27fa2f446968" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod_21540b5e-1c92-4b61-994d-e00cf5dc3b64" xlink:href="pets-20230331.xsd#pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod_21540b5e-1c92-4b61-994d-e00cf5dc3b64" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NonCompeteAgreementPeriod_c582babd-3cfc-4935-9894-003cfec66d37" xlink:href="pets-20230331.xsd#pets_NonCompeteAgreementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_NonCompeteAgreementPeriod_c582babd-3cfc-4935-9894-003cfec66d37" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8e73f1e3-8394-4d68-b911-3620a37c5232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8e73f1e3-8394-4d68-b911-3620a37c5232" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod_ebeced0b-db6c-48e4-990a-7cd4cf30ea97" xlink:href="pets-20230331.xsd#pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod_ebeced0b-db6c-48e4-990a-7cd4cf30ea97" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod_c4679c30-cc33-4f08-a83e-622db8524bdc" xlink:href="pets-20230331.xsd#pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod_c4679c30-cc33-4f08-a83e-622db8524bdc" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c35a962b-4577-492c-87c0-b5b6c263d143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c35a962b-4577-492c-87c0-b5b6c263d143" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod_f2b3cd46-7da8-4b7e-9446-152b16876b2f" xlink:href="pets-20230331.xsd#pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod_f2b3cd46-7da8-4b7e-9446-152b16876b2f" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SalaryAndWageOfficerSignOnBonus_ae517d0a-0fea-4dca-ac4a-73a58e280d7a" xlink:href="pets-20230331.xsd#pets_SalaryAndWageOfficerSignOnBonus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_SalaryAndWageOfficerSignOnBonus_ae517d0a-0fea-4dca-ac4a-73a58e280d7a" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc235ca8-d21f-4c19-9232-6ac2a99b5bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc235ca8-d21f-4c19-9232-6ac2a99b5bcb" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ContingentLumpSumSeverancePayment_7f68ed1f-4d76-4357-b159-f9740897fa42" xlink:href="pets-20230331.xsd#pets_ContingentLumpSumSeverancePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_ContingentLumpSumSeverancePayment_7f68ed1f-4d76-4357-b159-f9740897fa42" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedSeveranceCosts_a2bb9af3-6bc4-42f3-9d81-b8dad1523f29" xlink:href="pets-20230331.xsd#pets_AccruedSeveranceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_AccruedSeveranceCosts_a2bb9af3-6bc4-42f3-9d81-b8dad1523f29" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_e0fc6b0e-c7ee-4e6f-b0a8-332fdff41f7d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_e0fc6b0e-c7ee-4e6f-b0a8-332fdff41f7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_e0fc6b0e-c7ee-4e6f-b0a8-332fdff41f7d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_e0fc6b0e-c7ee-4e6f-b0a8-332fdff41f7d" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_e0fc6b0e-c7ee-4e6f-b0a8-332fdff41f7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4eb274dd-3b52-42d6-be7e-a4a786d711af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_e0fc6b0e-c7ee-4e6f-b0a8-332fdff41f7d" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4eb274dd-3b52-42d6-be7e-a4a786d711af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_DelrayBeachPropertyMember_8167d48f-bae9-4b38-bfad-919eb2a706ec" xlink:href="pets-20230331.xsd#pets_DelrayBeachPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4eb274dd-3b52-42d6-be7e-a4a786d711af" xlink:to="loc_pets_DelrayBeachPropertyMember_8167d48f-bae9-4b38-bfad-919eb2a706ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_bdcad787-9831-40b5-b773-8fe95d435974" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:to="loc_srt_TitleOfIndividualAxis_bdcad787-9831-40b5-b773-8fe95d435974" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_bdcad787-9831-40b5-b773-8fe95d435974_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_bdcad787-9831-40b5-b773-8fe95d435974" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_bdcad787-9831-40b5-b773-8fe95d435974_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_bb3a8475-4c22-43ba-96ed-deefff28d70a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_bdcad787-9831-40b5-b773-8fe95d435974" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_bb3a8475-4c22-43ba-96ed-deefff28d70a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_1c179764-7aab-4c21-a9c8-3e1aefa88f27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_bb3a8475-4c22-43ba-96ed-deefff28d70a" xlink:to="loc_srt_ChiefExecutiveOfficerMember_1c179764-7aab-4c21-a9c8-3e1aefa88f27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefFinancialOfficerMember_d220b9e9-4690-4f6a-80f2-58cc97aad4d0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_bb3a8475-4c22-43ba-96ed-deefff28d70a" xlink:to="loc_srt_ChiefFinancialOfficerMember_d220b9e9-4690-4f6a-80f2-58cc97aad4d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_502b573c-29d8-49a0-8d4b-4a4b26d1a13b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:to="loc_us-gaap_PlanNameAxis_502b573c-29d8-49a0-8d4b-4a4b26d1a13b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_502b573c-29d8-49a0-8d4b-4a4b26d1a13b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_502b573c-29d8-49a0-8d4b-4a4b26d1a13b" xlink:to="loc_us-gaap_PlanNameDomain_502b573c-29d8-49a0-8d4b-4a4b26d1a13b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_996f061d-5d8a-4228-a8cd-f3c58a22f2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_502b573c-29d8-49a0-8d4b-4a4b26d1a13b" xlink:to="loc_us-gaap_PlanNameDomain_996f061d-5d8a-4228-a8cd-f3c58a22f2d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_b2e443b1-24dd-47cd-ae6e-4068c19c2252" xlink:href="pets-20230331.xsd#pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_996f061d-5d8a-4228-a8cd-f3c58a22f2d3" xlink:to="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_b2e443b1-24dd-47cd-ae6e-4068c19c2252" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_399c886a-fba0-4ccb-a8c6-384293229cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:to="loc_us-gaap_AwardTypeAxis_399c886a-fba0-4ccb-a8c6-384293229cff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_399c886a-fba0-4ccb-a8c6-384293229cff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_399c886a-fba0-4ccb-a8c6-384293229cff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_399c886a-fba0-4ccb-a8c6-384293229cff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_399c886a-fba0-4ccb-a8c6-384293229cff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_980aec9f-236c-4433-b134-7e61144ca681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:to="loc_us-gaap_RestrictedStockMember_980aec9f-236c-4433-b134-7e61144ca681" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockMember_c459885a-6ac7-4de6-97c8-6a2f3873410d" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:to="loc_pets_PerformanceRestrictedStockMember_c459885a-6ac7-4de6-97c8-6a2f3873410d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockPriceHurdle1Member_3dfd0f54-331d-4594-b670-d25906a0071c" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockPriceHurdle1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:to="loc_pets_PerformanceRestrictedStockPriceHurdle1Member_3dfd0f54-331d-4594-b670-d25906a0071c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockPriceHurdle2Member_a2a403b2-e679-406c-855d-41f0e50e340b" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockPriceHurdle2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:to="loc_pets_PerformanceRestrictedStockPriceHurdle2Member_a2a403b2-e679-406c-855d-41f0e50e340b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockPriceHurdle3Member_0624d51f-2790-4807-95a9-564a9256cbd4" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockPriceHurdle3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:to="loc_pets_PerformanceRestrictedStockPriceHurdle3Member_0624d51f-2790-4807-95a9-564a9256cbd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockPriceHurdle4Member_591beaeb-3708-460e-b363-8d0005aad90c" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockPriceHurdle4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:to="loc_pets_PerformanceRestrictedStockPriceHurdle4Member_591beaeb-3708-460e-b363-8d0005aad90c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockPriceHurdle5Member_92d809fa-30f1-49fe-832a-a057205b991b" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockPriceHurdle5Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:to="loc_pets_PerformanceRestrictedStockPriceHurdle5Member_92d809fa-30f1-49fe-832a-a057205b991b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_240d23b2-b4f3-4c31-95e0-1b2ec3207a25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_240d23b2-b4f3-4c31-95e0-1b2ec3207a25" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_240d23b2-b4f3-4c31-95e0-1b2ec3207a25_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_240d23b2-b4f3-4c31-95e0-1b2ec3207a25" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_240d23b2-b4f3-4c31-95e0-1b2ec3207a25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b89a1793-aab5-48c8-bf19-fe204bc40452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_240d23b2-b4f3-4c31-95e0-1b2ec3207a25" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b89a1793-aab5-48c8-bf19-fe204bc40452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PetCareRxMember_58a8344e-483f-48f4-9bfa-651501f6d7bb" xlink:href="pets-20230331.xsd#pets_PetCareRxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b89a1793-aab5-48c8-bf19-fe204bc40452" xlink:to="loc_pets_PetCareRxMember_58a8344e-483f-48f4-9bfa-651501f6d7bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_16d9898f-a1c3-4215-a211-72ed801282a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_16d9898f-a1c3-4215-a211-72ed801282a3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_16d9898f-a1c3-4215-a211-72ed801282a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_16d9898f-a1c3-4215-a211-72ed801282a3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_16d9898f-a1c3-4215-a211-72ed801282a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8fcd5487-4a07-4fa8-865c-46821951979f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_16d9898f-a1c3-4215-a211-72ed801282a3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8fcd5487-4a07-4fa8-865c-46821951979f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedExpensesAndOtherCurrentLiabilitiesMember_8587d60e-40bd-45fa-aea3-2cfbed5b9dda" xlink:href="pets-20230331.xsd#pets_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8fcd5487-4a07-4fa8-865c-46821951979f" xlink:to="loc_pets_AccruedExpensesAndOtherCurrentLiabilitiesMember_8587d60e-40bd-45fa-aea3-2cfbed5b9dda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ad111051-f898-41f1-bb74-968d90101a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8fcd5487-4a07-4fa8-865c-46821951979f" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ad111051-f898-41f1-bb74-968d90101a4b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#MinorityInterestInvestmentinVetsterDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails" xlink:type="extended" id="id17434980d014afe9f86c08366a3db32_MinorityInterestInvestmentinVetsterDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_49d579bf-4fa2-40f4-946a-97cdf18ca73c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TermOfAgreement_487b6884-7ff2-489f-8f5c-207e34111b8d" xlink:href="pets-20230331.xsd#pets_TermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_49d579bf-4fa2-40f4-946a-97cdf18ca73c" xlink:to="loc_pets_TermOfAgreement_487b6884-7ff2-489f-8f5c-207e34111b8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NoncontrollingInterestOwnershipPercentagePurchased_ce80a996-929b-449b-af26-b52be6ae0b78" xlink:href="pets-20230331.xsd#pets_NoncontrollingInterestOwnershipPercentagePurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_49d579bf-4fa2-40f4-946a-97cdf18ca73c" xlink:to="loc_pets_NoncontrollingInterestOwnershipPercentagePurchased_ce80a996-929b-449b-af26-b52be6ae0b78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_ca173f08-e2c1-43ac-bfec-3f0e4bddd0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_49d579bf-4fa2-40f4-946a-97cdf18ca73c" xlink:to="loc_us-gaap_Investments_ca173f08-e2c1-43ac-bfec-3f0e4bddd0e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_a835935c-bb3e-4106-a21b-d719c7970868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_49d579bf-4fa2-40f4-946a-97cdf18ca73c" xlink:to="loc_us-gaap_MinorityInterestTable_a835935c-bb3e-4106-a21b-d719c7970868" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_99ed71a5-4d0e-4718-8eb8-63d9e7e7c048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_a835935c-bb3e-4106-a21b-d719c7970868" xlink:to="loc_us-gaap_TypeOfArrangementAxis_99ed71a5-4d0e-4718-8eb8-63d9e7e7c048" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_99ed71a5-4d0e-4718-8eb8-63d9e7e7c048_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_99ed71a5-4d0e-4718-8eb8-63d9e7e7c048" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_99ed71a5-4d0e-4718-8eb8-63d9e7e7c048_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24497599-5f85-437e-ad43-16b8ee8dafdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_99ed71a5-4d0e-4718-8eb8-63d9e7e7c048" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24497599-5f85-437e-ad43-16b8ee8dafdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PartnershipAgreementWithVetsterMember_1e9b262f-05e4-47f6-9a25-facc12244945" xlink:href="pets-20230331.xsd#pets_PartnershipAgreementWithVetsterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24497599-5f85-437e-ad43-16b8ee8dafdc" xlink:to="loc_pets_PartnershipAgreementWithVetsterMember_1e9b262f-05e4-47f6-9a25-facc12244945" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/SubsequentEventsDetails" xlink:type="extended" id="ibc380f4e57214af6ace874cdc524faae_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_a20d59b5-9a40-4f77-b352-1d9a058eb3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5d64d169-433b-4e3a-99e5-523d6554d7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a20d59b5-9a40-4f77-b352-1d9a058eb3fd" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5d64d169-433b-4e3a-99e5-523d6554d7b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8dad8d45-0ccb-4318-9674-c04e02ebab17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a20d59b5-9a40-4f77-b352-1d9a058eb3fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8dad8d45-0ccb-4318-9674-c04e02ebab17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_002d3ddc-15da-4d30-93ac-7a0d169316ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a20d59b5-9a40-4f77-b352-1d9a058eb3fd" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_002d3ddc-15da-4d30-93ac-7a0d169316ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_2f878d35-fe44-46bd-b735-8b4949a7ffa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a20d59b5-9a40-4f77-b352-1d9a058eb3fd" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_2f878d35-fe44-46bd-b735-8b4949a7ffa7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_a20d59b5-9a40-4f77-b352-1d9a058eb3fd" xlink:to="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5787891d-5081-49dd-85c9-4033d88c05ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5787891d-5081-49dd-85c9-4033d88c05ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5787891d-5081-49dd-85c9-4033d88c05ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5787891d-5081-49dd-85c9-4033d88c05ca" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5787891d-5081-49dd-85c9-4033d88c05ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a30e270d-0b48-4947-9a5f-fc6b3e17be32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5787891d-5081-49dd-85c9-4033d88c05ca" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a30e270d-0b48-4947-9a5f-fc6b3e17be32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PetCareRxMember_5a530f5f-82ba-4a13-b089-00a81727115d" xlink:href="pets-20230331.xsd#pets_PetCareRxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a30e270d-0b48-4947-9a5f-fc6b3e17be32" xlink:to="loc_pets_PetCareRxMember_5a530f5f-82ba-4a13-b089-00a81727115d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3b117fc9-1b96-4c4b-8853-e6e5056a324d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:to="loc_us-gaap_AwardTypeAxis_3b117fc9-1b96-4c4b-8853-e6e5056a324d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3b117fc9-1b96-4c4b-8853-e6e5056a324d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3b117fc9-1b96-4c4b-8853-e6e5056a324d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3b117fc9-1b96-4c4b-8853-e6e5056a324d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_16dc2583-04d4-4a8c-8ef5-e97e472bdafd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3b117fc9-1b96-4c4b-8853-e6e5056a324d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_16dc2583-04d4-4a8c-8ef5-e97e472bdafd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_02cea464-0fe8-4b37-8faa-5c091e7516d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_16dc2583-04d4-4a8c-8ef5-e97e472bdafd" xlink:to="loc_us-gaap_RestrictedStockMember_02cea464-0fe8-4b37-8faa-5c091e7516d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_e3e81d15-f0f6-474d-99e6-a42ab7e6cd4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:to="loc_us-gaap_GranteeStatusAxis_e3e81d15-f0f6-474d-99e6-a42ab7e6cd4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_e3e81d15-f0f6-474d-99e6-a42ab7e6cd4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_e3e81d15-f0f6-474d-99e6-a42ab7e6cd4c" xlink:to="loc_us-gaap_GranteeStatusDomain_e3e81d15-f0f6-474d-99e6-a42ab7e6cd4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_94b5a407-c88b-4a17-a024-addb91227763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_e3e81d15-f0f6-474d-99e6-a42ab7e6cd4c" xlink:to="loc_us-gaap_GranteeStatusDomain_94b5a407-c88b-4a17-a024-addb91227763" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_b0ea18a0-1fbd-476f-9e4c-49a45695a919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_94b5a407-c88b-4a17-a024-addb91227763" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_b0ea18a0-1fbd-476f-9e4c-49a45695a919" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3dfafbf4-d44b-449b-bb46-f5893c864edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:to="loc_us-gaap_PlanNameAxis_3dfafbf4-d44b-449b-bb46-f5893c864edf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3dfafbf4-d44b-449b-bb46-f5893c864edf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3dfafbf4-d44b-449b-bb46-f5893c864edf" xlink:to="loc_us-gaap_PlanNameDomain_3dfafbf4-d44b-449b-bb46-f5893c864edf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_027cf063-57a5-43ab-9b6d-2e6bcbb61511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3dfafbf4-d44b-449b-bb46-f5893c864edf" xlink:to="loc_us-gaap_PlanNameDomain_027cf063-57a5-43ab-9b6d-2e6bcbb61511" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_d9b2a66f-5cb3-4b09-9a5a-3850b02bce96" xlink:href="pets-20230331.xsd#pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_027cf063-57a5-43ab-9b6d-2e6bcbb61511" xlink:to="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_d9b2a66f-5cb3-4b09-9a5a-3850b02bce96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember_85ef4cd3-3276-4c8c-8312-0cbb37542c41" xlink:href="pets-20230331.xsd#pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_027cf063-57a5-43ab-9b6d-2e6bcbb61511" xlink:to="loc_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember_85ef4cd3-3276-4c8c-8312-0cbb37542c41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fa72d7f1-a61e-4aed-ba49-634b598d3696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fa72d7f1-a61e-4aed-ba49-634b598d3696" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fa72d7f1-a61e-4aed-ba49-634b598d3696_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fa72d7f1-a61e-4aed-ba49-634b598d3696" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fa72d7f1-a61e-4aed-ba49-634b598d3696_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c2a3952e-5736-421b-8afe-4ce6b944ad9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fa72d7f1-a61e-4aed-ba49-634b598d3696" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c2a3952e-5736-421b-8afe-4ce6b944ad9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8dc85066-aac5-4ef6-b79a-c8e875851de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c2a3952e-5736-421b-8afe-4ce6b944ad9f" xlink:to="loc_us-gaap_SubsequentEventMember_8dc85066-aac5-4ef6-b79a-c8e875851de6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_faf3d6a9-c561-4856-815a-8b50b92df62d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:to="loc_srt_TitleOfIndividualAxis_faf3d6a9-c561-4856-815a-8b50b92df62d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_faf3d6a9-c561-4856-815a-8b50b92df62d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_faf3d6a9-c561-4856-815a-8b50b92df62d" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_faf3d6a9-c561-4856-815a-8b50b92df62d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_de992929-d202-434a-a4ac-efdd4c4ee1bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_faf3d6a9-c561-4856-815a-8b50b92df62d" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_de992929-d202-434a-a4ac-efdd4c4ee1bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_01d96c24-1cf0-4109-9a7c-a21b87cf12c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_de992929-d202-434a-a4ac-efdd4c4ee1bc" xlink:to="loc_srt_DirectorMember_01d96c24-1cf0-4109-9a7c-a21b87cf12c3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/RelatedPartyTransactionDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#RelatedPartyTransactionDetails"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/RelatedPartyTransactionDetails" xlink:type="extended" id="ib19af121c0a84d6db4048da6a219980a_RelatedPartyTransactionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_526ccb4a-6df1-4ce9-82fc-caa6cc19777f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_ab0082f4-7521-49d0-9b61-2747f1f85663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_526ccb4a-6df1-4ce9-82fc-caa6cc19777f" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_ab0082f4-7521-49d0-9b61-2747f1f85663" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_4c37efff-834d-49b0-abf1-a610f8d84a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_526ccb4a-6df1-4ce9-82fc-caa6cc19777f" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_4c37efff-834d-49b0-abf1-a610f8d84a5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_b3d1b324-8d78-4df2-928f-7d2ee5b3da6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_526ccb4a-6df1-4ce9-82fc-caa6cc19777f" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_b3d1b324-8d78-4df2-928f-7d2ee5b3da6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1fa4f2a5-1e78-4afd-bc3e-94123383aec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_526ccb4a-6df1-4ce9-82fc-caa6cc19777f" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1fa4f2a5-1e78-4afd-bc3e-94123383aec0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6263d32a-163a-4784-a673-56e5abfe1926" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1fa4f2a5-1e78-4afd-bc3e-94123383aec0" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6263d32a-163a-4784-a673-56e5abfe1926" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6263d32a-163a-4784-a673-56e5abfe1926_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6263d32a-163a-4784-a673-56e5abfe1926" xlink:to="loc_us-gaap_RelatedPartyDomain_6263d32a-163a-4784-a673-56e5abfe1926_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_923ef7c5-a73d-4cd2-aeb5-ee152435b9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6263d32a-163a-4784-a673-56e5abfe1926" xlink:to="loc_us-gaap_RelatedPartyDomain_923ef7c5-a73d-4cd2-aeb5-ee152435b9fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ProphetMember_7b395eee-740a-48eb-8105-8d16b8f02b65" xlink:href="pets-20230331.xsd#pets_ProphetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_923ef7c5-a73d-4cd2-aeb5-ee152435b9fd" xlink:to="loc_pets_ProphetMember_7b395eee-740a-48eb-8105-8d16b8f02b65" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>pets-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:5cf93b28-3379-44eb-90e7-0c74c316f7e6,g:9a7e90f8-ce57-4497-9c85-b6b094af0e8b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_d3ed8c8f-7dd7-4275-b6ec-543a302e375f_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_5b6d8d9f-61bf-4720-975b-f3c695d7ba5d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_ef416b0f-48b2-4d8f-a305-d817cb5abdef_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94cf5640-10bd-48ee-ba19-1a05558b9e0e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_0fd99766-5b14-497d-8566-5c9a8b0918d2_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt expense</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_69ca55b4-c5c4-43c6-830c-ca8f37334cc4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_RestrictionPeriod_d053b8fa-7a17-44e7-a09e-62b969c7ccfe_terseLabel_en-US" xlink:label="lab_pets_RestrictionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restriction period</link:label>
    <link:label id="lab_pets_RestrictionPeriod_label_en-US" xlink:label="lab_pets_RestrictionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restriction Period</link:label>
    <link:label id="lab_pets_RestrictionPeriod_documentation_en-US" xlink:label="lab_pets_RestrictionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of restriction of forfeiture.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RestrictionPeriod" xlink:href="pets-20230331.xsd#pets_RestrictionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_RestrictionPeriod" xlink:to="lab_pets_RestrictionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_da7ee989-14d4-426d-b1e8-4ea9d96b67e3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_9c54f49c-6b85-4dcb-aca9-885071003ebc_terseLabel_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of real estate property (in square feet)</link:label>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_label_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of Real Estate Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfRealEstateProperty" xlink:to="lab_us-gaap_AreaOfRealEstateProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bde00c39-e424-482c-b3e4-6e9dcbf2a1f3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_6b7ad061-0867-47e4-a31a-32f7a79fe08b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_EmploymentTermSuccessiveRenewalPeriod_48dc5149-2931-4d64-bba0-564abb641987_terseLabel_en-US" xlink:label="lab_pets_EmploymentTermSuccessiveRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Successive renewal employment term</link:label>
    <link:label id="lab_pets_EmploymentTermSuccessiveRenewalPeriod_label_en-US" xlink:label="lab_pets_EmploymentTermSuccessiveRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employment Term, Successive Renewal Period</link:label>
    <link:label id="lab_pets_EmploymentTermSuccessiveRenewalPeriod_documentation_en-US" xlink:label="lab_pets_EmploymentTermSuccessiveRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employment Term, Successive Renewal Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmploymentTermSuccessiveRenewalPeriod" xlink:href="pets-20230331.xsd#pets_EmploymentTermSuccessiveRenewalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_EmploymentTermSuccessiveRenewalPeriod" xlink:to="lab_pets_EmploymentTermSuccessiveRenewalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_8ecb710a-8a17-43bb-8d09-01d15944ac42_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_ed89ed9c-d848-4702-8bfc-6502836c7e11_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_fc4e1f72-68a6-4ced-945c-1d301f2c0453_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party expenses</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_1f94e763-5672-4e7f-b897-a73a3d495c4c_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_02987853-30da-4819-9d69-abd941bb6cc9_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_9d80d588-6c42-40ea-a57d-1bd34772cf3c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salaries and benefits</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_cd003448-fa3a-404b-9b78-7e264eff64dc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_3c89876d-a1c6-4c73-8613-30544383cb92_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_aa439107-7941-4345-8d25-ae5fa4a74fe1_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_567e6b0d-228d-4cf6-bd1f-7b857a2dbb94_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_6ae2794e-800b-40c4-a91d-46c18adb3e15_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net deferred tax assets (liabilities)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_54cf5211-3a95-4f96-bcb1-8e4802405217_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock, net (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_338068b3-4a64-44ff-92e7-5bca1987988e_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Share Based Compensation</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm_93a693e6-1222-4c5a-a976-854ad235cac4_terseLabel_en-US" xlink:label="lab_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm_label_en-US" xlink:label="lab_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease Remaining Weighted Average Lease Term</link:label>
    <link:label id="lab_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm_documentation_en-US" xlink:label="lab_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm" xlink:href="pets-20230331.xsd#pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm" xlink:to="lab_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod_c7d14354-6a67-4927-a875-02a4ad0ddec7_terseLabel_en-US" xlink:label="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Absolute stock price hurdle period</link:label>
    <link:label id="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod_label_en-US" xlink:label="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Hurdle Period</link:label>
    <link:label id="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod_documentation_en-US" xlink:label="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Hurdle Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod" xlink:href="pets-20230331.xsd#pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod" xlink:to="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_c88743e0-7c80-4ec8-8fde-7db024c9d4e0_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod_4ed1a531-746e-42eb-a40e-9d39572a160c_terseLabel_en-US" xlink:label="lab_pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance pay health insurance benefits, without cause termination, period</link:label>
    <link:label id="lab_pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod_label_en-US" xlink:label="lab_pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Payment, Termination Without Cause, Health Insurance Benefits, Period</link:label>
    <link:label id="lab_pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod_documentation_en-US" xlink:label="lab_pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Payment, Termination Without Cause, Health Insurance Benefits, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod" xlink:href="pets-20230331.xsd#pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod" xlink:to="lab_pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_DirectorPlanMember_d98142c8-ea4c-4d21-a03d-48dfcabdb5b4_terseLabel_en-US" xlink:label="lab_pets_DirectorPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director Plan</link:label>
    <link:label id="lab_pets_DirectorPlanMember_label_en-US" xlink:label="lab_pets_DirectorPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director Plan [Member]</link:label>
    <link:label id="lab_pets_DirectorPlanMember_documentation_en-US" xlink:label="lab_pets_DirectorPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information relating to the 2006 and 2015 Director Plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_DirectorPlanMember" xlink:href="pets-20230331.xsd#pets_DirectorPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_DirectorPlanMember" xlink:to="lab_pets_DirectorPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_8e79ac10-ff6c-4168-8ced-8fee6d78284b_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amount</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_30430da5-1b79-4b9f-9e22-442f919bf357_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_43072611-edad-4138-b1aa-6b7c2e074e54_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_01aa22a7-9b2d-4adc-a7ca-ccb98ccb242f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, requisite service period</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories_89199f99-47d9-4b86-82f8-8a6e79bd488a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories - finished goods</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Finished Goods and Work in Process Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_dc5b3523-b762-41ac-937b-592e64a58b52_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_7852a76f-5edc-488c-a527-c6627c4bee02_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8e0298a1-da89-477f-943b-13295dc8d2e3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_8b685e6a-6970-4dca-a933-46edf96cccec_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_NonCompeteAgreementPeriod_88f880ee-41b4-4ad9-9cee-8497001b9a63_terseLabel_en-US" xlink:label="lab_pets_NonCompeteAgreementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete term</link:label>
    <link:label id="lab_pets_NonCompeteAgreementPeriod_label_en-US" xlink:label="lab_pets_NonCompeteAgreementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Compete Agreement, Period</link:label>
    <link:label id="lab_pets_NonCompeteAgreementPeriod_documentation_en-US" xlink:label="lab_pets_NonCompeteAgreementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Compete Agreement, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NonCompeteAgreementPeriod" xlink:href="pets-20230331.xsd#pets_NonCompeteAgreementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_NonCompeteAgreementPeriod" xlink:to="lab_pets_NonCompeteAgreementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_6b537a92-691c-4f35-9398-42601682025e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_7b5ea29f-8120-46b5-9aef-23e7b7087dc4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_AccruedSalesReturnsAndAllowancesCurrent_88086ec8-c14f-475a-aa80-b343f17e8cca_terseLabel_en-US" xlink:label="lab_pets_AccruedSalesReturnsAndAllowancesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued sales return allowance</link:label>
    <link:label id="lab_pets_AccruedSalesReturnsAndAllowancesCurrent_label_en-US" xlink:label="lab_pets_AccruedSalesReturnsAndAllowancesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued sales return allowance</link:label>
    <link:label id="lab_pets_AccruedSalesReturnsAndAllowancesCurrent_documentation_en-US" xlink:label="lab_pets_AccruedSalesReturnsAndAllowancesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents accrued sales returns and allowances. Used to reflect the current portion (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedSalesReturnsAndAllowancesCurrent" xlink:href="pets-20230331.xsd#pets_AccruedSalesReturnsAndAllowancesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_AccruedSalesReturnsAndAllowancesCurrent" xlink:to="lab_pets_AccruedSalesReturnsAndAllowancesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_AccruedMerchandiseCreditsAndRewardsCurrent_7dbc7811-6218-4c00-a23e-aeefa7eb0d67_terseLabel_en-US" xlink:label="lab_pets_AccruedMerchandiseCreditsAndRewardsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued merchandise credits / reward program</link:label>
    <link:label id="lab_pets_AccruedMerchandiseCreditsAndRewardsCurrent_label_en-US" xlink:label="lab_pets_AccruedMerchandiseCreditsAndRewardsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued merchandise credits / reward program</link:label>
    <link:label id="lab_pets_AccruedMerchandiseCreditsAndRewardsCurrent_documentation_en-US" xlink:label="lab_pets_AccruedMerchandiseCreditsAndRewardsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of accrued merchandise credits and rewards classified as current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedMerchandiseCreditsAndRewardsCurrent" xlink:href="pets-20230331.xsd#pets_AccruedMerchandiseCreditsAndRewardsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_AccruedMerchandiseCreditsAndRewardsCurrent" xlink:to="lab_pets_AccruedMerchandiseCreditsAndRewardsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_bd4d2684-cce6-4183-ac35-7c26ba0548ac_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_63c87096-668a-4286-a23e-15aad79ffaca_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_ContingentLumpSumSeverancePayment_4e9a5424-deef-4535-a630-dd24284addcd_terseLabel_en-US" xlink:label="lab_pets_ContingentLumpSumSeverancePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent lump sum severance payment</link:label>
    <link:label id="lab_pets_ContingentLumpSumSeverancePayment_label_en-US" xlink:label="lab_pets_ContingentLumpSumSeverancePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Lump Sum Severance Payment</link:label>
    <link:label id="lab_pets_ContingentLumpSumSeverancePayment_documentation_en-US" xlink:label="lab_pets_ContingentLumpSumSeverancePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Lump Sum Severance Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ContingentLumpSumSeverancePayment" xlink:href="pets-20230331.xsd#pets_ContingentLumpSumSeverancePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_ContingentLumpSumSeverancePayment" xlink:to="lab_pets_ContingentLumpSumSeverancePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_f5b9661f-8a67-48ff-ad27-f564be0aff52_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_fd97af26-3d33-4386-8272-633c23b35dfd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_69797e54-6dcd-4f8e-9ade-24555486dd0d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_NumberOfTenants_d1ec32a9-5267-4664-b000-b9f422034bec_terseLabel_en-US" xlink:label="lab_pets_NumberOfTenants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of tenants</link:label>
    <link:label id="lab_pets_NumberOfTenants_label_en-US" xlink:label="lab_pets_NumberOfTenants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Tenants</link:label>
    <link:label id="lab_pets_NumberOfTenants_documentation_en-US" xlink:label="lab_pets_NumberOfTenants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents number of tenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NumberOfTenants" xlink:href="pets-20230331.xsd#pets_NumberOfTenants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_NumberOfTenants" xlink:to="lab_pets_NumberOfTenants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_ed707fef-8a5d-4ed7-bcfd-a90ce411e0d8_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued, price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_1b18b94a-8955-4d49-a1fb-806c65abadce_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_OtherAssetsPolicyTextBlock_27335168-4a7e-4736-a62b-0b4c5619820a_terseLabel_en-US" xlink:label="lab_pets_OtherAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_pets_OtherAssetsPolicyTextBlock_label_en-US" xlink:label="lab_pets_OtherAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Policy Text Block]</link:label>
    <link:label id="lab_pets_OtherAssetsPolicyTextBlock_documentation_en-US" xlink:label="lab_pets_OtherAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_OtherAssetsPolicyTextBlock" xlink:href="pets-20230331.xsd#pets_OtherAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_OtherAssetsPolicyTextBlock" xlink:to="lab_pets_OtherAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_3b155ced-5128-4af9-9c0c-ab306eda2324_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b2daba-d638-4fcf-9929-448af3f9ca05_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_a75ab2a1-7fcd-43e5-9e20-d4376c9ffb6b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_0137ee5a-fe60-4b96-9a06-525ab9b6c7e1_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_6c93f3b3-4c13-4912-a5eb-3b9a887483d7_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_2870f433-b1e7-4d7b-8290-19a59dc97425_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6d9f79b6-0557-464d-a0fb-2dbe772cde84_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f4a5532c-bf5a-443b-8853-71e94f66500e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_5c803188-1ffa-4f35-ac10-ed99dde8c697_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_7fcd04d9-e888-42ee-9047-84d533f02fb7_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_ee8693ae-5193-4a5b-a9a8-6730af93b2dd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_adac2c5b-e32e-4a01-a44c-1558da18b1d9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7c545f17-ed4e-4c1d-8b46-b212c84309bf_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current taxes</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_42b3a6d7-0472-4d80-a8f4-8c5a2b52e0f4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_5582a996-ec97-4220-b9db-768bf1367bd0_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_2c5d489c-198d-4c1c-9c79-84677e50d87e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_96cdc5f7-09ac-4418-ad7f-8ba8866aba6b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_3bd687c5-afc3-4cda-aa28-df8f89d2e1ad_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_a61a15d3-a88c-4f71-b8fd-ec08c9e971ce_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_EmploymentTermInitialPeriod_15591332-c085-495c-a4ea-01cca4e209a4_terseLabel_en-US" xlink:label="lab_pets_EmploymentTermInitialPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial employment term</link:label>
    <link:label id="lab_pets_EmploymentTermInitialPeriod_label_en-US" xlink:label="lab_pets_EmploymentTermInitialPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employment Term, Initial Period</link:label>
    <link:label id="lab_pets_EmploymentTermInitialPeriod_documentation_en-US" xlink:label="lab_pets_EmploymentTermInitialPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employment Term, Initial Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmploymentTermInitialPeriod" xlink:href="pets-20230331.xsd#pets_EmploymentTermInitialPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_EmploymentTermInitialPeriod" xlink:to="lab_pets_EmploymentTermInitialPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fb2f0bf3-e343-4fe8-9309-9283800de6eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock hurdle price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_b35cd413-7267-4ac0-b75a-e412d8d77d9a_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefit Plan</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_PaymentsForStipend_97afed0f-dc01-4d91-b47e-cbb543eaaf72_terseLabel_en-US" xlink:label="lab_pets_PaymentsForStipend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash stipend</link:label>
    <link:label id="lab_pets_PaymentsForStipend_label_en-US" xlink:label="lab_pets_PaymentsForStipend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Stipend</link:label>
    <link:label id="lab_pets_PaymentsForStipend_documentation_en-US" xlink:label="lab_pets_PaymentsForStipend" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents payments for stipend.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PaymentsForStipend" xlink:href="pets-20230331.xsd#pets_PaymentsForStipend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_PaymentsForStipend" xlink:to="lab_pets_PaymentsForStipend" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b46656b1-44b2-4dd3-ada4-db59e5220957_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_6180a7b4-e287-4ff0-a806-8c05bfda6192_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_2577818b-a0ea-4510-b748-1546abc6304f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_fa90a24f-2452-409a-ac1b-4502e23ef8ee_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonemployee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonemployee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_90b23d46-0565-4ad7-92d5-cb778dcecc35_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_293240c5-4d62-4767-902a-649e5d739535_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, operating lease, payment to be received, 2028</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_e5b85cd9-3ab7-4a0d-b84c-a76e4d443179_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_851ca909-1843-451a-a80b-8b8817d6be98_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_8f590821-88ce-47e6-ac26-e8c2e51c5c21_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_dfbb13aa-4398-42c8-907d-6f080db8cbfc_terseLabel_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued sales tax</link:label>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_label_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Excise Tax Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_c0e9df70-0b5a-4336-b80d-e2bfeffc95cc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_e0d5d78a-d5b5-46c0-a068-2569d5ff7100_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, liquidation preference (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreference" xlink:to="lab_us-gaap_PreferredStockLiquidationPreference" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_39070ac4-d062-4d9e-bc43-16f69a54ab1c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_b6f4f265-daa3-4367-8ecc-a99aac7b1c0e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficersCompensation_fa037ff2-61c8-4afa-9788-3732e3467245_terseLabel_en-US" xlink:label="lab_us-gaap_OfficersCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual base salary</link:label>
    <link:label id="lab_us-gaap_OfficersCompensation_label_en-US" xlink:label="lab_us-gaap_OfficersCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salary and Wage, Officer, Excluding Cost of Good and Service Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficersCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficersCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficersCompensation" xlink:to="lab_us-gaap_OfficersCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_8fae070a-b11f-4234-9a8e-8638001b1d8b_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RentalIncomeNonoperating_efcd1103-43ab-4dcb-b8be-c4cb31bdfadf_terseLabel_en-US" xlink:label="lab_us-gaap_RentalIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rental revenue</link:label>
    <link:label id="lab_us-gaap_RentalIncomeNonoperating_label_en-US" xlink:label="lab_us-gaap_RentalIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rental Income, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RentalIncomeNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RentalIncomeNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RentalIncomeNonoperating" xlink:to="lab_us-gaap_RentalIncomeNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_50becdd8-3571-4e06-a59a-4e0b051cfc16_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_0dc799da-e7c4-4acb-b05e-ca52b8b214cd_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5cab1fdb-5759-4c41-a2ae-d5e886f9f37b_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_cd721b9e-b37f-4d7a-ae9f-887750a8d722_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExciseAndSalesTaxes_3bd9b1d9-9d6a-4976-a34e-490e7caf8c80_terseLabel_en-US" xlink:label="lab_us-gaap_ExciseAndSalesTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales tax exposure</link:label>
    <link:label id="lab_us-gaap_ExciseAndSalesTaxes_label_en-US" xlink:label="lab_us-gaap_ExciseAndSalesTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise and Sales Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExciseAndSalesTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExciseAndSalesTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExciseAndSalesTaxes" xlink:to="lab_us-gaap_ExciseAndSalesTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_8609ab40-6ae7-4470-a7a1-946afbd632b1_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minority Interest Investment in Vetster</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9a1f503b-caf8-4419-8190-4e5ad3824f22_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_c0059c54-7253-4536-b6af-a17da303dc2e_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_1326c64c-7491-471e-8d4a-c4825fe3ddc4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_e4364ae6-fc63-4de1-81d1-59dcd28ca565_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_c594d106-137d-4eaf-b976-d739a3366576_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Provision</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2b682732-5f9d-4f72-a226-c1002fc2ad30_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_c2430eb9-dcbc-488a-8802-05f60e5f1169_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_PetCareRxMember_bee75573-158c-49ae-83fa-ddc50da439ad_terseLabel_en-US" xlink:label="lab_pets_PetCareRxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PetCareRx</link:label>
    <link:label id="lab_pets_PetCareRxMember_label_en-US" xlink:label="lab_pets_PetCareRxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PetCareRx [Member]</link:label>
    <link:label id="lab_pets_PetCareRxMember_documentation_en-US" xlink:label="lab_pets_PetCareRxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PetCareRx</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PetCareRxMember" xlink:href="pets-20230331.xsd#pets_PetCareRxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_PetCareRxMember" xlink:to="lab_pets_PetCareRxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c641aae5-b5c1-425c-a3b6-3adfcd6cc9ee_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average restriction and forfeiture period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_794184d3-5f9f-457b-9d9e-41d3267facdb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories - finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_b9c30b8a-b826-46dd-b859-781b99ea80aa_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_56c5a16c-c672-4936-abca-cdab35aafbcf_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred stock compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_55bc382d-4931-4e3f-a26d-febb6929cd96_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f7876efa-dd5f-4e39-8eda-09d4c05f1ae8_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_124d408b-c846-4926-bb88-c69d065ab2cb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_25b21581-c1a2-47a9-9477-9bcce47183ad_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk</link:label>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierConcentrationRiskMember" xlink:to="lab_us-gaap_SupplierConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_4cbacc7d-44ed-4dbc-9b13-3d785bbbe3af_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_PerformanceRestrictedStockPriceHurdle2Member_bbb5effb-93e3-4313-b0df-ba28f9e26fdd_terseLabel_en-US" xlink:label="lab_pets_PerformanceRestrictedStockPriceHurdle2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Price Hurdle 2</link:label>
    <link:label id="lab_pets_PerformanceRestrictedStockPriceHurdle2Member_label_en-US" xlink:label="lab_pets_PerformanceRestrictedStockPriceHurdle2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Price Hurdle 2 [Member]</link:label>
    <link:label id="lab_pets_PerformanceRestrictedStockPriceHurdle2Member_documentation_en-US" xlink:label="lab_pets_PerformanceRestrictedStockPriceHurdle2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents Performance Restricted Stock Price Hurdle 2.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockPriceHurdle2Member" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockPriceHurdle2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_PerformanceRestrictedStockPriceHurdle2Member" xlink:to="lab_pets_PerformanceRestrictedStockPriceHurdle2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_9949089b-f2d8-4bb0-a58f-9c61c5ff77df_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_8ed00bd3-cf31-4253-a429-f6dd4303f5cf_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_a5d3862b-efc1-4241-bad3-89186e46f921_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Employee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_4f4ca431-5547-4ef2-9a74-9d99bf82b740_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember_8ce2f412-68c6-4a69-8726-484416bbb43b_terseLabel_en-US" xlink:label="lab_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Employee Equity Compensation Restricted Stock Plan</link:label>
    <link:label id="lab_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember_label_en-US" xlink:label="lab_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Employee Equity Compensation Restricted Stock Plan [Member]</link:label>
    <link:label id="lab_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember_documentation_en-US" xlink:label="lab_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Employee Equity Compensation Restricted Stock Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember" xlink:href="pets-20230331.xsd#pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember" xlink:to="lab_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_ac1482ee-eb12-46d4-aa84-aa22a145b50d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_d76db3f3-448c-4a4b-8475-f12a6f9abc6a_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_6462767b-d49e-4a87-bc19-6092a566fa5a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_ebc11c5c-4230-4421-b25c-733714f6e3b2_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_aa98b8dc-27c8-4e75-b9d9-e8b46b053e57_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_TerminationPeriodPeriodWithinChangeInControl_cc737cbf-69de-4767-a82f-db0e04318356_terseLabel_en-US" xlink:label="lab_pets_TerminationPeriodPeriodWithinChangeInControl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">"Good Reason" termination period</link:label>
    <link:label id="lab_pets_TerminationPeriodPeriodWithinChangeInControl_label_en-US" xlink:label="lab_pets_TerminationPeriodPeriodWithinChangeInControl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Period, Period Within Change In Control</link:label>
    <link:label id="lab_pets_TerminationPeriodPeriodWithinChangeInControl_documentation_en-US" xlink:label="lab_pets_TerminationPeriodPeriodWithinChangeInControl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Period, Period Within Change In Control</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TerminationPeriodPeriodWithinChangeInControl" xlink:href="pets-20230331.xsd#pets_TerminationPeriodPeriodWithinChangeInControl"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_TerminationPeriodPeriodWithinChangeInControl" xlink:to="lab_pets_TerminationPeriodPeriodWithinChangeInControl" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_0df1890c-cf75-49c4-8b38-1257c2257c2e_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, operating lease, payment to be received, 2027</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ba33e6a8-4ccc-4463-864e-562ffb15eb51_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_f10aa91e-3a12-4db5-92aa-7fde6eb9b2ac_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_EarningsPerShareBasicAndDilutedEPSAbstract_17b3f34a-0228-47c6-b709-35cc9600dbb3_terseLabel_en-US" xlink:label="lab_pets_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per common share:</link:label>
    <link:label id="lab_pets_EarningsPerShareBasicAndDilutedEPSAbstract_label_en-US" xlink:label="lab_pets_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS [Abstract]</link:label>
    <link:label id="lab_pets_EarningsPerShareBasicAndDilutedEPSAbstract_documentation_en-US" xlink:label="lab_pets_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:href="pets-20230331.xsd#pets_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:to="lab_pets_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_93bb94d1-1175-4980-be8f-2d408d77ced6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_4dd3fce6-9f8b-4ae4-8b37-adbaacfeed06_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_ContactCenterMember_2b1b962b-203d-4869-acc1-0723e7c9e99c_terseLabel_en-US" xlink:label="lab_pets_ContactCenterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call center</link:label>
    <link:label id="lab_pets_ContactCenterMember_label_en-US" xlink:label="lab_pets_ContactCenterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Center [Member]</link:label>
    <link:label id="lab_pets_ContactCenterMember_documentation_en-US" xlink:label="lab_pets_ContactCenterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disaggregate of revenue in contact center sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ContactCenterMember" xlink:href="pets-20230331.xsd#pets_ContactCenterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_ContactCenterMember" xlink:to="lab_pets_ContactCenterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_735b0265-a56e-4e79-be71-123e6ae43d21_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_dd3ddee9-566e-4ca2-ad5e-f4bdfb6a8673_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_DefinedContributionPlanWithIndividualAge_86358653-0e71-478b-b4c0-a69f98b23291_terseLabel_en-US" xlink:label="lab_pets_DefinedContributionPlanWithIndividualAge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, requisite age</link:label>
    <link:label id="lab_pets_DefinedContributionPlanWithIndividualAge_label_en-US" xlink:label="lab_pets_DefinedContributionPlanWithIndividualAge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan With Individual Age</link:label>
    <link:label id="lab_pets_DefinedContributionPlanWithIndividualAge_documentation_en-US" xlink:label="lab_pets_DefinedContributionPlanWithIndividualAge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The minimum age that the individual is required in order to participate in the defined contribution plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_DefinedContributionPlanWithIndividualAge" xlink:href="pets-20230331.xsd#pets_DefinedContributionPlanWithIndividualAge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_DefinedContributionPlanWithIndividualAge" xlink:to="lab_pets_DefinedContributionPlanWithIndividualAge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_39f0c6b8-8fb7-4c40-8304-af11c7dfadbb_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Improvements</link:label>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_PerformanceRestrictedStockPriceHurdle1Member_669c2244-8fa5-4bef-ba2f-4187ee4dd4d0_terseLabel_en-US" xlink:label="lab_pets_PerformanceRestrictedStockPriceHurdle1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Price Hurdle 1</link:label>
    <link:label id="lab_pets_PerformanceRestrictedStockPriceHurdle1Member_label_en-US" xlink:label="lab_pets_PerformanceRestrictedStockPriceHurdle1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Price Hurdle 1 [Member]</link:label>
    <link:label id="lab_pets_PerformanceRestrictedStockPriceHurdle1Member_documentation_en-US" xlink:label="lab_pets_PerformanceRestrictedStockPriceHurdle1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents Performance Restricted Stock Price Hurdle 1.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockPriceHurdle1Member" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockPriceHurdle1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_PerformanceRestrictedStockPriceHurdle1Member" xlink:to="lab_pets_PerformanceRestrictedStockPriceHurdle1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_0d6e3ee8-7a83-42a5-8733-d210009f02a3_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6ec565f8-7618-4e06-8a80-7299d0d18a33_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5bdcc194-7c03-466e-80d8-753eb8b2feda_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_76b9b336-7566-45b4-a3ca-740f8de41e26_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_90a596e1-7ed4-4058-b905-34b8ae11118c_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_EmployeePlanMember_a2a1ac43-989d-4ed9-8311-62b42d21cfee_terseLabel_en-US" xlink:label="lab_pets_EmployeePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Plan</link:label>
    <link:label id="lab_pets_EmployeePlanMember_label_en-US" xlink:label="lab_pets_EmployeePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Plan [Member]</link:label>
    <link:label id="lab_pets_EmployeePlanMember_documentation_en-US" xlink:label="lab_pets_EmployeePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information relating to the 2006 and 2016 Employee Plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmployeePlanMember" xlink:href="pets-20230331.xsd#pets_EmployeePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_EmployeePlanMember" xlink:to="lab_pets_EmployeePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_9365bef5-946e-47a4-b4ca-b0074f7f8352_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_562a406e-2d72-47ed-a5c1-150b56d93e89_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_b290fab3-c50d-48cf-8e47-ce63791e0bef_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of all products purchased</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_ProphetMember_56cd9f1e-4ef5-496b-932c-317010746659_terseLabel_en-US" xlink:label="lab_pets_ProphetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prophet</link:label>
    <link:label id="lab_pets_ProphetMember_label_en-US" xlink:label="lab_pets_ProphetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prophet [Member]</link:label>
    <link:label id="lab_pets_ProphetMember_documentation_en-US" xlink:label="lab_pets_ProphetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents Prophet.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ProphetMember" xlink:href="pets-20230331.xsd#pets_ProphetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_ProphetMember" xlink:to="lab_pets_ProphetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_2125bf55-9dfb-417f-a588-5b5d80ac8340_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_33ccfe9d-fc4e-4a6a-a129-01e7984beff0_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_AccruedSeveranceCosts_e93e1314-5b53-4ca7-a44a-6feaf3528469_terseLabel_en-US" xlink:label="lab_pets_AccruedSeveranceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued severance costs</link:label>
    <link:label id="lab_pets_AccruedSeveranceCosts_label_en-US" xlink:label="lab_pets_AccruedSeveranceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Severance Costs</link:label>
    <link:label id="lab_pets_AccruedSeveranceCosts_documentation_en-US" xlink:label="lab_pets_AccruedSeveranceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedSeveranceCosts" xlink:href="pets-20230331.xsd#pets_AccruedSeveranceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_AccruedSeveranceCosts" xlink:to="lab_pets_AccruedSeveranceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_35aef681-3d17-4b84-9184-5a993fe21abf_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_07ee7585-bdf9-44a9-9a81-1e1ac116591b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount_f8bccc16-eea4-44a1-ab26-64aab5550fa7_terseLabel_en-US" xlink:label="lab_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent differences</link:label>
    <link:label id="lab_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount_label_en-US" xlink:label="lab_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Permanent Differences, Amount</link:label>
    <link:label id="lab_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount_documentation_en-US" xlink:label="lab_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Permanent Differences, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount" xlink:href="pets-20230331.xsd#pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount" xlink:to="lab_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_9a9b341a-37f5-405e-ac25-112765541395_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_a65bd43b-e00d-43e8-946c-e48461cbbd69_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_6d7833e6-1b71-4c3f-aa1f-999bc5ba197c_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod_e2f1b376-0bb0-4a66-9ab7-3d6ad072e30b_terseLabel_en-US" xlink:label="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employment performance period</link:label>
    <link:label id="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod_label_en-US" xlink:label="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Performance Period</link:label>
    <link:label id="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod_documentation_en-US" xlink:label="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod" xlink:href="pets-20230331.xsd#pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod" xlink:to="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_fbdb10c9-2995-403e-aa62-c78b98383987_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_d0a2260d-ef08-409e-9a98-901d9c111fdf_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_c201f293-328e-44ab-b569-4e728d9e0e9e_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_9b59407d-ac1a-45dc-be4e-8cb8015c1f3f_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_ee8568f2-949a-49ec-9b84-807143e5e41c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_6c93ee07-e492-4639-8812-486c51836adb_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_2f17fc43-18e7-45cd-aa08-7c13bece040f_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_142325d2-762b-40d5-8d19-cb269625211a_terseLabel_en-US" xlink:label="lab_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Employee Equity Compensation Restricted Stock Plan</link:label>
    <link:label id="lab_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_label_en-US" xlink:label="lab_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Employee Equity Compensation Restricted Stock Plan [Member]</link:label>
    <link:label id="lab_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_documentation_en-US" xlink:label="lab_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to the 2016 Employee Equity Compensation Restricted Stock Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" xlink:href="pets-20230331.xsd#pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" xlink:to="lab_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_489410fe-97ae-4fe3-81e4-8255ac5bed20_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_85eb0bca-1de5-4e56-b490-3784db423254_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_aaab902b-ebc1-4f4b-b58e-f7aba4b2176b_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, operating lease, payment to be received, 2024</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_51684f99-cc22-4504-9d23-8808279048cf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fc111edb-f9b5-41a9-9003-8e978d3c112b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Increase) decrease in operating assets and increase (decrease) in liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_100f69c5-896f-413b-85dd-6a6c902bd440_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (numerator):</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_b0b52378-765b-4a9c-832f-2fb10361ced0_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_a4de55b1-4db1-4980-be43-66712b138a33_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, operating lease, payment to be received, 2026</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_a4b7dbcf-6428-4a27-befb-8b39e89cd26c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_5bff42f7-165d-45bc-b5fd-ce507faa2d86_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_546ea3d7-77f6-4c82-9faf-8afbb6d4518e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_1d324a74-c91d-406a-b7aa-e89b67c8d76d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_c60df04b-6ce9-4e8a-899a-32683a351d8e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_31d97a22-f83f-4ee9-8822-b9293a86967c_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, fixtures and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_79a7801e-4611-4b44-bbf0-b1507e8b92c6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_c44223e2-9a13-4c78-8009-30be75fb5e2f_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_InternetMember_def6a707-9674-411d-958f-2be097a74eef_terseLabel_en-US" xlink:label="lab_pets_InternetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internet</link:label>
    <link:label id="lab_pets_InternetMember_label_en-US" xlink:label="lab_pets_InternetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internet [Member]</link:label>
    <link:label id="lab_pets_InternetMember_documentation_en-US" xlink:label="lab_pets_InternetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disaggregate of revenue in internet sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_InternetMember" xlink:href="pets-20230331.xsd#pets_InternetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_InternetMember" xlink:to="lab_pets_InternetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_fb159211-0498-4115-86ea-056fe260563d_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_8581c832-3af8-4fa7-aa38-f70f3b787e3f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_a0604987-f780-48c2-8c60-96d46c187e34_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, shares issued upon conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_d1c4a645-1906-49c4-9d3e-9473abd841cb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, less allowance for doubtful accounts of $35 and $39, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_bfbb4fdb-f8ec-4ead-9668-d7498ee7a989_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_b0c71a47-271c-4ada-b7d9-3b264fa4ec89_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_a3d085c0-8251-4770-83d0-95216a0f9fda_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_b1bae96b-01ea-4df5-87ad-d6d43100d5d8_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_a9fbfa18-d959-418f-8b40-3724a6fc37fc_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_17dfe63b-6ab4-4bc6-8fe2-685e8f8ee755_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefFinancialOfficerMember_78b7382c-102a-4d9c-8752-b8dfeaed63b2_terseLabel_en-US" xlink:label="lab_srt_ChiefFinancialOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Financial Officer</link:label>
    <link:label id="lab_srt_ChiefFinancialOfficerMember_label_en-US" xlink:label="lab_srt_ChiefFinancialOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Financial Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefFinancialOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefFinancialOfficerMember" xlink:to="lab_srt_ChiefFinancialOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_0f1a3d84-9f8a-4193-98f1-04765718ef1e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsTotalMember_8c63b0c0-beef-4c99-83f4-5d78af416d27_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsTotalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service Benchmark</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsTotalMember_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsTotalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsTotalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsTotalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsTotalMember" xlink:to="lab_us-gaap_CostOfGoodsTotalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4ad9fa69-3f3d-49ba-adc0-82b8bb1bd250_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3014495f-b034-4107-886d-306c1575df7a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested restricted stock at March 31, 2022 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_cd61f808-42eb-47e8-8cfa-0b516e48adf5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested restricted stock outstanding at March 31, 2023 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_d845b0e1-4be9-43f3-acb1-762ec9b4b8b6_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_PerformanceRestrictedStockPriceHurdle4Member_5f3c6838-f4a2-4a76-94ef-44bf76b756df_terseLabel_en-US" xlink:label="lab_pets_PerformanceRestrictedStockPriceHurdle4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Price Hurdle 4</link:label>
    <link:label id="lab_pets_PerformanceRestrictedStockPriceHurdle4Member_label_en-US" xlink:label="lab_pets_PerformanceRestrictedStockPriceHurdle4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Price Hurdle 4 [Member]</link:label>
    <link:label id="lab_pets_PerformanceRestrictedStockPriceHurdle4Member_documentation_en-US" xlink:label="lab_pets_PerformanceRestrictedStockPriceHurdle4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents Performance Restricted Stock Price Hurdle 4.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockPriceHurdle4Member" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockPriceHurdle4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_PerformanceRestrictedStockPriceHurdle4Member" xlink:to="lab_pets_PerformanceRestrictedStockPriceHurdle4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_25f6b3f8-28f7-4f2b-9542-62e767ad31f9_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current taxes</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_PartnershipAgreementWithVetsterMember_3a4d09e9-df9e-4d59-a561-43b878ad7a56_terseLabel_en-US" xlink:label="lab_pets_PartnershipAgreementWithVetsterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement with Vetster</link:label>
    <link:label id="lab_pets_PartnershipAgreementWithVetsterMember_label_en-US" xlink:label="lab_pets_PartnershipAgreementWithVetsterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement with Vetster [Member]</link:label>
    <link:label id="lab_pets_PartnershipAgreementWithVetsterMember_documentation_en-US" xlink:label="lab_pets_PartnershipAgreementWithVetsterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents partnership agreement with Vestster.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PartnershipAgreementWithVetsterMember" xlink:href="pets-20230331.xsd#pets_PartnershipAgreementWithVetsterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_PartnershipAgreementWithVetsterMember" xlink:to="lab_pets_PartnershipAgreementWithVetsterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_702b06a3-c27d-4a42-a41e-f7f5fa066623_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_9afcf482-9b13-4645-8737-0574821b3656_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_d4cd1078-83dd-44a2-9741-b97b58125a68_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_811f1748-d3fa-474d-9a31-5642b4a72a17_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_ce3bf4e3-e8d4-46cc-a517-14858d9f56e8_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_8313408f-d20b-46d7-be7e-20faa678b332_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock shortfall (windfall) adjustments</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c6373944-2746-4405-96cb-350ff350ef34_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f5a4e319-e16e-4714-8a02-a6b088b96dec_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_PerformanceRestrictedStockPriceHurdle3Member_3233cc3e-a27f-497d-b313-ea8c4c60d602_terseLabel_en-US" xlink:label="lab_pets_PerformanceRestrictedStockPriceHurdle3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Price Hurdle 3</link:label>
    <link:label id="lab_pets_PerformanceRestrictedStockPriceHurdle3Member_label_en-US" xlink:label="lab_pets_PerformanceRestrictedStockPriceHurdle3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Price Hurdle 3 [Member]</link:label>
    <link:label id="lab_pets_PerformanceRestrictedStockPriceHurdle3Member_documentation_en-US" xlink:label="lab_pets_PerformanceRestrictedStockPriceHurdle3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents Performance Restricted Stock Price Hurdle 3.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockPriceHurdle3Member" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockPriceHurdle3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_PerformanceRestrictedStockPriceHurdle3Member" xlink:to="lab_pets_PerformanceRestrictedStockPriceHurdle3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9488addc-6e91-4625-8663-4a0bee6de656_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_99a84dfa-0c09-4a16-b0ff-80268339182d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9d5c493c-45af-4155-bc3e-1231d4f03ca3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_46a708a5-7bf7-461e-acf8-9e2d74d3f5cb_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8098d511-d1dd-47c3-a10a-0c5e5d46a1ca_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_164883d1-c632-4fba-aafd-ba95cd0e8a15_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6706c5e0-e8f1-4c2d-97e5-e3d4191a4d2e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_77e35005-539e-4812-9974-e777370cfbd8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_8af82216-58fd-4049-b99d-76767b789c9f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_4e094cfe-af9b-40f3-8a59-263b8760152a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_ff420e79-d22e-43ff-b624-1c2d21eeabe5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember_a1741b88-c719-400b-a539-c59a406b9731_terseLabel_en-US" xlink:label="lab_pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Outside Director Equity Compensation Restricted Stock Plan [Member]</link:label>
    <link:label id="lab_pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember_label_en-US" xlink:label="lab_pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Outside Director Equity Compensation Restricted Stock Plan [Member]</link:label>
    <link:label id="lab_pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember_documentation_en-US" xlink:label="lab_pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to the 2015 Outside Director Equity Compensation Restricted Stock Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember" xlink:href="pets-20230331.xsd#pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember" xlink:to="lab_pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_015bf65e-03c6-4a6b-bed1-c4774328a362_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_ff370aa3-a955-4437-97cd-b4bf19676c72_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_0f5ce3bf-2aad-47c0-a696-0c8d4022ff11_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_cb465c90-fedb-4c2a-9c91-03c60e8d8656_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_a2af6e6f-1db0-4e0f-b180-1b9e18408689_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_f2f586f3-ff28-46f6-860f-0b85a6ab1d3c_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_5b17fd15-60dd-4a3d-9004-e9e1be91d0b5_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_781a392b-ebfd-426e-80ad-33ece88ab45e_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_52f86ca3-d7dd-4134-a9b9-ef55686d28d6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8769d5b6-68e3-4b29-a8aa-1f59f9438b8e_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in diluted computation (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a426c550-0e19-4c60-becd-278bb715dca7_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_2705a1d2-ed38-46b9-bda9-b8f350f6788f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable in accrued expenses</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ca3abf75-f0d9-4f9c-a7b5-732de740989b_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_PerformanceRestrictedStockPriceHurdle5Member_934bcfe9-5814-4ac4-9b65-b1af14965fc6_terseLabel_en-US" xlink:label="lab_pets_PerformanceRestrictedStockPriceHurdle5Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Price Hurdle 5</link:label>
    <link:label id="lab_pets_PerformanceRestrictedStockPriceHurdle5Member_label_en-US" xlink:label="lab_pets_PerformanceRestrictedStockPriceHurdle5Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Price Hurdle 5 [Member]</link:label>
    <link:label id="lab_pets_PerformanceRestrictedStockPriceHurdle5Member_documentation_en-US" xlink:label="lab_pets_PerformanceRestrictedStockPriceHurdle5Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents Performance Restricted Stock Price Hurdle 5.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockPriceHurdle5Member" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockPriceHurdle5Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_PerformanceRestrictedStockPriceHurdle5Member" xlink:to="lab_pets_PerformanceRestrictedStockPriceHurdle5Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_16ff46ab-5a56-4ed1-b351-73f2d1b61dca_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_f0380fa6-6305-44a8-b3d5-bedb39a8fbc7_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minority interest purchased, amount</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_070c8ac0-1306-4f2a-891a-285912c91d30_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $.001 par value, 40,000 shares authorized; 21,084 and 20,979 shares issued and outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_AccruedCreditCardFeesCurrent_c501e940-2ba7-407c-a399-7520f3fe042b_terseLabel_en-US" xlink:label="lab_pets_AccruedCreditCardFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued credit card fees</link:label>
    <link:label id="lab_pets_AccruedCreditCardFeesCurrent_label_en-US" xlink:label="lab_pets_AccruedCreditCardFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued credit card fees</link:label>
    <link:label id="lab_pets_AccruedCreditCardFeesCurrent_documentation_en-US" xlink:label="lab_pets_AccruedCreditCardFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred and payable for credit card fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedCreditCardFeesCurrent" xlink:href="pets-20230331.xsd#pets_AccruedCreditCardFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_AccruedCreditCardFeesCurrent" xlink:to="lab_pets_AccruedCreditCardFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_2acff904-9d72-411a-b91f-15c78f034063_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_5edf3cdf-6d2c-4d70-9d23-30487c4fde2e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1828cd53-ef38-430f-8cce-723ff73e6883_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_4a6043f0-47fd-472b-a478-22142d6e5ddd_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock, released in period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_NoncontrollingInterestOwnershipPercentagePurchased_38cfcdd1-35b9-4752-abae-902574d23fc4_terseLabel_en-US" xlink:label="lab_pets_NoncontrollingInterestOwnershipPercentagePurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minority interest purchased, percent</link:label>
    <link:label id="lab_pets_NoncontrollingInterestOwnershipPercentagePurchased_label_en-US" xlink:label="lab_pets_NoncontrollingInterestOwnershipPercentagePurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Ownership Percentage Purchased</link:label>
    <link:label id="lab_pets_NoncontrollingInterestOwnershipPercentagePurchased_documentation_en-US" xlink:label="lab_pets_NoncontrollingInterestOwnershipPercentagePurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents minority interest purchased.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NoncontrollingInterestOwnershipPercentagePurchased" xlink:href="pets-20230331.xsd#pets_NoncontrollingInterestOwnershipPercentagePurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_NoncontrollingInterestOwnershipPercentagePurchased" xlink:to="lab_pets_NoncontrollingInterestOwnershipPercentagePurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_3f7fdbc4-20c1-424a-86fb-51a762a7d6ec_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_05f39fc9-d552-4876-b8cd-221aefb79261_terseLabel_en-US" xlink:label="lab_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent differences</link:label>
    <link:label id="lab_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_label_en-US" xlink:label="lab_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Permanent Differences, Percent</link:label>
    <link:label id="lab_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_documentation_en-US" xlink:label="lab_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Permanent Differences, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:href="pets-20230331.xsd#pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:to="lab_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c4a33286-4456-4a81-98f3-da51a1db8c08_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_225d117d-85f6-4d96-8335-ab724bc331f7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_da2e211a-3add-4e9f-8317-981f28615cd6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_738b95ca-1e76-4741-b112-2dd25ae666c4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of employees gross compensation eligible for match</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance_77031218-2bd9-4cce-9457-6ed012c73c32_terseLabel_en-US" xlink:label="lab_pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock available for issuance, automatic annual increase, percent</link:label>
    <link:label id="lab_pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance_label_en-US" xlink:label="lab_pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Automatic Increase In Shares Available For Issuance</link:label>
    <link:label id="lab_pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance_documentation_en-US" xlink:label="lab_pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents percentage of automatic increase in the amount of shares available for issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance" xlink:href="pets-20230331.xsd#pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance" xlink:to="lab_pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a6aa8040-36b7-478a-8882-a78f18c37752_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_72eb6960-1d10-4fd3-9a4b-a13a2be72f22_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_NonvestedRestrictedStockMember_48ba2d9e-9c6f-4fb5-adf6-d04dcd88ab36_terseLabel_en-US" xlink:label="lab_pets_NonvestedRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested Restricted Stock</link:label>
    <link:label id="lab_pets_NonvestedRestrictedStockMember_label_en-US" xlink:label="lab_pets_NonvestedRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested Restricted Stock [Member]</link:label>
    <link:label id="lab_pets_NonvestedRestrictedStockMember_documentation_en-US" xlink:label="lab_pets_NonvestedRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to non-vested restricted stock awards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NonvestedRestrictedStockMember" xlink:href="pets-20230331.xsd#pets_NonvestedRestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_NonvestedRestrictedStockMember" xlink:to="lab_pets_NonvestedRestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_75406e81-b7f7-416a-ac9e-91973846320a_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_1cba8f46-3cec-4349-8447-4496f6f11b1e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod_19ca64d5-595d-42eb-ac27-e59b07e1905c_terseLabel_en-US" xlink:label="lab_pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance pay health insurance benefits, change in control, period</link:label>
    <link:label id="lab_pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod_label_en-US" xlink:label="lab_pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Payment, Change In Control, Health Insurance Benefits, Period</link:label>
    <link:label id="lab_pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod_documentation_en-US" xlink:label="lab_pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Payment, Change In Control, Health Insurance Benefits, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod" xlink:href="pets-20230331.xsd#pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod" xlink:to="lab_pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_PercentageOfPropertyLeasedToTenants_07657f6e-be6e-4f77-bede-da30f3bb665f_terseLabel_en-US" xlink:label="lab_pets_PercentageOfPropertyLeasedToTenants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of property leased to tenants</link:label>
    <link:label id="lab_pets_PercentageOfPropertyLeasedToTenants_label_en-US" xlink:label="lab_pets_PercentageOfPropertyLeasedToTenants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Property Leased To Tenants</link:label>
    <link:label id="lab_pets_PercentageOfPropertyLeasedToTenants_documentation_en-US" xlink:label="lab_pets_PercentageOfPropertyLeasedToTenants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage amount of property that was leased to tenants of the property.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PercentageOfPropertyLeasedToTenants" xlink:href="pets-20230331.xsd#pets_PercentageOfPropertyLeasedToTenants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_PercentageOfPropertyLeasedToTenants" xlink:to="lab_pets_PercentageOfPropertyLeasedToTenants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_6889ef67-b3c2-48ec-ba94-3c89ef2eec5c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_b2875efc-d218-49f5-8f5a-9c0f6cc6d5bf_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_14ea320f-b2e7-419e-8397-cf31a587a5e3_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b84604ea-6db2-48be-8b37-3603323235ce_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal rate on income before taxes (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_TermOfAgreement_d6a0d800-a2d4-4037-ba9f-af1cf3ada2ae_terseLabel_en-US" xlink:label="lab_pets_TermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of agreement</link:label>
    <link:label id="lab_pets_TermOfAgreement_label_en-US" xlink:label="lab_pets_TermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Of Agreement</link:label>
    <link:label id="lab_pets_TermOfAgreement_documentation_en-US" xlink:label="lab_pets_TermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents term of agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TermOfAgreement" xlink:href="pets-20230331.xsd#pets_TermOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_TermOfAgreement" xlink:to="lab_pets_TermOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_bb81fee4-32fe-4113-9298-c369b5c8bdb0_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per share dividend (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_060f569e-416d-4a73-8677-f97b6aafdeb7_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per Share Dividend (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_label_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableAmountPerShare" xlink:to="lab_us-gaap_DividendsPayableAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_615b1d7e-90ff-4dcf-a6d3-ce7099530cb7_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_DelrayBeachPropertyMember_ed67b305-9932-4f0b-8ace-a3af0b581373_terseLabel_en-US" xlink:label="lab_pets_DelrayBeachPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delray Beach Property</link:label>
    <link:label id="lab_pets_DelrayBeachPropertyMember_label_en-US" xlink:label="lab_pets_DelrayBeachPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delray Beach Property [Member]</link:label>
    <link:label id="lab_pets_DelrayBeachPropertyMember_documentation_en-US" xlink:label="lab_pets_DelrayBeachPropertyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to the Delray Beach Property.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_DelrayBeachPropertyMember" xlink:href="pets-20230331.xsd#pets_DelrayBeachPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_DelrayBeachPropertyMember" xlink:to="lab_pets_DelrayBeachPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_4e0333e0-aa61-4784-9781-9d2155d5b33a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_2a244df8-cc86-4c4d-888c-c4c7910bd429_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_366516ff-daf4-4c5e-9281-3bb47558ab23_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_93969361-8bbc-465a-a7b5-c8639826594a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_NumberOfSeverancePayments_5991dd6f-4b46-413d-ae83-ac2971753c8d_terseLabel_en-US" xlink:label="lab_pets_NumberOfSeverancePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of severance payments</link:label>
    <link:label id="lab_pets_NumberOfSeverancePayments_label_en-US" xlink:label="lab_pets_NumberOfSeverancePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Severance Payments</link:label>
    <link:label id="lab_pets_NumberOfSeverancePayments_documentation_en-US" xlink:label="lab_pets_NumberOfSeverancePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Severance Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NumberOfSeverancePayments" xlink:href="pets-20230331.xsd#pets_NumberOfSeverancePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_NumberOfSeverancePayments" xlink:to="lab_pets_NumberOfSeverancePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_25b2d776-29a7-463b-bcc9-01f84febfd79_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_66d3e503-4491-4614-b217-b627246e20a1_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsDeclaredTableTextBlock_d4f36093-b63f-4b4a-96af-bc4a6cecc8c0_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Dividend Declaration</link:label>
    <link:label id="lab_us-gaap_DividendsDeclaredTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDeclaredTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDeclaredTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsDeclaredTableTextBlock" xlink:to="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_46e1bcf0-e463-4b0e-9c5d-2d5346993bfc_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_AccruedExpensesAndOtherCurrentLiabilitiesMember_82fdd8da-ee02-45fb-8913-9dea50c4571f_terseLabel_en-US" xlink:label="lab_pets_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_pets_AccruedExpensesAndOtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_pets_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses and Other Current Liabilities [Member]</link:label>
    <link:label id="lab_pets_AccruedExpensesAndOtherCurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_pets_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses and Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:href="pets-20230331.xsd#pets_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:to="lab_pets_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_aa362ad1-b231-4efb-b42d-5ad88548dad2_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_99dee1e2-dce4-46f7-8530-1ba28b0bac53_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock forfeited or expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_20aae281-c1ef-44d1-960c-b8e6529d19e6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_49a2e6dc-21f6-46b0-9e6d-5748448ca0eb_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_6e806229-4077-4016-bbd9-db03bac1542b_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued real estate taxes</link:label>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Taxes Other than Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_83a4590e-0232-4626-b46c-3d6c4e25de4b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_5ef53f33-7281-4159-ae60-1335ea8da40a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_e2517bb0-adaf-4ada-9eed-bc7ade865935_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets:</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_02a58ec8-fdd1-4d43-9e3b-19a81ddbcfdf_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_3b551b40-fc66-4ab1-a407-6d6cdf8679f9_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm_102a2955-fbf7-46b7-844e-9d6e761fd937_terseLabel_en-US" xlink:label="lab_pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employment term cancellation period</link:label>
    <link:label id="lab_pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm_label_en-US" xlink:label="lab_pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employment Term, Cancellation Period Prior To End Of Current Term</link:label>
    <link:label id="lab_pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm_documentation_en-US" xlink:label="lab_pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employment Term, Cancellation Period Prior To End Of Current Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm" xlink:href="pets-20230331.xsd#pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm" xlink:to="lab_pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_045ad0bb-ee3c-42f4-986a-42cffaf8ed18_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_94784a8a-036d-4831-a82c-03eacff22b02_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_dbeb4a55-abe5-4ded-8749-dce052d10f13_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7dcd3f65-afd1-4abd-a203-55f79fd3ec04_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_f15eee6b-bcad-4e0e-834e-cbf9f761aa23_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_10695942-0d72-4958-98da-28bef5bd6181_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_9f6b27e4-50bc-484c-903e-763796b4371c_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_9ec77a43-7409-4e7c-8a88-7c944f82103c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_c43e862d-5fb0-4330-ba62-19717e3e9c54_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_63b55c8e-7ac6-4a98-9695-dca5168411ed_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_bf21b08d-a0bf-4c63-9c36-ebeaefa3e156_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation costs related to restricted stock</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_23d9db0e-c8b0-4beb-8732-25038cc7d3a5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_1c7b242b-bcd7-4603-86a8-8dd7a4fe554b_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_b2a6ec8b-d06c-4171-befc-b73bdf41dd78_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_9026d82f-4db5-47b6-9b4e-e7e1e24b4e6a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_fd06b827-87e7-4700-8d24-762330d3cece_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_7c4b7313-c25e-4000-b3b9-385b373793d2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_EmployeeAndDirectorEquityCompensationPlanMember_18aa75b7-ccd2-44ab-b23a-6fe45c308ce8_terseLabel_en-US" xlink:label="lab_pets_EmployeeAndDirectorEquityCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee and Director Equity Compensation Plan</link:label>
    <link:label id="lab_pets_EmployeeAndDirectorEquityCompensationPlanMember_label_en-US" xlink:label="lab_pets_EmployeeAndDirectorEquityCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee and Director Equity Compensation Plan [Member]</link:label>
    <link:label id="lab_pets_EmployeeAndDirectorEquityCompensationPlanMember_documentation_en-US" xlink:label="lab_pets_EmployeeAndDirectorEquityCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to both the employee and director equity compensation plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmployeeAndDirectorEquityCompensationPlanMember" xlink:href="pets-20230331.xsd#pets_EmployeeAndDirectorEquityCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_EmployeeAndDirectorEquityCompensationPlanMember" xlink:to="lab_pets_EmployeeAndDirectorEquityCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_SixSuppliersMember_e876b889-448e-4b67-a6d7-5cc1afab84e8_terseLabel_en-US" xlink:label="lab_pets_SixSuppliersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Suppliers</link:label>
    <link:label id="lab_pets_SixSuppliersMember_label_en-US" xlink:label="lab_pets_SixSuppliersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Suppliers [Member]</link:label>
    <link:label id="lab_pets_SixSuppliersMember_documentation_en-US" xlink:label="lab_pets_SixSuppliersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Suppliers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SixSuppliersMember" xlink:href="pets-20230331.xsd#pets_SixSuppliersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_SixSuppliersMember" xlink:to="lab_pets_SixSuppliersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_SeverancePaymentBaseSalaryPeriod_c042013f-308c-4b56-8d94-be05469b763b_terseLabel_en-US" xlink:label="lab_pets_SeverancePaymentBaseSalaryPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance pay equal to based salary for number of periods</link:label>
    <link:label id="lab_pets_SeverancePaymentBaseSalaryPeriod_label_en-US" xlink:label="lab_pets_SeverancePaymentBaseSalaryPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Payment, Base Salary, Period</link:label>
    <link:label id="lab_pets_SeverancePaymentBaseSalaryPeriod_documentation_en-US" xlink:label="lab_pets_SeverancePaymentBaseSalaryPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Payment, Base Salary, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SeverancePaymentBaseSalaryPeriod" xlink:href="pets-20230331.xsd#pets_SeverancePaymentBaseSalaryPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_SeverancePaymentBaseSalaryPeriod" xlink:to="lab_pets_SeverancePaymentBaseSalaryPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_8f9801fa-54a6-493b-a047-f2d82db86900_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_b30ae6f2-1d4e-415d-b221-761a94f2e913_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_4c925618-8217-4095-bab2-4c2e361bcc64_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock shortfall (windfall) adjustment</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_FurnitureFixturesEquipmentAndComputerSoftwareMember_918083d8-ab1c-48a6-87a5-a5497a8c1882_terseLabel_en-US" xlink:label="lab_pets_FurnitureFixturesEquipmentAndComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, Fixtures, Equipment and Computer Software</link:label>
    <link:label id="lab_pets_FurnitureFixturesEquipmentAndComputerSoftwareMember_label_en-US" xlink:label="lab_pets_FurnitureFixturesEquipmentAndComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, Fixtures, Equipment and Computer Software [Member]</link:label>
    <link:label id="lab_pets_FurnitureFixturesEquipmentAndComputerSoftwareMember_documentation_en-US" xlink:label="lab_pets_FurnitureFixturesEquipmentAndComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refers to information regarding furniture, fixtures, equipment and computer software.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_FurnitureFixturesEquipmentAndComputerSoftwareMember" xlink:href="pets-20230331.xsd#pets_FurnitureFixturesEquipmentAndComputerSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_FurnitureFixturesEquipmentAndComputerSoftwareMember" xlink:to="lab_pets_FurnitureFixturesEquipmentAndComputerSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_cdeac1aa-d8a1-4fe3-90d3-66c9c7a7211e_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_d84744aa-aaa5-4383-99f9-b999efae93ff_terseLabel_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One time charge (benefit) for return to provision true up</link:label>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_label_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Adjustments, Settlements, and Unusual Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:to="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_5f62097d-0837-4337-a6cb-46d3cbbcff0f_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net deferred tax assets (liabilities)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8e427d83-3c79-45f0-a5be-679c76306cd7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_25b6c332-0ccb-4323-8a4a-732f1031f764_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares (denominator)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_eeb502bf-04b2-4404-80b3-9dbfed0f6d2e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt and inventory reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_AccruedExpensesAndOtherCurrentLiabilities_5f6c3943-6dd6-4a48-8cda-99b1e20b272b_terseLabel_en-US" xlink:label="lab_pets_AccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_pets_AccruedExpensesAndOtherCurrentLiabilities_4b0856b1-3c2e-4f98-a287-cf3f789caa17_totalLabel_en-US" xlink:label="lab_pets_AccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_pets_AccruedExpensesAndOtherCurrentLiabilities_label_en-US" xlink:label="lab_pets_AccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Current Liabilities</link:label>
    <link:label id="lab_pets_AccruedExpensesAndOtherCurrentLiabilities_documentation_en-US" xlink:label="lab_pets_AccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedExpensesAndOtherCurrentLiabilities" xlink:href="pets-20230331.xsd#pets_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="lab_pets_AccruedExpensesAndOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_31247e2d-7cca-43c8-9772-fe76560fdf6a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_ec76bd53-518d-4164-ac79-40a6376b8659_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_6dfea6c1-13b0-49cd-84d1-07796123a451_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_ReorderMember_8440001a-386c-4d4d-a036-55c4d8e7ef88_terseLabel_en-US" xlink:label="lab_pets_ReorderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reorder Customer</link:label>
    <link:label id="lab_pets_ReorderMember_label_en-US" xlink:label="lab_pets_ReorderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reorder Customer [Member]</link:label>
    <link:label id="lab_pets_ReorderMember_documentation_en-US" xlink:label="lab_pets_ReorderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disaggregate of revenue in reorder sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ReorderMember" xlink:href="pets-20230331.xsd#pets_ReorderMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_ReorderMember" xlink:to="lab_pets_ReorderMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_RevenueFromContractWithCustomerVariancePercentage_e17c7e23-7c64-4482-aecf-c3d988a655ba_terseLabel_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerVariancePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues, variance, percentage</link:label>
    <link:label id="lab_pets_RevenueFromContractWithCustomerVariancePercentage_label_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerVariancePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Variance Percentage</link:label>
    <link:label id="lab_pets_RevenueFromContractWithCustomerVariancePercentage_documentation_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerVariancePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of changes in revenue in current period comparing to the same period in the previous year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerVariancePercentage" xlink:href="pets-20230331.xsd#pets_RevenueFromContractWithCustomerVariancePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_RevenueFromContractWithCustomerVariancePercentage" xlink:to="lab_pets_RevenueFromContractWithCustomerVariancePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_59684149-b689-42c6-86f9-af2a4398a845_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_8c09d7df-4873-455e-b5c0-6e80ccf7dda0_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3add8765-dec7-4fc4-8a96-bc391238c9e7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6b14f05c-fca0-4496-bc48-89558eb0aa6e_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding used in basic computation (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_6d3c903d-9c6b-4f3a-b5ea-b2debd9c7b4d_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_AuditInformationAbstract_label_en-US" xlink:label="lab_pets_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_pets_AuditInformationAbstract_documentation_en-US" xlink:label="lab_pets_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AuditInformationAbstract" xlink:href="pets-20230331.xsd#pets_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_AuditInformationAbstract" xlink:to="lab_pets_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_ede9ccd7-449b-4e20-b839-b9342f8f3870_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_b095c2d0-9fdb-40db-9bd2-a7d9db4c5da5_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_ec4e6287-2d39-4723-a55e-e8e07739c645_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $.001 par value, 5,000 shares authorized; 3 convertible shares issued and outstanding with a liquidation preference of $4 per share</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_8abfc414-2702-4c04-81af-17b35ada63da_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_c9f16a05-860b-4f63-8fe2-23be10487a79_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_1dfeb85e-df1a-48b8-b682-ee1a1ae135c0_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5ee7cc0f-7068-48c5-8a45-50cc12bbc29d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_1530d883-7e60-468c-a593-7c9f430519f2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer match contribution percentage</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_83aa5b3a-a6c9-473b-b602-12139ce0ac00_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_ef7dbf73-e45d-49f5-aae1-8a7c6a3e96aa_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_ee3145da-6be8-4882-834b-c492609feeb5_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total noncurrent assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_a65ff03d-0210-4061-bc14-44b9ad7f77c8_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_c84977ea-b179-42d2-8878-2a6cc63a075a_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_aa5a4384-fdb0-4d1b-a9ef-492a4595455b_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issuable upon conversion of preferred shares (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_459737aa-b209-4140-a319-df00fe113379_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, operating lease, payment to be received, 2025</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_600fc3f5-73fd-4707-9489-551b28d423b3_terseLabel_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued sales tax</link:label>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Excise Tax Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_8dd1f22e-8337-458b-bc16-d91945240f2c_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_6ac3c9a3-49b7-488d-b28d-70e3431a302b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_15db3799-e203-4cd1-b696-e8c3a20669ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_c44ec811-e31c-4a43-ac01-6755165c95e8_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_76d5cb60-b368-4224-b042-4737dc02832c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_ecd4cfa5-70e4-40d8-9a44-caeb723e29eb_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_f0646a9b-30a4-4471-802a-58a4f9fe5106_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_62d8a32d-f54f-4f91-89a3-840d4336d103_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issuable upon the vesting of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_4a2ca561-2252-4dd6-9b9e-5ab2615ff1fa_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_e9ca60b0-3c9c-4b65-90d4-e0e457d7b022_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_079f1aa9-2293-4ab3-b95c-f948333e1142_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible and other assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_67b1f022-4d3b-4b7a-af4c-0873a814fbc7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted shares, vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_05bbf51b-3337-4615-b1b1-f0f7cc84afd8_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_738d09ee-e0b9-4d25-addf-0b009097c968_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_231a5304-b9bd-4bd4-8eff-af982fea0979_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_a4d8faef-ca18-479c-bec4-8b17149d21ed_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_a16a984c-d479-409d-895a-97930c7ee4e3_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_33bc22be-44ea-40c4-b953-cbea53ba37e1_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities for uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_NewOrderMember_e7688bd1-5bfc-4fa7-949f-e0cb53d143e6_terseLabel_en-US" xlink:label="lab_pets_NewOrderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Order Customer</link:label>
    <link:label id="lab_pets_NewOrderMember_label_en-US" xlink:label="lab_pets_NewOrderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Order Customer [Member]</link:label>
    <link:label id="lab_pets_NewOrderMember_documentation_en-US" xlink:label="lab_pets_NewOrderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disaggregate of revenue in new order sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NewOrderMember" xlink:href="pets-20230331.xsd#pets_NewOrderMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_NewOrderMember" xlink:to="lab_pets_NewOrderMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_800d864a-38d3-42f3-8d3f-108ecba5607c_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_0a7cb72f-2417-43fa-805c-f5e3fcec239b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_e60a05f0-99ee-4e39-834d-1f4ed6c2aeaf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_b7f33bc8-98a4-42b8-9532-692c70ee036d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_RevenueFromContractWithCustomerPercentage_a123d156-9932-4504-a8f6-6ccd384ef41b_terseLabel_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues, percentage</link:label>
    <link:label id="lab_pets_RevenueFromContractWithCustomerPercentage_label_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Percentage</link:label>
    <link:label id="lab_pets_RevenueFromContractWithCustomerPercentage_documentation_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenue from the specified category to the total revenue during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerPercentage" xlink:href="pets-20230331.xsd#pets_RevenueFromContractWithCustomerPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_RevenueFromContractWithCustomerPercentage" xlink:to="lab_pets_RevenueFromContractWithCustomerPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod_55c06d99-2389-4201-9701-de9402d460e3_terseLabel_en-US" xlink:label="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of absolute stock price hurdle period, consecutive days</link:label>
    <link:label id="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod_label_en-US" xlink:label="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Absolute Stock Price Hurdle Period</link:label>
    <link:label id="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod_documentation_en-US" xlink:label="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Absolute Stock Price Hurdle Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod" xlink:href="pets-20230331.xsd#pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod" xlink:to="lab_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_8716b04c-230c-47c8-9c87-97b338e0086a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction amount</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_804527e0-ba61-422a-8d0a-bb9b9eaac1d1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory reserve</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_22d540a4-ab1a-491b-bb6e-3f7bff342cfa_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_d4139a0d-b98d-4586-a671-b782bbaae7cb_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5b164eba-4ff0-4b08-b130-7b1d9c279df5_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b3f9b808-1ab0-4a48-ad8e-07cf32586c81_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_PerformanceRestrictedStockMember_7705f535-dc5d-4709-86ed-b6ad144d2f43_terseLabel_en-US" xlink:label="lab_pets_PerformanceRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock</link:label>
    <link:label id="lab_pets_PerformanceRestrictedStockMember_label_en-US" xlink:label="lab_pets_PerformanceRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock [Member]</link:label>
    <link:label id="lab_pets_PerformanceRestrictedStockMember_documentation_en-US" xlink:label="lab_pets_PerformanceRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents performance restricted stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockMember" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_PerformanceRestrictedStockMember" xlink:to="lab_pets_PerformanceRestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_RevenueFromContractWithCustomerVariance_5ea3dc85-3c5d-4811-86b4-76014cebf557_terseLabel_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerVariance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues, variance</link:label>
    <link:label id="lab_pets_RevenueFromContractWithCustomerVariance_label_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerVariance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Variance</link:label>
    <link:label id="lab_pets_RevenueFromContractWithCustomerVariance_documentation_en-US" xlink:label="lab_pets_RevenueFromContractWithCustomerVariance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of changes in revenue in current period comparing to the same period in the previous year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerVariance" xlink:href="pets-20230331.xsd#pets_RevenueFromContractWithCustomerVariance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_RevenueFromContractWithCustomerVariance" xlink:to="lab_pets_RevenueFromContractWithCustomerVariance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_aeff10de-d645-48c3-8b5e-04512e047972_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_8032fe89-7283-42c6-a3ed-6f0bc27883f1_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_1509ab91-c9f9-4b64-a6e9-582702a8b784_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_005a361a-db46-494f-897f-f4a233081932_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9999d4b1-5351-454a-b4c3-a25446023852_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_31ce34ab-4a24-4c24-8967-068afa5c403f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember_426410f8-2b42-4765-bf34-f62b695f1d03_terseLabel_en-US" xlink:label="lab_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Outside Director Equity Compensation Restricted Stock Plan ("2015 Director Plan")</link:label>
    <link:label id="lab_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember_label_en-US" xlink:label="lab_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Outside Director Equity Compensation Restricted Stock Plan ("2015 Director Plan") [Member]</link:label>
    <link:label id="lab_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember_documentation_en-US" xlink:label="lab_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refers to information regarding 2015 Outside Director Equity Compensation Restricted Stock Plan ("2015 Director Plan").</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" xlink:href="pets-20230331.xsd#pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" xlink:to="lab_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_02222240-f709-4601-a350-3be4d5ae71ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_49e7ae7d-2abe-491b-9cae-8653b8cc36a5_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_2dfd53d0-b9f7-4ecf-982f-81338670f566_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_SalaryAndWageOfficerSignOnBonus_30b62c0e-cc9c-4665-a367-87b132f106d9_terseLabel_en-US" xlink:label="lab_pets_SalaryAndWageOfficerSignOnBonus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sign on bonus</link:label>
    <link:label id="lab_pets_SalaryAndWageOfficerSignOnBonus_label_en-US" xlink:label="lab_pets_SalaryAndWageOfficerSignOnBonus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salary And Wage, Officer, Sign On Bonus</link:label>
    <link:label id="lab_pets_SalaryAndWageOfficerSignOnBonus_documentation_en-US" xlink:label="lab_pets_SalaryAndWageOfficerSignOnBonus" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salary And Wage, Officer, Sign On Bonus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SalaryAndWageOfficerSignOnBonus" xlink:href="pets-20230331.xsd#pets_SalaryAndWageOfficerSignOnBonus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_SalaryAndWageOfficerSignOnBonus" xlink:to="lab_pets_SalaryAndWageOfficerSignOnBonus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_84be31b9-9414-4e88-a103-cac67e295a92_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a447e68-e192-4482-bfa5-22db2869fc2f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_41d8ccb6-63c7-4e1e-b963-6e4f48772dd6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_a0bb7304-b587-470b-8fc3-2da4804af9ac_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Concentrations</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_78b62973-30ad-4d35-b18f-3297596649f9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_bfb371aa-500c-4947-877f-bc61fca11567_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_4ce8629f-89f9-46e9-a61b-d2f9da13d771_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_4bdad137-7b0d-4db1-aaed-ff941b7eb4a8_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional expenses</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_014e0871-7e6a-4167-a9cd-2131993f44d9_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_d6e2f6c5-6c01-42b8-a4ce-82989b9ff565_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_18097942-6431-41cb-8a78-0105d5367800_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_b57af5fb-1139-4fbe-98c9-07dedae2235a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c4af41d2-894d-44ee-9da9-2fe815a1a920_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes at U.S. statutory rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_5e143e56-3675-49fa-8e04-854194521cc8_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_ce150b85-1829-48e1-a8e9-d6b53a1a55f9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, matching contribution</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrent_d96c1a54-c36d-44dd-976f-701e99ddc8f6_terseLabel_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party expenses</link:label>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrent" xlink:to="lab_us-gaap_DueToRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c4a4babb-1a6b-4f85-988b-b02cf2568a26_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_34a782ba-e1f0-49b1-af04-8d5b05be4a74_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_832c852c-337d-4792-b266-ace539eb3fb0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fee9bc59-b4af-4342-9fd9-7b38c22a6966_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_73cf19a7-6724-4912-aae6-064d0c7516b5_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_14878e3b-2db7-4bc4-8f3b-38f5448aac30_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_8663c297-8c7b-47c5-9587-d5cb6a0a1069_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of minority interest investment in Vetster</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Subsidiaries and Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_4576f075-0cef-4131-a28e-d2454bd6caef_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_639926d8-885e-4eaf-be38-7707e71940e5_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_LumpSumSeverancePayments_f3b2cb33-5908-4f60-8a00-3d39453ee810_terseLabel_en-US" xlink:label="lab_pets_LumpSumSeverancePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lump-sum severance payments</link:label>
    <link:label id="lab_pets_LumpSumSeverancePayments_label_en-US" xlink:label="lab_pets_LumpSumSeverancePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lump Sum Severance Payments</link:label>
    <link:label id="lab_pets_LumpSumSeverancePayments_documentation_en-US" xlink:label="lab_pets_LumpSumSeverancePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents lump-sum severance payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_LumpSumSeverancePayments" xlink:href="pets-20230331.xsd#pets_LumpSumSeverancePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_LumpSumSeverancePayments" xlink:to="lab_pets_LumpSumSeverancePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_99415667-c62e-45c7-8e95-12897f7088d7_terseLabel_en-US" xlink:label="lab_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2016 Employee Equity Compensation Restricted Stock Plan</link:label>
    <link:label id="lab_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_label_en-US" xlink:label="lab_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2016 Employee Equity Compensation Restricted Stock Plan [Member]</link:label>
    <link:label id="lab_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_documentation_en-US" xlink:label="lab_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">represents the 2016 Employee Equity Compensation Restricted Stock Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember" xlink:href="pets-20230331.xsd#pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember" xlink:to="lab_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>pets-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:5cf93b28-3379-44eb-90e7-0c74c316f7e6,g:9a7e90f8-ce57-4497-9c85-b6b094af0e8b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.1800petmeds.com/role/Cover" xlink:type="simple" xlink:href="pets-20230331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d978e7bb-3b03-489f-a374-275f0fc7a26d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_DocumentType_d978e7bb-3b03-489f-a374-275f0fc7a26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_6dd5274b-700e-4ccb-83da-29c04bd8a0fd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_DocumentAnnualReport_6dd5274b-700e-4ccb-83da-29c04bd8a0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_05f5213c-7cd3-4d2d-980e-e96b1740a131" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_CurrentFiscalYearEndDate_05f5213c-7cd3-4d2d-980e-e96b1740a131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_76ecd4ee-f73a-40ce-9b2b-2c7ecd49fdb6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_DocumentPeriodEndDate_76ecd4ee-f73a-40ce-9b2b-2c7ecd49fdb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_f1e43181-8eae-48d4-acf2-91b4f214b97e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_DocumentTransitionReport_f1e43181-8eae-48d4-acf2-91b4f214b97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b95789bf-4e36-420c-948c-00d7880f2127" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityFileNumber_b95789bf-4e36-420c-948c-00d7880f2127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d8c2bfae-254a-4141-ac97-467e2fc0b459" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityRegistrantName_d8c2bfae-254a-4141-ac97-467e2fc0b459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_18308c71-383d-4980-8673-7c3adef47066" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_18308c71-383d-4980-8673-7c3adef47066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_d6c95367-b535-4d72-9858-24ba39429f79" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityTaxIdentificationNumber_d6c95367-b535-4d72-9858-24ba39429f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_817b79bb-5e23-450d-8ef1-b4d7d528e271" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityAddressAddressLine1_817b79bb-5e23-450d-8ef1-b4d7d528e271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a708e00d-acf6-419d-b323-9607bcbea81c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityAddressCityOrTown_a708e00d-acf6-419d-b323-9607bcbea81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c9ed2721-a813-4f70-8bc0-f4bfa01fbfbb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityAddressStateOrProvince_c9ed2721-a813-4f70-8bc0-f4bfa01fbfbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_637b4eb3-1653-4de7-ad7a-043c0d3f56f7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityAddressPostalZipCode_637b4eb3-1653-4de7-ad7a-043c0d3f56f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4806bfb1-db0d-467e-9dee-b757d37ffcc1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_CityAreaCode_4806bfb1-db0d-467e-9dee-b757d37ffcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_dbdf4f5a-d7e0-4154-9058-ca8e957eb7bc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_LocalPhoneNumber_dbdf4f5a-d7e0-4154-9058-ca8e957eb7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4b1aa569-061d-4c8a-890e-8c8e928066d7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_Security12bTitle_4b1aa569-061d-4c8a-890e-8c8e928066d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_6abff03c-f9c8-47fe-8e07-08565491144d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_TradingSymbol_6abff03c-f9c8-47fe-8e07-08565491144d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a2652a0f-ccaa-4e1f-9019-fe9f30a19f7a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_SecurityExchangeName_a2652a0f-ccaa-4e1f-9019-fe9f30a19f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_8255d40f-fcb8-4e97-a0d7-5d6d68ffc4dd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_8255d40f-fcb8-4e97-a0d7-5d6d68ffc4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_743fd6eb-a28e-4d0f-82b9-2d58c17257bd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityVoluntaryFilers_743fd6eb-a28e-4d0f-82b9-2d58c17257bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_49343b85-1fef-4850-9b61-860ee5aa4947" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityCurrentReportingStatus_49343b85-1fef-4850-9b61-860ee5aa4947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_1e4dc994-9269-4139-a054-da40e29c3ef0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityInteractiveDataCurrent_1e4dc994-9269-4139-a054-da40e29c3ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a06c9175-781a-4072-83dc-4cfa6b396628" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityFilerCategory_a06c9175-781a-4072-83dc-4cfa6b396628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a5fe2f93-6072-4ecc-9d50-64133d941a48" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntitySmallBusiness_a5fe2f93-6072-4ecc-9d50-64133d941a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_fb129c2f-7f41-4ff5-8dd4-2f33cf61ad59" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityEmergingGrowthCompany_fb129c2f-7f41-4ff5-8dd4-2f33cf61ad59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_5c76473e-3b06-4616-988d-c9df241636dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_IcfrAuditorAttestationFlag_5c76473e-3b06-4616-988d-c9df241636dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_110bd4c7-6ad7-403a-b0a3-a7f6eba6529f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityShellCompany_110bd4c7-6ad7-403a-b0a3-a7f6eba6529f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_c77e8ed6-79cd-4e1b-a51e-b366b6d49889" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityPublicFloat_c77e8ed6-79cd-4e1b-a51e-b366b6d49889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_463bb43d-8f98-42bd-a423-90bbbcb6d7f4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_463bb43d-8f98-42bd-a423-90bbbcb6d7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_eb837d69-e000-44a2-b488-792b595bcd7e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_eb837d69-e000-44a2-b488-792b595bcd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5c47a934-acbd-4139-b0b7-44f309722c04" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_EntityCentralIndexKey_5c47a934-acbd-4139-b0b7-44f309722c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_974a1d16-7cd7-47f0-b5f2-0d972f4251c0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_AmendmentFlag_974a1d16-7cd7-47f0-b5f2-0d972f4251c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f081c465-191f-4902-914e-dd025bb4e268" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_DocumentFiscalYearFocus_f081c465-191f-4902-914e-dd025bb4e268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_219e8995-be2b-4891-8b3b-527a54afc899" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2389cea-6383-4c58-8c46-dd68555bd02c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_219e8995-be2b-4891-8b3b-527a54afc899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/AuditInformation" xlink:type="simple" xlink:href="pets-20230331.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pets_AuditInformationAbstract_b5f0841e-0cbe-4824-a2c4-66423f2fd818" xlink:href="pets-20230331.xsd#pets_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_7b804a1f-58a0-48b0-9f5b-4937a86019d0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pets_AuditInformationAbstract_b5f0841e-0cbe-4824-a2c4-66423f2fd818" xlink:to="loc_dei_AuditorFirmId_7b804a1f-58a0-48b0-9f5b-4937a86019d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_2c910f3c-f1a9-4198-ad1e-1262e0cf1378" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pets_AuditInformationAbstract_b5f0841e-0cbe-4824-a2c4-66423f2fd818" xlink:to="loc_dei_AuditorName_2c910f3c-f1a9-4198-ad1e-1262e0cf1378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_ac14bae9-2436-48f9-8c24-c8025999c084" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pets_AuditInformationAbstract_b5f0841e-0cbe-4824-a2c4-66423f2fd818" xlink:to="loc_dei_AuditorLocation_ac14bae9-2436-48f9-8c24-c8025999c084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="pets-20230331.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6b2d6915-1b4f-4e85-9d90-df15b373d3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_6f7999b4-cf08-4a09-a2bd-61932bc93a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6b2d6915-1b4f-4e85-9d90-df15b373d3b5" xlink:to="loc_us-gaap_AssetsAbstract_6f7999b4-cf08-4a09-a2bd-61932bc93a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_2bc43060-d82b-4b84-9772-cb7574e4ef20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6f7999b4-cf08-4a09-a2bd-61932bc93a8f" xlink:to="loc_us-gaap_AssetsCurrentAbstract_2bc43060-d82b-4b84-9772-cb7574e4ef20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e609b8eb-62f7-4bf7-a754-180b560adb7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2bc43060-d82b-4b84-9772-cb7574e4ef20" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e609b8eb-62f7-4bf7-a754-180b560adb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_66ac6592-309e-46c1-a115-5299cff4df6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2bc43060-d82b-4b84-9772-cb7574e4ef20" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_66ac6592-309e-46c1-a115-5299cff4df6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_192a8213-34f1-4f2b-af7e-e97b22b93d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2bc43060-d82b-4b84-9772-cb7574e4ef20" xlink:to="loc_us-gaap_InventoryFinishedGoods_192a8213-34f1-4f2b-af7e-e97b22b93d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_09535db6-cc13-4b71-bdd3-9ab54e975912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2bc43060-d82b-4b84-9772-cb7574e4ef20" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_09535db6-cc13-4b71-bdd3-9ab54e975912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_0e81ce03-b344-4202-9c85-968c94d0889e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2bc43060-d82b-4b84-9772-cb7574e4ef20" xlink:to="loc_us-gaap_PrepaidTaxes_0e81ce03-b344-4202-9c85-968c94d0889e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_51728db4-9f7c-45ce-9422-263a5d37215d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2bc43060-d82b-4b84-9772-cb7574e4ef20" xlink:to="loc_us-gaap_AssetsCurrent_51728db4-9f7c-45ce-9422-263a5d37215d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_681400af-fb7a-4dd5-b022-7944dd44922a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6f7999b4-cf08-4a09-a2bd-61932bc93a8f" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_681400af-fb7a-4dd5-b022-7944dd44922a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6648d1a6-9be1-439c-8275-bfaec5ca2122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_681400af-fb7a-4dd5-b022-7944dd44922a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6648d1a6-9be1-439c-8275-bfaec5ca2122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_91a1c52c-f8a5-414d-9d3b-11ef79cabf25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_681400af-fb7a-4dd5-b022-7944dd44922a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_91a1c52c-f8a5-414d-9d3b-11ef79cabf25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_222528ed-9c8c-443f-b258-b40757413bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_681400af-fb7a-4dd5-b022-7944dd44922a" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_222528ed-9c8c-443f-b258-b40757413bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_25914355-77b9-44bf-acea-16cdc5377d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_681400af-fb7a-4dd5-b022-7944dd44922a" xlink:to="loc_us-gaap_AssetsNoncurrent_25914355-77b9-44bf-acea-16cdc5377d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_79644d85-42e2-4ce1-9b1a-8ebf92736c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_681400af-fb7a-4dd5-b022-7944dd44922a" xlink:to="loc_us-gaap_Assets_79644d85-42e2-4ce1-9b1a-8ebf92736c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_478b889f-609c-4e6e-ba19-7d800dc8b2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6b2d6915-1b4f-4e85-9d90-df15b373d3b5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_478b889f-609c-4e6e-ba19-7d800dc8b2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_4ec94802-4917-44e1-bf69-5ba01df07f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_478b889f-609c-4e6e-ba19-7d800dc8b2c0" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_4ec94802-4917-44e1-bf69-5ba01df07f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2a2705c0-c63a-4e18-a04c-533daf760f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4ec94802-4917-44e1-bf69-5ba01df07f7b" xlink:to="loc_us-gaap_AccountsPayableCurrent_2a2705c0-c63a-4e18-a04c-533daf760f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_de3162c9-1eb8-4472-bf73-e63dd3eef4c1" xlink:href="pets-20230331.xsd#pets_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4ec94802-4917-44e1-bf69-5ba01df07f7b" xlink:to="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_de3162c9-1eb8-4472-bf73-e63dd3eef4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bdf6889c-5493-4649-a64f-fe472da50602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4ec94802-4917-44e1-bf69-5ba01df07f7b" xlink:to="loc_us-gaap_LiabilitiesCurrent_bdf6889c-5493-4649-a64f-fe472da50602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d1537347-48dc-4816-bf06-c9f58bd6aba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4ec94802-4917-44e1-bf69-5ba01df07f7b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d1537347-48dc-4816-bf06-c9f58bd6aba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_27e8526d-e475-494d-9ddc-cbced3b8020a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4ec94802-4917-44e1-bf69-5ba01df07f7b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_27e8526d-e475-494d-9ddc-cbced3b8020a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_fb6e29e1-505f-4663-bb4c-76e2d9fcc82e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4ec94802-4917-44e1-bf69-5ba01df07f7b" xlink:to="loc_us-gaap_Liabilities_fb6e29e1-505f-4663-bb4c-76e2d9fcc82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d56d7adc-1540-4c78-b847-3bf8564c01e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4ec94802-4917-44e1-bf69-5ba01df07f7b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d56d7adc-1540-4c78-b847-3bf8564c01e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_9f7b5025-b57d-41e8-bb65-34feec1098f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_478b889f-609c-4e6e-ba19-7d800dc8b2c0" xlink:to="loc_us-gaap_StockholdersEquityAbstract_9f7b5025-b57d-41e8-bb65-34feec1098f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_8e9ad119-75a4-4a8e-944c-aa813de75294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9f7b5025-b57d-41e8-bb65-34feec1098f8" xlink:to="loc_us-gaap_PreferredStockValue_8e9ad119-75a4-4a8e-944c-aa813de75294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ae8d24c1-fab2-458c-a6af-f266c06ee50e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9f7b5025-b57d-41e8-bb65-34feec1098f8" xlink:to="loc_us-gaap_CommonStockValue_ae8d24c1-fab2-458c-a6af-f266c06ee50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_d4a69787-1e91-497a-8a20-7dd992b095c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9f7b5025-b57d-41e8-bb65-34feec1098f8" xlink:to="loc_us-gaap_AdditionalPaidInCapital_d4a69787-1e91-497a-8a20-7dd992b095c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fd9e5d63-9635-49e8-a9d7-aae6a0ceed35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9f7b5025-b57d-41e8-bb65-34feec1098f8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fd9e5d63-9635-49e8-a9d7-aae6a0ceed35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ae28f872-6bd1-4b26-b8a9-2ca8cf14fbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9f7b5025-b57d-41e8-bb65-34feec1098f8" xlink:to="loc_us-gaap_StockholdersEquity_ae28f872-6bd1-4b26-b8a9-2ca8cf14fbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_aecca39a-21c4-4f2e-b223-8c39fa29f93f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9f7b5025-b57d-41e8-bb65-34feec1098f8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_aecca39a-21c4-4f2e-b223-8c39fa29f93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="pets-20230331.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_56a4e42d-67d8-48ba-a3fa-5b4f5b1ee948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a682f7c8-1ca7-444e-a434-6c389c03982e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_56a4e42d-67d8-48ba-a3fa-5b4f5b1ee948" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a682f7c8-1ca7-444e-a434-6c389c03982e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1bc631f2-6851-4bcd-ac96-c10f8934902b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_56a4e42d-67d8-48ba-a3fa-5b4f5b1ee948" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1bc631f2-6851-4bcd-ac96-c10f8934902b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_ee678988-4209-4c08-8c66-5a5aecd8190f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_56a4e42d-67d8-48ba-a3fa-5b4f5b1ee948" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_ee678988-4209-4c08-8c66-5a5aecd8190f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_734fe8cf-95c4-4579-b6c3-b90fe898246a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_56a4e42d-67d8-48ba-a3fa-5b4f5b1ee948" xlink:to="loc_us-gaap_PreferredStockSharesIssued_734fe8cf-95c4-4579-b6c3-b90fe898246a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_24082537-5949-45d4-a7eb-b6d08fca4477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_56a4e42d-67d8-48ba-a3fa-5b4f5b1ee948" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_24082537-5949-45d4-a7eb-b6d08fca4477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_068362fa-ea05-46ff-8d64-e6674d7f3ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_56a4e42d-67d8-48ba-a3fa-5b4f5b1ee948" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_068362fa-ea05-46ff-8d64-e6674d7f3ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ca1e6a93-0a9c-42ae-8822-93a04bcfe2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_56a4e42d-67d8-48ba-a3fa-5b4f5b1ee948" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ca1e6a93-0a9c-42ae-8822-93a04bcfe2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5058ed94-8b12-4758-ab28-1bc77329ca60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_56a4e42d-67d8-48ba-a3fa-5b4f5b1ee948" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5058ed94-8b12-4758-ab28-1bc77329ca60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_250c70bc-a533-4257-8fcb-786e890fbc74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_56a4e42d-67d8-48ba-a3fa-5b4f5b1ee948" xlink:to="loc_us-gaap_CommonStockSharesIssued_250c70bc-a533-4257-8fcb-786e890fbc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3ae5b471-9229-486a-a5af-7a86220dfa8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_56a4e42d-67d8-48ba-a3fa-5b4f5b1ee948" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3ae5b471-9229-486a-a5af-7a86220dfa8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="pets-20230331.xsd#ConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_066b2380-2529-4123-b8bc-68a9acdccdc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_e6f4abb7-da70-4bf0-bce4-0cea10c3ca33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_066b2380-2529-4123-b8bc-68a9acdccdc4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_e6f4abb7-da70-4bf0-bce4-0cea10c3ca33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_5cdac730-3a13-4958-a49d-802160aabfb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_066b2380-2529-4123-b8bc-68a9acdccdc4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_5cdac730-3a13-4958-a49d-802160aabfb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ce7c9302-0b53-4a7e-9ff7-a3bcda3af237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_066b2380-2529-4123-b8bc-68a9acdccdc4" xlink:to="loc_us-gaap_GrossProfit_ce7c9302-0b53-4a7e-9ff7-a3bcda3af237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_e4da48cc-7114-4e07-a44b-e964d7af44a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_066b2380-2529-4123-b8bc-68a9acdccdc4" xlink:to="loc_us-gaap_OperatingExpensesAbstract_e4da48cc-7114-4e07-a44b-e964d7af44a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_b0f994c9-c524-4b9d-8f04-809b8c6e9722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e4da48cc-7114-4e07-a44b-e964d7af44a9" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_b0f994c9-c524-4b9d-8f04-809b8c6e9722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_545f7394-0068-4b8f-8529-51fb6bbb4ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e4da48cc-7114-4e07-a44b-e964d7af44a9" xlink:to="loc_us-gaap_AdvertisingExpense_545f7394-0068-4b8f-8529-51fb6bbb4ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_68112c4b-570c-408c-b835-480d3e24e58c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e4da48cc-7114-4e07-a44b-e964d7af44a9" xlink:to="loc_us-gaap_Depreciation_68112c4b-570c-408c-b835-480d3e24e58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_996a65c8-b15c-429b-bcd2-75257c5063e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e4da48cc-7114-4e07-a44b-e964d7af44a9" xlink:to="loc_us-gaap_OperatingExpenses_996a65c8-b15c-429b-bcd2-75257c5063e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3b27f8b6-1bd8-4723-82db-072ee76aa7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_066b2380-2529-4123-b8bc-68a9acdccdc4" xlink:to="loc_us-gaap_OperatingIncomeLoss_3b27f8b6-1bd8-4723-82db-072ee76aa7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_57de5fbd-f493-4517-a0ad-3d83bfff3e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_066b2380-2529-4123-b8bc-68a9acdccdc4" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_57de5fbd-f493-4517-a0ad-3d83bfff3e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_908abb9a-a9ed-4b51-826d-0cb1579bf06a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_57de5fbd-f493-4517-a0ad-3d83bfff3e36" xlink:to="loc_us-gaap_InvestmentIncomeInterest_908abb9a-a9ed-4b51-826d-0cb1579bf06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_53378d22-ff9a-4512-836a-8da2cc80739f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_57de5fbd-f493-4517-a0ad-3d83bfff3e36" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_53378d22-ff9a-4512-836a-8da2cc80739f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_8e638770-87a6-484b-92d3-97c600990888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_57de5fbd-f493-4517-a0ad-3d83bfff3e36" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_8e638770-87a6-484b-92d3-97c600990888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e8f42703-e320-4f75-bf7d-d930c76771f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_066b2380-2529-4123-b8bc-68a9acdccdc4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e8f42703-e320-4f75-bf7d-d930c76771f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8434363b-501d-4358-a2f5-4067e942a712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_066b2380-2529-4123-b8bc-68a9acdccdc4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8434363b-501d-4358-a2f5-4067e942a712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dc52cf3b-4193-4600-8ec5-7e4d631cb0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_066b2380-2529-4123-b8bc-68a9acdccdc4" xlink:to="loc_us-gaap_NetIncomeLoss_dc52cf3b-4193-4600-8ec5-7e4d631cb0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_436694d9-2faa-4af2-8066-591f28c143eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_066b2380-2529-4123-b8bc-68a9acdccdc4" xlink:to="loc_us-gaap_EarningsPerShareAbstract_436694d9-2faa-4af2-8066-591f28c143eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_076e8a1a-fb7d-4035-a78b-6a3c7300cfec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_436694d9-2faa-4af2-8066-591f28c143eb" xlink:to="loc_us-gaap_EarningsPerShareBasic_076e8a1a-fb7d-4035-a78b-6a3c7300cfec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b612427d-6bab-476d-8fdd-3bce78b7f376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_436694d9-2faa-4af2-8066-591f28c143eb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b612427d-6bab-476d-8fdd-3bce78b7f376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_819adeac-dc53-4827-b213-01bc0895f89c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_066b2380-2529-4123-b8bc-68a9acdccdc4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_819adeac-dc53-4827-b213-01bc0895f89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_712ad404-372c-46e7-948f-03ca9a9cf67b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_819adeac-dc53-4827-b213-01bc0895f89c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_712ad404-372c-46e7-948f-03ca9a9cf67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0878c332-fca3-4b16-bc5b-c3dcbc8a9ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_819adeac-dc53-4827-b213-01bc0895f89c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0878c332-fca3-4b16-bc5b-c3dcbc8a9ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_53736ece-9a97-4ffd-b5b5-ae5eedf697f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_066b2380-2529-4123-b8bc-68a9acdccdc4" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_53736ece-9a97-4ffd-b5b5-ae5eedf697f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" xlink:type="simple" xlink:href="pets-20230331.xsd#ConsolidatedStatementsofChangesinShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_1ff19848-0ff7-4267-9ae3-3be8c2c11dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dc6cb0b3-bf08-484d-96ff-ff66bdfe6145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_1ff19848-0ff7-4267-9ae3-3be8c2c11dec" xlink:to="loc_us-gaap_StatementTable_dc6cb0b3-bf08-484d-96ff-ff66bdfe6145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a399aacc-0204-4ab5-a106-b21b10e0d138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dc6cb0b3-bf08-484d-96ff-ff66bdfe6145" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a399aacc-0204-4ab5-a106-b21b10e0d138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ad9af337-05da-46e9-ba69-ef32cc53d13a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a399aacc-0204-4ab5-a106-b21b10e0d138" xlink:to="loc_us-gaap_EquityComponentDomain_ad9af337-05da-46e9-ba69-ef32cc53d13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_d33f865a-8dce-45f0-b67d-30bb35114c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ad9af337-05da-46e9-ba69-ef32cc53d13a" xlink:to="loc_us-gaap_PreferredStockMember_d33f865a-8dce-45f0-b67d-30bb35114c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bfe99d71-9d69-4eca-b842-5112d2ced972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ad9af337-05da-46e9-ba69-ef32cc53d13a" xlink:to="loc_us-gaap_CommonStockMember_bfe99d71-9d69-4eca-b842-5112d2ced972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_708b21e3-6359-46f5-b95b-6b58cb47b1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ad9af337-05da-46e9-ba69-ef32cc53d13a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_708b21e3-6359-46f5-b95b-6b58cb47b1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c99d258f-1fbe-4ef2-ba50-4cf654b33b28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ad9af337-05da-46e9-ba69-ef32cc53d13a" xlink:to="loc_us-gaap_RetainedEarningsMember_c99d258f-1fbe-4ef2-ba50-4cf654b33b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b4805a2a-58cd-4e2c-add4-878b918ed6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dc6cb0b3-bf08-484d-96ff-ff66bdfe6145" xlink:to="loc_us-gaap_StatementLineItems_b4805a2a-58cd-4e2c-add4-878b918ed6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b4805a2a-58cd-4e2c-add4-878b918ed6c4" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_503d63d5-e8a4-458e-b845-8acc525d2b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_SharesOutstanding_503d63d5-e8a4-458e-b845-8acc525d2b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bb8cf51b-1b77-435f-a136-937ab1fcd906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_StockholdersEquity_bb8cf51b-1b77-435f-a136-937ab1fcd906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6d32bc1e-7a38-428e-bfe4-052114b1ae06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6d32bc1e-7a38-428e-bfe4-052114b1ae06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_cf969546-92a4-45c9-99a6-e3ccff8f480e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_cf969546-92a4-45c9-99a6-e3ccff8f480e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_19d6c640-d68e-4b09-a04a-4c74b067492c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_19d6c640-d68e-4b09-a04a-4c74b067492c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_1e1b7309-ccc3-4c04-b715-f527f4f67d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_DividendsCommonStock_1e1b7309-ccc3-4c04-b715-f527f4f67d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_73d0a701-0a4d-4448-85d7-1ddf87fd64d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_NetIncomeLoss_73d0a701-0a4d-4448-85d7-1ddf87fd64d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_b5b299d3-21e5-4ea3-ad4e-c10de4186f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_SharesOutstanding_b5b299d3-21e5-4ea3-ad4e-c10de4186f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_76e7a43b-0404-4293-a028-34235d478b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91fdc802-fa94-453e-a361-d12c2312cb94" xlink:to="loc_us-gaap_StockholdersEquity_76e7a43b-0404-4293-a028-34235d478b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="pets-20230331.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_d213ae75-5dcd-46c8-b4e0-880f0653dbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1bb154bf-12be-4bb9-91fa-0b62f3503918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d213ae75-5dcd-46c8-b4e0-880f0653dbdb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1bb154bf-12be-4bb9-91fa-0b62f3503918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4a76f767-fb96-43f3-b2d2-d40933cf0a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1bb154bf-12be-4bb9-91fa-0b62f3503918" xlink:to="loc_us-gaap_NetIncomeLoss_4a76f767-fb96-43f3-b2d2-d40933cf0a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f3b1ac77-21f5-45f4-bf70-603f3a0c64ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1bb154bf-12be-4bb9-91fa-0b62f3503918" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f3b1ac77-21f5-45f4-bf70-603f3a0c64ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_7520f03b-4e18-4a21-8c65-db90ccc9e180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f3b1ac77-21f5-45f4-bf70-603f3a0c64ce" xlink:to="loc_us-gaap_Depreciation_7520f03b-4e18-4a21-8c65-db90ccc9e180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_fb515594-84f4-442a-906c-c9bd4507fa82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f3b1ac77-21f5-45f4-bf70-603f3a0c64ce" xlink:to="loc_us-gaap_ShareBasedCompensation_fb515594-84f4-442a-906c-c9bd4507fa82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c0f98056-19f0-4a84-8365-b9f7b3794ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f3b1ac77-21f5-45f4-bf70-603f3a0c64ce" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c0f98056-19f0-4a84-8365-b9f7b3794ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_da8d2fee-c9ba-470f-9bfc-9b53a95c3f56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f3b1ac77-21f5-45f4-bf70-603f3a0c64ce" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_da8d2fee-c9ba-470f-9bfc-9b53a95c3f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3c2a6e2-41ad-466f-8e90-950567229430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1bb154bf-12be-4bb9-91fa-0b62f3503918" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3c2a6e2-41ad-466f-8e90-950567229430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ad535839-85dc-4efc-b06c-e28f1b71d52a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3c2a6e2-41ad-466f-8e90-950567229430" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ad535839-85dc-4efc-b06c-e28f1b71d52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories_c2d05ec6-b5ff-4b84-a762-153f1b765591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3c2a6e2-41ad-466f-8e90-950567229430" xlink:to="loc_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories_c2d05ec6-b5ff-4b84-a762-153f1b765591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_393cb851-d2bd-47ff-b764-18e2c8782f74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3c2a6e2-41ad-466f-8e90-950567229430" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_393cb851-d2bd-47ff-b764-18e2c8782f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d99f3235-ee94-4769-b332-62699209eadb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3c2a6e2-41ad-466f-8e90-950567229430" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d99f3235-ee94-4769-b332-62699209eadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d773dbdb-c1e0-4bc5-aa8c-558ab6f0d352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3c2a6e2-41ad-466f-8e90-950567229430" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d773dbdb-c1e0-4bc5-aa8c-558ab6f0d352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3109849e-48cd-403e-abc4-dab3e1b968ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3c2a6e2-41ad-466f-8e90-950567229430" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3109849e-48cd-403e-abc4-dab3e1b968ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5254675b-e6bd-4e02-bdf8-b3258b723cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3c2a6e2-41ad-466f-8e90-950567229430" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5254675b-e6bd-4e02-bdf8-b3258b723cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd9485b5-5318-4c98-9f5c-50e63ca709a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1bb154bf-12be-4bb9-91fa-0b62f3503918" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd9485b5-5318-4c98-9f5c-50e63ca709a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_98bdca83-e7af-407a-a019-71aecf2aa594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d213ae75-5dcd-46c8-b4e0-880f0653dbdb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_98bdca83-e7af-407a-a019-71aecf2aa594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_6f3d99e3-0688-4784-84f6-6af13b33b381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_98bdca83-e7af-407a-a019-71aecf2aa594" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_6f3d99e3-0688-4784-84f6-6af13b33b381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c329298e-b189-4a81-a940-171cd6ab6c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_98bdca83-e7af-407a-a019-71aecf2aa594" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c329298e-b189-4a81-a940-171cd6ab6c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a69edd92-3505-4762-8ab3-d42a141f7aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_98bdca83-e7af-407a-a019-71aecf2aa594" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a69edd92-3505-4762-8ab3-d42a141f7aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f87b4e54-606a-4327-b35a-c3fd054b0870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d213ae75-5dcd-46c8-b4e0-880f0653dbdb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f87b4e54-606a-4327-b35a-c3fd054b0870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_4f25f388-d1d0-47b5-83a5-9dd4064196fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f87b4e54-606a-4327-b35a-c3fd054b0870" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_4f25f388-d1d0-47b5-83a5-9dd4064196fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0c7fa590-06af-4eda-a04c-6b925379c1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f87b4e54-606a-4327-b35a-c3fd054b0870" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0c7fa590-06af-4eda-a04c-6b925379c1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f7dd4e35-2925-4e33-b350-cd83d5240c94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d213ae75-5dcd-46c8-b4e0-880f0653dbdb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f7dd4e35-2925-4e33-b350-cd83d5240c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_be466079-c191-4003-9d72-1447e4003873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d213ae75-5dcd-46c8-b4e0-880f0653dbdb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_be466079-c191-4003-9d72-1447e4003873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_e9dfc393-dd7a-4f6b-8e06-bd7e6e6dca5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d213ae75-5dcd-46c8-b4e0-880f0653dbdb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_e9dfc393-dd7a-4f6b-8e06-bd7e6e6dca5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_712d5eb9-8f08-4f9c-9477-ae8dc1c55b43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d213ae75-5dcd-46c8-b4e0-880f0653dbdb" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_712d5eb9-8f08-4f9c-9477-ae8dc1c55b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_8bfd93ce-fb47-4153-abb4-77dd3c297280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_712d5eb9-8f08-4f9c-9477-ae8dc1c55b43" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_8bfd93ce-fb47-4153-abb4-77dd3c297280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_e0752d7e-5ab2-4e6f-8dcd-b1e7d26f3a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_712d5eb9-8f08-4f9c-9477-ae8dc1c55b43" xlink:to="loc_us-gaap_LiabilitiesAssumed1_e0752d7e-5ab2-4e6f-8dcd-b1e7d26f3a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="pets-20230331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d9211133-8c7a-4aa3-a9b9-61a43110ce30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_67abcacd-81ce-4709-aa1a-163818dc3062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9211133-8c7a-4aa3-a9b9-61a43110ce30" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_67abcacd-81ce-4709-aa1a-163818dc3062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/PropertyandEquipmentNet" xlink:type="simple" xlink:href="pets-20230331.xsd#PropertyandEquipmentNet"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/PropertyandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_aa74423d-3845-42f9-a1c4-75bc2d671109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_5a86df32-d771-49c5-9bf2-fdab9394628a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_aa74423d-3845-42f9-a1c4-75bc2d671109" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_5a86df32-d771-49c5-9bf2-fdab9394628a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilities" xlink:type="simple" xlink:href="pets-20230331.xsd#AccruedExpensesandOtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_64f82f1c-bad7-4f91-a02f-4e7e6aee48e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_fb7b811e-8045-4d4c-b3e5-6f9020604397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_64f82f1c-bad7-4f91-a02f-4e7e6aee48e4" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_fb7b811e-8045-4d4c-b3e5-6f9020604397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/IncomeTaxes" xlink:type="simple" xlink:href="pets-20230331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4d764986-c4c6-4b7f-86fa-05c8068a734b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_3c2239f1-6057-4eb5-bda4-6a7c3d76589a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4d764986-c4c6-4b7f-86fa-05c8068a734b" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_3c2239f1-6057-4eb5-bda4-6a7c3d76589a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="pets-20230331.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a7b7f528-2f8f-4ec3-82d3-bc5cef76294b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_10bd6481-e938-4e8a-ba0b-345600a3711b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7b7f528-2f8f-4ec3-82d3-bc5cef76294b" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_10bd6481-e938-4e8a-ba0b-345600a3711b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/RestrictedStock" xlink:type="simple" xlink:href="pets-20230331.xsd#RestrictedStock"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/RestrictedStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_82a72d2e-4957-48b3-8833-1164833f54aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ae34bb4a-3f96-44fc-b38f-0f5b505f6491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_82a72d2e-4957-48b3-8833-1164833f54aa" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ae34bb4a-3f96-44fc-b38f-0f5b505f6491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="pets-20230331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3050436d-2590-465c-beb0-0e6d270a96e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_561b8f19-b744-4b7f-8183-4a448eccaedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3050436d-2590-465c-beb0-0e6d270a96e1" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_561b8f19-b744-4b7f-8183-4a448eccaedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="pets-20230331.xsd#NetIncomePerShare"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/NetIncomePerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f64fca13-051c-4790-a791-133cf46dd04a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_6bbf5e86-7079-41f2-8fce-629593fbfc9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f64fca13-051c-4790-a791-133cf46dd04a" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_6bbf5e86-7079-41f2-8fce-629593fbfc9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="pets-20230331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a241b34e-1baf-409a-8fc9-ea6b603ca40e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_adf99e71-1603-4d56-b70c-3babaf8aed97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a241b34e-1baf-409a-8fc9-ea6b603ca40e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_adf99e71-1603-4d56-b70c-3babaf8aed97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/EmployeeBenefitPlan" xlink:type="simple" xlink:href="pets-20230331.xsd#EmployeeBenefitPlan"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/EmployeeBenefitPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_eb450c41-f667-4503-a19c-3ca839095873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_d83fcc53-3ca0-4b17-9f50-9204bab26117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_eb450c41-f667-4503-a19c-3ca839095873" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_d83fcc53-3ca0-4b17-9f50-9204bab26117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetster" xlink:type="simple" xlink:href="pets-20230331.xsd#MinorityInterestInvestmentinVetster"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetster" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_a5065853-0dbb-4564-9bc6-7c51ffbfde05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_3b9b558b-1629-46e6-9e51-3e128927b63f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_a5065853-0dbb-4564-9bc6-7c51ffbfde05" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_3b9b558b-1629-46e6-9e51-3e128927b63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/SubsequentEvents" xlink:type="simple" xlink:href="pets-20230331.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_7122e909-9fe3-4001-b4ae-80c98c915d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_ce0d1f76-9835-45f9-9990-a34d6a332426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_7122e909-9fe3-4001-b4ae-80c98c915d2c" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_ce0d1f76-9835-45f9-9990-a34d6a332426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/RelatedPartyTransaction" xlink:type="simple" xlink:href="pets-20230331.xsd#RelatedPartyTransaction"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/RelatedPartyTransaction" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_f0490f34-3397-4120-84a9-1660f71fc0de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_77192ea4-4ab9-46df-88d2-ff9ae1042062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_f0490f34-3397-4120-84a9-1660f71fc0de" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_77192ea4-4ab9-46df-88d2-ff9ae1042062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="pets-20230331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_ea57fedc-1d97-441f-a252-024e9544ed6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_ea57fedc-1d97-441f-a252-024e9544ed6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_d963805b-e76e-48c6-abcf-e73a945d2d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_d963805b-e76e-48c6-abcf-e73a945d2d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_e757347c-e483-416b-9100-4d2bdd4261be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_e757347c-e483-416b-9100-4d2bdd4261be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_f635ff8f-ebb2-4238-be30-483a99be6825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_us-gaap_UseOfEstimates_f635ff8f-ebb2-4238-be30-483a99be6825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_5d167c4f-3ea9-4e40-b6f4-932c9d9c8dba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_5d167c4f-3ea9-4e40-b6f4-932c9d9c8dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_e2480682-f676-4bdb-829a-6a3b7a9f58d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_e2480682-f676-4bdb-829a-6a3b7a9f58d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_ab854e87-ead3-42e3-b762-552a048ef191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_ab854e87-ead3-42e3-b762-552a048ef191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_d5b662a6-c479-4fb3-b1af-655ccccc52fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_d5b662a6-c479-4fb3-b1af-655ccccc52fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_OtherAssetsPolicyTextBlock_7c2e3221-7475-44ff-9b5b-87b0997d8ecd" xlink:href="pets-20230331.xsd#pets_OtherAssetsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_pets_OtherAssetsPolicyTextBlock_7c2e3221-7475-44ff-9b5b-87b0997d8ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_d2b79ea5-f2b8-4423-9af3-e6ea5a7f7d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_d2b79ea5-f2b8-4423-9af3-e6ea5a7f7d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_df797b4e-6f5a-4723-afc7-45c0162a82fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_df797b4e-6f5a-4723-afc7-45c0162a82fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_a4c62f99-3de8-4c36-bb30-cd7df362169d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_a4c62f99-3de8-4c36-bb30-cd7df362169d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_5ddadec0-1226-4cce-be54-01f413033a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_5ddadec0-1226-4cce-be54-01f413033a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_88d22831-1b77-4928-94d0-1c1635dc51f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_88d22831-1b77-4928-94d0-1c1635dc51f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_75814f06-d751-40c7-a2ce-909f5a65fcd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_75814f06-d751-40c7-a2ce-909f5a65fcd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_51e491d5-569d-47e6-b28f-25da36a78ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ccfef86-e3ea-4b16-a800-1d0b776a378e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_51e491d5-569d-47e6-b28f-25da36a78ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="pets-20230331.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e750f022-7285-4e09-b445-52b684d25427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_e0a5a9fd-ebe0-4a58-84a5-4f1fc8173bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e750f022-7285-4e09-b445-52b684d25427" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_e0a5a9fd-ebe0-4a58-84a5-4f1fc8173bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/PropertyandEquipmentNetTables" xlink:type="simple" xlink:href="pets-20230331.xsd#PropertyandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/PropertyandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ec6ae67f-1e55-4fb5-8aa7-95a45ef97c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_31c3862e-5dde-4b26-995b-76fe2230686c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ec6ae67f-1e55-4fb5-8aa7-95a45ef97c1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_31c3862e-5dde-4b26-995b-76fe2230686c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="pets-20230331.xsd#AccruedExpensesandOtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_ef399cac-1e19-4802-9307-84abf87f4017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_9b670435-1f90-4e90-8fce-637a1825f3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ef399cac-1e19-4802-9307-84abf87f4017" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_9b670435-1f90-4e90-8fce-637a1825f3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="pets-20230331.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a86121ab-3821-4a87-a985-7113c2e9224b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3889894c-4210-4dca-a21e-8c73b42c16b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a86121ab-3821-4a87-a985-7113c2e9224b" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3889894c-4210-4dca-a21e-8c73b42c16b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_c3c1e2b6-2c42-4906-9b8c-87c5ee885933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a86121ab-3821-4a87-a985-7113c2e9224b" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_c3c1e2b6-2c42-4906-9b8c-87c5ee885933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_00d5f4b8-7927-4977-8ce6-a96010f676e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a86121ab-3821-4a87-a985-7113c2e9224b" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_00d5f4b8-7927-4977-8ce6-a96010f676e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="pets-20230331.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_675dc859-2e49-48a9-964f-dc2709a6d978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDeclaredTableTextBlock_ec57ecd0-edd0-4003-85f2-6082e41d20c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDeclaredTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_675dc859-2e49-48a9-964f-dc2709a6d978" xlink:to="loc_us-gaap_DividendsDeclaredTableTextBlock_ec57ecd0-edd0-4003-85f2-6082e41d20c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/RestrictedStockTables" xlink:type="simple" xlink:href="pets-20230331.xsd#RestrictedStockTables"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/RestrictedStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8598b78-ea09-49b9-bb9f-32bc05368f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_c3f28ecf-3086-4c3b-ab05-49aa54f54ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8598b78-ea09-49b9-bb9f-32bc05368f76" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_c3f28ecf-3086-4c3b-ab05-49aa54f54ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="pets-20230331.xsd#NetIncomePerShareTables"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/NetIncomePerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3a56fdb1-0d65-48b3-9ace-08cccfe713bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7fc6e958-a603-42b1-80fa-c8e6fb8d21ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3a56fdb1-0d65-48b3-9ace-08cccfe713bb" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7fc6e958-a603-42b1-80fa-c8e6fb8d21ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d46ec175-58d6-40aa-af15-ec47b107af25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d46ec175-58d6-40aa-af15-ec47b107af25" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5c26e42f-7cac-419a-a5e5-66b9e44880ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5c26e42f-7cac-419a-a5e5-66b9e44880ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b866bc0-a03c-401b-bc5a-d579b716327b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5c26e42f-7cac-419a-a5e5-66b9e44880ce" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b866bc0-a03c-401b-bc5a-d579b716327b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_8992892d-1437-40bc-aa4a-60c4d48be29e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b866bc0-a03c-401b-bc5a-d579b716327b" xlink:to="loc_us-gaap_BuildingMember_8992892d-1437-40bc-aa4a-60c4d48be29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_FurnitureFixturesEquipmentAndComputerSoftwareMember_546f541f-608b-4496-ad00-e9f37f25832b" xlink:href="pets-20230331.xsd#pets_FurnitureFixturesEquipmentAndComputerSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4b866bc0-a03c-401b-bc5a-d579b716327b" xlink:to="loc_pets_FurnitureFixturesEquipmentAndComputerSoftwareMember_546f541f-608b-4496-ad00-e9f37f25832b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c2a3df29-6407-437c-b514-efe57e05b8ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_srt_RangeAxis_c2a3df29-6407-437c-b514-efe57e05b8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f0a6f5d9-4d7f-436b-835d-65e00e4d9753" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c2a3df29-6407-437c-b514-efe57e05b8ec" xlink:to="loc_srt_RangeMember_f0a6f5d9-4d7f-436b-835d-65e00e4d9753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bc6ce522-ac55-434d-8e9a-411a8b23aaf7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f0a6f5d9-4d7f-436b-835d-65e00e4d9753" xlink:to="loc_srt_MinimumMember_bc6ce522-ac55-434d-8e9a-411a8b23aaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ea2b1226-fbc8-4122-be54-ebbd7bf13973" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f0a6f5d9-4d7f-436b-835d-65e00e4d9753" xlink:to="loc_srt_MaximumMember_ea2b1226-fbc8-4122-be54-ebbd7bf13973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_deb37a1c-a7b7-421e-9409-0bbb63af8a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_deb37a1c-a7b7-421e-9409-0bbb63af8a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ce1b1043-8ad4-4aff-90b1-ab9a01bc1151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_deb37a1c-a7b7-421e-9409-0bbb63af8a66" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ce1b1043-8ad4-4aff-90b1-ab9a01bc1151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_b1f870d0-b952-4ccb-92b2-89fb1603e42e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ce1b1043-8ad4-4aff-90b1-ab9a01bc1151" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_b1f870d0-b952-4ccb-92b2-89fb1603e42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7922e6de-0371-4a49-acae-ebf023420f35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7922e6de-0371-4a49-acae-ebf023420f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e69e3bd2-f7db-47f5-b179-09c10ea79ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7922e6de-0371-4a49-acae-ebf023420f35" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e69e3bd2-f7db-47f5-b179-09c10ea79ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsTotalMember_520715f9-dd25-4954-9801-35d5ff3ef8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsTotalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e69e3bd2-f7db-47f5-b179-09c10ea79ea0" xlink:to="loc_us-gaap_CostOfGoodsTotalMember_520715f9-dd25-4954-9801-35d5ff3ef8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e4bb4a2e-a68d-48d3-a9ec-b1fbb01cac12" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_srt_CounterpartyNameAxis_e4bb4a2e-a68d-48d3-a9ec-b1fbb01cac12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bf8a2b72-70d3-4b1f-8aaf-7a2115a2c30a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_e4bb4a2e-a68d-48d3-a9ec-b1fbb01cac12" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bf8a2b72-70d3-4b1f-8aaf-7a2115a2c30a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SixSuppliersMember_3c83ce17-ae32-4c87-870b-3c5a607edce0" xlink:href="pets-20230331.xsd#pets_SixSuppliersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bf8a2b72-70d3-4b1f-8aaf-7a2115a2c30a" xlink:to="loc_pets_SixSuppliersMember_3c83ce17-ae32-4c87-870b-3c5a607edce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_6966cc68-35a3-44e0-ae1a-0a4ed7611f61" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_srt_MajorCustomersAxis_6966cc68-35a3-44e0-ae1a-0a4ed7611f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_f40870ce-cf2d-4512-aa5c-3d8245ae9b19" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_6966cc68-35a3-44e0-ae1a-0a4ed7611f61" xlink:to="loc_srt_NameOfMajorCustomerDomain_f40870ce-cf2d-4512-aa5c-3d8245ae9b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ReorderMember_9504eaec-dcba-405b-bcb7-ab9c2ba112bc" xlink:href="pets-20230331.xsd#pets_ReorderMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f40870ce-cf2d-4512-aa5c-3d8245ae9b19" xlink:to="loc_pets_ReorderMember_9504eaec-dcba-405b-bcb7-ab9c2ba112bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NewOrderMember_7f03ed88-7148-407c-9b3d-290d886b17e2" xlink:href="pets-20230331.xsd#pets_NewOrderMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f40870ce-cf2d-4512-aa5c-3d8245ae9b19" xlink:to="loc_pets_NewOrderMember_7f03ed88-7148-407c-9b3d-290d886b17e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_50d485dd-fc49-4ea5-b9d1-80487fb15548" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_srt_RestatementAxis_50d485dd-fc49-4ea5-b9d1-80487fb15548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_4a12357e-64a4-4efa-bf09-57c787bd6b07" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_50d485dd-fc49-4ea5-b9d1-80487fb15548" xlink:to="loc_srt_RestatementDomain_4a12357e-64a4-4efa-bf09-57c787bd6b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_f330c3ed-b18b-4f1a-97ab-be72daaa7787" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_4a12357e-64a4-4efa-bf09-57c787bd6b07" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_f330c3ed-b18b-4f1a-97ab-be72daaa7787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_73d80bef-d651-4242-853a-6408603d0df8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_73d80bef-d651-4242-853a-6408603d0df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_a582c03c-a2a5-442c-b208-f8699859a999" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_73d80bef-d651-4242-853a-6408603d0df8" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_a582c03c-a2a5-442c-b208-f8699859a999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_DelrayBeachPropertyMember_7fc48f4b-7498-49b2-a9e8-367ece7f7232" xlink:href="pets-20230331.xsd#pets_DelrayBeachPropertyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_a582c03c-a2a5-442c-b208-f8699859a999" xlink:to="loc_pets_DelrayBeachPropertyMember_7fc48f4b-7498-49b2-a9e8-367ece7f7232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c36ff398-a794-456d-b6e0-b3c35bab11ac" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_115428e9-345b-4472-8df2-b794da3cfe41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_115428e9-345b-4472-8df2-b794da3cfe41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ffac9ca7-71f7-438c-b3c2-0b45a0b79520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ffac9ca7-71f7-438c-b3c2-0b45a0b79520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_6d5ed59d-e6f1-4801-b240-be3e4fffc391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_InventoryValuationReserves_6d5ed59d-e6f1-4801-b240-be3e4fffc391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b96fe816-d08d-4d5d-a3e3-c37041d5d03d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b96fe816-d08d-4d5d-a3e3-c37041d5d03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PercentageOfPropertyLeasedToTenants_5514d261-65b1-441b-8baf-554490c9dbf4" xlink:href="pets-20230331.xsd#pets_PercentageOfPropertyLeasedToTenants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_pets_PercentageOfPropertyLeasedToTenants_5514d261-65b1-441b-8baf-554490c9dbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_eb503f70-9a8b-4b05-8eb0-42c60b36b51f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_eb503f70-9a8b-4b05-8eb0-42c60b36b51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NumberOfTenants_539443be-424e-4aae-8910-54273f88d3b0" xlink:href="pets-20230331.xsd#pets_NumberOfTenants"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_pets_NumberOfTenants_539443be-424e-4aae-8910-54273f88d3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm_d71b6eac-13f2-472a-a0c5-19af48fb3501" xlink:href="pets-20230331.xsd#pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm_d71b6eac-13f2-472a-a0c5-19af48fb3501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RentalIncomeNonoperating_5d125a6e-cd06-4b94-826f-1d83ca7636f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RentalIncomeNonoperating"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_RentalIncomeNonoperating_5d125a6e-cd06-4b94-826f-1d83ca7636f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_7215e30a-8a50-4059-a5fa-21a5ff312f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_7215e30a-8a50-4059-a5fa-21a5ff312f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_111a71d4-93ba-4b77-ad8d-6f27a1b67d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_111a71d4-93ba-4b77-ad8d-6f27a1b67d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_3c44dcbc-acf8-4684-8cd5-f98ca41f80ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_3c44dcbc-acf8-4684-8cd5-f98ca41f80ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_9a2a7606-14b2-4a4a-95f8-cecbf8180f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_9a2a7606-14b2-4a4a-95f8-cecbf8180f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_322312b5-e2ef-4cf1-921c-f3c3f7ba48f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_322312b5-e2ef-4cf1-921c-f3c3f7ba48f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ce3faf1a-75dd-4714-8534-28d99d5bd130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ce3faf1a-75dd-4714-8534-28d99d5bd130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_4219a3cb-c949-4c4e-93ec-8f8eb3918873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a4181c26-eec6-442d-9db9-05bd23fa8e90" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_4219a3cb-c949-4c4e-93ec-8f8eb3918873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ddb85fd1-55a2-4e8d-ac5e-5419d044f606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_dac8cba0-569b-47bc-9da0-ad4ff7cdd289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ddb85fd1-55a2-4e8d-ac5e-5419d044f606" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_dac8cba0-569b-47bc-9da0-ad4ff7cdd289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_2e8b30a4-c9f7-4a54-b81b-2bfb8469b2b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_dac8cba0-569b-47bc-9da0-ad4ff7cdd289" xlink:to="loc_srt_MajorCustomersAxis_2e8b30a4-c9f7-4a54-b81b-2bfb8469b2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_0085ee2a-86c3-4716-94b7-5e5d1c3127ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_2e8b30a4-c9f7-4a54-b81b-2bfb8469b2b3" xlink:to="loc_srt_NameOfMajorCustomerDomain_0085ee2a-86c3-4716-94b7-5e5d1c3127ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ReorderMember_aa9a84c4-c313-4301-a62a-4f0da68a78f9" xlink:href="pets-20230331.xsd#pets_ReorderMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_0085ee2a-86c3-4716-94b7-5e5d1c3127ab" xlink:to="loc_pets_ReorderMember_aa9a84c4-c313-4301-a62a-4f0da68a78f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NewOrderMember_fe4d1c76-0949-4671-aabd-c280faaff193" xlink:href="pets-20230331.xsd#pets_NewOrderMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_0085ee2a-86c3-4716-94b7-5e5d1c3127ab" xlink:to="loc_pets_NewOrderMember_fe4d1c76-0949-4671-aabd-c280faaff193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_47c259eb-dc0d-4cae-bb9c-38a12aa4f3c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_dac8cba0-569b-47bc-9da0-ad4ff7cdd289" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_47c259eb-dc0d-4cae-bb9c-38a12aa4f3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_6417f888-c15b-4f83-8271-9ad5ea348da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_47c259eb-dc0d-4cae-bb9c-38a12aa4f3c7" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_6417f888-c15b-4f83-8271-9ad5ea348da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_InternetMember_3be5bd56-f791-4b86-b39a-fe3b53ff4a77" xlink:href="pets-20230331.xsd#pets_InternetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_6417f888-c15b-4f83-8271-9ad5ea348da2" xlink:to="loc_pets_InternetMember_3be5bd56-f791-4b86-b39a-fe3b53ff4a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ContactCenterMember_122ea558-14b4-4864-ae27-6937edd42a94" xlink:href="pets-20230331.xsd#pets_ContactCenterMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_6417f888-c15b-4f83-8271-9ad5ea348da2" xlink:to="loc_pets_ContactCenterMember_122ea558-14b4-4864-ae27-6937edd42a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_daa31b16-4699-4498-9a39-917a1d47eb84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_dac8cba0-569b-47bc-9da0-ad4ff7cdd289" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_daa31b16-4699-4498-9a39-917a1d47eb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_b8344d9d-b093-4dcd-be27-a370fa4a20eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_daa31b16-4699-4498-9a39-917a1d47eb84" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_b8344d9d-b093-4dcd-be27-a370fa4a20eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerPercentage_b8c4baa6-184f-4bd8-bfff-3646baa3f203" xlink:href="pets-20230331.xsd#pets_RevenueFromContractWithCustomerPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_daa31b16-4699-4498-9a39-917a1d47eb84" xlink:to="loc_pets_RevenueFromContractWithCustomerPercentage_b8c4baa6-184f-4bd8-bfff-3646baa3f203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerVariance_dbee15ed-5967-4dab-ba36-06effcda27f3" xlink:href="pets-20230331.xsd#pets_RevenueFromContractWithCustomerVariance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_daa31b16-4699-4498-9a39-917a1d47eb84" xlink:to="loc_pets_RevenueFromContractWithCustomerVariance_dbee15ed-5967-4dab-ba36-06effcda27f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RevenueFromContractWithCustomerVariancePercentage_e25572ba-73a6-4bdc-9d65-328e1066eec8" xlink:href="pets-20230331.xsd#pets_RevenueFromContractWithCustomerVariancePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_daa31b16-4699-4498-9a39-917a1d47eb84" xlink:to="loc_pets_RevenueFromContractWithCustomerVariancePercentage_e25572ba-73a6-4bdc-9d65-328e1066eec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#PropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_45b3261a-cdb0-48c9-a3ae-24495c8133e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ad6bf3-f254-408a-a772-3685639bca4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_45b3261a-cdb0-48c9-a3ae-24495c8133e4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ad6bf3-f254-408a-a772-3685639bca4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aa32dfb7-5683-4e74-8ee1-71fc0f99d262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ad6bf3-f254-408a-a772-3685639bca4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aa32dfb7-5683-4e74-8ee1-71fc0f99d262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6174a54a-df2b-4907-b574-4ed33b756303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_aa32dfb7-5683-4e74-8ee1-71fc0f99d262" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6174a54a-df2b-4907-b574-4ed33b756303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_f27999f7-3702-4c2a-a4bf-0f1223e40d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6174a54a-df2b-4907-b574-4ed33b756303" xlink:to="loc_us-gaap_BuildingMember_f27999f7-3702-4c2a-a4bf-0f1223e40d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_fd9b24ad-d93a-48b0-bb32-2dc93e4806dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6174a54a-df2b-4907-b574-4ed33b756303" xlink:to="loc_us-gaap_LandMember_fd9b24ad-d93a-48b0-bb32-2dc93e4806dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_57d03599-627d-41bd-adc9-1f36d9272c81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6174a54a-df2b-4907-b574-4ed33b756303" xlink:to="loc_us-gaap_BuildingImprovementsMember_57d03599-627d-41bd-adc9-1f36d9272c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_579cee36-a009-459c-9569-b69f0612f5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6174a54a-df2b-4907-b574-4ed33b756303" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_579cee36-a009-459c-9569-b69f0612f5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_6571977b-2513-4cc4-ab0d-85b233406d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6174a54a-df2b-4907-b574-4ed33b756303" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_6571977b-2513-4cc4-ab0d-85b233406d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea0caab4-1f71-4718-8c84-ea9ce18d60db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ad6bf3-f254-408a-a772-3685639bca4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea0caab4-1f71-4718-8c84-ea9ce18d60db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_fa5b563f-94c3-4c33-a3f0-6e244e7222c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea0caab4-1f71-4718-8c84-ea9ce18d60db" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_fa5b563f-94c3-4c33-a3f0-6e244e7222c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_fb8d798d-1f26-48d2-ae48-ca54a6648412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea0caab4-1f71-4718-8c84-ea9ce18d60db" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_fb8d798d-1f26-48d2-ae48-ca54a6648412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e0262dfa-ad6d-48b8-a551-83eee46af8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ea0caab4-1f71-4718-8c84-ea9ce18d60db" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e0262dfa-ad6d-48b8-a551-83eee46af8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_d88e279a-922c-4036-902d-8f8e1e475455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_ebd9e914-711e-4e15-a518-5ba9e273fe8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d88e279a-922c-4036-902d-8f8e1e475455" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_ebd9e914-711e-4e15-a518-5ba9e273fe8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedCreditCardFeesCurrent_3f1ac9b2-778a-45cd-9f18-47e9348a2372" xlink:href="pets-20230331.xsd#pets_AccruedCreditCardFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d88e279a-922c-4036-902d-8f8e1e475455" xlink:to="loc_pets_AccruedCreditCardFeesCurrent_3f1ac9b2-778a-45cd-9f18-47e9348a2372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_368d517b-e362-4e7d-9877-a38f2773b3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d88e279a-922c-4036-902d-8f8e1e475455" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_368d517b-e362-4e7d-9877-a38f2773b3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedMerchandiseCreditsAndRewardsCurrent_1ad93b57-1519-4f26-b14c-65c5a79f8eac" xlink:href="pets-20230331.xsd#pets_AccruedMerchandiseCreditsAndRewardsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d88e279a-922c-4036-902d-8f8e1e475455" xlink:to="loc_pets_AccruedMerchandiseCreditsAndRewardsCurrent_1ad93b57-1519-4f26-b14c-65c5a79f8eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_764b1ce3-bfcf-4e13-a308-3cdf37756f39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d88e279a-922c-4036-902d-8f8e1e475455" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_764b1ce3-bfcf-4e13-a308-3cdf37756f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedSalesReturnsAndAllowancesCurrent_640e79f6-3728-4290-8c93-aa75e0993b5f" xlink:href="pets-20230331.xsd#pets_AccruedSalesReturnsAndAllowancesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d88e279a-922c-4036-902d-8f8e1e475455" xlink:to="loc_pets_AccruedSalesReturnsAndAllowancesCurrent_640e79f6-3728-4290-8c93-aa75e0993b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_77392aa9-d899-4521-bd86-900d3b24a3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d88e279a-922c-4036-902d-8f8e1e475455" xlink:to="loc_us-gaap_DividendsPayableCurrent_77392aa9-d899-4521-bd86-900d3b24a3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_6eeacda8-f00d-472c-be64-1742f5b3d2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d88e279a-922c-4036-902d-8f8e1e475455" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_6eeacda8-f00d-472c-be64-1742f5b3d2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cb37b8dd-853d-41a7-806a-913e675e6740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d88e279a-922c-4036-902d-8f8e1e475455" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cb37b8dd-853d-41a7-806a-913e675e6740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_173de1c7-7262-4a80-b5fe-503fb7114aa0" xlink:href="pets-20230331.xsd#pets_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d88e279a-922c-4036-902d-8f8e1e475455" xlink:to="loc_pets_AccruedExpensesAndOtherCurrentLiabilities_173de1c7-7262-4a80-b5fe-503fb7114aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#IncomeTaxesDeferredIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_076194cf-1436-4aaa-82e0-b2ae20569004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_c714e198-96d7-4a25-8b67-4605e693cd12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_076194cf-1436-4aaa-82e0-b2ae20569004" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_c714e198-96d7-4a25-8b67-4605e693cd12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_5a237b3f-9947-4ac9-8978-d938fd1fcf96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c714e198-96d7-4a25-8b67-4605e693cd12" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_5a237b3f-9947-4ac9-8978-d938fd1fcf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_ca2dbc5d-250e-492b-ab86-39c9e5d6173a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c714e198-96d7-4a25-8b67-4605e693cd12" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_ca2dbc5d-250e-492b-ab86-39c9e5d6173a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_21b0f47d-dd61-4079-96ec-6c48d28aebf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c714e198-96d7-4a25-8b67-4605e693cd12" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_21b0f47d-dd61-4079-96ec-6c48d28aebf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_c388898f-1b1a-4ada-b1a4-4320a74c67fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c714e198-96d7-4a25-8b67-4605e693cd12" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_c388898f-1b1a-4ada-b1a4-4320a74c67fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_dab14508-1462-4548-b020-6c022e35e939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_076194cf-1436-4aaa-82e0-b2ae20569004" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_dab14508-1462-4548-b020-6c022e35e939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0d6bf2f6-4e65-45bf-a249-8f1a08e40c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_dab14508-1462-4548-b020-6c022e35e939" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0d6bf2f6-4e65-45bf-a249-8f1a08e40c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_85cf01c4-d249-4c82-b3d4-11fd67900f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_076194cf-1436-4aaa-82e0-b2ae20569004" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_85cf01c4-d249-4c82-b3d4-11fd67900f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_a5ae1fc7-86db-4b1b-bee2-3fc066fa7913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_076194cf-1436-4aaa-82e0-b2ae20569004" xlink:to="loc_us-gaap_DeferredTaxLiabilities_a5ae1fc7-86db-4b1b-bee2-3fc066fa7913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e5b57ad6-8825-461a-a884-87ba82205a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_9e185f8f-c4ac-466e-ab55-b3e0edec29b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e5b57ad6-8825-461a-a884-87ba82205a76" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_9e185f8f-c4ac-466e-ab55-b3e0edec29b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_93ec74f6-502e-4c6e-a060-42d17150cb49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_9e185f8f-c4ac-466e-ab55-b3e0edec29b4" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_93ec74f6-502e-4c6e-a060-42d17150cb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f577b7d0-0b94-48c1-9150-cd6486c98d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_93ec74f6-502e-4c6e-a060-42d17150cb49" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f577b7d0-0b94-48c1-9150-cd6486c98d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_2a05f868-80e3-4de3-ae54-177c92945b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f577b7d0-0b94-48c1-9150-cd6486c98d54" xlink:to="loc_us-gaap_DomesticCountryMember_2a05f868-80e3-4de3-ae54-177c92945b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_43fec5b9-bab3-49f1-922a-680dfa9b5d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_9e185f8f-c4ac-466e-ab55-b3e0edec29b4" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_43fec5b9-bab3-49f1-922a-680dfa9b5d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_2c28fb06-2e1d-4bf4-b174-9ffaa447afe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_43fec5b9-bab3-49f1-922a-680dfa9b5d5f" xlink:to="loc_us-gaap_OperatingLossCarryforwards_2c28fb06-2e1d-4bf4-b174-9ffaa447afe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_2d58d81d-647f-443c-8bfd-58931510c93e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_43fec5b9-bab3-49f1-922a-680dfa9b5d5f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_2d58d81d-647f-443c-8bfd-58931510c93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_b8e8305d-9b74-4a75-8971-b8bdc87b6c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_43fec5b9-bab3-49f1-922a-680dfa9b5d5f" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_b8e8305d-9b74-4a75-8971-b8bdc87b6c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#IncomeTaxesComponentsofIncomeTaxProvisionDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_944b02d6-be86-4b08-b3d5-53a84296258e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_d19a2866-b2d5-46e2-934f-4ec51251fecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_944b02d6-be86-4b08-b3d5-53a84296258e" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_d19a2866-b2d5-46e2-934f-4ec51251fecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_10c89a07-b6b5-4399-b6d2-091ddef6a70a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_d19a2866-b2d5-46e2-934f-4ec51251fecf" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_10c89a07-b6b5-4399-b6d2-091ddef6a70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ee13d086-07a1-4158-803c-4903f6fdaeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_d19a2866-b2d5-46e2-934f-4ec51251fecf" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ee13d086-07a1-4158-803c-4903f6fdaeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_67002aa7-e8b5-48e3-a11d-46b428267703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_d19a2866-b2d5-46e2-934f-4ec51251fecf" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_67002aa7-e8b5-48e3-a11d-46b428267703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d3b8fc46-2c4d-48ec-aa81-e5869ad8c40c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_944b02d6-be86-4b08-b3d5-53a84296258e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d3b8fc46-2c4d-48ec-aa81-e5869ad8c40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a3ea4afa-fd05-4e4f-b9bd-14a0f028b2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d3b8fc46-2c4d-48ec-aa81-e5869ad8c40c" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a3ea4afa-fd05-4e4f-b9bd-14a0f028b2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_fd6a930a-5613-4d8a-aba6-9c33d6812c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d3b8fc46-2c4d-48ec-aa81-e5869ad8c40c" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_fd6a930a-5613-4d8a-aba6-9c33d6812c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_2356bcbb-aae1-459c-b3f4-5490b3f75b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d3b8fc46-2c4d-48ec-aa81-e5869ad8c40c" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_2356bcbb-aae1-459c-b3f4-5490b3f75b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b6f1703a-0421-4447-b25b-4cc6668927dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_944b02d6-be86-4b08-b3d5-53a84296258e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b6f1703a-0421-4447-b25b-4cc6668927dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#IncomeTaxesReconciliationofIncomeTaxProvisionDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_698a884e-acb4-47bd-9f23-f610ce5eec36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_b8578ee1-f416-489e-8c44-a788d96e5d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_698a884e-acb4-47bd-9f23-f610ce5eec36" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_b8578ee1-f416-489e-8c44-a788d96e5d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_54b5fd43-50ca-413a-897b-65675e5e89a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_698a884e-acb4-47bd-9f23-f610ce5eec36" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_54b5fd43-50ca-413a-897b-65675e5e89a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount_e97bb024-15e4-4ce9-8223-1221fa77a853" xlink:href="pets-20230331.xsd#pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_698a884e-acb4-47bd-9f23-f610ce5eec36" xlink:to="loc_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount_e97bb024-15e4-4ce9-8223-1221fa77a853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_9d3008ae-9a2c-4ce5-9af2-4670b4f78ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_698a884e-acb4-47bd-9f23-f610ce5eec36" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_9d3008ae-9a2c-4ce5-9af2-4670b4f78ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_a079f446-a918-4f87-b951-dd1be41f640b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_698a884e-acb4-47bd-9f23-f610ce5eec36" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_a079f446-a918-4f87-b951-dd1be41f640b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a2f9af10-afdb-4955-a698-6b3b33b53a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_698a884e-acb4-47bd-9f23-f610ce5eec36" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a2f9af10-afdb-4955-a698-6b3b33b53a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_04eb5ed4-b46e-4d6c-b671-c85b753c682e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_359b3576-c495-4b66-b423-b91c15c6482d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_04eb5ed4-b46e-4d6c-b671-c85b753c682e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_359b3576-c495-4b66-b423-b91c15c6482d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_6f4a2fa6-f663-4477-9e17-f85ac45e812f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_04eb5ed4-b46e-4d6c-b671-c85b753c682e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_6f4a2fa6-f663-4477-9e17-f85ac45e812f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_69be4079-29ec-4a7b-8803-39ffbe2f662a" xlink:href="pets-20230331.xsd#pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_04eb5ed4-b46e-4d6c-b671-c85b753c682e" xlink:to="loc_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_69be4079-29ec-4a7b-8803-39ffbe2f662a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_a309c03c-99e1-4ccf-b9bc-1735d83e2671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_04eb5ed4-b46e-4d6c-b671-c85b753c682e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_a309c03c-99e1-4ccf-b9bc-1735d83e2671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_b973e279-31ee-4e71-90c9-4eca640bdca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_04eb5ed4-b46e-4d6c-b671-c85b753c682e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_b973e279-31ee-4e71-90c9-4eca640bdca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b3882666-a5da-4eea-90f8-e58997e98741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_04eb5ed4-b46e-4d6c-b671-c85b753c682e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b3882666-a5da-4eea-90f8-e58997e98741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_efd657ad-e2b4-42e9-8df9-49b035b5bd21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_6d25de8d-aaf4-4ba3-baf9-78a420800ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_efd657ad-e2b4-42e9-8df9-49b035b5bd21" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_6d25de8d-aaf4-4ba3-baf9-78a420800ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a3374a35-be1d-4aa5-947f-005d17ed21ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6d25de8d-aaf4-4ba3-baf9-78a420800ebc" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a3374a35-be1d-4aa5-947f-005d17ed21ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6bd0a3e5-3ff7-404f-a3e1-7891cb17c32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a3374a35-be1d-4aa5-947f-005d17ed21ca" xlink:to="loc_us-gaap_ClassOfStockDomain_6bd0a3e5-3ff7-404f-a3e1-7891cb17c32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_4083c415-651f-416a-93cd-a083e0e99d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6bd0a3e5-3ff7-404f-a3e1-7891cb17c32b" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_4083c415-651f-416a-93cd-a083e0e99d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6d25de8d-aaf4-4ba3-baf9-78a420800ebc" xlink:to="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_b00b83ca-517c-43a7-98c8-f15dd05fec89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_PreferredStockSharesIssued_b00b83ca-517c-43a7-98c8-f15dd05fec89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f1edb3f7-7d86-42f4-826d-77a53013a21b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f1edb3f7-7d86-42f4-826d-77a53013a21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_9c9f55a8-6351-4c95-b7f5-16ea834b9314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_9c9f55a8-6351-4c95-b7f5-16ea834b9314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_3a9c40d4-ba1f-49fd-92e5-683a4add68c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_3a9c40d4-ba1f-49fd-92e5-683a4add68c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_614dc1ea-c884-4799-9263-9fd61017a86e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_614dc1ea-c884-4799-9263-9fd61017a86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_71d53b51-1b1d-40d0-b942-4ddc5e8b7321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_71d53b51-1b1d-40d0-b942-4ddc5e8b7321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_dc5115bf-1b41-4df0-aaa2-23c3b80db352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_dc5115bf-1b41-4df0-aaa2-23c3b80db352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_859350a0-7a13-423b-98b6-703f8e90641a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_859350a0-7a13-423b-98b6-703f8e90641a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_20368fa9-8864-499c-bc63-16a71750c722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_20368fa9-8864-499c-bc63-16a71750c722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_76e115aa-d666-402d-bcaa-9b97e3d9702e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_76e115aa-d666-402d-bcaa-9b97e3d9702e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_dd3ff33d-a8d0-4d59-9bd1-5a37264a69fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7b37c871-8519-45fd-810e-50c8b1f14706" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_dd3ff33d-a8d0-4d59-9bd1-5a37264a69fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/ShareholdersEquityDeclaredDividendsDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#ShareholdersEquityDeclaredDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/ShareholdersEquityDeclaredDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_14431e2f-21e2-4ef1-b443-8fa043fa1371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_5f9c9108-8e6a-4cbb-8a62-8a3ce77dd54a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_14431e2f-21e2-4ef1-b443-8fa043fa1371" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_5f9c9108-8e6a-4cbb-8a62-8a3ce77dd54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_d8ff1775-1923-41ce-b542-620a9ab52deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_14431e2f-21e2-4ef1-b443-8fa043fa1371" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_d8ff1775-1923-41ce-b542-620a9ab52deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#RestrictedStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0a5ca54c-b568-47ce-9247-4f3fdcaded80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2160ec-83a4-4163-a96a-b96320d4c2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0a5ca54c-b568-47ce-9247-4f3fdcaded80" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2160ec-83a4-4163-a96a-b96320d4c2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_39c0b8df-2a2b-4aad-91f6-ae960f12d26d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2160ec-83a4-4163-a96a-b96320d4c2fc" xlink:to="loc_us-gaap_PlanNameAxis_39c0b8df-2a2b-4aad-91f6-ae960f12d26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_39c0b8df-2a2b-4aad-91f6-ae960f12d26d" xlink:to="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember_b1536a61-8832-44c6-854c-80b529e0fb7b" xlink:href="pets-20230331.xsd#pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:to="loc_pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember_b1536a61-8832-44c6-854c-80b529e0fb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_501ae683-9ff0-4a63-a69c-48b800fad610" xlink:href="pets-20230331.xsd#pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:to="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_501ae683-9ff0-4a63-a69c-48b800fad610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember_b3be48a2-35e9-48bd-b33d-97d83a669892" xlink:href="pets-20230331.xsd#pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:to="loc_pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember_b3be48a2-35e9-48bd-b33d-97d83a669892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmployeeAndDirectorEquityCompensationPlanMember_873dc539-d4c3-46bc-8f15-28d59ab281eb" xlink:href="pets-20230331.xsd#pets_EmployeeAndDirectorEquityCompensationPlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:to="loc_pets_EmployeeAndDirectorEquityCompensationPlanMember_873dc539-d4c3-46bc-8f15-28d59ab281eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember_498d1636-e9a4-42ea-833e-c55c842095f5" xlink:href="pets-20230331.xsd#pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:to="loc_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember_498d1636-e9a4-42ea-833e-c55c842095f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_835f1e65-37f0-4caa-a85b-94015dd55d3f" xlink:href="pets-20230331.xsd#pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d9da75b3-9425-49ca-aa9e-774154cbdac6" xlink:to="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_835f1e65-37f0-4caa-a85b-94015dd55d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b130b3ab-05f2-4aa4-9277-a95a29cf08d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2160ec-83a4-4163-a96a-b96320d4c2fc" xlink:to="loc_us-gaap_AwardTypeAxis_b130b3ab-05f2-4aa4-9277-a95a29cf08d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b0479ba-b842-40e5-a17c-2ff5f8eb2b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b130b3ab-05f2-4aa4-9277-a95a29cf08d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b0479ba-b842-40e5-a17c-2ff5f8eb2b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_da9decee-f9a0-4d84-9484-1e6db8fccd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b0479ba-b842-40e5-a17c-2ff5f8eb2b86" xlink:to="loc_us-gaap_RestrictedStockMember_da9decee-f9a0-4d84-9484-1e6db8fccd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NonvestedRestrictedStockMember_8c911aaf-1d37-4c7d-9a19-0ec5bcd5b9e9" xlink:href="pets-20230331.xsd#pets_NonvestedRestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b0479ba-b842-40e5-a17c-2ff5f8eb2b86" xlink:to="loc_pets_NonvestedRestrictedStockMember_8c911aaf-1d37-4c7d-9a19-0ec5bcd5b9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ac32fee7-397a-41dd-aecb-1adfe3081446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b0479ba-b842-40e5-a17c-2ff5f8eb2b86" xlink:to="loc_us-gaap_CommonStockMember_ac32fee7-397a-41dd-aecb-1adfe3081446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd085357-c919-4a6e-a6af-056a80570d45" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2160ec-83a4-4163-a96a-b96320d4c2fc" xlink:to="loc_srt_RangeAxis_dd085357-c919-4a6e-a6af-056a80570d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_31b975e4-07f6-4823-a6af-9bf8ba281630" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dd085357-c919-4a6e-a6af-056a80570d45" xlink:to="loc_srt_RangeMember_31b975e4-07f6-4823-a6af-9bf8ba281630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_60a3a59d-36a5-43e1-94a2-f04a565e8366" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_31b975e4-07f6-4823-a6af-9bf8ba281630" xlink:to="loc_srt_MinimumMember_60a3a59d-36a5-43e1-94a2-f04a565e8366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f772b24e-0f70-491f-b571-694d85503d81" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_31b975e4-07f6-4823-a6af-9bf8ba281630" xlink:to="loc_srt_MaximumMember_f772b24e-0f70-491f-b571-694d85503d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_97c513ac-e1f9-4e6a-9031-6394120ae4f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2160ec-83a4-4163-a96a-b96320d4c2fc" xlink:to="loc_srt_TitleOfIndividualAxis_97c513ac-e1f9-4e6a-9031-6394120ae4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c5a9c54e-6948-4d28-be2e-5c3672c0ce63" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_97c513ac-e1f9-4e6a-9031-6394120ae4f0" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c5a9c54e-6948-4d28-be2e-5c3672c0ce63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_354e4e7f-73f7-4afa-8573-feacb245fce6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c5a9c54e-6948-4d28-be2e-5c3672c0ce63" xlink:to="loc_srt_ChiefExecutiveOfficerMember_354e4e7f-73f7-4afa-8573-feacb245fce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefFinancialOfficerMember_2e598aeb-96b7-4faf-b9c7-e4e5cbd99ab9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c5a9c54e-6948-4d28-be2e-5c3672c0ce63" xlink:to="loc_srt_ChiefFinancialOfficerMember_2e598aeb-96b7-4faf-b9c7-e4e5cbd99ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_500db0e5-b4ae-450c-8e71-e87019246e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2160ec-83a4-4163-a96a-b96320d4c2fc" xlink:to="loc_us-gaap_GranteeStatusAxis_500db0e5-b4ae-450c-8e71-e87019246e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_9f4be4f4-5810-40a8-adf0-70de286baa79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_500db0e5-b4ae-450c-8e71-e87019246e0b" xlink:to="loc_us-gaap_GranteeStatusDomain_9f4be4f4-5810-40a8-adf0-70de286baa79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_125e3a19-fffe-49a2-b6ee-ee477c37fa01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_9f4be4f4-5810-40a8-adf0-70de286baa79" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_125e3a19-fffe-49a2-b6ee-ee477c37fa01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2160ec-83a4-4163-a96a-b96320d4c2fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ca34d03f-c261-4847-9b9a-60aa6d191a24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ca34d03f-c261-4847-9b9a-60aa6d191a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance_a9732971-1347-48c8-b170-563c62cdc73f" xlink:href="pets-20230331.xsd#pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance_a9732971-1347-48c8-b170-563c62cdc73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_RestrictionPeriod_3536fe33-33bc-4073-8cfe-d71783d6babe" xlink:href="pets-20230331.xsd#pets_RestrictionPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_pets_RestrictionPeriod_3536fe33-33bc-4073-8cfe-d71783d6babe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_eeebc3f5-3fb0-469a-8a00-08e354bab38f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_eeebc3f5-3fb0-469a-8a00-08e354bab38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5f4bed38-3a0a-41b8-b223-0cb7fc66f45e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5f4bed38-3a0a-41b8-b223-0cb7fc66f45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f6cce813-1f4d-414f-8665-874c145fe27f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_ShareBasedCompensation_f6cce813-1f4d-414f-8665-874c145fe27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_236074ed-f650-4991-93c9-02935749576d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_236074ed-f650-4991-93c9-02935749576d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_2bd14725-070b-4164-a0e8-437887ba58d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_2bd14725-070b-4164-a0e8-437887ba58d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4d11bf79-cb34-4fc4-82a7-72edd8cdfb68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4d11bf79-cb34-4fc4-82a7-72edd8cdfb68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4f9212c6-8768-4c29-ae45-ed76cac7ee74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4f9212c6-8768-4c29-ae45-ed76cac7ee74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fb1b6c56-a681-4363-b85e-41451c7b03b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fb1b6c56-a681-4363-b85e-41451c7b03b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_af41673d-07d9-41c9-b780-8158207b6885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc99c13e-9ba0-4f7b-b944-0e843ee6afe5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_af41673d-07d9-41c9-b780-8158207b6885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#RestrictedStockNonvestedRestrictedStockDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f0ee1ba0-8b73-492b-989d-1d09fe602017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9614c66b-8ac5-4d47-a20f-cc836ac29504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f0ee1ba0-8b73-492b-989d-1d09fe602017" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9614c66b-8ac5-4d47-a20f-cc836ac29504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_46ea6caf-6fcc-4119-907e-7a09de6bbc23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9614c66b-8ac5-4d47-a20f-cc836ac29504" xlink:to="loc_us-gaap_PlanNameAxis_46ea6caf-6fcc-4119-907e-7a09de6bbc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5386e570-f68a-4e92-8c5b-fee3f242b430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_46ea6caf-6fcc-4119-907e-7a09de6bbc23" xlink:to="loc_us-gaap_PlanNameDomain_5386e570-f68a-4e92-8c5b-fee3f242b430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmployeePlanMember_3b46b495-4ffd-4e53-b1e0-eb3a2a59711b" xlink:href="pets-20230331.xsd#pets_EmployeePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_5386e570-f68a-4e92-8c5b-fee3f242b430" xlink:to="loc_pets_EmployeePlanMember_3b46b495-4ffd-4e53-b1e0-eb3a2a59711b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_DirectorPlanMember_329ebe78-7c8c-474b-9ca8-df102bd96bbb" xlink:href="pets-20230331.xsd#pets_DirectorPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_5386e570-f68a-4e92-8c5b-fee3f242b430" xlink:to="loc_pets_DirectorPlanMember_329ebe78-7c8c-474b-9ca8-df102bd96bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54df97d2-b7ba-4b2d-989e-e8d59faaa005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9614c66b-8ac5-4d47-a20f-cc836ac29504" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54df97d2-b7ba-4b2d-989e-e8d59faaa005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc71a1b3-ad82-40e9-8734-e7c8775b5cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54df97d2-b7ba-4b2d-989e-e8d59faaa005" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc71a1b3-ad82-40e9-8734-e7c8775b5cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a93ac882-e1b4-4007-9158-5d042a9d7678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc71a1b3-ad82-40e9-8734-e7c8775b5cf4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a93ac882-e1b4-4007-9158-5d042a9d7678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1d38accd-c2f4-4c5d-bc6e-b00bcd398b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc71a1b3-ad82-40e9-8734-e7c8775b5cf4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1d38accd-c2f4-4c5d-bc6e-b00bcd398b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_32302b91-fa77-45b6-b9d7-6a9508ec98ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc71a1b3-ad82-40e9-8734-e7c8775b5cf4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_32302b91-fa77-45b6-b9d7-6a9508ec98ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7e630cd7-cbf5-4100-a5e4-75bb5c956e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc71a1b3-ad82-40e9-8734-e7c8775b5cf4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7e630cd7-cbf5-4100-a5e4-75bb5c956e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3381752f-35a5-48d2-b4ac-e8a70e71d301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc71a1b3-ad82-40e9-8734-e7c8775b5cf4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3381752f-35a5-48d2-b4ac-e8a70e71d301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_07138f29-8046-4ab0-bd9b-3f009d431421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_63b354e0-10d4-4ead-b769-a8db21e30983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_07138f29-8046-4ab0-bd9b-3f009d431421" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_63b354e0-10d4-4ead-b769-a8db21e30983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#NetIncomePerShareBasicandDilutedNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_bcae04dc-fb63-4c59-8478-d06b60dc3f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_2c2852de-3d52-420d-b749-efe86a45cb51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bcae04dc-fb63-4c59-8478-d06b60dc3f69" xlink:to="loc_us-gaap_NetIncomeLossAbstract_2c2852de-3d52-420d-b749-efe86a45cb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fdcc463b-116f-4f8f-9891-2dfdda7c2531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_2c2852de-3d52-420d-b749-efe86a45cb51" xlink:to="loc_us-gaap_NetIncomeLoss_fdcc463b-116f-4f8f-9891-2dfdda7c2531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d9096ea6-5189-48d2-9720-d2163418797e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bcae04dc-fb63-4c59-8478-d06b60dc3f69" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d9096ea6-5189-48d2-9720-d2163418797e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1f8f3554-230a-4a30-b6e3-a309bbd86d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d9096ea6-5189-48d2-9720-d2163418797e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1f8f3554-230a-4a30-b6e3-a309bbd86d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7d0c9f31-08c3-4b3b-8c86-3dad5e68f48e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d9096ea6-5189-48d2-9720-d2163418797e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7d0c9f31-08c3-4b3b-8c86-3dad5e68f48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_76f2a3e5-b964-4271-8c70-d54556509014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d9096ea6-5189-48d2-9720-d2163418797e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_76f2a3e5-b964-4271-8c70-d54556509014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c1de15df-aaeb-44cd-a133-4b13beed78de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d9096ea6-5189-48d2-9720-d2163418797e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c1de15df-aaeb-44cd-a133-4b13beed78de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EarningsPerShareBasicAndDilutedEPSAbstract_9585bf9f-fb0a-4888-be0e-37415fff1676" xlink:href="pets-20230331.xsd#pets_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bcae04dc-fb63-4c59-8478-d06b60dc3f69" xlink:to="loc_pets_EarningsPerShareBasicAndDilutedEPSAbstract_9585bf9f-fb0a-4888-be0e-37415fff1676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b11e45a4-5219-4259-bbc8-8282b7ce3a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pets_EarningsPerShareBasicAndDilutedEPSAbstract_9585bf9f-fb0a-4888-be0e-37415fff1676" xlink:to="loc_us-gaap_EarningsPerShareBasic_b11e45a4-5219-4259-bbc8-8282b7ce3a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b8479888-7463-4c2d-9d39-33c3a53de140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pets_EarningsPerShareBasicAndDilutedEPSAbstract_9585bf9f-fb0a-4888-be0e-37415fff1676" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b8479888-7463-4c2d-9d39-33c3a53de140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#NetIncomePerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2542d382-7710-4523-88ef-214505b640ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b5d5c253-2fd7-43fd-975f-9af3fd9630ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2542d382-7710-4523-88ef-214505b640ff" xlink:to="loc_us-gaap_StatementTable_b5d5c253-2fd7-43fd-975f-9af3fd9630ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c5c9c880-6e32-4f4a-b913-0da96ca5ba3f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b5d5c253-2fd7-43fd-975f-9af3fd9630ba" xlink:to="loc_dei_LegalEntityAxis_c5c9c880-6e32-4f4a-b913-0da96ca5ba3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_11d65b59-c9b8-404e-b58e-23b3ad11ec89" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c5c9c880-6e32-4f4a-b913-0da96ca5ba3f" xlink:to="loc_dei_EntityDomain_11d65b59-c9b8-404e-b58e-23b3ad11ec89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_aa24bc59-400c-46f0-9bb7-26d1f4dd3128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b5d5c253-2fd7-43fd-975f-9af3fd9630ba" xlink:to="loc_us-gaap_StatementLineItems_aa24bc59-400c-46f0-9bb7-26d1f4dd3128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f53ba042-8c5a-4d32-a03a-5412cfcfd74a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_aa24bc59-400c-46f0-9bb7-26d1f4dd3128" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f53ba042-8c5a-4d32-a03a-5412cfcfd74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b284fa0d-4816-4380-9c33-6372fbe421f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b284fa0d-4816-4380-9c33-6372fbe421f4" xlink:to="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_e0fc6b0e-c7ee-4e6f-b0a8-332fdff41f7d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_e0fc6b0e-c7ee-4e6f-b0a8-332fdff41f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4eb274dd-3b52-42d6-be7e-a4a786d711af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_e0fc6b0e-c7ee-4e6f-b0a8-332fdff41f7d" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4eb274dd-3b52-42d6-be7e-a4a786d711af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_DelrayBeachPropertyMember_8167d48f-bae9-4b38-bfad-919eb2a706ec" xlink:href="pets-20230331.xsd#pets_DelrayBeachPropertyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_4eb274dd-3b52-42d6-be7e-a4a786d711af" xlink:to="loc_pets_DelrayBeachPropertyMember_8167d48f-bae9-4b38-bfad-919eb2a706ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_bdcad787-9831-40b5-b773-8fe95d435974" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:to="loc_srt_TitleOfIndividualAxis_bdcad787-9831-40b5-b773-8fe95d435974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_bb3a8475-4c22-43ba-96ed-deefff28d70a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_bdcad787-9831-40b5-b773-8fe95d435974" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_bb3a8475-4c22-43ba-96ed-deefff28d70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_1c179764-7aab-4c21-a9c8-3e1aefa88f27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_bb3a8475-4c22-43ba-96ed-deefff28d70a" xlink:to="loc_srt_ChiefExecutiveOfficerMember_1c179764-7aab-4c21-a9c8-3e1aefa88f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefFinancialOfficerMember_d220b9e9-4690-4f6a-80f2-58cc97aad4d0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefFinancialOfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_bb3a8475-4c22-43ba-96ed-deefff28d70a" xlink:to="loc_srt_ChiefFinancialOfficerMember_d220b9e9-4690-4f6a-80f2-58cc97aad4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_502b573c-29d8-49a0-8d4b-4a4b26d1a13b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:to="loc_us-gaap_PlanNameAxis_502b573c-29d8-49a0-8d4b-4a4b26d1a13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_996f061d-5d8a-4228-a8cd-f3c58a22f2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_502b573c-29d8-49a0-8d4b-4a4b26d1a13b" xlink:to="loc_us-gaap_PlanNameDomain_996f061d-5d8a-4228-a8cd-f3c58a22f2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_b2e443b1-24dd-47cd-ae6e-4068c19c2252" xlink:href="pets-20230331.xsd#pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_996f061d-5d8a-4228-a8cd-f3c58a22f2d3" xlink:to="loc_pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember_b2e443b1-24dd-47cd-ae6e-4068c19c2252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_399c886a-fba0-4ccb-a8c6-384293229cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:to="loc_us-gaap_AwardTypeAxis_399c886a-fba0-4ccb-a8c6-384293229cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_399c886a-fba0-4ccb-a8c6-384293229cff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_980aec9f-236c-4433-b134-7e61144ca681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:to="loc_us-gaap_RestrictedStockMember_980aec9f-236c-4433-b134-7e61144ca681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockMember_c459885a-6ac7-4de6-97c8-6a2f3873410d" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:to="loc_pets_PerformanceRestrictedStockMember_c459885a-6ac7-4de6-97c8-6a2f3873410d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockPriceHurdle1Member_3dfd0f54-331d-4594-b670-d25906a0071c" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockPriceHurdle1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:to="loc_pets_PerformanceRestrictedStockPriceHurdle1Member_3dfd0f54-331d-4594-b670-d25906a0071c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockPriceHurdle2Member_a2a403b2-e679-406c-855d-41f0e50e340b" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockPriceHurdle2Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:to="loc_pets_PerformanceRestrictedStockPriceHurdle2Member_a2a403b2-e679-406c-855d-41f0e50e340b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockPriceHurdle3Member_0624d51f-2790-4807-95a9-564a9256cbd4" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockPriceHurdle3Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:to="loc_pets_PerformanceRestrictedStockPriceHurdle3Member_0624d51f-2790-4807-95a9-564a9256cbd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockPriceHurdle4Member_591beaeb-3708-460e-b363-8d0005aad90c" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockPriceHurdle4Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:to="loc_pets_PerformanceRestrictedStockPriceHurdle4Member_591beaeb-3708-460e-b363-8d0005aad90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PerformanceRestrictedStockPriceHurdle5Member_92d809fa-30f1-49fe-832a-a057205b991b" xlink:href="pets-20230331.xsd#pets_PerformanceRestrictedStockPriceHurdle5Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09758b8a-0a92-4b3f-b8c2-e6106aa9e6c1" xlink:to="loc_pets_PerformanceRestrictedStockPriceHurdle5Member_92d809fa-30f1-49fe-832a-a057205b991b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_240d23b2-b4f3-4c31-95e0-1b2ec3207a25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_240d23b2-b4f3-4c31-95e0-1b2ec3207a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b89a1793-aab5-48c8-bf19-fe204bc40452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_240d23b2-b4f3-4c31-95e0-1b2ec3207a25" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b89a1793-aab5-48c8-bf19-fe204bc40452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PetCareRxMember_58a8344e-483f-48f4-9bfa-651501f6d7bb" xlink:href="pets-20230331.xsd#pets_PetCareRxMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b89a1793-aab5-48c8-bf19-fe204bc40452" xlink:to="loc_pets_PetCareRxMember_58a8344e-483f-48f4-9bfa-651501f6d7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_16d9898f-a1c3-4215-a211-72ed801282a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_16d9898f-a1c3-4215-a211-72ed801282a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8fcd5487-4a07-4fa8-865c-46821951979f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_16d9898f-a1c3-4215-a211-72ed801282a3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8fcd5487-4a07-4fa8-865c-46821951979f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedExpensesAndOtherCurrentLiabilitiesMember_8587d60e-40bd-45fa-aea3-2cfbed5b9dda" xlink:href="pets-20230331.xsd#pets_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8fcd5487-4a07-4fa8-865c-46821951979f" xlink:to="loc_pets_AccruedExpensesAndOtherCurrentLiabilitiesMember_8587d60e-40bd-45fa-aea3-2cfbed5b9dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ad111051-f898-41f1-bb74-968d90101a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8fcd5487-4a07-4fa8-865c-46821951979f" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ad111051-f898-41f1-bb74-968d90101a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_44388c93-142c-46cf-9ebc-645220523dc0" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExciseAndSalesTaxes_a215d802-bdb5-4d0b-a9a4-d8daf22bf28c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExciseAndSalesTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_ExciseAndSalesTaxes_a215d802-bdb5-4d0b-a9a4-d8daf22bf28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_f5639508-2858-4635-ade2-39c7ca6229b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_f5639508-2858-4635-ade2-39c7ca6229b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PercentageOfPropertyLeasedToTenants_c46e4cd7-9d2f-48aa-b81c-674537233482" xlink:href="pets-20230331.xsd#pets_PercentageOfPropertyLeasedToTenants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_PercentageOfPropertyLeasedToTenants_c46e4cd7-9d2f-48aa-b81c-674537233482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_82635e37-1c3b-4362-a799-064c5d17451f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_82635e37-1c3b-4362-a799-064c5d17451f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NumberOfTenants_5cb78bf1-fa67-4b4e-a3da-9a304d6af84d" xlink:href="pets-20230331.xsd#pets_NumberOfTenants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_NumberOfTenants_5cb78bf1-fa67-4b4e-a3da-9a304d6af84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm_96c1d47e-1b94-4491-ac64-ea482367a602" xlink:href="pets-20230331.xsd#pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm_96c1d47e-1b94-4491-ac64-ea482367a602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_f8a75e57-a8a0-42e8-8cad-0774f98ff71c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_f8a75e57-a8a0-42e8-8cad-0774f98ff71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PaymentsForStipend_abb04984-3813-4704-895d-0c5424b35a8a" xlink:href="pets-20230331.xsd#pets_PaymentsForStipend"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_PaymentsForStipend_abb04984-3813-4704-895d-0c5424b35a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NumberOfSeverancePayments_a773ac71-ced6-456c-ba07-9aa0de1a3a6a" xlink:href="pets-20230331.xsd#pets_NumberOfSeverancePayments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_NumberOfSeverancePayments_a773ac71-ced6-456c-ba07-9aa0de1a3a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_LumpSumSeverancePayments_5f5a5e60-9149-4966-8591-8b3aecdd5615" xlink:href="pets-20230331.xsd#pets_LumpSumSeverancePayments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_LumpSumSeverancePayments_5f5a5e60-9149-4966-8591-8b3aecdd5615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_00830b44-3888-4017-9846-10df9aea4993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_00830b44-3888-4017-9846-10df9aea4993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmploymentTermInitialPeriod_96b0b086-c03e-49f0-830a-a3287f39a519" xlink:href="pets-20230331.xsd#pets_EmploymentTermInitialPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_EmploymentTermInitialPeriod_96b0b086-c03e-49f0-830a-a3287f39a519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmploymentTermSuccessiveRenewalPeriod_171f055b-f52f-4a5c-8826-7b6f18c67525" xlink:href="pets-20230331.xsd#pets_EmploymentTermSuccessiveRenewalPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_EmploymentTermSuccessiveRenewalPeriod_171f055b-f52f-4a5c-8826-7b6f18c67525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm_9e9381ca-4c7b-47ad-829f-efad599cc4c7" xlink:href="pets-20230331.xsd#pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm_9e9381ca-4c7b-47ad-829f-efad599cc4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficersCompensation_f0794e01-c538-4768-a931-ed6f3560adc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficersCompensation"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_OfficersCompensation_f0794e01-c538-4768-a931-ed6f3560adc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TerminationPeriodPeriodWithinChangeInControl_42603387-4d45-4f8c-a56c-1faeb138b499" xlink:href="pets-20230331.xsd#pets_TerminationPeriodPeriodWithinChangeInControl"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_TerminationPeriodPeriodWithinChangeInControl_42603387-4d45-4f8c-a56c-1faeb138b499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SeverancePaymentBaseSalaryPeriod_e522d3b1-904e-4343-a573-6a91b05f8e90" xlink:href="pets-20230331.xsd#pets_SeverancePaymentBaseSalaryPeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_SeverancePaymentBaseSalaryPeriod_e522d3b1-904e-4343-a573-6a91b05f8e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod_afe71926-75fc-4171-9813-27fa2f446968" xlink:href="pets-20230331.xsd#pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod_afe71926-75fc-4171-9813-27fa2f446968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod_21540b5e-1c92-4b61-994d-e00cf5dc3b64" xlink:href="pets-20230331.xsd#pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod_21540b5e-1c92-4b61-994d-e00cf5dc3b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NonCompeteAgreementPeriod_c582babd-3cfc-4935-9894-003cfec66d37" xlink:href="pets-20230331.xsd#pets_NonCompeteAgreementPeriod"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_NonCompeteAgreementPeriod_c582babd-3cfc-4935-9894-003cfec66d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8e73f1e3-8394-4d68-b911-3620a37c5232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8e73f1e3-8394-4d68-b911-3620a37c5232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod_ebeced0b-db6c-48e4-990a-7cd4cf30ea97" xlink:href="pets-20230331.xsd#pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod_ebeced0b-db6c-48e4-990a-7cd4cf30ea97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod_c4679c30-cc33-4f08-a83e-622db8524bdc" xlink:href="pets-20230331.xsd#pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod_c4679c30-cc33-4f08-a83e-622db8524bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c35a962b-4577-492c-87c0-b5b6c263d143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c35a962b-4577-492c-87c0-b5b6c263d143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod_f2b3cd46-7da8-4b7e-9446-152b16876b2f" xlink:href="pets-20230331.xsd#pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod_f2b3cd46-7da8-4b7e-9446-152b16876b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_SalaryAndWageOfficerSignOnBonus_ae517d0a-0fea-4dca-ac4a-73a58e280d7a" xlink:href="pets-20230331.xsd#pets_SalaryAndWageOfficerSignOnBonus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_SalaryAndWageOfficerSignOnBonus_ae517d0a-0fea-4dca-ac4a-73a58e280d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc235ca8-d21f-4c19-9232-6ac2a99b5bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc235ca8-d21f-4c19-9232-6ac2a99b5bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ContingentLumpSumSeverancePayment_7f68ed1f-4d76-4357-b159-f9740897fa42" xlink:href="pets-20230331.xsd#pets_ContingentLumpSumSeverancePayment"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_ContingentLumpSumSeverancePayment_7f68ed1f-4d76-4357-b159-f9740897fa42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_AccruedSeveranceCosts_a2bb9af3-6bc4-42f3-9d81-b8dad1523f29" xlink:href="pets-20230331.xsd#pets_AccruedSeveranceCosts"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0fdf7bdb-5bb1-469d-a2f4-aafb13fd73ad" xlink:to="loc_pets_AccruedSeveranceCosts_a2bb9af3-6bc4-42f3-9d81-b8dad1523f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/EmployeeBenefitPlanDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#EmployeeBenefitPlanDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/EmployeeBenefitPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_15815e21-8d42-4116-98f2-5e8731512ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_6ceea4a4-b573-4c70-bba9-5e1698ad74f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_15815e21-8d42-4116-98f2-5e8731512ec1" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_6ceea4a4-b573-4c70-bba9-5e1698ad74f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_DefinedContributionPlanWithIndividualAge_106279d4-d83e-46d0-9238-a5e3350e5b53" xlink:href="pets-20230331.xsd#pets_DefinedContributionPlanWithIndividualAge"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_15815e21-8d42-4116-98f2-5e8731512ec1" xlink:to="loc_pets_DefinedContributionPlanWithIndividualAge_106279d4-d83e-46d0-9238-a5e3350e5b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_656b8368-6558-4a53-a755-fbda78103032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_15815e21-8d42-4116-98f2-5e8731512ec1" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_656b8368-6558-4a53-a755-fbda78103032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_e2417c11-89f7-409f-9836-b314d4db1518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_15815e21-8d42-4116-98f2-5e8731512ec1" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_e2417c11-89f7-409f-9836-b314d4db1518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_dbeae2fa-16eb-409d-a407-f046aae8bfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_15815e21-8d42-4116-98f2-5e8731512ec1" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_dbeae2fa-16eb-409d-a407-f046aae8bfa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#MinorityInterestInvestmentinVetsterDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_9a3d4b14-f465-487f-998b-9cdeb8e056ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_a835935c-bb3e-4106-a21b-d719c7970868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_9a3d4b14-f465-487f-998b-9cdeb8e056ba" xlink:to="loc_us-gaap_MinorityInterestTable_a835935c-bb3e-4106-a21b-d719c7970868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_99ed71a5-4d0e-4718-8eb8-63d9e7e7c048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_a835935c-bb3e-4106-a21b-d719c7970868" xlink:to="loc_us-gaap_TypeOfArrangementAxis_99ed71a5-4d0e-4718-8eb8-63d9e7e7c048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24497599-5f85-437e-ad43-16b8ee8dafdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_99ed71a5-4d0e-4718-8eb8-63d9e7e7c048" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24497599-5f85-437e-ad43-16b8ee8dafdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PartnershipAgreementWithVetsterMember_1e9b262f-05e4-47f6-9a25-facc12244945" xlink:href="pets-20230331.xsd#pets_PartnershipAgreementWithVetsterMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24497599-5f85-437e-ad43-16b8ee8dafdc" xlink:to="loc_pets_PartnershipAgreementWithVetsterMember_1e9b262f-05e4-47f6-9a25-facc12244945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_49d579bf-4fa2-40f4-946a-97cdf18ca73c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_a835935c-bb3e-4106-a21b-d719c7970868" xlink:to="loc_us-gaap_MinorityInterestLineItems_49d579bf-4fa2-40f4-946a-97cdf18ca73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TermOfAgreement_487b6884-7ff2-489f-8f5c-207e34111b8d" xlink:href="pets-20230331.xsd#pets_TermOfAgreement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_49d579bf-4fa2-40f4-946a-97cdf18ca73c" xlink:to="loc_pets_TermOfAgreement_487b6884-7ff2-489f-8f5c-207e34111b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_NoncontrollingInterestOwnershipPercentagePurchased_ce80a996-929b-449b-af26-b52be6ae0b78" xlink:href="pets-20230331.xsd#pets_NoncontrollingInterestOwnershipPercentagePurchased"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_49d579bf-4fa2-40f4-946a-97cdf18ca73c" xlink:to="loc_pets_NoncontrollingInterestOwnershipPercentagePurchased_ce80a996-929b-449b-af26-b52be6ae0b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_ca173f08-e2c1-43ac-bfec-3f0e4bddd0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_49d579bf-4fa2-40f4-946a-97cdf18ca73c" xlink:to="loc_us-gaap_Investments_ca173f08-e2c1-43ac-bfec-3f0e4bddd0e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_d634d1b7-19fd-46a7-90fb-05b5d6904f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_d634d1b7-19fd-46a7-90fb-05b5d6904f8e" xlink:to="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5787891d-5081-49dd-85c9-4033d88c05ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5787891d-5081-49dd-85c9-4033d88c05ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a30e270d-0b48-4947-9a5f-fc6b3e17be32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5787891d-5081-49dd-85c9-4033d88c05ca" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a30e270d-0b48-4947-9a5f-fc6b3e17be32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_PetCareRxMember_5a530f5f-82ba-4a13-b089-00a81727115d" xlink:href="pets-20230331.xsd#pets_PetCareRxMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a30e270d-0b48-4947-9a5f-fc6b3e17be32" xlink:to="loc_pets_PetCareRxMember_5a530f5f-82ba-4a13-b089-00a81727115d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3b117fc9-1b96-4c4b-8853-e6e5056a324d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:to="loc_us-gaap_AwardTypeAxis_3b117fc9-1b96-4c4b-8853-e6e5056a324d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_16dc2583-04d4-4a8c-8ef5-e97e472bdafd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3b117fc9-1b96-4c4b-8853-e6e5056a324d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_16dc2583-04d4-4a8c-8ef5-e97e472bdafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_02cea464-0fe8-4b37-8faa-5c091e7516d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_16dc2583-04d4-4a8c-8ef5-e97e472bdafd" xlink:to="loc_us-gaap_RestrictedStockMember_02cea464-0fe8-4b37-8faa-5c091e7516d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_e3e81d15-f0f6-474d-99e6-a42ab7e6cd4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:to="loc_us-gaap_GranteeStatusAxis_e3e81d15-f0f6-474d-99e6-a42ab7e6cd4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_94b5a407-c88b-4a17-a024-addb91227763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_e3e81d15-f0f6-474d-99e6-a42ab7e6cd4c" xlink:to="loc_us-gaap_GranteeStatusDomain_94b5a407-c88b-4a17-a024-addb91227763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_b0ea18a0-1fbd-476f-9e4c-49a45695a919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_94b5a407-c88b-4a17-a024-addb91227763" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_b0ea18a0-1fbd-476f-9e4c-49a45695a919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3dfafbf4-d44b-449b-bb46-f5893c864edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:to="loc_us-gaap_PlanNameAxis_3dfafbf4-d44b-449b-bb46-f5893c864edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_027cf063-57a5-43ab-9b6d-2e6bcbb61511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3dfafbf4-d44b-449b-bb46-f5893c864edf" xlink:to="loc_us-gaap_PlanNameDomain_027cf063-57a5-43ab-9b6d-2e6bcbb61511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_d9b2a66f-5cb3-4b09-9a5a-3850b02bce96" xlink:href="pets-20230331.xsd#pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_027cf063-57a5-43ab-9b6d-2e6bcbb61511" xlink:to="loc_pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember_d9b2a66f-5cb3-4b09-9a5a-3850b02bce96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember_85ef4cd3-3276-4c8c-8312-0cbb37542c41" xlink:href="pets-20230331.xsd#pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_027cf063-57a5-43ab-9b6d-2e6bcbb61511" xlink:to="loc_pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember_85ef4cd3-3276-4c8c-8312-0cbb37542c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fa72d7f1-a61e-4aed-ba49-634b598d3696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fa72d7f1-a61e-4aed-ba49-634b598d3696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c2a3952e-5736-421b-8afe-4ce6b944ad9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fa72d7f1-a61e-4aed-ba49-634b598d3696" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c2a3952e-5736-421b-8afe-4ce6b944ad9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8dc85066-aac5-4ef6-b79a-c8e875851de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c2a3952e-5736-421b-8afe-4ce6b944ad9f" xlink:to="loc_us-gaap_SubsequentEventMember_8dc85066-aac5-4ef6-b79a-c8e875851de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_faf3d6a9-c561-4856-815a-8b50b92df62d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:to="loc_srt_TitleOfIndividualAxis_faf3d6a9-c561-4856-815a-8b50b92df62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_de992929-d202-434a-a4ac-efdd4c4ee1bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_faf3d6a9-c561-4856-815a-8b50b92df62d" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_de992929-d202-434a-a4ac-efdd4c4ee1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_01d96c24-1cf0-4109-9a7c-a21b87cf12c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_de992929-d202-434a-a4ac-efdd4c4ee1bc" xlink:to="loc_srt_DirectorMember_01d96c24-1cf0-4109-9a7c-a21b87cf12c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_a20d59b5-9a40-4f77-b352-1d9a058eb3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_32329cc4-2bfd-4973-9083-5a070c019da3" xlink:to="loc_us-gaap_SubsequentEventLineItems_a20d59b5-9a40-4f77-b352-1d9a058eb3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5d64d169-433b-4e3a-99e5-523d6554d7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a20d59b5-9a40-4f77-b352-1d9a058eb3fd" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5d64d169-433b-4e3a-99e5-523d6554d7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8dad8d45-0ccb-4318-9674-c04e02ebab17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a20d59b5-9a40-4f77-b352-1d9a058eb3fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8dad8d45-0ccb-4318-9674-c04e02ebab17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_002d3ddc-15da-4d30-93ac-7a0d169316ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a20d59b5-9a40-4f77-b352-1d9a058eb3fd" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_002d3ddc-15da-4d30-93ac-7a0d169316ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_2f878d35-fe44-46bd-b735-8b4949a7ffa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a20d59b5-9a40-4f77-b352-1d9a058eb3fd" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_2f878d35-fe44-46bd-b735-8b4949a7ffa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/RelatedPartyTransactionDetails" xlink:type="simple" xlink:href="pets-20230331.xsd#RelatedPartyTransactionDetails"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/RelatedPartyTransactionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_c124bd7e-c0c8-4157-81a5-24e2696c2816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1fa4f2a5-1e78-4afd-bc3e-94123383aec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_c124bd7e-c0c8-4157-81a5-24e2696c2816" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1fa4f2a5-1e78-4afd-bc3e-94123383aec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6263d32a-163a-4784-a673-56e5abfe1926" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1fa4f2a5-1e78-4afd-bc3e-94123383aec0" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6263d32a-163a-4784-a673-56e5abfe1926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_923ef7c5-a73d-4cd2-aeb5-ee152435b9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6263d32a-163a-4784-a673-56e5abfe1926" xlink:to="loc_us-gaap_RelatedPartyDomain_923ef7c5-a73d-4cd2-aeb5-ee152435b9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pets_ProphetMember_7b395eee-740a-48eb-8105-8d16b8f02b65" xlink:href="pets-20230331.xsd#pets_ProphetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_923ef7c5-a73d-4cd2-aeb5-ee152435b9fd" xlink:to="loc_pets_ProphetMember_7b395eee-740a-48eb-8105-8d16b8f02b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_526ccb4a-6df1-4ce9-82fc-caa6cc19777f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1fa4f2a5-1e78-4afd-bc3e-94123383aec0" xlink:to="loc_us-gaap_StatementLineItems_526ccb4a-6df1-4ce9-82fc-caa6cc19777f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_ab0082f4-7521-49d0-9b61-2747f1f85663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_526ccb4a-6df1-4ce9-82fc-caa6cc19777f" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_ab0082f4-7521-49d0-9b61-2747f1f85663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_4c37efff-834d-49b0-abf1-a610f8d84a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_526ccb4a-6df1-4ce9-82fc-caa6cc19777f" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_4c37efff-834d-49b0-abf1-a610f8d84a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_b3d1b324-8d78-4df2-928f-7d2ee5b3da6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_526ccb4a-6df1-4ce9-82fc-caa6cc19777f" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_b3d1b324-8d78-4df2-928f-7d2ee5b3da6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_1.jpg
<DESCRIPTION>EX-4.2
<TEXT>
begin 644 image_1.jpg
MB5!.1PT*&@H    -24A$4@  '4P    +" (    _RG5D   !2DE$051X7NW;
ML0W# !#$,.^_=-RK3/'& >0:@IX'                    OO8#      #8
MU.P!                    ]WK# P      C&CV
M@'N]X0$      $8T>P                   ,"]WO         CFCT
M              #@7F]X      " $<T>                    <*\W/
M    P(AF#P                   +C7&QX      &!$LP<
M      #<ZPT/       PHMD#                    [O6&!P      &-'L
M 0                   /=ZPP,      (S0.0
;     .!/+[(EK+CB\\@      $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>pets-20230331_g1.jpg
<DESCRIPTION>10-K
<TEXT>
begin 644 pets-20230331_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7X5_#7P9_P4:_X*W^*/C?^W!X/_P""A^L?#&V^&'BB_M?!_@ZQU*[A
MM[>.VC:>.)UAGC2VC\H1JT[)*96$A=<+S^ZE?F)^T7_P;/\ PV^+7[0?B?XL
M?!_]KKQ5\./#'CK4'N_&?@?2M)\^*\:60R31Q3"YB6.)G9F6.2*94+''RX4
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MX8\*>%9X)7U.ZM9S<6[&.VW0Q1FXVSRN[EW$:1"-5.8_LS]ICX1_\%=_$/\
MP53^&'Q*_9X^-NDZ7^S1IVEV*?$;PG<75LMS?7*SWAN&1'MFD(:)[0#;*OW#
M@#DG[3HH _)C_@J1_P $>?V^M(_X*5Z3_P %@_\ @D=XO\,+\1GTY+3Q=X/\
M53)#%?NEG]B\Z,R8AECDM1'')&[1LK1+(CEF^3H_^"*7_!'C]K?X"_M>?$O_
M (*C_P#!3'QMH.K?&?XBP36EGHWA^99H-(@FDB::1W51&)"L$,,<<6Y8X48%
MV+X3]1** /Q;^.__  1Z_P""NW[ _P#P4/\ B9^VS_P17\6>"M2T7XRFZE\1
M^%?%<\$4FDW-U<?:9B([G;#)&EP7EA=7#(LC1&-E&9/IW_@W^_X([^//^"6_
MPF\;>./VC?'&G^)/B[\5]8AU#QC>Z7*\UO911&5HK9)756FD,EQ/++(%56:1
M5 81AV_0>B@ HHHH *\+_:P_Y+9\#_\ L>Y?_29J]TKPO]K#_DMGP/\ ^Q[E
M_P#29J /=**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "OP;_:"_;/_P"#BWX%?MKZ=^QEXQ_:<T?2-;\7
M:@R^!;^[\,>'8]+U>)W981#=RZ>!N9@(MLFU]Y56 ++G]Y*^'O\ @KK\0/\
M@COK\/AWX>?\%&OC-8Z;K?A;41JV@66A7]X=:L)'3 ;9IZ23Q1R81OG"JQB1
ML_(" #Y>_P"$ _X.Z/\ HM_A?_P$\)__ "%7V[_P2QT3_@I[HGPU\3P_\%0O
M%^G:QXD?7(V\,RZ=%IBK'8^2-ZG^SX8DSYF3\X+>^*XCP3_P<-_\$C_$VH0>
M'E_:EGL96VQQ7.M^$=4ACD/3+2FVV)GJ2Y45]C>!/'O@?XH>$+#X@?#;Q?IF
MOZ%JMN)]-UC1[Z.YMKJ,G&^.2,E7&01D'J"* -:BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KPO]K#_DMGP/_P"Q[E_])FKW2O"_VL/^2V? _P#['N7_
M -)FH ]THHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *_GI_8[N/\ @EU8?M<_'0?\%M;?4S\3O^%BWAL7
M\21ZH^G[?.D\SBQR=Y;!'G#RO*\OR^]?T+5^0G_!67_@HO\ \$,M:_:-U#X0
M_M+?LA:E\5_$_ARX_L[Q+XL\*6Z64MG+$=K6@O([JWFN7B(*E-WEH05#9#
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M31=?NM*ADO=/61&CD$$[*9(@R.ZL%(RKL#P30!^1'[;'[#O[17_!%3]HN?\
MX*2_\$R=!EO_ (;7F1\2?AH@DDM[&W+;G!C7YC9YRRNN6M7Y_P!42!T__!H^
M=W[+WQ7;'7Q_;_\ I$E?K4Z)(ACD0,K##*PR"/2N3^%GP#^"7P-DUA_@Q\)O
M#WA0>(+\7VM1^'=)BLTO+G;M\YTB55+D=6QD]\T =;1110 4444 %%%% !11
M10 4444 %%%% !1110 5X7^UA_R6SX'_ /8]R_\ I,U>Z5X7^UA_R6SX'_\
M8]R_^DS4 >Z4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%?G'K/_!T7_P $UM"UB[T2]T+XG&:SN9()
MBGA:V*[D8J<'[7R,B@#]$/$-]?:9H%]J6EV1N;FWLY9;>V52QED5"53 Y.2
M,#GFOSY_9'_X*?\ _!4CXB36GC+]IK_@EKK7AWP:_BNRT+59M-TW4[36M/\
MM3(D=^NG7D6^\M$=U$KQ'* LV"$(.9_Q%0?\$S/^@#\4/_"5MO\ Y+KZH_8!
M_P""C_[/G_!2/P/KWQ _9ZLO$4%AX=U9-/U >(]-CMI#,T0D&P)+("NTCDD<
M]J /?:*** "BBB@ HHHH **** "BBB@ HHHH **** "O"_VL/^2V? __ +'N
M7_TF:O=*\+_:P_Y+9\#_ /L>Y?\ TF:@#W2BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOX-UN_TY84/F1*_V2SFA2QB+8%OO,EQ*'>?*Y$_[)?\ !2G_ (*Y?L:^&?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *^'O^#B/QA\;O!/_  2X\8ZK\$;_ %&S>;5-/MO$][I4C)/!
MI$DVV8AD^949S#&Y'6.1P?E)K[AK\A/B)_P;C?MJ>/=3UR74O^"L6O'2M9N+
MEI]*NK/4I(/(E9B874W^UDVMM((P1VQ0!6^%_P#P:@_LM^+_ (;Z#XLOOVP?
M%VI2ZII%O>-J&AV-D+.X\V-7$D&Y7/ED-E26.1@U]U_\$R/^"8OPT_X)@_#K
MQ)\.?AG\1]=\26_B76H]2N;C78H4>%UA$05?*51C SSSFOSD\.?\&]WQQ^'/
MPE?QMX1_X+36VA>!-/CED?5M,DNK;2;9$D9)7,L>I"%%60,K'( 8$'!!K]"/
M^"3O[#_Q5_8D^$>OZ%\3_P!K:Z^,'_"4:M#JFD:[.\[I!;>0JA(VEN)MR-]\
M%6 .?QH ^K**** "BBB@ HHHH **** "BBB@ HHHH **** "O"_VL/\ DMGP
M/_['N7_TF:O=*\+_ &L/^2V? _\ ['N7_P!)FH ]THHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^#_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU'_Z1/:2T?O;^L4445]>?SF%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !6)\2?B1X#^#_@+5OBA\3_%=EH?A[0K&2\U?5M0F"0VT*#+,Q_0 9))
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M_P#MG_ ;Q9*+?Q'::U;"2QF.)2+#5=4M[D[3SA9+B('T+CUIW_!K];'XE_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M79ET^UDW//;0$]88RT*_+\OF";^+?0!^EU%%% !1110 4444 %%%% !1110
M4444 %%%% !7A?[6'_);/@?_ -CW+_Z3-7NE>%_M8?\ );/@?_V/<O\ Z3-0
M![I1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"-J_POUKQ&Z=)-<\578R?4K;/"I^F,>U>P>"/^"<?[!OP[V-X7_9(\!"2/\
MU<]_X=AO)5/J'N%=@??.:]7DXSK[SHTUY*4G^.A\%]9^C3E7\.AF6,DOYY4*
M,'Z<EYKYGPOXD_X.6Y=8O?[&^#W[&=]J%Q(?W#ZEXHRY_P"V$%LQ/X/6<?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%X>\-.'^"<HI<3>(O-"$US8? Q=J^([.?6E1[MVDUV?*I^%?L[_\$K?VJ/\
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MN/Q]656M5DY3G)W<F]VW_22T6@4445J>>%%%% !1110 4444 %%%% !1110
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M5H-EJ=A<+MN++4+5)H91Z,C@JP^HKYA^.7_!%G_@GC\<?.NYO@DGA/4)L_\
M$Q\$71TXIGT@ :V_.(UC]1XIP'^[XF-:/:I&S_\  H[OU/0_UJ\!>*],XR6M
MEM5[U,'54X7[NC6TC'NH7=MM3Z5\%^/O OQ(T./Q-\//&FDZ]ILO^JU#1=1B
MNH'^DD3,I_.M:ORG\:?\&]OQX^#FN2>./V(/VR[S3+].;>#59+C2[E0.0OVR
MR+;S]8D&>_/&3_PTC_P7\_8=_=_%SX33_$?P_:?>O+G1TU9!$.KFYTYEF3_>
MGS@]1VH_UCQN#TS#!SA_>A:<?5M;?B'_ !!CACB/WN#^),-B9/:EB.;"UO\
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MY\XAXBSOBO-ZN:9M7E6KU'>4I/7R26RBME%)12T22"BBBND\4**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN1^+7Q^^!'P#T?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 45_(+_P 11?\ P75_Z/E_\QGX8_\ E91_Q%%_\%U?^CY?_,9^&/\
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M?^I/JU??U? /_!KI_P H*O@;_P!S-_ZD^K5]_4 %%%% !1110 4444 %%%%
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MS^QQ)\4/^"5LD-UXX\/ZPEQKNA+X=@U.\U'23'(LOV.&97$D\<AB<1A2SH)
MH+!58 _+WPK_ ,%%/^"\G_!"S]ESX-WG[6W["_P]C^ FD6&F^&3IFFW7_$XM
M@(2P,\T5Y+]GO)@DLA+Q-%OW(5C8@56_X+^?&CP/^VC_ ,%3?^">\'A^].J_
M#CQU!X:UW28;N/"3VNLZ[:I)OC)(5F@AA5U/3&#TKG_^"@O_  5)_;!_X+N?
MLK^#?^":/P&_X)O_ !%TOXE:KXCTVX^(^IZMIS1Z;8S6JG<4<HOV:%IG61I;
MCRQ$B;,.6W#U;_@MW_P21_:7_9U_9P_8_P#VC?V2?!=[\1-?_92T/2])\5V.
MC6<D]S=I9/:W4-_% @,C0+=07&]5#,B7"-C:CL "E_P=@7'_  JO_@I1^Q;\
M>O",0M_$=IK3%+V$8E(L=8TZXMUR.2%>XF('^VWK7[Q5_/1XK\<_M!?\'*__
M  5D^ /COP=^QWXT^'OPA^"\UO?>,]7\76S")6CO8[N[A\[8L9DF-O!;11+N
MD^]*RJH8)^HG[3'_  4Y_:%^!W_!5/X8?L">#_V+-6\3>"?'6EV-UK/Q5MY+
ML6VBO//>1O&X2V>'*+;1L=TJG]\,@<$@'YW_ +%TY^+W_!Y=\:?%7C2,7-UX
M5T35ET5IQN^S?9]/L-.C*9^[^XDD'']]O4TOP4N/^%1_\'M?Q \&^"(A9V'B
MS0YDU>"W&U9?/\(V>J2E@.NZZB60^K<]:?\ \%#_  3^T7_P1K_X+[3_ /!7
MWPQ^S5XF^(GP=^(FCM#XE/A*T:633YY+".UN8)&"L(9/.MXKI#(%257:-7#*
MQ7H_^"'GP*_:0_;V_P""S/Q:_P""XOQN^ .N_#SP;J-A/8_#_3_$EL\-Q>S/
M;6]A$T8=5,L<5C;LLDJ@(99@J%MKA0#F/^#2><_%7_@H'^VA\?O%T8N/$=YK
M5L9+Z89E O\ 5=4N+@;CSAI+>(D=R@]*7_@U^N/^%:_\%C/VVO@#X2C%KX;@
MUS4G@L8!MBC^P>(;JVMP%' VQW,@'L:X7X>>//VB?^#9[_@J3^T!XF\<?L;>
M-/B%\)?C)<SWG@C6?"-LQAE)O9;JQB,^QD62(7,UO+$V) =LBJRE=_T[_P &
ML/[#/[27P_O_ (W?\%'/VLOAK?\ A#Q#\<?$'G>']!U:S>VNDLVN;B\N;IX9
M 'CCFGGC6,.%8K;E\%71B ?K_1110!P?Q!_:>^ 'PJ\1MX2^(GQ4TO2-22%)
M6L[N1@X1N5;@'@UXG\:_VB?@C\7/CO\ !BP^&OQ(TW6)K/QPS7,=F[$QAX"B
MDY ZL0*^E-6\$>"]>O#J&N>$-+O;@J%,]WI\<CD#H-S*3BO#?VF?!_A+P_\
M'#X)2Z#X6TZQ:3QU()&L[&.(L!;L1G:!G!YH ^AJ*** "BBB@ HHHH ****
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M;1    K[0#$?U$TW3=.T;3H-(TBP@M+2UA6&UM;:(1QPQJ %154 *H   '
MJ:BO;RK*,'E%%PHJ\GK*3UE)]V_Z1^7\>^(O$GB)F<<3F4U&G37+2HP7+2HP
MV4:<%HM$DWK)V5W9)(HHHKU#X,**** "BBB@ HKA_P!H7]I?X ?LG?#:[^+_
M .TE\7]!\%^&[+B75=?U!($=\$B*,'YII3@[8XPSL> I-?B[^V;_ ,'7?QK_
M &D/B$?V5/\ @B/^S;KOBCQ'J;M;V7C?5?#KWEY-V,UCI8!V*.&\Z[^51G?
MN,T ?SPUTO\ PJKQ3_PJS_A;GV;_ (EG]I_8^AW=/]9_N;ODS_>XK-\&^%=5
M\<>*K#PCHL>ZZU"Y6&+(X7)Y8^P&2?8&OO#_ (57X6_X5;_PJ3[-_P 2S^S/
ML?0;NG^L_P!_=\^?[W-?*<2<20R.=&"5W*5Y+M!;_-]/1GQ/%W%M/ANIAZ:5
MY3DG)=J:W?J^GHS\_*_H#\)?\&=_[6/Q\UR'QK_P4(_X*@7&M:EG=<II-K?Z
M_/)G[P6]U*:)E^IA;/I7X@Z[^RE\=]$O)H!X#GNHHY&6.XM)HI!*H/# *Q8
MCG! //(K^U_PK^W/^Q;XVVIX4_:T^&][(W2"+QI8^;^*&4,/RKW:69Y;75Z=
M:#])+_,^DH9SE&)2=+$0E?M*+_4^$?@)_P &B7_!(3X1>1=?$/PQXY^)=U&
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MG^5SC=@X8$#Z^HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OD/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *^)?^#A3QS\'_!/_!+CQQ%\
M8O DWB&+6KJSTWP]:V]UY#VVJO)OM[H2[6V>3Y;R$8/F!3&<"0D?;5?'G_!=
MSX=>+OBS_P $WO%WP^\!?L^:M\2=8U+4+"/3M$T*UGEO+643@K>Q+ CL3$1D
MC&UE+*W#&@#X4^!_[>O_  <VZ!\*M"TVP_8BM_%%I%I<"V6M>*/!,Z7US"$
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M:X8[!&JKG[5=;C@1+E5;A\D&,\+^P#_P1B\6>.?&0_:]_P""EE[=>)/%&JW
MO[?P=J]QYY\PX*RZBQR'8#&+8?(@ 5\\QK[I_P $UO\ @D-\(OV'--M_B'XU
M-KXK^)DT/^D:_)#FWTK<,-%9(PRO!*F9@)'&<;%8I7V'7D83)L7FE>.-S?6V
ML*2UC#SE_-+\/R7Z)G_B3P]P)E-7AKPZO%37+B,?)<M?$=XTNM&CV2M)^3O*
M;+>WM[2W2UM8$BBB0)''&H544#   X  [4^BBOK3^>FVW=A1110(**"0!DG
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M(8XK"_L;VSAGMKT>8#&KK*,*0Q.'!4J&8;@&;/Z!_P##\#_@IK\!/W?[4W[
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MGQ*T#Q%!MW>=H6LP7:8]<Q,PQ6_7K1E&<;Q=T>Y"<*D>:+NO(****HH****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K\:?\ @N?_ ,%1/^"CWP8G\9_LU:%\!->\ Z'8ZY9SZ#\;/!NK
M:A EU9,PDB7STC6.-Y ?*DC\SAU8#<,$_LM7S;_P5F_:%^ /[+_[$7B;XN_M
M%_!'0_B/I%G<6L.F>"O$6G07-KJ>I22A;=66>.1%"G=(7VDJL;%06P" ?GUX
M#_X.!/\ @IOIW@;1M/7_ ()->+-<$&DVT8UJ6QUF1M0VQ*/M!86AW%\;\Y.=
MV<FOI7_@@%>?MY^+/AC\4?BQ^VY:>.+%/%7CD7G@W1_'MU>O<65OY;&5+>.]
M8RQVH+Q)&.%/EL1GJ?*OVR/^"U/[6/PD\$?L\_L_?LH?LRZ1;_&3XI^!]/U?
M5/!^J:+/Y>C+*/)ALK:U\R(INDAG(\QL1PQKD'=N7ZH_X)'?\%$?%?\ P4$^
M!_B"\^+_ ,.8O"/Q(^'_ (FE\/>//#]NDB1172#(E2.0L\0)$B&-V9E>%QDC
M!H ^KZ*** "BBB@ HHHH **** "BBB@ HHHH **** "O"_VL/^2V? __ +'N
M7_TF:O=*\+_:P_Y+9\#_ /L>Y?\ TF:@#W2BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF=X7+&J=G.K+X81UD_\ )>;^5SY_.N(\%D[C2LZE>7PTXZR?^2\WYVN?0/\
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M[*N?+QU\E<R-QG8&#U\O?M8?\%@_VB_VVOB&_P"R-_P2P\&:TZZ@6ANO&-M
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M/@*F*HSJ4N5:<DVKOHM;[L^5SKAK(L@RRKC:%2K0Y%=*%22N^BUYMW9'X_\
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M_(\#M_\ @X?_ ."?,\>^6/QW"<_<D\-1D_\ CLY'ZT__ (B&O^">O_/;QO\
M^$RO_P >KW*X_P""8O\ P3YNI/-E_9 \" XQB/0XT'Y+@5'_ ,.O?^">O_1H
M7@C_ ,%"T>PXR_Y_4?\ P&0?VK]&M_\ ,NS'_P '4?\ (\1_XB&O^">O_/;Q
MO_X3*_\ QZN!_:9_X.*_V?-.^$.H)^RSH&NZEXTNU,&F/X@TA8+2QR.;F3]X
MQEV_PQ@?,WWB!U^K/^'7O_!/7_HT+P1_X*%KPC]OC_@AS^SM\;OA/+>?LL^
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MOV%/^"&>JZYXK'[4'_!2S79_%WBW4K@7I\(7M^;J-93@A]0GR?M+CC]RI,0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI]K,%>3>-?\ @\6_8ZTH/_P@G[&GQLUG'^K^VZ/:66[ZXFDQ^M=[X4_X-O\
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M7KA-5_X+#?\ !QA\77$3^.?$VB&X/R'[!'H7?&09'A 'Z?A7[(_\0S'[)_\
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MM;:T$G^)'_!9']F#1X9>L3?'BYGD'&2-@MU3T'#_ -,]AH/_  ;/?"O7\?\
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MQ7#6O_!MY^P';R;Y?%WQ+G&,;)?$-F!]?ELP?UJQ_P 0Y'_!/O\ Z#'Q#_\
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MY_"OW^HH _ '_B*R_P""M_PC!/[2'_!(I;01G]]_Q(=>T3&.O_'TD^/QK?\
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MUW]I[+RBMDOQ]-C?*.&:>#Q'U[&S]OB7O.6T?*"VBOQ]+V"BBBOH#ZD****
M"BBB@ HHHH **** "BBB@ HK\%_^"_7_  7Y^-EO\;/$/[$7[$?Q!NO"NC>%
M;I]-\:^-=$G\O4-1U!,K/:6TZG=;0PMF-G3;(\B. P0?/^/O_"TOB;_PEG_"
M??\ "QM>_MWS?-_MK^UYOM>_.=WG;M^<\YSFOZ[X!^B)Q/Q;P[2S7,L='!^V
MBITZ;INI/E:O%S]^"A=:V]YI/5)W2^?Q7$%##UG3A'FMN[V^[<_MJHK\%_\
M@@+_ ,%^?C9<?&SP]^Q%^VY\0;KQ5HWBJZ33?!7C76I_,U#3M0?"P6ES.QW7
M,,S8C5WW2)(Z L4/R?O17X/XE^&G$7A9Q$\JS5)W7-3J1NX5(-M75TFFFFI1
M:NGW33?JX+&T<=1]I3^:[!1117YX=84444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7>TF\JZL;B-@\-U;RX/ES1N 5)!4\JRLC,I]5HH _)C]FG_@TG_9>^$7QO\
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M _[+GCSQ9,F0DWB&_M-&@D/JIC-T^WZHI]J\N/\ P7>_X+O_ +7'^C?L9_\
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M>%KE-1\%>"=;@\O4-1U!,-!=W,##=;0PMB14?;(\B(2H0?/^NOQS_P""9O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"3RKC6/@IK7C>[AQLN_&?BJYER?5H;5H(&SZ-&1[5]9_!O\ 8W_9*_9X6/\
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M9:Y^R=K_ .SAX;O?V(Y_#C_#9;9DT!/"\7EVT8#'S%9" Z2[RQD$@$F\DO\
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ME;^U=_P:H6_A?Q/_ ,+J_P""7W[2VL> ?$=A*;G3/#_B'5)U2WDYP+74[?\
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MW[5'QW_8U^,>F?'?]G7X@7?AWQ%I;82XMR&BN821OMYXFRDT+X&Z-P0< \$
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M.,FO=G23J2AI[KEJUJ]6SZ3)<AK9;A_W#C!SUE*SE.5]?><ORV/QL_X>\_\
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M_H]3]Q]1U'3]'T^?5M6OX;6TM86FNKJYE"1PQJ"S.S-@*H ))/  K\LOVO\
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M "6SX'_]CW+_ .DS5[I7A?[6'_);/@?_ -CW+_Z3-0![I1110 4444 %%%%
M!1110 4444 %%%% !1110!G^*O"?A7QUX=N_"'C?PSI^LZ3J$)AO]+U6R2XM
M[F,]4DCD!5U/H017YL_MP_\ !K=^PK^T<;SQ?^S=>7GP=\3S;I%BT6+[7HLT
MAY^:R=@81T \B2-%&3Y;&OTVHKZWA/COB_@;&?6<BQLZ$GNHOW9?XX.\)_\
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M=.2B_2=N5_)L[J6*PU?^'-/T9V]%%%?)FX4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\7_L
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M\F.^AVP7*L>/+G2),#YF;-4?A#_P<;_\% ?V#O&UM\"?^"OG[(FKW4D1V?\
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M^UJ=/^/3E#U5U]Z/W-HK\Q_@%_P==?\ !-7XH>18?%[3/&_PVO'P)YM8T/\
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M0E2%V$\J#N.>PH ^NJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7;YM$GY^69)B:>)C5KJRCK:][OIL=K1117^>Y]:%%%% !1110 4444 %%%%
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MF?EC\ O^#M3_ ()]?$7R=/\ CC\._'7PZO'QYUS)8)JUA'Z_O;8^>V/^O?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ K^<O_ (.OOV0/&OPP_;DLOVN;
M71YIO"WQ-T2TMYM32,F.WU:R@6V>W<@84M;16\B9.7Q+C_5MC^C2N*_:%_9U
M^"G[5GPFU7X'?M!?#RP\3^%]9BV7NF7Z' 8?=EC=2'BE4\K(A5U/((K]5\&O
M$J?A7QQ2SITW4I.,J=6*MS.G)IOEOIS1E&,DG9/EY6U>ZX<QP2QV%=.]GNO4
M_BLJWH.@ZWXIURS\,^&M(N=0U+4;N.UT^PLH&EFN9Y&")%&B@EW9B%"@$DD
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M#X0^._A/^UO:PGXG_!SQG+X9\57\$4:?;2I=5>018C\Y9(9XV,8"-Y:L.6-
M'VW1110 4444 %%%% !1110 4444 %%%% !1110 5X7^UA_R6SX'_P#8]R_^
MDS5[I7A?[6'_ "6SX'_]CW+_ .DS4 >Z4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>"?\%+OV'-#_X*
M'?LA>(_V:]3\0C1[Z]>&^\/ZPT1D2RU"!M\3NHY:-OFC?'.R1B.0*][KP?\
MX*0?LQ?&G]KS]EW4/@K\ OCC<?#OQ'=ZK9W,'B:UNKF%XHHI=TD>ZV99/G''
M!QZT ?D[??L5?\',WA7]H?PO\1K#3=,UWQ)X)\)3^$O#'Q!77= EBBTMR0S,
M+EDEE8!B1)-"93U(8@U^D7_!'K_@G1XN_P"">WP%URS^,7CR+Q-\1_'_ (B?
M7O'.L6\SRQ?:&7"PK)( TVTF1VD8 L\S\8 KX@U7_@W[_P""M\&FSS:+_P %
M:]4N;M8R;>WN?%>O0QR/V#.)7*CW"GZ5]!?\&Y4WQ)B^ 7Q.\-_&WX_>(O&'
MC;P]\2[G1O%6B^)KZ>YG\/7=JGDM!'-+/+YT+E2P==@+!UVY7) /T5HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *\+_:P_Y+9\#_ /L>Y?\ TF:O=*\+
M_:P_Y+9\#_\ L>Y?_29J /=**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7BC4-4?3K;R OE;K[YXPS!FPORGKUH ^KJ*** "BBB@ HHHH **** "BBB@
MHHHH **** "O"_VL/^2V? __ +'N7_TF:O=*\+_:P_Y+9\#_ /L>Y?\ TF:@
M#W2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:*** "BBB@ HHHH **** "BBB@ HHHH **** "O"_P!K#_DMGP/_ .Q[E_\
M29J]TKPO]K#_ )+9\#_^Q[E_])FH ]THHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_.+]K#_ (-D/V"_
MC]J5_P",?A%K7B3X8>(+Z=[B272;PZAI[S.2S2/;7+%^6.=L<T:CL/3]':_%
MKQ5\*_\ @Y'_ ."F7C#5=*UOQG<?!?X=2:E/#;"69O#R26PD91^Z@#ZC.&0
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MF"[EW%$(7<N<9&=/]F+]KW]F/]M#X?-\4OV5_C?X?\<Z%'<&WN;W0KX2&UF
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M "O"_P!K#_DMGP/_ .Q[E_\ 29J]TKPO]K#_ )+9\#_^Q[E_])FH ]THHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "OPI_X.N?#>M?L^_M^_LA?\%&=3T.[N
M?"7A+Q-9VNNWEK 7%M+I^K0:G'$WH\L37)0?Q?9W]*_=:N7^,WP2^$'[1/PY
MU'X0_';X::+XN\,:O&$U'0O$&G1W5M. 0RDHX(#*P#*PPRL 000#0!^!O_!:
M#]I'X#?\%D_^"O/['_[./[#?Q%M/B#9:1J4<^O:UH,<CV]I%<W]M<7.XLH.8
M+.Q::08^4$*?F#*/V7^+W_!4']CCX%_MI>#O^"?OQ(^(%_9_%#QY96UUX:T6
M+0+J:&XBGDGBC+7"1F*/+6TPPS#&T9ZBKG[)G_!,;]@3]A?6]0\4?LG?LL>%
MO!FK:I"8+W6+"V>:]>$L&,(N)V>1(BP4F-6"$JO'RC'3^.OV*_V3_B;^T!H/
M[5?C_P" 7AK5OB/X7MXH/#WC*]T\/?Z?'$\KQK%)U4*TTI'O(WK0!^)VK_$S
MP!_P2M_X.X/&_P 7/VJM?3PGX!^*7ARXN-*\7:I&RV:QWUC;N)7< X07UI+;
M%NBL,MA<D:7_  30\0^'_P#@H[_P=?\ Q?\ V\_@-=/J_P .O!6A2F#Q-% Z
MVUPRZ/;:%!L+ ?Z[9<S1YP6CA=NU?LO^UA^PK^R#^W/X7LO!_P"UM^SYX<\=
M66FRO)IC:S9_Z18LX <P3QE98=VU=P1U#;5SG QH_LQ_LA_LR?L8_#]OA;^R
MQ\$/#_@;0I+@W%S9:#8B,W,Q 'FS2'+SO@!=\C,V !G  H _"?\ X(A?M-_
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M_"RN?\:]THH \+_X=[_!/_H;?'?_ (65S_C1_P .]_@G_P!#;X[_ /"RN?\
M&O=** /"_P#AWO\ !/\ Z&WQW_X65S_C1_P[W^"?_0V^._\ PLKG_&O=** /
M"_\ AWO\$_\ H;?'?_A97/\ C1_P[W^"?_0V^.__  LKG_&O=** /"_^'>_P
M3_Z&WQW_ .%E<_XT?\.]_@G_ -#;X[_\+*Y_QKW2B@#PO_AWO\$_^AM\=_\
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M'_#O?X)_]#;X[_\ "RN?\:]THH \+_X=[_!/_H;?'?\ X65S_C1_P[W^"?\
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M3_Z&WQW_ .%E<_XT?\.]_@G_ -#;X[_\+*Y_QKW2B@#PO_AWO\$_^AM\=_\
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MN?\ &C_AWO\ !/\ Z&WQW_X65S_C7NE% 'A?_#O?X)_]#;X[_P#"RN?\:/\
MAWO\$_\ H;?'?_A97/\ C7NE% 'QO^R#^R'\./BM\,=0\1^*?%7C 7$'BK4K
M*,6?BFXB3RH9RB9 /+8ZGO7JG_#O?X)_]#;X[_\ "RN?\:[/]FOX,ZG\#/ 5
M[X0U76H+^2Z\0WVHK-;QLJJL\I<)@]P#@UZ#0!X7_P .]_@G_P!#;X[_ /"R
MN?\ &C_AWO\ !/\ Z&WQW_X65S_C7NE% 'A?_#O?X)_]#;X[_P#"RN?\:/\
MAWO\$_\ H;?'?_A97/\ C7NE% 'A?_#O?X)_]#;X[_\ "RN?\:/^'>_P3_Z&
MWQW_ .%E<_XU[I10!X7_ ,.]_@G_ -#;X[_\+*Y_QH_X=[_!/_H;?'?_ (65
MS_C7NE% 'A?_  [W^"?_ $-OCO\ \+*Y_P :/^'>_P $_P#H;?'?_A97/^->
MZ44 >%_\.]_@G_T-OCO_ ,+*Y_QH_P"'>_P3_P"AM\=_^%E<_P"->Z44 >%_
M\.]_@G_T-OCO_P +*Y_QH_X=[_!/_H;?'?\ X65S_C7NE% 'A?\ P[W^"?\
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M"!\V?&KQM\9/^"</_!MKJ-]\?/%HN?B!X/\ V?H="N=16^$YAU:[MTT^T03
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M1PJF28E0H_IJUOXL>'_@+^Q_=_'+Q8P&E^#/AL^N:D2VW]Q::>;B3GM\L9H
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M^*_$T,<DBZ%;74D%U<(@)=H(YT0W"J 6)BW  9/'-?BG_P ' 'Q/_:<\'?\
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M;W,EM?21)]^2.WN4CDE1>K,BL%!&2,BNU_:E_;._97_8E\#0_$C]J[X[>'O
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M"65&)0  EE#?&_\ P:?_ /*$KX<_]C!XB_\ 3M<UY+^QKX:\3_MV_P#!??\
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M-8L(;#5-'+C5]:L8K>1+Z^O1O8O')<>5MW<B1@L6%211]T?M<_\ !$WX]?\
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MI<>"_P!FJTT:XTR#0[NY$)NI)_LK00I:%V=$,T4]RF1B%"L>5+;:^H?':_\
M#8O_  =B^%?"B_Z1H?[+WP0EU2^@;YHDU?4$(4GL',>J6;@=<VN>U 'VG^U!
M_P %:?\ @F]^QCX]3X6?M,_M@>$/"WB5D1Y=!FNGN;NV5P"C3Q6Z2-;AE(8&
M0*"IR..:]G^$WQ>^%GQX^'NF?%GX*_$/1O%7AG68/.TK7M U&.ZM;E,E24DC
M)4D,"I'564@@$$5^1'[6G_!+_P#X(]?\$FM+^+/[>/\ P5(UO7OCA=?&7Q/-
M;:)!XCT,SWUMJ5S'>WDL%H;=U1))=AQ<OY8A$**KKN.[5_X,[/@E^T'\*?\
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MMC^$[#P)^U)\$M \=:-IFHB_T_3?$5D)X8+D1O&)E4\!]CNN?1CZT ?S<?\
M!-?]L#_@FO\ M'?MA:K_ ,%1/^"\/[;\>K?$*UUD/X(^%[^!=<OM.TU83O@F
MD^RV4T MXF/[BT1R-RF28NS$'ZF_X.U-2T#]JK]C;]F+_@IA^S1?S>)O &B^
M(-0$.N1:=<6ZM!J0LY+::2*>-)84,FFO'F1%PTB+U90?TY_X<7?\$?O^D=OP
MO_\ "=3_ !KW;3?V9?V>])^ L?[+5I\&?#A^'$6D_P!EKX)N-*CFTW[%U\@P
M2 HR9YP0>>: /P._X.0?V[_V=/\ @L-<_LM_LI?L ?$.#QWXC\4>(I;NZLM-
M@D+Z5-?+:V]K;W *C9*"TYD3K&L)9L @G^AWPWH5IX7\.V'AG3RQ@TZRBM8"
MW79&@09_ "O!OV8?^"3O_!./]C/XAS?%K]F7]D+PAX4\331R1KKMK:/-=6Z.
M"'6"2=W-NK E2(MH(.#D<5]#4 ?A=_P:)?\ )XO[;O\ V-ND_P#IPUVO._C7
MX[_9U^'W_!V3XV\0_P#!7R+2CX#C\,I'\,KCQ[8BXT*T5K"V^PRLDJM"(!_I
MPW$;%NV9CM<%A^XO[/W[%?[)_P"RIXB\3>+?V<O@%X:\&ZGXRN(Y_%5[H6GB
M&35)$>5T:8C[Q#3RD>\C>M4/VLOV _V,OVZ=&LM#_:V_9Q\,>.8],W#3+K5[
M'%U9!OOK#<QE9HE; )5' ) )!(& #\5?^"?OBOX'^./^#L;5/$/_  2GAL8?
M@S)X3O?^%A/X+M/L^AW,2Z05EDBC1500G5/L>TJ C3 NF5;)_H)KRC]E+]AC
M]D+]ASPO>>#_ -DO]GOPUX%LM1D234VT6QQ/?,H(0SSN6EFVY;;O=MNXXQDU
MZO0 4444 %%%% !1110 4444 >,_\%!OVJO$_P"Q!^QWXX_:M\*?!"_^(D_@
MC34U"Y\*:9J0M)KBU$T:SS"4Q2[5AB9YW^0_)$U?D)_P4N_X+!?\$<?^"CW_
M  1F\7_%3QOX7\&:;\=/$^BQ6VE>")+%+OQ)HNMQ7"K"RWOV>-W@C0%_/^2-
MX6:,C<QBK]WYH8;B%[>XB62.12KHZY# \$$'J*^5E_X(=_\ !(U/BO\ \+J7
M_@G_ /#@:]]K^U _V+_H7G;MV_[#N^RYSS_JNM 'XW_$J3]H[Q__ ,$ /V(/
M^"<'Q4U#58?$W[0GQIM[#18-29C=)X4AU"3[-N#<^6OVS3Y8R?E6 1#@ 8_6
M#_@L!_P58_X<N?!OX>>.]-_9'U#QUX-U?5CH%]>:7XA&GP^'!'%&;=&!MYO,
M,D2S[%R@S;;2PW CZ.^)O[&_[,_QD^-?@/\ :)^)OPGLM7\9?#%IV\!ZQ<74
MZ_V.TP D:.))!$20J\LC$;5QC QUWQ0^%?PT^-O@+4_A9\8? &C^*/#6LV_D
M:KH.OZ='=VEW'D';)%("K8(!&1P0",$ T ?SN_\ !R5^U7_P3 _:T\)_ Z3_
M ()?7GAO7_C7J'CD7]IJOPQT%K34H[>=24@N&ABCD^UR7SP/'&V9D=)3A2_S
M?T0?".V\=V?PH\,6GQ1N4G\31>'K)/$4T9&V2_$""X8;>,&7>>.*\0_9M_X)
M"?\ !,_]D/XD#XO_ +.O[&G@WPWXHC+FUUV.S>YN;,L,,;=[AY#;$J2I,6S@
MD="17TA0!^%W_!J5_P I'?VY/^QMB_\ 3QJ]>[_L K_PU[_P<J_M7_M52?Z5
MHGP2\(:;\-O#S2<BWO)&47.T_P!Y9K+400.@N.>2#7Z%? C]BO\ 90_9A\8^
M)_B#^SY\ O#?A#6_&EP)_%>IZ)IXAFU20222!IF'WSOED;ZN?6I?V>/V//V;
M/V4+_P 8:K^S[\++3PY=>/\ Q)+K_C&Z@N[B>35=2E+%[B1IY'.268X4A06)
M &30!^&'_!R!_P %M;_X[?M-7?\ P24^#'QU@^&OPSTS6DT;XU_$M[2[N3<3
M!@+JS$5G')</:V_S)+'&N^>56C.(U)?[I_X(0?M*?\$*_AKX0T__ ()Z_P#!
M,WX_MXN\5W>GS:OXCOK_ ,$:S97WB&:)%$]Y<3W=E#$ H("0AP$7Y5!.XGZ3
M\7_\$6_^"4GC_P 6:IX[\:_L$_#C4]9UO49[_5M2O-!5YKNYFD:269V)RSL[
M,Q/<DUT_[/G_  3!_P""?'[*/Q$3XM_LW_LB>"/!GB6*SEM8];T'2%AN%AD
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MK.BVMYIEW9O:7>G7=NLL$\#(4:)T8%70J2I4@@@D&@#^4[]LSX<?\&]OAO\
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MX<6_COET;7[,3P"XC#*DNT_Q*'< _P"T: .!_P""5_\ RC#_ &<?^R#>#_\
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MUT6/_A9NJ>!]/^RZ-?1I;7']I3%8U6,PM&UI%OVA'NE5E+.RN?UM_P""[/\
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M;K4]0U7P%XEOAX8:ZSYT,<_]GLL]XX8K-=!B,,T<1V;WF_HUKY1C_P""&/\
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MU8X  &  * /SG^#W_!PQ_P $Z?VK_'OQ._9Q_P""IG[/_A;X-ZK\,=4FM8-
M^*LT>NQ:DR>=!>",/8JL4R;=GD@,TJ3#86&X#P+_ (-!%\3ZU^TA^U5XW^".
MEZMIO[/E]XE7_A#M.O@XMX[EKRY>UCC#DCSH[!HUFP=V&@WD_)7ZH_M1?\$F
MO^"</[:/CJ/XG_M-_L@^$/%7B1$1'UZ>T>WO+A$ "+--;O&\ZJ  !(6 ' XX
MKV#X.?!3X0_L\_#O3OA)\"OAIHGA'PQI,933M"\/:;':VT&3EB$C &YB2S,?
MF9B2222: /QU_P"#W+_DS;X,_P#93;G_ --TM?1G_!Q-^T#<_ C_ ((0Z]I&
MBSNNL?$73=!\&Z/'%DM,UX8WN(P!RQ:S@NQ@>M?;?[2_['/[+G[9/AS3O"/[
M4WP+\.^.],TB]:\TRQ\1V GCMIRA0R(#T8J2,^AJ#]H7]BW]F#]JS0O"GA?]
MH/X1V7B73? ^OVVM^%K"ZNIXX;&_MU*0S!(I$#E%9E"N&7#$8Y- 'S?\<?VD
M_AC_ ,$"?^",WA#6/&FBIJ-]\/\ P-H_A?P_H$4PC.N>(3:!?++C[JM*D]Q*
MPR1''*R@D!3^*7_!-?\ ; _X)K_M'?MA:K_P5$_X+P_MOQZM\0K760_@CX7O
MX%UR^T[35A.^":3[+930"WB8_N+1'(W*9)B[,0?Z1_VE?V0_V9?VQ_"=AX$_
M:D^"6@>.M&TS41?Z?IOB*R$\,%R(WC$RJ> ^QW7/HQ]:\7_X<7?\$?O^D=OP
MO_\ "=3_ !H _,;_ (.U-2T#]JK]C;]F+_@IA^S1?S>)O &B^(-0$.N1:=<6
MZM!J0LY+::2*>-)84,FFO'F1%PTB+U90?/?^#D']N_\ 9T_X+#7/[+?[*7[
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2OB!_P"%W-_\11_Q"'?\$;?^A*^('_A=S?\ Q% 'O_\ P_X_X(V_])"?A_\
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M_P#P+F_^-UX!_P 0AW_!&W_H2OB!_P"%W-_\11_Q"'?\$;?^A*^('_A=S?\
MQ% 'O_\ P_X_X(V_])"?A_\ ^!<W_P ;H_X?\?\ !&W_ *2$_#__ ,"YO_C=
M> ?\0AW_  1M_P"A*^('_A=S?_$4?\0AW_!&W_H2OB!_X7<W_P 10![_ /\
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M2OB!_P"%W-_\11_Q"'?\$;?^A*^('_A=S?\ Q% 'O_\ P_X_X(V_])"?A_\
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M_P#P+F_^-UX!_P 0AW_!&W_H2OB!_P"%W-_\11_Q"'?\$;?^A*^('_A=S?\
MQ% 'O_\ P_X_X(V_])"?A_\ ^!<W_P ;H_X?\?\ !&W_ *2$_#__ ,"YO_C=
M> ?\0AW_  1M_P"A*^('_A=S?_$4?\0AW_!&W_H2OB!_X7<W_P 10![_ /\
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M2OB!_P"%W-_\11_Q"'?\$;?^A*^('_A=S?\ Q% 'O_\ P_X_X(V_])"?A_\
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M_P#P+F_^-UX!_P 0AW_!&W_H2OB!_P"%W-_\11_Q"'?\$;?^A*^('_A=S?\
MQ% 'O_\ P_X_X(V_])"?A_\ ^!<W_P ;H_X?\?\ !&W_ *2$_#__ ,"YO_C=
M> ?\0AW_  1M_P"A*^('_A=S?_$4?\0AW_!&W_H2OB!_X7<W_P 10![_ /\
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M2OB!_P"%W-_\11_Q"'?\$;?^A*^('_A=S?\ Q% 'O_\ P_X_X(V_])"?A_\
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M_P""?.J_&CX8:A8Q?$#7];L]!\!I?VRSQK=R,99IGB;AUCMH9VY&W>8P?O4
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M"Y!91@9^\/45EV?QO^"^H?$27X06'Q>\+S^+;="\_A>'7[9M1C4#<2UL'\T
M#G)7IS0!U%%<JOQT^"3?$?\ X4XOQB\*GQ>%W?\ "*CQ#;?VEMV[L_9M_FXV
M\_=Z<UK>(/''@KPG>6>G^*O&&EZ9<:A(4T^#4-0CA>Y8%05C5V!<Y91@9^\/
M44 :E%<O8_'#X*ZG\1)_A#IOQ?\ "]QXLME+7/A>#Q!;/J,0 W$M;!_-48YY
M7I732RQ01-//(J(BEG=VP% ZDGL* '45QW@/]HG]G[XI^(+GPE\,?CIX.\1Z
MK9;OMFF:#XGM+RX@QC.^.*1F7&1G(&,UTOB#Q#H'A/1;GQ)XIURSTS3K.(R7
ME_J%RD,,"#JSNY"J/<G% %RBN.^&O[0_P ^,]Y<:=\'OCGX.\67%HI:[@\->
M)K2_>$ X)=8)&*\\<]Z^5OV_?B1_P5.\+?M[? SPM^Q[K_@6V^$.IZKIB_%B
MV\1:GI4.H2V[:HB70M8[J1;AV-IN"^2K$O@+EN* /MJBOSU_;L_X+CV/[+__
M  5)^"__  33\#>"M"O#X\O=/N?&WCG5];7[/HUE-=W-N]JD2$;;D?968O*X
M6,.OR.6ROWOJ'C7P;I/A-_'FJ^+=,MM#CM1=/K5Q?QI:+ 0")3,6V!""#NSC
MGK0!IT5SOPW^,'PE^,>ES:Y\(?BCX<\565O*(Y[SPWK<%]%&^,[6>%V /L37
M14 %%%?D%_P=9_\ !4;]NO\ X)L?\*&_X8J^.7_"%_\ ":?\)3_PDO\ Q3.F
M:C]L^Q_V1]G_ ./^VG\O9]JG^YMW;_FSM7 !^OM%?R"_\11?_!=7_H^7_P Q
MGX8_^5E'_$47_P %U?\ H^7_ ,QGX8_^5E ']?5%?D%_P:F?\%1OVZ_^"D__
M  OG_AM7XY?\)I_PA?\ PBW_  C7_%,Z9IWV/[9_:_VC_CPMH/,W_98/O[MN
MSY<;FS^OM !17SQ_P54_;TTK_@FE^PIXX_:_OO"G]O7?AVVMX-$T1I3&E[J%
MS/';VZ2..5B#R!W(YV(P'S$5^4?PC^.7_!WK^US^SM:?M]_!+XJ_#6P\'ZYI
MDVL^'OA[9:%HYN=0M%+;5@2>TFE^<*=B27:R'C."1D _>.BOSB_X(Q?\%G/B
M?_P4O_8$^)7Q0^)OP_M/#7Q/^%FGW":Q)IUE(FGZANLY9[2]BCE+%"QAD5XM
MS &+<"%D"+RG_!N5_P %;_VBOV\OV1?C%^T3^WC\1=$:W^'6O9?5[/18;""Q
MTV.P^TSR2"$?,%"NQ8\@"@#]2**_"3PK_P %;_\ @O;_ ,%IOB]XOE_X(W>#
MO#?PP^%'A#4?L<7B_P 5:?8RSW3'YHUN);Z*XC,[IB0P6\!\E74/(VY7;T+_
M ()V?\%K?^"EWP._X*3:7_P2@_X+.?#32Y/$WBEHX_"GCC0M.A@=Y9E<VTCB
MT M[FTG9#$LL21M%+E9 <.(P#]F:**_)W_@K_P#\%ROVJ?A]^VAH_P#P2>_X
M),_"?3_&'QLU-8AKVM:C;K<0Z/)+!]H6WAC=UB\Q+?$\L\Y,,,9P58[C& ?K
M%17X'?'[_@H?_P '/O\ P1O;P_\ M"?\%"(? WQ8^&&IZQ%9:O#IVG:;%':/
M("PMS<:=;6\MK*RJXCED2:+<N#O)"G]O/V</CQX*_:A^ ?@[]HKX<K=)HGC7
MP[::OIT-_#Y=Q#'/&K^5*G\,B$E&'(#*<$CF@#M:*XSPW^T=^SSXS\:S?#7P
M?\>?!FJ^([=F6?0--\46D][&5SN#0)(9!C!SD<8KLI)$B1I97"JH)9F. !ZF
M@!:*^.O^"J__  4/LO@5_P $U_C+^T9^QG\<_!NL>-?A_IEG+!)IFI6>K+82
MRZA;0,)X4=P,I(X <#GZ5M?\$2/VKOC)^V__ ,$O?A9^U)^T#J]G?^+_ !5;
M:J^LW=A8):Q2&#5[VUCVQ1@*N(H(P<=2">] 'U717(>#OV@_@)\1?%-UX&^'
MWQO\(:[K=CN^VZ/HWB6UNKJWV_>WQ1R,Z8[Y Q77T %%?G?_ ,''7_!5'X\?
M\$MOV8/ GBW]EZ+1)?'/C3X@)I=M!KNF&\B:PCM)Y)RL:NI+^:;10<]'/'(K
MQC]F7XW?\'=.K_M'> -+_:9_8^^'6E_#BY\::7%X^U*QU/P^T]IHK7<8O98Q
M%J\DA=;<R, B.V0,*QP" ?KO17Y'_P#!03_@KQ_P4?\ C1_P4YO_ /@DA_P1
MS\)>$H/%/A/2?MOCKQ[XOA26*V<0Q2R+&)-T<<,0G@B=VCE=YI-BJH3<^_\
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M^N^*_BKX'T_0?B#X"UJ+2_%D&C*ZV-XLL9DM[N%)&9HMX25&B+-M:(D'#A5
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MH Z^BH-2U+3M&TZ?5]8U""TM+6%I;FZN91''#&HRSLS$!5 !))X %?G_ /\
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ME;7<_F/\=^._&/Q.\8ZE\0?B#XDN]7UO5[M[G4M2OI2\MQ*QR68G\@!P
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M3W!BFOWBFN5$5NKR221Z>D(CVJ2'NY <#)KR/]IK_@J1^PM\$O\ @X+^'O\
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M)GB W;:KXQUG5+#6+N1[J3?<2J=0TZ=8I)#D-)&%<JS)G:S*?UU_X) >!/\
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M5?\ @QH7CCX%G2-+^,W@>X6/P_J>J3FW@U/3)) 9[&>559E",3/$Q#;7$B@
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M_$+PIX<U#4;73)"N(9A)'(([N8S;GE\X.,;4 7!)_JE^.WP9\$?M%_!/Q=\
M?B79R7'A[QKX;O=#UJ*%PKFUNH'ADV-@[7"N2K8X(![5^+GP(_X)M?\ !RI_
MP2]^&'C3]AG]A'Q=\*?&/PP\3:E>3>'?'6JZA]DU+P[]I01O<P))+&UM.557
M*;;J-) 63DL2 >.?L_>&OB=^V_\ \&QOQD^%_P"WQX;\;?VK^S7K-SXA^&%[
MX@6YL[CRXM*E6SBD,R[KB&$W5X@4G 0Q(,","O4?^#>/]A/X ^"O^"+WQ3_X
M*":'IVJ+\1O&/PJ\<^&M:N9=39K1K"$RLBI!C"/FVBRV><'UK[Z^%G_!,_\
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M?BI\.)[C5O#^N6L[W>G6^I_;;YUBD=4#M!+;W;1N57*,5<*YC"MY19?LF_\
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MX4:,/!=]:W7ASPII%TD4OBC4%/DM?ZA<0!XHQ';R7#(L>T,\F#$O#  _4O\
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M&?\ A6'ANRLHM2:?6BFH;HM-N;=ML'ED-^\E7'S#C)K0^&O_  2;_:P\*_\
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M_P#1CWQ _P#"BL?\* /V^HK\0?\ B-Y_99_Z,>^('_A16/\ A1_Q&\_LL_\
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M/S:_XC>?V6?^C'OB!_X45C_A1_Q&\_LL_P#1CWQ _P#"BL?\* /V^HK\0?\
MB-Y_99_Z,>^('_A16/\ A1_Q&\_LL_\ 1CWQ _\ "BL?\* /V^HK\0?^(WG]
MEG_HQ[X@?^%%8_X4?\1O/[+/_1CWQ _\**Q_PH _;ZBOQ!_XC>?V6?\ HQ[X
M@?\ A16/^%'_ !&\_LL_]&/?$#_PHK'_  H _;ZBOQ!_XC>?V6?^C'OB!_X4
M5C_A1_Q&\_LL_P#1CWQ _P#"BL?\* /V^HK\0?\ B-Y_99_Z,>^('_A16/\
MA1_Q&\_LL_\ 1CWQ _\ "BL?\* /V^KP#]N;_@ES^PI_P4G_ .$7_P"&U?@;
M_P )I_PA?V[_ (1K_BIM3T[[']L^S_:/^/"Y@\S?]E@^_NV[/EQN;/Y@?\1O
M/[+/_1CWQ _\**Q_PH_XC>?V6?\ HQ[X@?\ A16/^% 'V!_Q"Z?\$*O^C&O_
M #)GB?\ ^6='_$+I_P $*O\ HQK_ ,R9XG_^6=?'_P#Q&\_LL_\ 1CWQ _\
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MOB!_X45C_A0!^WU%?B#_ ,1O/[+/_1CWQ _\**Q_PH_XC>?V6?\ HQ[X@?\
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M%8_X4 ?M]17X@_\ $;S^RS_T8]\0/_"BL?\ "C_B-Y_99_Z,>^('_A16/^%
M'['>)?V?O@AXS^+WAWX_>+?A3H6I>-?"-C=6?ACQ/>Z;'+>:7#<[?/6"1@3'
MO"@$CG!< @.P/85^(/\ Q&\_LL_]&/?$#_PHK'_"C_B-Y_99_P"C'OB!_P"%
M%8_X4 ?M]17X@_\ $;S^RS_T8]\0/_"BL?\ "C_B-Y_99_Z,>^('_A16/^%
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M_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\
M_P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#P
MC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (
MVQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_
M .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^
M-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4
M?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\
M,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G
M_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_L
ML_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_
M]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\
M1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?
M#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P
M_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\
M\(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_
M  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ
M_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;
M'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C
M5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU
M7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_1
M0!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4
M <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'
M_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_
MPR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_
M[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^
MRS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_
M $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T
M;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5
M\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/
M_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\
M_P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#P
MC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (
MVQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_
M .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^
M-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4
M?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\
M,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G
M_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_L
ML_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_
M]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\
M1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?
M#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P
M_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\
M\(VQ_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_
M  C;'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ
M_P#C5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;
M'_XU7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C
M5=_10!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU
M7?T4 <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_1
M0!P'_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4
M <!_PR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'
M_#)_[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_
MPR?^RS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_
M[+/_ $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^
MRS_T;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_
M $;5\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T
M;5\/_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!P'_#)_[+/_ $;5
M\/\ _P (VQ_^-4?\,G_LL_\ 1M7P_P#_  C;'_XU7?T4 <!_PR?^RS_T;5\/
M_P#PC;'_ .-4?\,G_LL_]&U?#_\ \(VQ_P#C5=_10!E^$/!'@OX?:,OASP%X
M0TO0]/61I%L-(T^.VA#M]Y@D:A<GN<<UJ444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
0% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426066452720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>May 23, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-28827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PETMED EXPRESS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">65-0680967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">420 South Congress Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Delray Beach<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">526-4444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, PETS $.001 Par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PETS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 396.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,170,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Information to be set forth in our Proxy Statement relating to our 2023 Annual Meeting of Shareholders to be held on August&#160;3, 2023, is incorporated by reference in Items 10, 11, 12, 13, and 14 of Part III of this report.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001040130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426066454224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">RSM US LLP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Fort Lauderdale, Florida<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426065971264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 104,086<span></span>
</td>
<td class="nump">$ 111,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less allowance for doubtful accounts of $35 and $39, respectively</a></td>
<td class="nump">1,740<span></span>
</td>
<td class="nump">1,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Inventories - finished goods</a></td>
<td class="nump">19,023<span></span>
</td>
<td class="nump">32,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">4,719<span></span>
</td>
<td class="nump">4,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">1,883<span></span>
</td>
<td class="nump">681<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">131,451<span></span>
</td>
<td class="nump">150,995<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Noncurrent assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">26,178<span></span>
</td>
<td class="nump">24,464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible and other assets</a></td>
<td class="nump">5,860<span></span>
</td>
<td class="nump">860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">628<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total noncurrent assets</a></td>
<td class="nump">32,666<span></span>
</td>
<td class="nump">25,324<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">164,117<span></span>
</td>
<td class="nump">176,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">25,208<span></span>
</td>
<td class="nump">27,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_AccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">11,289<span></span>
</td>
<td class="nump">5,697<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">36,497<span></span>
</td>
<td class="nump">33,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">3,825<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">40,322<span></span>
</td>
<td class="nump">34,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.001 par value, 5,000 shares authorized; 3 convertible shares issued and outstanding with a liquidation preference of $4 per share</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.001 par value, 40,000 shares authorized; 21,084 and 20,979 shares issued and outstanding, respectively</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">18,277<span></span>
</td>
<td class="nump">11,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">105,488<span></span>
</td>
<td class="nump">130,496<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="nump">123,795<span></span>
</td>
<td class="nump">142,186<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 164,117<span></span>
</td>
<td class="nump">$ 176,319<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_AccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_AccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426066351728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred stock, liquidation preference (in dollars per share)</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">21,084,000<span></span>
</td>
<td class="nump">20,979,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">21,084,000<span></span>
</td>
<td class="nump">20,979,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21484-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426066072272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 256,858<span></span>
</td>
<td class="nump">$ 273,417<span></span>
</td>
<td class="nump">$ 309,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">185,844<span></span>
</td>
<td class="nump">195,341<span></span>
</td>
<td class="nump">219,267<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">71,014<span></span>
</td>
<td class="nump">78,076<span></span>
</td>
<td class="nump">89,948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">49,474<span></span>
</td>
<td class="nump">30,829<span></span>
</td>
<td class="nump">28,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising</a></td>
<td class="nump">19,424<span></span>
</td>
<td class="nump">18,799<span></span>
</td>
<td class="nump">21,641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">3,546<span></span>
</td>
<td class="nump">2,738<span></span>
</td>
<td class="nump">2,427<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">72,444<span></span>
</td>
<td class="nump">52,366<span></span>
</td>
<td class="nump">52,361<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">(Loss) income from operations</a></td>
<td class="num">(1,430)<span></span>
</td>
<td class="nump">25,710<span></span>
</td>
<td class="nump">37,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income, net</a></td>
<td class="nump">2,070<span></span>
</td>
<td class="nump">335<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="nump">944<span></span>
</td>
<td class="nump">1,026<span></span>
</td>
<td class="nump">1,315<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income</a></td>
<td class="nump">3,014<span></span>
</td>
<td class="nump">1,361<span></span>
</td>
<td class="nump">1,629<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">1,584<span></span>
</td>
<td class="nump">27,071<span></span>
</td>
<td class="nump">39,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">1,351<span></span>
</td>
<td class="nump">5,971<span></span>
</td>
<td class="nump">8,613<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 233<span></span>
</td>
<td class="nump">$ 21,100<span></span>
</td>
<td class="nump">$ 30,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 1.05<span></span>
</td>
<td class="nump">$ 1.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="nump">$ 1.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted average number of common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">20,275<span></span>
</td>
<td class="nump">20,176<span></span>
</td>
<td class="nump">20,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">20,339<span></span>
</td>
<td class="nump">20,358<span></span>
</td>
<td class="nump">20,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426066091712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholders' Equity - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Convertible Preferred Stock</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">20,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2020</a></td>
<td class="nump">$ 130,010<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 3,804<span></span>
</td>
<td class="nump">$ 126,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation</a></td>
<td class="nump">3,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared</a></td>
<td class="num">(22,639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,639)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">30,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,603<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">20,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">141,281<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">7,111<span></span>
</td>
<td class="nump">134,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation</a></td>
<td class="nump">4,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared</a></td>
<td class="num">(24,745)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,745)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">21,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,100<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">20,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">142,186<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">11,660<span></span>
</td>
<td class="nump">130,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation</a></td>
<td class="nump">6,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared</a></td>
<td class="num">(25,241)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,241)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">21,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">$ 123,795<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 18,277<span></span>
</td>
<td class="nump">$ 105,488<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426061572448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 233<span></span>
</td>
<td class="nump">$ 21,100<span></span>
</td>
<td class="nump">$ 30,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">3,546<span></span>
</td>
<td class="nump">2,738<span></span>
</td>
<td class="nump">2,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="nump">6,617<span></span>
</td>
<td class="nump">4,549<span></span>
</td>
<td class="nump">3,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(1,564)<span></span>
</td>
<td class="num">(345)<span></span>
</td>
<td class="nump">311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="nump">214<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>(Increase) decrease in operating assets and increase (decrease) in liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(41)<span></span>
</td>
<td class="nump">509<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories', window );">Inventories - finished goods</a></td>
<td class="nump">13,432<span></span>
</td>
<td class="nump">1,965<span></span>
</td>
<td class="num">(16,536)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="num">(1,202)<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="num">(959)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">147<span></span>
</td>
<td class="num">(363)<span></span>
</td>
<td class="num">(974)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(2,292)<span></span>
</td>
<td class="num">(12,048)<span></span>
</td>
<td class="nump">19,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">8,713<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="nump">1,221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(471)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">27,803<span></span>
</td>
<td class="nump">18,498<span></span>
</td>
<td class="nump">40,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Purchase of minority interest investment in Vetster</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(5,260)<span></span>
</td>
<td class="num">(1,752)<span></span>
</td>
<td class="num">(2,432)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(10,260)<span></span>
</td>
<td class="num">(1,752)<span></span>
</td>
<td class="num">(2,432)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(24,537)<span></span>
</td>
<td class="num">(24,384)<span></span>
</td>
<td class="num">(22,687)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(24,537)<span></span>
</td>
<td class="num">(24,384)<span></span>
</td>
<td class="num">(22,687)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="num">(6,994)<span></span>
</td>
<td class="num">(7,638)<span></span>
</td>
<td class="nump">14,956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents, at beginning of year</a></td>
<td class="nump">111,080<span></span>
</td>
<td class="nump">118,718<span></span>
</td>
<td class="nump">103,762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents, at end of year</a></td>
<td class="nump">104,086<span></span>
</td>
<td class="nump">111,080<span></span>
</td>
<td class="nump">118,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">4,312<span></span>
</td>
<td class="nump">6,085<span></span>
</td>
<td class="nump">10,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Dividends payable in accrued expenses</a></td>
<td class="nump">$ 1,262<span></span>
</td>
<td class="nump">$ 558<span></span>
</td>
<td class="nump">$ 198<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the book value of finished goods inventory and work in process inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426062217008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PetMed Express, Inc. and subsidiaries, d/b/a PetMeds&#174; (collectively, the "Company"), is a leading nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses. The Company markets and sells directly to consumers through its websites, toll-free numbers, and mobile applications. The Company offers consumers an attractive alternative for obtaining pet medications, foods, and supplies in terms of convenience, price, speed of delivery, and valued customer service.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Founded in 1996, the Company's executive headquarters offices are currently located in Delray Beach, Florida. The Company has a March 31 fiscal year and references herein to fiscal 2023, 2022, or 2021 refer to the Company's fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and include PetMed Express, Inc. and its  wholly owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates revenue by selling pet medication products and pet supplies. Certain pet supplies offered on the Company&#8217;s website are drop shipped to customers. The Company considers itself the principal in the arrangement because the Company controls the specified good before it is transferred to the customer. Revenue contracts contain one performance obligation, which is delivery of the product. Customer care and support is deemed not to be a material right to the contract. The transaction price is adjusted at the date of sale for any applicable sales discounts and an estimate of product returns, which are estimated based on historical patterns; however, this is not considered a key judgment.  Revenue is recognized when control transfers to the customer at the point in time in which shipment of the product occurs. This key judgment is determined as the shipping point represents the point in time in which the Company has a present right to payment, title has transferred to the customer, and the customer has assumed the risks and rewards of ownership. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outbound shipping and handling fees are an accounting policy election and are included in sales as the Company considers itself the principal in the arrangement given responsibility for supplier selection and discretion over pricing. Shipping costs associated with outbound freight after control over a product has transferred to a customer are an accounting policy election and are accounted for as fulfillment costs and are included in cost of sales.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disaggregates sales in the following two categories: (1) reorder sales vs new order sales, and (2) internet sales vs call center sales. The following table illustrates sales by various classifications:</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:29.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.855%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales (In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reorder sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New order sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,687)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,559)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internet sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Call center sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,858&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,559)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:29.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.855%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales (In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reorder sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New order sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,798)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internet sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Call center sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,215&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,798)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company changed the definition of a new customer on April 1, 2022, to include anyone who has not ordered over the past thirty-six months. The reorder and new order sales amounts for the years ended March&#160;31, 2022 and March&#160;31, 2021, respectively, reflect this new customer definition change. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the previous definition of a new customer, reorder and new order sales were $250.4 million and $23.0 million, respectively, for the year ended March&#160;31, 2022. Under the previous definition of a new customer, reorder and new order sales were $272.6 million and $36.6 million, respectively, for the  year ended March&#160;31, 2021. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Virtually all of the Company&#8217;s sales are paid by credit cards and the Company usually receives the cash settlement in two to three banking days. Credit card sales minimize accounts receivable balances relative to sales. The Company had no material contract asset or liability balances as of March&#160;31, 2023 and 2022.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains an allowance for doubtful accounts for losses that the Company estimates will arise from customers&#8217; inability to make required payments, arising from either credit card chargebacks or insufficient funds checks. The Company determines its estimates of the uncollectability of accounts receivable by analyzing historical bad debts and current economic trends in compliance with the provisions of Accounting Standards Codification ("ASC") Topic 326 ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses").</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The allowance for doubtful accounts was approximately $35 thousand  and $39 thousand at March&#160;31, 2023 and March&#160;31, 2022, respectively.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents at March&#160;31, 2023 and 2022 consisted of the Company&#8217;s cash accounts and money market accounts with a maturity of three months or less. The carrying amount of cash equivalents approximates fair value. The Company maintains its cash in bank deposit accounts which, at times,  may exceed federally insured limits. The Company has not experienced any losses in such accounts.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of prescription and non-prescription pet medications and pet supplies that are available for sale and are priced at the lower of cost or net realizable value using a weighted average cost method. The Company writes down its inventory for estimated obsolescence. The inventory reserve was approximately $48 thousand and $81 thousand at March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets. Our building is being depreciated over a period of thirty years. The furniture, fixtures, equipment, and computer software are being depreciated over periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNTQ4Mw_bad1a77d-7eb3-4209-80fa-1d8f0ecbb508">three</span> to ten years.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-lived Assets</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets is measured by a comparison of the carrying amount of the asset to the undiscounted cash flows expected to be generated from the asset.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intangible assets consist of a toll-free telephone number and internet domain names. In accordance with the ASC Topic 350 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) the intangible assets are not being amortized and are subject to an annual review for impairment.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the initial minority interest investment in Vetster. Details can be found in Note 12 below.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the Company's cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to the short-term nature of these instruments.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's advertising expense consists primarily of Internet marketing, direct mail/print, and television advertising. Internet costs are expensed in the month incurred and direct mail/print advertising costs are expensed </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">when the related catalogs, brochures, and postcards are produced, distributed, or superseded. Television advertising costs are expensed as the advertisements are televised.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 48% of our Delray Beach property, or approximately 88,000 square feet was leased to two tenants. At</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the leases with these two tenants had a remaining weighted average lease term of 2.0 years. The Company recorded approximately $710 thousand and $689 thousand in rental revenue in fiscal 2023 and 2022, respectively, which was included in other income. The Company expects to receive the following future lease payments, under the current lease agreements, over the next five years: $731 thousand in fiscal 2024; $566 thousand in fiscal 2025, $110 thousand in fiscal 2026, and $0 thousand in fiscal 2027 and 2028.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Income</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies ASC Topic 220 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reporting Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) which requires that all items that are recognized under accounting standards as components of comprehensive income be reported in a financial statement that is displayed with the same prominence as other financial statements. The items of other comprehensive income that are typically required to be displayed are foreign currency items, minimum pension liability adjustments, and unrealized gains and losses on certain investments in debt and equity securities. For the fiscal years ended March&#160;31, 2023, 2022 and 2021, the Company had no components of comprehensive income and therefore does not report comprehensive income or Consolidated Statements of Comprehensive Income. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the provisions of ASC Topic 740 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) which generally requires the recognition of deferred tax assets and liabilities for the expected future tax benefits or consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting carrying values and the tax bases of assets and liabilities and are measured by applying enacted tax rates and laws for the taxable years in which those differences are expected to reverse. As required by &#8220;Accounting for Uncertainty in Income Taxes&#8221; guidance, which clarifies ASC Topic 740, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the Consolidated Financial Statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies &#8220;Accounting for Uncertainty in Income Taxes&#8221; guidance to all tax positions for which the statute of limitations remains open. The Company had no liabilities for uncertain tax positions for both fiscal 2023 and fiscal 2022. The Company files tax returns in the U.S. federal jurisdiction and Florida,  Arizona, California, Connecticut, Idaho, Maryland, Michigan, Oklahoma, South Carolina, Virginia, Wisconsin, New Jersey, Georgia, Indiana, New York and the District of Columbia. With few exceptions, the Company is no longer subject to U.S. federal, state or local income tax examinations by tax authorities for years ending March&#160;31, 2019, or earlier. Any interest and penalties related to income taxes will be recorded to other income (expenses).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Concentrations</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases its products from a variety of sources, including certain manufacturers, domestic distributors, and wholesalers. We have multiple suppliers for each of our product lines to obtain the lowest cost. There were six suppliers from which we purchased approximately 69%  and 77% of all products in fiscal 2023 and 2022, respectively.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting for Share Based Compensation</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records compensation expense associated with restricted stock in accordance with ASC Topic 718 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Based Payment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The compensation expense related to all of the Company&#8217;s stock-based compensation arrangements is recorded as a component of general and administrative expenses.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, will have a material effect on the Company&#8217;s consolidated financial position, results of operations, or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426069395584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">Property and Equipment, Net<div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Major classifications of property and equipment consist of the following (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:69.815%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building Improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,149&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,231)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,685)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,464&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426065400544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text">Accrued Expenses and Other Current Liabilities<div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Major classifications of accrued expenses and other current liabilities consist of the following (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:69.815%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued credit card fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salaries and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued merchandise credits / reward program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales return allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued dividends payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued real estate taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,289&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,697&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426064678752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income TaxesDeferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The tax <div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are as follows (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:69.815%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt and inventory reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,527)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,989)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net deferred tax assets (liabilities)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(936)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, the Company had no federal or state net operating loss carryforwards.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the income tax provision consist of the following (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:54.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,915&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,316&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(982)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,564)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income tax provision computed at the U.S. federal statutory tax rates to income tax expense is as follows (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:54.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes at U.S. statutory rates</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock shortfall (windfall) adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(393)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2023, the Company recognized a stock compensation shortfall charge of approximately $208 thousand and recognized a one-time charge of approximately $382 thousand related to a return to provision true up of the fiscal 2022 income tax provision. In fiscal 2022, the Company recognized a stock compensation shortfall charge of approximately $33 thousand, and recognized a one-time benefit of approximately $29 thousand, related to a return to provision true up of the fiscal 2021 income tax provision. In fiscal 2021 the Company recognized a stock compensation windfall benefit of approximately $135 thousand, and recognized a one-time benefit of approximately $194 thousand, related to a return to provision true up of the fiscal 2020 income tax provision.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The differences between the effective income tax rate and the statutory U.S. federal income tax rate are as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.727%"><tr><td style="width:1.0%"/><td style="width:54.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal rate on income before taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock shortfall (windfall) adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Effective Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>The primary drivers for the increase in effective tax rate for the fiscal 2023 include the recognition of  permanent differences related to one-time acquisition costs and a non-deductible portion of restricted stock compensation. The state tax rate for fiscal 2023 includes continued expansion of operations as well as a one-time true up for new state filings for fiscal 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426064642816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text"><div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(5)&#160;&#160;&#160;&#160;Shareholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Equity</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred Stock</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 1998, the Company issued 250,000 shares of its $.001 par value preferred stock at a price of $4.00 per share, less issuance costs of $112 thousand. Each share of the preferred stock is convertible into approximately </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.05 shares of common stock at the election of the shareholder. The shares have a liquidation value of $4.00 per share and may pay dividends at the sole discretion of the Company. The Company does not anticipate paying dividends to the preferred shareholders in the foreseeable future. Each share of preferred stock is entitled to one vote on all matters submitted to a vote of shareholders of the Company. At March&#160;31, 2023 and 2022, 2,500 shares of the convertible preferred stock remained unconverted and outstanding.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Company has $110.0 million  of shares authorized under previously approved share repurchase programs. The share repurchase program does not have an expiration date and is intended to be implemented through purchases made from time to time in either the open market or through private transactions at the Company's discretion, subject to market conditions and other factors, in accordance with Securities and Exchange Commission requirements. There can be no assurances as to the timing and number of shares that will be repurchased under the share repurchase program, and the Company may modify or discontinue the share repurchase program at any time subject to compliance with applicable regulatory requirements. Shares purchased pursuant to the share repurchase program will either be cancelled or held in the Company's treasury.  During fiscal 2023 and 2022 the Company had no share repurchases. At March&#160;31, 2023 the Company had approximately $28.7 million remaining under the Company&#8217;s share repurchase program.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company&#8217;s financial performance. During fiscal 2023, our Board of Directors declared the following dividends:</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.272%"><tr><td style="width:1.0%"/><td style="width:20.254%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.045%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.045%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.953%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Declaration Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Per Share<br/>Dividend</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount<br/>(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment Date</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 20, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,297</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 27, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 25, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 12, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,323</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 19, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 7, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 18, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,323</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 6, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 20, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,325</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2023</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426069395584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restricted Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Restricted Stock</a></td>
<td class="text">Restricted Stock<div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2015, the Company&#8217;s 2015 Outside Director Equity Compensation Restricted Stock Plan (&#8220;2015 Director Plan&#8221;) became effective upon the approval of the plan by the Company&#8217;s Shareholders. The 2015 Director Plan authorized 400,000 shares of the Company's common stock available for issuance under the plan and provides for an automatic increase every year in the amount of shares available for issuance under the plan of 10% of the shares authorized under the plan. In July 2016, the Company&#8217;s 2016 Employee Equity Compensation Restricted Stock Plan (&#8220;2016 Employee Plan&#8221;) became effective upon the approval of the plan by the Company&#8217;s Shareholders. The 2016 Employee Plan authorized 1,000,000 shares of the Company's Common stock available for issuance under the plan. In July 2022, the Company&#8217;s 2022 Employee Equity Compensation Restricted Stock Plan (&#8220;2022 Employee Plan&#8221;) became effective upon the approval of the plan by the Company&#8217;s shareholders. The 2022 Employee Plan authorized 1,000,000 shares of the Company's common stock available for issuance.The value of the restricted stock is determined based on the market value of the stock at the issuance date. The restriction period or forfeiture period is determined by the Company&#8217;s Compensation Committee and is to be no less than 1 year and no more than ten years unless otherwise specified by the Compensation Committee.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records compensation expense associated with restricted stock in accordance with ASC Topic 718 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Based Payment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) (ASU 2016-09). At March&#160;31, 2023, the Company had 960,007 restricted common shares issued under the 2016 Employee Plan and 240,755 restricted common shares issued under the 2015 Director Plan. No shares had been issued under the 2022 Employee Plan as of March&#160;31, 2023. All shares in the 2016 Employee Plan and 2015 Director Plan were issued subject to a restriction or forfeiture period that lapses ratably on the first, second, and third anniversaries of the date of grant, and the fair value of which is being </span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amortized over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzkzNDU4NDg4NDU1MDU_5ab669ee-e73c-4623-8194-b9f525c9a887">one</span> to three-year restriction period, with the exception of performance restricted shares which were issued to the Chief Executive Officer and Chief Financial Officer.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company issued 90,000 restricted shares and 510,000 performance restricted shares to the Company&#8217;s CEO, in accordance with the CEO&#8217;s employment agreement, under the 2016 Employee Plan.  The performance restricted shares are based on achieving absolute stock hurdles within the three-year period from the grant date. If the shares meet the absolute stock price hurdle, they will only vest on the third anniversary of the date of grant. As of March&#160;31, 2023, none of the performance stock hurdles were met.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company issued 13,000 restricted shares and 3,000 performance restricted shares to the Company's new CFO, in accordance with the CFO's employment agreement, under the 2016 Employee Plan. The performance restricted shares are based on the attainment of performance criteria equally weighted between adjusted EBITDA and revenue. The shares for each grant will be released from restriction equally over a three year period on the anniversary of the grant date, and in the case of the performance restricted shares, subject to the attainment of performance criteria.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the fiscal years ended March&#160;31, 2023, 2022, and 2021, the Company recognized compensation expense related to the 2016 Employee Plan and the 2015 Director Plan of $6.6 million, $4.5 million, and $3.3 million, respectively. All stock-based compensation expense is recognized as a payroll-related expense and it is included within the general and administrative expenses line item within the Company&#8217;s Consolidated Statements of Income, and the offset is included in the additional paid-in capital line item of the Company&#8217;s Consolidated Balance Sheets.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February&#160;3, 2023, we issued 6,000 shares of our common stock to a consultant pursuant to a consulting agreement in exchange for consulting services. The securities were issued in reliance upon the exemption from the registration requirements of the Securities Act, as set forth in Section 4(a)(2) under the Securities Act as a transaction by an issuer not involving any public offering and the standard Securities Act restrictive legend and stop transfer instructions were noted on the stock certificate.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s non-vested restricted stock at March&#160;31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is as follows (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:54.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee<br/>Plan<br/>Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Director<br/>Plan<br/>Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Both Plans<br/>Number of<br/>Shares</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested restricted stock outstanding at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock granted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock forfeited or expired</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested restricted stock outstanding at March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753</span></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and 2022, there were 752,829 and 770,652, non-vested restricted shares subject to restriction and forfeiture outstanding, respectively. During the fiscal years ended March&#160;31, 2023 and 2022, the Company issued, net of forfeitures, 99,390 and 709,599 restricted shares, respectively. The weighted-average grant date fair value of restricted shares was $21.57 and $30.47 for fiscal years 2023 and 2022, respectively.  The total fair value of restricted shares vested was $2.4 million and $3.0 million for fiscal years 2023 and 2022, respectively.  At March&#160;31, 2023 and 2022, there were $9.1 million and $13.4 million of unrecognized compensation costs related to the restricted stock subject to restriction and forfeiture awards, respectively, which </span></div>is expected to be recognized over the remaining weighted average restriction and forfeiture period of 1.6 and 2.3 years for fiscal 2023 and 2022, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426065835264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company carries cash and cash equivalents and investments at fair value in the Consolidated Balance Sheets. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. ASC Topic 820 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Fair Value Measurements&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) establishes a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs which are supported by little or no market activity.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. At March&#160;31, 2023 and 2022 the Company had invested the majority of its $104.1 million and $111.1 million cash and cash equivalents balance in money market funds which are classified within Level 1.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426064710480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share</a></td>
<td class="text">Net Income Per Share<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the provisions of ASC Topic 260 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) basic net income per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted net income per common share includes the dilutive effect of potential restricted stock and the effects of the potential conversion of preferred shares, calculated using the </span><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">treasury stock method. Unvested restricted stock, and convertible preferred shares issued by the Company represent the only dilutive effect reflected in diluted weighted average shares outstanding.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented (in thousands, except for per share amounts):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:54.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (numerator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares (denominator)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding used in basic computation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,275</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,176</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,060</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares issuable upon the vesting of restricted stock</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares issuable upon conversion of preferred shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in diluted computation</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,339</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,358</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,119</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.52&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, 2022, and 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 745,854, 220,727, and 20,952 shares of common restricted stock, respectively, were excluded from the computations of diluted net income per common share, as their inclusion would have had an anti-dilutive effect on diluted net income per common share.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426064753840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal Matters and Routine Proceedings</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has settled complaints that had been filed with various states&#8217; pharmacy boards in the past. There can be no assurances made that other states will not attempt to take similar actions against the Company in the future. The Company also intends to vigorously defend its trade or service marks. There can be no assurance that the Company will be successful in protecting its trade or service marks. Legal costs related to the above matters are expensed as incurred. From time to time, the Company may be involved in and subject to disputes and legal proceedings, as well as demands, claims and threatened litigation that arise in the ordinary course of its business. These proceedings may include allegations involving business practices, infringement of intellectual property, employment or other matters. The ultimate outcome of any legal proceeding is often uncertain, there can be no assurance that the Company will be successful in any legal proceeding, and unfavorable outcomes could have a negative impact on our results of operations and financial condition. In accordance with ASC Topic 450-20 ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"), the Company records a liability in its financial statements for these matters when a loss is known or considered probable and the amount can be reasonably estimated. The Company reviews the status of each significant matter each accounting period as additional information is known and adjusts the loss provision when appropriate. If a matter is both probable to result in a liability and the amounts of loss can be reasonably estimated, the Company estimates and discloses the possible loss or range of loss to the extent necessary to make the financial statements not misleading. If the loss is not probable and cannot be reasonably estimated, a liability is </span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not recorded in the Company&#8217;s financial statements. Gain contingencies are not recorded until they are realized. Legal costs related to any legal matters are expensed as incurred.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales Tax</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2018, the United States Supreme Court rendered a decision in South Dakota v. Wayfair, Inc., holding that a state may require a remote seller with no physical presence in the state to collect and remit sales tax on goods and services provided to purchasers in the state, overturning certain existing court precedent. The Company has evaluated its state tax filings with respect to the Wayfair decision and currently collects and remits applicable sales taxes in all jurisdictions in which it has a physical presence or it believes Nexus exists. During the year ended March&#160;31, 2023, the Company received an assessment for sales tax; based upon this, the Company evaluated the various jurisdictions for additional exposure and recorded an increase of $7.8&#160;million for potential sales tax exposure. The Company included $4.0&#160;million in the "Accrued expenses and other current liabilities" line item and $3.8&#160;million in the "Other long-term liabilities" line item in the Consolidated Balance Sheets as of March&#160;31, 2023 with the offsetting expense  recognized in the "General and administrative" line item within the Consolidated Statements of Income for the year ended March&#160;31, 2023.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employment Agreements</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Board of Directors notified Menderes Akdag (&#8220;Mr. Akdag&#8221;), former CEO &amp; President and Director, that the Company would not extend Mr. Akdag&#8217;s employment agreement with the Company, and the employment agreement would therefore end on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 30, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in accordance with the scheduled end date of the agreement. Effective </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 31, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Board of Directors appointed Bruce S. Rosenbloom (&#8220;Mr. Rosenbloom&#8221;), the Company&#8217;s former Chief Financial Officer, as Interim Chief Executive Officer and President of the Company, until a permanent successor chief executive officer was appointed. Mr. Rosenbloom received an additional cash stipend of $10 thousand for the additional responsibilities while serving as Interim Chief Executive Officer and President, which ended on August&#160;30, 2021.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 11, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company and Mr. Akdag, entered into a CEO Separation Agreement and General Release setting forth certain matters relating to the expiration of Mr. Akdag&#8217;s employment with the Company (the &#8220;Separation Agreement&#8221;). The Separation Agreement provided that Mr. Akdag&#8217;s employment with the Company, and service as an officer and director of the Company, would terminate as of July 30, 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Separation Agreement also documented Mr. Akdag&#8217;s agreement that, during his remaining period of employment through July 30, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he would continue to provide his fulltime attention to the business affairs of the Company and cooperate with the Company&#8217;s Board of Directors on the transition to a new chief executive officer. The Separation Agreement provided that Mr. Akdag would be paid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">two</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lump-sum severance payments of $325 thousand each, with the first such payment to be paid, and was paid, on</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August&#160;10, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the second to be paid, and was paid, on December 31, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subject to his compliance with the terms and conditions of his then existing employment agreement, and the Separation Agreement. In exchange for the Company&#8217;s agreement to make the severance payments, Mr. Akdag granted the Company a full release of any and all claims that he may</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have against the Company and its affiliates and related parties.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a part of the Separation Agreement, the Company confirmed that the 37,800 restricted shares held by Mr. Akdag would be, and were, released from restriction and forfeiture on July 31, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and that the Company would, and did, cover the tax withholding obligations in connection with such release of shares from restriction and forfeiture. Under the Separation Agreement, Mr. Akdag agreed that he would continue to comply with his existing confidentiality, non-solicitation, and non-compete obligations, and he further agreed that until July 31, 2022,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he would comply with certain &#8220;standstill&#8221; covenants relating to the Company.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 25, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Board of Directors appointed Mathew N. Hulett ("Mr. Hulett&#8221;) as Chief Executive Officer and President of the Company and as a member of the Board of Directors. These appointments and the employment agreement were effective as of August 30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The employment agreement is for an initial term of three (3) years commencing on August 30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and will automatically renew for successive one (1) year terms, or for longer periods as mutually agreed upon by the parties, unless the employment agreement is expressly cancelled by either Mr. Hulett or the Company sixty (60) days prior to the end of the then current term, or is otherwise terminated as provided in the agreement. The employment agreement provides that Mr. Hulett will </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receive an annual base salary of $500 thousand, subject to periodic review for increases with the approval of the Board of Directors, and will be eligible to participate in the standard employee benefit plans generally available to executives and employees of the Company, including health insurance, life and disability insurance, restricted stock under the Company&#8217;s equity compensation plan(s), 401(k) plan, and paid time off and paid holidays. The employment agreement also provides that the Company will reimburse Mr. Hulett for his documented business expenses incurred in connection with his employment pursuant to the Company's standard reimbursement expense policy and practices. The employment agreement contains certain rights of Mr. Hulett and the Company to terminate Mr. Hulett&#8217;s employment, including termination by the Company for &#8220;Cause&#8221; as defined in the employment agreement, and termination by Mr. Hulett for &#8220;Good Reason&#8221; as defined in the employment agreement within twelve (12) months of a Change in Control as defined in the employment agreement. Mr. Hulett is also entitled to severance pay equal to twelve (12) months of Mr. Hulett&#8217;s current base salary and eighteen (18) months of health insurance benefits in the event of his termination by the Company without Cause, or termination by Mr. Hulett for Good Reason within twelve (12) months of a Change in Control. The foregoing severance benefits are conditioned upon Mr. Hulett&#8217;s execution of a release of claims and compliance with certain restrictive covenants. The employment agreement contains customary non-disclosure and non-solicitation provisions as well as a one (1) year non-compete following the termination of the agreement.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;30, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Hulett also received an award of 90,000 shares of restricted stock under the Company&#8217;s 2016 Employee Plan, which stock restrictions will lapse pro rata on each of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 30, 2022,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 30, 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 30, 2024,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which are subject to forfeiture in the event of termination of employment (except as provided in the restricted stock agreement). Mr. Hulett also received an award of 510,000 shares of performance restricted stock under the 2016 Employee Plan, which stock restrictions will lapse on the third anniversary of the date of grant based on (i) achieving absolute stock price hurdles within the three-year period from the date of grant, and (ii) continued employment through the performance period of three years from the date of grant, in accordance with the following schedule: 85,000 shares at the stock hurdle price of $40 per share, 107,000 shares at the stock hurdle price of $45 per share, 106,000 shares at the stock hurdle price of $50, 106,000 shares at the stock hurdle price of $55, and 106,000 shares at the stock hurdle price of $60.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should none of the absolute stock price hurdles be met during the three-year period from the date of grant, no shares would vest (as defined in the performance restricted stock agreement). Once the absolute stock price hurdle is achieved, it will be considered to have met the absolute stock price hurdle, regardless of the stock price on the third anniversary of the date of grant. The absolute stock price hurdle would be considered to have been met if the average closing stock price of the Company is at or above the absolute stock price hurdle for a period of ninety (90) consecutive trading days. If the shares would be considered to have met the absolute stock price hurdle, they will only vest on the third anniversary of date of grant, subject to Mr. Hulett&#8217;s continued employment through the performance period of three years from the date of grant (except as provided in the performance restricted stock agreement). As of March&#160;31, 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">none of the performance restricted stock vested, as no performance stock price hurdles were met.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;14, 2022, the Board of Directors appointed Christine Chambers ("Ms. Chambers") to serve as the Company&#8217;s Chief Financial Officer and to assume the duties of principal financial officer and principal accounting officer effective August&#160;3, 2022 (&#8220;Effective Date&#8221;). The Company entered into an offer letter with Ms. Chambers to set the terms and conditions of Ms. Chambers&#8217; employment as Chief Financial Officer of the Company. Ms. Chambers will receive an annual base salary of $375 thousand and received a one-time sign-on bonus in the amount of $50 thousand, subject to pro rata repayment if Ms. Chambers terminates employment with the Company within the first twelve months of employment. Ms. Chambers received an initial equity award  under the 2016 Employee Plan consisting of (i) an award of 13,000 restricted shares, and (ii) 3,000 performance restricted shares, which performance restricted shares will be based on the attainment of performance criteria equally weighted between adjusted EBITDA and revenue as of the fiscal year ended March&#160;31, 2023. The shares for each grant will be released from restriction equally over a three (3) year period on the anniversary of the grant date, subject to the attainment of performance criteria in the case of the performance restricted shares. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with Mr. Rosenbloom&#8217;s transition services and subsequent separation from employment with the Company, on August&#160;2, 2022 the Company and Mr. Rosenbloom entered into a CFO Transition and Separation Agreement (the "Separation Agreement&#8221;) pursuant to which Mr. Rosenbloom remained in his current position as CFO of the Company through and including August&#160;2, 2022, and following the termination of his </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">status as CFO, Mr. Rosenbloom continued to serve as an employee of the Company to provide transition services to the Company through his date of termination. His employment ended on December&#160;31, 2022 ("Separation Date&#8221;). While Mr. Rosenbloom served as an employee of the Company, he continued to receive his current base salary and benefits as was in effect. The Separation Agreement provided that Mr. Rosenbloom would be paid two lump-sum severance payments of $182 thousand each, with the first such payment to be paid on the Company&#8217;s next payroll date following the Separation Date, and was paid January 13, 2023, and the second to be paid on the Company&#8217;s next payroll date six-months following the Separation Date, subject to his compliance with the terms and conditions of his then existing employment agreement, and the Separation Agreement. In exchange for the Company&#8217;s agreement to make the severance payments, Mr. Rosenbloom granted the Company a full release of any and all claims that he may have against the Company and its affiliates and related parties.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a part of the Separation Agreement, the Company confirmed that the 13,275 restricted shares held by Mr. Rosenbloom under the 2016 Employee Plan were released from restriction and forfeiture on December&#160;31, 2022, Under the Separation Agreement, Mr. Rosenbloom&#8217;s existing non-compete obligation was reduced to a period of twelve (12) months.</span></div>In connection with the separation of the Company's former Chief Financial Officer, the Company has accrued the remaining $182 thousand payment with respect to the severance, pursuant to the Separation Agreement, included in "Accrued expenses and other current liabilities" on the Consolidated Balance Sheet as of March&#160;31, 2023.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426065952464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Employee Benefit Plan</a></td>
<td class="text">Employee Benefit Plan<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a 401(k) Savings Plan for eligible employees. The plan is a defined contribution plan that is administered by the Company. All regular, full-time employees are eligible for voluntary participation upon completing one year of service and having attained the age of 21. The plan provides for growth in savings through contributions and income from investments. It is subject to the provisions of the Employee Retirement Income Security Act of 1974</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as amended. Plan participants are allowed to contribute a specified percentage of their base salary. The Company matches 100% of the first 4% of the employees contribution. The matching contribution is funded subsequent to the calendar year. During the fiscal years ended March&#160;31, 2023, 2022, and 2021, the Company recorded $289 thousand, $238 thousand, and $245 thousand, respectively, of 401(k) matching contribution and administration expense to general and administrative expenses.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI https://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI https://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426064675168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Minority Interest Investment in Vetster<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Minority Interest Investment in Vetster</a></td>
<td class="text">Minority Interest Investment in Vetster<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;19, 2022, the Company engaged in a three-year partnership agreement with Vetster Inc. (&#8220;Vetster&#8221;), a veterinary telehealth Canadian company. The Company also purchased a 5% minority interest in Vetster in the amount of $5.0 million and received warrants for additional equity in Vetster, which are tied to future performance milestones. Under the terms of the agreement, the Company became the exclusive e-commerce provider for Vetster, and Vetster became the exclusive provider of telehealth and telemedicine services to the Company. The minority interest investment is being valued on the cost basis.  At March 31, 2023, we evaluated the investment in accordance with ASC Topic 321 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Equity Interests</span>) and determined it was not impaired.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426064673936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent EventsOn January&#160;13, 2023, the Company entered into an Agreement and Plan of Merger to acquire PetCareRx, Inc. ("PetCareRx"), a leading supplier of pet medications, food, and supplies, for an aggregate consideration of approximately $36.0 million in cash, subject to adjustment. The closing of the transaction was subject to customary closing conditions and certain state pharmacy license and permit filings related to the change of control of PetCareRx. The transaction was approved by the Board of Directors of both the Company and PetCareRx, and <div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the stockholders of PetCareRx, and closed on April&#160;3, 2023. Upon completion of the acquisition, PetCareRx became a wholly-owned subsidiary of the Company.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to March&#160;31, 2023, the Board of Directors approved and issued 42,142 restricted shares to employees of PetCareRx under the 2022 Employee Plan as part of a  retention initiative, which shares were issued subject to a restriction or forfeiture period that lapses on the first anniversary of the date of grant.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to March&#160;31, 2023, the Board of Directors approved and issued 11,910 restricted shares, net of forfeitures, to employees under the 2016 Employee Plan and 31,000 restricted shares to employees under the 2022 Employee Plan, which shares were issued subject to a restriction or forfeiture period that lapses ratably on the first, second, and third anniversaries of the date of grant. The Board also approved the issuance of a pro-rata portion of a non-employee director annual restricted stock grant in the amount of 1,623 restricted shares to Sandra Campos, a newly appointed director on the Board of Directors, under the 2015 Director Plan, which shares were issued subject to a restriction or forfeiture period that lapses ratably on the first, second, and third anniversaries of the date of grant.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;22, 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company&#8217;s Board of Directors declared a quarterly dividend of $0.30 per share on its common stock. The $6.3 million dividend will be payable on June&#160;12, 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to shareholders of record at the close of business on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;6, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426064739440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transaction<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transaction</a></td>
<td class="text">Related Party Transaction<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Board of Directors Chairman, Gian Fulgoni, serves on the board of directors of Prophet, a brand and marketing consulting company, which PetMed Express, Inc. engaged with in March 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for $292 thousand. The Company expensed $32 thousand in fiscal 2021, with the remaining $260 thousand expensed in fiscal 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This transaction was approved by the Company&#8217;s Board of Directors with terms that are comparable to those with an unrelated third party.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426061821120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and include PetMed Express, Inc. and its  wholly owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates revenue by selling pet medication products and pet supplies. Certain pet supplies offered on the Company&#8217;s website are drop shipped to customers. The Company considers itself the principal in the arrangement because the Company controls the specified good before it is transferred to the customer. Revenue contracts contain one performance obligation, which is delivery of the product. Customer care and support is deemed not to be a material right to the contract. The transaction price is adjusted at the date of sale for any applicable sales discounts and an estimate of product returns, which are estimated based on historical patterns; however, this is not considered a key judgment.  Revenue is recognized when control transfers to the customer at the point in time in which shipment of the product occurs. This key judgment is determined as the shipping point represents the point in time in which the Company has a present right to payment, title has transferred to the customer, and the customer has assumed the risks and rewards of ownership. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outbound shipping and handling fees are an accounting policy election and are included in sales as the Company considers itself the principal in the arrangement given responsibility for supplier selection and discretion over pricing. Shipping costs associated with outbound freight after control over a product has transferred to a customer are an accounting policy election and are accounted for as fulfillment costs and are included in cost of sales.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disaggregates sales in the following two categories: (1) reorder sales vs new order sales, and (2) internet sales vs call center sales. The following table illustrates sales by various classifications:</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:29.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.855%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales (In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reorder sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New order sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,687)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,559)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internet sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Call center sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,858&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,559)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:29.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.855%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales (In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reorder sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New order sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,798)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internet sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Call center sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,215&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,798)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company changed the definition of a new customer on April 1, 2022, to include anyone who has not ordered over the past thirty-six months. The reorder and new order sales amounts for the years ended March&#160;31, 2022 and March&#160;31, 2021, respectively, reflect this new customer definition change. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the previous definition of a new customer, reorder and new order sales were $250.4 million and $23.0 million, respectively, for the year ended March&#160;31, 2022. Under the previous definition of a new customer, reorder and new order sales were $272.6 million and $36.6 million, respectively, for the  year ended March&#160;31, 2021. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Virtually all of the Company&#8217;s sales are paid by credit cards and the Company usually receives the cash settlement in two to three banking days. Credit card sales minimize accounts receivable balances relative to sales. The Company had no material contract asset or liability balances as of March&#160;31, 2023 and 2022.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains an allowance for doubtful accounts for losses that the Company estimates will arise from customers&#8217; inability to make required payments, arising from either credit card chargebacks or insufficient funds checks. The Company determines its estimates of the uncollectability of accounts receivable by analyzing historical bad debts and current economic trends in compliance with the provisions of Accounting Standards Codification ("ASC") Topic 326 ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses").</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The allowance for doubtful accounts was approximately $35 thousand  and $39 thousand at March&#160;31, 2023 and March&#160;31, 2022, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents at March&#160;31, 2023 and 2022 consisted of the Company&#8217;s cash accounts and money market accounts with a maturity of three months or less. The carrying amount of cash equivalents approximates fair value. The Company maintains its cash in bank deposit accounts which, at times,  may exceed federally insured limits. The Company has not experienced any losses in such accounts.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">InventoriesInventories consist of prescription and non-prescription pet medications and pet supplies that are available for sale and are priced at the lower of cost or net realizable value using a weighted average cost method. The Company writes down its inventory for estimated obsolescence.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets. Our building is being depreciated over a period of thirty years. The furniture, fixtures, equipment, and computer software are being depreciated over periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNTQ4Mw_bad1a77d-7eb3-4209-80fa-1d8f0ecbb508">three</span> to ten years.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-lived Assets</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-lived Assets</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets is measured by a comparison of the carrying amount of the asset to the undiscounted cash flows expected to be generated from the asset.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Intangible Assets</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intangible assets consist of a toll-free telephone number and internet domain names. In accordance with the ASC Topic 350 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) the intangible assets are not being amortized and are subject to an annual review for impairment.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_OtherAssetsPolicyTextBlock', window );">Other Assets</a></td>
<td class="text">Other AssetsOther assets consist of the initial minority interest investment in Vetster.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the Company's cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to the short-term nature of these instruments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's advertising expense consists primarily of Internet marketing, direct mail/print, and television advertising. Internet costs are expensed in the month incurred and direct mail/print advertising costs are expensed </span></div>when the related catalogs, brochures, and postcards are produced, distributed, or superseded. Television advertising costs are expensed as the advertisements are televised.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income</a></td>
<td class="text">Comprehensive Income<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies ASC Topic 220 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reporting Comprehensive Income</span>&#8221;) which requires that all items that are recognized under accounting standards as components of comprehensive income be reported in a financial statement that is displayed with the same prominence as other financial statements. The items of other comprehensive income that are typically required to be displayed are foreign currency items, minimum pension liability adjustments, and unrealized gains and losses on certain investments in debt and equity securities. For the fiscal years ended March&#160;31, 2023, 2022 and 2021, the Company had no components of comprehensive income and therefore does not report comprehensive income or Consolidated Statements of Comprehensive Income.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the provisions of ASC Topic 740 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) which generally requires the recognition of deferred tax assets and liabilities for the expected future tax benefits or consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting carrying values and the tax bases of assets and liabilities and are measured by applying enacted tax rates and laws for the taxable years in which those differences are expected to reverse. As required by &#8220;Accounting for Uncertainty in Income Taxes&#8221; guidance, which clarifies ASC Topic 740, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the Consolidated Financial Statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies &#8220;Accounting for Uncertainty in Income Taxes&#8221; guidance to all tax positions for which the statute of limitations remains open. The Company had no liabilities for uncertain tax positions for both fiscal 2023 and fiscal 2022. The Company files tax returns in the U.S. federal jurisdiction and Florida,  Arizona, California, Connecticut, Idaho, Maryland, Michigan, Oklahoma, South Carolina, Virginia, Wisconsin, New Jersey, Georgia, Indiana, New York and the District of Columbia. With few exceptions, the Company is no longer subject to U.S. federal, state or local income tax examinations by tax authorities for years ending March&#160;31, 2019, or earlier. Any interest and penalties related to income taxes will be recorded to other income (expenses).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Business Concentrations</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Concentrations</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases its products from a variety of sources, including certain manufacturers, domestic distributors, and wholesalers. We have multiple suppliers for each of our product lines to obtain the lowest cost. There were six suppliers from which we purchased approximately 69%  and 77% of all products in fiscal 2023 and 2022, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Accounting for Share Based Compensation</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting for Share Based Compensation</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records compensation expense associated with restricted stock in accordance with ASC Topic 718 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Based Payment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The compensation expense related to all of the Company&#8217;s stock-based compensation arrangements is recorded as a component of general and administrative expenses.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, will have a material effect on the Company&#8217;s consolidated financial position, results of operations, or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_OtherAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_OtherAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426064678752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The following table illustrates sales by various classifications:<div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:29.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.855%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales (In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reorder sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New order sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,687)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,559)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internet sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Call center sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,858&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,559)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:29.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.855%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales (In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Variance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Variance</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reorder sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New order sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,798)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internet sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Call center sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,215&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,798)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426064728848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Major classifications of property and equipment consist of the following (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:69.815%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building Improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,149&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,231)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,685)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,464&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426064693536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Major classifications of accrued expenses and other current liabilities consist of the following (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:69.815%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued credit card fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salaries and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued merchandise credits / reward program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales return allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued dividends payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued real estate taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,289&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,697&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426066101280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text">The tax <div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are as follows (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:69.815%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt and inventory reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,527)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,989)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net deferred tax assets (liabilities)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(936)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Provision</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the income tax provision consist of the following (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:54.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,915&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,316&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(982)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,564)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income tax provision computed at the U.S. federal statutory tax rates to income tax expense is as follows (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:54.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes at U.S. statutory rates</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock shortfall (windfall) adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(393)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The differences between the effective income tax rate and the statutory U.S. federal income tax rate are as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.727%"><tr><td style="width:1.0%"/><td style="width:54.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal rate on income before taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock shortfall (windfall) adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Effective Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426064758560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsDeclaredTableTextBlock', window );">Schedule of Dividend Declaration</a></td>
<td class="text">During fiscal 2023, our Board of Directors declared the following dividends:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.272%"><tr><td style="width:1.0%"/><td style="width:20.254%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.045%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.045%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.953%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Declaration Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Per Share<br/>Dividend</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount<br/>(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment Date</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 20, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,297</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 27, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 25, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 12, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,323</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 19, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 7, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 18, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,323</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 6, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 20, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,325</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2023</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsDeclaredTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsDeclaredTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426064618768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restricted Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Schedule of Nonvested Share Activity</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s non-vested restricted stock at March&#160;31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is as follows (in thousands):</span></div><div style="margin-top:12pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:54.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee<br/>Plan<br/>Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Director<br/>Plan<br/>Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Both Plans<br/>Number of<br/>Shares</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested restricted stock outstanding at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">771</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock granted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock forfeited or expired</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested restricted stock outstanding at March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426065952464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Net Income Per Share</a></td>
<td class="text">The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented (in thousands, except for per share amounts):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:54.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.115%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (numerator):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares (denominator)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding used in basic computation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,275</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,176</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,060</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares issuable upon the vesting of restricted stock</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares issuable upon conversion of preferred shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in diluted computation</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,339</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,358</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,119</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.52&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426062797856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br> ft&#178; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2016 </div>
<div>ft&#178; </div>
<div>tenant</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>tenant</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 256,858<span></span>
</td>
<td class="nump">$ 273,417<span></span>
</td>
<td class="nump">$ 309,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Liabilities for uncertain tax positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=pets_DelrayBeachPropertyMember', window );">Delray Beach Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_PercentageOfPropertyLeasedToTenants', window );">Percentage of property leased to tenants</a></td>
<td class="nump">48.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of real estate property (in square feet) | ft&#178;</a></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_NumberOfTenants', window );">Number of tenants | tenant</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm', window );">Weighted average remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RentalIncomeNonoperating', window );">Rental revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 710<span></span>
</td>
<td class="nump">689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths', window );">Lessor, operating lease, payment to be received, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears', window );">Lessor, operating lease, payment to be received, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears', window );">Lessor, operating lease, payment to be received, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears', window );">Lessor, operating lease, payment to be received, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears', window );">Lessor, operating lease, payment to be received, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=pets_ReorderMember', window );">Reorder Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,633<span></span>
</td>
<td class="nump">244,505<span></span>
</td>
<td class="nump">263,152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=pets_ReorderMember', window );">Reorder Customer | Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,400<span></span>
</td>
<td class="nump">272,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=pets_NewOrderMember', window );">New Order Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,225<span></span>
</td>
<td class="nump">28,912<span></span>
</td>
<td class="nump">46,063<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=pets_NewOrderMember', window );">New Order Customer | Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="nump">$ 36,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk | Cost of Goods and Service Benchmark | Six Suppliers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of all products purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.00%<span></span>
</td>
<td class="nump">77.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=pets_FurnitureFixturesEquipmentAndComputerSoftwareMember', window );">Furniture, Fixtures, Equipment and Computer Software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=pets_FurnitureFixturesEquipmentAndComputerSoftwareMember', window );">Furniture, Fixtures, Equipment and Computer Software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_NumberOfTenants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents number of tenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_NumberOfTenants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_PercentageOfPropertyLeasedToTenants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage amount of property that was leased to tenants of the property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_PercentageOfPropertyLeasedToTenants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RentalIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income earned by providing the use of assets to an outside party in exchange for a payment or series of payments that is nonoperating in nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RentalIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=pets_DelrayBeachPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=pets_DelrayBeachPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pets_ReorderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pets_ReorderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pets_NewOrderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pets_NewOrderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pets_SixSuppliersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pets_SixSuppliersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=pets_FurnitureFixturesEquipmentAndComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=pets_FurnitureFixturesEquipmentAndComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426061656464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Disaggregation of Revenue by Type (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 256,858<span></span>
</td>
<td class="nump">$ 273,417<span></span>
</td>
<td class="nump">$ 309,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerPercentage', window );">Revenues, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariance', window );">Revenues, variance</a></td>
<td class="num">$ (16,559)<span></span>
</td>
<td class="num">$ (35,798)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariancePercentage', window );">Revenues, variance, percentage</a></td>
<td class="num">(6.10%)<span></span>
</td>
<td class="num">(11.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=pets_InternetMember', window );">Internet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 221,894<span></span>
</td>
<td class="nump">$ 230,263<span></span>
</td>
<td class="nump">$ 259,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerPercentage', window );">Revenues, percentage</a></td>
<td class="nump">86.40%<span></span>
</td>
<td class="nump">84.20%<span></span>
</td>
<td class="nump">83.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariance', window );">Revenues, variance</a></td>
<td class="num">$ (8,369)<span></span>
</td>
<td class="num">$ (29,141)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariancePercentage', window );">Revenues, variance, percentage</a></td>
<td class="num">(3.60%)<span></span>
</td>
<td class="num">(11.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=pets_ContactCenterMember', window );">Call center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 34,964<span></span>
</td>
<td class="nump">$ 43,154<span></span>
</td>
<td class="nump">$ 49,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerPercentage', window );">Revenues, percentage</a></td>
<td class="nump">13.60%<span></span>
</td>
<td class="nump">15.80%<span></span>
</td>
<td class="nump">16.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariance', window );">Revenues, variance</a></td>
<td class="num">$ (8,190)<span></span>
</td>
<td class="num">$ (6,657)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariancePercentage', window );">Revenues, variance, percentage</a></td>
<td class="num">(19.00%)<span></span>
</td>
<td class="num">(13.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=pets_ReorderMember', window );">Reorder Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 232,633<span></span>
</td>
<td class="nump">$ 244,505<span></span>
</td>
<td class="nump">$ 263,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerPercentage', window );">Revenues, percentage</a></td>
<td class="nump">90.60%<span></span>
</td>
<td class="nump">89.40%<span></span>
</td>
<td class="nump">85.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariance', window );">Revenues, variance</a></td>
<td class="num">$ (11,872)<span></span>
</td>
<td class="num">$ (18,647)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariancePercentage', window );">Revenues, variance, percentage</a></td>
<td class="num">(4.90%)<span></span>
</td>
<td class="num">(7.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=pets_NewOrderMember', window );">New Order Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 24,225<span></span>
</td>
<td class="nump">$ 28,912<span></span>
</td>
<td class="nump">$ 46,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerPercentage', window );">Revenues, percentage</a></td>
<td class="nump">9.40%<span></span>
</td>
<td class="nump">10.60%<span></span>
</td>
<td class="nump">14.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariance', window );">Revenues, variance</a></td>
<td class="num">$ (4,687)<span></span>
</td>
<td class="num">$ (17,151)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RevenueFromContractWithCustomerVariancePercentage', window );">Revenues, variance, percentage</a></td>
<td class="num">(16.20%)<span></span>
</td>
<td class="num">(37.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_RevenueFromContractWithCustomerPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenue from the specified category to the total revenue during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_RevenueFromContractWithCustomerPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_RevenueFromContractWithCustomerVariance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of changes in revenue in current period comparing to the same period in the previous year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_RevenueFromContractWithCustomerVariance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_RevenueFromContractWithCustomerVariancePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of changes in revenue in current period comparing to the same period in the previous year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_RevenueFromContractWithCustomerVariancePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=pets_InternetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=pets_InternetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=pets_ContactCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=pets_ContactCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pets_ReorderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pets_ReorderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pets_NewOrderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pets_NewOrderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426065975872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 41,409<span></span>
</td>
<td class="nump">$ 36,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(15,231)<span></span>
</td>
<td class="num">(11,685)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">26,178<span></span>
</td>
<td class="nump">24,464<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">14,997<span></span>
</td>
<td class="nump">14,997<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">3,700<span></span>
</td>
<td class="nump">3,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">3,917<span></span>
</td>
<td class="nump">2,834<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Computer Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">9,391<span></span>
</td>
<td class="nump">5,512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, fixtures and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 9,404<span></span>
</td>
<td class="nump">$ 9,106<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426061717696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Accrued sales tax</a></td>
<td class="nump">$ 5,098<span></span>
</td>
<td class="nump">$ 1,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_AccruedCreditCardFeesCurrent', window );">Accrued credit card fees</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Accrued salaries and benefits</a></td>
<td class="nump">1,564<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_AccruedMerchandiseCreditsAndRewardsCurrent', window );">Accrued merchandise credits / reward program</a></td>
<td class="nump">1,660<span></span>
</td>
<td class="nump">1,623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional expenses</a></td>
<td class="nump">559<span></span>
</td>
<td class="nump">459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_AccruedSalesReturnsAndAllowancesCurrent', window );">Accrued sales return allowance</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Accrued dividends payable</a></td>
<td class="nump">1,262<span></span>
</td>
<td class="nump">558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent', window );">Accrued real estate taxes</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_AccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">$ 11,289<span></span>
</td>
<td class="nump">$ 5,697<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_AccruedCreditCardFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for credit card fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_AccruedCreditCardFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_AccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_AccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_AccruedMerchandiseCreditsAndRewardsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accrued merchandise credits and rewards classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_AccruedMerchandiseCreditsAndRewardsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_AccruedSalesReturnsAndAllowancesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents accrued sales returns and allowances. Used to reflect the current portion (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_AccruedSalesReturnsAndAllowancesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6419918&amp;loc=d3e35281-107843<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426060975648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">$ 1,529<span></span>
</td>
<td class="nump">$ 364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation', window );">Deferred stock compensation</a></td>
<td class="nump">1,605<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Bad debt and inventory reserves</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">3,155<span></span>
</td>
<td class="nump">1,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(2,527)<span></span>
</td>
<td class="num">(1,989)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Total net deferred tax assets (liabilities)</a></td>
<td class="nump">$ 628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total net deferred tax assets (liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (936)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426066070128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Restricted stock shortfall (windfall) adjustment</a></td>
<td class="nump">$ 208<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="num">$ (135)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions', window );">One time charge (benefit) for return to provision true up</a></td>
<td class="nump">382<span></span>
</td>
<td class="num">$ (29)<span></span>
</td>
<td class="num">$ (194)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal net operating loss carryforwards</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126928070&amp;loc=d3e28511-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126928070&amp;loc=d3e28446-109314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426062924944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income Tax Provision (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 1,831<span></span>
</td>
<td class="nump">$ 5,801<span></span>
</td>
<td class="nump">$ 7,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">1,084<span></span>
</td>
<td class="nump">515<span></span>
</td>
<td class="nump">856<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current taxes</a></td>
<td class="nump">2,915<span></span>
</td>
<td class="nump">6,316<span></span>
</td>
<td class="nump">8,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(982)<span></span>
</td>
<td class="num">(317)<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(582)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Total deferred taxes</a></td>
<td class="num">(1,564)<span></span>
</td>
<td class="num">(345)<span></span>
</td>
<td class="nump">311<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 1,351<span></span>
</td>
<td class="nump">$ 5,971<span></span>
</td>
<td class="nump">$ 8,613<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426066296144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Income Tax Provision (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income taxes at U.S. statutory rates</a></td>
<td class="nump">$ 333<span></span>
</td>
<td class="nump">$ 5,685<span></span>
</td>
<td class="nump">$ 8,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal tax benefit</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">379<span></span>
</td>
<td class="nump">708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount', window );">Permanent differences</a></td>
<td class="nump">396<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Restricted stock shortfall (windfall) adjustment</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="num">(135)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other</a></td>
<td class="nump">139<span></span>
</td>
<td class="num">(185)<span></span>
</td>
<td class="num">(393)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 1,351<span></span>
</td>
<td class="nump">$ 5,971<span></span>
</td>
<td class="nump">$ 8,613<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Permanent Differences, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426062690992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Total Effective Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal rate on income before taxes (as a percent)</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal tax benefit</a></td>
<td class="nump">17.40%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent', window );">Permanent differences</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Restricted stock shortfall (windfall) adjustments</a></td>
<td class="nump">13.10%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other</a></td>
<td class="nump">8.80%<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total Effective Tax Rate</a></td>
<td class="nump">85.30%<span></span>
</td>
<td class="nump">22.10%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Permanent Differences, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426061776112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 1998</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Feb. 06, 2023</div></th>
<th class="th"><div>Nov. 07, 2022</div></th>
<th class="th"><div>Jul. 25, 2022</div></th>
<th class="th"><div>May 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Preferred stock, shares issued, price per share (in dollars per share)</a></td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="nump">$ 112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible preferred stock, shares issued upon conversion (in shares)</a></td>
<td class="nump">4.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred stock, liquidation preference (in dollars per share)</a></td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Share repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Per share dividend (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21484-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426066063520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholder's Equity - Declared Dividends (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Feb. 06, 2023</div></th>
<th class="th"><div>Nov. 07, 2022</div></th>
<th class="th"><div>Jul. 25, 2022</div></th>
<th class="th"><div>May 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Per Share Dividend (in dollars per share)</a></td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Total Amount</a></td>
<td class="nump">$ 6,325<span></span>
</td>
<td class="nump">$ 6,323<span></span>
</td>
<td class="nump">$ 6,323<span></span>
</td>
<td class="nump">$ 6,297<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426060660480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restricted Stock - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 03, 2023</div></th>
<th class="th"><div>Aug. 03, 2022</div></th>
<th class="th"><div>Aug. 30, 2021</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Jul. 31, 2015</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jul. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,617<span></span>
</td>
<td class="nump">$ 4,549<span></span>
</td>
<td class="nump">$ 3,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">753,000<span></span>
</td>
<td class="nump">771,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_CommonStockMember', window );">Common Stock | Share-Based Payment Arrangement, Nonemployee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares)</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember', window );">2015 Outside Director Equity Compensation Restricted Stock Plan [Member] | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance', window );">Common stock available for issuance, automatic annual increase, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember', window );">2016 Employee Equity Compensation Restricted Stock Plan | Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Restricted shares, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember', window );">2016 Employee Equity Compensation Restricted Stock Plan | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">960,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember', window );">2016 Employee Equity Compensation Restricted Stock Plan | Restricted Stock | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RestrictionPeriod', window );">Restriction period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember', window );">2016 Employee Equity Compensation Restricted Stock Plan | Restricted Stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RestrictionPeriod', window );">Restriction period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember', window );">2015 Outside Director Equity Compensation Restricted Stock Plan ("2015 Director Plan") | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember', window );">2015 Outside Director Equity Compensation Restricted Stock Plan ("2015 Director Plan") | Restricted Stock | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RestrictionPeriod', window );">Restriction period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember', window );">2015 Outside Director Equity Compensation Restricted Stock Plan ("2015 Director Plan") | Restricted Stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_RestrictionPeriod', window );">Restriction period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_EmployeeAndDirectorEquityCompensationPlanMember', window );">Employee and Director Equity Compensation Plan | Non-vested Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">752,829<span></span>
</td>
<td class="nump">770,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,390<span></span>
</td>
<td class="nump">709,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.57<span></span>
</td>
<td class="nump">$ 30.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation costs related to restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="nump">$ 13,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average restriction and forfeiture period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember', window );">2022 Employee Equity Compensation Restricted Stock Plan | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember', window );">The 2016 Employee Equity Compensation Restricted Stock Plan | Restricted Stock | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember', window );">The 2016 Employee Equity Compensation Restricted Stock Plan | Restricted Stock | Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of automatic increase in the amount of shares available for issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_RestrictionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of restriction of forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_RestrictionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_EmployeeAndDirectorEquityCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_EmployeeAndDirectorEquityCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=pets_NonvestedRestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=pets_NonvestedRestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426066909344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restricted Stock - Non-vested Restricted Stock (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested restricted stock at March 31, 2022 (in shares)</a></td>
<td class="nump">771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares)</a></td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Restricted stock vested (in shares)</a></td>
<td class="num">(118)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Restricted stock forfeited or expired (in shares)</a></td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested restricted stock outstanding at March 31, 2023 (in shares)</a></td>
<td class="nump">753<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_EmployeePlanMember', window );">Employee Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested restricted stock at March 31, 2022 (in shares)</a></td>
<td class="nump">702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares)</a></td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Restricted stock vested (in shares)</a></td>
<td class="num">(88)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Restricted stock forfeited or expired (in shares)</a></td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested restricted stock outstanding at March 31, 2023 (in shares)</a></td>
<td class="nump">684<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pets_DirectorPlanMember', window );">Director Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested restricted stock at March 31, 2022 (in shares)</a></td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares)</a></td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Restricted stock vested (in shares)</a></td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Restricted stock forfeited or expired (in shares)</a></td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested restricted stock outstanding at March 31, 2023 (in shares)</a></td>
<td class="nump">69<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_EmployeePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_EmployeePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_DirectorPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_DirectorPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426066364576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 104,086<span></span>
</td>
<td class="nump">$ 111,080<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426066907392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share - Basic and Diluted Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Net income (numerator):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 233<span></span>
</td>
<td class="nump">$ 21,100<span></span>
</td>
<td class="nump">$ 30,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Shares (denominator)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding used in basic computation (in shares)</a></td>
<td class="nump">20,275<span></span>
</td>
<td class="nump">20,176<span></span>
</td>
<td class="nump">20,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Common shares issuable upon the vesting of restricted stock (in shares)</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">172<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Common shares issuable upon conversion of preferred shares (in shares)</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in diluted computation (in shares)</a></td>
<td class="nump">20,339<span></span>
</td>
<td class="nump">20,358<span></span>
</td>
<td class="nump">20,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_EarningsPerShareBasicAndDilutedEPSAbstract', window );"><strong>Net income per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 1.05<span></span>
</td>
<td class="nump">$ 1.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="nump">$ 1.52<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_EarningsPerShareBasicAndDilutedEPSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share, Basic and Diluted EPS</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_EarningsPerShareBasicAndDilutedEPSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426068355760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share - Narrative (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)</a></td>
<td class="nump">745,854<span></span>
</td>
<td class="nump">220,727<span></span>
</td>
<td class="nump">20,952<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426055535472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ / shares in Units, ft&#178; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 13, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 03, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 02, 2022 </div>
<div>USD ($) </div>
<div>payment</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 10, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 31, 2016 </div>
<div>ft&#178; </div>
<div>tenant</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>tenant </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 11, 2021 </div>
<div>payment</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExciseAndSalesTaxes', window );">Sales tax exposure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_LumpSumSeverancePayments', window );">Lump-sum severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=pets_AccruedExpensesAndOtherCurrentLiabilitiesMember', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent', window );">Accrued sales tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent', window );">Accrued sales tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pets_PetCareRxMember', window );">PetCareRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate consideration</a></td>
<td class="nump">$ 36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_PaymentsForStipend', window );">Cash stipend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_NumberOfSeverancePayments', window );">Number of severance payments | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_LumpSumSeverancePayments', window );">Lump-sum severance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock, released in period (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_EmploymentTermInitialPeriod', window );">Initial employment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_EmploymentTermSuccessiveRenewalPeriod', window );">Successive renewal employment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm', window );">Employment term cancellation period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Annual base salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_TerminationPeriodPeriodWithinChangeInControl', window );">"Good Reason" termination period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_SeverancePaymentBaseSalaryPeriod', window );">Severance pay equal to based salary for number of periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod', window );">Severance pay health insurance benefits, without cause termination, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod', window );">Severance pay health insurance benefits, change in control, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_NonCompeteAgreementPeriod', window );">Non-compete term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer | The 2016 Employee Equity Compensation Restricted Stock Plan | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer | The 2016 Employee Equity Compensation Restricted Stock Plan | Performance Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod', window );">Absolute stock price hurdle period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod', window );">Employment performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod', window );">Achievement of absolute stock price hurdle period, consecutive days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer | The 2016 Employee Equity Compensation Restricted Stock Plan | Performance Restricted Stock Price Hurdle 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Stock hurdle price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer | The 2016 Employee Equity Compensation Restricted Stock Plan | Performance Restricted Stock Price Hurdle 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Stock hurdle price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer | The 2016 Employee Equity Compensation Restricted Stock Plan | Performance Restricted Stock Price Hurdle 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Stock hurdle price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer | The 2016 Employee Equity Compensation Restricted Stock Plan | Performance Restricted Stock Price Hurdle 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Stock hurdle price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer | The 2016 Employee Equity Compensation Restricted Stock Plan | Performance Restricted Stock Price Hurdle 5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Stock hurdle price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember', window );">Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_NumberOfSeverancePayments', window );">Number of severance payments | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_LumpSumSeverancePayments', window );">Lump-sum severance payments</a></td>
<td class="nump">$ 182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock, released in period (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Annual base salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_NonCompeteAgreementPeriod', window );">Non-compete term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_SalaryAndWageOfficerSignOnBonus', window );">Sign on bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_ContingentLumpSumSeverancePayment', window );">Contingent lump sum severance payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_AccruedSeveranceCosts', window );">Accrued severance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember', window );">Chief Financial Officer | The 2016 Employee Equity Compensation Restricted Stock Plan | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember', window );">Chief Financial Officer | The 2016 Employee Equity Compensation Restricted Stock Plan | Performance Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Restricted shares, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=pets_DelrayBeachPropertyMember', window );">Delray Beach Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_PercentageOfPropertyLeasedToTenants', window );">Percentage of property leased to tenants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of real estate property (in square feet) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_NumberOfTenants', window );">Number of tenants | tenant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm', window );">Weighted average remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_AccruedSeveranceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Severance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_AccruedSeveranceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_ContingentLumpSumSeverancePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Lump Sum Severance Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_ContingentLumpSumSeverancePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employment Term, Cancellation Period Prior To End Of Current Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_EmploymentTermInitialPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employment Term, Initial Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_EmploymentTermInitialPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_EmploymentTermSuccessiveRenewalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employment Term, Successive Renewal Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_EmploymentTermSuccessiveRenewalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_LumpSumSeverancePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents lump-sum severance payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_LumpSumSeverancePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_NonCompeteAgreementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Compete Agreement, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_NonCompeteAgreementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_NumberOfSeverancePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Severance Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_NumberOfSeverancePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_NumberOfTenants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents number of tenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_NumberOfTenants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_PaymentsForStipend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents payments for stipend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_PaymentsForStipend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_PercentageOfPropertyLeasedToTenants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage amount of property that was leased to tenants of the property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_PercentageOfPropertyLeasedToTenants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_SalaryAndWageOfficerSignOnBonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Salary And Wage, Officer, Sign On Bonus</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_SalaryAndWageOfficerSignOnBonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_SeverancePaymentBaseSalaryPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Severance Payment, Base Salary, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_SeverancePaymentBaseSalaryPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Severance Payment, Change In Control, Health Insurance Benefits, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Severance Payment, Termination Without Cause, Health Insurance Benefits, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Absolute Stock Price Hurdle Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Hurdle Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Performance Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_TerminationPeriodPeriodWithinChangeInControl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Termination Period, Period Within Change In Control</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_TerminationPeriodPeriodWithinChangeInControl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExciseAndSalesTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExciseAndSalesTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OfficersCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OfficersCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=pets_AccruedExpensesAndOtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=pets_AccruedExpensesAndOtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pets_PetCareRxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pets_PetCareRxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=pets_PerformanceRestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=pets_PerformanceRestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=pets_PerformanceRestrictedStockPriceHurdle1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=pets_PerformanceRestrictedStockPriceHurdle1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=pets_PerformanceRestrictedStockPriceHurdle2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=pets_PerformanceRestrictedStockPriceHurdle2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=pets_PerformanceRestrictedStockPriceHurdle3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=pets_PerformanceRestrictedStockPriceHurdle3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=pets_PerformanceRestrictedStockPriceHurdle4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=pets_PerformanceRestrictedStockPriceHurdle4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=pets_PerformanceRestrictedStockPriceHurdle5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=pets_PerformanceRestrictedStockPriceHurdle5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=pets_DelrayBeachPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=pets_DelrayBeachPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426068444016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1', window );">Defined contribution plan, requisite service period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_DefinedContributionPlanWithIndividualAge', window );">Defined contribution plan, requisite age</a></td>
<td class="text">21 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer match contribution percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Percentage of employees gross compensation eligible for match</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount', window );">Defined contribution plan, matching contribution</a></td>
<td class="nump">$ 289<span></span>
</td>
<td class="nump">$ 238<span></span>
</td>
<td class="nump">$ 245<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_DefinedContributionPlanWithIndividualAge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum age that the individual is required in order to participate in the defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_DefinedContributionPlanWithIndividualAge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=6409961&amp;loc=d3e20487-108367<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426065902288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Minority Interest Investment in Vetster (Details) - Partnership Agreement with Vetster<br> $ in Millions</strong></div></th>
<th class="th">
<div>Apr. 19, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_TermOfAgreement', window );">Term of agreement</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pets_NoncontrollingInterestOwnershipPercentagePurchased', window );">Minority interest purchased, percent</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Minority interest purchased, amount</a></td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_NoncontrollingInterestOwnershipPercentagePurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents minority interest purchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_NoncontrollingInterestOwnershipPercentagePurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pets_TermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents term of agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pets_TermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pets_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=pets_PartnershipAgreementWithVetsterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=pets_PartnershipAgreementWithVetsterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426062817296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 13, 2023</div></th>
<th class="th"><div>May 23, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>May 22, 2023</div></th>
<th class="th"><div>Feb. 06, 2023</div></th>
<th class="th"><div>Nov. 07, 2022</div></th>
<th class="th"><div>Jul. 25, 2022</div></th>
<th class="th"><div>May 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Per share dividend (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividend payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,325<span></span>
</td>
<td class="nump">$ 6,323<span></span>
</td>
<td class="nump">$ 6,323<span></span>
</td>
<td class="nump">$ 6,297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Per share dividend (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividend payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | 2016 Employee Equity Compensation Restricted Stock Plan | Subsequent Event | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Share-Based Payment Arrangement, Employee | 2016 Employee Equity Compensation Restricted Stock Plan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Share-Based Payment Arrangement, Employee | 2022 Employee Equity Compensation Restricted Stock Plan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pets_PetCareRxMember', window );">PetCareRx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate consideration</a></td>
<td class="nump">$ 36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pets_PetCareRxMember', window );">PetCareRx | Restricted Stock | Share-Based Payment Arrangement, Employee | 2022 Employee Equity Compensation Restricted Stock Plan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pets_PetCareRxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pets_PetCareRxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140426066312416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transaction (Details) - Prophet - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction amount</a></td>
<td class="nump">$ 292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Related party expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 260<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pets_ProphetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pets_ProphetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>pets-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:pets="http://www.1800petmeds.com/20230331"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="pets-20230331.xsd" xlink:type="simple"/>
    <context id="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7959696f96db466e9b00f9fc4eeb82c1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7e972f5105664cb4aee0fea2a9f74009_I20230523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>2023-05-23</instant>
        </period>
    </context>
    <context id="i714efa7810e34b859f1f6107bd4f64a9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7ac8d430365e42a4b70f68ccef80bf34_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3416e47de26f43d58c4f271301261758_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if2b4c181220f4db39c9e0becba7ebc10_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i79b8b340525c4eb8a08f09d3a55ef8a2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8a927b1cae4d427ca9524b822d0e3777_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6297e382c64245aba14e3a8758776fd1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i77867fa115ad4229b78a690feec18c68_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i783e64f7e14c4d83b9dd294bf39fd8e0_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i58e3d762d5314a6990e530bcd4c4d18d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie9f02128e65f491da7c5d94342b58dc4_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibd67589c03824ef980cf575bb38a75f9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1c9234aa9292474bad6f7065593e5f0b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibdec80ecca1749bf87b375959dbfc52b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6b4c2f87185043989137055d2cf642fa_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i18b907b4447547178f92755a7a787369_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i019127a3a95243a6ae3e4c850c18876f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1f72edc903074ac9927be8cc9b515cf9_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i720e3acebcb8463bb9efd73321969a20_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id57c020e5fba46ae82ba2f4abefb2b4e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iec836f5f293f4210978b95ba487a929f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i334440618f40456d855578e189633732_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iacce33dd5fc6414cb3f16213192efa4d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibdbd311dff074129bf3e72c5fa9aa7b6_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i93b7f39ad4204f01a6bd5a6bc7e705f0_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icdc896f1488b4f28b0e4be3ebf752847_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibbfe4071fa8748809761483ffc9187bb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaa78064ed1984d9f9c65b1990c55e3c4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i71efad11f57045af997e37ccc67cbd53_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icef79238d6ce4776ae259ffdd5d344cc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i03c0530e258a4275a1cb7f76f5abe23b_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7c2721102f674c4aa792ac925c98947d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0a150376f36844e98abbac7a0ca44c05_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i355171bb92204bbb82826b85e8bf5b37_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i25eddc1271dc4574990d86ce132c99cc_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:InternetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaf2f8f507c6540bfbb2862fd908a210f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:InternetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i09000bea25814401814d1dc5f414ac60_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:ContactCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib7e6d5eacd904a1ab0d4099df9b503b8_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:ContactCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3ac40e1ea4424774953a5e7ade0e7c7f_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8cf2f2c5e86445fda1c2ded520e7311d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0bdcdb0588154445be242f59b58aab0c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:InternetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic0f32aa6e61a47c49a1913e3aa0f4787_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">pets:ContactCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6721acf8ca444c08943e0f7c291b888b_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idb7030b6bef24f45acc0d76a3d1c20ec_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iec916a6095784855b5980a214c776678_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:ReorderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0813952b1f39495398373f357ec689b3_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pets:NewOrderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ieb4d6d234160419aa86c9553574519da_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic064ca7b2fd745a38c86d90733a87d1c_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pets:FurnitureFixturesEquipmentAndComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i04245b0d956b455691aa8ab5e83c2f75_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">pets:FurnitureFixturesEquipmentAndComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i32b7a8cc1d0c404abe3d6754f1eff32b_D20160101-20160131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">pets:DelrayBeachPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-01-31</endDate>
        </period>
    </context>
    <context id="i6809ba90db9c49ca8ac16d709434847a_I20160131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">pets:DelrayBeachPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-01-31</instant>
        </period>
    </context>
    <context id="ieadfd9293a5a48bba384353d2ebc519c_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">pets:DelrayBeachPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5fe3d97a1db0465f973b838299721edd_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">pets:DelrayBeachPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7915a8c7c6604a17bc9a1722e6e42a01_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">pets:DelrayBeachPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i880955555f9e48a3af629feacb66f2ca_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pets:SixSuppliersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if77a6bc751f7420aa5579831f599629c_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pets:SixSuppliersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3de47f4a3e584d9180f1d51a89d74e32_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2f4bce0e12164f66a7a0fbf509e0433d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia1866466e5d2446d92c17b6f5b54ae88_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7f77d055886f40e0890b240ffc4c5900_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8f90b592a09143caa1086b6421f0c29f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6b5b4824cd0443c996bd2417b7318871_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7e83a64a31d84e95a0d0bb5607943684_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie0086d69f42d465fbe2be778fd3669ae_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8009934e1ce1437faf934a21e11f53fa_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib3cce94c3217479d9c47e9c7a9569964_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0d41bb6533e64a78b0c413d60ab6d296_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id29065364981439b8297fe9c2b387741_I19980430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>1998-04-30</instant>
        </period>
    </context>
    <context id="i71c12e540590434c98c58ec2c09fb08c_D19980401-19980430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>1998-04-01</startDate>
            <endDate>1998-04-30</endDate>
        </period>
    </context>
    <context id="i11c1a95cfc3b42c8b1207c680949ce01_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifd52e04a4fe84d1c97fb1a7b1eb50021_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib0d6d76e24604cb9a18256bc00a989e9_I20220509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>2022-05-09</instant>
        </period>
    </context>
    <context id="iae9efd376d404db3a83df403c4b1f447_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i997f8d9c4d5c47d4a9bbe74962ed4629_I20221107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>2022-11-07</instant>
        </period>
    </context>
    <context id="i113e079495ae443ea4acdecad992dd93_I20230206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <instant>2023-02-06</instant>
        </period>
    </context>
    <context id="i3fa97c770ada498d940f7db2777193c8_I20150731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-31</instant>
        </period>
    </context>
    <context id="i3711637129e84cf495f85a1e1f12d159_D20150701-20150731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-07-01</startDate>
            <endDate>2015-07-31</endDate>
        </period>
    </context>
    <context id="ibec5936930e84c289028e660f01b73b1_I20160731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-07-31</instant>
        </period>
    </context>
    <context id="ia2f86689eec24b90a4591646dcc402a8_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="ida16bfdaf8b04ccd9cabdceb30574a33_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i35389028e9874b27a83eed9c5fc398cb_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="ia83cc28d498c4c9fafb92ce48449955b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8c496648613e49b6bd05ae478b147763_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i53ec65434cab4c1eb2a83616f99420e5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if0c556c9dc3149ad958abdf08932a7ed_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1b2659243cd348e8b9a71f890d8f3847_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib9e138b657114015a8d3f172c1e19f7e_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="iac19f43c73124a22b4617cf091f81d03_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="if7745f099643450b9ec65034832f389e_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i7f3fed9704204153a8fa0b54b227b2e1_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="if6933ff7bd564ae78075d75944fc25ee_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i0074779789d04c76ba59318f55ccc983_D20230203-20230203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-03</startDate>
            <endDate>2023-02-03</endDate>
        </period>
    </context>
    <context id="i7487aada4c7e48a9a152a316a2197596_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if9d97a210a094cbb962f8e5009bfda1a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:DirectorPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ief448de592ce4068b2e177f1aeea6dd8_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia93b8106781d4da387b3b15296d47a35_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:DirectorPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i77c3d270a0834d03b39b41eb3e174586_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iad7317540db946209e8de1718fbdb1da_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:DirectorPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie95c7dd15e734cdb96435d11a9f08ac5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:NonvestedRestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorEquityCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i96546148fd614f969f6f32c7d9c77fc6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:NonvestedRestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorEquityCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i890f993d4c6947ce85fae3592689d54b_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:NonvestedRestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorEquityCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iada85d4fb9a84a7ab431b36c77c5b07d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:NonvestedRestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:EmployeeAndDirectorEquityCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6c2de17c1b084f35b8463988b326e824_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">pets:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia1f7c6a0ee004443b3a68de9782c1f9c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6267e0b588824a56aa5efdad685990fc_D20210731-20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-08-30</endDate>
        </period>
    </context>
    <context id="i9d21b0cfcbc8452ea6025a3a67ef8073_I20210611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-11</instant>
        </period>
    </context>
    <context id="i4891cfdf6fc44c6aa3c0da9831b5308f_D20211231-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2432cc60a7f84868839476ea9782eeae_D20210810-20210810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-10</startDate>
            <endDate>2021-08-10</endDate>
        </period>
    </context>
    <context id="i2edb519042c6474b9a2fd6eca193f849_D20210731-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-30</startDate>
            <endDate>2021-08-30</endDate>
        </period>
    </context>
    <context id="i315520404bf24ebea1c2cb0c8e23b089_D20210830-20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-30</startDate>
            <endDate>2021-08-30</endDate>
        </period>
    </context>
    <context id="i63b1d72605c8405d8b027717916a080b_D20210830-20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-30</startDate>
            <endDate>2021-08-30</endDate>
        </period>
    </context>
    <context id="i7afc070e4bdf46fc9f7d226e6741e1c6_D20210830-20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-30</startDate>
            <endDate>2021-08-30</endDate>
        </period>
    </context>
    <context id="i1384889b25bd4d7185122232ce1451e8_I20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-30</instant>
        </period>
    </context>
    <context id="i5cbb8d45015a45ea84ddf37d27c11a68_D20210830-20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-30</startDate>
            <endDate>2021-08-30</endDate>
        </period>
    </context>
    <context id="i6808984e22ee45d58ea010775c3f55d4_I20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-30</instant>
        </period>
    </context>
    <context id="ic1dce613dc084e329c47918a37fe1c39_D20210830-20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-30</startDate>
            <endDate>2021-08-30</endDate>
        </period>
    </context>
    <context id="if5e6ea897b514a6f9570f9ac37ce2bb2_I20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-30</instant>
        </period>
    </context>
    <context id="i449b1d02eb98411ca0c78fbbde6ac2f1_D20210830-20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-30</startDate>
            <endDate>2021-08-30</endDate>
        </period>
    </context>
    <context id="i844106ae017246048418122f69f34ad0_I20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-30</instant>
        </period>
    </context>
    <context id="i068c52c343b44cc193b5a62f93d38549_D20210830-20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-30</startDate>
            <endDate>2021-08-30</endDate>
        </period>
    </context>
    <context id="ic863aef22f2d409193398f92e79e7c7f_I20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockPriceHurdle5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-30</instant>
        </period>
    </context>
    <context id="id26b0819bb5b4b09bda518b2201d5648_D20220803-20220803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-03</startDate>
            <endDate>2022-08-03</endDate>
        </period>
    </context>
    <context id="if0add0f1e60f4b04ae873731c0197067_D20220802-20220802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-02</startDate>
            <endDate>2022-08-02</endDate>
        </period>
    </context>
    <context id="iff7afa81075f467a8ee51d67a09ed71b_D20220803-20220803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-03</startDate>
            <endDate>2022-08-03</endDate>
        </period>
    </context>
    <context id="icd16eafa395744a48017a3ee602c42e8_D20220803-20220803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pets:PerformanceRestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:The2016EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-03</startDate>
            <endDate>2022-08-03</endDate>
        </period>
    </context>
    <context id="i25dd78455488483794c262cbc7525f11_I20220802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-02</instant>
        </period>
    </context>
    <context id="idc34f00e393f4f85af3ba71ed34d459b_D20230113-20230113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-13</startDate>
            <endDate>2023-01-13</endDate>
        </period>
    </context>
    <context id="id0a27942ed9c40ff9ddc967a8de7b5f6_D20221231-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ide541b5ccbaf4aae8f5059586a8aac5b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5d8f4dc33edd40a281b970a2cbdbe0c5_D20220419-20220419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pets:PartnershipAgreementWithVetsterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-19</startDate>
            <endDate>2022-04-19</endDate>
        </period>
    </context>
    <context id="ib12c1e8fbbbd41d29aae9c4166df1e67_I20220419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pets:PartnershipAgreementWithVetsterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-19</instant>
        </period>
    </context>
    <context id="i7fd3857af0904bd9905af80251e8beaf_D20230113-20230113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pets:PetCareRxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-13</startDate>
            <endDate>2023-01-13</endDate>
        </period>
    </context>
    <context id="i81d9acb2bf774cea93998dcf45c5f344_D20230401-20230523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pets:PetCareRxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-05-23</endDate>
        </period>
    </context>
    <context id="i52baab8375b34634bc096512ff056e08_D20230401-20230523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-05-23</endDate>
        </period>
    </context>
    <context id="id3432de5afd244aea63998346817ce66_D20230401-20230523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:A2022EmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-05-23</endDate>
        </period>
    </context>
    <context id="i21b9d44505884d13926569569baba59c_D20230401-20230523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pets:TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-05-23</endDate>
        </period>
    </context>
    <context id="i0cc0c13fe26b4d4896753ec70f10be17_I20230522">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-22</instant>
        </period>
    </context>
    <context id="i4469b631590844adbaaf420a00aa612e_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pets:ProphetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibb424c34659d462d8120e942e5596384_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pets:ProphetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i97c463b50b984fe9b48aa37d4d2bd8a2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pets:ProphetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="tenant">
        <measure>pets:tenant</measure>
    </unit>
    <unit id="payment">
        <measure>pets:payment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF80L2ZyYWc6MzAxNTBlNjUwYmZmNGFlYTg5NTk5MDlmNTA0OTNhNmMvdGFibGU6NWY4YjQ0N2JjZjNmNGUzMmIyOTgwNmZlOGM5MGM2MjAvdGFibGVyYW5nZTo1ZjhiNDQ3YmNmM2Y0ZTMyYjI5ODA2ZmU4YzkwYzYyMF8zLTEtMS0xLTIzNzU_c0f9976e-c1a4-4f65-8a2d-4922be50e93a">0001040130</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF80L2ZyYWc6MzAxNTBlNjUwYmZmNGFlYTg5NTk5MDlmNTA0OTNhNmMvdGFibGU6NWY4YjQ0N2JjZjNmNGUzMmIyOTgwNmZlOGM5MGM2MjAvdGFibGVyYW5nZTo1ZjhiNDQ3YmNmM2Y0ZTMyYjI5ODA2ZmU4YzkwYzYyMF80LTEtMS0xLTIzNzU_0c3cb554-0dc1-46e8-93e3-16a4ac108cd0">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF80L2ZyYWc6MzAxNTBlNjUwYmZmNGFlYTg5NTk5MDlmNTA0OTNhNmMvdGFibGU6NWY4YjQ0N2JjZjNmNGUzMmIyOTgwNmZlOGM5MGM2MjAvdGFibGVyYW5nZTo1ZjhiNDQ3YmNmM2Y0ZTMyYjI5ODA2ZmU4YzkwYzYyMF81LTEtMS0xLTIzNzU_499ef45a-c899-4396-8c7b-9376ebf436ee">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF80L2ZyYWc6MzAxNTBlNjUwYmZmNGFlYTg5NTk5MDlmNTA0OTNhNmMvdGFibGU6NWY4YjQ0N2JjZjNmNGUzMmIyOTgwNmZlOGM5MGM2MjAvdGFibGVyYW5nZTo1ZjhiNDQ3YmNmM2Y0ZTMyYjI5ODA2ZmU4YzkwYzYyMF82LTEtMS0xLTIzNzU_204e2740-e03d-4447-a289-c723bdff7bb6">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ic064ca7b2fd745a38c86d90733a87d1c_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNTQ4Mw_bad1a77d-7eb3-4209-80fa-1d8f0ecbb508">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <pets:RestrictionPeriod
      contextRef="if0c556c9dc3149ad958abdf08932a7ed_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzkzNDU4NDg4NDU1MDU_5ab669ee-e73c-4623-8194-b9f525c9a887">P1Y</pets:RestrictionPeriod>
    <dei:DocumentType
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzM2_0a58d2f3-5e5d-4cc9-903c-9ac18b6b7c03">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzI4_3162c1e2-9f2f-4210-bbc8-8aef91acd113">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8xMDk5NTExNjMyNjQz_74b99867-4384-47ca-9f9a-d42a7c08b7a1">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8xMDk5NTExNjMyNjQz_e9f7da1d-3418-4640-ae19-242c71b72fe5">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzI0_c1a340b9-3f6f-49a0-b4e4-5fc4e878cb1f">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzMw_01f75d42-8313-43df-a48d-53f87bc73d2e">000-28827</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV82NTk3MDY5NzcxNDYx_969ef4ea-f8f0-4876-afd5-83110f73318a">PETMED EXPRESS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8wLTAtMS0xLTIzNzU_cd85869f-fa80-4e19-9a17-e804170c56a7">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8wLTItMS0xLTIzNzU_d572a750-d18b-43e6-bc7a-b8f9b0030bed">65-0680967</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8zLTAtMS0xLTIzNzUvdGV4dHJlZ2lvbjo2YTU2MTY4MTQ2MTk0ODA0YWIxOTBiYTBhNTkwZDM4Yl80_465bd8b1-5363-4488-9834-6357bc97bc54">420 South Congress Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8zLTAtMS0xLTIzNzUvdGV4dHJlZ2lvbjo2YTU2MTY4MTQ2MTk0ODA0YWIxOTBiYTBhNTkwZDM4Yl84_fcf03a24-4a19-46ea-8672-42afd4f4abc3">Delray Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8zLTAtMS0xLTIzNzUvdGV4dHJlZ2lvbjo2YTU2MTY4MTQ2MTk0ODA0YWIxOTBiYTBhNTkwZDM4Yl8xMg_a84e7cd1-5bc7-46db-ac55-4ab77e8cce69">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8zLTAtMS0xLTIzNzUvdGV4dHJlZ2lvbjo2YTU2MTY4MTQ2MTk0ODA0YWIxOTBiYTBhNTkwZDM4Yl8xNQ_6c0f283a-c62d-4858-b1b7-cba4382b41d3">33445</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF82LTAtMS0xLTIzNzUvdGV4dHJlZ2lvbjpjYTk2OWZlOWQ4M2E0NDdlYTJhNDY1MzJjMTgyY2I4ZV81Nw_c9384ae9-170f-41ea-860e-874fdd8d0bac">561</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF82LTAtMS0xLTIzNzUvdGV4dHJlZ2lvbjpjYTk2OWZlOWQ4M2E0NDdlYTJhNDY1MzJjMTgyY2I4ZV82MQ_4688c264-4bae-46a6-85d5-ff5eaf4069d5">526-4444</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8xMi0wLTEtMS0yMzc1L3RleHRyZWdpb246NmZhM2QzZmFjNmRmNDJkNzhjMDUyZTA1NGYxYmE3ZjBfNA_7e841f8c-bd47-4174-b5a6-f911961ccd28">Common Stock, PETS $.001 Par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8xMi0xLTEtMS0yMzc1_d198a5e8-c9ab-4125-9966-8e2ce59074a2">PETS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NTE0M2NiMGQzZmNhNGY0ZTk4YWE4NzNjNjZkNmVjYjgvdGFibGVyYW5nZTo1MTQzY2IwZDNmY2E0ZjRlOThhYTg3M2M2NmQ2ZWNiOF8xMi0yLTEtMS0yMzc1L3RleHRyZWdpb246ZWYxNmJlMzYzMzQyNDdmZjg2YjFjY2Q2MDk0Y2FhOGVfOA_41593fc2-573b-4d20-b336-4bb14aa7e84e">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzMx_5b9c17bd-118e-4c67-be26-4b4a3162e1ae">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzI2_faea22a2-1ee9-47db-ac84-56012e293eb2">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzMy_3b992ed8-c8ab-4d53-8671-e944ccac94cb">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzMz_ea59d16e-868c-474d-a4b6-39974e8acce1">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NDdkN2FhNDJhMTk0NGQ4Yzk4NDcxM2QwMGRmYTIzZDcvdGFibGVyYW5nZTo0N2Q3YWE0MmExOTQ0ZDhjOTg0NzEzZDAwZGZhMjNkN18wLTQtMS0xLTIzNzU_b322a986-8856-444a-8129-edef1898f007">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NDdkN2FhNDJhMTk0NGQ4Yzk4NDcxM2QwMGRmYTIzZDcvdGFibGVyYW5nZTo0N2Q3YWE0MmExOTQ0ZDhjOTg0NzEzZDAwZGZhMjNkN18xLTUtMS0xLTIzNzU_04984b96-e407-4697-8aae-d03dda51f9be">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGFibGU6NDdkN2FhNDJhMTk0NGQ4Yzk4NDcxM2QwMGRmYTIzZDcvdGFibGVyYW5nZTo0N2Q3YWE0MmExOTQ0ZDhjOTg0NzEzZDAwZGZhMjNkN18yLTUtMS0xLTIzNzU_176a82bb-432f-4009-8cbd-4a1922906e3a">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzM0_8cbd792e-1872-4a5b-9f6f-c2893b7708fc">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8zMzI3_aec5231c-7834-4e2c-a169-4182aec9025b">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i7959696f96db466e9b00f9fc4eeb82c1_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8xMDk5NTExNjMxNzk2_5327fdf5-8a41-42cc-b04f-b7457f459b2d"
      unitRef="usd">396400000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i7e972f5105664cb4aee0fea2a9f74009_I20230523"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV8xMDk5NTExNjMxMTQy_ddd46181-49b3-4b12-90d9-f71533996921"
      unitRef="shares">21170977</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xL2ZyYWc6NDIyOGRhODJlYzBjNDkwZWExNDAyMjIyYzQxYjhmNDEvdGV4dHJlZ2lvbjo0MjI4ZGE4MmVjMGM0OTBlYTE0MDIyMjJjNDFiOGY0MV82NTk3MDY5NzcxNDU5_bbd6fa68-77cc-481b-bb1d-f31e121fd7bc">Information to be set forth in our Proxy Statement relating to our 2023 Annual Meeting of Shareholders to be held on August&#160;3, 2023, is incorporated by reference in Items 10, 11, 12, 13, and 14 of Part III of this report.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83MC9mcmFnOjUwZjIwOTBjOWFhNTQ4YTNiZjE4MzhlNDFjMWVlNjBiL3RhYmxlOjZkOTk1ZmIyOTg1MTRkYzg5NmQ1YWQ5YWNkYjRhYmJiL3RhYmxlcmFuZ2U6NmQ5OTVmYjI5ODUxNGRjODk2ZDVhZDlhY2RiNGFiYmJfMS0wLTEtMS0yMzc1L3RleHRyZWdpb246NWRhOGJhNjZhYTQzNDU0ZmJmN2UxYzFjMmE2NWFiZTRfNzA_a6b72f2f-a863-4e3a-a12d-76e96a56f8ae">49</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83My9mcmFnOmZmMjI0MmQ3NjY4YjQyYTk5MGE1OWY1Y2E0MDRkMDIwL3RleHRyZWdpb246ZmYyMjQyZDc2NjhiNDJhOTkwYTU5ZjVjYTQwNGQwMjBfMzMzNw_92baf9fd-f7d7-4067-b0e5-411681afaed8">RSM US LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83My9mcmFnOmZmMjI0MmQ3NjY4YjQyYTk5MGE1OWY1Y2E0MDRkMDIwL3RleHRyZWdpb246ZmYyMjQyZDc2NjhiNDJhOTkwYTU5ZjVjYTQwNGQwMjBfMzMzOA_8ac18bf6-cc45-4d18-94c2-a88984eb2ea9">Fort Lauderdale, Florida</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNC0xLTEtMS0yMzc1_aa3447da-eff8-4594-a992-579c41b7cf20"
      unitRef="usd">104086000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNC0zLTEtMS0yMzc1_738a1f9a-dc1e-48ea-bed6-f35a586882a6"
      unitRef="usd">111080000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNS0wLTEtMS0yMzc1L3RleHRyZWdpb246NjgyZTdiNzY4OTQ4NGRhNDg1OTAyMDNiY2Q0OWFhYTZfNjU_a5b21e48-85ec-4508-860f-031986e4d6f9"
      unitRef="usd">35000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNS0wLTEtMS0yMzc1L3RleHRyZWdpb246NjgyZTdiNzY4OTQ4NGRhNDg1OTAyMDNiY2Q0OWFhYTZfNzI_4e998e50-83b1-4688-9e9f-790eeb4c26dc"
      unitRef="usd">39000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNS0xLTEtMS0yMzc1_58ec4f3b-f343-43fd-bd6b-00b65fddb93d"
      unitRef="usd">1740000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNS0zLTEtMS0yMzc1_d35df2b1-1c20-45b7-9350-a8d761c8ce07"
      unitRef="usd">1913000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryFinishedGoods
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNi0xLTEtMS0yMzc1_dcce7415-6ced-4a51-a7c8-473c1937c7fa"
      unitRef="usd">19023000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNi0zLTEtMS0yMzc1_0de4243c-830e-4ba8-9ba0-7f66904f05ad"
      unitRef="usd">32455000</us-gaap:InventoryFinishedGoods>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNy0xLTEtMS0yMzc1_72253d81-e5bf-46f9-b785-491ae234c800"
      unitRef="usd">4719000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNy0zLTEtMS0yMzc1_0c0b7312-a18d-4edf-8837-3773f5279749"
      unitRef="usd">4866000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidTaxes
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfOC0xLTEtMS0yMzc1_69286241-6f8a-4f45-a060-5047f6e0002c"
      unitRef="usd">1883000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfOC0zLTEtMS0yMzc1_9749b105-82a0-49d2-a03a-1e156e2a9c8c"
      unitRef="usd">681000</us-gaap:PrepaidTaxes>
    <us-gaap:AssetsCurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTAtMS0xLTEtMjM3NQ_8eec5112-d2f5-4b4d-86af-0ace3fe7a299"
      unitRef="usd">131451000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTAtMy0xLTEtMjM3NQ_c69e9d20-0732-4700-b639-55ff48674c39"
      unitRef="usd">150995000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTMtMS0xLTEtMjM3NQ_e40a3614-0f89-4759-b281-9277482ebe8a"
      unitRef="usd">26178000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTMtMy0xLTEtMjM3NQ_dd46a9e9-1538-4108-8077-8585ef4e763b"
      unitRef="usd">24464000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTQtMS0xLTEtMjM3NQ_1950da11-2c20-40f7-9d4e-9da37bda41e4"
      unitRef="usd">5860000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTQtMy0xLTEtMjM3NQ_34f11394-d8ea-4e90-a7e0-1c7668d70b52"
      unitRef="usd">860000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTUtMS0xLTEtNDY4NjE_343ba841-18c7-4a58-9fdf-98b063c39c06"
      unitRef="usd">628000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTUtMy0xLTEtNDY4Njk_f5a33a8f-8714-4c1c-8620-1155940dc2e3"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:AssetsNoncurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTYtMS0xLTEtMjM3NQ_32f4e0ee-46ef-4821-a880-1e47fc49a53b"
      unitRef="usd">32666000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTYtMy0xLTEtMjM3NQ_f89e70fb-e8c8-47dc-b2e1-ee2ccf76e057"
      unitRef="usd">25324000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTgtMS0xLTEtMjM3NQ_caf7d48c-65a6-4917-bbfb-152b7472642e"
      unitRef="usd">164117000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMTgtMy0xLTEtMjM3NQ_bb2d1e3d-533e-427f-957e-083adc18319a"
      unitRef="usd">176319000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjMtMS0xLTEtMjM3NQ_ebdf9af9-5d41-4f5f-bc89-5fb5f631d701"
      unitRef="usd">25208000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjMtMy0xLTEtMjM3NQ_8f8fa9d7-8979-48d9-8914-28246621d3e6"
      unitRef="usd">27500000</us-gaap:AccountsPayableCurrent>
    <pets:AccruedExpensesAndOtherCurrentLiabilities
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjQtMS0xLTEtMjM3NQ_ee94923c-1d1f-44a8-9d72-bdf69457e364"
      unitRef="usd">11289000</pets:AccruedExpensesAndOtherCurrentLiabilities>
    <pets:AccruedExpensesAndOtherCurrentLiabilities
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjQtMy0xLTEtMjM3NQ_04cb039d-d6d0-4b08-bb82-822d0a6149cb"
      unitRef="usd">5697000</pets:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:LiabilitiesCurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjYtMS0xLTEtMjM3NQ_f2891451-c319-4e4d-be8a-d6f05ed53792"
      unitRef="usd">36497000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjYtMy0xLTEtMjM3NQ_ee6ce710-f2b8-4876-8cfd-718ce7f8e2ee"
      unitRef="usd">33197000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjgtMS0xLTEtMjM3NQ_51e7563b-5fe3-41ab-ab57-4613134a2111"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMjgtMy0xLTEtMjM3NQ_59b2af25-f28c-44ed-a0c0-c31011b3c778"
      unitRef="usd">936000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzAtMS0xLTEtNDY5ODI_29cbb90c-0d61-4c71-a7ce-742dbd35708b"
      unitRef="usd">3825000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzAtMy0xLTEtNDY5OTA_bfc30073-b6ee-4a06-b660-a84afdd5bf9e"
      unitRef="usd">0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzAtMS0xLTEtMjM3NQ_73204927-8aa6-46ae-9512-4460ef795d9f"
      unitRef="usd">40322000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzAtMy0xLTEtMjM3NQ_0dcd470d-4159-43b7-89b7-c00bec272e6c"
      unitRef="usd">34133000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzItMS0xLTEtMjM3NQ_553aeb59-0edf-4c90-b611-960f02e752e2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzItMy0xLTEtMjM3NQ_f84141f1-2551-4e4a-88b3-0db5c8febd9e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzIx_3c851fa3-c5e5-411d-bc4f-405743745f15"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzIx_46c2ea72-8a94-4deb-b463-2a11134b54ee"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzM1_1c98ec42-6c16-4db6-b27d-66039a1edab5"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzM1_a84040dd-4c03-45c4-8c74-bed924bab26b"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzU3_15d279e4-b2cb-46d7-8060-bf5b234e88d5"
      unitRef="shares">3000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzU3_33d54900-0b69-4c06-8b9f-ae1a592b0a82"
      unitRef="shares">3000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzU3_508fd268-8ff8-4640-9c9c-6c1470b5b0c3"
      unitRef="shares">3000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzU3_9c3566a4-13ce-45fa-944a-93f06015a84e"
      unitRef="shares">3000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzEzNQ_d5d3f869-705a-4dc7-937c-36f6e853bc82"
      unitRef="usdPerShare">4</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOjhhNTg3MjZiOTYzMTQ2NDU4ZTM1MDRiODQ3OGIzMDdjXzEzNQ_f01a4ea6-5066-4855-987e-acc26089b7c0"
      unitRef="usdPerShare">4</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockValue
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMS0xLTEtMjM3NQ_604f386a-e494-42ce-bf5f-fbc788289606"
      unitRef="usd">9000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzUtMy0xLTEtMjM3NQ_06af4464-553f-4ff5-8fe0-a111d8cc9fba"
      unitRef="usd">9000</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzE4_a5837df7-42b5-4967-b7e4-e099a8d0efe0"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzE4_fd47d065-d204-49ca-873c-409c25a40d8f"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzMy_d4f0d3a9-d89c-47ed-9395-ebff57589250"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzMy_e1c18375-8011-4a47-b2e0-b37a25585345"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzU0_37e4ad86-c459-481d-b7da-eac52bc4a625"
      unitRef="shares">21084000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzU0_445ef6d9-94a0-41bd-ad78-071c7bb32dc2"
      unitRef="shares">21084000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzYx_1d83efe2-abc7-4d94-ae54-0a7818ace439"
      unitRef="shares">20979000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMC0xLTEtMjM3NS90ZXh0cmVnaW9uOmUzYWZhZGY1NjFhNDQ1ZGI5MmUxNGI1Y2VjMDdjNTdlXzYx_7519cef8-5e50-4f55-bddf-c5836ec4edec"
      unitRef="shares">20979000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMS0xLTEtMjM3NQ_4c06692b-474a-4fc8-a333-4a74d180405b"
      unitRef="usd">21000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzYtMy0xLTEtMjM3NQ_4bcc9b35-d3b8-48b9-9b81-ff4e076262c7"
      unitRef="usd">21000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzctMS0xLTEtMjM3NQ_4da5f399-9233-47e3-9364-383744627cf7"
      unitRef="usd">18277000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzctMy0xLTEtMjM3NQ_72a55746-346d-4b8a-bf84-d42170067069"
      unitRef="usd">11660000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzgtMS0xLTEtMjM3NQ_ba1f7e2b-ee2a-47d0-968c-fbf89321746c"
      unitRef="usd">105488000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfMzgtMy0xLTEtMjM3NQ_644f7bfd-56e9-459e-ac72-9cae8e5d85b3"
      unitRef="usd">130496000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNDAtMS0xLTEtMjM3NQ_f1fa5dc1-4ce0-43c5-b936-a0434d048790"
      unitRef="usd">123795000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNDAtMy0xLTEtMjM3NQ_635e1548-5123-461a-a86e-9f1c5149b438"
      unitRef="usd">142186000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNDItMS0xLTEtMjM3NQ_2f2a1de5-3482-4d1f-8a8c-16b480b05748"
      unitRef="usd">164117000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83Ni9mcmFnOjdjZmMxYjU5MDg2NjQ5MDliODMyNTE3NGE4NzliZDgwL3RhYmxlOmFhMjM0MjFhNmRhNzRiMjNiMjAyN2VhNjA4MWNiY2IxL3RhYmxlcmFuZ2U6YWEyMzQyMWE2ZGE3NGIyM2IyMDI3ZWE2MDgxY2JjYjFfNDItMy0xLTEtMjM3NQ_92028c26-1e95-4ba3-9633-9243158df3d9"
      unitRef="usd">176319000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMy0xLTEtMS0yMzc1_79bf46b7-49a0-4e13-861a-167f9aa577df"
      unitRef="usd">256858000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMy0zLTEtMS0yMzc1_d1185e71-6ac9-4ee5-b056-bd981176e964"
      unitRef="usd">273417000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMy01LTEtMS0yMzc1_d9788913-b60e-486d-a735-c12d18aad1d2"
      unitRef="usd">309215000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfNC0xLTEtMS0yMzc1_7be41f1b-bed9-47a2-b358-158999b7b72d"
      unitRef="usd">185844000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfNC0zLTEtMS0yMzc1_18e21fa0-0f05-4959-9abb-8a06c26a3e34"
      unitRef="usd">195341000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfNC01LTEtMS0yMzc1_35c32b6e-7c72-4244-a995-d09a6a674ab6"
      unitRef="usd">219267000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfNi0xLTEtMS0yMzc1_20c7fffb-9433-40c7-abab-d3142c2ae5b0"
      unitRef="usd">71014000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfNi0zLTEtMS0yMzc1_bd5ac786-68b7-4b73-afe4-9100ac204917"
      unitRef="usd">78076000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfNi01LTEtMS0yMzc1_2193baf7-0fca-4794-95d9-25bef2f17d5f"
      unitRef="usd">89948000</us-gaap:GrossProfit>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfOS0xLTEtMS0yMzc1_2f034576-680d-41f2-9670-f12d0cb56b25"
      unitRef="usd">49474000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfOS0zLTEtMS0yMzc1_aa8228f0-b1f9-46a5-a95f-8135a52ab401"
      unitRef="usd">30829000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfOS01LTEtMS0yMzc1_a49b0c49-aba4-433c-b0a4-031123d5e7ab"
      unitRef="usd">28293000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AdvertisingExpense
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTAtMS0xLTEtMjM3NQ_626ed563-bea9-4aec-a880-bb300e759eb1"
      unitRef="usd">19424000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTAtMy0xLTEtMjM3NQ_21c9d5a6-a658-4002-a539-45173d978714"
      unitRef="usd">18799000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTAtNS0xLTEtMjM3NQ_cc6dca2f-ace4-455f-8652-75c86d9d30b4"
      unitRef="usd">21641000</us-gaap:AdvertisingExpense>
    <us-gaap:Depreciation
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTEtMS0xLTEtMjM3NQ_1f57b94c-2669-41b1-a198-b811506a6bf8"
      unitRef="usd">3546000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTEtMy0xLTEtMjM3NQ_33fc5639-c9bf-4f12-af0e-4c8b0ba80837"
      unitRef="usd">2738000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTEtNS0xLTEtMjM3NQ_a9d9729f-ed39-4c0c-a1ce-735769c67fa2"
      unitRef="usd">2427000</us-gaap:Depreciation>
    <us-gaap:OperatingExpenses
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTItMS0xLTEtMjM3NQ_84c38e6f-2f01-4c76-9059-1a3e46e0c1d4"
      unitRef="usd">72444000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTItMy0xLTEtMjM3NQ_30852859-897c-4ec6-9c5a-5f5fc9c65cc8"
      unitRef="usd">52366000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTItNS0xLTEtMjM3NQ_dab2cf7e-458e-482c-a0fa-abcae076e805"
      unitRef="usd">52361000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTQtMS0xLTEtMjM3NQ_25429755-855f-4cc3-a323-0f7c9d0a7080"
      unitRef="usd">-1430000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTQtMy0xLTEtMjM3NQ_88ac6a93-9a24-4290-9676-21c10aebc8d4"
      unitRef="usd">25710000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTQtNS0xLTEtMjM3NQ_13d7a910-7759-4195-93a4-c73bf2bbc01c"
      unitRef="usd">37587000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTctMS0xLTEtMjM3NQ_1e44c04a-1dbc-4cc4-a3a1-3647fd26db83"
      unitRef="usd">2070000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTctMy0xLTEtMjM3NQ_3ad864c6-8b69-4812-90f5-987cdadf81aa"
      unitRef="usd">335000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTctNS0xLTEtMjM3NQ_167bbee1-8732-4906-9b9f-2296e8bc7040"
      unitRef="usd">314000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTgtMS0xLTEtMjM3NQ_dbe2b274-c682-453a-a594-d58a9b19a1f7"
      unitRef="usd">944000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTgtMy0xLTEtMjM3NQ_20e45602-3272-4304-8d9c-a6f27bfd5802"
      unitRef="usd">1026000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTgtNS0xLTEtMjM3NQ_ebfb5d53-a398-4888-bf79-166320340dfe"
      unitRef="usd">1315000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTktMS0xLTEtMjM3NQ_03417507-b2de-4b5a-81ed-aa11f27cfa6d"
      unitRef="usd">3014000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTktMy0xLTEtMjM3NQ_a52f62d8-cdbd-45f9-ad12-db6d75d70cf6"
      unitRef="usd">1361000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMTktNS0xLTEtMjM3NQ_35fbe69a-964c-46da-9484-c09647c03a96"
      unitRef="usd">1629000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjEtMS0xLTEtMjM3NQ_bd927f07-d118-427d-8499-8f23f58cb76c"
      unitRef="usd">1584000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjEtMy0xLTEtMjM3NQ_d8dcb703-796f-4491-85eb-c8fffec9690f"
      unitRef="usd">27071000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjEtNS0xLTEtMjM3NQ_3457ffb8-7b9b-4e67-b692-810d827a5ab8"
      unitRef="usd">39216000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjMtMS0xLTEtMjM3NQ_a689c7bb-1078-47bd-9705-19a4966f9a60"
      unitRef="usd">1351000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjMtMy0xLTEtMjM3NQ_c535e803-2e13-460f-b54a-8ca130149858"
      unitRef="usd">5971000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjMtNS0xLTEtMjM3NQ_8de28684-21d9-459f-b33d-ebfbc6397c42"
      unitRef="usd">8613000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjUtMS0xLTEtMjM3NQ_b0b879c1-d383-410f-82f6-788ecb51a526"
      unitRef="usd">233000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjUtMy0xLTEtMjM3NQ_cd21e5e9-a3b1-404a-b44e-502b37e2ba78"
      unitRef="usd">21100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjUtNS0xLTEtMjM3NQ_b37b92ad-6302-4c1c-9722-1599e99b008d"
      unitRef="usd">30603000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjgtMS0xLTEtMjM3NQ_d2bfa01c-5a29-4917-ac8a-c8b57d6cb921"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjgtMy0xLTEtMjM3NQ_cd71d48f-7fea-42f3-ac1c-4dcc52bdc801"
      unitRef="usdPerShare">1.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjgtNS0xLTEtMjM3NQ_c1dde608-280e-42e5-a7f7-3ef179fa31ea"
      unitRef="usdPerShare">1.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjktMS0xLTEtMjM3NQ_310a9d87-3c9d-4890-ad9c-31a332bc8486"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjktMy0xLTEtMjM3NQ_4ff76ea3-5102-4d22-af2e-527b972b54cc"
      unitRef="usdPerShare">1.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMjktNS0xLTEtMjM3NQ_341ca90e-d139-4023-844a-f76312e36e42"
      unitRef="usdPerShare">1.52</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzItMS0xLTEtMjM3NQ_caaab262-9e9c-415f-b508-c1817251a4a3"
      unitRef="shares">20275000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzItMy0xLTEtMjM3NQ_d5af1298-eb0c-46f5-a6de-2b144b7cee44"
      unitRef="shares">20176000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzItNS0xLTEtMjM3NQ_43703929-3717-458e-8737-57ed602d93fe"
      unitRef="shares">20060000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzMtMS0xLTEtMjM3NQ_341bc466-6949-4767-80a3-cccf357ea1a8"
      unitRef="shares">20339000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzMtMy0xLTEtMjM3NQ_51f9369a-7607-45fa-9b11-d0fa60d21797"
      unitRef="shares">20358000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzMtNS0xLTEtMjM3NQ_0d1d058d-0425-47c6-8807-565c73abde28"
      unitRef="shares">20119000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzUtMS0xLTEtMjM3NQ_c59059b5-129b-4d95-b0bb-6cbed7c9d83e"
      unitRef="usdPerShare">1.20</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzUtMy0xLTEtMjM3NQ_67dd887f-eb29-4d2f-bb60-07fc22c9bd32"
      unitRef="usdPerShare">1.20</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF83OS9mcmFnOjhiMjQ5MzQ0NzAzNzRjZGVhZDMxZmU3NGIwMWM0YmU4L3RhYmxlOjk2YjM0OGYwN2IwMjQ4Y2VhN2MzNDJiNTY3YjZiNzU3L3RhYmxlcmFuZ2U6OTZiMzQ4ZjA3YjAyNDhjZWE3YzM0MmI1NjdiNmI3NTdfMzUtNS0xLTEtMjM3NQ_7daa72a1-8985-4800-88c8-6ed8022212c7"
      unitRef="usdPerShare">1.12</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:SharesOutstanding
      contextRef="if2b4c181220f4db39c9e0becba7ebc10_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMy0xLTEtMS0yMzc1_6aa455fc-0628-428c-bb6e-bb3a23b1cc87"
      unitRef="shares">3000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="if2b4c181220f4db39c9e0becba7ebc10_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMy0zLTEtMS0yMzc1_fd1b8126-a048-4a8f-93c5-c46a63f98bd6"
      unitRef="usd">9000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i79b8b340525c4eb8a08f09d3a55ef8a2_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMy01LTEtMS0yMzc1_9b90263b-b296-43b5-bd64-f98f3d45a841"
      unitRef="shares">20166000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i79b8b340525c4eb8a08f09d3a55ef8a2_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMy03LTEtMS0yMzc1_135f3042-69b9-4f3d-b875-2fe6bfd1f0d4"
      unitRef="usd">20000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8a927b1cae4d427ca9524b822d0e3777_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMy05LTEtMS0yMzc1_d6d617c7-85e9-4c3d-88e3-eba90baf5388"
      unitRef="usd">3804000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6297e382c64245aba14e3a8758776fd1_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMy0xMS0xLTEtMjM3NQ_581cc90a-e9e4-497e-8338-6c12fdbd2c24"
      unitRef="usd">126177000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i77867fa115ad4229b78a690feec18c68_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMy0xMy0xLTEtMjM3NQ_0656e63d-b5b7-4be8-80ce-ad1d0c8adabe"
      unitRef="usd">130010000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i783e64f7e14c4d83b9dd294bf39fd8e0_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfNS01LTEtMS0yMzc1_da397f65-2893-4a22-a31b-57218ba2c3ff"
      unitRef="shares">103000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i58e3d762d5314a6990e530bcd4c4d18d_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfNy05LTEtMS0yMzc1_65a941d7-827f-4543-b418-95479e511c76"
      unitRef="usd">3307000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfNy0xMy0xLTEtMjM3NQ_5c2188d5-7c51-4f7b-b3d0-f523aaf9054c"
      unitRef="usd">3307000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DividendsCommonStock
      contextRef="ie9f02128e65f491da7c5d94342b58dc4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTEtMTEtMS0xLTIzNzU_108b2168-b3be-4210-b96c-a766acc4a76e"
      unitRef="usd">22639000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTEtMTMtMS0xLTIzNzU_e5a1dd15-a61f-4f21-9abf-f683f98399ad"
      unitRef="usd">22639000</us-gaap:DividendsCommonStock>
    <us-gaap:NetIncomeLoss
      contextRef="ie9f02128e65f491da7c5d94342b58dc4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTMtMTEtMS0xLTIzNzU_1d9ef895-2ac6-481a-a389-3abf51d618d8"
      unitRef="usd">30603000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTMtMTMtMS0xLTIzNzU_563a9182-1523-40b2-ba61-23a7b035bdf6"
      unitRef="usd">30603000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="ibd67589c03824ef980cf575bb38a75f9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTUtMS0xLTEtMjM3NQ_1e950cdd-7d36-4973-b2c7-00eeefd28af3"
      unitRef="shares">3000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ibd67589c03824ef980cf575bb38a75f9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTUtMy0xLTEtMjM3NQ_62614b78-67ce-4e7e-98fa-0e9fbabe6fbe"
      unitRef="usd">9000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i1c9234aa9292474bad6f7065593e5f0b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTUtNS0xLTEtMjM3NQ_9768811e-7379-4b23-bb3c-2f9c7cd50f36"
      unitRef="shares">20269000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i1c9234aa9292474bad6f7065593e5f0b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTUtNy0xLTEtMjM3NQ_18e91b2f-84fe-44cf-ac93-ccc3090b6eb9"
      unitRef="usd">20000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibdec80ecca1749bf87b375959dbfc52b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTUtOS0xLTEtMjM3NQ_83852823-6d70-4f22-bafa-c89b4f767bde"
      unitRef="usd">7111000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6b4c2f87185043989137055d2cf642fa_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTUtMTEtMS0xLTIzNzU_e76be814-3145-43c7-baca-cb2f9f5281b2"
      unitRef="usd">134141000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i18b907b4447547178f92755a7a787369_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTUtMTMtMS0xLTIzNzU_696d78dc-71fe-4763-9fde-cb510ce9bc5e"
      unitRef="usd">141281000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i019127a3a95243a6ae3e4c850c18876f_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTctNS0xLTEtMjM3NQ_14c65d40-a1d2-4ef6-a185-99305e4b7a34"
      unitRef="shares">710000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i019127a3a95243a6ae3e4c850c18876f_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTctNy0xLTEtMjM3NQ_2c4505aa-e0a5-415d-a585-ebc4e947c627"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTctMTMtMS0xLTIzNzU_af4f4cf6-2ed0-46db-b77b-a3080067cd44"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1f72edc903074ac9927be8cc9b515cf9_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTktOS0xLTEtMjM3NQ_2a61c069-19f2-4a33-ab80-852940686f3a"
      unitRef="usd">4549000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMTktMTMtMS0xLTIzNzU_43587b7c-35fd-4749-8a47-e9fe4999d10c"
      unitRef="usd">4549000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DividendsCommonStock
      contextRef="i720e3acebcb8463bb9efd73321969a20_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjEtMTEtMS0xLTIzNzU_c68a4a71-5e59-41d0-8d94-22c06e16de4d"
      unitRef="usd">24745000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjEtMTMtMS0xLTIzNzU_bb0399fd-8a4f-4897-8df5-8555d6281611"
      unitRef="usd">24745000</us-gaap:DividendsCommonStock>
    <us-gaap:NetIncomeLoss
      contextRef="i720e3acebcb8463bb9efd73321969a20_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjMtMTEtMS0xLTIzNzU_ecc03ea8-73d4-4cf5-a75d-7adaa98d72aa"
      unitRef="usd">21100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjMtMTMtMS0xLTIzNzU_d2955d76-1810-4df8-96b3-ba69e204b243"
      unitRef="usd">21100000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="id57c020e5fba46ae82ba2f4abefb2b4e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjUtMS0xLTEtMjM3NQ_da1dd40e-0f47-47e1-b7c4-269842154cd8"
      unitRef="shares">3000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id57c020e5fba46ae82ba2f4abefb2b4e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjUtMy0xLTEtMjM3NQ_d9c13f25-cc37-49cd-a549-0f65c940afce"
      unitRef="usd">9000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="iec836f5f293f4210978b95ba487a929f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjUtNS0xLTEtMjM3NQ_18af31c3-cbcb-47d4-9bef-17c7ae5e107c"
      unitRef="shares">20979000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iec836f5f293f4210978b95ba487a929f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjUtNy0xLTEtMjM3NQ_1b4ce978-c294-4c98-93c7-418b494c449e"
      unitRef="usd">21000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i334440618f40456d855578e189633732_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjUtOS0xLTEtMjM3NQ_9a68b809-9700-4441-97a7-2be1700fdd31"
      unitRef="usd">11660000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iacce33dd5fc6414cb3f16213192efa4d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjUtMTEtMS0xLTIzNzU_c0b303e0-5d3b-461f-9a67-9b1b8968aa51"
      unitRef="usd">130496000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjUtMTMtMS0xLTIzNzU_5b0a47c2-88cf-428e-ba09-f1e1d9be664b"
      unitRef="usd">142186000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ibdbd311dff074129bf3e72c5fa9aa7b6_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjctNS0xLTEtMjM3NQ_49e898ad-668f-4baa-b791-1481dee1e9f9"
      unitRef="shares">105000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i93b7f39ad4204f01a6bd5a6bc7e705f0_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjktOS0xLTEtMjM3NQ_8dc047ce-d1c3-409f-b8b2-90505993ffd4"
      unitRef="usd">6617000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMjktMTMtMS0xLTIzNzU_52a5cf8b-a5e4-48cb-a71c-d082567b2955"
      unitRef="usd">6617000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DividendsCommonStock
      contextRef="icdc896f1488b4f28b0e4be3ebf752847_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzEtMTEtMS0xLTIzNzU_7555c55c-9446-4786-a577-47a0bdd3e2a6"
      unitRef="usd">25241000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzEtMTMtMS0xLTIzNzU_a92b3fcd-51ca-4bd6-918d-c6a771c2b0b1"
      unitRef="usd">25241000</us-gaap:DividendsCommonStock>
    <us-gaap:NetIncomeLoss
      contextRef="icdc896f1488b4f28b0e4be3ebf752847_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzMtMTEtMS0xLTIzNzU_180dafef-2f9b-4b36-a1e2-4a38d50bee47"
      unitRef="usd">233000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzMtMTMtMS0xLTIzNzU_70ec8acd-c6b4-4791-96c4-76019876945a"
      unitRef="usd">233000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="ibbfe4071fa8748809761483ffc9187bb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzUtMS0xLTEtMjM3NQ_4d03b4b4-1931-4375-999d-d7982bdc2680"
      unitRef="shares">3000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ibbfe4071fa8748809761483ffc9187bb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzUtMy0xLTEtMjM3NQ_4d7a99c1-1ee3-4216-958c-fbd09d3a968b"
      unitRef="usd">9000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="iaa78064ed1984d9f9c65b1990c55e3c4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzUtNS0xLTEtMjM3NQ_a1a66b88-c01f-4073-bcac-cf6cb40b6e9f"
      unitRef="shares">21084000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iaa78064ed1984d9f9c65b1990c55e3c4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzUtNy0xLTEtMjM3NQ_98fdafde-ae0b-487f-86da-097f45aa6951"
      unitRef="usd">21000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i71efad11f57045af997e37ccc67cbd53_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzUtOS0xLTEtMjM3NQ_d0604cce-15c8-44c2-b3e9-b46e38157a67"
      unitRef="usd">18277000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icef79238d6ce4776ae259ffdd5d344cc_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzUtMTEtMS0xLTIzNzU_18615d1e-bbe1-4cc3-8f99-3bb1978fe689"
      unitRef="usd">105488000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84Mi9mcmFnOjgyNTg2YmVhYmYwYjQ0ODQ4MzUxMzRkM2ExOWJjM2I1L3RhYmxlOmY0MDA2N2JhNzRmZjRlNmFiZmFlYzgwY2Y0NGRlZGU2L3RhYmxlcmFuZ2U6ZjQwMDY3YmE3NGZmNGU2YWJmYWVjODBjZjQ0ZGVkZTZfMzUtMTMtMS0xLTIzNzU_fc02745e-d9d8-4bca-aea4-8a18cf01d92e"
      unitRef="usd">123795000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMy0xLTEtMS0yMzc1_de0f4ee4-0b81-40a7-9e4c-abd1095f0b5a"
      unitRef="usd">233000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMy0zLTEtMS0yMzc1_8c7a18a7-f087-4b0e-94ec-5ff716bb5b4a"
      unitRef="usd">21100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMy01LTEtMS0yMzc1_497ad03f-bb41-416d-845e-662f7c045355"
      unitRef="usd">30603000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNS0xLTEtMS0yMzc1_31abed63-09ef-4d35-8fb5-6878f8dab3fd"
      unitRef="usd">3546000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNS0zLTEtMS0yMzc1_34aa7ee9-c6b6-43f8-9f49-343323986575"
      unitRef="usd">2738000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNS01LTEtMS0yMzc1_fd139dba-535c-4633-9552-c2461dd3db81"
      unitRef="usd">2427000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNi0xLTEtMS0yMzc1_f65532d0-c02e-4e13-8efc-d9b202b18e5c"
      unitRef="usd">6617000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNi0zLTEtMS0yMzc1_d4bc9f76-4243-4fc7-8a61-00c9e0d5d3d0"
      unitRef="usd">4549000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNi01LTEtMS0yMzc1_ccf4d3e1-2e27-461c-955a-0a60f434f012"
      unitRef="usd">3307000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNy0xLTEtMS0yMzc1_7285c290-8555-40c0-88de-062f53063d66"
      unitRef="usd">-1564000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNy0zLTEtMS0yMzc1_61d0bb84-af71-468c-862e-cc6838041112"
      unitRef="usd">-345000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNy01LTEtMS0yMzc1_0649364c-505c-4ef8-8269-e5a518cf22e1"
      unitRef="usd">311000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfOC0xLTEtMS0yMzc1_c12a03fd-f905-41e3-8df9-07388edf42ec"
      unitRef="usd">214000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfOC0zLTEtMS0yMzc1_259fe610-1300-4156-9c57-daf50cf309ed"
      unitRef="usd">165000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfOC01LTEtMS0yMzc1_b00e4467-5c4e-4b88-a57c-0527b5584ae7"
      unitRef="usd">130000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTAtMS0xLTEtMjM3NQ_e851f67e-e5f9-4b34-b6d7-55bc80333b5f"
      unitRef="usd">41000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTAtMy0xLTEtMjM3NQ_68e94e96-5d0d-4b71-9757-be9b7be35fb9"
      unitRef="usd">-509000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTAtNS0xLTEtMjM3NQ_ec43c124-b6f3-4886-871b-9982c74f016d"
      unitRef="usd">-1126000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTEtMS0xLTEtMjM3NQ_37d0c18e-a58d-4ad3-aa8f-5ad3c8583f7b"
      unitRef="usd">-13432000</us-gaap:IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories>
    <us-gaap:IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTEtMy0xLTEtMjM3NQ_b57140bc-8429-4c62-99f2-7d72d8678713"
      unitRef="usd">-1965000</us-gaap:IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories>
    <us-gaap:IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTEtNS0xLTEtMjM3NQ_eb028268-f774-4315-81c0-e95bdc2ebd6f"
      unitRef="usd">16536000</us-gaap:IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTItMS0xLTEtMjM3NQ_6316115e-0459-46c1-a2bd-78e315fac611"
      unitRef="usd">1202000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTItMy0xLTEtMjM3NQ_a2b40924-306d-4431-82ab-99121e850831"
      unitRef="usd">-278000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTItNS0xLTEtMjM3NQ_1f481654-3664-4055-ab42-a00bfe2a2a4c"
      unitRef="usd">959000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTMtMS0xLTEtMjM3NQ_45c28604-8f33-4c89-bdf8-8234f1774173"
      unitRef="usd">-147000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTMtMy0xLTEtMjM3NQ_d069691e-06c7-4a1a-93cf-dbc5dec171ba"
      unitRef="usd">363000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTMtNS0xLTEtMjM3NQ_2eb731b5-56a5-465f-bce8-394b0c687db5"
      unitRef="usd">974000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTQtMS0xLTEtMjM3NQ_d657fd33-9536-4745-84f8-cfefa6d608bd"
      unitRef="usd">-2292000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTQtMy0xLTEtMjM3NQ_f478fdb4-30ea-494d-b84d-8cc7b0d7fcbd"
      unitRef="usd">-12048000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTQtNS0xLTEtMjM3NQ_3a27c9ef-ea0c-46b6-a008-afff095441de"
      unitRef="usd">19890000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTUtMS0xLTEtMjM3NQ_b24f3cd0-d894-4fcd-8b48-bc2ef995302a"
      unitRef="usd">8713000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTUtMy0xLTEtMjM3NQ_d6f13907-96d3-4f32-a79f-e83c94e41199"
      unitRef="usd">-50000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTUtNS0xLTEtMjM3NQ_bebef5df-6829-4286-8a11-5711a41a85ab"
      unitRef="usd">1221000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTYtMS0xLTEtMjM3NQ_ff77e6d3-a15c-48c9-9c64-51e9d96a344b"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTYtMy0xLTEtMjM3NQ_166b7779-f19e-4672-abe2-364edc0ffc66"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTYtNS0xLTEtMjM3NQ_d22a1d6d-e556-4ba3-85d0-fb969f0fd250"
      unitRef="usd">-471000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTctMS0xLTEtMjM3NQ_8379d842-3621-4975-8ea4-671bd7b8e742"
      unitRef="usd">27803000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTctMy0xLTEtMjM3NQ_705fc710-b734-4efe-af53-d30c97afcf95"
      unitRef="usd">18498000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMTctNS0xLTEtMjM3NQ_b8e0626a-65ba-4d67-812b-6789dbb205c4"
      unitRef="usd">40075000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjAtMS0xLTEtMjUxNTU_8caa7831-042b-4647-b589-99b4629ac528"
      unitRef="usd">5000000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjAtMy0xLTEtMjUxNTk_f02951d1-54a4-4627-ac88-45740efce801"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjAtNS0xLTEtMjUxNjg_eb3f7682-1deb-473d-be28-98f763bfd4a8"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjAtMS0xLTEtMjM3NQ_0eb0ec59-d284-4db5-8b7a-cf3fe2585806"
      unitRef="usd">5260000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjAtMy0xLTEtMjM3NQ_c61e5d3d-428a-477a-9587-6ced0357630a"
      unitRef="usd">1752000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjAtNS0xLTEtMjM3NQ_9de354c8-018c-415a-87f5-d0097d6ff0f1"
      unitRef="usd">2432000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjEtMS0xLTEtMjM3NQ_8f86ebcb-8900-4bfb-9da3-09310badb2c6"
      unitRef="usd">-10260000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjEtMy0xLTEtMjM3NQ_bb63ddf5-fd33-4bbc-ab3b-371f0a868128"
      unitRef="usd">-1752000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjEtNS0xLTEtMjM3NQ_69632b09-7cc8-4e85-8fa3-af080c879eda"
      unitRef="usd">-2432000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjQtMS0xLTEtMjM3NQ_4e75c44a-1e43-448a-9bf9-20664840b06c"
      unitRef="usd">24537000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjQtMy0xLTEtMjM3NQ_61009a0f-46a8-4b24-bbec-09310717798d"
      unitRef="usd">24384000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjQtNS0xLTEtMjM3NQ_9d453e24-353a-47b1-a70f-13b34f1b21bf"
      unitRef="usd">22687000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjYtMS0xLTEtMjM3NQ_3c65f63e-2483-4516-9d39-6cf479688549"
      unitRef="usd">-24537000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjYtMy0xLTEtMjM3NQ_4d63b3f0-79d5-4b15-a4e9-f7a8cfa1a318"
      unitRef="usd">-24384000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjYtNS0xLTEtMjM3NQ_c9e9f692-e181-4283-aed0-26352fa5efe1"
      unitRef="usd">-22687000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjgtMS0xLTEtMjM3NQ_45cd6530-4d8f-4085-b4de-c3cdffdb8a8c"
      unitRef="usd">-6994000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjgtMy0xLTEtMjM3NQ_d2a990c6-691b-402c-bb2f-b70efca46719"
      unitRef="usd">-7638000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMjgtNS0xLTEtMjM3NQ_b225042b-d80b-4604-a815-585859917524"
      unitRef="usd">14956000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzAtMS0xLTEtMjM3NQ_d27452ce-2faa-46fa-b7e6-365b3ce35ca5"
      unitRef="usd">111080000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i18b907b4447547178f92755a7a787369_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzAtMy0xLTEtMjM3NQ_9b26a215-8c5f-4a79-95ba-9e5ffa443ec1"
      unitRef="usd">118718000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i77867fa115ad4229b78a690feec18c68_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzAtNS0xLTEtMjM3NQ_bce7b0ef-9f01-47bd-9fd9-41a83637a9bd"
      unitRef="usd">103762000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzItMS0xLTEtMjM3NQ_10bd4ee3-6480-44fb-87a9-3d98383630a0"
      unitRef="usd">104086000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzItMy0xLTEtMjM3NQ_30cf4159-1369-4505-b268-9afc5fa7428a"
      unitRef="usd">111080000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i18b907b4447547178f92755a7a787369_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzItNS0xLTEtMjM3NQ_5887bbc1-6e9c-4059-9955-14b17dd1e9ae"
      unitRef="usd">118718000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzYtMS0xLTEtMjM3NQ_8d6a2169-d338-440e-b004-aed8401b23f7"
      unitRef="usd">4312000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzYtMy0xLTEtMjM3NQ_c457f53e-1c27-4de9-9d70-afef404502a2"
      unitRef="usd">6085000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfMzYtNS0xLTEtMjM3NQ_f62ea809-e4d0-4daf-a5dc-5b8877190cab"
      unitRef="usd">10018000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:LiabilitiesAssumed1
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNDAtMS0xLTEtMjM3NQ_97ee71e6-8e53-4758-ba01-085a857f9d2b"
      unitRef="usd">1262000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNDAtMy0xLTEtMjM3NQ_bbfeac13-d50f-45d2-a90a-7a858561f333"
      unitRef="usd">558000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF84NS9mcmFnOmNjNWZlNWJkMzQ1ZDRmZWY4NDdhYjU1ODIwN2VkYjM2L3RhYmxlOjAxYTk1MDU5ZjcxYTQ2YjY5ZjZjZWMyOWJmOWU2NDQwL3RhYmxlcmFuZ2U6MDFhOTUwNTlmNzFhNDZiNjlmNmNlYzI5YmY5ZTY0NDBfNDAtNS0xLTEtMjM3NQ_bbc577f9-7480-448e-86b8-331fca80e42e"
      unitRef="usd">198000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MjQ_b31856bd-130e-4602-85eb-61bbdf5400d6">Summary of Significant Accounting Policies&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Organization&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;PetMed Express, Inc. and subsidiaries, d/b/a PetMeds&#xae; (collectively, the "Company"), is a leading nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses. The Company markets and sells directly to consumers through its websites, toll-free numbers, and mobile applications. The Company offers consumers an attractive alternative for obtaining pet medications, foods, and supplies in terms of convenience, price, speed of delivery, and valued customer service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Founded in 1996, the Company's executive headquarters offices are currently located in Delray Beach, Florida. The Company has a March 31 fiscal year and references herein to fiscal 2023, 2022, or 2021 refer to the Company's fiscal years ended March&#160;31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and include PetMed Express, Inc. and its  wholly owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates revenue by selling pet medication products and pet supplies. Certain pet supplies offered on the Company&#x2019;s website are drop shipped to customers. The Company considers itself the principal in the arrangement because the Company controls the specified good before it is transferred to the customer. Revenue contracts contain one performance obligation, which is delivery of the product. Customer care and support is deemed not to be a material right to the contract. The transaction price is adjusted at the date of sale for any applicable sales discounts and an estimate of product returns, which are estimated based on historical patterns; however, this is not considered a key judgment.  Revenue is recognized when control transfers to the customer at the point in time in which shipment of the product occurs. This key judgment is determined as the shipping point represents the point in time in which the Company has a present right to payment, title has transferred to the customer, and the customer has assumed the risks and rewards of ownership. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outbound shipping and handling fees are an accounting policy election and are included in sales as the Company considers itself the principal in the arrangement given responsibility for supplier selection and discretion over pricing. Shipping costs associated with outbound freight after control over a product has transferred to a customer are an accounting policy election and are accounted for as fulfillment costs and are included in cost of sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disaggregates sales in the following two categories: (1) reorder sales vs new order sales, and (2) internet sales vs call center sales. The following table illustrates sales by various classifications:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.855%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Sales (In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$ Variance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% Variance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reorder sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New order sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,687)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internet sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Call center sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.855%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Sales (In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$ Variance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% Variance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reorder sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New order sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internet sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Call center sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company changed the definition of a new customer on April 1, 2022, to include anyone who has not ordered over the past thirty-six months. The reorder and new order sales amounts for the years ended March&#160;31, 2022 and March&#160;31, 2021, respectively, reflect this new customer definition change. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the previous definition of a new customer, reorder and new order sales were $250.4 million and $23.0 million, respectively, for the year ended March&#160;31, 2022. Under the previous definition of a new customer, reorder and new order sales were $272.6 million and $36.6 million, respectively, for the  year ended March&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Virtually all of the Company&#x2019;s sales are paid by credit cards and the Company usually receives the cash settlement in two to three banking days. Credit card sales minimize accounts receivable balances relative to sales. The Company had no material contract asset or liability balances as of March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains an allowance for doubtful accounts for losses that the Company estimates will arise from customers&#x2019; inability to make required payments, arising from either credit card chargebacks or insufficient funds checks. The Company determines its estimates of the uncollectability of accounts receivable by analyzing historical bad debts and current economic trends in compliance with the provisions of Accounting Standards Codification ("ASC") Topic 326 ("&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses").&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The allowance for doubtful accounts was approximately $35 thousand  and $39 thousand at March&#160;31, 2023 and March&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents at March&#160;31, 2023 and 2022 consisted of the Company&#x2019;s cash accounts and money market accounts with a maturity of three months or less. The carrying amount of cash equivalents approximates fair value. The Company maintains its cash in bank deposit accounts which, at times,  may exceed federally insured limits. The Company has not experienced any losses in such accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of prescription and non-prescription pet medications and pet supplies that are available for sale and are priced at the lower of cost or net realizable value using a weighted average cost method. The Company writes down its inventory for estimated obsolescence. The inventory reserve was approximately $48 thousand and $81 thousand at March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets. Our building is being depreciated over a period of thirty years. The furniture, fixtures, equipment, and computer software are being depreciated over periods ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNTQ4Mw_bad1a77d-7eb3-4209-80fa-1d8f0ecbb508"&gt;three&lt;/span&gt; to ten years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets is measured by a comparison of the carrying amount of the asset to the undiscounted cash flows expected to be generated from the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intangible assets consist of a toll-free telephone number and internet domain names. In accordance with the ASC Topic 350 (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) the intangible assets are not being amortized and are subject to an annual review for impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consist of the initial minority interest investment in Vetster. Details can be found in Note 12 below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of the Company's cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to the short-term nature of these instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Advertising&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's advertising expense consists primarily of Internet marketing, direct mail/print, and television advertising. Internet costs are expensed in the month incurred and direct mail/print advertising costs are expensed &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;when the related catalogs, brochures, and postcards are produced, distributed, or superseded. Television advertising costs are expensed as the advertisements are televised.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximately 48% of our Delray Beach property, or approximately 88,000 square feet was leased to two tenants. At&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2023,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the leases with these two tenants had a remaining weighted average lease term of 2.0 years. The Company recorded approximately $710 thousand and $689 thousand in rental revenue in fiscal 2023 and 2022, respectively, which was included in other income. The Company expects to receive the following future lease payments, under the current lease agreements, over the next five years: $731 thousand in fiscal 2024; $566 thousand in fiscal 2025, $110 thousand in fiscal 2026, and $0 thousand in fiscal 2027 and 2028.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Comprehensive Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies ASC Topic 220 (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reporting Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) which requires that all items that are recognized under accounting standards as components of comprehensive income be reported in a financial statement that is displayed with the same prominence as other financial statements. The items of other comprehensive income that are typically required to be displayed are foreign currency items, minimum pension liability adjustments, and unrealized gains and losses on certain investments in debt and equity securities. For the fiscal years ended March&#160;31, 2023, 2022 and 2021, the Company had no components of comprehensive income and therefore does not report comprehensive income or Consolidated Statements of Comprehensive Income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes under the provisions of ASC Topic 740 (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) which generally requires the recognition of deferred tax assets and liabilities for the expected future tax benefits or consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting carrying values and the tax bases of assets and liabilities and are measured by applying enacted tax rates and laws for the taxable years in which those differences are expected to reverse. As required by &#x201c;Accounting for Uncertainty in Income Taxes&#x201d; guidance, which clarifies ASC Topic 740, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the Consolidated Financial Statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies &#x201c;Accounting for Uncertainty in Income Taxes&#x201d; guidance to all tax positions for which the statute of limitations remains open. The Company had no liabilities for uncertain tax positions for both fiscal 2023 and fiscal 2022. The Company files tax returns in the U.S. federal jurisdiction and Florida,  Arizona, California, Connecticut, Idaho, Maryland, Michigan, Oklahoma, South Carolina, Virginia, Wisconsin, New Jersey, Georgia, Indiana, New York and the District of Columbia. With few exceptions, the Company is no longer subject to U.S. federal, state or local income tax examinations by tax authorities for years ending March&#160;31, 2019, or earlier. Any interest and penalties related to income taxes will be recorded to other income (expenses).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Concentrations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company purchases its products from a variety of sources, including certain manufacturers, domestic distributors, and wholesalers. We have multiple suppliers for each of our product lines to obtain the lowest cost. There were six suppliers from which we purchased approximately 69%  and 77% of all products in fiscal 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting for Share Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records compensation expense associated with restricted stock in accordance with ASC Topic 718 (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Based Payment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). The compensation expense related to all of the Company&#x2019;s stock-based compensation arrangements is recorded as a component of general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, will have a material effect on the Company&#x2019;s consolidated financial position, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MjE_95c811a3-b44e-426b-9968-438514c7fff2">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and include PetMed Express, Inc. and its  wholly owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MTk_a5c1b3b1-5f67-46fe-9397-2fd5b665fa0b">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates revenue by selling pet medication products and pet supplies. Certain pet supplies offered on the Company&#x2019;s website are drop shipped to customers. The Company considers itself the principal in the arrangement because the Company controls the specified good before it is transferred to the customer. Revenue contracts contain one performance obligation, which is delivery of the product. Customer care and support is deemed not to be a material right to the contract. The transaction price is adjusted at the date of sale for any applicable sales discounts and an estimate of product returns, which are estimated based on historical patterns; however, this is not considered a key judgment.  Revenue is recognized when control transfers to the customer at the point in time in which shipment of the product occurs. This key judgment is determined as the shipping point represents the point in time in which the Company has a present right to payment, title has transferred to the customer, and the customer has assumed the risks and rewards of ownership. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outbound shipping and handling fees are an accounting policy election and are included in sales as the Company considers itself the principal in the arrangement given responsibility for supplier selection and discretion over pricing. Shipping costs associated with outbound freight after control over a product has transferred to a customer are an accounting policy election and are accounted for as fulfillment costs and are included in cost of sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disaggregates sales in the following two categories: (1) reorder sales vs new order sales, and (2) internet sales vs call center sales. The following table illustrates sales by various classifications:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.855%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Sales (In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$ Variance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% Variance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reorder sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New order sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,687)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internet sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Call center sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.855%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Sales (In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$ Variance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% Variance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reorder sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New order sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internet sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Call center sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company changed the definition of a new customer on April 1, 2022, to include anyone who has not ordered over the past thirty-six months. The reorder and new order sales amounts for the years ended March&#160;31, 2022 and March&#160;31, 2021, respectively, reflect this new customer definition change. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the previous definition of a new customer, reorder and new order sales were $250.4 million and $23.0 million, respectively, for the year ended March&#160;31, 2022. Under the previous definition of a new customer, reorder and new order sales were $272.6 million and $36.6 million, respectively, for the  year ended March&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Virtually all of the Company&#x2019;s sales are paid by credit cards and the Company usually receives the cash settlement in two to three banking days. Credit card sales minimize accounts receivable balances relative to sales. The Company had no material contract asset or liability balances as of March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains an allowance for doubtful accounts for losses that the Company estimates will arise from customers&#x2019; inability to make required payments, arising from either credit card chargebacks or insufficient funds checks. The Company determines its estimates of the uncollectability of accounts receivable by analyzing historical bad debts and current economic trends in compliance with the provisions of Accounting Standards Codification ("ASC") Topic 326 ("&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses").&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The allowance for doubtful accounts was approximately $35 thousand  and $39 thousand at March&#160;31, 2023 and March&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MjI_a654d18f-3b46-4105-ab62-0ed6c4892afb">The following table illustrates sales by various classifications:&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.855%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Sales (In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$ Variance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% Variance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reorder sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New order sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,687)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internet sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Call center sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.855%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Sales (In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$ Variance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% Variance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reorder sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New order sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internet sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Call center sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i03c0530e258a4275a1cb7f76f5abe23b_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMy0xLTEtMS0yMzc1_7e6920eb-ca95-4f17-9446-f625aa16c469"
      unitRef="usd">232633000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i03c0530e258a4275a1cb7f76f5abe23b_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMy0zLTEtMS0yMzc1_94ef7964-ec10-445f-ad8e-92a4a8cbebbe"
      unitRef="number">0.906</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7c2721102f674c4aa792ac925c98947d_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMy01LTEtMS0yMzc1_1afdcc1f-ddf3-4d7f-985c-a529d37755fc"
      unitRef="usd">244505000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i7c2721102f674c4aa792ac925c98947d_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMy03LTEtMS0yMzc1_a4b1b0c6-b2f9-4f23-99a5-f52b51e86f50"
      unitRef="number">0.894</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="i03c0530e258a4275a1cb7f76f5abe23b_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMy05LTEtMS0yMzc1_ff7967a8-69f2-43ba-8066-3a92a25a93d0"
      unitRef="usd">-11872000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="i03c0530e258a4275a1cb7f76f5abe23b_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMy0xMS0xLTEtMjM3NQ_c6a2a2cf-8ad8-4634-9b88-06cc0d5facb4"
      unitRef="number">-0.049</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0a150376f36844e98abbac7a0ca44c05_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNC0xLTEtMS0yMzc1_6c226187-bf23-4b42-bb5c-fd787198a693"
      unitRef="usd">24225000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i0a150376f36844e98abbac7a0ca44c05_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNC0zLTEtMS0yMzc1_6b60b596-8954-4338-b468-c1407e17f445"
      unitRef="number">0.094</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i355171bb92204bbb82826b85e8bf5b37_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNC01LTEtMS0yMzc1_2060f07b-d50b-4d94-97b9-bb96e7325842"
      unitRef="usd">28912000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i355171bb92204bbb82826b85e8bf5b37_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNC03LTEtMS0yMzc1_52d9ab56-39ff-4285-b125-f49a1b272043"
      unitRef="number">0.106</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="i0a150376f36844e98abbac7a0ca44c05_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNC05LTEtMS0yMzc1_b9707769-812d-44a5-a187-1c1adb383465"
      unitRef="usd">-4687000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="i0a150376f36844e98abbac7a0ca44c05_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNC0xMS0xLTEtMjM3NQ_3309979e-4b5b-44f5-acf6-6a497d5b56b1"
      unitRef="number">-0.162</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNi0xLTEtMS0yMzc1_7bbdd364-d318-4ea1-aaba-10ec0a16e212"
      unitRef="usd">256858000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNi0zLTEtMS0yMzc1_7114bc31-5a50-4c0e-a7b1-d7121a5414b2"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNi01LTEtMS0yMzc1_49081fe9-edc8-4bf1-9e30-bb4e01f2a267"
      unitRef="usd">273417000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNi03LTEtMS0yMzc1_69e571c3-5bbc-4778-85ef-39ac2d527ea6"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNi05LTEtMS0yMzc1_2b0540ac-fe3d-47fa-b8e5-ba6f6c60509e"
      unitRef="usd">-16559000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfNi0xMS0xLTEtMjM3NQ_0cda8670-bb76-474d-ae79-787ea9e8a231"
      unitRef="number">-0.061</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i25eddc1271dc4574990d86ce132c99cc_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOC0xLTEtMS0yMzc1_75bb4dc4-c1bd-4a7d-88aa-28205cb018b5"
      unitRef="usd">221894000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i25eddc1271dc4574990d86ce132c99cc_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOC0zLTEtMS0yMzc1_212efa5d-e4bf-4bbe-a3a3-97e3ae52fa37"
      unitRef="number">0.864</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iaf2f8f507c6540bfbb2862fd908a210f_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOC01LTEtMS0yMzc1_f0d5748a-00b4-4d20-9ae6-20db42d9b410"
      unitRef="usd">230263000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="iaf2f8f507c6540bfbb2862fd908a210f_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOC03LTEtMS0yMzc1_1a9a2b1d-ec1d-4bf7-aee9-c7ee2991ca49"
      unitRef="number">0.842</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="i25eddc1271dc4574990d86ce132c99cc_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOC05LTEtMS0yMzc1_79edb6ef-1dc4-45b5-b11a-30c7e4fe84b8"
      unitRef="usd">-8369000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="i25eddc1271dc4574990d86ce132c99cc_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOC0xMS0xLTEtMjM3NQ_dfded334-66d7-4cc2-805b-403f5bea7db1"
      unitRef="number">-0.036</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i09000bea25814401814d1dc5f414ac60_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOS0xLTEtMS0yMzc1_a50700fc-74d4-47e9-96af-fc02ef2a5d05"
      unitRef="usd">34964000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i09000bea25814401814d1dc5f414ac60_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOS0zLTEtMS0yMzc1_841ae2b9-60c6-41fc-8c8a-ecc131f542f3"
      unitRef="number">0.136</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib7e6d5eacd904a1ab0d4099df9b503b8_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOS01LTEtMS0yMzc1_da6c7cf9-f800-47df-9560-2d4683c6f89f"
      unitRef="usd">43154000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="ib7e6d5eacd904a1ab0d4099df9b503b8_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOS03LTEtMS0yMzc1_73528f54-71a3-4ee0-8b3b-b326bb8eb498"
      unitRef="number">0.158</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="i09000bea25814401814d1dc5f414ac60_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOS05LTEtMS0yMzc1_11809235-ff56-43ee-b6be-3a484ef5190a"
      unitRef="usd">-8190000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="i09000bea25814401814d1dc5f414ac60_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfOS0xMS0xLTEtMjM3NQ_602a7383-ace0-477b-b9b3-b9ae8488efe9"
      unitRef="number">-0.190</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMTEtMS0xLTEtMjM3NQ_aa00a4e0-dd3d-40cf-a365-ab51aa110fab"
      unitRef="usd">256858000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMTEtMy0xLTEtMjM3NQ_a5684f79-a508-462a-91fb-1f79acfc396a"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMTEtNS0xLTEtMjM3NQ_f0ada208-8167-4fed-96d8-30874d9b8ebc"
      unitRef="usd">273417000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMTEtNy0xLTEtMjM3NQ_fafae6de-1233-42b9-a6ba-39954b5d07ee"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMTEtOS0xLTEtMjM3NQ_8b556b91-cfce-4161-a162-1d4e07a54fc9"
      unitRef="usd">-16559000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOmE3Yjg2Mjk4MGVmNDQxZGZiMzJlMGQ2NWVhYTQ3ZWFhL3RhYmxlcmFuZ2U6YTdiODYyOTgwZWY0NDFkZmIzMmUwZDY1ZWFhNDdlYWFfMTEtMTEtMS0xLTIzNzU_c64873f1-44fb-426a-9e9c-c5957870627e"
      unitRef="number">-0.061</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7c2721102f674c4aa792ac925c98947d_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMy0xLTEtMS0yMzc1_e3ab1fe0-7271-49db-aa71-75f384c32a5f"
      unitRef="usd">244505000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i7c2721102f674c4aa792ac925c98947d_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMy0zLTEtMS0yMzc1_96b0ed4f-c020-4347-ae6e-57037b2132e3"
      unitRef="number">0.894</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3ac40e1ea4424774953a5e7ade0e7c7f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMy01LTEtMS0yMzc1_dbceaeb5-5306-4f87-b2e6-6f076a0df57e"
      unitRef="usd">263152000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i3ac40e1ea4424774953a5e7ade0e7c7f_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMy03LTEtMS0yMzc1_ac58c6c9-0814-418d-b717-307659385269"
      unitRef="number">0.851</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="i7c2721102f674c4aa792ac925c98947d_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMy05LTEtMS0yMzc1_c7cca39b-639b-4c4a-a708-a3b77953bb4c"
      unitRef="usd">-18647000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="i7c2721102f674c4aa792ac925c98947d_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMy0xMS0xLTEtMjM3NQ_c93fcb48-b461-444f-9ecc-f09427ef68d4"
      unitRef="number">-0.071</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i355171bb92204bbb82826b85e8bf5b37_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNC0xLTEtMS0yMzc1_5107c913-8c73-4c21-825a-f406006dc215"
      unitRef="usd">28912000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i355171bb92204bbb82826b85e8bf5b37_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNC0zLTEtMS0yMzc1_cef99d13-ccc5-4bc5-a8e6-f78f575a3261"
      unitRef="number">0.106</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8cf2f2c5e86445fda1c2ded520e7311d_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNC01LTEtMS0yMzc1_3004befc-7f7b-42cd-991b-15b4683472c8"
      unitRef="usd">46063000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i8cf2f2c5e86445fda1c2ded520e7311d_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNC03LTEtMS0yMzc1_552b3716-ed20-4a38-81cc-3006a9e777f1"
      unitRef="number">0.149</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="i355171bb92204bbb82826b85e8bf5b37_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNC05LTEtMS0yMzc1_01134d67-8b2b-40f4-bd18-daca7d13a912"
      unitRef="usd">-17151000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="i355171bb92204bbb82826b85e8bf5b37_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNC0xMS0xLTEtMjM3NQ_33982f84-c299-473a-9157-b7dd65504abc"
      unitRef="number">-0.372</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNi0xLTEtMS0yMzc1_7d9700b0-9f32-4c23-8b7e-86d609aae637"
      unitRef="usd">273417000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNi0zLTEtMS0yMzc1_4170cda1-13ab-44fe-9fda-42c9e0549eef"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNi01LTEtMS0yMzc1_a20e330c-9322-40c6-b8fe-726f18fef16b"
      unitRef="usd">309215000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNi03LTEtMS0yMzc1_8d8f8973-c611-482f-a5ad-ef723b47cc61"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNi05LTEtMS0yMzc1_ccf461f5-5ce6-414a-bd63-e524f7dd5921"
      unitRef="usd">-35798000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfNi0xMS0xLTEtMjM3NQ_4594a500-4709-4ca1-a069-c26747161356"
      unitRef="number">-0.116</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iaf2f8f507c6540bfbb2862fd908a210f_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOC0xLTEtMS0yMzc1_a15ed05e-ed04-430d-83aa-21c19dd19f61"
      unitRef="usd">230263000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="iaf2f8f507c6540bfbb2862fd908a210f_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOC0zLTEtMS0yMzc1_9ec0b23e-cff3-4b69-8399-6d4bd9861034"
      unitRef="number">0.842</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0bdcdb0588154445be242f59b58aab0c_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOC01LTEtMS0yMzc1_0c0a55dc-04e0-4d2f-9e1a-9fa65d2c8180"
      unitRef="usd">259404000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i0bdcdb0588154445be242f59b58aab0c_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOC03LTEtMS0yMzc1_21516098-fc83-47a1-b8d4-fd96fefbe3c1"
      unitRef="number">0.839</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="iaf2f8f507c6540bfbb2862fd908a210f_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOC05LTEtMS0yMzc1_633b4436-da69-490b-9383-0d2ed705839e"
      unitRef="usd">-29141000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="iaf2f8f507c6540bfbb2862fd908a210f_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOC0xMS0xLTEtMjM3NQ_1e9cf6f2-af71-463b-8006-c191f0b39bf7"
      unitRef="number">-0.112</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib7e6d5eacd904a1ab0d4099df9b503b8_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOS0xLTEtMS0yMzc1_6b49899a-49a9-46f3-9456-bf01949d936e"
      unitRef="usd">43154000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="ib7e6d5eacd904a1ab0d4099df9b503b8_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOS0zLTEtMS0yMzc1_ad6018ee-da5d-444b-8f49-aa7296c3eb13"
      unitRef="number">0.158</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic0f32aa6e61a47c49a1913e3aa0f4787_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOS01LTEtMS0yMzc1_7075c00a-44af-440e-8735-8d3cb5c99391"
      unitRef="usd">49811000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="ic0f32aa6e61a47c49a1913e3aa0f4787_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOS03LTEtMS0yMzc1_2f470590-913a-4297-9849-cbc598119719"
      unitRef="number">0.161</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="ib7e6d5eacd904a1ab0d4099df9b503b8_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOS05LTEtMS0yMzc1_47ea013f-3035-480d-a5f8-a12374dba9b8"
      unitRef="usd">-6657000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="ib7e6d5eacd904a1ab0d4099df9b503b8_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfOS0xMS0xLTEtMjM3NQ_c33050df-05c2-4d99-853d-c43d18fe210e"
      unitRef="number">-0.134</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMTEtMS0xLTEtMjM3NQ_f2ef81d9-0a3c-443c-899e-f9194e3f77aa"
      unitRef="usd">273417000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMTEtMy0xLTEtMjM3NQ_613a3957-9021-45f4-a791-501bd570e314"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMTEtNS0xLTEtMjM3NQ_171cee22-c9da-4fb8-82ea-51997fcabbf0"
      unitRef="usd">309215000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <pets:RevenueFromContractWithCustomerPercentage
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMTEtNy0xLTEtMjM3NQ_23bb0016-4f6a-4ca2-9a1d-cd4ae06def0b"
      unitRef="number">1.000</pets:RevenueFromContractWithCustomerPercentage>
    <pets:RevenueFromContractWithCustomerVariance
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMTEtOS0xLTEtMjM3NQ_d981eba1-6329-4692-85c6-94a1b21b4f47"
      unitRef="usd">-35798000</pets:RevenueFromContractWithCustomerVariance>
    <pets:RevenueFromContractWithCustomerVariancePercentage
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RhYmxlOjcxNWZkMDc4MDUyZDRiYTI5OGUzOTkxNDFiMmJlMTBkL3RhYmxlcmFuZ2U6NzE1ZmQwNzgwNTJkNGJhMjk4ZTM5OTE0MWIyYmUxMGRfMTEtMTEtMS0xLTIzNzU_f83cda13-155b-413f-abf7-c9f2bba8c94b"
      unitRef="number">-0.116</pets:RevenueFromContractWithCustomerVariancePercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6721acf8ca444c08943e0f7c291b888b_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY0MTA2OQ_12edf5ef-8c55-4878-af3d-5c343b7950b3"
      unitRef="usd">250400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idb7030b6bef24f45acc0d76a3d1c20ec_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY0MTA3OQ_27fd307a-c67e-40f7-93f1-9bdc39181a59"
      unitRef="usd">23000000.0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iec916a6095784855b5980a214c776678_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY0MTA5NA_27e8162d-d0af-4f1c-90f2-94e3117abada"
      unitRef="usd">272600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0813952b1f39495398373f357ec689b3_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY0MTEwMw_3d46cd50-039e-478b-a330-d96c14941b6b"
      unitRef="usd">36600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMzcyNg_b1c5cdc4-5421-4eed-a39a-91d83e34cb99"
      unitRef="usd">35000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2MzI2OQ_fac7d24b-efda-4187-8188-b0515d33adf2"
      unitRef="usd">39000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MzE_c68feb92-a23d-4330-9833-93a8127b090c">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents at March&#160;31, 2023 and 2022 consisted of the Company&#x2019;s cash accounts and money market accounts with a maturity of three months or less. The carrying amount of cash equivalents approximates fair value. The Company maintains its cash in bank deposit accounts which, at times,  may exceed federally insured limits. The Company has not experienced any losses in such accounts.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MjY_29f997b9-a24c-4c53-a5f3-8e6bff7fc332">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MzM_dd1b3c99-27b7-475f-9b80-b1a57b259015">InventoriesInventories consist of prescription and non-prescription pet medications and pet supplies that are available for sale and are priced at the lower of cost or net realizable value using a weighted average cost method. The Company writes down its inventory for estimated obsolescence.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryValuationReserves
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNTEyNQ_64e468b2-31ac-460b-9368-2c72b2984ed7"
      unitRef="usd">48000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNTEzMg_23706bee-217d-409b-8303-249be6f80b51"
      unitRef="usd">81000</us-gaap:InventoryValuationReserves>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3Mjc_1a7399f2-8dd3-400b-8b5c-685b0c66dab4">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets. Our building is being depreciated over a period of thirty years. The furniture, fixtures, equipment, and computer software are being depreciated over periods ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNTQ4Mw_bad1a77d-7eb3-4209-80fa-1d8f0ecbb508"&gt;three&lt;/span&gt; to ten years.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ieb4d6d234160419aa86c9553574519da_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNTM3Mw_e93d9c9d-456a-4ec4-9401-253911112b6c">P30Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i04245b0d956b455691aa8ab5e83c2f75_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNTQ4OQ_805d72e4-4a4e-4509-90c4-18c863c5f163">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MjM_1b8abe6f-19d7-4129-98e1-f876492c4257">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets is measured by a comparison of the carrying amount of the asset to the undiscounted cash flows expected to be generated from the asset.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MjA_60cd28f8-bc62-4471-9d7c-17077c162db0">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intangible assets consist of a toll-free telephone number and internet domain names. In accordance with the ASC Topic 350 (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) the intangible assets are not being amortized and are subject to an annual review for impairment.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <pets:OtherAssetsPolicyTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNjU5NzA2OTc5NjkzMQ_30d4b3ef-88d2-4648-b25e-9eeee25cabef">Other AssetsOther assets consist of the initial minority interest investment in Vetster.</pets:OtherAssetsPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MTY_d8eea629-8f2b-4c1d-bd3f-5d3b948695a7">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of the Company's cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to the short-term nature of these instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3Mjg_63559c86-d792-48ff-9be7-bf6aec0b728a">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Advertising&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's advertising expense consists primarily of Internet marketing, direct mail/print, and television advertising. Internet costs are expensed in the month incurred and direct mail/print advertising costs are expensed &lt;/span&gt;&lt;/div&gt;when the related catalogs, brochures, and postcards are produced, distributed, or superseded. Television advertising costs are expensed as the advertisements are televised.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <pets:PercentageOfPropertyLeasedToTenants
      contextRef="i32b7a8cc1d0c404abe3d6754f1eff32b_D20160101-20160131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzEwNg_986e0344-c1b5-47f6-95a0-a4dc9f2a8d91"
      unitRef="number">0.48</pets:PercentageOfPropertyLeasedToTenants>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="i6809ba90db9c49ca8ac16d709434847a_I20160131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzE0NA_e19b4b37-6fdc-4bee-af17-6d5ce500c16b"
      unitRef="sqft">88000</us-gaap:AreaOfRealEstateProperty>
    <pets:NumberOfTenants
      contextRef="i32b7a8cc1d0c404abe3d6754f1eff32b_D20160101-20160131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNDA1MjI_3ea848b2-6a43-4450-a84f-5bdaa0116c0e"
      unitRef="tenant">2</pets:NumberOfTenants>
    <pets:NumberOfTenants
      contextRef="ieadfd9293a5a48bba384353d2ebc519c_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfNDA1MjY_a5dc2a83-af87-4443-a530-99985959a454"
      unitRef="tenant">2</pets:NumberOfTenants>
    <pets:LessorOperatingLeaseRemainingWeightedAverageLeaseTerm
      contextRef="ieadfd9293a5a48bba384353d2ebc519c_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzI3Ng_1ac70759-4e9c-46de-ae77-4d0ccd4ef9c5">P2Y</pets:LessorOperatingLeaseRemainingWeightedAverageLeaseTerm>
    <us-gaap:RentalIncomeNonoperating
      contextRef="ieadfd9293a5a48bba384353d2ebc519c_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzMxNg_543435d9-bb6e-4ea3-a44d-531e1d25a08d"
      unitRef="usd">710000</us-gaap:RentalIncomeNonoperating>
    <us-gaap:RentalIncomeNonoperating
      contextRef="i5fe3d97a1db0465f973b838299721edd_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzMyNA_1a07da5a-0fb3-4bc6-8a08-8c52b22b4aeb"
      unitRef="usd">689000</us-gaap:RentalIncomeNonoperating>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
      contextRef="i7915a8c7c6604a17bc9a1722e6e42a01_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzU0OQ_7efc7150-529d-4891-b35e-f1887d9a3379"
      unitRef="usd">731000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears
      contextRef="i7915a8c7c6604a17bc9a1722e6e42a01_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzU2OA_716f821a-d6ec-4c5e-86db-fece113f33ba"
      unitRef="usd">566000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears
      contextRef="i7915a8c7c6604a17bc9a1722e6e42a01_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzU4Nw_5219e687-8422-4f3c-bf0f-9ddc3a8ee934"
      unitRef="usd">110000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears
      contextRef="i7915a8c7c6604a17bc9a1722e6e42a01_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzYxMA_3396c76e-639e-4d0c-9528-293ca70a1255"
      unitRef="usd">0</us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedFiveYears
      contextRef="i7915a8c7c6604a17bc9a1722e6e42a01_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY2NzYxMA_e19d8b79-6ce1-493a-9310-cf3854bc6f64"
      unitRef="usd">0</us-gaap:LessorOperatingLeasePaymentsToBeReceivedFiveYears>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MTc_77692c16-444b-4199-a1f9-0c974098a912">Comprehensive Income&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies ASC Topic 220 (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reporting Comprehensive Income&lt;/span&gt;&#x201d;) which requires that all items that are recognized under accounting standards as components of comprehensive income be reported in a financial statement that is displayed with the same prominence as other financial statements. The items of other comprehensive income that are typically required to be displayed are foreign currency items, minimum pension liability adjustments, and unrealized gains and losses on certain investments in debt and equity securities. For the fiscal years ended March&#160;31, 2023, 2022 and 2021, the Company had no components of comprehensive income and therefore does not report comprehensive income or Consolidated Statements of Comprehensive Income.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MzQ_7f6b5115-a729-41f2-9e18-d3fa73b89bb0">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes under the provisions of ASC Topic 740 (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) which generally requires the recognition of deferred tax assets and liabilities for the expected future tax benefits or consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting carrying values and the tax bases of assets and liabilities and are measured by applying enacted tax rates and laws for the taxable years in which those differences are expected to reverse. As required by &#x201c;Accounting for Uncertainty in Income Taxes&#x201d; guidance, which clarifies ASC Topic 740, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the Consolidated Financial Statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies &#x201c;Accounting for Uncertainty in Income Taxes&#x201d; guidance to all tax positions for which the statute of limitations remains open. The Company had no liabilities for uncertain tax positions for both fiscal 2023 and fiscal 2022. The Company files tax returns in the U.S. federal jurisdiction and Florida,  Arizona, California, Connecticut, Idaho, Maryland, Michigan, Oklahoma, South Carolina, Virginia, Wisconsin, New Jersey, Georgia, Indiana, New York and the District of Columbia. With few exceptions, the Company is no longer subject to U.S. federal, state or local income tax examinations by tax authorities for years ending March&#160;31, 2019, or earlier. Any interest and penalties related to income taxes will be recorded to other income (expenses).&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTY0OTI2NzQ0NTc2MDQ_3c543b00-ffa2-430a-9c3f-9dde8c739249"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTY0OTI2NzQ0NTc2MDQ_8fd1e0a0-961b-40f9-87ef-e75933882505"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MzI_49cd202e-31b9-4829-9e20-918d63ab492a">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Concentrations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company purchases its products from a variety of sources, including certain manufacturers, domestic distributors, and wholesalers. We have multiple suppliers for each of our product lines to obtain the lowest cost. There were six suppliers from which we purchased approximately 69%  and 77% of all products in fiscal 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i880955555f9e48a3af629feacb66f2ca_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfOTQyOQ_96949aa6-0844-4f81-9d81-930e9f959e9e"
      unitRef="number">0.69</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if77a6bc751f7420aa5579831f599629c_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA5OTUxMTY0ODU4OQ_50390ce7-fb08-4690-bdb2-b3aa19a84b83"
      unitRef="number">0.77</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3MTg_43aa84e6-ae8a-4165-ad6c-3e00d36ef112">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting for Share Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records compensation expense associated with restricted stock in accordance with ASC Topic 718 (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Based Payment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). The compensation expense related to all of the Company&#x2019;s stock-based compensation arrangements is recorded as a component of general and administrative expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85MS9mcmFnOjM4YmNiOTEwMTJlYjQxN2Y4OWFlMGI0ZGUwOTBjMWUxL3RleHRyZWdpb246MzhiY2I5MTAxMmViNDE3Zjg5YWUwYjRkZTA5MGMxZTFfMTA3Mjk_b506a18b-bed0-4622-906c-ee02c48a7fa8">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, will have a material effect on the Company&#x2019;s consolidated financial position, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RleHRyZWdpb246MmJiYTYxYTRkOTY0NDM1NTg5MDdjOWMzMmMwMDFkYWFfMTIx_c9a46f5f-3561-49e1-b72b-8e284b784e96">Property and Equipment, Net&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Major classifications of property and equipment consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building Improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RleHRyZWdpb246MmJiYTYxYTRkOTY0NDM1NTg5MDdjOWMzMmMwMDFkYWFfMTIy_1843ee11-e36c-4545-8a76-0b19794ecc46">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Major classifications of property and equipment consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building Improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3de47f4a3e584d9180f1d51a89d74e32_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfMy0xLTEtMS0yMzc1_5d536928-81a7-445c-a040-6f008a8ec7af"
      unitRef="usd">14997000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2f4bce0e12164f66a7a0fbf509e0433d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfMy0zLTEtMS0yMzc1_4306be32-708f-49bb-9956-187a264d2e65"
      unitRef="usd">14997000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia1866466e5d2446d92c17b6f5b54ae88_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNC0xLTEtMS0yMzc1_f2afb0ce-bce2-4d5c-a619-2adf9974fcb6"
      unitRef="usd">3700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7f77d055886f40e0890b240ffc4c5900_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNC0zLTEtMS0yMzc1_4feee6fa-8229-4bb8-bbdd-2fc9b26830a4"
      unitRef="usd">3700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8f90b592a09143caa1086b6421f0c29f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNS0xLTEtMS0yMzc1_f4474a7c-8a0c-4500-adf6-ddfdaedd6bc0"
      unitRef="usd">3917000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6b5b4824cd0443c996bd2417b7318871_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNS0zLTEtMS0yMzc1_b48fca57-dca6-4d50-8b86-ee4f0682fd09"
      unitRef="usd">2834000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7e83a64a31d84e95a0d0bb5607943684_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNi0xLTEtMS0yMzc1_56c07ee3-6212-4ea7-89be-27e04b1a4281"
      unitRef="usd">9391000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie0086d69f42d465fbe2be778fd3669ae_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNi0zLTEtMS0yMzc1_66b0f609-eb6d-427c-a036-eda5de43c210"
      unitRef="usd">5512000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8009934e1ce1437faf934a21e11f53fa_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNy0xLTEtMS0yMzc1_4cb735d7-86d6-4bf5-a8fe-27f5cc671b82"
      unitRef="usd">9404000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib3cce94c3217479d9c47e9c7a9569964_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfNy0zLTEtMS0yMzc1_00bfead6-d3d4-4ed9-9776-179ffe02a54f"
      unitRef="usd">9106000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfOC0xLTEtMS0yMzc1_07fef377-d2d8-499c-9d09-816558ffcd35"
      unitRef="usd">41409000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfOC0zLTEtMS0yMzc1_0ef803bc-5f2c-47ab-9b1e-c16af3856882"
      unitRef="usd">36149000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfOS0xLTEtMS0yMzc1_7bcbb73a-2973-455b-aae7-d648bbe73f9f"
      unitRef="usd">15231000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfOS0zLTEtMS0yMzc1_31fee37f-1f49-456e-b590-6c0499907653"
      unitRef="usd">11685000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfMTEtMS0xLTEtMjM3NQ_ead0f069-9f1f-45b3-8396-c6874fbe8663"
      unitRef="usd">26178000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF85NC9mcmFnOjJiYmE2MWE0ZDk2NDQzNTU4OTA3YzljMzJjMDAxZGFhL3RhYmxlOmI4YjQxNDAzMTEzODQzNDZhMDIwMmEyNjA4OGY3YzViL3RhYmxlcmFuZ2U6YjhiNDE0MDMxMTM4NDM0NmEwMjAyYTI2MDg4ZjdjNWJfMTEtMy0xLTEtMjM3NQ_34cd8635-6075-4934-b6a8-fc029ad07360"
      unitRef="usd">24464000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90ZXh0cmVnaW9uOjY2YmU5OWQ3MjZjYTRhNmI4ZmMyMTY3ODlhMzQ4YjZhXzE3MA_6ae61ecd-b6e3-4f13-ac53-2f5d6128d25e">Accrued Expenses and Other Current Liabilities&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Major classifications of accrued expenses and other current liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued credit card fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued salaries and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued merchandise credits / reward program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales return allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued real estate taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90ZXh0cmVnaW9uOjY2YmU5OWQ3MjZjYTRhNmI4ZmMyMTY3ODlhMzQ4YjZhXzE2OQ_2fb52252-ac0f-43fe-84b8-a41c0f4398c1">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Major classifications of accrued expenses and other current liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued credit card fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued salaries and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued merchandise credits / reward program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales return allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued real estate taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzMtMS0xLTEtMjM3NQ_3f61e7a6-aaf9-42cf-9219-a7499bba715b"
      unitRef="usd">5098000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzMtMy0xLTEtMjM3NQ_df9c45f0-f3b4-4965-874c-d211a8e52b4c"
      unitRef="usd">1106000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <pets:AccruedCreditCardFeesCurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzQtMS0xLTEtMjM3NQ_b356bfb0-7af0-4d7a-bc20-350d41bcc1eb"
      unitRef="usd">401000</pets:AccruedCreditCardFeesCurrent>
    <pets:AccruedCreditCardFeesCurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzQtMy0xLTEtMjM3NQ_370a2c10-5f49-4f69-838c-305542110dfb"
      unitRef="usd">428000</pets:AccruedCreditCardFeesCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzUtMS0xLTEtMjM3NQ_0acfceb6-9593-49f9-b0b8-ce4e91206d2a"
      unitRef="usd">1564000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzUtMy0xLTEtMjM3NQ_d76b79c6-9f37-4157-acba-5c6d9be45024"
      unitRef="usd">1134000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <pets:AccruedMerchandiseCreditsAndRewardsCurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzYtMS0xLTEtMjM3NQ_e21dce7b-6cea-4c31-a7b3-5e969f796e3f"
      unitRef="usd">1660000</pets:AccruedMerchandiseCreditsAndRewardsCurrent>
    <pets:AccruedMerchandiseCreditsAndRewardsCurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzYtMy0xLTEtMjM3NQ_8dab2300-f9ef-495d-985b-38ab0cf3c6d6"
      unitRef="usd">1623000</pets:AccruedMerchandiseCreditsAndRewardsCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzctMS0xLTEtMjM3NQ_eb77c33d-805d-4be5-bbbd-33326375d123"
      unitRef="usd">559000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzctMy0xLTEtMjM3NQ_ebf38236-c15e-4e98-86be-c7f7856d1535"
      unitRef="usd">459000</us-gaap:AccruedProfessionalFeesCurrent>
    <pets:AccruedSalesReturnsAndAllowancesCurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzgtMS0xLTEtMjM3NQ_114b1617-ea85-4760-93dc-428bfc79fa67"
      unitRef="usd">221000</pets:AccruedSalesReturnsAndAllowancesCurrent>
    <pets:AccruedSalesReturnsAndAllowancesCurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzgtMy0xLTEtMjM3NQ_0dcaf801-10ff-4649-aba1-346353acdbd7"
      unitRef="usd">190000</pets:AccruedSalesReturnsAndAllowancesCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzktMS0xLTEtMjM3NQ_bc731e61-2226-4bb8-b7da-a0f3e9a58e85"
      unitRef="usd">1262000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzktMy0xLTEtMjM3NQ_7cd2cca4-e496-41fc-9caa-990ea06e8b3f"
      unitRef="usd">558000</us-gaap:DividendsPayableCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzEwLTEtMS0xLTIzNzU_2f531f82-d1f6-4bd3-9dc6-0f831a883029"
      unitRef="usd">118000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzEwLTMtMS0xLTIzNzU_a504e461-1628-4d52-aaf0-e767316e6775"
      unitRef="usd">111000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzExLTEtMS0xLTIzNzU_465a623f-3fdb-46fc-bc29-c03db5e40678"
      unitRef="usd">406000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzExLTMtMS0xLTIzNzU_8683da2f-8937-4f13-89d0-7bbdbeba084b"
      unitRef="usd">88000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <pets:AccruedExpensesAndOtherCurrentLiabilities
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzEzLTEtMS0xLTIzNzU_e1bda705-c9c9-4124-88b4-454ed99db1ae"
      unitRef="usd">11289000</pets:AccruedExpensesAndOtherCurrentLiabilities>
    <pets:AccruedExpensesAndOtherCurrentLiabilities
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDAvZnJhZzo2NmJlOTlkNzI2Y2E0YTZiOGZjMjE2Nzg5YTM0OGI2YS90YWJsZTozMGE0NTBiNGNjNDA0ZjNiOGIzMWZiZmMyOWU4NTRkNi90YWJsZXJhbmdlOjMwYTQ1MGI0Y2M0MDRmM2I4YjMxZmJmYzI5ZTg1NGQ2XzEzLTMtMS0xLTIzNzU_b07ab58a-74e7-4a22-8ca8-0dfb4823c35c"
      unitRef="usd">5697000</pets:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzEzODE_8de99699-55b0-476e-8b28-6329714acbe9">Income TaxesDeferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The tax &lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debt and inventory reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023, the Company had no federal or state net operating loss carryforwards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the income tax provision consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of income tax provision computed at the U.S. federal statutory tax rates to income tax expense is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes at U.S. statutory rates&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock shortfall (windfall) adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2023, the Company recognized a stock compensation shortfall charge of approximately $208 thousand and recognized a one-time charge of approximately $382 thousand related to a return to provision true up of the fiscal 2022 income tax provision. In fiscal 2022, the Company recognized a stock compensation shortfall charge of approximately $33 thousand, and recognized a one-time benefit of approximately $29 thousand, related to a return to provision true up of the fiscal 2021 income tax provision. In fiscal 2021 the Company recognized a stock compensation windfall benefit of approximately $135 thousand, and recognized a one-time benefit of approximately $194 thousand, related to a return to provision true up of the fiscal 2020 income tax provision.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The differences between the effective income tax rate and the statutory U.S. federal income tax rate are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal rate on income before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock shortfall (windfall) adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Effective Tax Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The primary drivers for the increase in effective tax rate for the fiscal 2023 include the recognition of  permanent differences related to one-time acquisition costs and a non-deductible portion of restricted stock compensation. The state tax rate for fiscal 2023 includes continued expansion of operations as well as a one-time true up for new state filings for fiscal 2022.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzEzODI_47a932fe-d521-416c-b0c4-48bb1bcbc210">The tax &lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debt and inventory reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzMtMS0xLTEtMjM3NQ_498eb0ef-9c82-4ae9-af36-a3eff1b87661"
      unitRef="usd">1529000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzMtMy0xLTEtMjM3NQ_fe3fdef4-c407-4c67-9cef-427443b3aee0"
      unitRef="usd">364000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzQtMS0xLTEtMjM3NQ_15dbdb69-e9f0-4dea-8ead-b889658db06a"
      unitRef="usd">1605000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzQtMy0xLTEtMjM3NQ_4eba37b5-0335-404f-bf9d-6b971e3dadad"
      unitRef="usd">662000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzUtMS0xLTEtMjM3NQ_37de034b-5849-4b8f-b8af-8d3206be8c05"
      unitRef="usd">21000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzUtMy0xLTEtMjM3NQ_2e81708a-9c59-469f-ac1f-b5a725b583da"
      unitRef="usd">27000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzctMS0xLTEtMjM3NQ_55b053e3-dae4-43dd-abaa-81eec842be6d"
      unitRef="usd">3155000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzctMy0xLTEtMjM3NQ_fe43c2eb-f568-4cd9-a6b9-4a507f814e90"
      unitRef="usd">1053000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzEwLTEtMS0xLTIzNzU_b6e6bc92-5ea7-430e-b6ae-7c66395bffc0"
      unitRef="usd">2527000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzEwLTMtMS0xLTIzNzU_00e3f132-be7e-438b-9c5f-7b2a3c79b615"
      unitRef="usd">1989000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzEyLTEtMS0xLTIzNzU_eb7d1f49-9db9-4400-a679-85584b22b66c"
      unitRef="usd">628000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo1Mzg5YjQ0NDhlOGI0MzQyODgyNDc4NTNmYjk5M2I2Ny90YWJsZXJhbmdlOjUzODliNDQ0OGU4YjQzNDI4ODI0Nzg1M2ZiOTkzYjY3XzEyLTMtMS0xLTIzNzU_467928ab-ecb9-4bbe-a3ca-c3cd1bf60181"
      unitRef="usd">936000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i0d41bb6533e64a78b0c413d60ab6d296_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzQxOA_0818778b-3559-41ed-82cd-b549716343d8"
      unitRef="usd">0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzEzODM_220766c2-7bb0-47af-a781-0b19c77d41dc">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the income tax provision consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzQtMS0xLTEtMjM3NQ_b0511a30-c410-423d-850b-185af39689a9"
      unitRef="usd">1831000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzQtMy0xLTEtMjM3NQ_cd58d72f-c130-4917-be37-9d37ffd131d4"
      unitRef="usd">5801000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzQtNS0xLTEtMjM3NQ_25486641-faaa-4a47-9dbc-ddc9ba8bf6d9"
      unitRef="usd">7446000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzUtMS0xLTEtMjM3NQ_a109e299-7daa-43da-b7f2-e909169a19b5"
      unitRef="usd">1084000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzUtMy0xLTEtMjM3NQ_caa8f9e5-d1c0-4f8f-8f9c-2a424e4d406d"
      unitRef="usd">515000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzUtNS0xLTEtMjM3NQ_7ec555ee-7cd9-4112-ae36-4b5bdf107c7a"
      unitRef="usd">856000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzYtMS0xLTEtMjM3NQ_a8feeadc-0cde-4936-a0c3-4541de7722bb"
      unitRef="usd">2915000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzYtMy0xLTEtMjM3NQ_9a3de9a5-6338-4235-b412-9aa83d6eac5e"
      unitRef="usd">6316000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzYtNS0xLTEtMjM3NQ_a36172d9-15af-40de-9b1e-c1baa95a0b4a"
      unitRef="usd">8302000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzktMS0xLTEtMjM3NQ_5d0e9d62-53c1-479f-b591-0f740ebe0539"
      unitRef="usd">-982000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzktMy0xLTEtMjM3NQ_d4425e2f-6e5e-4bd9-b011-e379dcbfe81f"
      unitRef="usd">-317000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzktNS0xLTEtMjM3NQ_430a555c-738f-434f-8227-1e02d71f8be6"
      unitRef="usd">279000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzEwLTEtMS0xLTIzNzU_f22614ac-e77c-477c-b20e-6c274ead767a"
      unitRef="usd">-582000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzEwLTMtMS0xLTIzNzU_efbabc2d-8d63-4b15-9f27-abb53fb640cb"
      unitRef="usd">-28000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzEwLTUtMS0xLTIzNzU_85e0fdd0-b020-419f-bbfd-92fc38882fc5"
      unitRef="usd">32000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzExLTEtMS0xLTIzNzU_0c4140f0-ff7a-4e2b-bea5-93fb0b405101"
      unitRef="usd">-1564000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzExLTMtMS0xLTIzNzU_fc15e8a9-0d3e-47ec-bfe3-cbd471df6b5b"
      unitRef="usd">-345000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzExLTUtMS0xLTIzNzU_1ab5adef-034e-45fb-a864-cb0332b183fd"
      unitRef="usd">311000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzEzLTEtMS0xLTIzNzU_51caf488-730e-44f9-8b96-f8d3d9e4d146"
      unitRef="usd">1351000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzEzLTMtMS0xLTIzNzU_53e36139-8156-4b2a-9920-18ae0cec4c65"
      unitRef="usd">5971000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTphZWY3NmJjOTRiZTE0ZWVkODhkZTA3YzViOWI3Y2U3Ni90YWJsZXJhbmdlOmFlZjc2YmM5NGJlMTRlZWQ4OGRlMDdjNWI5YjdjZTc2XzEzLTUtMS0xLTIzNzU_96caec58-b9eb-4723-957d-6e0533539cc7"
      unitRef="usd">8613000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzEzODA_b4ae7117-732a-4ee9-beaa-a488fcbcafc3">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of income tax provision computed at the U.S. federal statutory tax rates to income tax expense is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes at U.S. statutory rates&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock shortfall (windfall) adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The differences between the effective income tax rate and the statutory U.S. federal income tax rate are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal rate on income before taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock shortfall (windfall) adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Effective Tax Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzMtMS0xLTEtMjM3NQ_f6b45725-42d9-4591-9cd3-3f66258741c2"
      unitRef="usd">333000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzMtMy0xLTEtMjM3NQ_421e2187-08e4-437d-ba10-e4d1be54d288"
      unitRef="usd">5685000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzMtNS0xLTEtMjM3NQ_6cb9fc5a-0904-4225-b589-9b1aae5d2db1"
      unitRef="usd">8235000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzQtMS0xLTEtMjM3NQ_88a9a873-d504-4a46-b55b-24e76940e47e"
      unitRef="usd">275000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzQtMy0xLTEtMjM3NQ_3c356d4e-3e3d-4bd2-b986-40767dc09424"
      unitRef="usd">379000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzQtNS0xLTEtMjM3NQ_89b29f26-8ae6-45c7-85f9-bd39a52d857d"
      unitRef="usd">708000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzUtMS0xLTEtNDg3OTM_4bf1582d-1109-4726-add9-fae3cb973124"
      unitRef="usd">396000</pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount>
    <pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzUtMy0xLTEtNDg4MDQ_52ebd06c-23ed-4eee-860e-c35bb944d865"
      unitRef="usd">59000</pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount>
    <pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzUtNS0xLTEtNDk1OTg_25a58ddc-6e5a-4dd8-9924-809dac1aa7ec"
      unitRef="usd">198000</pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzUtMS0xLTEtMjM3NQ_0e124d92-86c0-4796-a5b9-b4fd7727ecfa"
      unitRef="usd">208000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzUtMy0xLTEtMjM3NQ_7d7e1baa-dc42-4284-9573-b67766a0177b"
      unitRef="usd">33000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzUtNS0xLTEtMjM3NQ_4c316c34-012a-4ae1-a2f8-ae095d806dad"
      unitRef="usd">-135000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzYtMS0xLTEtMjM3NQ_3d90acfe-cc57-4685-876f-23d3bf206ca2"
      unitRef="usd">139000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzYtMy0xLTEtMjM3NQ_75b5f864-893d-4301-8f81-8fd1183822fe"
      unitRef="usd">-185000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzYtNS0xLTEtMjM3NQ_d45ac858-c51e-4ce6-a753-a88e08e3eced"
      unitRef="usd">-393000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzgtMS0xLTEtMjM3NQ_0ff40c77-a33c-4498-b9c4-895a3d1fb783"
      unitRef="usd">1351000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzgtMy0xLTEtMjM3NQ_f054f819-9025-4741-9701-6d3f31d16af4"
      unitRef="usd">5971000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTpiNTc4NjEzN2QyZTQ0YmIwYjU5ODEwMzFhMGUwYWQyMy90YWJsZXJhbmdlOmI1Nzg2MTM3ZDJlNDRiYjBiNTk4MTAzMWEwZTBhZDIzXzgtNS0xLTEtMjM3NQ_a782bd38-1b2c-425a-ad5f-0f7f3dba3534"
      unitRef="usd">8613000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzc2OTY1ODEzOTgwMzY_9af58416-b2c2-41b7-8280-0bd9b1129692"
      unitRef="usd">208000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzc2OTY1ODEzOTgwOTY_b5803a94-9331-47d8-8201-cddc3c5a588f"
      unitRef="usd">382000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzc2OTY1ODEzOTcxMDc_6e9598b6-4f9b-4fce-b750-05ec0ea2fc4d"
      unitRef="usd">33000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzc2OTY1ODEzOTcxNjM_296b723d-f4fb-49e3-979c-f26c74a9ccb6"
      unitRef="usd">-29000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzc2OTY1ODEzOTczNDE_beb66582-8103-47c6-892a-999c995cdc2b"
      unitRef="usd">-135000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90ZXh0cmVnaW9uOjNjNzgyMDhkYTQ5ODQwNDRhNjc1NzM5YjAxYTQwNGEzXzc2OTY1ODEzOTczOTc_1822d3fd-6074-4b36-b138-97603fe25aed"
      unitRef="usd">-194000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzMtMS0xLTEtNDg5NDI_28207e45-5070-4b0e-9660-698606bdc965"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzMtMy0xLTEtNDkwMzE_fb302b2c-cf6c-4a03-b7c6-c0b65886af15"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzMtNS0xLTEtNDkyNjA_bc83fad2-e1ad-461b-9345-10aa5597abbf"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzQtMS0xLTEtNDg5NTY_96f6fe9f-90e2-4d09-afe0-c6b89958b77e"
      unitRef="number">0.174</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzQtMy0xLTEtNDkwNDA_be8d63ed-19dc-42ec-8d92-ef4767f05ccd"
      unitRef="number">0.014</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzQtNS0xLTEtNDkyNjk_1324bcff-0493-4f33-af7c-5631d517729e"
      unitRef="number">0.018</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzUtMS0xLTEtNDg5NjU_20485845-5819-402b-960a-8ea3ef5062f7"
      unitRef="number">0.250</pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzUtMy0xLTEtNDkwNDk_c9d3dcce-8374-4eda-9b48-7fb6d66e9811"
      unitRef="number">0.002</pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzUtNS0xLTEtNDkyNzg_55329626-7ec5-45f3-ac89-320baaf8a87d"
      unitRef="number">0.005</pets:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzYtMS0xLTEtNDg5NzM_63a468ae-5c2b-407d-aa28-ca02717f1f41"
      unitRef="number">0.131</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzYtMy0xLTEtNDkwNTg_8a2e212f-fa49-4711-be58-2d70b4fbb7bd"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzYtNS0xLTEtNDkyODY_e3e14b2a-1a81-4327-a75b-17bf4d0fb696"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzctMS0xLTEtNDg5ODE_f0bd5234-9e59-47a5-9729-add8557fed24"
      unitRef="number">0.088</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzctMy0xLTEtNDkwNjc_265649db-b3e7-4544-b432-101647c785f5"
      unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzctNS0xLTEtNDkyOTQ_a5b08f1e-9739-4a81-b00e-eb522f7c6ca1"
      unitRef="number">-0.010</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzktMS0xLTEtNDg5ODk_ca91a4f9-7edf-422e-b4eb-47e580a77795"
      unitRef="number">0.853</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzktMy0xLTEtNDkwNzU_485c9134-a323-4ca3-88f9-ef4109fd6f27"
      unitRef="number">0.221</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDMvZnJhZzozYzc4MjA4ZGE0OTg0MDQ0YTY3NTczOWIwMWE0MDRhMy90YWJsZTo3ZWJjOTc3NzQ3YjM0MmExYjY2NzU0MjFiZGMyODUxOS90YWJsZXJhbmdlOjdlYmM5Nzc3NDdiMzQyYTFiNjY3NTQyMWJkYzI4NTE5XzktNS0xLTEtNDkzMDI_4283de09-256d-48ff-97ec-0da836e21a4c"
      unitRef="number">0.220</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzI1MDY_1f9f06f4-4e95-4336-99fc-6fbc8afb290a">&lt;div style="margin-top:18pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(5)&#160;&#160;&#160;&#160;Shareholders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Equity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 1998, the Company issued 250,000 shares of its $.001 par value preferred stock at a price of $4.00 per share, less issuance costs of $112 thousand. Each share of the preferred stock is convertible into approximately &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.05 shares of common stock at the election of the shareholder. The shares have a liquidation value of $4.00 per share and may pay dividends at the sole discretion of the Company. The Company does not anticipate paying dividends to the preferred shareholders in the foreseeable future. Each share of preferred stock is entitled to one vote on all matters submitted to a vote of shareholders of the Company. At March&#160;31, 2023 and 2022, 2,500 shares of the convertible preferred stock remained unconverted and outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; Company has $110.0 million  of shares authorized under previously approved share repurchase programs. The share repurchase program does not have an expiration date and is intended to be implemented through purchases made from time to time in either the open market or through private transactions at the Company's discretion, subject to market conditions and other factors, in accordance with Securities and Exchange Commission requirements. There can be no assurances as to the timing and number of shares that will be repurchased under the share repurchase program, and the Company may modify or discontinue the share repurchase program at any time subject to compliance with applicable regulatory requirements. Shares purchased pursuant to the share repurchase program will either be cancelled or held in the Company's treasury.  During fiscal 2023 and 2022 the Company had no share repurchases. At March&#160;31, 2023 the Company had approximately $28.7 million remaining under the Company&#x2019;s share repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company&#x2019;s financial performance. During fiscal 2023, our Board of Directors declared the following dividends:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.272%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Declaration Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Per Share&lt;br/&gt;Dividend&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Record Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Amount&lt;br/&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 9, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$0.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 20, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$6,297&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 27, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 25, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$0.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 12, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$6,323&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 19, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 7, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$0.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 18, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$6,323&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 6, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$0.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 20, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$6,325&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesIssued
      contextRef="id29065364981439b8297fe9c2b387741_I19980430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0Xzcy_f17bd57f-bde5-4078-9eef-468d10c0442a"
      unitRef="shares">250000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="id29065364981439b8297fe9c2b387741_I19980430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzkzNDU4NDg4NDAyNjk_45af075c-e45c-4bcf-b230-35fc1bfc0790"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="id29065364981439b8297fe9c2b387741_I19980430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzEzNQ_e0ca2a86-cdab-4abc-9855-c93d0db09ba6"
      unitRef="usdPerShare">4.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i71c12e540590434c98c58ec2c09fb08c_D19980401-19980430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzE3Mg_55233ad3-61b8-4602-907e-febccc400796"
      unitRef="usd">112000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="id29065364981439b8297fe9c2b387741_I19980430"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzI0NA_3dda27f4-a659-4047-b117-9aecaecc601b"
      unitRef="shares">4.05</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="id29065364981439b8297fe9c2b387741_I19980430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzM0NQ_7514ea5e-25b6-4fc1-a20c-b8ad43cec03a"
      unitRef="usdPerShare">4.00</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i11c1a95cfc3b42c8b1207c680949ce01_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzY2MA_875ad199-e19d-42f2-bd3f-7f7f37bb8cd1"
      unitRef="shares">2500</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ifd52e04a4fe84d1c97fb1a7b1eb50021_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzY2MA_e9ad8e5e-76f5-4889-8908-69de7413db81"
      unitRef="shares">2500</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzEwOTk1MTE2MzIzNjY_9ebdaf26-90b4-422c-ac5b-9a32388aab40"
      unitRef="usd">110000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzE5MTU_17f3ed3e-a8be-4443-b2a6-fed611d8c6fd"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzE5MTU_f29d92f8-8f07-4316-a118-82d03fba28c7"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzE5NzM_ab31aedf-2684-43a2-abf1-d3271d3476ae"
      unitRef="usd">28700000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:DividendsDeclaredTableTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90ZXh0cmVnaW9uOjBiOTEyY2UxODQwYzRiMjE4YTQ3YjZhZDkxYTg0ZDY0XzI1MDc_2bd8612e-68ec-4d56-9da5-519ea5c2bb3b">During fiscal 2023, our Board of Directors declared the following dividends:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.272%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Declaration Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Per Share&lt;br/&gt;Dividend&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Record Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Amount&lt;br/&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 9, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$0.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 20, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$6,297&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 27, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 25, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$0.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 12, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$6,323&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 19, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 7, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$0.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 18, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$6,323&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 6, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$0.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 20, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$6,325&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DividendsDeclaredTableTextBlock>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="ib0d6d76e24604cb9a18256bc00a989e9_I20220509"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzItMi0xLTEtMjM3NQ_2c834c52-c635-467e-932e-fafc54522c86"
      unitRef="usdPerShare">0.30</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="ib0d6d76e24604cb9a18256bc00a989e9_I20220509"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzItNi0xLTEtMjM3NQ_0b2f5b8e-5789-4dab-b1af-ae5c6113f8e9"
      unitRef="usd">6297000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="iae9efd376d404db3a83df403c4b1f447_I20220725"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzMtMi0xLTEtMjM3NQ_b369b55b-69fb-47a4-a3f6-295eb7d70bdf"
      unitRef="usdPerShare">0.30</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="iae9efd376d404db3a83df403c4b1f447_I20220725"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzMtNi0xLTEtMjM3NQ_f5f6e30d-28bd-41cf-b918-6a0d0d0d50ad"
      unitRef="usd">6323000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i997f8d9c4d5c47d4a9bbe74962ed4629_I20221107"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzQtMi0xLTEtMjM3NQ_a79bbef6-f433-483c-a1fa-bec8251c3453"
      unitRef="usdPerShare">0.30</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i997f8d9c4d5c47d4a9bbe74962ed4629_I20221107"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzQtNi0xLTEtMjM3NQ_ca3ef7e1-c798-410c-9cac-711d016bf6cb"
      unitRef="usd">6323000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i113e079495ae443ea4acdecad992dd93_I20230206"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzUtMi0xLTEtMjM3NQ_2704b643-91a6-44f9-b485-c729dcfdf36b"
      unitRef="usdPerShare">0.30</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i113e079495ae443ea4acdecad992dd93_I20230206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDYvZnJhZzowYjkxMmNlMTg0MGM0YjIxOGE0N2I2YWQ5MWE4NGQ2NC90YWJsZTpkYjM2MmVjZmU4MzI0MzU3YWZlNGQ3YTU4YWU2NjQ4Ni90YWJsZXJhbmdlOmRiMzYyZWNmZTgzMjQzNTdhZmU0ZDdhNThhZTY2NDg2XzUtNi0xLTEtMjM3NQ_089410a1-d4d7-475a-aca3-d74c8cb7cd2d"
      unitRef="usd">6325000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzIzMTM_c075cd7d-5b58-416c-958d-cc1e0afc012a">Restricted Stock&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2015, the Company&#x2019;s 2015 Outside Director Equity Compensation Restricted Stock Plan (&#x201c;2015 Director Plan&#x201d;) became effective upon the approval of the plan by the Company&#x2019;s Shareholders. The 2015 Director Plan authorized 400,000 shares of the Company's common stock available for issuance under the plan and provides for an automatic increase every year in the amount of shares available for issuance under the plan of 10% of the shares authorized under the plan. In July 2016, the Company&#x2019;s 2016 Employee Equity Compensation Restricted Stock Plan (&#x201c;2016 Employee Plan&#x201d;) became effective upon the approval of the plan by the Company&#x2019;s Shareholders. The 2016 Employee Plan authorized 1,000,000 shares of the Company's Common stock available for issuance under the plan. In July 2022, the Company&#x2019;s 2022 Employee Equity Compensation Restricted Stock Plan (&#x201c;2022 Employee Plan&#x201d;) became effective upon the approval of the plan by the Company&#x2019;s shareholders. The 2022 Employee Plan authorized 1,000,000 shares of the Company's common stock available for issuance.The value of the restricted stock is determined based on the market value of the stock at the issuance date. The restriction period or forfeiture period is determined by the Company&#x2019;s Compensation Committee and is to be no less than 1 year and no more than ten years unless otherwise specified by the Compensation Committee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records compensation expense associated with restricted stock in accordance with ASC Topic 718 (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Based Payment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) (ASU 2016-09). At March&#160;31, 2023, the Company had 960,007 restricted common shares issued under the 2016 Employee Plan and 240,755 restricted common shares issued under the 2015 Director Plan. No shares had been issued under the 2022 Employee Plan as of March&#160;31, 2023. All shares in the 2016 Employee Plan and 2015 Director Plan were issued subject to a restriction or forfeiture period that lapses ratably on the first, second, and third anniversaries of the date of grant, and the fair value of which is being &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amortized over a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzkzNDU4NDg4NDU1MDU_5ab669ee-e73c-4623-8194-b9f525c9a887"&gt;one&lt;/span&gt; to three-year restriction period, with the exception of performance restricted shares which were issued to the Chief Executive Officer and Chief Financial Officer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, the Company issued 90,000 restricted shares and 510,000 performance restricted shares to the Company&#x2019;s CEO, in accordance with the CEO&#x2019;s employment agreement, under the 2016 Employee Plan.  The performance restricted shares are based on achieving absolute stock hurdles within the three-year period from the grant date. If the shares meet the absolute stock price hurdle, they will only vest on the third anniversary of the date of grant. As of March&#160;31, 2023, none of the performance stock hurdles were met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, the Company issued 13,000 restricted shares and 3,000 performance restricted shares to the Company's new CFO, in accordance with the CFO's employment agreement, under the 2016 Employee Plan. The performance restricted shares are based on the attainment of performance criteria equally weighted between adjusted EBITDA and revenue. The shares for each grant will be released from restriction equally over a three year period on the anniversary of the grant date, and in the case of the performance restricted shares, subject to the attainment of performance criteria.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; For the fiscal years ended March&#160;31, 2023, 2022, and 2021, the Company recognized compensation expense related to the 2016 Employee Plan and the 2015 Director Plan of $6.6 million, $4.5 million, and $3.3 million, respectively. All stock-based compensation expense is recognized as a payroll-related expense and it is included within the general and administrative expenses line item within the Company&#x2019;s Consolidated Statements of Income, and the offset is included in the additional paid-in capital line item of the Company&#x2019;s Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On February&#160;3, 2023, we issued 6,000 shares of our common stock to a consultant pursuant to a consulting agreement in exchange for consulting services. The securities were issued in reliance upon the exemption from the registration requirements of the Securities Act, as set forth in Section 4(a)(2) under the Securities Act as a transaction by an issuer not involving any public offering and the standard Securities Act restrictive legend and stop transfer instructions were noted on the stock certificate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s non-vested restricted stock at March&#160;31, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee&lt;br/&gt;Plan&lt;br/&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Director&lt;br/&gt;Plan&lt;br/&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Both Plans&lt;br/&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested restricted stock outstanding at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;771&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested restricted stock outstanding at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023 and 2022, there were 752,829 and 770,652, non-vested restricted shares subject to restriction and forfeiture outstanding, respectively. During the fiscal years ended March&#160;31, 2023 and 2022, the Company issued, net of forfeitures, 99,390 and 709,599 restricted shares, respectively. The weighted-average grant date fair value of restricted shares was $21.57 and $30.47 for fiscal years 2023 and 2022, respectively.  The total fair value of restricted shares vested was $2.4 million and $3.0 million for fiscal years 2023 and 2022, respectively.  At March&#160;31, 2023 and 2022, there were $9.1 million and $13.4 million of unrecognized compensation costs related to the restricted stock subject to restriction and forfeiture awards, respectively, which &lt;/span&gt;&lt;/div&gt;is expected to be recognized over the remaining weighted average restriction and forfeiture period of 1.6 and 2.3 years for fiscal 2023 and 2022, respectively.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i3fa97c770ada498d940f7db2777193c8_I20150731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzI1Mw_52177db4-edce-46c1-9dfa-08282d9d39e8"
      unitRef="shares">400000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <pets:PercentageOfAutomaticIncreaseInSharesAvailableForIssuance
      contextRef="i3711637129e84cf495f85a1e1f12d159_D20150701-20150731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzQ0Ng_5be3636c-28f0-479e-bfd8-3570a9bf56a2"
      unitRef="number">0.10</pets:PercentageOfAutomaticIncreaseInSharesAvailableForIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ibec5936930e84c289028e660f01b73b1_I20160731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzcwOQ_b6a919db-975e-4ff3-a2c9-2ec1368615fc"
      unitRef="shares">1000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ia2f86689eec24b90a4591646dcc402a8_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwOTk1MTE2MzAzOTQ_657af689-5bcc-4125-873d-9c244bd46ef1"
      unitRef="shares">1000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <pets:RestrictionPeriod
      contextRef="ida16bfdaf8b04ccd9cabdceb30574a33_D20220701-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwMDQ_90d4820a-8de6-4574-93c0-7a2d9be5fd83">P1Y</pets:RestrictionPeriod>
    <pets:RestrictionPeriod
      contextRef="i35389028e9874b27a83eed9c5fc398cb_D20220701-20220731"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwMjQ_3371af5e-c2a7-468d-990e-297d06a2999d">P10Y</pets:RestrictionPeriod>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ia83cc28d498c4c9fafb92ce48449955b_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzExMDQ_a9c6983c-84ca-4f31-812e-8def1b9a3f98"
      unitRef="shares">960007</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i8c496648613e49b6bd05ae478b147763_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzExNzI_9aad001d-bc07-4975-a5a0-89baecc36cfb"
      unitRef="shares">240755</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i53ec65434cab4c1eb2a83616f99420e5_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwOTk1MTE2MzEzNTU_fcb5ebad-12c1-4229-9155-7fe1a62f59b4"
      unitRef="shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <pets:RestrictionPeriod
      contextRef="i1b2659243cd348e8b9a71f890d8f3847_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzkzNDU4NDg4NDU1Mzk_bf534249-8394-4272-a7dd-dd5676175d3c">P3Y</pets:RestrictionPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib9e138b657114015a8d3f172c1e19f7e_D20210801-20210831"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwOTk1MTE2MzQ0NDU_fbe183ab-7798-43e2-bcff-1a67099a309a"
      unitRef="shares">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iac19f43c73124a22b4617cf091f81d03_D20210801-20210831"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwOTk1MTE2MzQ0NTU_27e45f23-c839-4328-8c84-1e79d9eabf3d"
      unitRef="shares">510000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod
      contextRef="iac19f43c73124a22b4617cf091f81d03_D20210801-20210831"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzkzNDU4NDg4NDU1Mzg_bfa2a13d-1fec-4a25-8783-02f5929cd313">P3Y</pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if7745f099643450b9ec65034832f389e_D20220801-20220831"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwOTk1MTE2MzQ0ODQ_8101f77c-f97e-48bd-89a6-34b8987ec54a"
      unitRef="shares">13000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i7f3fed9704204153a8fa0b54b227b2e1_D20220801-20220831"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwOTk1MTE2MzQ0OTI_c7ee0ea6-dde9-43dd-8521-2d3dc932f7e6"
      unitRef="shares">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if6933ff7bd564ae78075d75944fc25ee_D20220801-20220831"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzkzNDU4NDg4NDU1NDA_19d08ef2-88a4-4008-a46f-6c13ccb09981">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensation
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzE2MzM_dd0208f0-4c2d-4041-b870-689d472580a4"
      unitRef="usd">6600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzE2Mzc_f3eb7b13-f6f3-4425-aa53-cc900077a6ae"
      unitRef="usd">4500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzE2NDU_d7431a4e-4875-4c97-ae81-131952a5c165"
      unitRef="usd">3300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0074779789d04c76ba59318f55ccc983_D20230203-20230203"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzEwOTk1MTE2MzEzOTU_66d2b6bc-1807-4822-9ae6-1e587ee92567"
      unitRef="shares">6000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzIzMTQ_c8917680-492f-45e4-8335-729085a1df7d">&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s non-vested restricted stock at March&#160;31, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee&lt;br/&gt;Plan&lt;br/&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Director&lt;br/&gt;Plan&lt;br/&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Both Plans&lt;br/&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested restricted stock outstanding at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;771&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested restricted stock outstanding at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i7487aada4c7e48a9a152a316a2197596_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzItMS0xLTEtMjM3NQ_03357ee6-93fa-430b-8025-8b5f0c92dc6b"
      unitRef="shares">702000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if9d97a210a094cbb962f8e5009bfda1a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzItMy0xLTEtMjM3NQ_e26f42db-58f3-4952-b492-b31887b55411"
      unitRef="shares">69000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzItNS0xLTEtMjM3NQ_d17b520c-fa2c-442e-8199-7a1f6b75a243"
      unitRef="shares">771000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ief448de592ce4068b2e177f1aeea6dd8_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzQtMS0xLTEtMjM3NQ_5bbf84e0-43eb-4d33-a40a-91cfdc809892"
      unitRef="shares">88000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia93b8106781d4da387b3b15296d47a35_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzQtMy0xLTEtMjM3NQ_2745e31c-e454-49cc-a82f-d89291130b59"
      unitRef="shares">39000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzQtNS0xLTEtMjM3NQ_c440fe02-a8ac-4b73-9e5b-d794c0af261b"
      unitRef="shares">127000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ief448de592ce4068b2e177f1aeea6dd8_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzYtMS0xLTEtMjM3NQ_7b6f9a23-2591-4ef6-a04a-f9353cbc858e"
      unitRef="shares">88000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ia93b8106781d4da387b3b15296d47a35_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzYtMy0xLTEtMjM3NQ_0059c36e-bb5d-4d32-a660-59c5055010a0"
      unitRef="shares">30000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzYtNS0xLTEtMjM3NQ_88dcb886-a3a5-448c-a010-e8f9048f615a"
      unitRef="shares">118000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ief448de592ce4068b2e177f1aeea6dd8_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzgtMS0xLTEtMjM3NQ_22e1df68-c24f-4f44-94fe-4cab512f09aa"
      unitRef="shares">18000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ia93b8106781d4da387b3b15296d47a35_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzgtMy0xLTEtMjM3NQ_22caf30a-9c2d-46a4-943f-471bb53e3442"
      unitRef="shares">9000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzgtNS0xLTEtMjM3NQ_fa3eeb37-7a4c-4909-b770-6852696b7ea6"
      unitRef="shares">27000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i77c3d270a0834d03b39b41eb3e174586_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzEwLTEtMS0xLTIzNzU_9b299c0b-63fa-46b5-b1e4-90a6d66695cf"
      unitRef="shares">684000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iad7317540db946209e8de1718fbdb1da_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzEwLTMtMS0xLTIzNzU_311e1329-d5a5-41fc-8df3-fc20213e4549"
      unitRef="shares">69000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90YWJsZToxNDQ3MzUxYjAyNmU0NDcxYTBlZDkxODU1NWQ2MzRjZS90YWJsZXJhbmdlOjE0NDczNTFiMDI2ZTQ0NzFhMGVkOTE4NTU1ZDYzNGNlXzEwLTUtMS0xLTIzNzU_889c66ee-1723-44c8-93d0-dc8c4b726136"
      unitRef="shares">753000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie95c7dd15e734cdb96435d11a9f08ac5_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzE3ODE_2c97510b-b0cc-41db-80a5-0bda7f58351b"
      unitRef="shares">752829</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i96546148fd614f969f6f32c7d9c77fc6_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzE3ODg_0027880f-7607-4ef3-91e0-7c68ce545825"
      unitRef="shares">770652</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i890f993d4c6947ce85fae3592689d54b_D20220401-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzE5NTY_9a152243-faef-4877-917c-979b74d2e4c5"
      unitRef="shares">99390</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="iada85d4fb9a84a7ab431b36c77c5b07d_D20210401-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzE5NjM_34c23e49-5650-4205-85b1-0c38e54642fb"
      unitRef="shares">709599</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i890f993d4c6947ce85fae3592689d54b_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzc2OTY1ODE0MDQ4Nzg_00c51082-238a-4ff5-8d62-70afd34f9734"
      unitRef="usdPerShare">21.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iada85d4fb9a84a7ab431b36c77c5b07d_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzc2OTY1ODE0MDQ4Njk_8c89718e-a621-45ef-bcd8-40d2b9bbbe94"
      unitRef="usdPerShare">30.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i890f993d4c6947ce85fae3592689d54b_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzc2OTY1ODE0MDQ5MTE_aab71b9d-14b7-48ea-96be-3362ba30f66e"
      unitRef="usd">2400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="iada85d4fb9a84a7ab431b36c77c5b07d_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzc2OTY1ODE0MDQ4OTM_f8178e37-17d8-490b-b2fb-fb26514a5047"
      unitRef="usd">3000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ie95c7dd15e734cdb96435d11a9f08ac5_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzIwMjQ_acdb95fd-5142-4509-b3d2-4fd5270f79b9"
      unitRef="usd">9100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i96546148fd614f969f6f32c7d9c77fc6_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzIwMzE_87780225-9aac-4128-82c7-2221ce9856eb"
      unitRef="usd">13400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i890f993d4c6947ce85fae3592689d54b_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzIyNjk_4c4e94d7-ef34-4bb4-94cb-94a9b95010e0">P1Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="iada85d4fb9a84a7ab431b36c77c5b07d_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMDkvZnJhZzo1ZWZiYWVjOGUwOTE0NmMxYmM4NWZmMjM5YjEzYjI2My90ZXh0cmVnaW9uOjVlZmJhZWM4ZTA5MTQ2YzFiYzg1ZmYyMzliMTNiMjYzXzIyNzY_f692fbb5-8f81-4637-b0e8-9eed7a474875">P2Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTIvZnJhZzpjYWFhMjk5ZWFlYWM0YmExOTAxN2QzMmZmOGJjYmEzNS90ZXh0cmVnaW9uOmNhYWEyOTllYWVhYzRiYTE5MDE3ZDMyZmY4YmNiYTM1XzEzMjk_ecdee0db-4c43-4a84-9a50-4893c8a33e6a">Fair Value Measurements&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company carries cash and cash equivalents and investments at fair value in the Consolidated Balance Sheets. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. ASC Topic 820 (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Fair Value Measurements&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) establishes a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 - Unobservable inputs which are supported by little or no market activity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. At March&#160;31, 2023 and 2022 the Company had invested the majority of its $104.1 million and $111.1 million cash and cash equivalents balance in money market funds which are classified within Level 1.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i714efa7810e34b859f1f6107bd4f64a9_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTIvZnJhZzpjYWFhMjk5ZWFlYWM0YmExOTAxN2QzMmZmOGJjYmEzNS90ZXh0cmVnaW9uOmNhYWEyOTllYWVhYzRiYTE5MDE3ZDMyZmY4YmNiYTM1XzEwOTk1MTE2MzAyMzU_52656de7-86da-446a-99f8-9e480f4dd0af"
      unitRef="usd">104100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7ac8d430365e42a4b70f68ccef80bf34_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTIvZnJhZzpjYWFhMjk5ZWFlYWM0YmExOTAxN2QzMmZmOGJjYmEzNS90ZXh0cmVnaW9uOmNhYWEyOTllYWVhYzRiYTE5MDE3ZDMyZmY4YmNiYTM1XzEwOTk1MTE2MzAyNDQ_a10578fc-4d7d-4d82-a3b4-3db53f550f58"
      unitRef="usd">111100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90ZXh0cmVnaW9uOjkyNzg1N2U1OTIzMzQ1NTdhNmQyOWY5NWU3MzBkMGMxXzExMTU_17bf944d-799b-4a21-94db-fd2b7b77d454">Net Income Per Share&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with the provisions of ASC Topic 260 (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) basic net income per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted net income per common share includes the dilutive effect of potential restricted stock and the effects of the potential conversion of preferred shares, calculated using the &lt;/span&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;treasury stock method. Unvested restricted stock, and convertible preferred shares issued by the Company represent the only dilutive effect reflected in diluted weighted average shares outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented (in thousands, except for per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (numerator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares (denominator)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding used in basic computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,176&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,060&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common shares issuable upon the vesting of restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common shares issuable upon conversion of preferred shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in diluted computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,339&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,358&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,119&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023, 2022, and 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 745,854, 220,727, and 20,952 shares of common restricted stock, respectively, were excluded from the computations of diluted net income per common share, as their inclusion would have had an anti-dilutive effect on diluted net income per common share.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90ZXh0cmVnaW9uOjkyNzg1N2U1OTIzMzQ1NTdhNmQyOWY5NWU3MzBkMGMxXzExMTQ_90d0c50f-410a-4e65-ac01-e49de628d9be">The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented (in thousands, except for per share amounts):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (numerator):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares (denominator)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding used in basic computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,176&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,060&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common shares issuable upon the vesting of restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common shares issuable upon conversion of preferred shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in diluted computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,339&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,358&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,119&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzQtMS0xLTEtMjM3NQ_ffdf4b63-f1b7-4e99-b201-b453572a15ae"
      unitRef="usd">233000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzQtMy0xLTEtMjM3NQ_c1ed6152-80fa-4d10-85de-f3ed6295e8b9"
      unitRef="usd">21100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzQtNS0xLTEtMjM3NQ_8d197b32-fda8-4d7d-9144-a73c4baa894e"
      unitRef="usd">30603000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzgtMS0xLTEtMjM3NQ_a3ad0c4f-5d72-4661-9bf9-505ef76a761c"
      unitRef="shares">20275000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzgtMy0xLTEtMjM3NQ_0f5f1d0e-10f7-4945-80ee-65a9a7cadc7f"
      unitRef="shares">20176000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzgtNS0xLTEtMjM3NQ_fcf45a4e-401d-4dc1-94a0-59b5d583c185"
      unitRef="shares">20060000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzktMS0xLTEtMjM3NQ_df00b9fa-c9ae-4b64-ad4a-5877ec28c181"
      unitRef="shares">54000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzktMy0xLTEtMjM3NQ_80eda5cf-8987-4326-aa24-d1170b74e690"
      unitRef="shares">172000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzktNS0xLTEtMjM3NQ_fb4f4b1b-af76-4ee8-a69d-5acbee9b3c8a"
      unitRef="shares">49000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzEwLTEtMS0xLTIzNzU_0ca874e5-f4a6-4779-92a7-4f47df712c85"
      unitRef="shares">10000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzEwLTMtMS0xLTIzNzU_2bb5eb30-dca4-4454-b061-c401b598603f"
      unitRef="shares">10000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzEwLTUtMS0xLTIzNzU_d1c7777d-97a5-4b7a-8a37-3efd43e2b512"
      unitRef="shares">10000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzExLTEtMS0xLTIzNzU_e2f8c6e3-caff-4bf6-91d4-14b69752ed76"
      unitRef="shares">20339000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzExLTMtMS0xLTIzNzU_49d68d64-282b-42c6-95b1-cf4f61d916a8"
      unitRef="shares">20358000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzExLTUtMS0xLTIzNzU_7e57a4d2-196a-4cbc-be7a-b2ff29c2870a"
      unitRef="shares">20119000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzE1LTEtMS0xLTIzNzU_4d7371e5-aa2b-4492-a47a-a3bb5f963ae9"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzE1LTMtMS0xLTIzNzU_f61d7210-2a5c-434f-9710-7e3cfd3e3b5f"
      unitRef="usdPerShare">1.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzE1LTUtMS0xLTIzNzU_a03392b1-208e-40c1-a2e8-0545ac91671b"
      unitRef="usdPerShare">1.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzE2LTEtMS0xLTIzNzU_c0d26afb-b9bf-4819-b2e9-2ab3e5b21ffe"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzE2LTMtMS0xLTIzNzU_a51117a3-a7ee-4e73-9ec6-a58469f3b983"
      unitRef="usdPerShare">1.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90YWJsZTo5NzFmNjQ4NGM3ZGE0NTViODU4Mzc3N2JhOWVkZDg3ZC90YWJsZXJhbmdlOjk3MWY2NDg0YzdkYTQ1NWI4NTgzNzc3YmE5ZWRkODdkXzE2LTUtMS0xLTIzNzU_04e97e54-8bf2-4c73-b8b2-8f61c1721d5b"
      unitRef="usdPerShare">1.52</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90ZXh0cmVnaW9uOjkyNzg1N2U1OTIzMzQ1NTdhNmQyOWY5NWU3MzBkMGMxXzg3OA_e9e2c629-3dff-4aeb-a98c-65e210e96006"
      unitRef="shares">745854</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90ZXh0cmVnaW9uOjkyNzg1N2U1OTIzMzQ1NTdhNmQyOWY5NWU3MzBkMGMxXzg4Mg_34d9cf63-4836-4c66-8b38-8d48e5fb5906"
      unitRef="shares">220727</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTUvZnJhZzo5Mjc4NTdlNTkyMzM0NTU3YTZkMjlmOTVlNzMwZDBjMS90ZXh0cmVnaW9uOjkyNzg1N2U1OTIzMzQ1NTdhNmQyOWY5NWU3MzBkMGMxXzg5MA_94b16787-b1e6-4215-8981-e488f2e475cc"
      unitRef="shares">20952</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzk0MTA_1641dd52-bb19-42e0-a3a3-cfc4300dffa4">Commitments and Contingencies&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal Matters and Routine Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has settled complaints that had been filed with various states&#x2019; pharmacy boards in the past. There can be no assurances made that other states will not attempt to take similar actions against the Company in the future. The Company also intends to vigorously defend its trade or service marks. There can be no assurance that the Company will be successful in protecting its trade or service marks. Legal costs related to the above matters are expensed as incurred. From time to time, the Company may be involved in and subject to disputes and legal proceedings, as well as demands, claims and threatened litigation that arise in the ordinary course of its business. These proceedings may include allegations involving business practices, infringement of intellectual property, employment or other matters. The ultimate outcome of any legal proceeding is often uncertain, there can be no assurance that the Company will be successful in any legal proceeding, and unfavorable outcomes could have a negative impact on our results of operations and financial condition. In accordance with ASC Topic 450-20 ("&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Loss Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;"), the Company records a liability in its financial statements for these matters when a loss is known or considered probable and the amount can be reasonably estimated. The Company reviews the status of each significant matter each accounting period as additional information is known and adjusts the loss provision when appropriate. If a matter is both probable to result in a liability and the amounts of loss can be reasonably estimated, the Company estimates and discloses the possible loss or range of loss to the extent necessary to make the financial statements not misleading. If the loss is not probable and cannot be reasonably estimated, a liability is &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;not recorded in the Company&#x2019;s financial statements. Gain contingencies are not recorded until they are realized. Legal costs related to any legal matters are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales Tax&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 21, 2018, the United States Supreme Court rendered a decision in South Dakota v. Wayfair, Inc., holding that a state may require a remote seller with no physical presence in the state to collect and remit sales tax on goods and services provided to purchasers in the state, overturning certain existing court precedent. The Company has evaluated its state tax filings with respect to the Wayfair decision and currently collects and remits applicable sales taxes in all jurisdictions in which it has a physical presence or it believes Nexus exists. During the year ended March&#160;31, 2023, the Company received an assessment for sales tax; based upon this, the Company evaluated the various jurisdictions for additional exposure and recorded an increase of $7.8&#160;million for potential sales tax exposure. The Company included $4.0&#160;million in the "Accrued expenses and other current liabilities" line item and $3.8&#160;million in the "Other long-term liabilities" line item in the Consolidated Balance Sheets as of March&#160;31, 2023 with the offsetting expense  recognized in the "General and administrative" line item within the Consolidated Statements of Income for the year ended March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employment Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 28, 2021,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Board of Directors notified Menderes Akdag (&#x201c;Mr. Akdag&#x201d;), former CEO &amp;amp; President and Director, that the Company would not extend Mr. Akdag&#x2019;s employment agreement with the Company, and the employment agreement would therefore end on &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;July 30, 2021,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in accordance with the scheduled end date of the agreement. Effective &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;July 31, 2021,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Board of Directors appointed Bruce S. Rosenbloom (&#x201c;Mr. Rosenbloom&#x201d;), the Company&#x2019;s former Chief Financial Officer, as Interim Chief Executive Officer and President of the Company, until a permanent successor chief executive officer was appointed. Mr. Rosenbloom received an additional cash stipend of $10 thousand for the additional responsibilities while serving as Interim Chief Executive Officer and President, which ended on August&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 11, 2021,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company and Mr. Akdag, entered into a CEO Separation Agreement and General Release setting forth certain matters relating to the expiration of Mr. Akdag&#x2019;s employment with the Company (the &#x201c;Separation Agreement&#x201d;). The Separation Agreement provided that Mr. Akdag&#x2019;s employment with the Company, and service as an officer and director of the Company, would terminate as of July 30, 2021.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Separation Agreement also documented Mr. Akdag&#x2019;s agreement that, during his remaining period of employment through July 30, 2021,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he would continue to provide his fulltime attention to the business affairs of the Company and cooperate with the Company&#x2019;s Board of Directors on the transition to a new chief executive officer. The Separation Agreement provided that Mr. Akdag would be paid &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;two&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lump-sum severance payments of $325 thousand each, with the first such payment to be paid, and was paid, on&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;August&#160;10, 2021,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and the second to be paid, and was paid, on December 31, 2021,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;subject to his compliance with the terms and conditions of his then existing employment agreement, and the Separation Agreement. In exchange for the Company&#x2019;s agreement to make the severance payments, Mr. Akdag granted the Company a full release of any and all claims that he may&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;have against the Company and its affiliates and related parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, as a part of the Separation Agreement, the Company confirmed that the 37,800 restricted shares held by Mr. Akdag would be, and were, released from restriction and forfeiture on July 31, 2021,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and that the Company would, and did, cover the tax withholding obligations in connection with such release of shares from restriction and forfeiture. Under the Separation Agreement, Mr. Akdag agreed that he would continue to comply with his existing confidentiality, non-solicitation, and non-compete obligations, and he further agreed that until July 31, 2022,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he would comply with certain &#x201c;standstill&#x201d; covenants relating to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 25, 2021,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Board of Directors appointed Mathew N. Hulett ("Mr. Hulett&#x201d;) as Chief Executive Officer and President of the Company and as a member of the Board of Directors. These appointments and the employment agreement were effective as of August 30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The employment agreement is for an initial term of three (3) years commencing on August 30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and will automatically renew for successive one (1) year terms, or for longer periods as mutually agreed upon by the parties, unless the employment agreement is expressly cancelled by either Mr. Hulett or the Company sixty (60) days prior to the end of the then current term, or is otherwise terminated as provided in the agreement. The employment agreement provides that Mr. Hulett will &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;receive an annual base salary of $500 thousand, subject to periodic review for increases with the approval of the Board of Directors, and will be eligible to participate in the standard employee benefit plans generally available to executives and employees of the Company, including health insurance, life and disability insurance, restricted stock under the Company&#x2019;s equity compensation plan(s), 401(k) plan, and paid time off and paid holidays. The employment agreement also provides that the Company will reimburse Mr. Hulett for his documented business expenses incurred in connection with his employment pursuant to the Company's standard reimbursement expense policy and practices. The employment agreement contains certain rights of Mr. Hulett and the Company to terminate Mr. Hulett&#x2019;s employment, including termination by the Company for &#x201c;Cause&#x201d; as defined in the employment agreement, and termination by Mr. Hulett for &#x201c;Good Reason&#x201d; as defined in the employment agreement within twelve (12) months of a Change in Control as defined in the employment agreement. Mr. Hulett is also entitled to severance pay equal to twelve (12) months of Mr. Hulett&#x2019;s current base salary and eighteen (18) months of health insurance benefits in the event of his termination by the Company without Cause, or termination by Mr. Hulett for Good Reason within twelve (12) months of a Change in Control. The foregoing severance benefits are conditioned upon Mr. Hulett&#x2019;s execution of a release of claims and compliance with certain restrictive covenants. The employment agreement contains customary non-disclosure and non-solicitation provisions as well as a one (1) year non-compete following the termination of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August&#160;30, 2021,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mr. Hulett also received an award of 90,000 shares of restricted stock under the Company&#x2019;s 2016 Employee Plan, which stock restrictions will lapse pro rata on each of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;August 30, 2022,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;August 30, 2023,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;August 30, 2024,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which are subject to forfeiture in the event of termination of employment (except as provided in the restricted stock agreement). Mr. Hulett also received an award of 510,000 shares of performance restricted stock under the 2016 Employee Plan, which stock restrictions will lapse on the third anniversary of the date of grant based on (i) achieving absolute stock price hurdles within the three-year period from the date of grant, and (ii) continued employment through the performance period of three years from the date of grant, in accordance with the following schedule: 85,000 shares at the stock hurdle price of $40 per share, 107,000 shares at the stock hurdle price of $45 per share, 106,000 shares at the stock hurdle price of $50, 106,000 shares at the stock hurdle price of $55, and 106,000 shares at the stock hurdle price of $60.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Should none of the absolute stock price hurdles be met during the three-year period from the date of grant, no shares would vest (as defined in the performance restricted stock agreement). Once the absolute stock price hurdle is achieved, it will be considered to have met the absolute stock price hurdle, regardless of the stock price on the third anniversary of the date of grant. The absolute stock price hurdle would be considered to have been met if the average closing stock price of the Company is at or above the absolute stock price hurdle for a period of ninety (90) consecutive trading days. If the shares would be considered to have met the absolute stock price hurdle, they will only vest on the third anniversary of date of grant, subject to Mr. Hulett&#x2019;s continued employment through the performance period of three years from the date of grant (except as provided in the performance restricted stock agreement). As of March&#160;31, 2023,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;none of the performance restricted stock vested, as no performance stock price hurdles were met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July&#160;14, 2022, the Board of Directors appointed Christine Chambers ("Ms. Chambers") to serve as the Company&#x2019;s Chief Financial Officer and to assume the duties of principal financial officer and principal accounting officer effective August&#160;3, 2022 (&#x201c;Effective Date&#x201d;). The Company entered into an offer letter with Ms. Chambers to set the terms and conditions of Ms. Chambers&#x2019; employment as Chief Financial Officer of the Company. Ms. Chambers will receive an annual base salary of $375 thousand and received a one-time sign-on bonus in the amount of $50 thousand, subject to pro rata repayment if Ms. Chambers terminates employment with the Company within the first twelve months of employment. Ms. Chambers received an initial equity award  under the 2016 Employee Plan consisting of (i) an award of 13,000 restricted shares, and (ii) 3,000 performance restricted shares, which performance restricted shares will be based on the attainment of performance criteria equally weighted between adjusted EBITDA and revenue as of the fiscal year ended March&#160;31, 2023. The shares for each grant will be released from restriction equally over a three (3) year period on the anniversary of the grant date, subject to the attainment of performance criteria in the case of the performance restricted shares. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with Mr. Rosenbloom&#x2019;s transition services and subsequent separation from employment with the Company, on August&#160;2, 2022 the Company and Mr. Rosenbloom entered into a CFO Transition and Separation Agreement (the "Separation Agreement&#x201d;) pursuant to which Mr. Rosenbloom remained in his current position as CFO of the Company through and including August&#160;2, 2022, and following the termination of his &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;status as CFO, Mr. Rosenbloom continued to serve as an employee of the Company to provide transition services to the Company through his date of termination. His employment ended on December&#160;31, 2022 ("Separation Date&#x201d;). While Mr. Rosenbloom served as an employee of the Company, he continued to receive his current base salary and benefits as was in effect. The Separation Agreement provided that Mr. Rosenbloom would be paid two lump-sum severance payments of $182 thousand each, with the first such payment to be paid on the Company&#x2019;s next payroll date following the Separation Date, and was paid January 13, 2023, and the second to be paid on the Company&#x2019;s next payroll date six-months following the Separation Date, subject to his compliance with the terms and conditions of his then existing employment agreement, and the Separation Agreement. In exchange for the Company&#x2019;s agreement to make the severance payments, Mr. Rosenbloom granted the Company a full release of any and all claims that he may have against the Company and its affiliates and related parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, as a part of the Separation Agreement, the Company confirmed that the 13,275 restricted shares held by Mr. Rosenbloom under the 2016 Employee Plan were released from restriction and forfeiture on December&#160;31, 2022, Under the Separation Agreement, Mr. Rosenbloom&#x2019;s existing non-compete obligation was reduced to a period of twelve (12) months.&lt;/span&gt;&lt;/div&gt;In connection with the separation of the Company's former Chief Financial Officer, the Company has accrued the remaining $182 thousand payment with respect to the severance, pursuant to the Separation Agreement, included in "Accrued expenses and other current liabilities" on the Consolidated Balance Sheet as of March&#160;31, 2023.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ExciseAndSalesTaxes
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTA1OTU_92316257-a165-4725-8d7b-6dd0be62b4ee"
      unitRef="usd">7800000</us-gaap:ExciseAndSalesTaxes>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent
      contextRef="i6c2de17c1b084f35b8463988b326e824_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTA2MTA_3f30a977-9d90-4794-b5d6-41cbe6349b4f"
      unitRef="usd">4000000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent
      contextRef="ia1f7c6a0ee004443b3a68de9782c1f9c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTA2MjQ_48d200fd-a201-4fed-89eb-54c38aff392c"
      unitRef="usd">3800000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <pets:PaymentsForStipend
      contextRef="i6267e0b588824a56aa5efdad685990fc_D20210731-20210830"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzI2ODY_0acf2435-1dc2-4bb6-827d-c1c356af2c45"
      unitRef="usd">10000</pets:PaymentsForStipend>
    <pets:NumberOfSeverancePayments
      contextRef="i9d21b0cfcbc8452ea6025a3a67ef8073_I20210611"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4MjMyNTk_a45be89b-b7ca-47f9-8601-2b4bc5b2a19a"
      unitRef="payment">2</pets:NumberOfSeverancePayments>
    <pets:LumpSumSeverancePayments
      contextRef="i4891cfdf6fc44c6aa3c0da9831b5308f_D20211231-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzM2NDY_08816367-4f05-427d-9ce8-864717d087d4"
      unitRef="usd">325000</pets:LumpSumSeverancePayments>
    <pets:LumpSumSeverancePayments
      contextRef="i2432cc60a7f84868839476ea9782eeae_D20210810-20210810"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzM2NDY_4b76b8d0-574d-4bea-ae39-5410a6376167"
      unitRef="usd">325000</pets:LumpSumSeverancePayments>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i2edb519042c6474b9a2fd6eca193f849_D20210731-20210731"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzQyMDc_a7e024f3-4366-4515-9e86-059ea1546b7f"
      unitRef="shares">37800</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <pets:EmploymentTermInitialPeriod
      contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTM5NTc_1a57d3ea-61f1-4106-8a81-966b837c861d">P3Y</pets:EmploymentTermInitialPeriod>
    <pets:EmploymentTermSuccessiveRenewalPeriod
      contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTM5NjU_22833fa2-4a48-44c9-9692-d671dbad1218">P1Y</pets:EmploymentTermSuccessiveRenewalPeriod>
    <pets:EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm
      contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTM5NzI_36bd3e44-88cb-417a-88d6-8f3c3210410e">P60D</pets:EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm>
    <us-gaap:OfficersCompensation
      contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzU2NzI_8148d1c2-aed8-4f83-b385-17cacb4774c3"
      unitRef="usd">500000</us-gaap:OfficersCompensation>
    <pets:TerminationPeriodPeriodWithinChangeInControl
      contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTM5ODA_bb5dba05-4c25-4bbd-a295-937b3d90eb17">P12M</pets:TerminationPeriodPeriodWithinChangeInControl>
    <pets:SeverancePaymentBaseSalaryPeriod
      contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTM5ODg_11e176ab-a145-4095-846b-96fea0084968">P12M</pets:SeverancePaymentBaseSalaryPeriod>
    <pets:SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod
      contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTM5OTY_658b97f0-3858-4120-9de2-588c165a9348">P18M</pets:SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod>
    <pets:SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod
      contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTQwMDQ_e5c758fb-bddd-4f89-8a80-515a581f1185">P12M</pets:SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod>
    <pets:NonCompeteAgreementPeriod
      contextRef="i64c37b2240d14c149babfa0aa83dc363_D20210830-20210830"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTQwMTI_27150318-5bdb-4793-9b3d-dbd948e97bd4">P1Y</pets:NonCompeteAgreementPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i315520404bf24ebea1c2cb0c8e23b089_D20210830-20210830"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2ODQ1ODI_2de9c24a-1f22-4a2b-9f89-eefbc01150ce"
      unitRef="shares">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i63b1d72605c8405d8b027717916a080b_D20210830-20210830"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2ODQ1ODY_c8848183-5f17-4fd5-b194-f9e5be026c9d"
      unitRef="shares">510000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod
      contextRef="i63b1d72605c8405d8b027717916a080b_D20210830-20210830"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4MjM0NDk_dcff6b12-ee3d-45bd-98ad-21c81206b996">P3Y</pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod>
    <pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod
      contextRef="i63b1d72605c8405d8b027717916a080b_D20210830-20210830"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4MjM0NTA_5b25e125-4892-441c-bf81-c751691244b4">P3Y</pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i7afc070e4bdf46fc9f7d226e6741e1c6_D20210830-20210830"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgxNDA_da9d7858-fdcf-49b2-8d6e-d3a7140bf4cd"
      unitRef="shares">85000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1384889b25bd4d7185122232ce1451e8_I20210830"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgxNzk_20f8ba12-aee3-4666-9901-2762c4e284b2"
      unitRef="usdPerShare">40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i5cbb8d45015a45ea84ddf37d27c11a68_D20210830-20210830"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgxOTM_2f717ac6-010e-4bd1-8b26-20229a6d8f8d"
      unitRef="shares">107000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i6808984e22ee45d58ea010775c3f55d4_I20210830"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgyMzI_06f4e227-1d05-4984-aec6-3d3b7c95b980"
      unitRef="usdPerShare">45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ic1dce613dc084e329c47918a37fe1c39_D20210830-20210830"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgyNDY_b7b34f76-7721-404f-adaf-7fcadb3e9977"
      unitRef="shares">106000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if5e6ea897b514a6f9570f9ac37ce2bb2_I20210830"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgyODU_2140fabb-9807-435d-95b8-60241864382e"
      unitRef="usdPerShare">50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i449b1d02eb98411ca0c78fbbde6ac2f1_D20210830-20210830"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgyODk_3af27fb1-2d3a-41a5-bb83-f9deb41d334c"
      unitRef="shares">106000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i844106ae017246048418122f69f34ad0_I20210830"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgzMjg_0123a16c-1975-43c5-bd29-c6b839d8338a"
      unitRef="usdPerShare">55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i068c52c343b44cc193b5a62f93d38549_D20210830-20210830"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgzMzY_a4a20452-eb1b-4336-ae2b-b314d912a1df"
      unitRef="shares">106000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ic863aef22f2d409193398f92e79e7c7f_I20210830"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzgzNzU_2c4da929-8089-4cd0-97d0-15f90d9cba73"
      unitRef="usdPerShare">60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod
      contextRef="i63b1d72605c8405d8b027717916a080b_D20210830-20210830"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4MjM0MjU_df0c69aa-e209-42fb-b565-81f081e9ecc3">P3Y</pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod>
    <pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod
      contextRef="i63b1d72605c8405d8b027717916a080b_D20210830-20210830"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTQwMTk_16115086-71a0-4666-b2a7-d920fd184e09">P90D</pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod>
    <pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod
      contextRef="i63b1d72605c8405d8b027717916a080b_D20210830-20210830"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4MjM0MDA_147bdbd4-ca81-4c82-b4f4-160e7034d590">P3Y</pets:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod>
    <us-gaap:OfficersCompensation
      contextRef="id26b0819bb5b4b09bda518b2201d5648_D20220803-20220803"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2NzEwOTU_909c8110-5948-489a-8583-670f4c34d4a0"
      unitRef="usd">375000</us-gaap:OfficersCompensation>
    <pets:SalaryAndWageOfficerSignOnBonus
      contextRef="if0add0f1e60f4b04ae873731c0197067_D20220802-20220802"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2NzExMDc_cbf3d466-e851-485b-9078-cee8ec31fb34"
      unitRef="usd">50000</pets:SalaryAndWageOfficerSignOnBonus>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iff7afa81075f467a8ee51d67a09ed71b_D20220803-20220803"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2ODQ2MDI_2c8a80d1-c51e-4e60-9601-5c7799e0e492"
      unitRef="shares">13000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="icd16eafa395744a48017a3ee602c42e8_D20220803-20220803"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2ODQ2MTY_6175a259-ad99-4e87-9341-1625c6bd57e3"
      unitRef="shares">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="icd16eafa395744a48017a3ee602c42e8_D20220803-20220803"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTQwMjc_050787e9-fdf2-4286-8a42-fb2fd7678aad">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <pets:NumberOfSeverancePayments
      contextRef="i25dd78455488483794c262cbc7525f11_I20220802"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4MjM0NTE_9186bb5d-c369-4dfe-b0e0-09a6d6f9e26a"
      unitRef="payment">2</pets:NumberOfSeverancePayments>
    <pets:ContingentLumpSumSeverancePayment
      contextRef="if0add0f1e60f4b04ae873731c0197067_D20220802-20220802"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2NzEyODM_59cd74e3-0cc5-4c15-8a86-f21abc1d8484"
      unitRef="usd">182000</pets:ContingentLumpSumSeverancePayment>
    <pets:LumpSumSeverancePayments
      contextRef="idc34f00e393f4f85af3ba71ed34d459b_D20230113-20230113"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2NzEyODM_c074de10-7bdd-4aa0-9af5-ca7ecea42e81"
      unitRef="usd">182000</pets:LumpSumSeverancePayments>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="id0a27942ed9c40ff9ddc967a8de7b5f6_D20221231-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2NzEyOTc_69a3456d-a162-43cf-8efc-5d0ca3ff766c"
      unitRef="shares">13275</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <pets:NonCompeteAgreementPeriod
      contextRef="if0add0f1e60f4b04ae873731c0197067_D20220802-20220802"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzY1OTcwNjk4NTQwMzQ_3a2f1c42-594e-4649-9e19-c87e1c3c7f9e">P12M</pets:NonCompeteAgreementPeriod>
    <pets:AccruedSeveranceCosts
      contextRef="ide541b5ccbaf4aae8f5059586a8aac5b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMTgvZnJhZzoyNzE0Y2E0NzUzNjI0OGZlOWY3MjE1MWNiYmRhOWZlMC90ZXh0cmVnaW9uOjI3MTRjYTQ3NTM2MjQ4ZmU5ZjcyMTUxY2JiZGE5ZmUwXzEwOTk1MTE2ODQ2NDE_e0e35b5b-53d1-4e19-96e8-709b8d0475ab"
      unitRef="usd">182000</pets:AccruedSeveranceCosts>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4Xzg5Mg_2724b4d2-cb83-4f53-bd36-31674a7eb8f6">Employee Benefit Plan&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a 401(k) Savings Plan for eligible employees. The plan is a defined contribution plan that is administered by the Company. All regular, full-time employees are eligible for voluntary participation upon completing one year of service and having attained the age of 21. The plan provides for growth in savings through contributions and income from investments. It is subject to the provisions of the Employee Retirement Income Security Act of 1974&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as amended. Plan participants are allowed to contribute a specified percentage of their base salary. The Company matches 100% of the first 4% of the employees contribution. The matching contribution is funded subsequent to the calendar year. During the fiscal years ended March&#160;31, 2023, 2022, and 2021, the Company recorded $289 thousand, $238 thousand, and $245 thousand, respectively, of 401(k) matching contribution and administration expense to general and administrative expenses.&lt;/span&gt;</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4XzI2Nw_9cfb675d-f5e0-43c8-8e42-6ac99df4a5ad">P1Y</us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1>
    <pets:DefinedContributionPlanWithIndividualAge
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4XzMxMg_a707b76e-b627-4813-82d3-aaa3b98a6fea">P21Y</pets:DefinedContributionPlanWithIndividualAge>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4XzE2NDkyNjc0NDE3Nzc3_49a388d7-d5d7-4bea-bb43-160c6bcdaea0"
      unitRef="number">1</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4XzE2NDkyNjc0NDE3Nzgz_e44c8b6e-07b3-47b8-bcc1-73b3f7539ddb"
      unitRef="number">0.04</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4Xzc2NQ_29094337-e168-424f-b4d3-68c99e15fefa"
      unitRef="usd">289000</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
      contextRef="i748e2b668b6f495595f17f005c4a3661_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4Xzc2OQ_b5c31cef-f819-4604-9e94-fb5bb223ff7e"
      unitRef="usd">238000</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
      contextRef="i3416e47de26f43d58c4f271301261758_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjEvZnJhZzo5MGEzMjFlMTBkN2U0MTBhOTYwNjAxMmRkYTg4MjQ2OC90ZXh0cmVnaW9uOjkwYTMyMWUxMGQ3ZTQxMGE5NjA2MDEyZGRhODgyNDY4Xzc3Nw_af1c14ab-db7f-45d7-8b83-952e91a52b84"
      unitRef="usd">245000</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF81ODQvZnJhZzo2YmJkYTcxNWI5ZjM0MmVkODNlZjVjOGIzYWJjY2JlZS90ZXh0cmVnaW9uOjZiYmRhNzE1YjlmMzQyZWQ4M2VmNWM4YjNhYmNjYmVlXzY1OTcwNjk3NzE4Njc_fdeb5463-67ee-44ad-8f88-fb99e3c4df4e">Minority Interest Investment in Vetster&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;19, 2022, the Company engaged in a three-year partnership agreement with Vetster Inc. (&#x201c;Vetster&#x201d;), a veterinary telehealth Canadian company. The Company also purchased a 5% minority interest in Vetster in the amount of $5.0 million and received warrants for additional equity in Vetster, which are tied to future performance milestones. Under the terms of the agreement, the Company became the exclusive e-commerce provider for Vetster, and Vetster became the exclusive provider of telehealth and telemedicine services to the Company. The minority interest investment is being valued on the cost basis.  At March 31, 2023, we evaluated the investment in accordance with ASC Topic 321 (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Equity Interests&lt;/span&gt;) and determined it was not impaired.</us-gaap:MinorityInterestDisclosureTextBlock>
    <pets:TermOfAgreement
      contextRef="i5d8f4dc33edd40a281b970a2cbdbe0c5_D20220419-20220419"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF81ODQvZnJhZzo2YmJkYTcxNWI5ZjM0MmVkODNlZjVjOGIzYWJjY2JlZS90ZXh0cmVnaW9uOjZiYmRhNzE1YjlmMzQyZWQ4M2VmNWM4YjNhYmNjYmVlXzY1OTcwNjk3NzE4Njg_4aa44e0f-cdf2-408e-a67b-7543f772afe8">P3Y</pets:TermOfAgreement>
    <pets:NoncontrollingInterestOwnershipPercentagePurchased
      contextRef="ib12c1e8fbbbd41d29aae9c4166df1e67_I20220419"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF81ODQvZnJhZzo2YmJkYTcxNWI5ZjM0MmVkODNlZjVjOGIzYWJjY2JlZS90ZXh0cmVnaW9uOjZiYmRhNzE1YjlmMzQyZWQ4M2VmNWM4YjNhYmNjYmVlXzEwOTk1MTE2MzEyNTE_a952e312-a48a-4ff5-bbf9-d65a1eaf5d5d"
      unitRef="number">0.05</pets:NoncontrollingInterestOwnershipPercentagePurchased>
    <us-gaap:Investments
      contextRef="ib12c1e8fbbbd41d29aae9c4166df1e67_I20220419"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF81ODQvZnJhZzo2YmJkYTcxNWI5ZjM0MmVkODNlZjVjOGIzYWJjY2JlZS90ZXh0cmVnaW9uOjZiYmRhNzE1YjlmMzQyZWQ4M2VmNWM4YjNhYmNjYmVlXzEwOTk1MTE2MzIyNzA_cb2221b5-7a56-4e21-ba99-cb0b36d6e014"
      unitRef="usd">5000000.0</us-gaap:Investments>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3XzEyNjE_dd16cf51-6f8c-416d-82e9-612314ed1e1f">Subsequent EventsOn January&#160;13, 2023, the Company entered into an Agreement and Plan of Merger to acquire PetCareRx, Inc. ("PetCareRx"), a leading supplier of pet medications, food, and supplies, for an aggregate consideration of approximately $36.0 million in cash, subject to adjustment. The closing of the transaction was subject to customary closing conditions and certain state pharmacy license and permit filings related to the change of control of PetCareRx. The transaction was approved by the Board of Directors of both the Company and PetCareRx, and &lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the stockholders of PetCareRx, and closed on April&#160;3, 2023. Upon completion of the acquisition, PetCareRx became a wholly-owned subsidiary of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to March&#160;31, 2023, the Board of Directors approved and issued 42,142 restricted shares to employees of PetCareRx under the 2022 Employee Plan as part of a  retention initiative, which shares were issued subject to a restriction or forfeiture period that lapses on the first anniversary of the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to March&#160;31, 2023, the Board of Directors approved and issued 11,910 restricted shares, net of forfeitures, to employees under the 2016 Employee Plan and 31,000 restricted shares to employees under the 2022 Employee Plan, which shares were issued subject to a restriction or forfeiture period that lapses ratably on the first, second, and third anniversaries of the date of grant. The Board also approved the issuance of a pro-rata portion of a non-employee director annual restricted stock grant in the amount of 1,623 restricted shares to Sandra Campos, a newly appointed director on the Board of Directors, under the 2015 Director Plan, which shares were issued subject to a restriction or forfeiture period that lapses ratably on the first, second, and third anniversaries of the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;May&#160;22, 2023,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company&#x2019;s Board of Directors declared a quarterly dividend of $0.30 per share on its common stock. The $6.3 million dividend will be payable on June&#160;12, 2023,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to shareholders of record at the close of business on &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;6, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i7fd3857af0904bd9905af80251e8beaf_D20230113-20230113"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3XzEwOTk1MTE2MzEyOTE_37292373-683f-4313-b277-ee03fceba1a1"
      unitRef="usd">36000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i81d9acb2bf774cea93998dcf45c5f344_D20230401-20230523"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3Xzg3OTYwOTMwMzA5NTI_337ca3a1-2ce4-4cea-9aa0-5089911fac5c"
      unitRef="shares">42142</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i52baab8375b34634bc096512ff056e08_D20230401-20230523"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3XzY0_b039ed59-08d8-4c06-8bd5-81415ec98d64"
      unitRef="shares">11910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id3432de5afd244aea63998346817ce66_D20230401-20230523"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3Xzc2OTY1ODE0MDEwMTA_67d038fc-f0e0-4adf-8275-fc7487cfee1d"
      unitRef="shares">31000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i21b9d44505884d13926569569baba59c_D20230401-20230523"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3XzEwOTk1MTE2MzIxNjY_a7d6d6f9-0229-4ccd-a9ce-fded65913de2"
      unitRef="shares">1623</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i0cc0c13fe26b4d4896753ec70f10be17_I20230522"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3XzExMjA_6f4e8c76-583b-423e-97f5-512827dc9b11"
      unitRef="usdPerShare">0.30</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i0cc0c13fe26b4d4896753ec70f10be17_I20230522"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMjcvZnJhZzo3YWUxN2Y2M2RjY2U0ZjZhOGRlMDFmM2M3ZWQzNWZkNy90ZXh0cmVnaW9uOjdhZTE3ZjYzZGNjZTRmNmE4ZGUwMWYzYzdlZDM1ZmQ3XzExNTg_d97cfff4-541e-45d6-a0e1-d37a0d9605b1"
      unitRef="usd">6300000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMzAvZnJhZzoyOTM4M2YxODUzMjc0ODFhYjc3NzNhNjA2MjYyZDg1YS90ZXh0cmVnaW9uOjI5MzgzZjE4NTMyNzQ4MWFiNzc3M2E2MDYyNjJkODVhXzQ1Mg_1211f036-7815-42cd-9a98-0bf6fd03f6ad">Related Party Transaction&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Board of Directors Chairman, Gian Fulgoni, serves on the board of directors of Prophet, a brand and marketing consulting company, which PetMed Express, Inc. engaged with in March 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for $292 thousand. The Company expensed $32 thousand in fiscal 2021, with the remaining $260 thousand expensed in fiscal 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; This transaction was approved by the Company&#x2019;s Board of Directors with terms that are comparable to those with an unrelated third party.&lt;/span&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="i4469b631590844adbaaf420a00aa612e_D20210301-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMzAvZnJhZzoyOTM4M2YxODUzMjc0ODFhYjc3NzNhNjA2MjYyZDg1YS90ZXh0cmVnaW9uOjI5MzgzZjE4NTMyNzQ4MWFiNzc3M2E2MDYyNjJkODVhXzIzMA_d87e7676-6e37-4947-a7e7-814b2c92d8b9"
      unitRef="usd">292000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="ibb424c34659d462d8120e942e5596384_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMzAvZnJhZzoyOTM4M2YxODUzMjc0ODFhYjc3NzNhNjA2MjYyZDg1YS90ZXh0cmVnaW9uOjI5MzgzZjE4NTMyNzQ4MWFiNzc3M2E2MDYyNjJkODVhXzI1NQ_95b13104-2d62-4f09-84ee-90e9dc260333"
      unitRef="usd">32000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="i97c463b50b984fe9b48aa37d4d2bd8a2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllY2I1OGEwZjI1YTQ2MTM5M2VjYTVlZmNmZDMyYTM4L3NlYzo5ZWNiNThhMGYyNWE0NjEzOTNlY2E1ZWZjZmQzMmEzOF8xMzAvZnJhZzoyOTM4M2YxODUzMjc0ODFhYjc3NzNhNjA2MjYyZDg1YS90ZXh0cmVnaW9uOjI5MzgzZjE4NTMyNzQ4MWFiNzc3M2E2MDYyNjJkODVhXzI5MQ_8f14d6db-ea2a-4c21-b4ce-1f28228f8446"
      unitRef="usd">260000</us-gaap:DueToRelatedPartiesCurrent>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>66
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M&-S*,KCF//\34XYTMF:)*0O>(W*&!]T^_-/2LFH8;*G5:566P37G^T^A!+?
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M5T$Y![M_D-*<#'= UZG3OU!+ P04    "  +1;=65@!E/MH%  !W&   &
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MO;F=1!.4\A6K,OU)[G_G1X<"8R^1F:K_HOU1%D]04BDM\Z,R(,A%<?AE3\=
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M!.7AE/MPH^6V/BA^E%K+O+[<< :PC0"\7TFIO]^8L^?3_QJ6_P)02P,$%
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M"-NP+*^394.+W-[(ED+#_<X^IG %)]($0/]*"/W8,)>\^E(?_0%02P,$%
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MQ?)N5V5K+:+$2A_[J#53OJC 2J8:DUV$]<Y0*ZL?JB"K'Z (=ZT8T]?<OMX
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M5M@>&O4%@Y6PVY.>Z9:4.N6%M^5=&3+"3ON,8QU%*4\B#-2/=;6@'-9*Q'
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M.:;B$[1A5[I(U(]W.=YM,./687= P\.2B-HGZU>6:?U*W0AD* RG.P7_0T$
MX/8[XS!"TQ72S&J:0F__Z?Q=$\Z^Y:HFK235Y?5F8?4 ]$@]&$O]\FVXY]QU
M<;Y;!V10K*BEU-;S784DXN]\%.!2OG45TR'H:KYWRAN" -6UO;A_#58@.^N"
MA=$55SAX3?>R$.R*3K4O'=-"YTPG5GMRB-\F8VYQA*X1EQL8T 7]ZC2VB9\/
MU%OJ^=')#+:,/,X'OKLF$L]KY&2BN>W*?1_-=X^,-*)*E&TIU9J2'3G5!#/=
MZ*)>(CD@9= U]@Q\E+"/MO)T\78[W0(VU/.E\NE7(SEW0VZ^I<N6X<::J)%+
MPU NQFME.1\SDLR+)C12G[B4,IRM'Y&4S\GI$D.'(@D4BB;3.:7JEVNSJV^8
MS\M+KE3)XQN5?%5A-CC$/[=KRG5O>2W2.?9&/[J0++LIF+\9$#L8AQ?QR%K(
M\ND>=>72NV.WO3M);C1OL5F7F8]2XC68+)QX'>.@8XQ?NA] S)P)9NF1Z=Q6
M+..552F5R]#(9&Q,= ,B%""240KEZW"$8*-=<Y/4'/R8Q;O"4=ALVUK-Z71$
MT@OD&G,?JQ/Z(06[C6=B=*!6EC5U2&"N/'YO*F7XZ BK)T?+-/C"LO/[!)VY
M+3=9V$G9M#LWE8764_?"GX"8,?@GS8$..81T63BV$:9MVKB#8[]*.N_\FFQC
MD*1O^*<J+(W\L*QYVOPL[UI^C=8.E]_T(9:M*)/E9HFIP\'EQ8G<S(U?*K?E
MWZ8A2U5NPQ_I=QW&TP"\7SI7Q2^T0/-CQ3?_#U!+ P04    "  +1;=6P6 #
MEM@"  !2!@  &    'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;)55;4_;,!#^
M*Z<,32!%Y+4OZ=I*E(&&!%,%VO9AV@<WN30>B1ULA\*_WSDIH4RET[XX=_;=
M<\^=?9?I1JI[72 :>*I*H6=.84P]\3R=%E@Q?2IK%'222U4Q0ZI:>[I6R++6
MJ2J]T/>'7L6X<.;3=F^IYE/9F)(+7"K0354Q];S 4FYF3N"\;-SR=6'LAC>?
MUFR-=VB^U4M%FM>C9+Q"H;D4H#"?.6?!9!%;^];@.\>-WI'!9K*2\MXJ5]G,
M\2TA+#$U%H'1YQ'/L2PM$-%XV&(Z?4CKN"N_H%^VN5,N*Z;Q7)8_>&:*F3-V
M(,.<-:6YE9LON,UG8/%26>IVA4UG&U/$M-%&5EMGTBLNNB][VM9AQV'LO^,0
M;AW"EG<7J&7YF1DVGRJY 66M"<T*;:JM-Y'CPE[*G5%TRLG/S)>*[E>99V B
M@XN'AM=4<>/"5S13SU  :^:E6[!%!Q:^ Q:$<".%*31<B RSMP >,>OIA2_T
M%N%!Q!NF3B$*7 C],#J %_7I1BU>](]T75B63)BW6<//LY4VBA[*KWVY=\CQ
M?F3;/!-=LQ1G#G6'1O6(SOSCAV#H?SK .^YYQX?0__>:#H+MIWH@ MRPWU)!
M6C*M><Y39OM)@\RAWG7"OHXI'7-MK(4I$')94N]SL89C+FA'-IKL]<F$@%5:
M]/=KEQ 6#2\S:WP$0>PFR>A5N+9A(G?D^]NUM[VJB,HCVNB:SI)@!*$[CF(X
MEU7=&%1P)W.S80HA<:,D@($[H-=ZV2C!3:/0A9P_64'_E4KBQGY,:^ /(0Y(
M22 :ND&<P#5J/:&IDC954S*#&0T#*F?*V_+ <3!PPR@X(2%PA^/!"2SW%LL%
M014^@I!01V,KQ&X\C&'?H_%V^KQ"M6ZGF:9R-\)T+=_O]@/SK)L3K^;=M*7*
MKSE=8HDYN?JGHX$#JIM@G6)DW4Z-E30T@UJQH*&/RAK0>2ZE>5%L@/XW,O\#
M4$L#!!0    (  M%MU:C-2:_$0,  "X'   9    >&PO=V]R:W-H965T<R]S
M:&5E=#$P+GAM;*V5;6_3,!" _\HI( 32M+PTS=K25FH'""0FJDW !\0'-[DT
M9HX=;&?M_CWG)$T[J:M XD,2V[E[[LT^3[=*WYL"T<*N%-+,O,+::N+[)BVP
M9.9252CI3ZYTR2Q-]<8WE4:6-4JE\*,@2/R2<>G-I\W:2L^GJK:"2UQI,'59
M,OVX1*&V,R_T]@NW?%-8M^#/IQ7;X!W:K]5*T\SO*1DO41JN)&C,9]XBG"QC
M)]\(?..X-4=C<)&LE;IWDT_9S N<0R@PM8[ Z/. URB$ Y$;OSNFUYMTBL?C
M/?U#$SO%LF8&KY7XSC-;S+R1!QGFK!;V5FT_8A?/T/%2)4SSAFTK&U]YD-;&
MJK)3)@]*+MLOVW5Y.%(8!<\H1)U"U/C=&FJ\?,<LFT^UVH)VTD1S@R;41IN<
MX](5Y<YJ^LM)S\X7::IKS.#]CLILT "3&7RQ!6JXKK5&:>$S9VLNN.5HIKXE
MFT[33SO^LN5'S_##"&Z4M(6!]S+#["G )V=[CZ.]Q\OH+/&&Z4L8A!<0!='@
M#&_09V#0\ ;/\%;LD:U%%WF3#B8,_%BLC=6T9WZ>BKDEQJ>)[AQ-3,52G'ET
M4 SJ!_3FKUZ$2?#VC+]Q[V]\COX?*G:6?]K[?S,*-^R7TI *9@S/><K< 32@
M<CJ$+0>/.:KAI!U'''%24N/&.DV2@5P):B)<;N UE[2B:D/ZYLV$#.JTZ'>%
M>T6P]]DP5UW+=O 2AA?!>$3?\"(,DEXBU9AQ"RG3&>1(PG$00AR-CA%,\\[=
M-4K,N34$&2:Q0PWB7K)$<H2DN,$.:\"G[K5U[$JKC68EJ21)X-[DZEZ1_N5H
M7*]CXI">X7 ,,3U/8]%H:TT=S66#R10ABD((QT$OEO$'GB&E!JIV=Y.Q*(D(
M=XB)6C@9,I99=,DA;!B.Z F[NNY+=5R/F)(V.B#^LHJ4;C(_&C?Y3\97<.H4
M^$<]C)*X:3JUVP&UM&T[ZU?[RV#1]L"#>'N3T&;8<-IO G-2#2ZOAA[HMCNW
M$ZNJIB.NE:7^V@P+NM!0.P'ZGRME]Q-GH+\BYW\ 4$L#!!0    (  M%MU9'
M0LO/N04  +$/   9    >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;*U7;6_;
M-A#^*P>O'6S L_5BR5*6!,A+B^5#L2!I-PS#/M 297.52)>DXF2_?G>4+,NM
MXZ;=OI#2B7=\GGL3>;I1^J-9<6[AL2JE.1NLK%V?3*<F6_&*F8E:<XE?"J4K
M9O%5+Z=FK3G+G5)53@//BZ<5$W)P?NIDM_K\5-6V%)+?:C!U53']=,E+M3D;
M^(.MX$XL5Y8$T_/3-5OR>VX_K&\UODT[*[FHN#1"2="\.!M<^">7,UKO%OPF
M^,;TGH&8+)3Z2"\W^=G (T"\Y)DE"PRG!W[%RY(,(8Q/K<U!MR4I]I^WUM\Z
M[LAEP0R_4N7O(K>KLT$R@)P7K"[MG=K\PEL^$=G+5&G<")MF;1@.(*N-556K
MC @J(9N9/;9^Z"DDWC,*0:L0.-S-1@[E-;/L_%2K#6A:C=;HP5%UV@A.2 K*
MO=7X5:">/;^1F:HXO&>/W)Q.+5HD^31KM2\;[> 9;3^ =TK:E8$W,N?YOH$I
M0NGP!%L\E\%1B^^8GD#HCR'P@O"(O;#C%SI[X5?YP;4P6:E,K3G\>;$P5F-&
M_'6(<V-Q=M@B5<F)6;.,GPVP# S7#WQP_N,/?NS]? 3OK,,[.V;]J_%XN?8U
M+[C6/ ?1""T)J8ZH(,"N.$BL>90"+PH4&5 %6%ZME<;JA%R@5'.9H=*"VPWG
MTBEE3.LG(9? *E5+2TK,&([J3.90"K80I; "M;!C0"$DDYE@)6Z,ABTIKFN]
M5H8W"F2RL62@-HB6M':(N\43>+_B+T-K5\S"$FL=M#"HH\"(I12%R!CB=2B4
M=/KYUD5DM\=B3]ZGQ#!W&#$KL9D9& KRB:H-*IG1"6#R9JLN>VD(X/K+/4[@
M(LMTC3+^B,V57/$*_'$4I#B'\6RG@^6??01T!BUCKHWYX]B+((X#N&2$=&$=
M9"$?N+0*7='FI(' AV .[Y5%[Q]B&H[]*$)[7A3NH^PQ/H%;C3\ ;9_<+OQ3
M+=;8DBT, \0['\'0'Z=).FJWH8PZM-6P9W*$).,@P7&8AO$(+NQG?AN[I+A"
MTDP^P0I92@4%S[G&'3 [C&6V25Y"QEQ.85V;)C4Q?S9,YVW"D.N4Y++-%Y3T
M<TNK!^'^+ADFA#!VNZ:)+]G]/,)_<*:;7G<PV#CX<%4C?6G;@GO; J<()Z&/
M<S1./)KGX]DLAGO'!J.0S"#R(TBBN'5FMF<G&*?X-1Z'?@S)./3V,ZNWT3!-
M HQ+Z&-T@GG:;C",G#1(1A &!Y("#6 HHWA&JK,(5_E^NVSGIOW:;-,VC!I2
MZ9SF9!S[H7.]YNC5#(/>Y"VZ]AG75^O:(@C6-*4/D_M)%VT*=>VRFI0PUE3>
MJF^HK2 0YEAAOB1L-WUB",8!V0%H-L?Z#$-'-TXB1S<(H];%?<^,F_PL.B:$
M=<$E+X3%J$008F3F7@*W'(\6E*![+2Q,8XA2\-,$[CC^J41FNVY@5MC!"E9B
MI#%%<WH: <O_QK."J\P K2+&H1]B%']%EVKPPQ3?DXABFX:C[X_K#:[%OR@J
M?UFH%&]LL_]0* \UKAWN;,7TDKL_QQI!/ H\7/'R"5X1]&W87+_9LXEU_)/%
M ^'S^F$2[/0U+QEY#?.%X8NMM:3G'6N++1CJ=5?T';'@8*9.]MD'_SM[#-H6
M_/@(^VT6'7!?VC/P_?3]E]#WOXG]-E&/@,=T_8_T_73VO_#WGN%/3>VY4U%S
M**$S1T^76D9WR-EUDKT.]\7RO1/&RSK7MO,[ \BLM;G@6-?;B@[\B0>O/YN^
ML6_Y\\D,M?QV3' \W+Z"R)GW)H$;(QR_M8T9;%H3WZG3./0FV+=>M_TL<7NC
M+";9$,G0W'2U-UTDZ,Q_1P23:!(2Z<"9P@G!'3JJ3WO7J(ICD=)E$8\5=#IM
M;E2=M+N/7C37L-WRYC*+L5H*/&26O$!5;S*/!G@:=1?$YL6JM;N4+93%*YY[
M7.&=FFM:@-\+I>SVA3;H;NGG_P)02P,$%     @ "T6W5E"^-F77!0  $PX
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M3-P,D/].V+48S-_],#E+/APQ\+0S\/08^O\.Q'&4'V<_L3X2>_?#13HY_]
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M],O[!&Q\4,2)-VVXQ OCZ4D0AC6]P="R 7U?&JJ$?L(.]J^ZQ3]02P,$%
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M>4>2\WYT#YOZ JY]%-Y"/(P37))A//'+).N&0O]P' Y3N'(':?;/-/283_8
MIN/)X&PRQA-D,DVG^\/!.0+L,].EZGF[XD[-_2U%[@;835AO6(0TA I8&5WY
M^#\I9D1[I?+[7B,//\6$"4/-AWZK&UE B96$#ZPH_%_ V?3;LT&G?L7"\*4_
MO5'O5H*UO_9W+_HOP X*%Y1NM[O>785;S:-XN!MBZ-<"_95\A:KQ<#J)P(3[
M5OAPNO9WG*5V>&/RKR5>4;DA 3Q?:9R][0<9Z"Z]BW\!4$L#!!0    (  M%
MMU9:B[X:EA(  (P[   9    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;-U;
M6W/;.++^*RCMU*Q3I<B2;"?>R:7*N<SL3&TVJ3A[YF%K'R 2DC A"2T!6M;^
M^O-U R!!B5+LF=J7?;$E$FCT#=U?-Z"76U-_M6NEG+@OB\J^&JV=V_QP?FZS
MM2JEG9B-JO!F:>I2.GRM5^=V4RN9\Z2R.)]/I\_.2ZFKT>N7_.Q3_?JE:5RA
M*_6I%K8I2UGOWJC";%^-9J/XX+->K1T].'_]<B-7ZE:Y?VP^U?AVWE+)=:DJ
MJTTE:K5\-;J9_?#FDL;S@/_3:FN3SX(D61CSE;[\G+\:38DA5:C,$06)?W?J
MK2H*(@0V_AUHCMHE:6+Z.5+_D66'+ MIU5M3_*ISMWXUNAZ)7"UE4[C/9OM7
M%>2Y(GJ9*2S_%5L_]FH^$EECG2G#9'!0ZLK_E_=!#\F$Z^F1"?,P8<Y\^X68
MRW?2R=<O:[,5-8T&-?K HO)L,*<K,LJMJ_%68YY[_=:4I7;0LK-"5KEX:RJG
MJY6J,JWLRW.')6C@>1;(O?'DYD?(S>;B RBLK7A?Y2KO$S@';RV#\\C@F_E)
MBA]D/1$7L[&83^<7)^A=M )?,+V+WR.P>*=M5AC;U$K\\V9A70VO^=>0&OPB
ME\.+T$[ZP6YDIEZ-L%6LJN_4Z/7W?YH]F[XX(<)E*\+E*>J/M]D?("?^IE:R
M$!^D<ZKV[S]C;X.$^%2;3*D<0ZWXLE:85VYDM1-K:855SA4J%QF>%0@-(.W6
MTN%=+A9*56*IZ?56N[6XD[4V#>8XZ93]_D_7\]GS%V*SEMATV4XLC*QS*W0%
M"DILI'436@X6RF0%8J(R0EJ83%89^"UEKOQ:!N/K0!4K%05&.D&"E!LGG!%.
M?E7"ZE(7LN;P8"I(N *[UO%B4:*P]K)Q<(Q)3UA96(/W3E7@$33O],K4D*;8
M46S 4Z%)]IJX,N &KJ S!2X1=$_(X25(>6 !,,HV&<2TRZ8@MC:U<13?JM7)
M=;P1,V,QIE8%-)*S D!?+LP=C0OV!3OJ'A'?8H0DK6=-7:M\(GZL32D<XC%/
MQ/]QC[U2[H@[7=V9X@YSP1OYBFT6OX$_FI-KNVG(%/2\8(8VG0>-:;4M@C/]
MSY%XH,^QR. [I9_AUL@Y4#-H%]KIE>2@SFJ"_U@5C61JT$-Z@;1-C<=FR9I9
M-!8^:[W.\3A9FGF'H$4#W<F"6/.NX(4AW<;9F$9^ @.,\799TS:AC<.KP D*
M2C:-EVRC:K<;"SA;879^4!U\,FC;>Q+2A\8#<-HX;!?FF#2ZKR*A+5Y! Z*!
M@]0.;LHF^&,.-+32F!7>5$MY9VJY*%K6+"FUR+&+X3)25*PI?-18 4:&/:!S
M.)B%3,2L("4$91+))2R#J,*N6.6:7DS$SY2:,YB-V>:(<'/[5GPQ&YV)RZOI
MT_E4G(W$WPS4WP]-HR=]'ZP5D<%2\!"YT' 3WKID_FYEC@<^V '2T'S;N?]V
M#?5B.JT%=7^MS+8BLX%=JW.H.B<U+5@GWBGQOS0-C!ML ">UIL* G5#6&S;O
M1XQ:W1&TX+G$3,.:4C);(Q:M*KW4(.4"2_XYZ:=AR044J@UO39E[#4JRHT=G
MM"-:MHD_F?_66.?78J' _9UF0.5%W9"CUAI<PA#PN[@LJ"S@JYVTV,#>KNPT
MB8+[:F!9>*43^NA;+3[V+I+[!*P\SQM0TK0\DX0AX-LKU:X10IBZ=[2]*D5^
M35L?STN*[1RTARQ/B:#4M@"*A5)9]%9%VK_NV1G"T+.C\O0\SL_WSN@C82)N
M2&_#'CD1/V%7D[<E7DXAN4>0/*$@FCM^!XX*_1_RLB-1OMOBWX[RM[+ DE_D
MO?A8B5\:9/DY0Z_9M3?:/RI-5&]]4KUM@&Y*DJVIB<'*;Q&) )YY+X,TMP@>
M:_%.?C5.BKN)^%7NEE+78VS\;#(6:U-P=/.1W"N#(W*M_MWHFN(,UD"60TY#
M>*U]A$"HVZQW%EN% A>V,,6.H&E/ H(#&U,\9@N"AG;"LG@.XH&WE3&Y=[J0
M+</VR+W:-DV= <J0OE+"8X%\60,(5,1U",30IK:\/S-6!5C*5 Z33@Z0D;J3
M1<.FH;@4> 5# $2<C%@\2+0):9,6#BKKU,H^22:K7+&+<MI.4$L[NX!VR(%;
MH15+@@PG?FN0,G.=Q3R':* 19[1C%N6 ;K'W-&V 0JL[T/F[ND?<8JGAM>^:
MVIM0B9T"EB)'R($9H< 6NA^$:J4))R!*(&=AWW*&I(C<LON"RRWX^X83O;9[
M<:-5)#V-(+(O&=%+XB1\WF-[KZBPGR2Y:48;FR/+=\\GUP@.14&*)@(;0^&%
M=VKK/I%2W[X!1.3BN\O)M*41O&=TDV5U@Y=AYWES>4 0;-E&$>S[D2"<#J6K
MD@=^=Y&P%4E^Y-F%J59/L;'+8_/;$%194^B<E?9&%IQP;ZETM!0%('O?9-X7
M&50MEX3HR<B!>U8?LM5_N@@W^@GHK(::?.9!L:JI@"*$D#)#1(<8NNW",SA!
M<" L%%+T<;>:B/<=P+I9U2J00/CZ@" RO^9A,^\Z;ZB4(.KO$%@R9VH.U<BX
M1-9'+RMNON9R)<XH4,^G+SZ@^N0G_'WV I"#<BVT_O;]1_&]+#<O4 @I0@>5
MCS21]G@ @C%ZHF#.*0N+IM0Y+21P449I.CL$0N,VZPX/YV48&H)717JC>/=+
M@UAQ,8T*T8>XBX-<ME9Y0\493<L9F/KLV"X G2^7BMLI@>CL&UI&-#*$C^%V
M=4-.-T$5B<"R* RJBE37W>-.X8/I,QAAK=52_-CFTH]+P"=5<S7Q,Q:L=1G&
MO+]76<,LAS&LP\YT0<A6PS[+2@)<*$9H1 #.! >9HFHIFD!Q*Q-1)Z(O3S_F
M=4$IDQ;(S^D-FPGQ9S8%)XAEC)B#_R?C*3<0'(T;G6(W17G*8=B?CQ5\'&*_
MWUQPDYMF!<S8.LJD10*SGI7; CAU8Y0[M#;'!$(>O$ENU4;Z*J#;H#PMQHO/
MJN#@&T,,A(8SQM0:00LC&DXS$?5M="!+D>O43MK?/^*,O@2O&V(O^IX/[X,"
M=%"!=OFCEA^GH(.A?-6ZD,? ?M\<^&38V/!(.+Q3(6CW]O4)CKE5D9NLH6]J
M*/AT(82$&HO<YW6D7H(5,$92@5#-THF(ZMPTJ_5^C $KGF</:1N&94%S3!95
M:,%-!3)RY4MZ;]ZVY)9+PCYV3QD> AE?8*H#%;<B#00CXY,/4A-V45R2JMGM
ML8W]>#<(8B^H8:7Q<FM$T92;I[8I87@ 2 ZZ&[EK$]YW%_.K;M]3V3?NI%I"
M 1R UG$.\1RH>W>BV.._=7MXUAHBY@NKJ/(^/?D=XE2Y@"]V83UIXY#5N*NG
M^WF#O-(&JX3:GN6B\8YJS18B#^6LCL,A+7.30-T#CE/U%V/BOJD3[TWJOT-M
MCQ,SK? J0LC6L]@K*=Y$2!C]C:!S:$GY;J:O5'P[9*!O*$/[#RZ,8-W6N+$V
M@Z 4P'T+) 1XSER27T6/'])(/P9#X_"0,GHAO;IX/KZ>3BE9N!IH&*_L6A*\
M62ORR]V JP970/@>1^&1@&K.7)Y*+#U@@:72U SM<,6L[VI#R&<<HAL^9%1$
M>;\!FB8GBG6@612Z:\"1:%4XP&%7XSV0F"9(]0TV)RA<\[#@L#H[=; ;Y:V!
M#^,7>__.LT/>G=1^,$/N:P5-O;_*5$\)X&;:R6#<*N>G1$,1M.JD]2^YS5PS
MK$\9\6@DU?2\%UT[CF+:#-D-!6:5@[VB"#F-50^XY XS:C 69_P00>97#T9V
M'R2&;,7?)^*O@(_.B;,1*=5_B0F5O/OWX#&__6AGE#XVA=>'',4&;V"L.]8X
M#I>IA:I:1.N3ZAX*$CX%#,[7H<ZDLDQSG<BU&'.(,>+LX@G7+QPW2^KJD)L?
M "V_^ZA)*QMGJ)N' KR@4IDR$U?&'H!R8@(>.YMYNC[TCJE$IU%4#4)!/DUS
M85<VU),&J>!17% C!/CS%(Y!A'<+RK9'M<2.3NT .MK(** 65"2 #+88N6MG
M;-$/T,+J>P?,]6SZ!/7$CKHLFD8$&.=1+X<"2A.Q%":A6"9J>],"6VKRM]B'
MO:%-OJ&>3"J4H]8*<VR7L /3K/J T1FB5Q5U\A>,3%$LUSM.TU?3#I[W$J-7
MN,Y"@Y=M$?L*MLN3W'*] ^&C'CSN/ %)6B% Z-"!96-E>D.(I^M)53E1\,+"
MW1;PEZ6&H*COK5AYC$W&OY.ZB+W<%N+XO1$G[Z.L<6AI, I4LH ,2'+^A&&,
MFGZI8M.VZ[>WK]/<XTSV%2X68_!^ZJ96G]MQ'%.5]<&9^#^S*/\NI[.SKT_X
MNU>-AU2:CTJ6W9,UMQ)V]H3Q&0+W/>#@B*16NESPT5'B'&1,BO4)?&X!:MO/
MB6W4H;S%B:)C:8,%&EFYO=#[9]L9M.6#)\2VRX;2B0^'[5G4"8$I;Q$N:=-"
M3;<4;*R8@G0Q/$8]$%-MD=$/XGNU3>H@<8KNHDLD2.H+">FM;*R*N8C/^I:Z
MZK;P"7#8)[]GG$#])X/2Y#/WZ!^W1MN6VJKBCF+K_(DH_4T& H!(6HP],8+.
MH&I3/)#N)&44/L >2!"!C\>AZ!X^I8U ^<,<X6/ %C%>IG&*MS09FD[:SV;7
M*8G];1SC1=OE!C\^_3)R/VY34IAIG&"#<J0^;:'$-(]6MO=P:F:M#+E:I[26
M>SK3:"N/F.2&?-='/M\UD"F43 Z;]PN<=O=$A'FG.ASUH.W'-WG(-H3^\NZ6
M202$*4SL3NEL>BHN^UD_A9%+4Q1F&WOPJ1T.>W<?#Y#'N!<+R$%[K:IM2%!_
MF8ZG2'X!<>/!(P+\?#I[%CJU2%&?.)3[OI.?F4#W<%>CD!M_3"\ UDET?Q1Z
M ,V @_L/+GRXZ#^\C,N1FR1).ZED]MU_3XN)?<]0BJJ-&T(@!RII%?]D\C M
M7\WVU0Q@P<>[Y(TG5/Y[51S;(6M=$R<5.*IM0#OT(K: N50.1S*8<Z8!YJE?
MXKN."SAP0X=TO!80'IA=-W5>!.RCXRI0QU/VW]!'XLKM8!UOPS.-16+IE0_U
MFQC")OKIFE,>>WO<?6R-(RWP;C?%9O@/XOHJM4K #5Y8+V:0F2#BY93X\&/'
M8C9]_HBI5_VISQX^]6KZV E77LN/FO1L.A&WZW".475G Z?L#Q1;*A>[B8]S
M@\I$OGRI"\2*#7B8>T]NDG03?O278TZRS(F:?9L.][5KP7AR#X1:8=3W(<F^
M08Z@\$JR+EJ G8YZU [TV>84\VWK<8!;OGM'+.M@-\JC2+64CMCA4[;Z%;AF
MUZ!"EV^,?4N%7!(G^[&"M:@*_,N4M[2-U3]=6:.5/7(/%S%Z)O\#>G=T28*-
M9RJ40.P\I[2]YWQ)HAA"7O^MP'0JP3S8SV\&#G3'O3U[DA2IBF^V6+YKD0P=
MC/#40H%%PF$15#V[C-GYFXVCM^N:&VB*<!\U=RRUCN ,\>OHB0?*M>_.#.&+
M(^> OG#PU^)*[[-YPX=FE%<1CJB8+I*[..DQ3/<^N7\5!W3]H@@TO+SM869W
M1/H.MNT?*+57&'J'97P(1,?YBJ]@<3I*U>"5X$YVV]/Q\29MBDR/:ZJ_VR?]
ME1_8&[EXGAQAA#L6 >$0=GW*-3M=<GM*%8*IFK;H")?H?!X[TE^)4+!6\0Q$
M+_<4%(O6TZ=_"1[Q!RNA#NE*D&[VGB)2R!:[?:%YX1'<*3SFPY@-?N015(+\
M9A><A@]:]@D6\B..;=PPVH.^DX/:A-;".3:"HV(EWF=-"62UIB-EZ>M3:C7[
M\I*",Y1'-PGYIB$>O'_S\Y=W-\'ZP-)-[*AZ=5NZ573B-L>7+OI3!F',[X-B
M9/GXT41DCL\6Y%[WM8W 0=;#-.N7R?F.5^)W#]1,<*@L%).G BR+QZ<^^UVB
MPQL0'-V2H\KVJEJX76TA-%].Z$XU6"\GCY^[YO,\1*VA$_WDZL+^J?Z/'\67
MCB>:,'@XRL?LHU,'[+U&F'?<@UL3=/#L$R"?/89^Q\;$U2WSLX=68A[F([BV
M1=67>AQ.B4[4SK1BN*3KUQGO\]>A@#1'85^W#=E]SKH3\"&[]AN"K1S<?(R7
M<3H> 4KZC<7V&L?^*2XR4VJ)?E+ZE:^0[$G&PN2GI>%#J)X*8I9(;;7?F^J:
M-I:/GND"):?+1QVT)ZP^_K1]=CW_?:?M,8#L(Y!*W3L:7L.=O*7ZCK6G^_ZY
MN_A%(J%".[.+M(<Q>&+_< :LOG\:<MHW>/D?/-]/O.-_]I ?WC('Y#I]R)\H
MXB0X80S_F'/_@P@S?M I^T!^:UUG^&B<MPG23Y.%"^UI-7700IX,_<+N//F%
M9*GJ%?\.E'_.4CG_8\GV:?M3TQO_"\MNN/^=*A#+BEJZA5IBZG3R_&KD3U7B
M%V<V_'O+A7'.E/QQK2040P/P?FF,BU]H@?8'N*__'U!+ P04    "  +1;=6
MP%'G?,4#  !I"   &0   'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6R=5MMN
MVT80_94!FQ8MH(H2)2>.*PF0G 3U0P##;M*'H@\K<DANO>0RNTO)^ON>75*4
M'-A&T0=)>YDY<^:VH\5>FP=;,CMZK%1MEU'I7',5QS8MN1)VK!NN<9-K4PF'
MK2EBVQ@665"J5)Q,)F_C2L@Z6BW"V:U9+73KE*SYUI!MJTJ8PX:5WB^C:70\
MN)-%Z?Q!O%HTHN![=E^:6X-=/*!DLN+:2EV3X7P9K:=7F[F7#P)?)>_MV9J\
M)UNM'_SF)EM&$T^(%:?.(PC\[/B:E?) H/&MQXP&DU[Q?'U$_Q1\AR];8?E:
MJS]EYLIE=!E1QKEHE;O3^]^Y]^?"XZ5:V?!-^TYV!HMI:YVN>F7L*UEWO^*Q
MC\.9PN7D!86D5T@"[\Y08/E!.+%:&+TGXZ6!YA?!U: -<K+V2;EW!K<2>F[U
ML6J4/C#3AFO.I:-;)>I%[ #M!>*TA]ET,,D+,-.$/NO:E98^UAEG3P%B<!J(
M)4=BF^15Q,_"C&DV'5$R26:OX,T&1V<!;_8"WAT[:1CEY(ZN6OIKO;7.H##^
M?L[C#F_^/)YOEBO;B)27$;K!LMEQM/KIA^G;R6^OL)T/;.>OH?_WM/P/&/JC
M9+K652/J _F^=?A8$C2?3']^^(7NQ4[6A>UDT?;$2A9RJYBXA[/C@-%X >DU
MT0:PG%&*&C!RVX:&"]>N%"[(9"A>:1T;B&T/.!\XC&FM%!J\:)4P(\I;I7YU
M:/R3.1*&3RP\I9U6+7B; S7".)G*1@2;;8.O%+@*Z:X+TC73@84AG9//D4R9
M1)U1&7PDX;SO8.3IX WR8LGTS+O&Z)W,P, ;+9!$5Y*LR?8A<J71;5$^\=L&
M [(&"W UNL)ZQ];YTD/@;D(X;+O]!^\2.1U,!S,V*(.!/QDR=U:W-QWF/:>M
MD>Y :P! ?/K^W9Q&)& 88NB^<9>Z(3*P&R(H%)Y@[ZP^$<8IV893F4O<-&Q2
M6.HC 1ZR>_/@,')S&']7.@XCPM)T,OGQ2#N7QCJ:#_M3"L]#U.$$?9^%)U6#
MX.2M]\+'R/*WUGO>ARD5"@XBFSZE8_J ,$"]LVMQ&<XMA2 0'I"T'%Z0\)V,
M0FZPPNE9!:+X4FV\TIOD\CUN=&LA.,)V=GFV]<IODOG%V1%:O^$P6=1AY+WN
MF^AYYSS L1-,5['\B/F*",/% DUJX,7W4CL^2MGQ<V]+?/;\5VR*,.1\Q-$B
MW2083H<YNN[&QTF\&\((6N$? \4Y5"?C=Q<1F6ZP=1NGFS!,MMIA-(5EB?\"
M;+P [G.MW7'C#0S_+E;_ E!+ P04    "  +1;=6#J,2974#  #(!P  &0
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MB2 6,V=;<+R:V+@10XUH$J<,'\IM<#2K"!<6U\I8I\(]7)F #GV@QHY^Y'L
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MV@#GO>;S%N$J+[AW<,KVOGIRZV,5='S'4;G$ZEW=*<E-?MEYV&UB?]Z\#H9
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M49@M?]PHB;Q( _!^94Q1?:$%ZE^KO?P_4$L#!!0    (  M%MU8,@"'$HP,
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M+?[ID,9OP/=KK=UQX@.,?V,6_P)02P,$%     @ "T6W5G]]]PKF @  1@8
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M:/<+NSHVBCQ(*FUDT8!)0<'+^LE>FO=P!+@.S@#"!A ZW74BIW+.#(O'2NY
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MA@X7A"DWFHE8=T?P6)2YW"'" U<TDE+!7)H,%CD3VN9T,A"M$FT(A(OT7=
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M[=^4Z]!*_XJ'!XE2:"<H.RO<DBH;7TPCT*')AX55C6^L&V6I3?MI2>\B:B=
MYUNE[&'A#/0O[>H/4$L#!!0    (  M%MU8]"?N45P@  +5"   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(Y+GAM;+6<76_;.!J%_PKA'0Q:(%M;E"P[G<1
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MP#]?QC%[/\B^H'S@9/(_4$L#!!0    (  M%MU:&0Y^%R ,  +\3   9
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M+@4HG$V<$_\X'EG[VN ;QZ5>6X-E,I7RUFXNTHGCV80PQ\18!$9_"SS#/+=
ME,;O%:;3AK2.Z^L']/.:.W&9,HUG,O_.4Y--G)$#*<Y8E9MKN?R *SY]BY?(
M7->_L&QL!YX#2:6-+%;.E$'!1?//[E8ZK#GX@R<<@I5#L.W0>\(A7#F$SW7H
MK1QZM3(-E5J'F!D6C95<@K+6A&87M9BU-]'GPE[[C5'TE).?B2Y$(@N$+^P.
M-;R!3TPI9F\"#F(TC.?ZD$Z_WL1P\/(07@(7\"63E68BU6/74 (6QDU6P4Z;
M8,$3P?P +J4PF8;W(L5T$\"ES-OT@X?T3X.=B)=,'4'HOX; "\*.A,Z>[QYT
MN,?/=_=WL G;RPAKO/ )O,\E6O7%'#Y*K>&,+N.>*GO)5*KAQT>RA@N#A?[9
M)7T#W>N&MMWC6)<LP8E#[4&C6J 3O7KA#[QW7;+M$RS>$]B&I+U6TMXN].@:
MM5$\,9@"U5)R"SJ3RLQ8GL/!DHO4K@Z!I;^HU*B;F2YEFPC#.H)MHXLH\$9C
M=[$NV&.;,-PTB1^;O/'#?FNT0:_?TNOOI/>97@E#;1B2C*DY5>T4!<ZX.01Z
M;Z@MFTH),!)*)1>\;M5&50A5V<6S"358YS *MGCV'Y,(WFX1[;#QW_:ZB0Y:
MHH.=1&/J4MKPQ'8J.*D,W2(W]_#C$HLIJLZ"V GXKP6Q3[!X3V ;0@Y;(8?_
MK\<,]RGI/L'B/8%M2#IJ)1WM?#?/,25-<Q TI<E6WMS*FZS+VZ7HZ%&M>%L5
MMS/VO\JT)[!&)G=M["B0VH\=WXBSK(1I/N'M:3LAGM2#T=;Y*4V.S:#W%Z89
M.^D+.^="0XXS@O2.AM1;5#/*-1LCRWJXF4I#HU*]S&CZ164-Z/E,2O.PL0':
M>3KZ U!+ P04    "  +1;=6JS<;SD\#  !'#   &0   'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6RM5UUOTS 4_2M60 @D6.)\=[216 ."!Z2);?#L-;=M
MM,0.MMN.?X_M9%F;CZZ:^M+&SCDGY]X;W]Y.=XP_B#6 1(]E0<7,6DM97=JV
M6*RA).*"54#5G27C)9%JR5>VJ#B0S)#*PG8=)[1+DE,KF9J]:YY,V486.85K
MCL2F+ G_=P4%V\TL;#UM_,I7:ZDW[&1:D17<@+RKKKE:V:U*EI= 1<XHXK"<
M65_P98H-P2!^Y[ 3>]=(AW+/V(->_,AFEJ,=00$+J26(^MK"'(I"*RD??QM1
MJWVF)NY?/ZE_,\&K8.Z)@#DK_N297,^LV$(9+,FFD+_8[CLT 05:;\$*83[1
MKL$Z%EILA&1E0U8.RIS6W^2Q2<0> 8<C!+<AN%V"/T+P&H)W*L%O"+[)3!V*
MR4-*)$FFG.T0UVBEIB],,@U;A9]37?<;R=7=7/%D\H,N6 GHECR"0)_0G)45
MHT"E0&R)GF^B:\ZVN2GV^Q0DR0OQ0<'O;E+T_NT']!;E%-VNV480FHFI+94S
MK6\O&A=7M0MWQ 5VT4]&Y5J@KS2#[%# 5B&U<;E/<5VY1Q5_$GZ!//P1N8[K
M#1B:GTYW!^CIZ71\)!JOK9)G]+P1O?F&<U44)'69AM);T_UANNX=EZ(B"YA9
MJCD(X%NPDG=O<.A\'DK-.<72,XD=I,UOT^8?4T^^00:<%$,)JXF1(>K>N$UP
M[*E2;?<3T0<%L=,!I7U0Y/MA"SHP'K3&@Z/&;R21,&2[IH7[MIW8[]CN@P(<
M=%SW,7$P8CIL38='3=\R20K5LUYX5</>D]U)U]Z\#PH]''9BZ(-BSW&'@XC:
M(**C)RV%):@ LG'_T3F/VCG%TC.)'>0M;O,6O_:HQ;TR?9K$;J?@ R /1YV"
M]T%N-!FN]Z3U/7G=29OT#04]UP,@-^Z8[F.\D7<4.\\_VLX)1RU[\5UM9 X,
MXB#L-HPAF.=W6\8 RL-X))2]^0.?$$K5CA=JE%7#A)D[QL/"_>[M!=WN/8 *
M)E&W?0^@XA![G;#LO0FK!+XRDZI "[:ALAY*VMUV&OYB9L#._I6>DLWD]BQ3
MC]AJ9ECE5* "EDK2N8A4B^;UU%HO)*O,''?/I)H*S>5:3?K -4#=7S(FGQ;Z
M >U_A^0_4$L#!!0    (  M%MU:E8?-9=@,  , *   9    >&PO=V]R:W-H
M965T<R]S:&5E=#,V+GAM;*U6T7*C-A3]%0W=Z20S&V/ !I/:GDE,=[H/._7$
M2?O0Z8,,%Z,&)%>2[>S?]PHPL0&[>=@7&XES#O=<Z4IW>A#R564 FKP5.5<S
M*]-Z>V_;*LZ@H&H@ML#Q32ID034.Y<966PDT*4E%;KO#H6\7E'%K/BWGEG(^
M%3N=,PY+2=2N**C\_@BY.,PLQSI./+%-ILV$/9]NZ096H%^V2XDCNU%)6 %<
M,<&)A'1F/3CW46CP)> /!@=U\DR,D[40KV;P-9E90Q,0Y!!KHT#Q;P\+R',C
MA&'\6VM:S2<-\?3YJ/ZE](Y>UE3!0N1_LD1G,VMBD012NLOUDSC\!K6?L=&+
M1:[*7W*HL4.+Q#NE15&3,8*"\>J?OM5Y."$X_@6"6Q/<-F%T@>#5!.^CA%%-
M&)69J:R4>8BHIO.I% <B#1K5S$.9S)*-]ADWR[[2$M\RY.GY5QZ+ L@S?0-%
M[L@3Q(+'+&>T7!61DG< 64JQ9^5ZWT2@*<O5+5)>5A&Y^71+/A'&R7,F=HKR
M1$UMC=&9;]AQ'<EC%8E[(1+')=\$UYDBO_($DG,!&VTUWMRCMT?WJN(W*@?$
M<SX3=^AZ/0$M/DYW>^C1Q^G.%3=>LU)>J>?][TJ1B*DX%VHG@?SUL%9:8O7\
MW9?Q2G'4KVA.E'NUI3',+#PR%,@]6/.??W+\X2]]V?J18M$/$CO+Y*C)Y.B:
M^C&3NMSS5).7P6I E*9ZIX7\3B35T+M_*]6@5#7'Z7[N>;BO]J=)ZF+&_F1\
M#HJZH(GKO8/.3(T;4^.KIE88/V )OEO[3#A>&UC"*20@:6YFR1HXI$SWV:OT
M_9.HW* 5^:*+\8*PY:Z+"8:3?G-^8\Z_:FX)>,1SX)HD+$U! H_[E\COQA?Z
M+0]=S+AMH0MQP@L6@L9"<-7"$V"=LEA#@EM-Q*]$94+JE.8YN3DPGIBG6T*3
M?_#,QVNU=X6"[@J=9+9RU\6T]VC4A=PYE[;?I+$WN6KO=YV![(MYTDVEUTKW
MHHNY<SI%TP/R0J\_ZK").KP:];/06!?;YE[#-NJLA/H,A9WBQ>0Y+4==T#@,
M6J"H"YKX3MN1?7*W%R W98^D2"QV7%=783/;M&$/9??1FG_$]JSJIMYEJMX.
M;ZH-XXKDD*+D<!!@!<NJ7ZH&6FS+#F(M-/8CY6.&+29( \#WJ1#Z.# ?:)K6
M^7]02P,$%     @ "T6W5D,]?P%I P  (0L  !D   !X;"]W;W)K<VAE971S
M+W-H965T,S<N>&ULK99-<]LV$(;_"H:9=.R91/R2*,F5.&-;\22'3#URVAXZ
M/4#D4D1- @H 6>Z_[P*D68F!:!_B@P6 NR_V67SMXB#DHRH!-'FN*ZZ67JGU
M[LKW559"3=5([(#CET+(FFKLRJVO=A)H;IWJRH^"(/%KRKB7+NS8O4P78J\K
MQN%>$K6O:RK_O8%*')9>Z+T,K-FVU&; 3Q<[NH4'T+_O[B7V_$XE9S5PQ00G
M$HJE=QU>K>;&WAK\P>"@CMK$D&R$>#2=+_G2"TQ 4$&FC0+%GR>XA:HR0AC&
M]U;3ZZ8TCL?M%_4[RXXL&ZK@5E1_LER72V_FD1P*NJ_T6AP^0\LS,7J9J)3]
M3PZ-;8+&V5YI4;?.&$'->/-+G]L\'#F$R1F'J'6(^@[C,PYQZQ"_U6'<.HQM
M9AH4FX<5U31=2'$@TEBCFFG89%IOQ&?<+/N#EOB5H9].O_!,U$"^T6=0Y"-9
M0R9XQBI&[:J(@GP3FE;D4U& 72%C2=94 [E8@::L4I<+7V,@1L[/VDEOFDFC
M,Y.&$?DJN"X5^<1SR$\%?"3H,*(7C)MH4/$KE2,2AQ](%$2Q(Z#;M[M'#O?5
MV]W# 9JX6Y38ZL6O+@I9,9550NTED+^N-TI+/"A_NS+>*([=BN;RN%([FL'2
MP]M!@7P"+_WE79@$O[JR]3/%5C])["23XRZ3XR'U] YRD+A_I=FQN*%9D]D-
MX(4)1-M=?T$5H60',@.NG;NYF2,,["3F(GU*@Y%9Z:?CI+W):O6:U0GFI,.<
M#&(^:,/7PEFJ#X3CFX'GMV@S@*.(S:%@VH78Z(?A25CA=-QC=)H%8<]L=<9L
MYJ9,.LIDD/(>\*+GN$@D9W@?2> 9*!=,XLSQI,>2.(,,HA[+&;.)FV7:L4P'
M6=: 9YEE&G*"=WSV2%0II"YH59&+ ^.Y:5T2FO^#3P"^LMK).74N6MS?F$ZS
M(.COS.& +X)1'+R_'#B3LPY]-JCTFRY!NG!FSCAGT_G)7P]N>"Z,.ODAZ@;W
M%<<0,S2(.^]PYX-*YQY05P;FK@S,)G&/V6D6_7#5S)W'(.IM7/^H>*A!;FT1
MID@F]EPW#W WVM5YU[:\Z8W?8/W7E&O_RS3%([Z/6\85J:! R6 TQ?M!-@59
MT]%B9TN4C=!8\-AFB34L2&. WPLA]$O'3-!5Q>E_4$L#!!0    (  M%MU;
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M-I\6L'$[3"TFMWR/-^1N(%<+3MB!#%8__F!-S5_:/ ()<R!A+B3,@X3YD+
M"-8PWK@RWEA'7]W+A9@P1D+$E?-NJEF3\TP6OI8S9E'RILV'!7N:L]4>Y+"R
M)Z;\61J'NL/.PT9G04Z7(%?;F;Z.@(3YD+  "-9PQ*1RQ*2?(_:8H0..,Y*[
M(:1QC!E'>\(*9[0:HZAB7AM,<VB:UHDO.D4YG:)<;:?Z.@,2YD/" B!8PQG3
MRAG3_S%72*.P:$..QNAAEZ+>66V(QR=6T;:L[R(%"7,A81XDS(>$!4"PAO%F
ME?%F6N,5FR)E,YQ*AVTH%ZW;]]F9C2S+/C&2MJ:^1H*$N9 P#Q+F0\("(%C#
M2//*2'.MD=8T/1 FHL=8SE/ZG4^VIZETFHK/LR!7=D)%O99=G\*&YN3$?-K6
M]34?),R%A'F0,!\2%@#!&N9;5.9;]%L^X^AK%H4XSY 5;B1J>NN^;"ZN+IM7
M(YRK$:ZV5WVM 0GS(6$!$*QA#<L\)KG,_[2WHIG@ J=AE&ZO34'Z&OIF!4K:
ME0]MG:)<T)9YH#0?E!9 T9HNJJ5*K0X;)4;V&=OL,%>+'-TRG-P@G(D=9=$_
MTF XH5DJ6AVDI?=VD-6R'3O/#CB@M;J@- ^4YH/2 BA:TVOVT6NVWFOY9[RC
MU_C5^4G+Z^TN^VSF.3/6U1 7M$T>*,T'I050M*9;COEM2YO%U,Q,C*@O,-7Z
M5INC:H&:Z0HT#5[2ZM.5/9^=SU:@&6Y0F@=*\T%I 12MZ;]CFMNZDN>NLE)A
M=(A"DH8]]MEZ=F^C0=(<4)I;TA:-9.NH^2_@=0GRNP0%5X*:8WU,8%OZ#';]
M4_YQ7YW/0*VC"YF@78/2'%":"TKS0&D^*"V HC4=>$R46U/(KW,MR$SM&I3F
M@-)<4)H'2O-!:0$4K>G 8\;<TJ?,(?()D&G?=4D[_:[X='?5)<H%;9D'2O-!
M:0$4K7"143N%E1"VS4_D<;11&^SBT%%56IWZ>YN?=3LI7UNW3G%V[X@ICA)^
MP&P;I1S%Y$DBS>%,3L2L.)U7W BZS\]Z/5(A:))?[@@."5,!\OD3I>+E1E50
MG9%<_0M02P,$%     @ "T6W5A60L/:B @  U <  !D   !X;"]W;W)K<VAE
M971S+W-H965T,SDN>&ULK95=;YLP%(;_BL6JK96Z0( D:Y<@M275-JE3U+3;
MQ;0+!TZ"58.9;9+VW^_84)1&),I%;\ ?YWDY'_AXO!'R264 FCSGO% 3)].Z
MO'1=E6204]43)12XLQ0RIQJG<N6J4@)-+91SU_>\H9M35CC1V*[-9#06E>:L
M@)DDJLIS*E^N@8O-Q.D[KPOW;)5IL^!&XY*N8 [ZL9Q)G+FM2LIR*!03!9&P
MG#A7_<MI:.RMP2\&&[4U)B:2A1!/9O(]G3B><0@X)-HH4'RMX08X-T+HQK]&
MTVD_:<#M\:OZK8T=8UE0!3>"_V:ISB;.%X>DL*05U_=B\PV:> 9&+Q%<V2?9
M-+:>0Y)*:9$W,'J0LZ)^T^<F#UM /]P#^ W@'PL$#1 <"X0-$.X"P1Y@T  V
M=+>.W28NIII&8RDV1!IK5#,#FWU+8[Y88?Z3N9:XRY#3T3RC$C+!4Y"?%)G^
MJYA^(9])# G'C93$;,U2*%)%3F/0E'%UAMN/\YB<GIR1$^(29104805Y+)A6
MY[B(XX=,5(HB-W8UNFD^YB:-2]>U2_X>EVYAT2/>\)SXGA]TX#>'\9]BC?C(
MXGX''A_&?U2\1_S!7GQZ&+^C+\2[Z*)=K$Q;'K\MCV_E@CUR34'^7"V4EGBH
M_G:ELY8(NR5,H[E4)4U@XF G42#7X$0?/_2'WM>NY+ZG6/R>8M-W$GM3AZ"M
M0W!(/9J!)/:HM >"G.)?G@J.QT21$K?M.3CKJD\M?6&E3=]>1UX/?^SU=MJ/
ML(F/L)D>MGD3>]C&'AZ,_4%HRLE5+JI"=X57TZ.M3PX#?[ 37Z?1;H#'&$T[
MC/R+T4Z([E9'-/?='94K5BC"88F8UQMA%Y7U'5)/M"AMDUP(C2W7#C.\=D$:
M ]Q?"J%?)Z;OMA=Y]!]02P,$%     @ "T6W5C]DX-DM#0   \$  !D   !X
M;"]W;W)K<VAE971S+W-H965T-# N>&ULQ=U=<]I6 L;QKZ)A.SO)C!.0Q(O)
MVIY)K'<I;29IMA>=O9#A8#0!R96$'>_TPZ\$&"&0#[#]I[YI;:+SDX1YK"/T
M&%T\).FW;"I$KGR?S^+LLC7-\[MW[78VFHIYF+U-[D1<_,LD2>=A7GR;WK:S
MNU2$X^6@^:RM=3K]]CR,XM;5Q?*Q3^G51;+(9U$L/J5*MIC/P_3Q@Y@E#Y<M
MM?7TP.?H=IJ7#[2O+N["6_%%Y%_O/J7%=^V-,H[F(LZB)%92,;ELO5??!;WE
M@.42_X[$0[;UM5+NRDV2?"N_<<>7K4ZY16(F1GE)A,7_[L6UF,U*J=B./]9H
M:[/.<N#VUT^ZM=SY8F=NPDQ<)[/?HG$^O6R=MY2QF(2+6?XY>7#$>H=ZI3=*
M9MGRO\K#>ME.2QDMLCR9KP<76S"/XM7_P^_K)V)K@-I]9H"V'J =.T!?#]"/
M'=!=#^CN#N@],Z"W'M [=@W]]8#^L0,&ZP&#8P><KP><[PS0]&<&#-<#AKL#
MGMMIM?/TD^L<NU'JYH=]]$];??IQJ\N?=WOUPEJ^*HTP#Z\NTN1!2<OE"Z_\
M8OG27HXO7HQ17*;P2YX6_QH5X_*KSR++TVB4B['R)4]&WY0WRL]AFH9E-I17
MALC#:):]+A[]^L507OWT6OE):2O9-$Q%ID2Q\C6.\NRL>+#X^M=ILLC">)Q=
MM/-BRTJ_/5IOA;G:"NV9K5"5CTF<3S/%C,=BW##>/3!>DP#MXBG9/"_:T_/R
M09.*EKAYJW3T,T7K:'K#!EW+A[]?W&Z&:PW#C2.&ZYWE<+7IZ3QFN/KLVBWY
M<&\QDPZWCU][T\8[1Z]=[36]%.3#/X;I9NU-/SCO^.%-^^X?/[QIWX/C][TO
M>17KFW3K2T]_QOM2!O7-A^(H-5:NDWEQZ,["Y<'O?1'Q^%84A]-<N7E4MI?[
M%#XN'W[_$*9CY?>@(!4W%_/L/PW[\V&U_F[S^LLIQ+OL+AR)RU8Q1\A$>B]:
M5__\A]KO_*LI4R1FD)A)8A:)V23FD)A+8AZ)^2060%@MW]U-OKLR??OHG2V/
MWK=%K,OO7A7'X]51^G53:J7JJ:DE,8/$3!*S2,PF,8?$W!767V+E*=Q],;D:
M=#J=B_;]=A[)=?HD%D!8+8^]31Y[TCPNCZ/+L\*Q,MHZWC9E4"J=FD$2,TC,
M)#&+Q&P2<TC,76&#K0SV^^I@)X'["W5[W6%](7]_(5WO[$@!M.VUQ/0WB>E+
M$_-S$K^Y+XYB16#2W8/9@8.8%#XU0"1FD)A)8A:)V23FD)C;WSN(#7KZ_D&L
M8;&!NK>83VY: &&UL TV81M(PU:< LZ+D[_5&SU_-I_U52>&9TH13C&_FR6/
M0C0%4+JR4P-(8@:)F21FD9A-8@Z)N23FD9A/8@&$U<)\O@GS^0N_MW-.YIO$
M#!(S2<PB,9O$'!)S2<PC,9_$ @BKY7NXR??PA[RW,]R;U/3WIC37TE6?FD82
M,TG,(C&;Q!P2<TG,(S&?Q ((JZ51[5072CO2/):7HY1?%GD6C85B1*D8Y4FJ
MF'\LHORQ?@#>NZ;Z:1;&RN\?Q?Q&I/\I)MZ["S3%6+XUIQY]4<U -1/5+%2S
M4<U!-1?5/%3S42V@M'KRMRH2Z@O/M-<;0(6=U Q4,U'-0C4;U1Q4<U'-0S4?
MU0)*JX==J\*N'?,>V6K*'2[R:9)&_RT"/2D.]E&6+<)X) Y-P>6K.#G.I&:@
MFHEJ%JK9J.:LM>WSJFZGLW=FY:)K]5#-1[6 TNI!K:I-JK19L1/4^S":A3<S
M4<OI61G@9%X<K$=*&,>+<*9$\2@5Q1'Z3+D3Z:@X0C?F%VTUH9J!:B:J6:AF
MHYJSULJIY"; G;?J;GK1TA*J^:@64%H]O55Q294WE\J"HV*N+RZ=<!;]IW(]
MC<1$L:*X2'A4)/J7R20:B;0QQVC/"=4,5#-1S4(U&]4<5'-1S4,U']4"2JOG
MO2I&J;V7/H=&"U6H9J":B6H6JMFHYJ":BVH>JOFH%E!:/>Q5ITN5E[JV+UTM
MSY+/E++C%<6WY:P[2IK^PN>#W#PYOVBA"]7, \^>KCR*,&WZ*RH+W0X;U1Q4
M<U'-0S4?U0)*JV>UJH2I\D[8_S\1/^HJ%MH10S4#U4Q4LU#-1C4'U5Q4\U#-
M1[6 TNI!K^IBZDOWQ52T,(9J!JJ9J&:AFHUJ#JJYJ.:AFH]J :75PUYUQU1Y
M>0RYBD66=ZY1S4 U$]4L5+-1S4$U5]WO&@[+LN'NGRJA:_51+6C8![53O[!7
M_P")JC"F'2R,03/KXJ&/41S-%_.FG,HWX]2<HIJ!:B:J6:AFHYJ#:BZJ>:CF
MHUI :?7(5TTQ[:6;8AK:%$,U ]5,5+-0S48U!]5<5/-0S4>U@-+J8:^:8IJ\
M*?9TE"[S_?S;VG+DY,"B73!4,U'-.O#DJ\LWR1NSB=:^4,U%-0_5?%0+**V>
MS:H<ILG+8>S<._S^[-P;;8JAFH%J)JI9J&:CFH-J+JIYJ.:C6D!I]<A7C3*M
M^])S;[1.AFH&JIFH9J&:C6H.JKFHYJ&:CVH!I=7#7M7)-/D';1TY]T8K8:AF
MH)J):M:!)U_M/-M0L=$-<5#-134/U7Q4"RBMGLZJ_Z7)&TQ_]4^E7[66PF9D
M^6#K]9&5$_FVG1QZM$>&:B:J6:AFHYJ#:BZJ>:CFHUI :?7? U6W3!N\])0<
M[9>AFH%J)JI9J&:CFH-J+JIYJ.:C6D!I];!7_3)-6FE!*B?R59P<9[1!AFHF
MJEFH9J.:@VKN6MNN:VC=SJ#7VZF<H&OU42V@M'I0JVZ8)N^&_6VS\P.U%;1>
MAFH&JIFH9J&:C6H.JKFHYJ&:CVH!I=5O$E,UU?3."\_3=;2CAFH&JIFH9J&:
MC6H.JKFHYJ&:CVH!I=7#7G74=&DMYLBWSN7(R8%%>V:H9J*:A6HVJCFHYAYX
MF3U;T/'0S?!1+:"T>C:K2IDN;S7]K5/SYULM\JT\.?QH9PW53%2S4,U&-0?5
M7%3S4,U'M8#2ZK\1MF[@^.)W<&1OX<C>PY&]B2-[%T?V-H[L?1S9&SFR=W)D
M;^7(WLOQ1U38]*K"IDM;,\=.S=$:&JH9J&:BFH5J-JHYJ.8>>)D]_P$S'KH=
M/JH%E%8/9U4YT^6MITV;/(S'\KGYNDF^=6N[8WHK\M6?'&NTK(9J)JI9J&:C
MFH-J+JIYJ.:C6D!I]:A7_36]_]*3;K2DAFH&JIFH9J&:C6H.JKFHYJ&:CVH!
MI=7#7I74=/D'H/V%.]#*Y9-3C+;/4,U$-0O5;%1S4,U=:_4[T6KGVLY]FKVF
MY0:=?D_;N14MNG4!I=635S7&='ECS'UJA263O>B=*;'(#^8/K8NAFH%J)JI9
MJ&:CFH-JKKY?%QL.]>'NC: ;%AMTAKWA[NW4T8T+**T>OZH'ILM[8+^)Z'9:
M!.Y->"_2\%:L;C"IC,-<*),P2I7[<+9853;'R6P6IEGYIM0JC\UQ1!M=J&:@
MFHEJ%JK9J.:@FKO6AELYT]2WO=W/"VM83.^\[0YVTXAVL"BMEL9NU<'JRC\M
MS*H25QP.5P<]934O;<J:7#LU:ZAFH)J):A:JV:CFH)J[U@;;6>ONWJ[*:UA*
MW[NIE8]N64!I]:15!:BNO)GR-4[%*+F-EW^=,-I^>V>49'E63$5G83D/S9.]
M66EC$M&F%*H9J&:BFH5J-JHYJ.:NM>V,#=7]).XOI>I[@?7130LHK1[%JN_4
ME?>=GJ:@RM,4--VZ EI>9YDDZ41$^2(5D@NB\I6<G$"TKH1J)JI9J&:CFH-J
M[H&7X:JKJ R4>1+GTTSI%R=!CXW71P] VNK*JJ(_2>KY<Y2/[F% :?4@5S6E
M[J'/V]*T'W<7"?G*3PXX6E%"-1/5+%2S4<U!-1?5/%3S42V@M'K0JXI2M_O"
MET:[:+T)U0Q4,U'-0C4;U1Q4<U'-0S4?U0)*JX>]JCQUY94GXD_ZY:LX.<YH
MK0G53%2SUIKLO@3KI**-)51S&W9B[[07K2&A6D!I]?A5-:2N_&.T?IT*!?T@
MV]6MD\WO8K3(HWLANW6R?--.CBU:4$(U$]4L5+-1S4$U%]4\5/-1+:"T^J^!
MJJ#4?>E/T>JB/294,U#-1#4+U6Q4<U#-134/U7Q4"RBM'O:J$]65=Z(^[U80
MEZ6,XKM#TVRT"H5J1K>AA+,_D371E5JH9A^W"PZZ4A?5/%3S42V@M'KHJB94
M5]Z$^D$3;2N*BS/D*)Q))]IH:0K5#%0S4<U"-1O5'%1S4<U#-1_5 DJK_1KH
M516LWDM_#%8/;6VAFH%J)JI9J&:CFH-J+JIYJ.:C6D!I];!7+;#><1^#=>I$
M6\Z>'&%U_UW>_?Z=@:[4/&ZE%KI2&]4<5'-1S4,U']4"2EN%KIU-A<B-, ^O
M+N8BO1778C;+E%&RB//R,+OUJ)**27G;\G?OM59[[W%3?>>H#8^[ZCM_^7B[
MXJ\N[L);\3%,;Z,X4V9B4JRJ\W;0:REI629[^B9/[BY;Q=[>)'F>S)=?3D4X
M%FFY0/'ODR3)G[XI5_"0I-^6NW/U/U!+ P04    "  +1;=6F+$"\MH#  !2
M$0  &0   'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6S=6-MNVS@0_15""RQ:
M((Y$*KXDM07$21;M0[>&T\O#H@^T-+:$2*1*4G;\]TM*LN2L+D&,9!_Z8O,V
MPS/#X3F@ICLN'F0(H-!C$C,YLT*ETBO;EGX("97G/ 6F9]9<)%3IKMC8,A5
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MQ:)JH:J!XH5I*K9<08MB'E-H.XG0!O!^Q[DZ#?0'FD9V]1]02P,$%     @
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MKB(HL:(MMP]J]P/[?":>KU#<A"_L>MLD@J(U5HD>["(03'8G?>GK<  879X
MD!Y W@/&)P!I#T@_"QCW@'&H3)=*J,.*6IIG6NU >VO'YB^AF 'MTF?2MWUC
MM7ME#F?S>_=GW<I""80U:MC45"-\A7NJ-?4=@2\KM)1Q<^:TQK^:++;.L8?'
M1>]DT3DA)YR,"-PI:6L#-[+$\BU!["(>PB;[L!?D0\8[JB\@'9T#24AZ)*#E
MY^'D"'SU>?CH@VS2H0EIX!N?X)M+RTK&VU#P#1:M9I:AJ]9+P5M7,*BT$K!4
MHFDM#>.B*KBA6C*Y-:]].X>Y4*VT\(7)OE=GQYK5!7,9@O%KX3F?CB=7DW$6
M/Q^6\'\S0I(IF;XU6QTQ2[Y-R&#5520^^$4%ZFT8=0.%C[=K^Z =MLD\#-$[
M_<)MF6XIO-)T*\IU9<ND 8Z5HTPNII,(=#?VG6!5$P;A45DW5N%:NTV)VANX
M]THINQ>\@V'WYO\ 4$L#!!0    (  M%MU8?W#^/M!4  )!Z 0 9    >&PO
M=V]R:W-H965T<R]S:&5E=#0U+GAM;,W=6V_;2(*&X;]">!N+'B =ZRRG)S&0
MA.=#,4BF=RX6>\'(98MHB7235 Y __@A9=I4651)FKR#WIO$5LRG*%'^0I8^
ME5Y_S8O?RZ64E?%MO<K*-Q?+JKK_]?*R7"SE.BE?YO<RJ__E-B_6255_6]Q=
MEO>%3&ZV&ZU7EZ/!8':Y3M+LXOKU]K8/Q?7K?%.MTDQ^*(QRLUXGQ?=W<I5_
M?7,QO'B\X6-ZMZR:&RZO7]\G=_*3K'Z[_U#4WUT^*3?I6F9EFF=&(6_?7+P=
M_AI?C9H-MC_Q/ZG\6NY\;31WY7.>_]Y\X]V\N1@T>R17<E$U1%+_]46^EZM5
M(]7[\4>+7CR-V6RX^_6C;F_O?'UG/B>E?)^O_IG>5,LW%U<7QHV\33:KZF/^
MU97M'9HVWB)?E=L_C:_MSPXNC,6FK/)UNW&]!^LT>_@[^=8^$#L;C$8'-ABU
M&XR>;S \L,&XW6#\?(-7!S:8M!M,GFTP/G0?INT&TU/OPZS=8/9L@\FA$>;M
M!O-31[AJ-[@Z]5%ZU6[PZM0-AH/'(S<X>9.G@_W\:(_'AS9Y/-S#O>,]/;3)
MXP$?/C_BX]FA31X/^?#Y,3_X  \?#_K#$_[RX1F__74QDRJY?EWD7XVB^?G:
M:[[8_LYMMZ]_2]*LB8=/55'_:UIO5UV_S]?KM*I_WZO22+(;XWV>56EV)[-%
M*DOC9U-62;HJ_V;\9%P:Y3(IZAO3S/@M2ZORA7%;_?=_#>=7?V]N^L<RWY2U
M4-_\D_+]Z\NJWL]FM,M%NT_^PSZ-#NS3T(CJO5B6AI7=R)N>[<61[4<:X+)^
M@)X>I='CH_1NI!7])'MI#,<OC-%@-#9^^V0:/__TMYX=>Z]G3+EX:8R'6V;4
M/IP]BJE7WF[N7AJ#<:NT.W-8LT[11L^T^^1[\YSHX>S3[^)0\T@Y)^S5>* R
MNT_"@W?7/0$>#H[NGW?D";%9[=S-@SOCGW(OCSX?@M,5S;Z$/_:(]XC1";\T
M#_LUG'594<DLZ7UF"3T7)<73W7SZ'6RUP_L8'SN.S2_VXV/7^ZQ7 F/\%*OC
MK3L^X,;54A;&;KC^;UC_B.%5<EW^7\]^OGOP)OU><Y+X:WF?+.2;B_HLL)3%
M%WEQ73^@L\'?^V*(Q$P2LTC,)C&'Q%P2\TC,)[& Q$(2BTA,D%@,84HL39YB
M::+3KS\EJ_K_SBKY9LAO]WFY*61?%&F-<Z.(Q$P2LTC,)C&'Q%P2\TC,)[&
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M$U!+ 0(4 Q0    (  M%MU8'04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ "T6W5GVG.BSO    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ "T6W5IE<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    "  +1;=6@J2/V:@'   V+P  &
M        @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ "T6W5BZ4K/\V @  M04  !@              ("![ \  'AL+W=O<FMS
M:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    (  M%MU96 &4^V@4  '<8   8
M              " @5@2  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"
M% ,4    "  +1;=6(S-.NDX#  #@"P  &               @(%H&   >&PO
M=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ "T6W5BO4$5++!0
M.!H  !@              ("![!L  'AL+W=O<FMS:&5E=',O<VAE970U+GAM
M;%!+ 0(4 Q0    (  M%MU;J@J$&#P8  +$J   8              " @>TA
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    "  +1;=6';]\
M9KX&  #V'P  &               @($R*   >&PO=V]R:W-H965T<R]S:&5E
M=#<N>&UL4$L! A0#%     @ "T6W5H^Z34KT%   N#@  !@
M ("!)B\  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    (  M%
MMU;!8 .6V (  %(&   8              " @5!$  !X;"]W;W)K<VAE971S
M+W-H965T.2YX;6Q02P$"% ,4    "  +1;=6HS4FOQ$#   N!P  &0
M        @(%>1P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0
M   (  M%MU9'0LO/N04  +$/   9              " @:9*  !X;"]W;W)K
M<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ "T6W5E"^-F77!0  $PX
M !D              ("!EE   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q0
M2P$"% ,4    "  +1;=6BYF"2L0(  !$&@  &0              @(&D5@
M>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    (  M%MU;:"CH6
M500  .$)   9              " @9]?  !X;"]W;W)K<VAE971S+W-H965T
M,30N>&UL4$L! A0#%     @ "T6W5D42!DR#!     L  !D
M ("!*V0  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    "  +
M1;=66HN^&I82  ",.P  &0              @('E:   >&PO=V]R:W-H965T
M<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    (  M%MU; 4>=\Q0,  &D(   9
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M970R,2YX;6Q02P$"% ,4    "  +1;=6#( AQ*,#  #2"   &0
M    @(%YG@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (
M  M%MU9_??<*Y@(  $8&   9              " @5.B  !X;"]W;W)K<VAE
M971S+W-H965T,C,N>&UL4$L! A0#%     @ "T6W5FK;<24? P  % <  !D
M             ("!<*4  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"
M% ,4    "  +1;=6LJA3%!8%   +#0  &0              @('&J   >&PO
M=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    (  M%MU9:1V0*NP(
M !P&   9              " @1.N  !X;"]W;W)K<VAE971S+W-H965T,C8N
M>&UL4$L! A0#%     @ "T6W5B&]&BW- @  2 8  !D              ("!
M!;$  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    "  +1;=6
M<[]1FE #  !U!P  &0              @($)M   >&PO=V]R:W-H965T<R]S
M:&5E=#(X+GAM;%!+ 0(4 Q0    (  M%MU8]"?N45P@  +5"   9
M      " @9"W  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%
M  @ "T6W5I2JI+.H!0  ?"(  !D              ("!'L   'AL+W=O<FMS
M:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    "  +1;=6AD.?A<@#  "_$P
M&0              @(']Q0  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+
M 0(4 Q0    (  M%MU;H#X%C9P,  "4+   9              " @?S)  !X
M;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ "T6W5D4?C14+
M P  50H  !D              ("!FLT  'AL+W=O<FMS:&5E=',O<VAE970S
M,RYX;6Q02P$"% ,4    "  +1;=61KBFDDD#  !;"P  &0
M@('<T   >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    (  M%
MMU:K-QO.3P,  $<,   9              " @5S4  !X;"]W;W)K<VAE971S
M+W-H965T,S4N>&UL4$L! A0#%     @ "T6W5J5A\UEV P  P H  !D
M         ("!XM<  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4
M    "  +1;=60SU_ 6D#   A"P  &0              @(&/VP  >&PO=V]R
M:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    (  M%MU; TUK/?04  "\I
M   9              " @2_?  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL
M4$L! A0#%     @ "T6W5A60L/:B @  U <  !D              ("!X^0
M 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    "  +1;=6/V3@
MV2T-   #P0  &0              @(&\YP  >&PO=V]R:W-H965T<R]S:&5E
M=#0P+GAM;%!+ 0(4 Q0    (  M%MU:8L0+RV@,  %(1   9
M  " @2#U  !X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @
M"T6W5D+\E) M @  #P4  !D              ("!,?D  'AL+W=O<FMS:&5E
M=',O<VAE970T,BYX;6Q02P$"% ,4    "  +1;=6>&<@9.T#  #4#@  &0
M            @(&5^P  >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4
M Q0    (  M%MU;.BU" 50(  (<%   9              " @;G_  !X;"]W
M;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ "T6W5A_</X^T%0
MD'H! !D              ("!10(! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX
M;6Q02P$"% ,4    "  +1;=6R:.BR2P#  "."P  &0              @($P
M& $ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    (  M%MU:
M3"P060(  '\%   9              " @9,; 0!X;"]W;W)K<VAE971S+W-H
M965T-#<N>&UL4$L! A0#%     @ "T6W5E;IR4R,!@  CT8  !D
M     ("!(QX! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (  M%MU:.83CZO0$  'H=   :
M          "  7 P 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    (  M%MU:<*],/O0$  '<=   3              "  64R 0!;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     Y #D A@\  %,T 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>145</ContextCount>
  <ElementCount>264</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>51</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Changes in Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Changes in Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/PropertyandEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Accrued Expenses and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilities</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Restricted Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/RestrictedStock</Role>
      <ShortName>Restricted Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Net Income Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/NetIncomePerShare</Role>
      <ShortName>Net Income Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Employee Benefit Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/EmployeeBenefitPlan</Role>
      <ShortName>Employee Benefit Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Minority Interest Investment in Vetster</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetster</Role>
      <ShortName>Minority Interest Investment in Vetster</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Related Party Transaction</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/RelatedPartyTransaction</Role>
      <ShortName>Related Party Transaction</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/PropertyandEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/PropertyandEquipmentNet</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilities</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/IncomeTaxes</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/ShareholdersEquity</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Restricted Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/RestrictedStockTables</Role>
      <ShortName>Restricted Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/RestrictedStock</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Net Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/NetIncomePerShareTables</Role>
      <ShortName>Net Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/NetIncomePerShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Summary of Significant Accounting Policies - Disaggregation of Revenue by Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Disaggregation of Revenue by Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails</Role>
      <ShortName>Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/PropertyandEquipmentNetTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Income Taxes - Deferred Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Deferred Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Income Taxes - Components of Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails</Role>
      <ShortName>Income Taxes - Components of Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Income Taxes - Reconciliation of Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Income Taxes - Reconciliation of Total Effective Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Total Effective Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Shareholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails</Role>
      <ShortName>Shareholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Shareholder's Equity - Declared Dividends (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/ShareholdersEquityDeclaredDividendsDetails</Role>
      <ShortName>Shareholder's Equity - Declared Dividends (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Restricted Stock - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails</Role>
      <ShortName>Restricted Stock - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Restricted Stock - Non-vested Restricted Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails</Role>
      <ShortName>Restricted Stock - Non-vested Restricted Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/FairValueMeasurements</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Net Income Per Share - Basic and Diluted Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails</Role>
      <ShortName>Net Income Per Share - Basic and Diluted Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Net Income Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails</Role>
      <ShortName>Net Income Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/CommitmentsandContingencies</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Employee Benefit Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/EmployeeBenefitPlanDetails</Role>
      <ShortName>Employee Benefit Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/EmployeeBenefitPlan</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Minority Interest Investment in Vetster (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails</Role>
      <ShortName>Minority Interest Investment in Vetster (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetster</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/SubsequentEvents</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="pets-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Related Party Transaction (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/RelatedPartyTransactionDetails</Role>
      <ShortName>Related Party Transaction (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.1800petmeds.com/role/RelatedPartyTransaction</ParentRole>
      <Position>49</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. pets-20230331.htm 4</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrent in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. pets-20230331.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: pets:RestrictionPeriod, us-gaap:PropertyPlantAndEquipmentUsefulLife -  pets-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="pets-20230331.htm">pets-20230331.htm</File>
    <File>pets-20230331.xsd</File>
    <File>pets-20230331_cal.xml</File>
    <File>pets-20230331_def.xml</File>
    <File>pets-20230331_lab.xml</File>
    <File>pets-20230331_pre.xml</File>
    <File>pets-20230331xexx1071.htm</File>
    <File>pets-20230331xexx211.htm</File>
    <File>pets-20230331xexx231.htm</File>
    <File>pets-20230331xexx311.htm</File>
    <File>pets-20230331xexx312.htm</File>
    <File>pets-20230331xexx321.htm</File>
    <File>pets-20230331xexx42.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>pets-20230331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="552">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>72
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "pets-20230331.htm": {
   "axisCustom": 0,
   "axisStandard": 21,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 552,
    "http://xbrl.sec.gov/dei/2022": 37
   },
   "contextCount": 145,
   "dts": {
    "calculationLink": {
     "local": [
      "pets-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "pets-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "pets-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pets-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pets-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "pets-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 420,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 1,
    "http://www.1800petmeds.com/20230331": 1,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 6
   },
   "keyCustom": 35,
   "keyStandard": 229,
   "memberCustom": 26,
   "memberStandard": 24,
   "nsprefix": "pets",
   "nsuri": "http://www.1800petmeds.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.1800petmeds.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Accrued Expenses and Other Current Liabilities",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilities",
     "shortName": "Accrued Expenses and Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.1800petmeds.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Shareholders' Equity",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.1800petmeds.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Restricted Stock",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.1800petmeds.com/role/RestrictedStock",
     "shortName": "Restricted Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.1800petmeds.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Net Income Per Share",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.1800petmeds.com/role/NetIncomePerShare",
     "shortName": "Net Income Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.1800petmeds.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Employee Benefit Plan",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.1800petmeds.com/role/EmployeeBenefitPlan",
     "shortName": "Employee Benefit Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Minority Interest Investment in Vetster",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetster",
     "shortName": "Minority Interest Investment in Vetster",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.1800petmeds.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.1800petmeds.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Related Party Transaction",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.1800petmeds.com/role/RelatedPartyTransaction",
     "shortName": "Related Party Transaction",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "21",
     "role": "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Property and Equipment, Net (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.1800petmeds.com/role/PropertyandEquipmentNetTables",
     "shortName": "Property and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables",
     "shortName": "Accrued Expenses and Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.1800petmeds.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsDeclaredTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Shareholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.1800petmeds.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsDeclaredTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Restricted Stock (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.1800petmeds.com/role/RestrictedStockTables",
     "shortName": "Restricted Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Net Income Per Share (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.1800petmeds.com/role/NetIncomePerShareTables",
     "shortName": "Net Income Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i714efa7810e34b859f1f6107bd4f64a9_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InventoryValuationReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i714efa7810e34b859f1f6107bd4f64a9_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i714efa7810e34b859f1f6107bd4f64a9_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Summary of Significant Accounting Policies - Disaggregation of Revenue by Type (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails",
     "shortName": "Summary of Significant Accounting Policies - Disaggregation of Revenue by Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "3",
      "lang": "en-US",
      "name": "pets:RevenueFromContractWithCustomerPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i714efa7810e34b859f1f6107bd4f64a9_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Property and Equipment, Net (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails",
     "shortName": "Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i714efa7810e34b859f1f6107bd4f64a9_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i714efa7810e34b859f1f6107bd4f64a9_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesAndExciseTaxPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails",
     "shortName": "Accrued Expenses and Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i714efa7810e34b859f1f6107bd4f64a9_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesAndExciseTaxPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i714efa7810e34b859f1f6107bd4f64a9_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Income Taxes - Deferred Income Taxes (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails",
     "shortName": "Income Taxes - Deferred Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i714efa7810e34b859f1f6107bd4f64a9_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Income Taxes - Narrative (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.1800petmeds.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Income Taxes - Components of Income Tax Provision (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails",
     "shortName": "Income Taxes - Components of Income Tax Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Income Taxes - Reconciliation of Income Tax Provision (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails",
     "shortName": "Income Taxes - Reconciliation of Income Tax Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Income Taxes - Reconciliation of Total Effective Tax Rate (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails",
     "shortName": "Income Taxes - Reconciliation of Total Effective Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "id29065364981439b8297fe9c2b387741_I19980430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Shareholders' Equity - Narrative (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails",
     "shortName": "Shareholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "id29065364981439b8297fe9c2b387741_I19980430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i113e079495ae443ea4acdecad992dd93_I20230206",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsPayableAmountPerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Shareholder's Equity - Declared Dividends (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.1800petmeds.com/role/ShareholdersEquityDeclaredDividendsDetails",
     "shortName": "Shareholder's Equity - Declared Dividends (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i714efa7810e34b859f1f6107bd4f64a9_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.1800petmeds.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i714efa7810e34b859f1f6107bd4f64a9_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Restricted Stock - Narrative (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
     "shortName": "Restricted Stock - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i0074779789d04c76ba59318f55ccc983_D20230203-20230203",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i7ac8d430365e42a4b70f68ccef80bf34_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Restricted Stock - Non-vested Restricted Stock (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails",
     "shortName": "Restricted Stock - Non-vested Restricted Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i714efa7810e34b859f1f6107bd4f64a9_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Fair Value Measurements (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.1800petmeds.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Net Income Per Share - Basic and Diluted Net Income Per Share (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails",
     "shortName": "Net Income Per Share - Basic and Diluted Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Net Income Per Share - Narrative (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails",
     "shortName": "Net Income Per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ExciseAndSalesTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Commitments and Contingencies (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ExciseAndSalesTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Employee Benefit Plan (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.1800petmeds.com/role/EmployeeBenefitPlanDetails",
     "shortName": "Employee Benefit Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i5d8f4dc33edd40a281b970a2cbdbe0c5_D20220419-20220419",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pets:TermOfAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Minority Interest Investment in Vetster (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails",
     "shortName": "Minority Interest Investment in Vetster (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i5d8f4dc33edd40a281b970a2cbdbe0c5_D20220419-20220419",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pets:TermOfAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.1800petmeds.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i0cc0c13fe26b4d4896753ec70f10be17_I20230522",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:DividendsPayableAmountPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i4469b631590844adbaaf420a00aa612e_D20210301-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Related Party Transaction (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.1800petmeds.com/role/RelatedPartyTransactionDetails",
     "shortName": "Related Party Transaction (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "i4469b631590844adbaaf420a00aa612e_D20210301-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Statements of Income",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome",
     "shortName": "Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "if2b4c181220f4db39c9e0becba7ebc10_I20200331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Statements of Changes in Shareholders' Equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity",
     "shortName": "Consolidated Statements of Changes in Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "if2b4c181220f4db39c9e0becba7ebc10_I20200331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Property and Equipment, Net",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.1800petmeds.com/role/PropertyandEquipmentNet",
     "shortName": "Property and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230331.htm",
      "contextRef": "ie840d82820fe45bdb028d8ac3f764526_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 51,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r468",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r468",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r468",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r468",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r468",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "pets_A2022EmployeeEquityCompensationRestrictedStockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Employee Equity Compensation Restricted Stock Plan",
        "label": "2022 Employee Equity Compensation Restricted Stock Plan [Member]",
        "terseLabel": "2022 Employee Equity Compensation Restricted Stock Plan"
       }
      }
     },
     "localname": "A2022EmployeeEquityCompensationRestrictedStockPlanMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_AccruedCreditCardFeesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "pets_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for credit card fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued credit card fees",
        "terseLabel": "Accrued credit card fees"
       }
      }
     },
     "localname": "AccruedCreditCardFeesCurrent",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pets_AccruedExpensesAndOtherCurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Expenses And Other Current Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedExpensesAndOtherCurrentLiabilities",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails",
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pets_AccruedExpensesAndOtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Expenses and Other Current Liabilities",
        "label": "Accrued Expenses and Other Current Liabilities [Member]",
        "terseLabel": "Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "AccruedExpensesAndOtherCurrentLiabilitiesMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_AccruedMerchandiseCreditsAndRewardsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "pets_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of accrued merchandise credits and rewards classified as current.",
        "label": "Accrued merchandise credits / reward program",
        "terseLabel": "Accrued merchandise credits / reward program"
       }
      }
     },
     "localname": "AccruedMerchandiseCreditsAndRewardsCurrent",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pets_AccruedSalesReturnsAndAllowancesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "pets_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents accrued sales returns and allowances. Used to reflect the current portion (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued sales return allowance",
        "terseLabel": "Accrued sales return allowance"
       }
      }
     },
     "localname": "AccruedSalesReturnsAndAllowancesCurrent",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pets_AccruedSeveranceCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Severance Costs",
        "label": "Accrued Severance Costs",
        "terseLabel": "Accrued severance costs"
       }
      }
     },
     "localname": "AccruedSeveranceCosts",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pets_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "xbrltype": "stringItemType"
    },
    "pets_ContactCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disaggregate of revenue in contact center sales.",
        "label": "Contact Center [Member]",
        "terseLabel": "Call center"
       }
      }
     },
     "localname": "ContactCenterMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_ContingentLumpSumSeverancePayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Lump Sum Severance Payment",
        "label": "Contingent Lump Sum Severance Payment",
        "terseLabel": "Contingent lump sum severance payment"
       }
      }
     },
     "localname": "ContingentLumpSumSeverancePayment",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pets_DefinedContributionPlanWithIndividualAge": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum age that the individual is required in order to participate in the defined contribution plan.",
        "label": "Defined Contribution Plan With Individual Age",
        "terseLabel": "Defined contribution plan, requisite age"
       }
      }
     },
     "localname": "DefinedContributionPlanWithIndividualAge",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/EmployeeBenefitPlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_DelrayBeachPropertyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to the Delray Beach Property.",
        "label": "Delray Beach Property [Member]",
        "terseLabel": "Delray Beach Property"
       }
      }
     },
     "localname": "DelrayBeachPropertyMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_DirectorPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information relating to the 2006 and 2015 Director Plans.",
        "label": "Director Plan [Member]",
        "terseLabel": "Director Plan"
       }
      }
     },
     "localname": "DirectorPlanMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_EarningsPerShareBasicAndDilutedEPSAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share, Basic and Diluted EPS",
        "label": "Earnings Per Share, Basic and Diluted EPS [Abstract]",
        "terseLabel": "Net income per common share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedEPSAbstract",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Permanent Differences, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Permanent Differences, Amount",
        "terseLabel": "Permanent differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pets_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Permanent Differences, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Permanent Differences, Percent",
        "terseLabel": "Permanent differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pets_EmployeeAndDirectorEquityCompensationPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to both the employee and director equity compensation plans.",
        "label": "Employee and Director Equity Compensation Plan [Member]",
        "terseLabel": "Employee and Director Equity Compensation Plan"
       }
      }
     },
     "localname": "EmployeeAndDirectorEquityCompensationPlanMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_EmployeePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information relating to the 2006 and 2016 Employee Plans.",
        "label": "Employee Plan [Member]",
        "terseLabel": "Employee Plan"
       }
      }
     },
     "localname": "EmployeePlanMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employment Term, Cancellation Period Prior To End Of Current Term",
        "label": "Employment Term, Cancellation Period Prior To End Of Current Term",
        "terseLabel": "Employment term cancellation period"
       }
      }
     },
     "localname": "EmploymentTermCancellationPeriodPriorToEndOfCurrentTerm",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_EmploymentTermInitialPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employment Term, Initial Period",
        "label": "Employment Term, Initial Period",
        "terseLabel": "Initial employment term"
       }
      }
     },
     "localname": "EmploymentTermInitialPeriod",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_EmploymentTermSuccessiveRenewalPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employment Term, Successive Renewal Period",
        "label": "Employment Term, Successive Renewal Period",
        "terseLabel": "Successive renewal employment term"
       }
      }
     },
     "localname": "EmploymentTermSuccessiveRenewalPeriod",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_FurnitureFixturesEquipmentAndComputerSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to information regarding furniture, fixtures, equipment and computer software.",
        "label": "Furniture, Fixtures, Equipment and Computer Software [Member]",
        "terseLabel": "Furniture, Fixtures, Equipment and Computer Software"
       }
      }
     },
     "localname": "FurnitureFixturesEquipmentAndComputerSoftwareMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_InternetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disaggregate of revenue in internet sales.",
        "label": "Internet [Member]",
        "terseLabel": "Internet"
       }
      }
     },
     "localname": "InternetMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_LessorOperatingLeaseRemainingWeightedAverageLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessor, Operating Lease Remaining Weighted Average Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "LessorOperatingLeaseRemainingWeightedAverageLeaseTerm",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_LumpSumSeverancePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents lump-sum severance payments.",
        "label": "Lump Sum Severance Payments",
        "terseLabel": "Lump-sum severance payments"
       }
      }
     },
     "localname": "LumpSumSeverancePayments",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pets_NewOrderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disaggregate of revenue in new order sales.",
        "label": "New Order Customer [Member]",
        "terseLabel": "New Order Customer"
       }
      }
     },
     "localname": "NewOrderMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_NonCompeteAgreementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Compete Agreement, Period",
        "label": "Non-Compete Agreement, Period",
        "terseLabel": "Non-compete term"
       }
      }
     },
     "localname": "NonCompeteAgreementPeriod",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_NoncontrollingInterestOwnershipPercentagePurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents minority interest purchased.",
        "label": "Noncontrolling Interest Ownership Percentage Purchased",
        "terseLabel": "Minority interest purchased, percent"
       }
      }
     },
     "localname": "NoncontrollingInterestOwnershipPercentagePurchased",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pets_NonvestedRestrictedStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to non-vested restricted stock awards.",
        "label": "Non-vested Restricted Stock [Member]",
        "terseLabel": "Non-vested Restricted Stock"
       }
      }
     },
     "localname": "NonvestedRestrictedStockMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_NumberOfSeverancePayments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Severance Payments",
        "label": "Number Of Severance Payments",
        "terseLabel": "Number of severance payments"
       }
      }
     },
     "localname": "NumberOfSeverancePayments",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pets_NumberOfTenants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents number of tenants.",
        "label": "Number Of Tenants",
        "terseLabel": "Number of tenants"
       }
      }
     },
     "localname": "NumberOfTenants",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pets_OtherAssetsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Assets",
        "label": "Other Assets [Policy Text Block]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsPolicyTextBlock",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to information regarding 2015 Outside Director Equity Compensation Restricted Stock Plan (\"2015 Director Plan\").",
        "label": "2015 Outside Director Equity Compensation Restricted Stock Plan (\"2015 Director Plan\") [Member]",
        "terseLabel": "2015 Outside Director Equity Compensation Restricted Stock Plan (\"2015 Director Plan\")"
       }
      }
     },
     "localname": "OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_PartnershipAgreementWithVetsterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents partnership agreement with Vestster.",
        "label": "Partnership Agreement with Vetster [Member]",
        "terseLabel": "Partnership Agreement with Vetster"
       }
      }
     },
     "localname": "PartnershipAgreementWithVetsterMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_PaymentsForStipend": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents payments for stipend.",
        "label": "Payments For Stipend",
        "terseLabel": "Cash stipend"
       }
      }
     },
     "localname": "PaymentsForStipend",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pets_PercentageOfAutomaticIncreaseInSharesAvailableForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents percentage of automatic increase in the amount of shares available for issuance.",
        "label": "Percentage Of Automatic Increase In Shares Available For Issuance",
        "terseLabel": "Common stock available for issuance, automatic annual increase, percent"
       }
      }
     },
     "localname": "PercentageOfAutomaticIncreaseInSharesAvailableForIssuance",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pets_PercentageOfPropertyLeasedToTenants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage amount of property that was leased to tenants of the property.",
        "label": "Percentage Of Property Leased To Tenants",
        "terseLabel": "Percentage of property leased to tenants"
       }
      }
     },
     "localname": "PercentageOfPropertyLeasedToTenants",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pets_PerformanceRestrictedStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents performance restricted stock.",
        "label": "Performance Restricted Stock [Member]",
        "terseLabel": "Performance Restricted Stock"
       }
      }
     },
     "localname": "PerformanceRestrictedStockMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_PerformanceRestrictedStockPriceHurdle1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Performance Restricted Stock Price Hurdle 1.",
        "label": "Performance Restricted Stock Price Hurdle 1 [Member]",
        "terseLabel": "Performance Restricted Stock Price Hurdle 1"
       }
      }
     },
     "localname": "PerformanceRestrictedStockPriceHurdle1Member",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_PerformanceRestrictedStockPriceHurdle2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Performance Restricted Stock Price Hurdle 2.",
        "label": "Performance Restricted Stock Price Hurdle 2 [Member]",
        "terseLabel": "Performance Restricted Stock Price Hurdle 2"
       }
      }
     },
     "localname": "PerformanceRestrictedStockPriceHurdle2Member",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_PerformanceRestrictedStockPriceHurdle3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Performance Restricted Stock Price Hurdle 3.",
        "label": "Performance Restricted Stock Price Hurdle 3 [Member]",
        "terseLabel": "Performance Restricted Stock Price Hurdle 3"
       }
      }
     },
     "localname": "PerformanceRestrictedStockPriceHurdle3Member",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_PerformanceRestrictedStockPriceHurdle4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Performance Restricted Stock Price Hurdle 4.",
        "label": "Performance Restricted Stock Price Hurdle 4 [Member]",
        "terseLabel": "Performance Restricted Stock Price Hurdle 4"
       }
      }
     },
     "localname": "PerformanceRestrictedStockPriceHurdle4Member",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_PerformanceRestrictedStockPriceHurdle5Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Performance Restricted Stock Price Hurdle 5.",
        "label": "Performance Restricted Stock Price Hurdle 5 [Member]",
        "terseLabel": "Performance Restricted Stock Price Hurdle 5"
       }
      }
     },
     "localname": "PerformanceRestrictedStockPriceHurdle5Member",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_PetCareRxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PetCareRx",
        "label": "PetCareRx [Member]",
        "terseLabel": "PetCareRx"
       }
      }
     },
     "localname": "PetCareRxMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_ProphetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Prophet.",
        "label": "Prophet [Member]",
        "terseLabel": "Prophet"
       }
      }
     },
     "localname": "ProphetMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_ReorderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disaggregate of revenue in reorder sales.",
        "label": "Reorder Customer [Member]",
        "terseLabel": "Reorder Customer"
       }
      }
     },
     "localname": "ReorderMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_RestrictionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of restriction of forfeiture.",
        "label": "Restriction Period",
        "terseLabel": "Restriction period"
       }
      }
     },
     "localname": "RestrictionPeriod",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_RevenueFromContractWithCustomerPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of revenue from the specified category to the total revenue during the period.",
        "label": "Revenue From Contract With Customer Percentage",
        "terseLabel": "Revenues, percentage"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPercentage",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pets_RevenueFromContractWithCustomerVariance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of changes in revenue in current period comparing to the same period in the previous year.",
        "label": "Revenue From Contract With Customer Variance",
        "terseLabel": "Revenues, variance"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerVariance",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pets_RevenueFromContractWithCustomerVariancePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of changes in revenue in current period comparing to the same period in the previous year.",
        "label": "Revenue From Contract With Customer Variance Percentage",
        "terseLabel": "Revenues, variance, percentage"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerVariancePercentage",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pets_SalaryAndWageOfficerSignOnBonus": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Salary And Wage, Officer, Sign On Bonus",
        "label": "Salary And Wage, Officer, Sign On Bonus",
        "terseLabel": "Sign on bonus"
       }
      }
     },
     "localname": "SalaryAndWageOfficerSignOnBonus",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pets_SeverancePaymentBaseSalaryPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Severance Payment, Base Salary, Period",
        "label": "Severance Payment, Base Salary, Period",
        "terseLabel": "Severance pay equal to based salary for number of periods"
       }
      }
     },
     "localname": "SeverancePaymentBaseSalaryPeriod",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Severance Payment, Change In Control, Health Insurance Benefits, Period",
        "label": "Severance Payment, Change In Control, Health Insurance Benefits, Period",
        "terseLabel": "Severance pay health insurance benefits, change in control, period"
       }
      }
     },
     "localname": "SeverancePaymentChangeInControlHealthInsuranceBenefitsPeriod",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Severance Payment, Termination Without Cause, Health Insurance Benefits, Period",
        "label": "Severance Payment, Termination Without Cause, Health Insurance Benefits, Period",
        "terseLabel": "Severance pay health insurance benefits, without cause termination, period"
       }
      }
     },
     "localname": "SeverancePaymentTerminationWithoutCauseHealthInsuranceBenefitsPeriod",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Absolute Stock Price Hurdle Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Absolute Stock Price Hurdle Period",
        "terseLabel": "Achievement of absolute stock price hurdle period, consecutive days"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAbsoluteStockPriceHurdlePeriod",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Hurdle Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Hurdle Period",
        "terseLabel": "Absolute stock price hurdle period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedHurdlePeriod",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Performance Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Nonvested, Performance Period",
        "terseLabel": "Employment performance period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedPerformancePeriod",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_SixSuppliersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Six Suppliers",
        "label": "Six Suppliers [Member]",
        "terseLabel": "Six Suppliers"
       }
      }
     },
     "localname": "SixSuppliersMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_TermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents term of agreement.",
        "label": "Term Of Agreement",
        "terseLabel": "Term of agreement"
       }
      }
     },
     "localname": "TermOfAgreement",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_TerminationPeriodPeriodWithinChangeInControl": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination Period, Period Within Change In Control",
        "label": "Termination Period, Period Within Change In Control",
        "terseLabel": "\"Good Reason\" termination period"
       }
      }
     },
     "localname": "TerminationPeriodPeriodWithinChangeInControl",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pets_The2016EmployeeEquityCompensationRestrictedStockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "represents the 2016 Employee Equity Compensation Restricted Stock Plan.",
        "label": "The 2016 Employee Equity Compensation Restricted Stock Plan [Member]",
        "terseLabel": "The 2016 Employee Equity Compensation Restricted Stock Plan"
       }
      }
     },
     "localname": "The2016EmployeeEquityCompensationRestrictedStockPlanMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to the 2015 Outside Director Equity Compensation Restricted Stock Plan.",
        "label": "2015 Outside Director Equity Compensation Restricted Stock Plan [Member]",
        "terseLabel": "2015 Outside Director Equity Compensation Restricted Stock Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandFifteenOutsideDirectorEquityCompensationRestrictedStockPlanMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pets_TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to the 2016 Employee Equity Compensation Restricted Stock Plan.",
        "label": "2016 Employee Equity Compensation Restricted Stock Plan [Member]",
        "terseLabel": "2016 Employee Equity Compensation Restricted Stock Plan"
       }
      }
     },
     "localname": "TwoThousandSixteenEmployeeEquityCompensationRestrictedStockPlanMember",
     "nsuri": "http://www.1800petmeds.com/20230331",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefFinancialOfficerMember": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Financial Officer [Member]",
        "terseLabel": "Chief Financial Officer"
       }
      }
     },
     "localname": "ChiefFinancialOfficerMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r172",
      "r173",
      "r262",
      "r265",
      "r440",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r232",
      "r453",
      "r506",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r294",
      "r397",
      "r417",
      "r435",
      "r436",
      "r450",
      "r460",
      "r463",
      "r504",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r294",
      "r397",
      "r417",
      "r435",
      "r436",
      "r450",
      "r460",
      "r463",
      "r504",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r232",
      "r453",
      "r506",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r292",
      "r294",
      "r322",
      "r323",
      "r324",
      "r396",
      "r397",
      "r417",
      "r435",
      "r436",
      "r450",
      "r460",
      "r463",
      "r500",
      "r504",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r292",
      "r294",
      "r322",
      "r323",
      "r324",
      "r396",
      "r397",
      "r417",
      "r435",
      "r436",
      "r450",
      "r460",
      "r463",
      "r500",
      "r504",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": {
     "auth_ref": [
      "r434",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Axis]",
        "terseLabel": "Name of Property [Axis]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": {
     "auth_ref": [
      "r434",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Domain]",
        "terseLabel": "Name of Property [Domain]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r172",
      "r173",
      "r262",
      "r265",
      "r441",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r143",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r206",
      "r238",
      "r239",
      "r353",
      "r370",
      "r371",
      "r372",
      "r373",
      "r383",
      "r385",
      "r386",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r143",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r206",
      "r238",
      "r239",
      "r353",
      "r370",
      "r371",
      "r372",
      "r373",
      "r383",
      "r385",
      "r386",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r143",
      "r174",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r188",
      "r206",
      "r353",
      "r370",
      "r371",
      "r372",
      "r383",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r497",
      "r498",
      "r544",
      "r546",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "Previously Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r495",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r11",
      "r462"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r233",
      "r234"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, less allowance for doubtful accounts of $35 and $39, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent": {
     "auth_ref": [
      "r91",
      "r126",
      "r139"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "pets_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes.",
        "label": "Accrual for Taxes Other than Income Taxes",
        "terseLabel": "Accrued real estate taxes"
       }
      }
     },
     "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "pets_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Employee Benefits, Current",
        "terseLabel": "Accrued salaries and benefits"
       }
      }
     },
     "localname": "AccruedEmployeeBenefitsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "pets_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional expenses"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r63",
      "r150"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r6",
      "r462"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r330",
      "r331",
      "r332",
      "r484",
      "r485",
      "r486",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r88",
      "r89",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "verboseLabel": "Share based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r155",
      "r235",
      "r240"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of a real estate property.",
        "label": "Area of Real Estate Property",
        "terseLabel": "Area of real estate property (in square feet)"
       }
      }
     },
     "localname": "AreaOfRealEstateProperty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r123",
      "r132",
      "r151",
      "r169",
      "r221",
      "r224",
      "r228",
      "r236",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r261",
      "r365",
      "r367",
      "r375",
      "r462",
      "r502",
      "r503",
      "r550"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r145",
      "r157",
      "r169",
      "r236",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r261",
      "r365",
      "r367",
      "r375",
      "r462",
      "r502",
      "r503",
      "r550"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r169",
      "r236",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r261",
      "r365",
      "r367",
      "r375",
      "r502",
      "r503",
      "r550"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total noncurrent assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Noncurrent assets:"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r112",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingImprovementsMember": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Addition, improvement, or renovation to a facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building Improvements [Member]",
        "terseLabel": "Building Improvements"
       }
      }
     },
     "localname": "BuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r364",
      "r458",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r103",
      "r104",
      "r364",
      "r458",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r105",
      "r106",
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Aggregate consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r38",
      "r148",
      "r438"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets",
      "http://www.1800petmeds.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r33",
      "r38",
      "r44"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash and cash equivalents, at end of year",
        "periodStartLabel": "Cash and cash equivalents, at beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r33",
      "r118"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r169",
      "r192",
      "r196",
      "r200",
      "r202",
      "r210",
      "r211",
      "r236",
      "r251",
      "r254",
      "r255",
      "r256",
      "r260",
      "r261",
      "r263",
      "r264",
      "r267",
      "r271",
      "r279",
      "r375",
      "r437",
      "r474",
      "r480",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r16",
      "r127",
      "r137"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r67",
      "r245",
      "r246",
      "r430",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock authorized for issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r484",
      "r485",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity",
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r5",
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r5",
      "r462"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $.001 par value, 40,000 shares authorized; 21,084 and 20,979 shares issued and outstanding, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r82",
      "r83",
      "r84",
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "Employee Benefit Plan"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/EmployeeBenefitPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "Accounting for Share Based Compensation"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r48",
      "r49",
      "r116",
      "r117",
      "r232",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r48",
      "r49",
      "r116",
      "r117",
      "r232",
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r48",
      "r49",
      "r116",
      "r117",
      "r232",
      "r429",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r131",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Business Concentrations"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r48",
      "r49",
      "r116",
      "r117",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Percentage of all products purchased"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r48",
      "r49",
      "r116",
      "r117",
      "r232",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r109",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r457",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r457",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r263",
      "r264",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r3",
      "r4",
      "r72",
      "r75",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Convertible preferred stock, shares issued upon conversion (in shares)"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r24",
      "r399"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsTotalMember": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of product sold and service rendered, when it serves as benchmark in concentration of risk calculation.",
        "label": "Cost of Goods and Service Benchmark [Member]",
        "terseLabel": "Cost of Goods and Service Benchmark"
       }
      }
     },
     "localname": "CostOfGoodsTotalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r482",
      "r538",
      "r540"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r102",
      "r349",
      "r357",
      "r482"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current taxes"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current taxes"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r482",
      "r538",
      "r540"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1": {
     "auth_ref": [
      "r81",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Deferred Compensation Arrangement with Individual, Requisite Service Period",
        "terseLabel": "Defined contribution plan, requisite service period"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/EmployeeBenefitPlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r482",
      "r539",
      "r540"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "verboseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r339",
      "r340"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r36",
      "r102",
      "r350",
      "r356",
      "r357",
      "r482"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r339",
      "r340"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "totalLabel": "Total deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r482",
      "r539",
      "r540"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "verboseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r536"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Total net deferred tax assets (liabilities)"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r536"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "auth_ref": [
      "r100",
      "r537"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation",
        "terseLabel": "Deferred stock compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "auth_ref": [
      "r100",
      "r537"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "terseLabel": "Bad debt and inventory reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r100",
      "r537"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r94",
      "r536"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Total net deferred tax assets (liabilities)"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r100",
      "r537"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Percentage of employees gross compensation eligible for match"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/EmployeeBenefitPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Employer match contribution percentage"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/EmployeeBenefitPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount",
        "terseLabel": "Defined contribution plan, matching contribution"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/EmployeeBenefitPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r36",
      "r61"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r290",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r299",
      "r326",
      "r327",
      "r329",
      "r333",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r79",
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsDeclaredTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.",
        "label": "Dividends Declared [Table Text Block]",
        "terseLabel": "Schedule of Dividend Declaration"
       }
      }
     },
     "localname": "DividendsDeclaredTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.",
        "label": "Dividends Payable, Amount Per Share",
        "terseLabel": "Per Share Dividend (in dollars per share)",
        "verboseLabel": "Per share dividend (in dollars per share)"
       }
      }
     },
     "localname": "DividendsPayableAmountPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ShareholdersEquityDeclaredDividendsDetails",
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "pets_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Accrued dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r124",
      "r133"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Total Amount",
        "verboseLabel": "Dividend payable"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ShareholdersEquityDeclaredDividendsDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r11",
      "r253",
      "r254",
      "r255",
      "r259",
      "r260",
      "r261",
      "r390",
      "r483"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Related Parties, Current",
        "terseLabel": "Related party expenses"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r165",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r190",
      "r192",
      "r200",
      "r201",
      "r202",
      "r206",
      "r372",
      "r373",
      "r412",
      "r415",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome",
      "http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r165",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r192",
      "r200",
      "r201",
      "r202",
      "r206",
      "r372",
      "r373",
      "r412",
      "r415",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome",
      "http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r342"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Total Effective Tax Rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r170",
      "r342",
      "r358"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal rate on income before taxes (as a percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r534",
      "r535"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "terseLabel": "Restricted stock shortfall (windfall) adjustment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesNarrativeDetails",
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "auth_ref": [
      "r534",
      "r535"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent",
        "terseLabel": "Restricted stock shortfall (windfall) adjustments"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r535",
      "r541"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofTotalEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r328"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation costs related to restricted stock"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average restriction and forfeiture period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r71",
      "r142",
      "r161",
      "r162",
      "r163",
      "r174",
      "r175",
      "r176",
      "r178",
      "r185",
      "r188",
      "r209",
      "r237",
      "r280",
      "r330",
      "r331",
      "r332",
      "r352",
      "r353",
      "r371",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r386",
      "r418",
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExciseAndSalesTaxes": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services.",
        "label": "Excise and Sales Taxes",
        "terseLabel": "Sales tax exposure"
       }
      }
     },
     "localname": "ExciseAndSalesTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r114",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture, fixtures and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r56",
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GranteeStatusAxis": {
     "auth_ref": [
      "r295",
      "r297",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of recipient to whom award is granted.",
        "label": "Grantee Status [Axis]",
        "terseLabel": "Grantee Status [Axis]"
       }
      }
     },
     "localname": "GranteeStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusDomain": {
     "auth_ref": [
      "r295",
      "r297",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted.",
        "label": "Grantee Status [Domain]",
        "terseLabel": "Grantee Status [Domain]"
       }
      }
     },
     "localname": "GranteeStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r22",
      "r169",
      "r221",
      "r223",
      "r227",
      "r229",
      "r236",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r261",
      "r375",
      "r448",
      "r502"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r60",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r20",
      "r122",
      "r128",
      "r141",
      "r221",
      "r223",
      "r227",
      "r229",
      "r413",
      "r448"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r170",
      "r343",
      "r345",
      "r348",
      "r354",
      "r359",
      "r361",
      "r362",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r171",
      "r187",
      "r188",
      "r220",
      "r341",
      "r355",
      "r360",
      "r416"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Total provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome",
      "http://www.1800petmeds.com/role/IncomeTaxesComponentsofIncomeTaxProvisionDetails",
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r160",
      "r337",
      "r338",
      "r345",
      "r346",
      "r347",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r342"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income taxes at U.S. statutory rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesReconciliationofIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the book value of finished goods inventory and work in process inventory.",
        "label": "Increase (Decrease) in Finished Goods and Work in Process Inventories",
        "negatedLabel": "Inventories - finished goods"
       }
      }
     },
     "localname": "IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "(Increase) decrease in operating assets and increase (decrease) in liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "auth_ref": [
      "r197",
      "r198",
      "r202"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock",
        "terseLabel": "Common shares issuable upon conversion of preferred shares (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r202",
      "r298"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Common shares issuable upon the vesting of restricted stock (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r57",
      "r59"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible and other assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Inventories - finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r147",
      "r156",
      "r208",
      "r242",
      "r243",
      "r244",
      "r398",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r55",
      "r476"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory reserve"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r26",
      "r219"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income, net"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Minority interest purchased, amount"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Five",
        "terseLabel": "Lessor, operating lease, payment to be received, 2028"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Four",
        "terseLabel": "Lessor, operating lease, payment to be received, 2027"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year One",
        "terseLabel": "Lessor, operating lease, payment to be received, 2024"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Three",
        "terseLabel": "Lessor, operating lease, payment to be received, 2026"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Two",
        "terseLabel": "Lessor, operating lease, payment to be received, 2025"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r12",
      "r169",
      "r236",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r261",
      "r366",
      "r367",
      "r368",
      "r375",
      "r447",
      "r502",
      "r550",
      "r551"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r10",
      "r125",
      "r135",
      "r462",
      "r481",
      "r496",
      "r545"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r41",
      "r42",
      "r43"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "terseLabel": "Dividends payable in accrued expenses"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r146",
      "r169",
      "r236",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r261",
      "r366",
      "r367",
      "r368",
      "r375",
      "r462",
      "r502",
      "r550",
      "r551"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "terseLabel": "Minority Interest Investment in Vetster"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetster"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r19",
      "r23",
      "r108",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r167"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r167"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r33",
      "r34",
      "r37"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r21",
      "r37",
      "r129",
      "r140",
      "r144",
      "r158",
      "r159",
      "r163",
      "r169",
      "r177",
      "r179",
      "r180",
      "r182",
      "r183",
      "r187",
      "r188",
      "r199",
      "r221",
      "r223",
      "r227",
      "r229",
      "r236",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r261",
      "r373",
      "r375",
      "r448",
      "r502"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity",
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome",
      "http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "terseLabel": "Net income (numerator):"
       }
      }
     },
     "localname": "NetIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OfficersCompensation": {
     "auth_ref": [
      "r478"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.",
        "label": "Salary and Wage, Officer, Excluding Cost of Good and Service Sold",
        "terseLabel": "Annual base salary"
       }
      }
     },
     "localname": "OfficersCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r221",
      "r223",
      "r227",
      "r229",
      "r448"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "(Loss) income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Federal net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r0",
      "r45",
      "r53",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "pets_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Stock issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).",
        "label": "Payments to Acquire Interest in Subsidiaries and Affiliates",
        "negatedTerseLabel": "Purchase of minority interest investment in Vetster"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "auth_ref": [
      "r4",
      "r72",
      "r73",
      "r480",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.",
        "label": "Preferred Stock, Liquidation Preference Per Share",
        "terseLabel": "Preferred stock, liquidation preference (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r4",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r4",
      "r462"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $.001 par value, 5,000 shares authorized; 3 convertible shares issued and outstanding with a liquidation preference of $4 per share"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r439",
      "r449",
      "r499"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r66",
      "r431",
      "r432",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/PropertyandEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r62",
      "r149"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r64",
      "r136",
      "r414",
      "r462"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      },
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets",
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r64",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r166",
      "r241"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Bad debt expense"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r293",
      "r389",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r121",
      "r389"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction, Amounts of Transaction",
        "terseLabel": "Related party transaction amount"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r119"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Related party expenses"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r293",
      "r389",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r387",
      "r388",
      "r390",
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RelatedPartyTransaction"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RentalIncomeNonoperating": {
     "auth_ref": [
      "r27"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income earned by providing the use of assets to an outside party in exchange for a payment or series of payments that is nonoperating in nature.",
        "label": "Rental Income, Nonoperating",
        "terseLabel": "Rental revenue"
       }
      }
     },
     "localname": "RentalIncomeNonoperating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r7",
      "r79",
      "r134",
      "r422",
      "r427",
      "r462"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r142",
      "r174",
      "r175",
      "r176",
      "r178",
      "r185",
      "r188",
      "r237",
      "r330",
      "r331",
      "r332",
      "r352",
      "r353",
      "r371",
      "r418",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r217",
      "r218",
      "r222",
      "r225",
      "r226",
      "r230",
      "r231",
      "r232",
      "r289",
      "r290",
      "r399"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyTypeDetails",
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r291",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "pets_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales and Excise Tax Payable, Current",
        "terseLabel": "Accrued sales tax"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r126",
      "r139"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.",
        "label": "Sales and Excise Tax Payable",
        "terseLabel": "Accrued sales tax"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Provision"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Net Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "terseLabel": "Schedule of Nonvested Share Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r120",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r295",
      "r297",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r68",
      "r69",
      "r70",
      "r72",
      "r73",
      "r74",
      "r76",
      "r77",
      "r78",
      "r79",
      "r152",
      "r153",
      "r154",
      "r210",
      "r263",
      "r264",
      "r265",
      "r267",
      "r271",
      "r277",
      "r279",
      "r450",
      "r474",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Restricted shares, vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Restricted stock forfeited or expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Restricted stock granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r311",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Non-vested restricted stock outstanding at March 31, 2023 (in shares)",
        "periodStartLabel": "Non-vested restricted stock at March 31, 2022 (in shares)",
        "terseLabel": "Non-vested restricted stock (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r311",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Stock hurdle price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Restricted stock vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNonvestedRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails",
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails",
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "auth_ref": [
      "r297",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-Based Payment Arrangement, Employee [Member]",
        "terseLabel": "Share-Based Payment Arrangement, Employee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": {
     "auth_ref": [
      "r295",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-Based Payment Arrangement, Nonemployee [Member]",
        "terseLabel": "Share-Based Payment Arrangement, Nonemployee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementNonemployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Preferred stock, shares issued, price per share (in dollars per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Computer Software"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/PropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r169",
      "r192",
      "r196",
      "r200",
      "r202",
      "r210",
      "r211",
      "r236",
      "r251",
      "r254",
      "r255",
      "r256",
      "r260",
      "r261",
      "r263",
      "r264",
      "r267",
      "r271",
      "r279",
      "r375",
      "r437",
      "r474",
      "r480",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r18",
      "r71",
      "r142",
      "r161",
      "r162",
      "r163",
      "r174",
      "r175",
      "r176",
      "r178",
      "r185",
      "r188",
      "r209",
      "r237",
      "r280",
      "r330",
      "r331",
      "r332",
      "r352",
      "r353",
      "r371",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r386",
      "r418",
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity",
      "http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.1800petmeds.com/role/RelatedPartyTransactionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r209",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity",
      "http://www.1800petmeds.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r71",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "terseLabel": "Restricted stock, released in period (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r4",
      "r5",
      "r71",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity",
      "http://www.1800petmeds.com/role/RestrictedStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r71",
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r4",
      "r5",
      "r71",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "terseLabel": "Share repurchases (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r5",
      "r8",
      "r9",
      "r54",
      "r462",
      "r481",
      "r496",
      "r545"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets",
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r80",
      "r168",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r278",
      "r280",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r382",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r382",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r382",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r382",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r393",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.",
        "label": "Supplier Concentration Risk [Member]",
        "terseLabel": "Supplier Concentration Risk"
       }
      }
     },
     "localname": "SupplierConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": {
     "auth_ref": [
      "r92",
      "r93"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.",
        "label": "Tax Adjustments, Settlements, and Unusual Provisions",
        "terseLabel": "One time charge (benefit) for return to provision true up"
       }
      }
     },
     "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/MinorityInterestInvestmentinVetsterDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r336",
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Liabilities for uncertain tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r50",
      "r51",
      "r52",
      "r212",
      "r213",
      "r215",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r191",
      "r202"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Shares used in diluted computation (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome",
      "http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Shares (denominator)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r190",
      "r202"
     ],
     "calculation": {
      "http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding used in basic computation (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome",
      "http://www.1800petmeds.com/role/NetIncomePerShareBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
        "terseLabel": "Weighted average number of common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 5))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r464": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r465": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r466": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r467": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r468": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r469": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r471": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r472": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r473": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409961&loc=d3e20487-108367",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "https://asc.fasb.org/topic&trid=2127225",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "https://asc.fasb.org/topic&trid=2197446",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28511-109314",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28446-109314",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>73
<FILENAME>0001040130-23-000033-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001040130-23-000033-xbrl.zip
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M;_VCS/SK:'SZ00\D98 HW13F&+0ZNU>MWM\ Q'W_]/PL./D B'-^].FTLXM
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M6WW7\UV?3%]176F^-R]Y-K=1M^Y;Q ,>\C#AH98L# V7'JC0B6+&R)@J\O'
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M4%!5*-6@LT11M#:@V=4Z1?M:9.]$J@_ZK\0@'8IL1< 44AX9'VR:D%$&EK$
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MJ-"9(>N(V\0'6R[FD@92,QV1.""44C#T#&$!,7'M\MB@] :EO\<'%#],+_=
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MG.-\-.QBOMD9 LO9O3#]D;D9SG@JI'D%'P^+3GZY46.?%&78QT0EGB\H<YD
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M("D+80>Z+8IS>'W>[AW!'/_\U/[</6_MO1^?=G8)S.OJI+?OGY[_D;1W/T8
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MX7\;_O?8_,_ZIC)8BW$0Y\!HP:;JEB.@8ZI_ZZ]@D/;=6R^4/6"<\):BT7"
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M/;S*S-BF@?Q" N?]SC$>T!?1$"N@?\6%3U=9ETO+#.3"#$(F:=&KHI8#>+?
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M\!+#2UB58]?=B,OGSB_D5XM8!^CCZV/;I=N"E?,M!.M8\R_TURH#N"&OX]'
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M]DD HT;LEJOZMXL:[9VTD:$Q@;DG# !'<@FEJ%@PD=A#[:>X+*\LF[.\M#<
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MF%/JC)T:5_KP,U]F/U5N73(LD_A; #/E!>E7 ]8VD[J_!I?%M&706]'-)_G
M^ABMJS4/?=25IB-/]77=G22'U%0K7$<'V=S&!.JR)H\?O3X\>/0D("L6R23=
MX9[?CQ"G>*]P%S))3IN'HHXDZM(B<"@-]4"R>D9A]S OM]' <[ZAOCNXE?3
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MY09DC^_P*0R__2/T4@FUQ_ V;\JY=N+C3ZCBAI:P\5[?<.@V#D]PN%IZ:BP
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M3_R5KE3$:1[5B<3\9&B#GE!-Q135^2B$=6IS<[%<#^7T-=>!7N>1/C]J!O+
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M/4=+)5ZP\7Q"<X'U@^S;2F =-.]>0&''[VRWTS@YSD&;%J[^O $'7D",L<I
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MT/D:^$U[#PI8$-02^2DN'?^2R%L-29/U?I\9.SBI"Q5^<J'LM$CSN;:S"6M
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M^=3UU.$5*M\ [Y[-?F?$LA%<<.() IY':J/LG_(]1;.5OWM!)><!V-4+A4J
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MLL"A02/K?8$R^/.Z$?H_&FI(F"":T.9M/YP7S#-:Q+V#/M*>8-U[0TN#HO2
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MN)=L)[0[AWX+"\U$+T,#A0Q!0+^'@%9&LY4XPO<@ZBMJ7^C@-G*X*'.:%K.
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MU8^&@0-2.Q!ED?1$E#<!%8P+?.%>2LY\S8DR^K(C1=.&JC EY5P153A+IS;
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MI85HM!!61@:6\FQ!.*NQP\3QK&IYU(LRZ\ZS'HYJ7L,R !TDED;4E%)YDB7
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MXRT9.XQE)S4JREE&1DN&F2J&37 QZ!:VBA2BPKJ<K7IQ9:]R+KB 9^D(:P3
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M\-E>*.8,G,"!E(3GTPI]9&U4N)8:JB5,%5Y+]N;H!.3FB&C<1.4FZ)?HHXI
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MBA)@=7DGHL');Z<IXM('YR[I/$K042")9^%EDX9 U^89O[=Z) Y$KJ>._?1
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M86!TYP#JBJ;U\@0*U'"%2)AA,L'@C.&B)3=?A<ZD=AV&7=/5@B!K7>FC9B'
M -+TD^GMHJ_91!O N@.L[V\ Z[?@61X.8/V"\PO[@(W5!>=-0*W-1/1L?R)5
M:6\3Q#@Q<\JP;^NIN<E T2K/6J=GQ<5*<OK6G8\!,&KP>7UHS.Q[Z%@*3ENZ
MD[/;(T=<7VJ;5+_M;(-8_9'91"<QIPZ.GLGN  [<Y37G3;S0 T%?%J<(R8SM
MZ8>>+D=>('KR&4N,2=I$SN&*$/-F4WWXK@N@*T.-#"G/-B!@;Y4C;JWOS,V
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M1#,33$-5L_!HL.#DCHKB:+0=FAY,=& \.$D?DS_HD_8402@F@T,#1_Y6FT#
MD5@3]#2YU-BC--Y;B:XGFBT+U(+7G2U\!DECXJRELNRT)L[(M,!BK*0$:Q^/
MU;FP)NV/Q#,-<$JU.*5FAFF*S43<!<(=*1SAD5QARE$9_17@HJ+*Z4G33X),
M<A0BZ)#P3$+\?C)>"CDCFH$5(2*O$^3TYU>TG=N!,3M7JZ]3U#_I8<OR)IPH
MSU?$NN7H(L\;H<RB+X1"MZ(4-!-STC"^K^9:N#X.+4?@!0&33,M/8>]GO",(
M-^<=$R]JRDP=(2913,NJ)(*<<Y"M!5P.NL=BWSQIB1Z#\B*,T0%ZS>,B8\Q<
M[TQ0P- % D+W@A3I73@$%ZDEY=$"SETG,:-?I+SDE<*]-E^O/=/U;7I)+1&'
MIP_QR1&V@T&PY^M2/G)&4,[MAF+@(Z1)2A-D2= MVY%Q5Y8X]]*!3+;N_9D=
M3OL7DG1,A#<'3&N))UF#7!>#2#+1(\->Z'^.[G7%V6$LVQ5GB'G="*@7K *U
M-H[01"UGQ-G[?^W5O.CT_[,F^:0V)PX-E75L/<X$^&7=(&M1A$,)7SP3 +\-
M55HY.><IF.#^:=\!^&7[\+E9A_W]1JNY1@I),UHK[\R=E2D<(X@>V!51!XAA
M!T%FV[GF^YXO9-0WCEQ[Q['0"=8XT[L-+B^64*8LF<QC8 /49L92Y1=*)N-Z
M ]#CB,A/H=0$>B+S7%1P3I0X*Q$= 'X>I!B]4KO2$4@V;@$&>T>>-Y^39&I;
M33\QC)_;6;_0<MR,@5CO"-^!- J2)\F'8$-_) G=!P6S3C\CW@X(;EDT.>BE
M(?Q[[>E_FE//^&0?O, Q*UT4(2F0?$X^,E)V4(8+C"1O;C>7?%FY?5NO8IRJ
M #LC\'GKW[ "^KU#EQX%%*+:# $%YA$;7"$=!=Z#FLZ\:FAKK?&BE7.(C"'1
M ,ITXP0,LAZHH[1;U6R+U91=4&<]6]>L0^T@]"S'W8).I.25G50M[R2_EV@,
M/N9G>OPH^M"C)XA!4-<YMC<Z35ZGGRH;19R-DS_2I?7^['EU5$['"=5"6,+3
M_1YO4Y4%8R3MXQ,[:5JN*(3RF\7K&.^<F69!LF;D0]C!X@36XG39@(C</F:C
M!P1ZI+JEJ5W+.H8#YXR3P[3W<L^F9&WG.>T9F1#[RZ*B2WN2:MZVF*01YUZ(
M.Q!,8/84 JTC31R_#Z-&D;BR'^.:E[W<E))7:'.3'2NN@77UL"EI$OGE^4UL
M6/W/KLX;$J[DYBTG72L4/<72C9J_5A W\M7XXD*3*S4]-_#D>!2%OGG8<$I3
M-4*9T>F>LJ5"M6\9L<_*UX.0F>:M"UZ)%\%4PD3P+N85K)'N!F;&T_?!9?G)
MX1N%(Q$]IA^*+%A#E,<02]=OS0C+IG3[J(DLR+GHE/#.%69)7[E<&+NCN)U7
MXQ7KO' 6 _LUUX'B'1FNI<$%9O>AFZ^K;G.WG=AH4WJ$LAIMU**79O.\S%%2
M)9]UTM76)G((06F<18=<"H0DG>@/^[;V%+ #!>4T&(FE"@R+07)\\?U'K-V5
M@(3G[&%03= CC$<U]",O)SI<<2S7T&N2_2YH_Q42,/1DC!%H\5[1@&)([)D[
M*:.-*/21*U]W7!B#UY$-Z*01)%$]-S4.4F<@)<G&PR$CS&J^NH"#=O]@FMV"
MC;-J;^ X-$'[4V39G:&T\Y,WH2]MU_>T=<&/V#EM9Q)KIU+W9$(-!BI8B<+'
M>TY_T]@J-/@S,F:\CHDH1G?L0"[&!US^@PD',GY#.HT><.1*<VQ/8/KJ_8SQ
MJB2#;./%*Z[.+R+5[L5 $R&JI[<1>G0W11OL@,,./-]@!V[!LSP('D9X\</=
M"Y!B\,WKFH=2$^\<2E3PBC2?LQL4[&U*PX<VT9ZO_FPC,VBMKGT.2A,*D1:[
M/RO4_W0<][S%-YZ[F&'\RPLOV?.QV&Q?_*CD;O Q)=G[O!7?SY'?BI,TDB9*
M:U&CI]3B9GT2WPNIT+.\TL.3CAQX3'3PW%+J[&MF28[*S#Y9O;Q76!.B&(H<
ME5#5$X["*E9//"#X'W7J_!IHF1?0+@].>[MFK.L+&GBFNECE#21V^?*D:8?]
M4:4*H*J&I'NU#TFY(K021QS=&RS*UY?#=7PS:T*FK;A>)(LC_^1-'ZT+K7-0
MI* @T&&9;<%LJJ$>$]PTN- IJ13$ 8Z/;F"YN\8Y7^C<]=!1EGW)Z6$E,(4
M>YD+ZZ%UIV>F=D7SC@ 1C5;-W<GA7A/KE>/[WB;@HX'Q'6!7K BX85CG'53A
M'.)=91RM=W=ZZ98:)[]<Y6/,'_<E(PA[;7=G".V@XGI5XS"PD;(=KKPYI9(Q
M-24D93JG/YP@>H5(B-VU2L7_$U%+EM&W'+G#Q [U.'G';]![8O;6K_S$X?5M
M') 7*-E$/"XX^&I(E-3TD:F$=;D3HAXG'[_-$/;6'R^RBQ88UA4YA[1"*>0S
M:898 V/3BS/.Q493H*28H<@^!VMB3E$>@7Q*$YGC1EK7ST_MYX,!+ZISP\@
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M<$U2SA+WD\-KD)"]Z:3UZV:)+L']<>27@W42ZDJHT@&C@U/*HZ/'"<3)1%C
M<U3HU<GK+ JCE0V7NUFQ0RD<+I^OH&M% K=1X<'5F)BXB1:6TC*WU4@?AY4M
M %77VQ%TB6B!.BFA^41.QR@F@ 3<V\RI]$%*IBRFEF;6*S *CV+3J;GF*MQS
M=KS@O9"U)FCD47^N%.P7/ _N/"=D3K3TN9"-S>AVP 7;[8+-BII+L!#6#Z^
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MP@JJ@-D18^1GY%=Y4P)+1]:(CT'JUHE<9XJO&UV(J_*B S2X'):7E]32OUS
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M<7V]X_I:U=+-\;,Y?C;3M)FFFT,<CNSU[_8D;7R3S34VOLD%>_PCR>C==&)
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MH(#74!8+@+'I.9-09DN/P="%'P-\B!@GPR4T;?$I3#9C>!*!AYL&&'DH2OB
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M1@O$]@S)!UC%#&@.DP42MGH87@[41 )/D0-A5T(ZB0.8UW?D):[9!6^ YK]
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M0G FXZ+,F>-=P=0VV(PKK+)EB%Q57CH@:4=[.=K0%NK+:IF9MU-?IG9+:U2
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M$OSTJUF0W?MQ*\UJ<7IOLS_5)?D&U>:NR@\5Y>-\=F.=U<]2^9=R31\N5K"
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MN&X:( TS%*.RL7R+V70*P(4CAQ1$%O>!!PHB<@Y CSNU;+0)N52X17O>!#T
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MY!.3)MDM)G$"S</@_":C2 >8PNRS4-QK7(:@$H VFE$L30*0!*#[Y2O7N!:
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M,F$<F0DC,V$VI&)A7U;1*4SXV_X?^\=O#I2/_SXXN*8D85_F_N(0(Q?9#,;
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M..<!G/-^VJ(/#BPYJCCR4@/G"&:1%88CV":L<<18DM3&EBEEWU89L_5'$W^
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MR1QRU$C$F1,(4,H1H#6QP(75G(RN1<K9Q$]EURZ[]KUW[=K8H>S:<S( FV
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M"I@E6F#.C#:$*2Q$H#Y)3I,MZ&T&>J=#R%%)%S7AB!$N$&=> 7P]P!=V8Y,
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M@/:D@DA<Z11<#CE$B[CA 3D-?VCOE<-!)9^A36@;\]FH0\%V8['=+ U1$+U
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M/>[1QH^?=I[62P_K*+NRA*(X<V<KG?8^#UJIWSMK=;J?XF!*#Y<"/XMNHZ9
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MI'&^#(]9$BY:%?(5>'9+[I^UC<"O=)G8Y_;TM#4J2%U*Q2Y_&9&'Y"PRT!5
M/!6:<.!M^#, N8O$";=>XA*56RJJ/YJ*REF!%<;)(\4#F&T*U*V1-J'D,8V)
M6A&P *+G;2,;4GFI%!195%;J^9!>7%2/@]_)H)SFQ$;J#)*Y>!HG@&3MM471
M>\)($IRFG*7Q-DNMU$TK==.*P3-C\#@591#1^F PM\0Z'#@V)B3C!&9.EZ#<
MDA'F9% N6.F53P8EC3$8/"$A(R1&-'"IF9=)F[2QQ5F;B&+PK+;!,R?2B\'S
M./B=C,DI)J@&NP8I8AGB,6*D'7/(,2J=T]%QH\'@$9MS)_(I!D\Q>);6X'E0
M6NKY73PE)M<,KIR,R1&BL:%,H)0$B$,6(W+21<0LUSPF00RV.28'?S]Y;<EB
MY2PL+?7<?IT2DWL21^U43$YB:A73#%D?LW)18/08Q^ /&S77.J9HP/(QMR0$
M6=M"L?-=B[UOZ/\>;2PH'7#I8>GA>O=P':+O/YN6>O*.\>@1[KQFO,*Z[0$#
MT.P]KJ2T7E-S<'\DZVZ:@]9B;#E8@B'DG$?8)V29%,@Z0:PE!"?K:DMJ_6 @
M+9$"G),>EX@E2D+L98;_Y23\A=0\*8.LP!IQ22WZ_^Q]:5,;R;;M7U%P[WVO
M.X)TYSRX;Q!!&[L?'2W1MO'QP5^('$%82!Q)&,.O?SNK)*$)FT& D.J<: P:
MJK(R<Z]<>S8D.43@->N39T;:!=6'? KA?WZ-\8G,Y!496T,R5A7;7C4T;DR2
ML81ML!2 6!.I$$\Q(".#1@QKQ8/)?DF_L'+;%1E;63)6E>I^(>(_2<:233;*
M$!&AC"&>XS&M=!8Q8P1W(F 58T7&*C)6D;%EB'>HRH"O#A#O3?(P[820SA $
M&G!$G$B"+)$4D< C5E;PY,T""H%7#.P%,;"JB/AZ0,&UC7SWJG'UZ=!+KA5+
M)'?P=D#*I$4F&H\\L&JE%994Q8=6$5\/-E;X6'_K6W@B^#<TOVW]+_P8CNG4
M=H^:[=)A2^'J@\=%F1V]9G(2'DY@PS?390["R)<;S6PY@?!X+7O6BZ^'O_P>
MFKVSEKU\W6P7@RR^]/O@CH/I%F<S<U?<L'S[]XMFZ!^_-O25HBKK8P-?\>#&
MY;OD5:&J32UW^1XUKPP7-[Z-7Y$;W_O19<TKS=6]KOKC][A@U5BKL:[[6,7M
M)/8GT2,_YU-DYK-S.%%9..&9 %[-!?B#:+NUM^T00ZUNN_ZXQLCF+33P.P3X
M/.%';[F*RZ7!SU^7CSG I_;+;KO6/^Z<PY5";X:-W.T1EW#S90+].)OM93S_
M;6Q=*_OPV8"]SL^_UHO_W[6AIKO.L_ _\V?A/C'K"PGG7<1%JOM5]UO?".T/
ML9B3JC;:R\^<O4M8CZ>*$H)IDHI[;JTRU'I#A3?:<!6JL)Z%V)!/_/?&YR]?
MZSN>UW<^77[9^= \V-\5>W]^@OM]_=[8>=>LG_[5JN__\77:AMRX@K&<OK]H
M7!U=-/;_^MKX\Z_C;(O^ L\&8\#US[N7!Z>?OM?__)!& 9;#]-G(K",I8J2H
M(HB;X! L,4%*)*:Y9]2*!'R6\TV!Q7)4&ZBR:!\K,.=AHK[>@3E/)\"3Q=&,
M=#@&GI#'%"/.>*[?+R,2"C/E*&$TLHTM;1[>L6A5TF:K6B$5X_D1XV'6<QQ)
MM)Q3KA0W@ED1E0T11^55V<8$#V&05(QGV0%SJCB:\]%&)Y!@6"*>M$*.1HED
MPDI:')+(+G,J<W6T!_<\J1C/LLCY7,;S0%&O&,_3"/!D=33KA?;2&X0UX8@3
M'9!31"$&\BL,TX+*W+%(S EZJ1A/Q7C6A?'<)5IX 4:>*EIX.;!RLCJ:5]Y;
M9AR2^4=>6F05UL@RIQ2<=LYQO[%%]*;DLRE;57FT%RC<CV39J>)]G\56.U4/
MPQN6O.,:.2YSS"]/R$3O4<*&4Q63U(%O;*E%A/N^>-)S9Y?<_%Y-2\U?\F7N
MXY2K6DPNX?:]BXE*"**(<R8G:3CG<BJ'=%I$[9)P3%5.N9<$](TW4TXY0;#R
MAC"DO6+ VBA!F@J+$L<28QG@!;&Q1?6F(4O2E?=1"NFM9K?).UJH'B;IE87J
M:>1WTB?G8S(F@/QZ[P7B#GY8'25*2B>AA&54DIPJ__"&1:O27W)!T%$1GA4E
M/-HGFJ@'V).<BQ0L\33$("B.BA$2*I_<"P/,29\<@Z5S,7=H3"JGL?J C"$.
M$>%RQR*NJ-<;6UQN8LF6 S(KPO-(A.>!DEX1GJ>1WTF7G! 4N"B1*(8<A&19
M+A+F/0*YEM9$I53*A(>_FBU(41&>BO"L"^&YBTMN 2:>RB6W'%@YZ9+#A# >
MI$+:4> Z.''D M$H6&\5*(W6$ I8J3:)>(@9OZ(Y2R/<CV38J5QRSV*IG7+)
M,68T39HC3XU!7+%<HUHHY%0(4@C,;:Z*RM2K64OM4POS\[.>A70LNJWG_Q;7
M>*1.,=4(JQ&N]PC7P?E^WXY%E6JVA.=45>A^72E=<\KYKH)1&#N,3&(T.]\9
M:&HJ(BV#Q,;:*)E:6)G[2DM;%CFO2M6_7 &>]+Z#6&(?+$&$69<+HT80Y6"S
M6\E$++@!0K.@0O6KHI=5UNB*\OS0&,V)C%R%2 $'61#:\T0589A02930E?O]
MA2'FI/O=4AP9PQX91FENLRB1TP";"I:;P"^)2+>QQ;#9I.3!14 JRK,L<C[?
M+OTP4:\HS],(\*3_70>=M%$,>4D(XIHF9(4-*"9%F>/*^S+@L*(\%>599\IS
MIYS8AYMY*@?\<H#E5$ZL3UR2))#P42).N$4N2(:BH#RI$(2A )9,;"HSVU.Z
M<L"_0.%^)-M.Y8!_%FOME .>"\.MP!AQA0WBWA)DL33(4ZFX(I(P(8'[D#G)
M%I4#?HD<\#=U%%HBSV<UQ&J(+VJ(Z^"&W\VE[RLO_$KH9W=0SVRB22>!E9>"
M8Y><HUK2% S6%FA;JKSP+XG7[4VGP%LB8L B(OC)$6<X(,VL191X8D(@)F6+
M%F5XDU8I82].5;N;IO9 4:],TD\CP%-UJ:/'CK*(?$H,<0<:F6;&(!FX"T9+
M@AG?V-)\3EQT99&N+-(5XYEA/-@%'QP66A/!.1<N4DZ3,$YH:QWVE1/^A0'F
MI!,>>VR%"!YA'C'B@>;:;L0BDZP4@7I-- ;&(\PFQP^NY5\QGF61\[F,YX&B
M7C&>IQ'@22<\)0)DT&B4O ;&HRQ!3@>.@*C*%).+S(/*HEF5!%\QGC5F/'?Q
MP2_ R%/YX)<#*R=]\)(QQSF3*%A0#+G!#AD&J(D#C4'!P<=,;L)A-@FODN!?
M$,VYHP_^X9:=R@?_++;:*1\\B<8GF2BR*7<1E,PAC;%$GAB2L&/&)57XX*LD
M^/7H%?O&MEJULBMUU2_VY?<2N0-E<RK*(*+U .+<$M!6 \?&A 3**V9.5WZY
M%X7U'Z?\<M)QHXVQP-DL$#>9&#)<2.02)H:;8)@$XL9S\[0E:3A9=15Y)"/5
M R6],E(]C?Q.NN5LD)CH&$'Q$B%W$ &FEKC)39^ID9Y%1Q@P-?%J-O2Y:IY6
M-4^K",\,X?$X,6JMC))8KCR<BZ#TL,BLQ8DKK2JWW L#S$FWG,)*>(R!\'";
MX >.2"LFD [,.^&-888 X3&;FBQ)O\F*\#P2X7F@I%>$YVGD=\HK!TN#A<$(
MEBK7 #$*&0V$QSLO#,BL4<0 X9%5M]B*\*PQX;F+5VX!)I[**[<<6#GIE>,J
M6DQ80@P#P^$:!V1%TL@2RA0/SAJG-[;DIA15L]@7Q'+NZ)1[N%VG<LH]BZ%V
MNEDL8UC@D! 6GB(>C$%:,-C/G(5<U0?6, +S8:]F#;5KVRWV88FQM_7]W^(:
MCU01N!IA-<+U'N$Z>-_O6YEZ,LNX?(0;$XU76&^[PP0L]QE75;5>4SI8+]6Z
M<3J8:$R:!(.P91YQ#C^T,1$E0PR/+"EE[<+J6M]9D%Z0!OA >'Q!*%'5Q'[)
MXG\Y(?Z2,,N,4,C ZB N$D=6&8($)BX(A2,C?$$E(I]"^)]?8WPB,WE%QM:0
MC%7UME<-C1M3 ?.*P.ZF%'F3.Q,DIY&FT2)!C%')6^<27EC%[8J,K2P9JZIU
MOQ#QGR1CE#F',9$@^=+FFI44&4M@;P=N(Y8A)NPJ,E:1L8J,+4.\0U4)?'6
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M0F\\@)ZK>>Y.L^=;G1Q0M"S8WW@SQ/Z_F@>G;VD=/O]EYRMM[+R_:NQ_XGN
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MS\Z[9YVAUI\O65ZI5SOOP6CSMZY'//KPJ]J3==<93AQLR>WBR8 *+6]CG>=
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M*RE)4;^>/CC69/DRKBH(6U4(6U2^^<(@K$*INZ'49()ZBBR%F#CR'"O$O52
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M$K1'MDG$@TU#%5%;8OE]+*)6R>^BY7?:1\69I]&A)*1&W >#K'3 UJS *FF
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M*YAPQ$0.+"(P+9KZ@)S@1A'). MZ8ZO=F9&Y6HH@0J!V=++RFAM39OVC,UR
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MF]%@SQ 7G(2H%*7.Y=Q\\W"><2>I>4$5LM85!AY+K:A@X"E@8%+9,):%:*Q
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MA%R((N>Q:&2 M2,N]?]G[TV;XDB2=>&_4L:][SUJ,X+)V#(BU&,RHP7JP]@
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M[]("]MI$C_G<E2@]+10U6F!_2S"@G(HR<FSK5P;,^/U>G\$CN0CL2:\_S#&
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M*V(8O_Q?(S#S>+'BDOF7MQ>CK=E2]\<QC# E VDIY'!T%0L:4]U&:SNGX6'
M=[6@<Y1&5Y1V0WEL3T][F"H!8*H_0BBU 2\;Q*[K]'HG,U)Y\O%$-"_UU];B
M^K@=4^O=V'F[GU+;QWY.+-G!T$?[I+YF^UOT56)I?4V6MA,A7U/^6!97;EV+
M,6=8%;RBSJ' B'A^8AP_L5<_\<Q.376C-3N?64?.Q-/B[> 8MJE]F@7Z[9PJ
M)2M5+)S4&@QA*TN+T:9@0ZFE,47R=9Z_XG4.M^;%\D+9IX!L7]?]&0?O>OT/
MU7B>4*WKAS9)=MC^UJ?#POK$!)>$!L^(<*XDFJE //4<ECLQ+Y9W/@-BZHT&
M.?^EAN136XZ.2TRJ:"P0="RB"Q(=K& SW)9VUVO'9(7W@6(V1T> 8&O,7^O#
MGP+S-^YVNA*]2T7O.$%Q&H6NMW(0.!N>&'_*&/=#/+55('MB/>7;&J/TS]C)
M;M[&D 4R!MC0>/*;T%65K(%>[28;Y;1=/Q:-Y*N \#S\;;W"/VI5L&QXC4*H
M?(I+)S")3"!(O]7KUZ=C'#G%J#N6ZU5N3J7,%A1%C<M!38 6&L;:/S"#13=6
M9#J3-+R<^#"I-O3\"/^*RZRHB2V$V[O>"E5 Y;B-='@"9#F5(X9999/-'A[W
M>Z.CX];*0KCDY; I%1TW*0$YME=Q4U[@-.IT<B(P,GZW2L.M6'Z<)FL3AM\&
M<PQ21>%Z55)H7&"[\>8N08V]RNLU[,/$VLTK,0/U[#($=GO14$_;89)Y.SPQ
M&^=2)'A:(;4Y-&@"HZ[PR3NOA631E@63EEO B$D#",P>;5J4=,:CO;/W;@8%
M-LU1/D1LE@(&8P,+9YS7,$F/#NPS3#J-W2=T-._Q?->[GW?/]PZ^'%HA7=3&
M$:>\)4(E0W2)<4TGG)>.66HLZ.NSWJ7=31[E"'IG=')*!J,34(+USK=J.AO<
MUBX1VE"?0BJ3%\*#6<)]$:S1G#K)"YTJNX2RVB[!7ZZP2_X- _LP.EE"D"_6
M.MEE>VB=:$U+7F(CYD(2@8:)\5$#M0E%52BT"N+J"BIS^P:F#O.^+*Q*6NA2
M:VZ$*J/%H%B,-M;VI,92PO4OJWV[_;X)ITJG0T&D$@&LRFB)C=P0*6AA2ZY*
M6JJU-YPMEF.^PL[$9/GUB7Y-H(JSS^*XX6+4GK6>J\ NNBNJOR8]/)^&XGM4
M+#1M/=,55EQX>1.E  30ZX8KJ:JU%7U$.+%REBYY^=0Y.838^=AD>]9%CV;E
MH(;0]>&IK(SQ^B$>8AFGU"V+&4TB2LL@<3Z%%;_YXWRLI'%3S>/R*:-KZF#)
M(D18G\+41_!5DVTV-@.R"8$.@R9[K#$.,-6N/O-7'1?-F8TK.ID89_GDW9(C
MJK8^:0J65[O3'A\C:I*-8<O1N_A3>/YV)C[S[-RW>7:-K;F,O&=3((%]0".>
M-/8??G6[<BDL!B>I*;!_J%#"&<M2**,',,\!+)EY5[NZIEQ*[N>^,QB,8J@2
M0__(CHNJ%^6?X](<^;+-,["-?^_W!C?,<'QY1MC[\]TM?VA5+)A(G A>ED1(
M*HF)NB2%--%2*4JG$N JM:Z+)1[[Z7HH5:V4XXBN@?,EWH):U46L;5*+M+I$
M2O.4)@$9]BO%-IXA1WVX"AQ>"2J695:LU^Y7^,5C4GFE%^VWK"2;O/B>Z[0G
M)[B1<[NQVH.L2C,,GE(]]?Y>LV$;K8^8/7*%A)D01E:38:S %IUI6;N?5\-!
M[3V5"P^2*509M&T\/ Y$23#-R[>K*CO5 N"G^(R(4?K);*LO<YV"?DYQFQY(
M%<.<ICFVHKFE3L_)WC01CCH0D5L"PT9U.G7X(1-AUW:'B\&/FFQ_"GV[WT01
M6TRNI-6MTQQV+5QRUMK;:/WWJ!.'P]:K-905U1]-( MQS%V2$RK4C!CHI#*N
MZJ\71]04OJ@'-CE=>'F662[Z-<[YJ8)9-24T@9.G10@;CTH).>"P="7;]9D:
MS$%NY^,1.?$X[Q5<TWIU5>6M4GBN'&.B"%1X*HRS+MG"6LV#YR5O''&\F$KL
MF'*]39)C#^"E.]4 *H2YZ,8/HS[F"[\XT#B==;XK]P[\(;52!1XM*6FB1-"B
M)-IJ2DQ9.LV5UR4- "#GRV7]DO.MLP5_@L=$$9!TGS;7/#K8RY5I[&C8P](=
M8+9T\*0;AO;RP;8JU2I']KH/RBH?QF_^$T>S8IIKF.;SQT/&-.?),B*LT$0(
M;X!?#".A5#0X&RC#BHIT.=-4'JYU/#F)&X\'-$"A54'\?-;B9(2UE8 Z:F";
MCSB"35;5!<L.#DS6ZV $^E*MEO$VGM+$$ET>_58=3'N%QP#21]0\4<ZM63]8
M:P ;?OZ0%/BV&EZ&]Q7Q_0$_^@>][6[83_6I(KQP*4T&>_[22?)BYY"7#L2X
M$$1K[T".*PN_!1#FB7N.A8]I$=?>E,4B3<+ZX0'G-E)!G=)4I65FJQ,]KLTQ
M-"3<3+=8H@N)Z P+DHWS@#)"&R<=U =XIO*J+\4-]3V#2:)"39A98JZJZUQ1
M74>LJNNLJNNLJNNLJNL\0'6=:ZOES%77X:GD6FA7BD()J;0&NN7:4,XBMR:8
M9UO_MC[64!7P[F(=3)?SAFT'J]'=]D##7:#4L@24)LQ2^U,&".=B=Y W\ 7G
MGWQD"(\T%3I0SXB- 1![TIPXKB6AREOOA%*P"Z!.EP5)FG23]>DJKQ5<!UA<
ME7?,2+ZI$S*8!+-SP<6O0""7^JOJL$I=M#0"=;?K^HL9ZOOV*>:03@K-= ,^
MH8)1,<(]W9C: *$Z0,^MHRJ3'4V'K[;=:2HYCI-&*TG0W#R?M[I>5ZO(&<;1
M=F .[6Y=9W6]U6FGV)1LG%3;''\]7UJ_-1H'$N;CZUB_9WB>7= -?>;QOQK\
MLMX2!7WUY9?\=[4T.4DUY^'V4II\<IQ/A9\/KH"5.;UZ%ELN%(KMQ_:)RP5T
MIV G;B8&+*92L\<IO^,J#4W)JF7!EQSMF SI%%XPLMWAG-?\OP:3#1V/(]_0
M'*$_Q9A(Y?P<5^2]8L(H5S!D/O;H9QT^:,XEU+-KG*'-.N"@QJG\LR[;N1,$
MTP32W-*>V*;- W'YZEC"6SL:Q":,D"L>IW9W8AQ<D<$Q^_BYS:F?_GNO%UI_
MY@J=MWO'N,+ 6>Q\_<'.EH/)3&K;-O_\*X_@;<Y$V>FB-N[W.DOMVQ/X[OC%
MB>U9"W=_:_/0.1F<Q:Q/SR0>3,-*&482 ]O#@RFBHP"'*5NT</,*9C:PK6K%
MD3CJ-;\AR6Q,TR"P=Q8N&,+,]=^!AV;R@U#&H?N[]R D-I]N^ALHH0\9C%SA
MREN1%9+5T2&ED:K2.F*I +(J@**T*!TQ98JV*+0PI;Z.K)9(S<9G,HT,L_)%
MD8R= 1Z4(J:$$ J>WFB8)?-_9RV_TVCQWRHP,5A1S=54<_#IL)3:&94* B 2
M\"38!<2$R(C4VM-26L,%4HV^BFKF,58#YL9U!6$3JTAHSGV\7.&>55O:RGN:
M'717J\\IO?F0FG">*.>4WXH8;T^,[\]VM]X?1NF5U-BU/H2 QHW!&%Y!))56
M:IHHU?(.FK%"FEAYY:B'D&^BX<:$BG5<QVFZ3:AB&8:L+)#JC*R=SDN::GTQ
MGPT\1K%-NM+7.$E%N1$,'@TPV :2%U.)PKCYTCB[:#KG:%(K?S#=H\/^^'#<
M7J_[MDIS&N=9K4)P5]+\P<XA4U06G&J"A36Q"A\G!F @"2X8H:-1#@\"71:"
MFTXM2[U.IW?6U"F=EIP+I6%^UEI;RZHGK)*?)B^?MIX1]\_4-3FK73JW[$5)
MI<3:K\(E)J*+EGKF7>%U9-P5VESC]EM,KL:7(/ /TWZ_S7[NH)&-@O/));4"
MSDG6V]D; VIWV,_.CD&N&W@ RF#_-.=;_HY'&P8[W24R:96./990VV?[!U_H
M[L$VV]]Z3_>W0$*%:#P3EM#$,%. @4V!JCG&Y'Q!07SYN/;&%.O%,J_CI'?E
M+3QKK*!E:[OQ#?Z1?6A5H93JSJG$W[I56,>>5EVB6GT[1%U7=:!!<EZQ_^SQ
MN":MZ<DE%#^AM>%/;6T>.^=KM1R74(I84<KDY96,1F-J*L0T=8QFWA\P!U*G
MK*!7\9N/I\-EF3@+>F2,:W^9<6[>%\(IN:-!L;*07HM"!NT*IA15AI:VT(5;
M(9SGC7 ^'7JMA:::$YDH5F0(DCAJ!$DF2A<+5GH3UMY(>BW$.8W]O.9H^E\!
M=^X*;YJJ.L?M/A)T%PB[/ZA#]?A%4P<T'^*M^TK /:_:O[0LEMVI2M35.6'U
MNT[[6#3K>-0/G3K@6[/9E9Z"N[#$M ?MA[' 7J_[%58OAO_.,[K"_S N?_/"
MR'^FZ$VQM_7E,/B42D<9('H>"';X($;;0!CU&N1ZZ8PI\> ,2%F"7H=Y7T13
MN&O<9WZ&#JLXZ*LV$.$XK699@:^<%3S%/Y-J8,^<$O^83&I%CM>1X\'FH71,
M1HJA46W WA34$Y<T)5Y)6AK*A'"B)L?J\,8"/5Y&B)<44YXXSIJRRJ]O"1&4
M3;Y0110N)%$F;Y(*C)6Q5()&ZLMK(,)4':\52'@:9'GT;6]K\S!8$Q0&QA+(
M2"*,8T2',I+ K:*B<$EX  9:7HD+ZG2=2MU6BK;6NM=EV,$6Y4V>HS:*V8@:
M!@.26@1%M:2,,<Y\I$+2J.MB<8])9&/A]U<5)PZ;&'(YBIGXMH KW]EV_S^V
M,XHOF\8NOARR(FEG*6;T14Y$69;$&"PYITKF161:.+;V1BRA+]"0%8VMWU)<
M2>^<#D(65%HAH]4BA,1!9"E/J2WU2EP]/U+:/]@]9 F0C_4E*6@1"2@C2K1C
M)6XB,[8,.NF ):_5P\JK4A?::"!E%J.00>IH88!*2<^3E$&LY-4S(;+SW8N=
MPZ),N)6*T( Y;+"Q(+F YGC@3GDCG=$%R*O% GAWEU>>!A]+RH,O@(PX,UX
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M7:OI*O]#INV-UD_I2MA9K/"*WM@_>X/8=9U>[V1L^ ]AN:L> ME!@/5:L]R
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MREY3%>G]=F5IZFE_0#P=WO$F,2"CQ5[7]H $'[<,/S"B<2DO8T1+;,+0M*,
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MW5.I^T^SEYG;RG_7ZGQ>V=_=&O1QFXP(3[[/S_GT(]:5"6N<XK;6O*]L.IR
MFSX3>L5JHI/?9T8,I ,Q^EA+(^:[CL>4L+Z"H#F#:2CQ-EM2CR+F 3W<DR <
M2HI<_A<WM[WD*E%Z%9;YY:OA.AC'/ 58E7/']8#H X799\>A8UP.2>N3Q[
MQQ\/J%!(\!KSN/'<>3]TID.XVTC,42^)0FSX*7:H$K,8DDHA#K*(6$-7!M3&
MQ[*Q0/SGU+U*Q]K".ZR:+:IDML8?\=2"J'3"^R_>$8E-3H-#B2:9P>TD@7OD
M[=7J2>G=I$O859!"?L0ZA?&0!V\;SUZ[]/^F_&A!LF!/@Z0FZS=V$4CV*V2;
M#3]A0\;88#XT.?"&<0-YV./>%$E&T4A9,=Y['S)8!=%$&9$!S7C*7-)/6=.3
MQBW9#]/IM7G1H957S-<8P;'Q&K1X0"_HW"@8,0E-HFC*)]AAL24C9.&AQ'-"
M& ?G73P>JI=E_569O2)UI^%Z#X(%HO"*&X@$SH ,124=!J](S$I9K@WI;Y_>
M1/B#84(XX(;!<0"72&-8(ILCC;^[FL+.(,%%)<D!V>%-@57H@*9SN<!@Y:0#
M=P72&23]FR.<#33@@!"27+T1A&-4HK@;+E.%<:TH;H\[=7B%;1-,40<G#01C
M\6PH(QXW?DOXI+#^V-+%R8$Q+V1@PV*F8,#G#@EID\6,9^XFZG!%R<=:<P.W
M1D!\ E-DRK-:F$CV1]=43+T!#1!7':].=SA\$1LX (W_9D(G9!T>X.R&?I31
M.FQ;X1O2#4ZCS#2!X*,S^01H!JQWL*!Z!-IG*3/.3P;*$=\/5"[&:+$A$N_S
M6Q]$00EO\I.3<!2/F11=102W)BMCA#G3M,4/7-[$?*Z%?.A'O[AN$=L7L6VR
M*>L9#PN-):N=G@47;9'0QZ*HMB0QXT%D(UV*E>><I1]. $UX%7X"#^50%[')
M[,9LMWW&:CM(L"C@ZU/8$8G/NI_ 'L0J(7DGU@=S#+M4/. NPE$A "X88)W\
MK.M\';"S1>=G3)D'E-=6AJL"5O&?3)S&%7?J_>/Z5XF-HL0$P"\ZD4Y/&\!F
M?+H@FD@NK"GB!0TSBB_6&_,/D0K,S\B/([:*SQFQ/*1T$J7KRBZ=X [& B^5
M]8*,04JBO0?TZ_J1,XW64*%"JN/E8YV7+R?@F,(HT=?B(&,%M'S-K-3/"<94
M]%Y"?9:V0V*T 6P*=YJ_/ ,-\UV9>=#EM\-/@^ED9INXZ&#(ZA%F2U.VS+T$
MFT?K(;NB#1UENR+QI>T@(V9,2Y##\% "ASTK(6>MSB>89(OGJ>$<XB'YQ2TP
M'#[$5L%-ELQ93>.%.6!HP*,2,%,F:._"F:>A,T$A<*L^VL0!\ZNZX149^?<D
MT0?XY7-00.X-R%'VJPAG@TCO&]U^]P,*A.T*6[;B;6Z(;=YD&),=OO)QNW:(
M==6Z"KGA'9(AO0G"7U(9$=- 89O<KD]9'W@!;=L@ZBFFLQ/Q$YNFKN\R0RQV
MX5*V? G>D]PIC658.JT</?(0KW!#R2_&_?[HP=W^G!OEZ68MH(CR'C;"V'*G
MS UDZYOSG$HB_BT:5(\#KD?A1T/"?/Z?L&VL\QXVO,9 02>8H"1GFC89QA#
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M6CQ4%W#)4<HB5-)4;_PJ)T="(Z!X&U=&!\%-:2[U$\UDJ.!;+YJC6H'M'HA
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M\ 8V. >#4/&T35="4]]G W] (J'9[SQKY-*V''O2UG'=4<P/YBK'TY-+:>^
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M>'5^M<5U?D=VX-[!?ZXGP\%?_Q]02P,$%     @ "T6W5I^17CKB#0  Y9@
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M!$4+X;=#0M=AW_UC,4\G9,/F_407KJQ$359+4"@6LX%8*!1C.4MF9&26-X?
M-1KVY>G%N4%^/4^+8_PM?#Y_ ?83*[B.1230J"*HDBG!-)1L\.Q3SH%[B=B8
MN\W4C"D>V@L'UQ'>2 '-0/YZWH?Y^VF<X04A+S^GV4FM%?]ML<B?IK/91#!/
M+EM8$-$84+4L&ZL+#T4R67-45*V!OPU=8XJ<FH*DN5(:AM&+C[CLO[R=A7E/
MJ6^U^1]KP:H"F'+4XHT2$)4D )/-!L^T &%$<B8+QE-KF-Q%SYB"IZ;P:*:$
MQJ[R^3EO0I$!BYD"^V $\>851&L-&"R.?C<23-D@?O)Y&R=)H>CB9-YW[S#A
M]#30,B3!KIE#EWS.U39'1O(-/@']7X,H5J6LO$,96S-W!SWC<Y2[H.!&'-A*
M \T0_CQT'VI-GOZJR^TTS%95^OYY6"Z_D%D^2VY1<4-L.9 \U3B5TI88F(6
M/$L5DV.&MZXD;4/8^#QE"Y2TUTG+<M-'RF HOL-NPF)E27#@"25Y:BL@2(S
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MSY 2X[*2':)A(+AE48HH./(L5.M]_%Y #7ERSWGC/;S90]';.'.PP'N(]MW
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M;IA'NSQY_74Q'2\+./TZ_+RLX_1UK#3N>O-B,<?INTF9_PY37.,U]6J,%H4
MUDP+'2R#S#G#4)0KTG@E;RP76\Z]]WCY^9#A*.)ON#S,IO/!VUH+>+D&)@DJ
M%QF8U;QF[+K$HB$W'0L:AV3:>^SD[-!3KZT(].EJ-?CFA6=C?>XOQH9YKE]!
M;.X_=8"QBPW91:OMY_/#]N$!PK^IO@,DU\>D7,,I'&AQR('I[ K!L9%Y93*S
M!CE'G8,SG6)3IU;@%BNMO?YV$5ACO?V5)'6YN-S<14XVH9&203*&@.C,/))E
MJ6D1\5$J@&X'% ]H[IN7'F\S/4CLDQ8R:V@X+8' YVM $&044EI68O+T>H(4
MT1 38\PN%J%"MY#P0\J[_M(GJ+R]9=:#EW,KSGS-P<L8E0-!9KB+M+!(@2QH
M'AB/,5H%Q8-M73#Y'CAG8_JT%GT/=8UO0;MFY'>!UE.@[1Y8IPFP-5/A0]0X
M4/['6#BN04Q8*PUIQ3SD6H&H%!9X% QB '(*DQ"F=?+*T:GQ0 #M%,S81>Q]
M=&I8?/PX&N+T%L2-F2**=SSS6DU$,IU29$%&R7PH45BN4,OFM<[OAW3\*$HS
M]=TLZM=0]KU4<[HU&W[&<;JXA.D_EU/"!2G19F1<.5$SJ0(9LX!D!14NE9:\
MJ-8%0!_"]#W8&_LKH8=;A+?Q;="M)T@7?,>R/&Y@>S3FQP$:?9 N#=1Q% _F
M!DZT 57,DA67(].NUK,2CK;;D 1'FD@(K=/63D.7W4V2([)E%RWTPI+9_$WY
M]\DDS]Y/KFJ=&<F=,"6PG*5A.I#C'6J5!?+CZRT6+#ZVOJ!\-Y)'8(H<I+%;
M=#A8W(TC5<]KS16<?H3I_,MKN%Q9XJACU""1@:TU$WQ6# (F&F>)D8L$272Z
M%/1 P.JN=Y^->=%$N UOHB_#=/AQ,4T7,,-G--1EZMI-B!N2=P#9\LBG*[#C
M'P@=KL/)L130^N2H,]A(OKF,3C+RI133A)&<-2C,@23O#&12O%/5Z<?-DGM.
MG4Y$DEWDWI <R]R$=\//&^]Z4R=3):_(6W<,4%5OVCM&WG5D*AFPW&%.V*VN
MQ>UG'_DXHQ\-3-J)K_EYU7]-IIMJ?JMRZ398FY+U9(0 C4S3=@<HH+:QP>RL
M$,5V"E8^>&AU\\UG90$<*-B&E4PJFDK<-^4;3&L>=P'5<+_?"N3X^_NA&IKT
M)=[&N_EV<$5S6F<2LE0D[5-&2 9@$E/92VT 0Q2=2HD_+IW?LUL?1>6[2+7U
MWOP6EX]9[RO!<(U AD=.M7X -S7],+H:0$\R@A RID[;\C>//>Z.W$C.DR9"
M:IUE^QI_?W,-BBM<8?:>.:$]07&)A:@RDX'33VT4#F4G?7W[W">OL /$U-PS
MFFU:S:Q2_GG6OMY%+:E>/$2HK0&R8)YK[TH4QNA.1?@?]'^^>>U9&4J'B+1A
M]:X;4#:7=3J :1H-N0'@!&FPAZCC;K4>(,O^IN\F0Q^$5,8AL[IVIZ:WUQ9R
M@1F7G'<QV\A;I%<>2;'WI<?VIM==1-A8G^\2CF$ZG/PVQ4_#R6(V^D(._&0Z
MQ[Q)252*)]HL6!3U3D0M'1 <T Z/3F8 <(2P@7H?PG'L(,9!*IKT)-_&D8NK
M4J_/QOE92HO+Q8@^Y!?X<8IIN-RB7N L38<?5[O5YL+.ZFB/C X>L;!LC:BE
M166M) $U9=Q;KC+/I<W&?0#(,]OFCZ6NAG4<NP)?V;P;Q)MT@ Z8F]H.^^$\
MA8EQ-"KL2,!F>FQNM^R)'8R7J=X]!$D;O-8RL2BY9\7;$+P)$$*+",_CXMZ]
M5M"3HMXNZFL=2GJ!HRE\^1DA76Q0??6_D_9%1^8T[0,Z1%F/MSQ3UF%"5YQ4
MW<(46U]Q;'OI&.J9-)?M5H/J-!WGOC4;)ANS(2[SO'OO0M?I[<?L3+>[.&YT
MJPN6UA5E<]%!:&<,@' J1@PN0Q*J=.Q6UPE'SQWLR!50(@K+-$V,>C7=LP J
ML" <B*P=1J^[;$.'E\!Z=<H.=M$KK7,@BYD'Q71.]!U*QT Y7D"#Y-BZGLIY
M=+#;A3\M.MCMHJC69P(/X+TJ>T<HDXX E@FO"],Q>_+J2Z&]0EOZN2J2JT[[
M<.=7G@DU>I1S^P.]>U'^':;#VDUOD".B,)B9"=818VL,!I1EW&(I*8-T-WM+
M[,>%S0N_(R;L)>.&13EVP7B-M2B-<3("<PIJZXN<:CMSPY3T*+BUB,FW9,1W
MN4H<*/<>;BK?&[PCP]&G")P9&VH&>ZS8Z"-D78I+.4O?NG?\DRA%>HA]T4S@
MIRY%NB5!1J*/BH-F*=0>K& TBUY$)F,AJ="P9&Q3P^))I /NI-#[TP%W$>S1
M4L*Z@/INT@%WTE"GW+!]Q'LTW7/N#:($YFU2M;JZ94%'QPR:+)(2TD$G]_1Q
MZ7RW=,#V*M]%JOVF P($\#K1V)0@)(H+!I: Z<(S6 _.E]#1(GR$Z8 [R7E[
M.N N0NHY';"@)N2.'(QE57OK" K$S)+TO "4(D(WG^YQI@/NK; #Q-3/=>M;
M;L$[&.'L^06,QSA:+BO:)6D"1I83STS72\0QAL24!R$!=%&I=9N9+KC.QL3J
M31D-_?BN&#<Y.QU0]E?<H0/"DY5X:*SA'2ET@'I.L/ILKJ%HX8KWGB5A:IZ6
M5\Q+6B@#9(.@M,_0NMGC*4GT<.&'1\&A7;32VC1\62\UCG&^N8(8T<1L+"LN
M"%;K5K.H K""*AI5B@;G.MD:WS[W)%4<FHM^TD9NK<W%.E0:Z7.LD-9XA)0(
MQOC:@4\S[:UF4$^N;% .<]82@NZDQSL>?G[*/%2"6R=EZPR,398(7*LS_QKG
M!V15//#$-ID2N\"^D?T0-9GO0N:D.-?9\Y"3D\9"M"8$!SAXX-D]=4>YBADC
M\$1^AF:BU.) 3GCFD]<,(204/EN>C]8<Y56KK(:M;_CWZ60V&Q0PT5A5R%&K
M+EM2BH$JG%F46J.34J;6+>[N1_2(VC[LQXS.?6!V5T /90NW9DS2@K,4^S@_
MNYQ,Y\/_6?Y\ZV &)?KL@L\D(FEKA0Q)BZRF!1R,!FNUU]WJ#.U I%;8SXYR
M)U'J,3M:T:XP0"ZMS 489%M+LD3/:),7S"M$U!;*K=AG?RL7X3D[$C43?@\!
MEW?I O-B="U_]W;/GF7D"0T!C$6Q(@V9?MP38N<D4];3HAMB(J^O,4FZ8CO6
M47G/-.E%%:<^.']0=M=*70,HF@DURFW)2Z$M6S./*)@3)?$20J:9<JQUZ/2M
M!/JAPQ[]/'=1RS&WKFO5L+M _*.?YX&JW:,KXSYZ.1&%K'#U1!M8+C(R';AC
MT;AZ(3@K%1W-I)L)PT^7.@WZ>?;-G%W4T0-C;G2;+-*%4),>E..U")VD)5;'
MPG@14BK4/.O6Y'@*_3QW4M+]_3QWD7 /SOLK&'^]MI]#E!HRRT%!-<@YBU%)
M)G,*!,1SFW-C75^]_?STO*=D>YS3+R\_3B>?EN;MILBD<9DK$P*STI$3)F(F
M=RP%LN*5S4$ZF7SK'C3;T9P?!QI)O@_W=]TFE@:]^?8%?L+1Y..JO.GL&E#R
MX%!9!IP'IDU(+!@;6+2A<"MD,3?KCQWN_W8%=WZ,Z4<O/5PI^-J,F)!N^A&O
MD5GC1' N,FEJMEQ*FD'DF7D3I5*:5CO=.J]I.YKSHT@CR6_M3=/ZF/+EF+[%
M]_ 99Z]A6CLI?#KDYO=]CVMS0-D9\(W3R>0P*(/<EJBU+=PKE:0-D$H)5IL\
MN._!A\W&-\0XJ!>\7TUFL^?T["]E,J7%(\^N0G1:%4PFT@H!D<@1BF!!DKEI
M/<\%0JS=)1I/RPZP#EV'MK]B()/T)7++) K:8F/1M36'9J$4 *T=%&R]#FU'
M<_QUJ#4G;JY#C23?@U/S2Z%1U<GU=<*]A3DM6FDR3L/1ZB3KW05MK3_##//S
MR>5'',^6/_WE<\+9C/[!SS@F%<V?7=;""0.9C<^>AF)U;6*K56(^ELR,#TH8
MP:L9WYA)K<=P?OP[J99[<-,(S[/\7XO9?.DFO,/Y?'44,:-]_F_CQ6P!(S(M
M/@UK*&LVB!Z]XB:S$*O= ,XP'YQ@T<><O(LV->\%N!/ \^-;?_KIP;_;+HS5
MV4E X4WQA24-B6EKD2Q%8UA4R#%CDB&V+K[R *1C'6:>;EO<7?*/Y1#SZPK[
M;#&_F$R'Z])GM!XFIXMEADLD=Z,.A5O.M,S""<-3U*WS)^Y&<JJCRJ:ZGC27
M>0^;U&U4:X^V"ZZ>3B*W83K-\6,+O3U(A0.$?DQ2%.-<=)DS'FM=6)]H'258
M+&6KO4W!9]-ZESDN&1XX4#PF%W:1=0\<(!0XFP_3LC/6=%.Y4 *G]<]ZYCG6
MFEGT!=!H)IQ+009MXE43]U:U1>X"<GQKM(V>;I85.5C(QRL/63VOB\F(WC&K
M$=#:)^WPX%^'IS8JY[@C_!NAP.*="XCHR-;7N6H::UTPRPL*Y4$/.CS_P#N
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M2NM=['Y$Y\"6AC*_(^QV<(3VZB[W<LP_?UE*8)4<8;,T&3UA@T)K8@3%(I3
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M*Z$>&&9/4M+TA0R&''U)*;O6EZ;N!/((,PEZU_&DM8):AS2_)C+<#<VG( 1
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MY!(C1-&I,EO+>\Q/MM5L+[1]E%3HP;!_4>NCT>XTHS%4G_C9Y62Q;/V\'-V
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M--#S8B 2&\ZC^<I>C[L[,L/_LK^IL+=[F9<LHA)\0_%XC]8CN]\4MB(+'IK
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M@=#*?U2CT_!5\>SLKGM<@&G9"5_KJ^=/3UF8XG=< Q%<P'N,N'&BCV?YK_\
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MF?U!7I@OK)G<QDMV/OD*3+M8T;N4LW+1<^SY,:LW+2+LEUP@WA]/"L$9LKF
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M$_DG01&1@J"WP\K?$&R#.9KTRM(!2$(2_T:PC3$4VU6=+HG+VFBW0<S7P-&
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M.RJZI4L"5%A:]:K\H/UZJ'UNR[$SZ)8O%$>4&A>(DX'OU1RNQ:Z+DT?TL[=
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MVD8U9(U%#_00P8,&B=AJT39T'&8'80]A4!RJ43+U9GQY_,759T]D1T[52Y/
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MZR^RDIPQU%*@?/\RYCP)TCEQTSX4TYU^XW-X8_/MGWP?,O[:Q BVO6Y!@Z\
MZ@IER( HB'=X3#OYZ#(F"JBVQ)2NOSE0J6%?U<5"&P,'SS@)+&\ 5&H79#;#
M]&2WT8.1]?Q&/O_I90Q08@^VG>VMZ[B!";[CH><(\YEU]=2B-\W)HHF-MI_D
M_>F"+!2.=#!/>NB&UCT8&_9JS_F!-=,]GMF8^5R,)[O[G04M;9X!\D[>*_>
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M?^O,S@ U'\015F;)(I8W!.(JQS05/H*9PW/F]#=V]7N/N0:HW/-V/'%NY1W
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MX/"FF1U=@P$< K%Q\Q]S7096M]Q6 H\E[B$$%IE9^";O*Z/N-H9J69<V#3
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M"8-9M5[7@:DNL!SS7+-^://B+9/LVXC<Z]U.*5^;OP%.-E;?_"V[ZK"OT;4
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M'YM#'!)# TV]E,%%5;]NQ#Y-^X'>K/9T4#ZD++0PBK]@[YL'AM5?GRJK=<&
M^VGJ!/2]*+=[ )5*AC07[]_DHH*A@>8-:22\@Z#3$2.K+-/'6'M<"?,0.Q-_
MS:/.G[4'/O#K$6=YUFI[V:/Z3[@$@?&Z$62M'"-!FI3D(\)8YC&PPZ(&H:/&
M+6E3S$#?M@G;7Q]K<IM\LKBH%FGRRH.-8J5NR- H"$B42.-DV$Y@(9TU6!+;
M:H'Y@ G&BC21%Y!G-]SP32,-GT]#IT0YW@,NDX8DVRQL8\E!V/BH0M-C\_A
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M\N^.#,LCX'&VP.#5FVAJR?$WG)6S6([]\XW<7]"B(.A6Z $0]L9R4=^N6R5
MX:QCA"ZL3"/0^!KZ2^6B)(P>#N;)).B%$O]6F:JC+^SS+B+XXJT1>+]HM676
M>@JR8YV RH_X=@23_KH./W#^^["^X^H&.SB)BXHW!1J\ZE&<-68 NZZEY0EZ
M=EZ-$5K\\A'JC]4/UV-;F?XMZ.$A#AJ"I =P#IBF*YPQ6K(!ZX?G[]K>UW+
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MP-KYS9=AP2S-MC*!-E3+=PSH5N$(K:'DFK(+E*"=O\,^Z9?>:MS5B<+OCV$
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M;,.^@X !*<G'%S[$SK$4?.6H1:E3EJ^.0XC'2$#V12ZJK>1+O1HR"V0RZ(
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M2KC.RYG7-@EE[_BB<\YU7[IUC[KZG<FT$QG1#ZZM+DI(;-Z35 F]]9M0R'#
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MDE5TKYOL^>,#I8$RDX[NZJSQM^+SI/?.YL&70P.XV5D*,D?/Y%5]>G+BKV$
M)=S:\#: S<TIBHC1R#WP7VY'9B&,'E<<^(@2V#7(=>-E!"\HN."!<S^+"N<)
MV@5NI)'AZ23322&=F]-\E(F?G';Y:4W1]76/R!*"?4FXV1TM*,E)[%@CSPXP
MT5&*D8]ZX+5^SH!+;Z%=2$76Z G5:ZTM(47FNPZ23LNL6]T'</<(XN%@.=Z;
M&BWVP=[&,&(UDR2$/QTHBO=LRR_PDFHV^"HFI!+^YA]OUTVJ%@;NWO7[Y;.
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MAHV(UP!B;@)/;=YY8,PA.6ZK9V(S,%!@J BLW<S'8#%T)F)C(F>UV'P4+*K
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M^:Y=I=X[&BB$O.$N8@T2<%O+@4N"HP>BLLMJI!CO\SN+W*LSG"_,89!9&]N
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M?$D0VH#&C"U VKK1%%8:T!B..$%*[O#($H$V1YX+K1N@'!F9"*!E+F6.4XI
MX<GH9LBEJ;3$M6/G#G1YS,NC 1GO31W)<ACB9CGGX5'O8W8A5A-LUQ.G)"_V
M/@PMK*ZMF^N:^Q #"6[]"L+=B<1#K@0_ULJL&3> <***[1C/S,_I)<B.N?D
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ML(VBE[]N6UB.K;TO],76P<[ MOSPDXTG4I;TC2MZ_@U.P@P$5+M@$2MN$'$
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ME/K3X9R#;Z!;L+1O2#D#6K3F2%_X"9#/O+U_.'Y 8:Y[YWC7-%,3:-1AB16
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MR.(OMJ@^O,">\'S#\4QM]:!NKTZI]9-:Q/,/4OVAE_^.QP,28IC.![C9 >W
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M?5IIGGZ&U?Y'<3?B2QU>3)%Q\9+G+1QGG%2&97C^HT64!(LX(#7 Q:[',\6
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M:U5[X+=1,3@OE6,E(7=.5.!BS\7GI,<*?=@SV#XD8([MPTAPS, =?Q5MS5D
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M>QN]97[]#4DFE()S4OQ@=*OWM8RLA?(UOW%:)67KU7@!#!H]G@,70._]LGR
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MBR,U@7*OX3=O\Y)M>MU[)(!?-B'ARSTM?%%4<@=L/S@T!'ZQ&E"79TF-,F1
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MV)2Q_H,ICU)O V29!BB#)EI!*E5?JS/%H;$J](R+\6;AZ-C&^KD_C;T0,8A
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ME*KZ\Q3&PG%6$L$+)0!]R<4M^U'0,;(&&53"Q:$US3 4]\\EU5=%(YM>:5^
M]UYA8M)W)B^*-VR-9"0"GFOC?:VXZO.8RNEX:HY=*N61.>J.4+2"TJU .8>P
M_?2U'[H^CH*3];I:#7//^WE^HQE6 /$<P6<-U%IC2JA-+T'\1QCG%]F@V*N/
M<^KC:'RTY)67BTZCN:VERVZS#G7/5><^V6;=,K^HK'8X0NPKJ814%]R.&0N%
M^.&XWLD!SE,%(#[ULDDPL0TG;*I?W%;\TQD5KZ]U^-(VPMO->3%F1 8?2,GR
MB0S$<!W+\9[+"<*^WD8D2@-$%.&7 D%@&T%]X4##>[">;B,\,.,>=/U^?;0
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M-BRQ1P!B"8YZ/G@2#_$[P'ZP ,DYS>8PU7#4^&U$JQ;L:J/,<\;>+^CH.B"
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MH#7:S%8/ZPD<5FJD+M4\Z%!;J)N(+\_]P6EZJN*$^=FCUN@&]FN<(9@:S(H
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MV+>SO"D1BOW)216 !*EY>PF!?1.#/3.*/&ECXWJM<#HHNA*F0;LSBMOH#?Q
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MM>F6I;I7>Z?!9%QU8,1$12#E['RWV-N]G MP.3_<1D\'DQF7H4\$ZBG,A'/
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MW9(OY>,U\LE7O:.:)H25TN6SJ<(RMP\W4?_QA)2Z&I'ATUA,&$5P8>@09:Q
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M]MK)PDKX'&6F*.KV$V4?G CG$+A/>;J<0_'F*K=] CB=4EXJUHH-&S\JSAL
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M>W<(G=:KWE%NN'B9."6M^'*3NL.V3VRB?>WWU\]4?AHB6$7(%IQ@J\ *G?P
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M0_#+ 9_.^7-8#E88]I,NW#[4_R=\59A"WBFXCG;7%Y1[+V(\#*,IV_I_TE9
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MNB,+*@-LDT2Z(=M4__CIKRW*/X,M\>#V,LS.HLH=,4\2RV'B2067.R#/Y=>
M$0;ZK-K;G1ZRZ8JI!]P:?EFJD(K2! I*8ZW*IAG$DG-(":&49UIH!6Y54,].
M-;>KU8Y2L"%UL%V]!V!+#Y@7V,;VB@U#S-U;=A$,7QZT\Q--ZU6[R/"1I^WR
M&\-$Q2>E<JYWWWY9B(6B09PI%<$TY!@BJB@D&<8PSN)(QBC-(N04+7AJDMF)
MA]5J39> T4H:DSHM+?.=>X&T$P;7PC.^Y5RCT5B._D;OY WHZ+TQEO3E6ACY
M\+JH:F-O^DM1B+8<L2R_FY)V7XNEQ\Z,?4AYDA$GIYA4.O0Q^5PN]#X[T%)N
ME*LO\E%_/O<F8J\L[DKZ<+NN[XLR_[]2W#X8210NL*+2J$"0A:&"*(H1)!1+
MB%-3(C)DH<!N-2+MYIV;W&CCP,HMW>"Q)?P&T"WI@#:T.QJ\+=?!TK;M']VQ
MQ4X#[(YD\'D#[(YJ<-L/K+NIV@TF7U9IRUFG-4"[07%D:W9\?9BP^F)*\RS;
M-/"/Q6H;S;^0BHLP#(R*0QE$@C/(,).0(\[BD E%A5.V]KF)YB:.6CJU//HN
M5SUU.]W M!,Q/B :6:9TZ+0T-FF36RK]R9!+.'@2&F>GF51*7&+VN5BX^/PP
M.= .^*&HJG>:Q%-M[5])591R6S!"5F]_:/U)SY&O].WV?2T?3(%/S76MV=<S
MW;U?Z?TJJWJ1!$QR(;3ZDV0A1#)((4T(-3^Q( FYXF'J8ND=D=:YF8:[^BFL
MX<?<C+[GE?&RF-)FP\O1C+G8=J)N)DLXLK3L5N\GP^?/P.Q]L&,5['C=K.^N
M6HYLBTSOL0<V_/F3LQ,L@B=1/2:EDTK["2!_?F!,,>45BO)]L=1O5&WQZ*T1
M.! \(T10*#..3%%F??L,$GW[I$FDKZ%1B+A3X\/S4\WM_MDXS#M*_]CT2:^?
M'+N$]>#JH.M>C=84ZNT6J*YP_VU=ESE;UTTL5EV S[0)FAO#Z'X9))_*[>F)
MIM=G>QD^J<+VOS$X&.J1YJ(+D[Q=B29&LLVFV<1?)YRR4 D&DRPA$'$40AI1
M"44B,4X547'F9%ZSF'-NLJ0C&<C]<-*B"2?E73CID%0U&_3M!(UG3$>6.!LX
M-Y4,=\&Y+<4C1,$[ .0OWNGBC%/'.]E"<"+>R?I53Z53FPA\_=_7^A_SNEIP
MD44A,[%-<:8@$AF%5!(%,<ZR)*!8_SIRT7TO33@W!;9-B!6;@$$?M5.?0VPG
M:GP"-[*<.5$]M9/=)N6FHW?$ZJEGD!FK?.KSZ5ZV?NH9YB\64#WWWL"<WB:'
MQS08-4D]S?"F&3QAH2"0B)1"1+(4TAA)_5.@M22J,,=.T=TGYIC;!>;K)C7/
M7&&:3LJ.Z;LG8+03%U>",[*$Z#+PFCB!!J)OO7+5/5OW//>^$G5/S#!MCNYY
M%H_2<WL>';:]?\U71=DTRVH-*6^VG<)W*5<X#0AE*( IE1E$* L@S6@("4JI
M8B*-(^:4O6\QY]RV_X;DK>U3_V ZB#6%KO(5^$]]C]._<),)-MC;R0C/B(XL
M,\Z8D\&.ZI$Z43G Y$FXV,PXJ;!Q@."Y\'%YU4_]D-TV(#1421 S:&X76@2%
M!.*0!!#)A(H81TA%3HT?SLXT-\%C$@>ZR_?E)"9'4"WO'SZ@&OL6<J)TR"@2
MY"(8(U4/>2%I<9'=2_5#KI4,55DO?J7_IRA?KZM:;X*RNOV15PL>! GA"8)9
ME)@27B:+7]]%( TS0>,@%CRR2GTX/?S<9,"&./";H<XRO^$,<OU[_GH\1M[H
MME!8;^Q^COMVLWYS;R?KO^UV\9E!)]FZ_0QM]NN%IP8F(!B;IKG<M0;-O?SS
MKIQD&$<I3Q&'&2(A1%DH(1:(0HYPE"@9"\&14S+"A0GGMI%;$_V.X.$E-"Y"
M;7>V^P1PY)W?A]T(M3MMD?&5JG!INFG3%BR9/TIAL'UO8%5@6MW?KH3YC_'A
M?J=+4W^XR:)ZVMUJ)8I31&4*%4_UW4#(4*L*(H0)$5Q$F-,D=<IXLIIU;I*F
MR34V1KGFASVZ'>L#6R%N)VN\XSCV5>,<A#=M"N43^*W[[SA=LUW@\E5"V&K.
M:0L)N\!P5$[8Z>5KJY&9Q*UB96;XI,YTLWM>C"PA2(1!"L,X$Q!)K<$PXTPQ
M71QH'*=IDJ7#BI$YTS(W ;9?^6K'C/G;7B/'SYLHY*'UQ]R7S$[63;00(TM
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M7?6WO+[?)'"\7W4%_ VE^G^&Z$62,![C2!@A;^J=Q@K2*!502<92$A$NB%.
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MV;N#=R$$WV' *>/SW?E\%KP_8("!9<<VC0<[E]RVG_J"$$0"3!A4D< 0,19
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MC,76EC;[>>>V04W2;[[BQ4/3)-%TLFA< H8)R_(0KL!;6-C&@7-L]V%'],[
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M,DP)BU%(89R9F*0@D9#R*(%A&&5IDJ P)HE;+,#IB>9V)&WH=$[^.(ND;0C
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M28CCE HK#\?QT'-S/6RHL_>Y/H/JLF-U.  C"]\-89<K43DY34_S>X5G]-F
MD[D_3S.R[^,\\\3 (BNF:[.^TU2OBX>'8M7H2XM(A9DRK5A"+#.M=W"M@=
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M?PF0R_WH+XXP3.!]E'5;0^Q#4>UZ889!H%+"$XA)JK1LBQG$B1 PI2DWNJU
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M,V$L$ F5Z])':MQL%@NA3_)5;-YQ4R#E>C-[\SB7ZMTOR;>F9LMGI>9<KIN
MAAA+BI)(099(<Q5<2$A0D4.N4$Q3DM-46O7RN$)G:FJC8A7L> 4-LW;*XAJF
M_7HB(%(#JX@+( 7L'V2)19]RT$-T%(/^UUXI7!M]%'U@*6*K"FP?]S,C; HW
MW6_>2STB7527SGK>G@\>GC&"LTAK#9@)9HXM3&L,AG*(,GU*3/1_*7>Z&P[
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M;D>TP!-K=Z1[N>D:>%-H!>N< )NY.R@YOY^_SJ\[_2\Z1>D'R?,;!O] A\W
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M1L.6+OXYWSQ685!ZU92/\Z>'5>T.?;OZ0>?+F;9$8L95!*4V K6>B4R7CU3
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M"JV=>./<RB2)LB0I(([R7/\19Y Q44#!(J2/T7&*$R>]X<G'U-1*Z[Y?2[H
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MTW25 /H$_[/AM7*R-MPZ+777B;#2C0/".[C^K-6!81ZTW /#_EZEM@* +^-
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MH(4!O&J!^.T.[+  +1CUSE3#$;!2\HM,8Z@JS.,R/VZ%YQ>9F)/JT2_#A4<
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MJPUIH:OUHH'DSM5"Y/[I%^*ZX'*)^>VY5G8RM^%L3085-]]LH?$7\_E9F'W
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MA4'410#+1'510O-T6M+SQNOVTW['6<[CA=?);G)U^?DU?;*:%.8X,:Z!>UY
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M]])_GDV7EY.&W\P_GL75-$_#\MPY>5$*>2,DZ-7$%$EQ'$I@QM4IZ6YS:&_
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MDMX.XUPWXF!DL]@(=W=R@N-IN6.3>2T]=8Q1O/[/6YF]G20U,FR7S[_FTE\
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MQGOU:;$.LXN4HF"6U]&M.8M:'D>!AG>, \4MFI8F%A=;S^6^GY+>H'2*MN]
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MWPQ0N)BKIVUF4E,@;(3-H'C,$(@)X$6:[(45Y%D.9%?N4C-N1NJI;,R)6N@
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MEB.(3KKBQG?+Y1KSF_6"PJX/N)C.M^/R=FH@NXK+ORWJ8'+&G&1154_HZH0
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M;6</(G%8F#4 Q8-.M.?3T-#'?1_"8C6CK_HZ_>/F!4T];MK&%5N../HHC"C
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M:TG);^';M9EQDY/0)#ZFLB+K< D<%@WH+2HK8CW\;AT:GX&/@2\<CH?5H0\
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MD=#/WT]Q^T'])88E_I__\=]02P,$%     @ "T6W5AO93XM<#P  644  !D
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M%=E1%2 T)[.I4V4<7/#E*D+5H8"L%%BO"/DI/"MS*F%ZT74W;%T,?9$.$)A
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MD;_KV[N#%[*]<Z>AK%HU]061(:\N(W?!:14C?H=F69/#<_<H2&*KM)G+!/<
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M\&M92!:O7F@7'S7AA,@$P4Y-."Q3*F432!8!$H:)8&A;1O$?6<RH*)I 29A
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MD8,Z<.U\EXL[T_F_T!5U@J=/T,(%[NYC#/EO@3O.SEE2IN!)9VCH592A*LA
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M@U+^*KBFE!QWQ$70V'1K 1]J.%G9^"-,W12+MC)\#6J#TA;9]D/G.KUT=+*
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MDM%7H3]!7V"]8N=_3AEL'9V#SSRR@\45@_E&<0&LY_3I_+,IK%4U$710Z,X
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M[%(" '!E=',M,C R,S S,S$N>'-D4$L! A0#%     @ "T6W5JFO/+N3&0
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M+3(P,C,P,S,Q>&5X>#$P-S$N:'1M4$L! A0#%     @ "T6W5JQ.C7$5!0
M*B(  !@              ( !R[4% '!E=',M,C R,S S,S%X97AX,C$Q+FAT
M;5!+ 0(4 Q0    (  M%MU8DC;>MJP,  (X,   8              "  1:[
M!0!P971S+3(P,C,P,S,Q>&5X>#(S,2YH=&U02P$"% ,4    "  +1;=6P'17
MN$X(  #.*   &               @ 'WO@4 <&5T<RTR,#(S,#,S,7AE>'@S
M,3$N:'1M4$L! A0#%     @ "T6W5EN%KQ@_"   V2@  !@
M ( !>\<% '!E=',M,C R,S S,S%X97AX,S$R+FAT;5!+ 0(4 Q0    (  M%
MMU;3A$;(WP0  "@8   8              "  ?#/!0!P971S+3(P,C,P,S,Q
M>&5X>#,R,2YH=&U02P$"% ,4    "  +1;=68P0C'4(2   E;@  %P
M        @ $%U04 <&5T<RTR,#(S,#,S,7AE>'@T,BYH=&U02P4&      X
,#@"V P  ?.<%

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
